data_2a2y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2a2y _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.2 t30 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.176 0.512 . . . . 1.8500000000000001 111.137 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -91.47 124.98 36.05 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.456 -0.942 . . . . 1.4399999999999999 108.456 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 35' ' ' ILE . 10.4 mt -137.12 154.4 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 119.918 -0.713 . . . . 1.8300000000000001 111.205 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.56 138.63 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.723 -0.843 . . . . 2.0099999999999998 108.723 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 p -91.06 163.5 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.942 -1.099 . . . . 1.24 108.683 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -129.67 163.65 25.63 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.836 0.827 . . . . 2.8500000000000001 109.986 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 -17.49 21.78 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.174 -1.047 . . . . 2.3399999999999999 108.174 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -73.42 -44.56 58.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.374 -0.973 . . . . 1.6699999999999999 108.374 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 146.51 39.08 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.236 -0.915 . . . . 1.8600000000000001 109.294 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -69.0 -179.44 1.5 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.099 -1.001 . . . . 1.97 108.632 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 17' ' ' GLU . 27.2 m -78.62 -50.2 19.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.872 -1.142 . . . . 1.29 109.458 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 4.1 pt-20 -57.88 -19.69 31.26 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.076 -1.015 . . . . 1.5600000000000001 110.529 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.61 -30.37 69.09 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.379 -1.451 . . . . 1.3799999999999999 108.239 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -23.57 22.28 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.845 -0.742 . . . . 2.3500000000000001 109.015 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.41 -27.8 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 106.532 -1.655 . . . . 1.1299999999999999 106.532 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.37 -48.94 20.65 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.117 -1.068 . . . . 1.1799999999999999 108.117 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -66.73 -22.01 66.06 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.537 -0.727 . . . . 1.22 109.597 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 t -78.79 -54.41 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.154 -0.966 . . . . 1.1399999999999999 109.783 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.1 tt -55.6 -28.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.147 -0.97 . . . . 1.3 108.924 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.67 -43.97 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.231 -1.026 . . . . 1.1499999999999999 108.231 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 28' ' ' ASN . 44.8 mt -63.8 -39.73 94.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.53 -0.731 . . . . 1.8700000000000001 109.692 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 3.2 t80 -69.77 -0.93 7.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 2.3599999999999999 108.786 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -90.72 -26.69 19.41 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.981 -1.118 . . . . 1.71 107.981 177.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -86.82 3.96 43.14 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.519 -0.738 . . . . 1.8799999999999999 109.648 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.64 6.84 34.95 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.171 -1.172 . . . . 0.47999999999999998 110.171 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -75.7 95.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -1.234 . . . . 1.0900000000000001 109.407 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -87.37 -33.95 18.97 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.232 -0.918 . . . . 1.55 108.82 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -99.5 147.71 25.02 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.366 0.603 . . . . 1.5800000000000001 109.807 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.15 149.07 10.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 119.163 -1.015 . . . . 1.28 109.488 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.1 mt -129.7 117.24 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.494 0.664 . . . . 1.0900000000000001 110.732 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mp -100.68 127.17 47.18 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.893 -0.781 . . . . 1.0800000000000001 108.893 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -115.3 139.93 49.55 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.015 -1.106 . . . . 3.21 108.015 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.81 163.96 28.83 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 119.379 -1.391 . . . . 0.28000000000000003 110.444 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 41' ' ' ARG . 36.4 p -137.46 148.1 45.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.503 -0.998 . . . . 1.1399999999999999 110.914 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 36.94 -85.65 0.01 OUTLIER Glycine 0 N--CA 1.5 2.947 0 O-C-N 122.0 -0.438 . . . . 0.34999999999999998 112.179 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -87.14 -42.87 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -1.174 . . . . 3.6000000000000001 110.34 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.58 -22.34 66.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.66 -1.275 . . . . 1.0900000000000001 109.511 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 44' ' ' SER . 8.3 tt -48.23 -54.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 1.6599999999999999 109.978 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.497 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.61 -26.57 65.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.906 -1.121 . . . . 1.51 110.903 -178.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -41.27 95.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.638 -1.289 . . . . 2.4399999999999999 109.066 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.83 -38.73 82.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 1.1000000000000001 109.245 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.75 -66.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.654 -0.654 . . . . 1.01 110.643 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 52' ' ' SER . 0.4 OUTLIER -44.52 -53.54 6.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.797 -0.564 . . . . 1.26 109.804 -178.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.0 t -46.15 -55.19 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.555 -0.715 . . . . 1.78 109.494 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -64.66 -44.68 89.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.395 -0.816 . . . . 2.1600000000000001 110.037 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.518 ' CG ' ' H ' ' B' ' 70' ' ' SER . 4.6 t30 -58.46 -48.33 81.08 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.094 -1.004 . . . . 1.8500000000000001 108.467 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 2.1 p -67.46 -29.18 68.57 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.942 -0.762 . . . . 1.1799999999999999 108.942 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.79 -25.39 44.29 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.385 -0.969 . . . . 1.1499999999999999 108.385 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -76.28 -46.32 28.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.007 -1.849 . . . . 1.6599999999999999 106.007 177.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 16.6 t0 -57.63 -6.96 0.56 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.827 -1.079 . . . . 1.5800000000000001 108.351 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' A' ' 54' ' ' LYS . 3.1 tpt85 -76.35 -46.53 27.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.727 -0.608 . . . . 1.99 110.148 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' ASP . 6.1 tp -152.42 -29.03 0.16 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.41 -0.916 . . . . 2.48 110.292 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.71 -49.32 0.64 Allowed Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.022 -1.561 . . . . 0.41999999999999998 109.229 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER -74.68 -49.79 20.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -1.223 . . . . 1.3799999999999999 109.055 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.97 23.36 1.36 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.79 -1.724 . . . . 0.29999999999999999 108.79 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.531 ' H ' ' C ' ' A' ' 59' ' ' ASP . 24.1 t -149.86 139.51 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 121.505 -0.997 . . . . 1.22 108.511 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.5 mm-40 -143.27 142.36 31.33 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.229 1.014 . . . . 2.0699999999999998 110.864 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 tt -93.84 94.26 8.41 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.471 -0.786 . . . . 1.3100000000000001 109.114 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.427 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -79.33 -35.37 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.904 -1.122 . . . . 2.0299999999999998 110.126 -179.138 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 64' ' ' VAL . 15.2 m-80 -165.99 157.63 13.94 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.139 -1.425 . . . . 1.76 112.155 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.1 t -158.16 145.37 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.397 -1.335 . . . . 1.49 107.397 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -148.11 165.23 31.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.754 -1.216 . . . . 2.02 108.896 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.36 129.64 15.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 1.1000000000000001 111.007 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -152.38 171.52 31.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.964 -1.655 . . . . 0.51000000000000001 108.964 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.523 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 9.9 p -112.08 156.45 22.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.693 0.759 . . . . 0.82999999999999996 110.366 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.29 175.84 13.03 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.511 -0.743 . . . . 1.29 109.552 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.4 t -87.99 132.78 32.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.388 -0.82 . . . . 1.54 110.651 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 34.4 ttt-85 -143.85 99.97 3.5 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.487 -0.931 . . . . 2.96 108.487 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.2 t70 85.69 40.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.205 0.526 . . . . 1.3799999999999999 109.643 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 60.32 37.68 20.11 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.379 1.085 . . . . 3.4300000000000002 108.897 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -155.51 149.0 25.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.111 -0.993 . . . . 3.9100000000000001 108.765 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -83.02 140.88 32.46 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.223 -0.991 . . . . 2.9900000000000002 109.626 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.3 tt -144.31 156.95 15.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.176 -0.676 . . . . 1.0700000000000001 109.176 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.415 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -87.9 152.79 21.81 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.394 -0.816 . . . . 1.03 109.4 -178.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 9.8 p90 -146.82 151.87 37.82 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.063 -1.023 . . . . 4.2599999999999998 110.348 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.75 137.53 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-N 115.667 -0.697 . . . . 1.5800000000000001 111.488 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.5 mt -110.23 104.71 13.57 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.076 -2.194 . . . . 1.05 105.076 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.436 ' CD1' ' HG1' ' B' ' 68' ' ' THR . 1.4 tp -106.82 120.47 42.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.878 -0.514 . . . . 1.6699999999999999 110.081 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -103.69 168.23 9.28 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.907 -0.775 . . . . 0.65000000000000002 108.907 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tp -160.57 160.11 31.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.951 -1.099 . . . . 2.02 109.999 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -142.15 145.26 34.01 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.52 -0.548 . . . . 2.02 109.52 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -105.08 136.62 44.24 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.55 -0.719 . . . . 2.2999999999999998 109.373 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 t -107.63 -7.55 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.878 -1.156 . . . . 1.3899999999999999 107.878 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 117.977 -1.011 . . . . 2.6200000000000001 109.437 179.591 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 49.5 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.421 0.629 . . . . 1.72 111.387 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.1 pt-20 -93.1 121.88 34.9 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.38 -0.97 . . . . 1.49 108.38 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 40.1 mt -134.63 150.91 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.735 -0.603 . . . . 1.8 110.009 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.9 138.91 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.878 . . . . 2.02 108.909 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 p -90.26 160.1 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.967 -1.083 . . . . 1.1699999999999999 108.499 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 12.1 mtt-85 -130.74 167.7 18.41 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.874 0.845 . . . . 2.9399999999999999 110.505 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.25 -4.65 21.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.507 -0.923 . . . . 2.2999999999999998 108.507 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 2.8 t -83.49 -29.05 28.27 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.647 -0.821 . . . . 1.76 110.447 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.411 ' O ' ' OD1' ' B' ' 15' ' ' ASN . 7.5 mttm -83.8 -113.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.78 -1.2 . . . . 1.8999999999999999 109.415 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' B' ' 14' ' ' LYS . 2.6 m120 -166.18 173.63 10.02 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.393 -1.336 . . . . 1.96 107.393 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 22.1 m -70.9 -51.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.606 -1.309 . . . . 1.29 109.112 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 6.0 pt-20 -63.11 -24.94 68.13 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.147 -0.97 . . . . 1.7 110.106 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.42 -38.42 91.08 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.39 -1.444 . . . . 1.46 108.359 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.76 -22.3 31.94 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.894 -0.722 . . . . 2.3100000000000001 109.841 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.08 -31.05 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.074 -1.454 . . . . 1.2 107.074 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 37.4 mt -70.63 -48.64 53.98 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.264 -1.013 . . . . 1.1899999999999999 108.264 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -65.62 -26.04 67.65 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.477 -0.764 . . . . 1.21 109.906 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.57 -54.14 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.11 -0.994 . . . . 1.1299999999999999 110.026 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 5.5 tt -55.15 -28.54 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 1.3999999999999999 109.246 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 t -73.38 -43.32 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.198 -0.939 . . . . 1.27 108.631 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mt -62.37 -45.97 90.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.45 -0.781 . . . . 1.8300000000000001 109.524 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' B' ' 30' ' ' GLY . 3.0 t80 -53.92 -48.0 70.63 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.746 -1.205 . . . . 2.3500000000000001 107.746 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -31.01 2.16 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.208 -0.597 . . . . 1.6799999999999999 109.577 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -84.77 5.43 28.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.952 -1.093 . . . . 1.9399999999999999 110.031 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 27' ' ' PHE . . . 100.25 6.08 53.85 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.924 -1.27 . . . . 0.42999999999999999 109.924 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 43.5 mm -76.17 88.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.067 -1.255 . . . . 1.3400000000000001 108.588 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -83.49 -39.08 20.95 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.21 -0.931 . . . . 1.46 109.152 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -93.58 142.11 27.71 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.643 -0.661 . . . . 1.2 109.592 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 p -155.57 151.03 10.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.546 -0.862 . . . . 1.27 109.683 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.56 112.81 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.439 0.638 . . . . 1.1599999999999999 110.055 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -95.53 133.05 39.98 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.542 -0.724 . . . . 1.22 109.187 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.99 140.03 52.96 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.463 -0.94 . . . . 3.2200000000000002 108.463 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.99 164.19 28.59 Favored Glycine 0 N--CA 1.502 3.089 0 C-N-CA 119.498 -1.334 . . . . 0.28000000000000003 110.232 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.548 ' O ' ' N ' ' B' ' 41' ' ' ARG . 76.9 p -135.87 146.37 47.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.701 -0.882 . . . . 1.1100000000000001 110.763 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 36.27 -84.02 0.0 OUTLIER Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.847 -0.533 . . . . 0.28999999999999998 112.615 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.0 OUTLIER -84.5 -45.31 12.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -1.187 . . . . 3.6699999999999999 110.443 -178.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.76 -23.92 66.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.727 -1.233 . . . . 1.3799999999999999 109.045 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 7.9 tt -53.85 -20.71 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 1.54 109.036 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.11 -34.58 13.59 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.279 0.562 . . . . 1.5600000000000001 110.196 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -25.38 66.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 2.4399999999999999 110.212 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.26 -45.74 54.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.962 -1.086 . . . . 1.02 109.975 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.88 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 1.1399999999999999 109.68 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' B' ' 52' ' ' SER . 2.7 t70 -57.43 -56.37 22.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 1.25 109.474 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 10.3 t -43.89 -49.48 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.672 -0.643 . . . . 1.77 110.006 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.446 ' C ' ' CD1' ' B' ' 50' ' ' TYR . 1.1 t80 -68.33 -53.18 25.92 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.426 -0.797 . . . . 2.1800000000000002 110.295 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . 0.523 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 1.2 t30 -50.3 -45.88 54.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.032 -1.042 . . . . 1.75 108.527 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.6 OUTLIER -68.67 -37.15 79.39 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.559 -0.857 . . . . 1.0600000000000001 109.171 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 tp -65.89 -26.84 67.8 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.378 -0.826 . . . . 1.22 108.817 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -75.25 -38.69 60.43 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.664 -1.236 . . . . 1.8300000000000001 107.664 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.26 -7.78 0.41 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.036 -0.727 . . . . 1.46 109.036 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' B' ' 54' ' ' LYS . 21.1 mmm180 -82.66 -39.41 22.1 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.548 -0.72 . . . . 1.99 110.727 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.14 -35.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 117.928 -1.509 . . . . 2.5699999999999998 112.595 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.78 -55.03 2.57 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 118.548 -1.786 . . . . 0.39000000000000001 108.919 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' B' ' 61' ' ' VAL . 0.4 OUTLIER -72.16 -48.68 41.62 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.149 -1.206 . . . . 1.3999999999999999 108.575 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.79 25.11 1.81 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 108.969 -1.652 . . . . 0.37 108.969 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.487 ' H ' ' C ' ' B' ' 59' ' ' ASP . 13.0 t -153.07 140.2 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.392 -1.064 . . . . 1.1799999999999999 108.72 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.5 mm-40 -143.87 141.9 30.54 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.297 1.046 . . . . 2.1200000000000001 111.669 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.34 94.33 9.08 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.421 -0.809 . . . . 1.3799999999999999 109.346 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.429 ' O ' ' ND2' ' B' ' 65' ' ' ASN . 0.0 OUTLIER -74.53 -39.55 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.945 -1.097 . . . . 2.0 110.53 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' B' ' 64' ' ' VAL . 21.4 m-80 -164.46 164.69 21.88 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.336 -1.346 . . . . 1.8600000000000001 111.831 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 59.2 t -161.07 143.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.718 -1.216 . . . . 1.5700000000000001 107.718 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -147.76 165.13 31.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.899 -1.125 . . . . 2.04 108.645 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' THR . . . . . 0.436 ' HG1' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -148.78 129.48 14.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.088 -1.007 . . . . 0.92000000000000004 110.232 -178.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.551 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -149.29 169.58 29.61 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.061 -1.216 . . . . 0.34999999999999998 110.061 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.518 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 23.9 p -104.32 151.21 23.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 122.038 -0.684 . . . . 0.84999999999999998 109.986 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.65 172.01 16.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 1.49 110.224 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 67.9 t -87.58 133.95 29.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.474 -0.766 . . . . 1.46 110.692 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 17.7 ttt-85 -146.36 101.39 3.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.544 -0.722 . . . . 2.8799999999999999 109.301 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 1.6 t70 82.2 41.84 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.319 0.58 . . . . 1.3500000000000001 109.509 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 60.48 32.29 20.49 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.121 0.962 . . . . 3.3700000000000001 109.212 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -151.9 154.96 37.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.563 -0.903 . . . . 3.8999999999999999 108.563 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -87.37 142.17 28.08 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.389 -0.924 . . . . 2.9700000000000002 110.644 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 tt -142.56 157.33 18.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.404 -0.962 . . . . 1.3700000000000001 108.404 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.15 149.51 24.6 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.797 -0.816 . . . . 1.04 108.797 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.551 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 9.1 p90 -144.49 149.89 36.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.38 -0.825 . . . . 4.29 109.899 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 tt -122.08 138.95 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 115.899 -0.591 . . . . 1.55 111.766 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 21.0 mt -108.99 106.99 17.18 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.518 -2.03 . . . . 1.1599999999999999 105.518 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.5 119.48 39.52 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 118.343 0.519 . . . . 1.55 110.566 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -102.81 164.84 11.39 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.912 -0.773 . . . . 0.70999999999999996 108.912 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 tp -160.4 152.19 19.94 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.607 -0.837 . . . . 2.1200000000000001 109.708 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -136.86 136.07 38.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.452 -0.573 . . . . 2.0 109.452 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -95.18 137.17 34.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.48 -0.762 . . . . 2.2999999999999998 109.313 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 40.0 t -108.92 -6.85 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 1.46 108.21 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.964 -1.017 . . . . 2.6299999999999999 109.513 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.978 0.418 . . . . 1.8500000000000001 111.033 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 7.0 pt-20 -91.67 117.03 29.37 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.604 -1.258 . . . . 1.4399999999999999 107.604 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 35' ' ' ILE . 12.6 mt -122.43 147.98 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-O 121.889 0.852 . . . . 1.8300000000000001 112.062 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -111.78 128.17 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.65 0.738 . . . . 2.0099999999999998 109.796 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -88.4 164.9 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.398 -0.964 . . . . 1.24 108.398 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -138.0 174.9 10.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.439 -0.788 . . . . 2.8500000000000001 109.827 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -8.38 15.09 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.208 -1.034 . . . . 2.3399999999999999 108.208 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.44 -12.34 37.72 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.35 -1.352 . . . . 1.6699999999999999 107.35 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' CB ' ' HE2' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -90.44 -130.41 0.09 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.996 -1.483 . . . . 1.8600000000000001 106.996 178.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.79 155.21 21.12 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.803 -1.186 . . . . 1.97 108.925 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.5 m -62.7 -37.24 78.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 122.121 0.962 . . . . 1.29 108.859 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.86 -31.61 59.37 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.22 -0.925 . . . . 1.5600000000000001 108.523 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.33 -32.04 73.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.614 -1.304 . . . . 1.3799999999999999 111.452 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.47 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 85.2 m-70 -90.37 -18.63 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 119.806 -1.809 . . . . 2.3500000000000001 108.74 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.09 -32.15 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 105.147 -2.168 . . . . 1.1299999999999999 105.147 176.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.2 mt -69.53 -53.01 21.12 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.729 -1.123 . . . . 1.1799999999999999 109.294 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -65.86 -28.81 69.24 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.98 -1.075 . . . . 1.22 109.546 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 23.2 t -68.72 -54.42 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.421 -0.799 . . . . 1.1399999999999999 109.01 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 tt -63.5 -17.05 19.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.181 -0.949 . . . . 1.3 108.978 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -76.95 -46.7 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.064 -1.023 . . . . 1.1499999999999999 109.408 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.22 -33.13 75.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.614 -1.304 . . . . 1.8700000000000001 110.273 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 4.2 t80 -64.33 -24.73 67.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.79 -1.559 . . . . 2.3599999999999999 106.79 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -27.29 69.18 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.096 -0.956 . . . . 1.71 109.398 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -89.89 -4.69 57.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.901 -1.124 . . . . 1.8799999999999999 109.254 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.74 12.22 15.1 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.368 -1.093 . . . . 0.47999999999999998 110.368 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 31' ' ' ILE . 46.4 mm -75.16 106.46 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.038 -1.272 . . . . 1.0900000000000001 108.475 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.57 -36.91 15.06 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.339 -0.851 . . . . 1.55 110.306 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.95 143.32 31.24 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.827 0.822 . . . . 1.5800000000000001 110.456 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.67 141.46 14.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 119.555 -0.858 . . . . 1.28 109.942 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -120.81 126.37 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 115.887 -0.597 . . . . 1.0900000000000001 110.321 -178.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.81 125.13 51.63 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 120.2 -0.6 . . . . 1.0800000000000001 109.753 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -108.42 131.59 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.752 -1.203 . . . . 3.21 107.752 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.69 152.75 21.79 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 119.893 -1.146 . . . . 0.28000000000000003 110.717 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.595 ' O ' ' N ' ' A' ' 41' ' ' ARG . 18.0 p -132.3 139.61 48.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.842 -0.799 . . . . 1.1399999999999999 112.243 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 39.51 -85.08 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 N-CA-C 111.406 -0.677 . . . . 0.34999999999999998 111.406 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -82.09 -54.2 5.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.256 -1.143 . . . . 3.6000000000000001 109.913 -178.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -19.34 48.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.785 -1.197 . . . . 1.0900000000000001 108.564 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.9 tt -53.97 -30.91 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.388 -0.82 . . . . 1.6599999999999999 110.673 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.6 -22.53 27.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.563 -1.336 . . . . 1.51 108.54 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' VAL . 24.3 mmtp -63.33 -69.24 0.28 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.078 -1.823 . . . . 2.4399999999999999 106.078 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -29.22 -38.18 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.784 0.802 . . . . 1.1000000000000001 109.959 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' LYS . 65.8 t -73.64 -74.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.696 -0.627 . . . . 1.01 110.578 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -39.8 -56.55 1.73 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.412 0.625 . . . . 1.26 110.838 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.51 ' CG2' ' H ' ' A' ' 50' ' ' TYR . 31.2 m -47.19 -54.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.465 -0.772 . . . . 1.78 109.035 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER -58.34 -52.64 64.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 4.2999999999999998 109.634 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.648 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 2.5 t30 -53.21 -52.74 57.9 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.605 -1.257 . . . . 1.8500000000000001 107.605 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.5 p -59.44 -33.29 71.09 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.242 -1.022 . . . . 1.1799999999999999 108.242 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 tp -78.98 -25.13 43.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.111 -0.993 . . . . 1.1499999999999999 108.9 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -79.02 -45.19 20.69 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.216 -2.142 . . . . 1.6599999999999999 105.216 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.53 -7.9 0.47 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.817 -1.179 . . . . 1.5800000000000001 107.817 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.535 ' H ' ' C ' ' A' ' 54' ' ' LYS . 6.9 tpt180 -72.03 -48.74 42.39 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.589 0.709 . . . . 1.99 109.834 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.0 tp -153.73 -24.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.203 -0.999 . . . . 2.48 110.994 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.37 -48.94 0.07 OUTLIER Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.77 -1.205 . . . . 0.41999999999999998 110.181 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -72.3 -41.9 66.08 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.395 -1.062 . . . . 1.3799999999999999 109.548 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.65 28.96 8.34 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 108.844 -1.703 . . . . 0.29999999999999999 108.844 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.2 t -154.58 130.21 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.541 -1.281 . . . . 1.22 107.541 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 86' ' ' LYS . 1.7 mm100 -136.98 158.44 44.46 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.349 1.071 . . . . 2.0699999999999998 111.926 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.4 tt -94.73 114.6 26.54 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.495 -0.928 . . . . 1.3100000000000001 108.495 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -22.11 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.166 -0.959 . . . . 2.0299999999999998 109.712 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -173.57 157.02 3.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.549 -1.344 . . . . 1.76 109.835 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -159.78 130.94 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.703 -0.851 . . . . 1.49 108.703 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -142.0 157.63 44.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.131 0.967 . . . . 2.02 110.16 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -132.6 147.37 52.34 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.293 -1.002 . . . . 1.1000000000000001 108.293 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.631 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -175.27 154.34 17.73 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.414 -2.675 . . . . 0.51000000000000001 106.414 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.631 ' HG ' ' ND2' ' B' ' 51' ' ' ASN . 52.7 p -103.78 169.21 8.65 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 119.085 1.442 . . . . 0.82999999999999996 110.128 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.24 164.88 34.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 1.29 109.525 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.75 91.65 3.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.638 -0.825 . . . . 1.54 109.874 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 47.0 ttt-85 -95.02 112.06 23.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.991 -1.068 . . . . 2.96 110.048 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.1 t70 77.73 39.75 0.17 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.454 -0.573 . . . . 1.3799999999999999 109.454 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.417 ' CG ' HH11 ' A' ' 75' ' ' ARG . 0.0 OUTLIER 60.86 29.43 19.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.462 -0.774 . . . . 3.4300000000000002 108.954 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.66 144.99 30.74 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.026 -1.047 . . . . 3.9100000000000001 108.671 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -84.35 126.54 33.31 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.94 1.353 . . . . 2.9900000000000002 111.428 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 tt -136.4 147.53 27.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 106.943 -1.503 . . . . 1.0700000000000001 106.943 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.71 159.59 17.73 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.077 -1.014 . . . . 1.03 110.938 -176.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.631 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 6.4 p90 -145.91 153.32 40.71 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.869 0.842 . . . . 4.2599999999999998 110.608 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.4 tt -125.14 132.63 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.623 0.725 . . . . 1.5800000000000001 109.822 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.39 121.63 44.97 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.092 -1.448 . . . . 1.05 107.092 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.65 123.86 34.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.206 -0.934 . . . . 1.6699999999999999 111.072 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -97.7 169.68 9.52 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.437 0.637 . . . . 0.65000000000000002 110.11 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mt -159.68 140.04 11.99 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.362 -0.935 . . . . 2.02 110.349 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 62' ' ' GLN . 2.2 tmtp? -122.9 145.64 48.28 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.941 -0.475 . . . . 2.02 109.92 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.548 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 14.7 mmt85 -103.85 138.66 40.12 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.186 -0.946 . . . . 2.2999999999999998 109.863 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.78 -6.84 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.718 -0.845 . . . . 1.3899999999999999 108.718 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 CA-C-O 118.058 -0.972 . . . . 2.6200000000000001 109.573 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 121.264 0.554 . . . . 1.72 110.451 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.8 pt-20 -93.62 120.96 34.54 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.144 -0.973 . . . . 1.49 108.944 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 mt -123.58 146.0 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.971 0.891 . . . . 1.8 111.217 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 p -105.45 129.38 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.147 -0.686 . . . . 2.02 109.147 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -89.45 166.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.526 -0.87 . . . . 1.1699999999999999 108.749 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -141.18 175.78 9.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.431 -0.793 . . . . 2.9399999999999999 109.996 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.433 ' C ' ' CD ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -112.96 -4.82 13.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.074 -1.084 . . . . 2.2999999999999998 108.074 179.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -18.06 34.24 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.718 -0.845 . . . . 1.76 108.718 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -92.97 -115.91 0.09 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.443 -0.947 . . . . 1.8999999999999999 108.443 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.21 166.06 12.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.389 -0.82 . . . . 1.96 108.967 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.88 -35.12 73.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.043 0.925 . . . . 1.29 108.823 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 16.0 pt-20 -73.59 -37.97 65.28 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.03 -1.044 . . . . 1.7 108.8 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . 0.41 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 0.3 OUTLIER -54.41 -36.66 64.22 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.653 -1.28 . . . . 1.46 111.772 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.477 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 90.3 m-70 -91.39 -18.64 23.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.271 -1.518 . . . . 2.3100000000000001 109.105 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -36.61 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 105.158 -2.164 . . . . 1.2 105.158 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.15 -52.16 44.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.377 -0.829 . . . . 1.1899999999999999 108.983 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.89 -28.39 68.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -0.969 . . . . 1.21 109.844 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 18.4 t -69.4 -53.55 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 1.1299999999999999 108.951 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 tt -64.14 -18.92 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.197 -0.939 . . . . 1.3999999999999999 109.116 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 63.4 t -75.58 -46.68 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 1.27 109.244 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.33 -33.45 76.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.796 -1.19 . . . . 1.8300000000000001 110.073 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 0.517 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 4.9 t80 -64.92 -28.23 69.39 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.926 -1.509 . . . . 2.3500000000000001 106.926 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -29.24 68.38 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.321 -0.854 . . . . 1.6799999999999999 109.116 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -88.19 -0.59 57.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 1.9399999999999999 109.466 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.07 12.14 26.34 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.588 -1.005 . . . . 0.42999999999999999 110.588 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 33.6 mm -75.18 107.35 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.951 -1.323 . . . . 1.3400000000000001 107.863 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -91.48 -41.33 10.9 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.317 -0.865 . . . . 1.46 110.518 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -97.17 143.72 27.7 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.569 0.7 . . . . 1.2 110.217 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -153.16 136.94 8.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 119.006 -1.078 . . . . 1.27 111.111 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.4 128.58 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 115.958 -0.565 . . . . 1.1599999999999999 110.048 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.42 124.66 52.15 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.555 -0.716 . . . . 1.22 110.114 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -107.74 130.57 54.94 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.775 -0.578 . . . . 3.2200000000000002 109.449 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.12 153.51 23.4 Favored Glycine 0 N--CA 1.502 3.06 0 C-N-CA 119.502 -1.333 . . . . 0.28000000000000003 111.02 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.657 ' O ' ' N ' ' B' ' 41' ' ' ARG . 62.2 p -133.93 141.42 47.31 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.964 -0.727 . . . . 1.1100000000000001 112.558 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 34.98 -78.98 0.0 OUTLIER Glycine 0 N--CA 1.504 3.191 0 N-CA-C 111.873 -0.491 . . . . 0.28999999999999998 111.873 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.657 ' N ' ' O ' ' B' ' 39' ' ' THR . 1.4 mtp85 -83.3 -55.92 4.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.002 -1.293 . . . . 3.6699999999999999 109.374 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -16.41 59.96 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.995 -1.066 . . . . 1.3799999999999999 109.841 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 tt -59.69 -25.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.165 -0.959 . . . . 1.54 109.664 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.08 -25.86 27.3 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.89 -1.152 . . . . 1.5600000000000001 107.89 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 47' ' ' VAL . 24.3 mmtp -63.32 -71.33 0.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.597 -1.631 . . . . 2.4399999999999999 106.597 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -24.53 -43.29 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.375 0.607 . . . . 1.02 111.271 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' B' ' 45' ' ' LYS . 94.5 t -77.54 -60.32 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.168 -0.958 . . . . 1.1399999999999999 110.361 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ASP . . . . . 0.427 ' O ' ' OG ' ' B' ' 52' ' ' SER . 1.9 t0 -46.37 -62.63 1.27 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.046 -1.034 . . . . 1.25 109.456 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' B' ' 50' ' ' TYR . 33.3 m -42.84 -51.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.824 -0.806 . . . . 1.77 108.824 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' B' ' 51' ' ' ASN . 0.1 OUTLIER -62.31 -50.53 71.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 4.3499999999999996 109.744 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . 0.631 ' ND2' ' HG ' ' A' ' 70' ' ' SER . 1.3 t30 -54.57 -54.53 40.03 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.729 -1.188 . . . . 1.75 107.896 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.1 OUTLIER -59.01 -37.81 77.78 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.57 -0.852 . . . . 1.0600000000000001 108.832 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.1 tp -67.1 -23.48 65.84 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.128 -0.982 . . . . 1.22 108.379 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -39.38 50.12 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.769 -1.197 . . . . 1.8300000000000001 107.769 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.94 -12.72 2.15 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.384 -0.826 . . . . 1.46 109.227 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -73.58 -43.48 59.66 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.035 -1.066 . . . . 1.99 109.39 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.9 tp -154.61 -23.59 0.12 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.368 -1.333 . . . . 2.5699999999999998 112.209 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 65.15 -58.78 0.09 OUTLIER Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.224 -1.465 . . . . 0.39000000000000001 109.551 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.95 -42.59 73.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -1.1 . . . . 1.3999999999999999 109.773 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.42 25.42 5.66 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.896 -1.682 . . . . 0.37 108.896 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' B' ' 58' ' ' GLY . 73.5 t -154.65 131.65 2.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.318 -1.364 . . . . 1.1799999999999999 107.318 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.1 mm100 -135.28 153.07 52.02 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.148 0.975 . . . . 2.1200000000000001 112.273 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 7.4 tt -94.0 113.17 25.11 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.783 -1.191 . . . . 1.3799999999999999 107.783 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -16.43 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.205 -0.935 . . . . 2.0 110.302 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.415 ' O ' ' CG2' ' B' ' 66' ' ' VAL . 0.9 OUTLIER -176.35 156.69 1.62 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.642 -1.286 . . . . 1.8600000000000001 110.209 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' B' ' 65' ' ' ASN . 54.1 t -160.42 131.87 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.936 -0.764 . . . . 1.5700000000000001 108.936 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -142.48 160.23 40.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.947 0.879 . . . . 2.04 110.14 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.26 152.24 50.52 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.249 -1.019 . . . . 0.92000000000000004 108.249 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.638 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -175.03 154.16 17.52 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.391 -2.284 . . . . 0.34999999999999998 107.391 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.528 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 25.2 p -98.61 161.97 13.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.161 -1.199 . . . . 0.84999999999999998 109.343 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -146.05 159.19 43.61 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.035 -1.04 . . . . 1.49 109.95 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.38 90.6 3.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.325 -0.95 . . . . 1.46 109.55 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 53.8 ttt-85 -97.02 112.03 23.98 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.107 -0.996 . . . . 2.8799999999999999 109.846 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.2 t70 78.21 39.13 0.16 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.152 -0.685 . . . . 1.3500000000000001 109.152 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.27 26.79 16.05 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.288 -0.634 . . . . 3.3700000000000001 109.288 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -146.04 148.39 32.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.048 -1.032 . . . . 3.8999999999999999 108.509 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -87.02 134.62 33.47 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.913 1.339 . . . . 2.9700000000000002 112.508 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -137.76 150.18 25.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.291 -1.322 . . . . 1.3700000000000001 107.542 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.25 148.99 24.88 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.165 -0.96 . . . . 1.04 109.531 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.638 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.5 p90 -140.38 149.64 42.93 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.654 0.74 . . . . 4.29 110.598 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 tt -124.62 130.82 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 122.094 0.949 . . . . 1.55 110.463 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 12.0 mt -104.2 119.06 38.13 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.288 -1.745 . . . . 1.1599999999999999 106.288 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 tt -127.98 121.67 30.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 1.55 110.824 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -96.5 168.69 10.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.664 0.745 . . . . 0.70999999999999996 110.222 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mt -159.78 136.78 9.41 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.891 -0.723 . . . . 2.1200000000000001 110.06 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' B' ' 62' ' ' GLN . 2.0 tmtp? -121.86 146.75 46.79 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.233 -0.655 . . . . 2.0 109.233 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . 0.517 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 15.5 mmt85 -102.15 141.8 34.42 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.277 -0.89 . . . . 2.2999999999999998 110.465 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.23 -12.33 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.881 -0.785 . . . . 1.46 108.881 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 118.028 -0.987 . . . . 2.6299999999999999 109.558 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.3 t30 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.436 0.636 . . . . 1.8500000000000001 110.441 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 6.8 pt-20 -93.03 117.6 30.24 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.271 -0.893 . . . . 1.4399999999999999 108.769 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 35' ' ' ILE . 20.6 mt -119.04 142.29 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-O 121.709 0.766 . . . . 1.8300000000000001 111.598 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.8 t -109.02 128.74 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.765 0.793 . . . . 2.0099999999999998 110.282 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 p -89.25 164.11 2.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.612 -0.885 . . . . 1.24 108.612 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.76 173.57 11.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.559 -0.713 . . . . 2.8500000000000001 109.758 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 pttt -92.85 -9.06 41.68 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.878 -0.786 . . . . 2.3399999999999999 108.878 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -91.28 -0.27 57.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.204 -1.035 . . . . 1.6699999999999999 108.204 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.527 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -118.28 134.14 55.29 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.462 -1.31 . . . . 1.8600000000000001 107.462 178.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -69.87 175.69 4.18 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.845 -1.159 . . . . 1.97 109.773 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.57 -31.86 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.355 -0.98 . . . . 1.29 108.355 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -74.75 -31.12 61.7 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.585 -0.846 . . . . 1.5600000000000001 108.95 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -33.88 70.01 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.644 -1.285 . . . . 1.3799999999999999 111.319 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.506 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 1.1 m80 -95.74 -19.34 19.74 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.448 -1.407 . . . . 2.3500000000000001 108.487 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -36.84 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 104.523 -2.399 . . . . 1.1299999999999999 104.523 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 mt -68.18 -51.27 47.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.708 -1.133 . . . . 1.1799999999999999 109.009 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -67.27 -31.77 72.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.17 -0.956 . . . . 1.22 109.442 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 32.5 t -68.55 -52.59 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -0.811 . . . . 1.1399999999999999 108.964 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 tt -61.31 -22.43 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.166 -0.959 . . . . 1.3 109.017 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.64 -41.67 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.165 -0.959 . . . . 1.1499999999999999 109.265 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mt -67.83 -37.3 81.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.874 -1.142 . . . . 1.8700000000000001 110.025 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 18.6 t80 -61.1 -28.26 68.96 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.994 -1.484 . . . . 2.3599999999999999 106.994 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.62 -25.68 66.46 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.42 -0.809 . . . . 1.71 109.02 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -89.88 -9.36 49.25 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.509 -0.923 . . . . 1.8799999999999999 108.509 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.47 14.07 10.01 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.193 -1.163 . . . . 0.47999999999999998 110.193 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -75.66 107.58 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.26 . . . . 1.0900000000000001 108.688 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.05 -37.66 12.66 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.418 -0.801 . . . . 1.55 109.97 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -96.89 139.92 32.21 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.401 0.62 . . . . 1.5800000000000001 109.614 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.39 136.66 12.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 119.279 -0.968 . . . . 1.28 110.086 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -116.1 124.75 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.229 0.537 . . . . 1.0900000000000001 110.682 -178.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.6 mp -104.38 116.65 32.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.971 -0.456 . . . . 1.0800000000000001 109.802 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.56 127.29 49.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.397 -0.964 . . . . 3.21 108.397 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.423 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -142.66 157.66 26.79 Favored Glycine 0 N--CA 1.508 3.44 0 O-C-N 121.093 -1.005 . . . . 0.28000000000000003 111.636 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.67 ' CG2' ' CD2' ' A' ' 80' ' ' TYR . 7.2 p -141.58 147.7 38.09 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.434 -1.039 . . . . 1.1399999999999999 112.84 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 38.67 -87.28 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.617 -0.993 . . . . 0.34999999999999998 110.617 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' THR . 2.9 mtp180 -82.68 -51.78 7.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.348 -1.089 . . . . 3.6000000000000001 109.506 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.56 -21.47 62.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.222 -0.924 . . . . 1.0900000000000001 109.028 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 44' ' ' SER . 6.5 tt -53.83 -33.81 24.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.579 -0.7 . . . . 1.6599999999999999 110.756 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.427 ' OG ' ' OG ' ' B' ' 79' ' ' SER . 0.0 OUTLIER -83.09 -23.45 33.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 1.51 108.91 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 14' ' ' LYS . 21.1 mmtp -65.18 -69.22 0.31 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.682 -1.97 . . . . 2.4399999999999999 105.682 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -34.31 -46.43 0.26 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.216 0.532 . . . . 1.1000000000000001 110.484 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.7 t -63.53 -66.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.076 -1.015 . . . . 1.01 109.694 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 52' ' ' SER . 13.1 t0 -44.76 -44.85 9.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.561 -0.712 . . . . 1.26 109.199 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' LEU . 60.5 t -50.11 -55.19 6.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.704 -0.798 . . . . 1.78 108.936 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.635 ' CD2' ' N ' ' A' ' 51' ' ' ASN . 1.1 t80 -58.5 -60.49 3.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.064 -1.022 . . . . 4.2999999999999998 110.607 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.635 ' N ' ' CD2' ' A' ' 50' ' ' TYR . 9.2 t-20 -49.11 -52.61 25.0 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.985 -1.117 . . . . 1.8500000000000001 107.985 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 48' ' ' ASP . 2.8 m -62.18 -39.02 91.29 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.847 -0.798 . . . . 1.1799999999999999 108.847 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 49' ' ' VAL . 12.5 tp -72.94 -24.06 60.76 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.067 -1.021 . . . . 1.1499999999999999 108.884 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' TYR . 4.1 tmtt? -81.34 -39.86 24.45 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.18 -1.575 . . . . 1.6599999999999999 107.227 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -52.68 -14.56 0.54 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.857 -1.164 . . . . 1.5800000000000001 107.857 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.483 ' N ' ' C ' ' A' ' 54' ' ' LYS . 11.5 mmm180 -56.15 -53.51 56.21 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.035 -0.666 . . . . 1.99 109.972 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.5 tp -161.83 -3.95 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 118.93 -1.108 . . . . 2.48 109.917 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.53 -50.94 0.1 OUTLIER Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.705 -1.236 . . . . 0.41999999999999998 110.392 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -71.91 -41.52 67.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.255 -1.144 . . . . 1.3799999999999999 110.521 -178.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.97 25.31 8.92 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.773 -1.331 . . . . 0.29999999999999999 109.773 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.8 t -155.27 133.6 2.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.944 -1.327 . . . . 1.22 108.29 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 86' ' ' LYS . 9.9 mm-40 -140.06 156.83 46.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.406 1.098 . . . . 2.0699999999999998 111.966 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.6 tt -97.08 118.45 33.53 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.044 -0.98 . . . . 1.3100000000000001 108.537 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.528 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -108.35 -17.13 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.813 -0.755 . . . . 2.0299999999999998 110.37 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 64' ' ' VAL . 0.2 OUTLIER -175.5 153.42 1.48 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.411 -1.431 . . . . 1.76 110.154 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.2 t -159.5 133.78 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.464 -0.939 . . . . 1.49 108.464 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 82' ' ' LEU . 19.7 tt0 -144.11 163.05 34.7 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.265 1.031 . . . . 2.02 110.6 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -136.51 157.18 47.39 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.751 -0.833 . . . . 1.1000000000000001 108.751 -178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.01 145.15 7.73 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 107.682 -2.167 . . . . 0.51000000000000001 107.682 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.67 ' H ' ' ND2' ' B' ' 51' ' ' ASN . 97.3 p -94.99 160.09 14.73 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.893 -1.357 . . . . 0.82999999999999996 109.356 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.12 176.63 11.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.823 -1.151 . . . . 1.29 111.118 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.24 131.4 37.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.503 0.668 . . . . 1.54 109.865 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 3.6 ttt85 -148.74 103.05 3.35 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.692 -0.855 . . . . 2.96 108.692 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.7 t0 87.19 36.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.062 0.458 . . . . 1.3799999999999999 110.117 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 65.6 33.55 8.43 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.083 0.944 . . . . 3.4300000000000002 109.363 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -158.3 155.24 28.47 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.234 -0.916 . . . . 3.9100000000000001 109.723 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -86.05 137.99 32.29 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.893 -1.123 . . . . 2.9900000000000002 109.982 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 tt -142.3 156.96 19.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-N 115.236 -0.893 . . . . 1.0700000000000001 109.489 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.05 151.6 23.1 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.958 0.885 . . . . 1.03 110.015 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.67 ' CD2' ' CG2' ' A' ' 39' ' ' THR . 0.4 OUTLIER -135.62 137.19 41.66 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.123 -1.066 . . . . 4.2599999999999998 108.123 -178.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 81' ' ' ILE . 5.1 tt -116.68 130.38 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.542 -0.91 . . . . 1.5800000000000001 108.542 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' GLN . 52.9 mt -110.22 120.54 42.78 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.145 -1.428 . . . . 1.05 107.145 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -127.46 128.27 45.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.161 -0.962 . . . . 1.6699999999999999 111.051 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -101.23 171.4 7.63 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.948 -0.569 . . . . 0.65000000000000002 109.548 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 mt -162.54 141.96 9.26 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.548 -0.861 . . . . 2.02 109.859 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -126.63 149.19 49.63 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.103 0.477 . . . . 2.02 110.593 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.459 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 17.9 mmt85 -108.06 139.99 41.89 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.627 -0.671 . . . . 2.2999999999999998 110.185 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.457 ' O ' ' CG1' ' A' ' 88' ' ' VAL . 4.3 t -115.01 -6.0 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.382 -0.969 . . . . 1.3899999999999999 108.382 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.48 0 CA-C-O 117.967 -1.016 . . . . 2.6200000000000001 109.497 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.24 0.543 . . . . 1.72 112.251 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 5.8 pt-20 -93.03 111.93 23.72 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.204 -1.406 . . . . 1.49 107.204 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 18.7 mt -114.12 139.29 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.607 -0.683 . . . . 1.8 109.851 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 82.9 t -102.69 126.02 56.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.704 -0.623 . . . . 2.02 109.579 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.32 163.91 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.914 -1.143 . . . . 1.1699999999999999 107.914 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.2 173.98 10.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.314 -0.866 . . . . 2.9399999999999999 109.899 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.526 ' N ' ' OE1' ' B' ' 42' ' ' GLU . 7.6 pttt -96.65 -9.21 29.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.951 -0.759 . . . . 2.2999999999999998 108.951 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -89.72 -4.78 57.54 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.649 -0.871 . . . . 1.76 108.649 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -99.34 -131.0 0.22 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.694 -1.224 . . . . 1.8999999999999999 107.694 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -166.77 163.83 16.5 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.544 -0.91 . . . . 1.96 108.544 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -63.39 -37.41 79.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.179 -1.045 . . . . 1.29 108.179 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 6.8 pt-20 -76.24 -38.03 56.9 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.75 -0.78 . . . . 1.7 109.035 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . 0.436 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 10.4 t70 -59.41 -31.59 69.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.721 -1.237 . . . . 1.46 111.598 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.473 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 0.3 OUTLIER -93.41 -16.44 24.58 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.173 -1.58 . . . . 2.3100000000000001 108.222 178.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.06 -34.78 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 104.784 -2.302 . . . . 1.2 104.784 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 57.5 mt -68.81 -52.31 31.45 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.972 -1.013 . . . . 1.1899999999999999 109.191 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -66.49 -29.83 70.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.19 -0.944 . . . . 1.21 109.499 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 24.3 t -70.06 -53.39 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.845 . . . . 1.1299999999999999 109.202 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 tt -62.41 -20.47 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.076 -1.015 . . . . 1.3999999999999999 108.944 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -72.1 -42.55 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.233 -0.917 . . . . 1.27 109.035 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mt -67.01 -36.31 81.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.97 -1.081 . . . . 1.8300000000000001 109.569 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 0.511 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 23.3 t80 -61.16 -28.23 68.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.436 -1.32 . . . . 2.3500000000000001 107.436 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -26.17 67.64 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.64 -0.709 . . . . 1.6799999999999999 109.195 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -90.42 -1.98 57.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.173 -0.954 . . . . 1.9399999999999999 109.455 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.88 12.28 24.53 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.912 -1.275 . . . . 0.42999999999999999 109.912 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 mm -76.78 106.12 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.024 -1.28 . . . . 1.3400000000000001 108.545 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.85 -38.6 12.23 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.22 -0.925 . . . . 1.46 110.821 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -98.59 142.58 29.99 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.57 0.7 . . . . 1.2 110.24 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.41 137.11 11.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 119.221 -0.992 . . . . 1.27 110.802 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.61 125.63 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-N 116.089 -0.505 . . . . 1.1599999999999999 110.344 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 mp -105.36 120.21 41.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.67 -0.644 . . . . 1.22 110.696 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.43 124.36 46.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.612 -0.68 . . . . 3.2200000000000002 109.168 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.437 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -138.64 153.83 22.78 Favored Glycine 0 N--CA 1.51 3.592 0 O-C-N 121.041 -1.037 . . . . 0.28000000000000003 111.567 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.626 ' O ' ' N ' ' B' ' 41' ' ' ARG . 3.8 p -138.38 143.9 40.03 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.551 -0.97 . . . . 1.1100000000000001 112.794 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 36.26 -83.17 0.0 OUTLIER Glycine 0 N--CA 1.499 2.863 0 N-CA-C 111.15 -0.78 . . . . 0.28999999999999998 111.15 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.626 ' N ' ' O ' ' B' ' 39' ' ' THR . 5.2 mtp180 -82.03 -53.19 6.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.201 -1.176 . . . . 3.6699999999999999 110.072 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' B' ' 12' ' ' LYS . 1.3 pm0 -64.27 -18.39 64.52 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.55 -1.344 . . . . 1.3799999999999999 109.223 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 tt -54.4 -30.86 21.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.073 -1.017 . . . . 1.54 109.84 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -24.92 32.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 1.5600000000000001 108.948 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' B' ' 46' ' ' ALA . 17.1 mmtp -65.86 -68.59 0.36 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.621 -1.992 . . . . 2.4399999999999999 105.621 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -33.21 -50.64 0.31 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 116.163 -0.472 . . . . 1.02 111.281 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.01 -59.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.768 -1.208 . . . . 1.1399999999999999 109.68 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 21.3 t0 -48.51 -47.61 38.81 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.193 -0.942 . . . . 1.25 108.666 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' B' ' 53' ' ' LEU . 88.8 t -48.61 -53.6 6.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.776 -0.769 . . . . 1.77 109.038 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.614 ' CD2' ' N ' ' B' ' 51' ' ' ASN . 0.9 OUTLIER -59.67 -56.58 20.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.244 -0.91 . . . . 4.3499999999999996 111.304 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' ' 70' ' ' SER . 21.1 t-20 -54.76 -48.51 72.55 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.759 -1.2 . . . . 1.75 107.759 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 1.5 m -63.37 -39.58 94.9 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.534 -0.866 . . . . 1.0600000000000001 108.92 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.48 ' O ' ' CG ' ' B' ' 56' ' ' ARG . 10.0 tp -74.86 -26.32 59.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 1.22 109.04 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 50' ' ' TYR . 5.1 tmtt? -80.28 -46.1 16.77 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.069 -1.645 . . . . 1.8300000000000001 106.859 177.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -49.98 -11.84 0.07 Allowed 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.353 -1.294 . . . . 1.46 108.284 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.545 ' H ' ' C ' ' B' ' 54' ' ' LYS . 9.1 mmm180 -54.03 -54.5 38.33 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.827 0.822 . . . . 1.99 110.297 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.0 tp -159.83 -3.78 0.07 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.622 -0.881 . . . . 2.5699999999999998 108.622 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.69 -47.96 0.11 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.944 -1.122 . . . . 0.39000000000000001 110.561 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -73.77 -43.69 58.22 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.286 -1.126 . . . . 1.3999999999999999 110.398 -178.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.34 22.87 7.87 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 109.857 -1.297 . . . . 0.37 109.857 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -154.49 135.44 4.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 120.872 -1.37 . . . . 1.1799999999999999 108.455 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.6 tp60 -140.19 155.24 47.01 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.342 1.068 . . . . 2.1200000000000001 112.145 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.09 119.1 32.46 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.344 -0.844 . . . . 1.3799999999999999 108.88 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.4 ' O ' ' CG ' ' B' ' 65' ' ' ASN . 0.1 OUTLIER -102.09 -28.27 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.426 -0.796 . . . . 2.0 110.972 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' B' ' 64' ' ' VAL . 1.3 m120 -173.37 161.28 4.12 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.498 -1.377 . . . . 1.8600000000000001 109.41 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -159.47 132.82 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.636 -0.875 . . . . 1.5700000000000001 108.636 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' B' ' 82' ' ' LEU . 28.4 tt0 -142.46 161.74 37.27 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.988 0.899 . . . . 2.04 109.969 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -136.59 159.25 42.37 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.959 -0.756 . . . . 0.92000000000000004 108.959 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.4 144.19 7.09 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 107.926 -2.07 . . . . 0.34999999999999998 107.926 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.535 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 14.4 p -93.58 160.07 14.94 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.968 -1.313 . . . . 0.84999999999999998 108.39 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.83 175.92 12.04 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.744 -1.182 . . . . 1.49 110.941 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.47 132.28 34.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.85 -0.74 . . . . 1.46 109.283 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.3 ttt-85 -151.73 103.24 2.92 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.556 -0.715 . . . . 2.8799999999999999 109.158 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 3.7 t0 86.91 35.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.102 0.477 . . . . 1.3500000000000001 109.85 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.77 29.02 8.74 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.991 0.901 . . . . 3.3700000000000001 109.451 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -156.74 157.51 35.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.344 -0.848 . . . . 3.8999999999999999 109.601 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -87.51 139.85 30.12 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.987 -1.085 . . . . 2.9700000000000002 110.943 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 tt -142.22 158.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.571 -0.74 . . . . 1.3700000000000001 109.107 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' SER . . . . . 0.427 ' OG ' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -86.37 149.26 25.15 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.015 0.912 . . . . 1.04 110.198 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.615 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.4 OUTLIER -133.95 137.27 44.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.464 -0.939 . . . . 4.29 108.464 -179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' B' ' 81' ' ' ILE . 5.6 tt -118.02 129.6 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.866 -0.79 . . . . 1.55 108.866 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' B' ' 67' ' ' GLN . 6.3 mt -106.9 119.27 38.9 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.703 -1.591 . . . . 1.1599999999999999 106.703 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 3.7 tt -126.76 126.73 43.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.061 -1.024 . . . . 1.55 111.08 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -99.48 169.59 9.21 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.342 -0.614 . . . . 0.70999999999999996 109.342 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 mt -162.44 137.55 6.97 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.802 -0.759 . . . . 2.1200000000000001 109.395 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -124.97 151.6 45.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.793 -0.567 . . . . 2.0 109.492 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . 0.511 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 19.0 mmt85 -107.5 141.23 39.25 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.469 0.652 . . . . 2.2999999999999998 110.275 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . 0.435 ' O ' ' CG1' ' B' ' 88' ' ' VAL . 13.7 t -115.18 -6.47 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.251 -1.018 . . . . 1.46 108.251 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.022 -0.989 . . . . 2.6299999999999999 109.528 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.6 HD22 ' CG1' ' A' ' 8' ' ' ILE . 1.8 t-20 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.131 -0.322 . . . . 1.8500000000000001 110.131 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 112.34 23.6 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.524 -1.36 . . . . 1.4399999999999999 108.166 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.6 ' CG1' HD22 ' A' ' 6' ' ' ASN . 4.8 mm -125.13 148.88 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 122.288 1.042 . . . . 1.8300000000000001 111.79 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.7 t -111.94 129.82 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.537 0.684 . . . . 2.0099999999999998 110.485 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.2 162.9 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.866 -1.161 . . . . 1.24 107.866 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -131.66 167.2 19.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.344 -0.847 . . . . 2.8500000000000001 110.136 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.2 pttp -87.93 -16.31 34.2 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.806 -1.183 . . . . 2.3399999999999999 107.806 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -74.37 -67.5 0.62 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.542 -1.651 . . . . 1.6699999999999999 106.542 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.538 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.1 mtmm -58.0 143.44 43.21 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.241 -0.912 . . . . 1.8600000000000001 110.113 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -72.27 178.09 4.12 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.48 0.657 . . . . 1.97 110.342 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.51 -31.86 39.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.908 0.861 . . . . 1.29 108.715 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -73.77 -30.77 62.97 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.454 -0.899 . . . . 1.5600000000000001 109.219 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -30.51 69.63 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 120.445 -1.409 . . . . 1.3799999999999999 110.881 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.483 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 41.0 m80 -95.33 -19.75 19.71 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.585 -1.322 . . . . 2.3500000000000001 108.236 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.71 -35.63 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 104.896 -2.261 . . . . 1.1299999999999999 104.896 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.8 mt -69.04 -52.5 27.93 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.823 -1.08 . . . . 1.1799999999999999 108.703 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -66.76 -26.46 66.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 1.22 109.895 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 13.9 t -73.62 -53.14 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.256 -0.902 . . . . 1.1399999999999999 108.804 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tt -55.39 -24.57 15.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.503 -0.925 . . . . 1.3 108.503 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.8 t -69.25 -40.81 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.234 -0.987 . . . . 1.1499999999999999 109.443 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.51 -38.03 88.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.524 -1.36 . . . . 1.8700000000000001 109.613 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -28.61 69.68 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.071 -1.455 . . . . 2.3599999999999999 107.071 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.36 -28.43 59.09 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.29 -0.868 . . . . 1.71 108.729 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -90.43 -18.43 25.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 1.8799999999999999 109.222 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.43 17.22 7.21 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.793 -1.323 . . . . 0.47999999999999998 109.793 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mm -74.19 113.99 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.395 -1.062 . . . . 1.0900000000000001 108.793 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -93.38 -34.59 13.41 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 119.71 -0.796 . . . . 1.55 111.366 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.81 135.88 42.6 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.625 0.726 . . . . 1.5800000000000001 111.351 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 p -149.55 141.92 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.96 -0.696 . . . . 1.28 110.297 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -122.35 124.9 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 116.06 -0.518 . . . . 1.0900000000000001 110.767 -178.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mp -106.36 123.08 47.52 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.279 -0.568 . . . . 1.0800000000000001 110.042 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -99.75 125.73 45.69 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.29 -1.004 . . . . 3.21 108.29 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.17 142.34 13.58 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.562 -1.304 . . . . 0.28000000000000003 110.827 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 41' ' ' ARG . 54.1 p -126.31 135.72 51.86 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.878 0.846 . . . . 1.1399999999999999 111.908 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 37.97 -87.41 0.01 OUTLIER Glycine 0 N--CA 1.496 2.678 0 O-C-N 121.623 -0.673 . . . . 0.34999999999999998 111.815 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -80.11 -51.77 8.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.041 -1.27 . . . . 3.6000000000000001 109.901 -178.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.66 -19.28 37.85 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.611 -1.305 . . . . 1.0900000000000001 107.59 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' OG ' ' A' ' 79' ' ' SER . 2.2 tt -54.51 -33.66 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.719 -0.613 . . . . 1.6599999999999999 110.934 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.612 ' CB ' ' HG ' ' B' ' 79' ' ' SER . 0.6 OUTLIER -83.77 -21.92 32.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.857 -1.152 . . . . 1.51 108.615 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.533 ' NZ ' ' O ' ' A' ' 14' ' ' LYS . 22.8 mmtp -66.17 -70.43 0.24 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.368 -1.715 . . . . 2.4399999999999999 106.368 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -29.46 -51.34 0.11 Allowed 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.439 0.638 . . . . 1.1000000000000001 110.598 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.86 -68.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.37 -0.831 . . . . 1.01 109.937 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 52' ' ' SER . 12.8 t70 -45.54 -48.1 14.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.716 . . . . 1.26 109.584 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' A' ' 52' ' ' SER . 91.7 t -47.36 -58.56 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.936 -0.764 . . . . 1.78 108.936 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -61.84 -54.52 40.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.16 -0.963 . . . . 4.2999999999999998 111.432 -178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.575 ' ND2' ' HG ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -53.74 -48.27 69.82 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.691 -1.256 . . . . 1.8500000000000001 107.804 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.495 ' N ' ' CG ' ' A' ' 51' ' ' ASN . 22.1 p -59.43 -35.88 74.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.839 -1.171 . . . . 1.1799999999999999 107.839 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 tp -79.09 -22.12 45.71 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.095 -1.076 . . . . 1.1499999999999999 108.095 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.98 -43.96 21.09 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.506 -2.035 . . . . 1.6599999999999999 105.506 177.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -56.05 -9.21 0.57 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.562 -1.273 . . . . 1.5800000000000001 107.562 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 54' ' ' LYS . 8.8 tpt180 -70.83 -49.34 47.3 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.599 0.714 . . . . 1.99 109.559 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.1 tp -153.86 -15.45 0.14 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.381 -0.928 . . . . 2.48 110.794 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 61' ' ' VAL . . . 63.27 -55.62 0.05 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.004 -1.238 . . . . 0.41999999999999998 110.004 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -73.08 -40.09 65.3 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.633 -0.922 . . . . 1.3799999999999999 109.496 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.431 ' O ' ' CD ' ' A' ' 87' ' ' ARG . . . -83.34 23.57 6.19 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 108.883 -1.687 . . . . 0.29999999999999999 108.883 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' GLY . 2.8 t -155.15 131.71 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.57 -1.27 . . . . 1.22 107.57 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.7 mm-40 -138.09 157.4 46.4 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.427 1.108 . . . . 2.0699999999999998 111.796 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.5 tt -94.55 116.4 28.73 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.363 -0.835 . . . . 1.3100000000000001 109.504 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.34 -20.97 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.323 -0.861 . . . . 2.0299999999999998 109.396 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.59 148.61 1.98 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.232 -1.387 . . . . 1.76 110.323 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -157.63 134.09 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.755 -0.831 . . . . 1.49 108.755 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -144.92 159.9 42.17 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.077 0.942 . . . . 2.02 110.667 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -135.44 151.81 50.77 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.537 -0.912 . . . . 1.1000000000000001 108.537 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.69 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -176.47 157.23 22.6 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 106.512 -2.635 . . . . 0.51000000000000001 106.512 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.534 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 94.4 p -99.38 161.25 13.72 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 119.051 1.426 . . . . 0.82999999999999996 110.396 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -155.77 175.73 13.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.102 -0.999 . . . . 1.29 110.737 178.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.434 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.02 134.59 29.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.72 0.771 . . . . 1.54 110.799 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 25.2 ttt-85 -145.7 101.39 3.55 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.321 -0.992 . . . . 2.96 108.321 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.9 t0 85.96 36.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.224 0.535 . . . . 1.3799999999999999 109.766 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.1 32.36 12.78 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.967 0.889 . . . . 3.4300000000000002 109.304 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -150.57 149.84 30.43 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.66 -0.867 . . . . 3.9100000000000001 108.66 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -85.73 137.38 32.85 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.482 1.134 . . . . 2.9900000000000002 110.077 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 tt -142.9 156.52 17.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.072 -0.967 . . . . 1.0700000000000001 108.778 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.483 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -87.92 155.82 19.66 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.453 -0.779 . . . . 1.03 111.145 -176.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.69 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 7.7 p90 -146.47 153.75 40.79 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.774 0.797 . . . . 4.2599999999999998 110.466 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.34 132.49 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.419 0.628 . . . . 1.5800000000000001 109.993 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.3 mt -106.86 120.71 42.77 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.763 -1.569 . . . . 1.05 106.763 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 tt -128.99 124.84 36.02 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.313 -0.955 . . . . 1.6699999999999999 110.582 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -101.4 172.0 7.25 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.663 -0.699 . . . . 0.65000000000000002 109.465 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 tp -159.42 143.03 14.68 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 118.978 -1.089 . . . . 2.02 111.135 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -118.72 142.45 47.66 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.768 -0.827 . . . . 2.02 108.768 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.431 ' CD ' ' O ' ' A' ' 60' ' ' GLY . 16.2 tpp180 -104.16 138.81 40.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.326 -0.858 . . . . 2.2999999999999998 109.726 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.85 -7.18 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.052 -0.721 . . . . 1.3899999999999999 109.052 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 117.978 -1.01 . . . . 2.6200000000000001 109.587 179.422 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . 0.457 ' OD1' ' CD1' ' B' ' 26' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 111.841 0.311 . . . . 1.72 111.841 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.75 107.52 19.23 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.018 -1.676 . . . . 1.49 107.147 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.437 ' CG1' ' OD1' ' B' ' 6' ' ' ASN . 43.1 mm -122.13 141.75 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 122.06 0.933 . . . . 1.8 110.215 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.0 t -101.26 129.05 52.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.778 -0.647 . . . . 2.02 109.476 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.9 164.27 2.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.613 -1.254 . . . . 1.1699999999999999 107.613 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.451 ' HE ' ' CE ' ' B' ' 14' ' ' LYS . 11.6 mtt-85 -138.21 174.55 10.44 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.844 0.831 . . . . 2.9399999999999999 110.149 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -103.56 -8.56 19.95 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.014 -1.106 . . . . 2.2999999999999998 108.014 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.43 -14.9 41.92 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.741 -0.784 . . . . 1.76 109.616 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.451 ' CE ' ' HE ' ' B' ' 11' ' ' ARG . 0.5 OUTLIER -97.81 -118.79 0.13 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.409 -0.96 . . . . 1.8999999999999999 108.409 178.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.77 170.24 9.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.1 -1.0 . . . . 1.96 108.656 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.89 -32.85 45.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.187 -1.042 . . . . 1.29 108.187 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.455 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 7.3 pt-20 -77.1 -40.42 45.99 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.792 -0.763 . . . . 1.7 109.098 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . 0.455 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 66.4 t0 -58.45 -31.87 68.18 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.605 -1.31 . . . . 1.46 110.975 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.47 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 17.2 m80 -91.21 -16.89 26.92 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.137 -1.602 . . . . 2.3100000000000001 108.546 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.22 -34.88 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.322 -2.103 . . . . 1.2 105.322 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 72.4 mt -67.97 -52.97 29.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.144 -0.935 . . . . 1.1899999999999999 108.949 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.04 -25.88 68.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.3 -0.875 . . . . 1.21 109.755 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 20.1 t -74.57 -52.96 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.422 -0.798 . . . . 1.1299999999999999 109.282 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 tt -57.04 -24.83 21.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.562 -0.903 . . . . 1.3999999999999999 108.562 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.32 -41.78 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.323 -0.861 . . . . 1.27 109.248 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.457 ' CD1' ' OD1' ' B' ' 6' ' ' ASN . 4.5 mt -65.15 -39.63 93.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.681 -1.262 . . . . 1.8300000000000001 109.342 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -32.02 69.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.215 -1.402 . . . . 2.3500000000000001 107.215 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -30.8 54.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.769 -0.826 . . . . 1.6799999999999999 108.769 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -89.54 -6.36 56.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 1.9399999999999999 109.926 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.39 16.47 24.76 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.556 -1.418 . . . . 0.42999999999999999 109.556 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.9 113.88 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.814 -1.18 . . . . 1.3400000000000001 107.814 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -98.35 -40.4 8.33 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.37 -0.832 . . . . 1.46 112.211 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -96.11 137.59 34.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 1.2 111.307 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -152.52 141.17 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.985 -1.086 . . . . 1.27 111.57 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.55 128.32 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 115.589 -0.732 . . . . 1.1599999999999999 110.605 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.91 122.56 47.47 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.471 -0.768 . . . . 1.22 110.034 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -102.96 130.07 49.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.331 -0.856 . . . . 3.2200000000000002 108.851 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.16 147.65 19.26 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.654 -1.26 . . . . 0.28000000000000003 110.649 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.613 ' O ' ' N ' ' B' ' 41' ' ' ARG . 42.6 p -129.71 140.06 51.19 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.074 -0.662 . . . . 1.1100000000000001 112.117 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 33.51 -80.78 0.0 OUTLIER Glycine 0 N--CA 1.503 3.148 0 O-C-N 121.847 -0.533 . . . . 0.28999999999999998 112.325 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.0 OUTLIER -83.53 -54.04 5.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.968 -1.313 . . . . 3.6699999999999999 109.45 -178.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -15.84 36.83 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.845 -1.159 . . . . 1.3799999999999999 109.048 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.405 ' CG2' ' O ' ' B' ' 40' ' ' GLY . 10.1 tt -58.25 -26.24 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.334 -0.854 . . . . 1.54 110.027 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -26.22 22.13 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.456 -0.942 . . . . 1.5600000000000001 108.456 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' B' ' 46' ' ' ALA . 23.3 mmtp -63.18 -69.64 0.26 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.167 -1.79 . . . . 2.4399999999999999 106.167 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -29.71 -50.41 0.11 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 116.159 -0.473 . . . . 1.02 111.582 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.61 -59.33 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.802 -1.186 . . . . 1.1399999999999999 109.957 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' B' ' 52' ' ' SER . 12.3 t70 -52.19 -51.87 55.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.141 -0.975 . . . . 1.25 108.612 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' B' ' 48' ' ' ASP . 60.4 t -41.34 -61.33 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 109.028 -0.73 . . . . 1.77 109.028 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' B' ' 50' ' ' TYR . 0.1 OUTLIER -62.36 -50.75 70.33 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.515 -0.74 . . . . 4.3499999999999996 109.906 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . 0.534 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -50.72 -55.22 17.63 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.975 -1.12 . . . . 1.75 107.975 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.477 ' N ' ' CG ' ' B' ' 51' ' ' ASN . 0.8 OUTLIER -59.9 -35.52 75.03 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.643 -0.823 . . . . 1.0600000000000001 109.256 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.1 tp -72.1 -24.15 61.44 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.892 -1.13 . . . . 1.22 109.417 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.07 -29.72 31.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.266 -1.521 . . . . 1.8300000000000001 107.277 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.0 -13.85 13.37 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.897 -1.149 . . . . 1.46 107.897 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -71.5 -42.66 67.76 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.492 -0.883 . . . . 1.99 109.342 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.3 tp -153.95 -18.21 0.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.532 -1.267 . . . . 2.5699999999999998 111.602 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 65.86 -62.88 0.13 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.365 -1.494 . . . . 0.39000000000000001 109.365 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -69.64 -41.61 75.36 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.387 -1.066 . . . . 1.3999999999999999 109.089 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' B' ' 87' ' ' ARG . . . -76.81 20.03 3.08 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.592 -1.403 . . . . 0.37 109.592 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' B' ' 59' ' ' ASP . 2.5 t -153.16 131.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.412 -1.329 . . . . 1.1799999999999999 107.412 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' B' ' 86' ' ' LYS . 3.0 mm-40 -134.0 153.35 51.84 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.048 0.928 . . . . 2.1200000000000001 112.207 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 7.6 tt -93.54 116.49 29.01 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.177 -1.045 . . . . 1.3799999999999999 108.177 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.83 -25.82 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.262 -0.899 . . . . 2.0 110.206 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -172.42 151.58 2.51 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.85 -1.156 . . . . 1.8600000000000001 109.284 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 96.1 t -154.53 133.82 3.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.193 -1.04 . . . . 1.5700000000000001 108.193 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -141.11 159.84 41.37 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.769 0.795 . . . . 2.04 109.47 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -138.98 151.85 47.2 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.109 -0.7 . . . . 0.92000000000000004 109.109 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.665 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -174.81 160.38 29.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.683 -1.767 . . . . 0.34999999999999998 108.683 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.575 ' HG ' ' ND2' ' A' ' 51' ' ' ASN . 89.9 p -98.35 155.11 17.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.275 -1.132 . . . . 0.84999999999999998 109.403 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -151.9 172.86 15.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.67 -1.269 . . . . 1.49 110.996 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.423 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -89.64 136.63 23.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.847 0.832 . . . . 1.46 110.917 -178.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 5.2 ttt-85 -148.96 100.21 3.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.973 -0.751 . . . . 2.8799999999999999 108.973 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 4.7 t0 85.07 36.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.246 -0.65 . . . . 1.3500000000000001 109.246 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.44 28.5 11.6 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.849 0.833 . . . . 3.3700000000000001 109.328 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.54 152.04 36.15 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.826 -0.805 . . . . 3.8999999999999999 108.826 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 9.6 ttm-85 -87.29 141.65 28.48 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.018 -1.073 . . . . 2.9700000000000002 111.099 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.91 158.58 23.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.635 -0.876 . . . . 1.3700000000000001 108.635 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' SER . . . . . 0.612 ' HG ' ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -87.84 148.14 24.8 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.514 -0.741 . . . . 1.04 109.553 -178.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.665 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.8 p90 -140.75 148.11 40.19 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.573 0.702 . . . . 4.29 109.948 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 6.4 tt -123.22 131.01 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.631 0.729 . . . . 1.55 110.037 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -105.98 123.06 47.38 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.149 -1.426 . . . . 1.1599999999999999 107.149 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -132.4 125.25 30.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.028 -1.045 . . . . 1.55 110.938 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -99.83 169.66 9.08 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.802 -0.635 . . . . 0.70999999999999996 109.933 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 tp -159.86 136.1 8.84 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.55 -0.86 . . . . 2.1200000000000001 110.661 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 62' ' ' GLN . 7.8 tmtt? -118.36 138.3 52.52 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.52 -0.919 . . . . 2.0 108.52 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . 0.403 HH11 ' CG2' ' B' ' 61' ' ' VAL . 16.6 tpp180 -95.48 143.7 26.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.465 -0.772 . . . . 2.2999999999999998 110.753 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.22 -13.48 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.877 -0.786 . . . . 1.46 108.877 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.303 -1.428 0 CA-C-O 117.98 -1.009 . . . . 2.6299999999999999 109.534 179.781 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.426 ' OD1' ' CD1' ' A' ' 31' ' ' ILE . 2.4 m120 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.023 0.44 . . . . 1.8500000000000001 111.329 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 7.0 pt-20 -92.09 115.58 28.19 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.989 -1.485 . . . . 1.4399999999999999 106.989 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.0 mt -115.64 140.0 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-O 122.132 0.968 . . . . 1.8300000000000001 111.592 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.8 124.71 62.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.986 -0.552 . . . . 2.0099999999999998 109.83 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.53 165.07 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.631 -1.248 . . . . 1.24 107.631 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -140.19 175.43 9.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.913 . . . . 2.8500000000000001 109.671 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.1 pttm -101.83 -9.71 20.52 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.006 -0.739 . . . . 2.3399999999999999 109.006 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 t -90.71 -7.89 51.35 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.828 -1.175 . . . . 1.6699999999999999 107.828 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.15 -132.76 0.18 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.423 -1.325 . . . . 1.8600000000000001 107.423 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.81 159.65 21.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.557 -1.339 . . . . 1.97 109.4 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 17' ' ' GLU . 16.5 m -61.66 -40.97 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-O 121.869 0.842 . . . . 1.29 109.284 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 3.5 pt-20 -77.86 -32.35 52.0 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.265 -0.897 . . . . 1.5600000000000001 108.871 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 52.3 t0 -62.78 -31.07 71.96 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.63 -1.294 . . . . 1.3799999999999999 111.164 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.486 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 1.6 m-70 -95.23 -17.15 21.96 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.176 -1.578 . . . . 2.3500000000000001 108.389 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -31.89 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 104.436 -2.431 . . . . 1.1299999999999999 104.436 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 mt -70.43 -52.85 19.27 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.32 -1.309 . . . . 1.1799999999999999 109.057 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -67.38 -29.46 68.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 1.22 109.671 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 25.5 t -70.03 -54.29 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 1.1399999999999999 108.964 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 tt -60.89 -20.36 21.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.203 -0.935 . . . . 1.3 108.894 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -72.46 -40.83 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.095 -1.003 . . . . 1.1499999999999999 109.025 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.03 -36.78 80.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.784 -1.197 . . . . 1.8700000000000001 109.965 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -61.73 -24.72 66.99 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.237 -1.394 . . . . 2.3599999999999999 107.237 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -27.03 68.67 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.343 -0.844 . . . . 1.71 109.109 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -89.32 -2.31 58.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 1.8799999999999999 109.535 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.409 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . 107.74 12.4 22.73 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.898 -1.281 . . . . 0.47999999999999998 109.898 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.456 HD13 HG23 ' A' ' 31' ' ' ILE . 50.0 mm -76.44 106.16 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.063 -1.257 . . . . 1.0900000000000001 108.927 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -92.52 -35.76 13.42 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.312 -0.867 . . . . 1.55 110.232 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -98.63 140.12 33.33 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.387 0.613 . . . . 1.5800000000000001 109.608 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.47 142.85 15.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 119.188 -1.005 . . . . 1.28 110.221 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.2 127.33 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.987 -0.551 . . . . 1.0900000000000001 110.477 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.71 118.37 35.43 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.501 0.667 . . . . 1.0800000000000001 109.322 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.32 134.36 49.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.667 -0.864 . . . . 3.21 108.667 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.5 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -145.14 157.28 27.29 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 120.036 -1.078 . . . . 0.28000000000000003 111.155 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 41' ' ' ARG . 14.9 p -139.0 146.92 41.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.466 -1.02 . . . . 1.1399999999999999 112.664 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 39.76 -86.92 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.628 -0.989 . . . . 0.34999999999999998 110.628 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -85.23 -51.86 6.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.32 -1.106 . . . . 3.6000000000000001 109.682 -178.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -25.51 60.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.819 -1.176 . . . . 1.0900000000000001 108.895 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 44' ' ' SER . 7.0 tt -49.74 -36.37 11.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.552 -0.717 . . . . 1.6599999999999999 110.83 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.494 ' H ' ' HG ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -83.54 -23.57 32.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.007 -1.058 . . . . 1.51 108.989 -178.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 46' ' ' ALA . 7.8 mmtt -62.29 -70.7 0.18 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 104.497 -2.409 . . . . 2.4399999999999999 104.497 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -31.47 -49.63 0.16 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.17 0.51 . . . . 1.1000000000000001 110.576 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.37 -69.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.225 -0.922 . . . . 1.01 109.549 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.424 ' O ' ' OG ' ' A' ' 52' ' ' SER . 3.6 t0 -45.81 -49.04 15.54 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.52 -0.738 . . . . 1.26 109.563 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.424 ' O ' ' OG ' ' A' ' 52' ' ' SER . 70.4 t -48.14 -59.64 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.646 -0.822 . . . . 1.78 109.105 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -60.06 -53.45 57.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 4.2999999999999998 110.228 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.48 ' CG ' ' H ' ' B' ' 70' ' ' SER . 0.5 OUTLIER -52.48 -49.82 63.95 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.662 -1.236 . . . . 1.8500000000000001 107.662 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 21.0 p -62.07 -35.04 77.45 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.73 -0.841 . . . . 1.1799999999999999 108.73 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.446 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 7.5 tp -77.34 -22.38 51.94 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.065 -1.022 . . . . 1.1499999999999999 108.737 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' C ' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -79.89 -42.5 24.04 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.172 -1.58 . . . . 1.6599999999999999 106.858 177.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.49 -16.11 0.1 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.783 -1.099 . . . . 1.5800000000000001 108.051 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.506 ' N ' ' C ' ' A' ' 54' ' ' LYS . 12.2 mmm180 -59.31 -55.7 31.49 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.356 0.598 . . . . 1.99 110.251 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 mt -159.16 0.58 0.09 Allowed 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 118.689 -1.204 . . . . 2.48 110.595 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 61' ' ' VAL . . . 64.92 -58.52 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.527 -1.321 . . . . 0.41999999999999998 110.209 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -70.96 -41.98 70.36 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.495 -1.003 . . . . 1.3799999999999999 110.49 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.49 17.64 3.24 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.414 -1.475 . . . . 0.29999999999999999 109.414 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.453 ' H ' ' C ' ' A' ' 59' ' ' ASP . 2.4 t -155.94 127.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.785 -1.191 . . . . 1.22 107.785 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.6 mm-40 -132.94 157.51 44.96 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.176 0.988 . . . . 2.0699999999999998 111.375 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.05 112.6 24.29 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.072 -0.714 . . . . 1.3100000000000001 109.072 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -20.86 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 2.0299999999999998 110.001 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.42 ' O ' ' CG2' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -167.86 153.23 7.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.18 -1.575 . . . . 1.76 109.784 177.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 65' ' ' ASN . 70.3 t -159.65 129.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.463 -0.773 . . . . 1.49 109.457 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 82' ' ' LEU . 12.9 tt0 -146.06 164.79 31.03 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.285 1.04 . . . . 2.02 110.902 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.6 p -139.27 158.06 44.82 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.894 -0.78 . . . . 1.1000000000000001 108.894 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 80' ' ' TYR . . . -174.55 147.38 9.12 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 107.195 -2.362 . . . . 0.51000000000000001 107.195 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.523 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 87.4 p -93.45 163.05 13.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.662 -1.493 . . . . 0.82999999999999996 110.175 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -147.85 159.88 43.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.237 -0.914 . . . . 1.29 110.648 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.17 87.71 2.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 118.991 -1.084 . . . . 1.54 109.226 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 46.1 ttt-85 -96.11 111.19 23.3 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.963 -1.086 . . . . 2.96 110.301 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.0 t70 80.64 37.25 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.888 -0.507 . . . . 1.3799999999999999 110.178 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.46 28.86 15.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.397 -0.815 . . . . 3.4300000000000002 109.129 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.26 146.14 28.51 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.083 -1.011 . . . . 3.9100000000000001 108.776 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.677 ' NH2' HD22 ' B' ' 51' ' ' ASN . 5.5 tpt180 -84.46 133.23 34.49 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.779 1.276 . . . . 2.9900000000000002 111.256 -177.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.5 tt -141.34 155.72 21.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.436 -1.256 . . . . 1.0700000000000001 108.831 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.55 151.71 23.24 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.139 0.971 . . . . 1.03 111.305 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.5 ' CD1' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -131.45 135.5 47.18 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.455 -0.943 . . . . 4.2599999999999998 108.455 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.441 ' CG2' ' O ' ' A' ' 81' ' ' ILE . 2.8 tt -117.11 126.79 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.168 -1.049 . . . . 1.5800000000000001 108.168 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 67' ' ' GLN . 16.8 mt -107.5 121.06 43.86 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.311 -1.366 . . . . 1.05 107.311 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 tt -131.89 126.12 33.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.035 . . . . 1.6699999999999999 111.123 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -100.56 171.61 7.62 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.784 -0.644 . . . . 0.65000000000000002 109.985 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 tp -159.49 142.38 14.07 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.112 -1.035 . . . . 2.02 110.72 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.59 ' O ' ' N ' ' A' ' 62' ' ' GLN . 13.7 tmtt? -121.85 141.21 51.48 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 116.073 -0.512 . . . . 2.02 110.442 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.1 mmt-85 -99.21 137.24 38.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.099 -1.001 . . . . 2.2999999999999998 109.705 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.31 -0.79 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.537 -0.912 . . . . 1.3899999999999999 108.537 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 t80 . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 118.028 -0.987 . . . . 2.6200000000000001 109.53 179.524 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.442 0.639 . . . . 1.72 110.792 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.7 pt-20 -93.4 117.62 30.3 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.303 -0.999 . . . . 1.49 108.303 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 45.5 mt -113.23 133.9 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.741 0.782 . . . . 1.8 110.574 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -98.7 123.02 51.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.361 0.6 . . . . 2.02 109.703 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.92 165.38 2.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.163 -1.051 . . . . 1.1699999999999999 108.163 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 26.9 mtt-85 -141.79 175.33 9.79 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.431 -0.793 . . . . 2.9399999999999999 109.747 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -102.53 -9.09 20.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.38 -0.97 . . . . 2.2999999999999998 108.38 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -84.79 -14.49 47.99 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.478 -0.889 . . . . 1.76 109.614 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -94.95 -118.25 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.18 -0.95 . . . . 1.8999999999999999 108.944 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.5 168.6 9.29 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.396 -0.815 . . . . 1.96 109.06 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.429 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 15.1 m -68.25 -38.4 79.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.881 0.848 . . . . 1.29 109.097 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.429 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 8.0 pt-20 -76.7 -31.46 57.22 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.024 -1.048 . . . . 1.7 109.51 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -32.28 72.6 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.453 -1.404 . . . . 1.46 111.268 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.474 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 3.1 m-70 -94.96 -16.81 22.49 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.335 -1.478 . . . . 2.3100000000000001 108.409 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.15 -35.21 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 104.538 -2.393 . . . . 1.2 104.538 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.93 -49.07 61.29 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.649 -1.16 . . . . 1.1899999999999999 109.011 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -70.25 -32.06 69.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.153 -0.967 . . . . 1.21 109.536 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 25.0 t -68.11 -52.53 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 1.1299999999999999 109.165 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 tt -62.19 -23.31 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.217 -0.927 . . . . 1.3999999999999999 108.883 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 t -69.88 -39.91 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.111 -0.993 . . . . 1.27 109.27 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -68.71 -38.76 80.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.758 -1.214 . . . . 1.8300000000000001 109.822 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.2 -27.64 65.91 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.81 -1.552 . . . . 2.3500000000000001 106.81 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -25.25 68.28 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.235 -0.893 . . . . 1.6799999999999999 109.143 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -91.64 0.62 57.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 1.9399999999999999 109.351 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.25 25.8 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.034 -1.226 . . . . 0.42999999999999999 110.034 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.42 HD13 HG23 ' B' ' 31' ' ' ILE . 39.1 mm -78.08 108.49 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.931 -1.335 . . . . 1.3400000000000001 108.393 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.7 OUTLIER -94.38 -37.97 11.2 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.409 -0.807 . . . . 1.46 110.642 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -100.38 139.03 36.63 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.714 -0.616 . . . . 1.2 110.046 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.75 142.93 16.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.089 -1.044 . . . . 1.27 111.234 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.85 124.79 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-N 115.889 -0.596 . . . . 1.1599999999999999 110.405 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mp -103.19 114.21 28.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.305 -0.872 . . . . 1.22 109.848 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -98.66 122.97 42.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 3.2200000000000002 109.761 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.507 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -137.59 153.33 22.01 Favored Glycine 0 N--CA 1.505 3.266 0 C-N-CA 119.86 -1.162 . . . . 0.28000000000000003 111.357 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.61 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 1.4 p -139.79 147.28 40.56 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 122.174 0.987 . . . . 1.1100000000000001 112.949 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 36.93 -87.62 0.01 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.632 -0.987 . . . . 0.28999999999999998 110.632 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -82.63 -52.77 6.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -1.084 . . . . 3.6699999999999999 109.503 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -19.48 54.24 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.901 -1.124 . . . . 1.3799999999999999 109.224 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 6.6 tt -54.58 -28.61 19.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.267 -0.896 . . . . 1.54 109.618 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.501 ' H ' ' HG ' ' B' ' 44' ' ' SER . 0.2 OUTLIER -84.98 -26.83 26.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.5600000000000001 108.921 -178.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.452 ' O ' ' C ' ' B' ' 46' ' ' ALA . 9.9 mmtt -64.0 -69.62 0.27 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.819 -1.919 . . . . 2.4399999999999999 105.819 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -32.42 -49.69 0.22 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 116.123 -0.49 . . . . 1.02 111.166 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.91 -62.74 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.73 -1.231 . . . . 1.1399999999999999 109.884 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ASP . . . . . 0.438 ' O ' ' OG ' ' B' ' 52' ' ' SER . 7.5 t0 -48.22 -52.57 20.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 1.25 108.646 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 54.2 t -44.42 -55.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.722 -0.844 . . . . 1.77 108.722 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' B' ' 54' ' ' LYS . 0.1 OUTLIER -63.97 -51.89 62.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.542 -0.724 . . . . 4.3499999999999996 110.503 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . 0.677 HD22 ' NH2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -53.25 -51.08 63.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.311 -1.366 . . . . 1.75 107.311 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 3.8 p -59.18 -36.73 75.84 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.564 -0.902 . . . . 1.0600000000000001 108.564 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.473 ' O ' ' CG ' ' B' ' 56' ' ' ARG . 5.4 tp -77.13 -24.06 51.7 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.211 -0.931 . . . . 1.22 109.069 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . 0.564 ' C ' ' H ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -81.78 -44.57 16.81 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 119.843 -1.786 . . . . 1.8300000000000001 107.286 178.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' B' ' 55' ' ' ASP . 1.4 t0 -50.88 -11.22 0.08 Allowed 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.171 -1.377 . . . . 1.46 107.88 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.564 ' H ' ' C ' ' B' ' 54' ' ' LYS . 9.3 mmm180 -56.96 -57.25 13.36 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.119 0.961 . . . . 1.99 110.352 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.0 OUTLIER -156.53 -1.92 0.12 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.137 -1.061 . . . . 2.5699999999999998 108.137 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.0 -52.93 0.1 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.011 -1.09 . . . . 0.39000000000000001 110.427 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' B' ' 61' ' ' VAL . 0.3 OUTLIER -72.51 -45.44 59.36 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.473 -1.016 . . . . 1.3999999999999999 110.329 -178.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.93 21.08 0.82 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 109.395 -1.482 . . . . 0.37 109.395 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' B' ' 59' ' ' ASP . 2.5 t -156.65 130.76 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.032 -1.275 . . . . 1.1799999999999999 107.894 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.5 mm-40 -132.92 150.11 52.19 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.029 0.919 . . . . 2.1200000000000001 111.695 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' B' ' 63' ' ' LEU . 7.0 tt -94.23 114.83 27.0 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.84 -1.17 . . . . 1.3799999999999999 107.84 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.36 -11.77 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.419 -0.801 . . . . 2.0 110.729 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' B' ' 84' ' ' ARG . 0.5 OUTLIER -175.57 146.42 0.77 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.343 -1.473 . . . . 1.8600000000000001 109.655 178.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -156.79 134.29 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.507 -0.746 . . . . 1.5700000000000001 109.038 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . 0.483 ' O ' ' N ' ' B' ' 82' ' ' LEU . 23.6 tt0 -146.28 162.87 37.16 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.133 0.968 . . . . 2.04 110.943 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.74 164.86 20.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.303 -0.999 . . . . 0.92000000000000004 108.303 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.55 136.85 3.05 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.024 -1.63 . . . . 0.34999999999999998 109.024 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.609 ' HG ' ' CZ ' ' B' ' 77' ' ' ARG . 51.8 p -94.36 156.81 16.32 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.185 -1.185 . . . . 0.84999999999999998 108.231 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.83 173.09 17.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.805 -1.184 . . . . 1.49 110.605 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 t -89.54 137.75 20.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.805 -0.813 . . . . 1.46 108.805 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 27.3 ttt-85 -149.67 103.47 3.25 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.098 -1.075 . . . . 2.8799999999999999 108.098 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.3 t70 82.22 34.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.434 -0.95 . . . . 1.3500000000000001 108.434 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 66.45 25.84 10.15 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.727 0.775 . . . . 3.3700000000000001 109.12 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -147.32 152.22 37.87 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.412 -0.805 . . . . 3.8999999999999999 108.995 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.609 ' CZ ' ' HG ' ' B' ' 70' ' ' SER . 3.5 ttt180 -88.08 138.71 31.21 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.598 1.19 . . . . 2.9700000000000002 112.253 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.01 156.41 22.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.016 -1.105 . . . . 1.3700000000000001 108.016 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 2.8 m -86.68 151.52 23.34 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.203 -0.935 . . . . 1.04 110.372 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.61 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.2 OUTLIER -133.32 133.95 43.2 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.133 -1.062 . . . . 4.29 108.133 -178.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' B' ' 81' ' ' ILE . 3.5 tt -116.06 128.79 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.872 -0.788 . . . . 1.55 108.872 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' B' ' 67' ' ' GLN . 4.4 mt -106.64 118.44 36.67 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.631 -1.618 . . . . 1.1599999999999999 106.631 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tt -128.18 124.47 36.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 1.55 110.317 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' B' ' 65' ' ' ASN . 23.0 ttt180 -99.96 170.76 8.29 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.443 0.64 . . . . 0.70999999999999996 109.965 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 tp -162.47 127.56 3.28 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.363 -0.935 . . . . 2.1200000000000001 110.783 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 62' ' ' GLN . 12.6 tmtt? -109.1 148.65 30.5 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.199 -0.667 . . . . 2.0 109.199 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 29.3 mmt-85 -101.18 141.81 33.53 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.276 -0.89 . . . . 2.2999999999999998 110.416 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.74 -7.79 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.032 -0.729 . . . . 1.46 109.032 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 13.5 t80 . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 117.973 -1.013 . . . . 2.6299999999999999 109.54 179.438 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.554 ' ND2' ' CG2' ' A' ' 34' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.898 -0.408 . . . . 1.8500000000000001 109.898 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 4.4 pt-20 -91.26 119.11 31.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.454 -1.404 . . . . 1.4399999999999999 108.793 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.462 ' CG1' ' OD1' ' A' ' 6' ' ' ASN . 2.7 mt -129.76 145.99 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 CA-C-O 122.242 1.02 . . . . 1.8300000000000001 111.732 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.7 t -107.96 130.27 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.585 0.707 . . . . 2.0099999999999998 109.632 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.47 162.98 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.244 -1.021 . . . . 1.24 108.244 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.23 175.01 9.99 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.276 1.036 . . . . 2.8500000000000001 111.216 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.91 -12.47 18.2 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.086 -1.079 . . . . 2.3399999999999999 108.086 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.512 ' C ' ' HZ1' ' A' ' 14' ' ' LYS . 30.0 p -86.42 -15.35 40.58 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.828 -0.749 . . . . 1.6699999999999999 109.437 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.512 ' HZ1' ' C ' ' A' ' 13' ' ' THR . 4.9 mmpm? -91.71 -123.55 0.08 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.118 -0.989 . . . . 1.8600000000000001 108.841 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.49 167.09 13.95 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.887 -1.153 . . . . 1.97 107.887 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.06 -30.12 46.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.897 -1.149 . . . . 1.29 107.897 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -79.46 -37.85 35.95 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.504 -0.878 . . . . 1.5600000000000001 109.328 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -33.23 69.21 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 120.146 -1.596 . . . . 1.3799999999999999 110.899 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.491 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 70.4 m-70 -91.74 -16.87 26.25 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 120.379 -1.451 . . . . 2.3500000000000001 108.922 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.56 -32.73 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 105.294 -2.113 . . . . 1.1299999999999999 105.294 176.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.9 mt -70.36 -56.15 7.38 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.228 -0.896 . . . . 1.1799999999999999 109.517 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -64.79 -27.47 68.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 1.22 110.26 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 38.8 t -73.25 -50.26 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.235 -0.915 . . . . 1.1399999999999999 109.262 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 tt -64.52 -18.13 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.203 -0.935 . . . . 1.3 108.675 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 t -74.95 -44.62 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.293 -0.879 . . . . 1.1499999999999999 108.835 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -67.15 -31.95 72.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.008 -1.057 . . . . 1.8700000000000001 110.147 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.596 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 15.6 t80 -65.36 -24.87 67.35 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.225 -1.398 . . . . 2.3599999999999999 107.225 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -64.01 -27.32 69.04 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.36 -0.836 . . . . 1.71 109.318 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -89.41 -2.42 58.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.996 -1.065 . . . . 1.8799999999999999 109.317 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.17 15.8 13.6 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.088 -1.205 . . . . 0.47999999999999998 110.088 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.462 HG23 HD12 ' A' ' 31' ' ' ILE . 48.8 mm -79.54 105.98 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.02 -1.282 . . . . 1.0900000000000001 108.566 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -94.41 -37.77 11.28 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.337 -0.852 . . . . 1.55 110.482 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 3.4 mt-10 -95.08 135.27 36.84 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.297 -0.877 . . . . 1.5800000000000001 109.697 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.554 ' CG2' ' ND2' ' A' ' 6' ' ' ASN . 2.8 p -149.14 138.55 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.329 -0.948 . . . . 1.28 110.466 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.99 127.64 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 115.911 -0.586 . . . . 1.0900000000000001 110.865 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -112.75 122.28 47.21 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.291 -0.633 . . . . 1.0800000000000001 109.291 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.76 136.98 45.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.442 -0.947 . . . . 3.21 108.442 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.34 156.68 26.26 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 119.501 -1.333 . . . . 0.28000000000000003 111.32 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.671 ' O ' ' N ' ' A' ' 41' ' ' ARG . 43.4 p -134.02 142.84 47.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.907 -0.76 . . . . 1.1399999999999999 112.151 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 35.49 -77.19 0.0 OUTLIER Glycine 0 N--CA 1.503 3.122 0 CA-C-O 121.346 0.415 . . . . 0.34999999999999998 112.182 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.671 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -87.11 -58.37 2.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.249 . . . . 3.6000000000000001 109.429 -179.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -20.91 21.72 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.1 -1.0 . . . . 1.0900000000000001 108.933 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.4 tt -53.65 -33.84 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.152 -0.967 . . . . 1.6599999999999999 111.046 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.494 ' H ' ' HG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -87.14 -24.48 24.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.727 -1.233 . . . . 1.51 108.499 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -58.39 -67.7 0.33 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.206 -2.146 . . . . 2.4399999999999999 105.206 177.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -34.32 -48.01 0.32 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 120.998 0.428 . . . . 1.1000000000000001 110.556 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.62 -64.93 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.034 -1.041 . . . . 1.01 109.343 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' O ' ' OG ' ' A' ' 52' ' ' SER . 56.3 t0 -46.53 -51.81 14.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.436 -0.95 . . . . 1.26 108.436 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.5 t -46.93 -57.34 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.875 -1.157 . . . . 1.78 107.875 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -58.35 -57.5 12.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.401 -0.812 . . . . 4.2999999999999998 110.598 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.48 ' CG ' ' H ' ' B' ' 70' ' ' SER . 1.1 t30 -51.76 -53.44 39.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.899 -1.148 . . . . 1.8500000000000001 107.899 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 19.9 p -59.4 -39.03 82.1 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.434 -0.906 . . . . 1.1799999999999999 109.101 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -75.53 -24.33 56.74 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.993 -1.067 . . . . 1.1499999999999999 109.023 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' A' ' 56' ' ' ARG . 5.9 tmtt? -80.88 -40.97 23.87 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.738 -1.949 . . . . 1.6599999999999999 105.738 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -57.92 -7.18 0.69 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.331 -1.304 . . . . 1.5800000000000001 107.817 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.4 tpt180 -71.59 -46.07 60.35 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.624 0.726 . . . . 1.99 110.067 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 mt -154.44 -19.47 0.13 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.777 -0.769 . . . . 2.48 109.657 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.79 -50.34 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.321 -1.112 . . . . 0.41999999999999998 110.321 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -74.54 -41.73 60.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.347 -1.09 . . . . 1.3799999999999999 109.94 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.25 25.05 7.34 Favored Glycine 0 N--CA 1.48 1.62 0 N-CA-C 109.273 -1.531 . . . . 0.29999999999999999 109.273 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 t -151.97 119.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 106.943 -1.503 . . . . 1.22 106.943 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.1 mm100 -126.58 159.64 32.95 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.096 0.95 . . . . 2.0699999999999998 111.604 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 tt -94.67 116.69 29.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.923 -0.769 . . . . 1.3100000000000001 108.923 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -22.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.212 -0.93 . . . . 2.0299999999999998 109.482 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.402 ' O ' ' CG2' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -172.04 154.01 3.33 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.76 -1.176 . . . . 1.76 109.741 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 65' ' ' ASN . 77.7 t -159.46 130.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.41 -0.959 . . . . 1.49 108.41 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -141.38 162.0 36.53 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.985 0.898 . . . . 2.02 109.945 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.57 148.77 51.64 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.84 -0.8 . . . . 1.1000000000000001 108.84 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.637 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -172.04 155.35 23.53 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.602 -1.799 . . . . 0.51000000000000001 108.602 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.515 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 83.2 p -100.48 156.85 17.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.188 -1.184 . . . . 0.82999999999999996 109.907 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -144.18 160.27 41.22 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.085 -1.009 . . . . 1.29 110.278 179.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.43 91.07 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.808 -0.757 . . . . 1.54 111.141 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 9.0 ttt85 -96.07 107.84 20.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.064 -1.023 . . . . 2.96 110.18 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.8 t0 84.08 36.22 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.127 0.489 . . . . 1.3799999999999999 110.263 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.466 ' CG ' HH11 ' A' ' 75' ' ' ARG . 0.0 OUTLIER 62.6 29.82 16.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.378 -0.826 . . . . 3.4300000000000002 108.794 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -145.09 144.09 30.76 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.022 -1.103 . . . . 3.9100000000000001 108.022 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -84.25 136.28 34.0 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.822 1.296 . . . . 2.9900000000000002 110.84 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.0 tt -143.91 155.79 15.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-N 114.316 -1.311 . . . . 1.0700000000000001 108.156 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.402 ' HG ' ' CB ' ' B' ' 44' ' ' SER . 9.7 p -90.49 154.35 19.7 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 121.356 -0.84 . . . . 1.03 111.43 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.637 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.8 p90 -143.56 150.91 39.54 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.81 0.814 . . . . 4.2599999999999998 109.702 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 tt -124.51 133.61 68.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.724 0.773 . . . . 1.5800000000000001 109.582 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.2 mt -107.8 128.58 54.72 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.663 -1.236 . . . . 1.05 107.663 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 tt -137.13 127.43 26.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.976 -1.077 . . . . 1.6699999999999999 111.519 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -104.9 166.36 10.44 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.681 -0.69 . . . . 0.65000000000000002 110.295 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 4.7 tp -157.87 137.01 11.66 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.437 -0.905 . . . . 2.02 111.458 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -117.31 137.11 52.64 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.727 -0.471 . . . . 2.02 109.727 178.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 16.9 mmt85 -94.17 144.49 25.46 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.212 -0.93 . . . . 2.2999999999999998 109.721 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -123.63 -6.5 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.909 -0.774 . . . . 1.3899999999999999 108.909 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 118.049 -0.976 . . . . 2.6200000000000001 109.51 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . 0.449 HD21 ' CD1' ' B' ' 8' ' ' ILE . 1.1 t30 . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.361 0.124 . . . . 1.72 110.887 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.1 pt-20 -92.06 105.12 17.43 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.183 -1.573 . . . . 1.49 108.032 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.449 ' CD1' HD21 ' B' ' 6' ' ' ASN . 4.0 mt -116.33 135.05 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.698 0.761 . . . . 1.8 109.954 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -97.79 127.72 49.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.508 0.671 . . . . 2.02 109.483 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.33 160.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.946 -1.131 . . . . 1.1699999999999999 107.946 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 172.25 12.97 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.934 0.873 . . . . 2.9399999999999999 110.538 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.99 -13.02 39.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.705 -0.85 . . . . 2.2999999999999998 108.705 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 47.8 p -76.86 -70.27 0.47 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.885 -1.524 . . . . 1.76 106.885 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 139.9 33.93 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.386 -0.821 . . . . 1.8999999999999999 110.148 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -72.84 178.59 4.14 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.473 0.654 . . . . 1.96 109.843 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.11 -29.25 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.92 0.866 . . . . 1.29 108.795 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 13.0 pt-20 -74.62 -39.15 62.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.607 -0.886 . . . . 1.7 108.607 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 17.4 t0 -57.16 -29.54 63.72 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.088 -1.008 . . . . 1.46 111.375 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.482 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 52.4 m-70 -94.83 -19.51 20.26 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 119.977 -1.702 . . . . 2.3100000000000001 107.946 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -35.81 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 105.069 -2.197 . . . . 1.2 105.069 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -69.14 -51.92 33.38 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.204 -0.907 . . . . 1.1899999999999999 108.732 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -66.78 -30.73 71.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 1.21 110.126 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 42.2 t -71.71 -55.12 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.142 -0.974 . . . . 1.1299999999999999 109.41 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 tt -58.67 -21.97 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 1.3999999999999999 108.982 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 t -71.12 -39.86 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.179 -0.951 . . . . 1.27 108.95 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.44 -44.98 73.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 1.8300000000000001 109.942 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 0.582 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 18.4 t80 -54.42 -27.5 37.36 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.29 -1.374 . . . . 2.3500000000000001 107.29 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -62.76 -24.92 67.95 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.533 -0.758 . . . . 1.6799999999999999 109.575 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -91.6 -4.38 55.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.917 -1.114 . . . . 1.9399999999999999 109.083 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.16 14.13 14.01 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.429 -1.468 . . . . 0.42999999999999999 109.429 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -78.83 102.18 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.006 -1.291 . . . . 1.3400000000000001 108.666 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.15 -35.03 14.79 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.278 -0.889 . . . . 1.46 111.517 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.68 135.42 44.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.382 -0.824 . . . . 1.2 110.471 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.59 142.5 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.305 -0.958 . . . . 1.27 111.707 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.86 123.42 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 121.204 0.526 . . . . 1.1599999999999999 111.012 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 mp -102.5 121.89 43.26 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.439 -0.788 . . . . 1.22 110.141 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -103.01 128.56 49.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.223 -0.923 . . . . 3.2200000000000002 109.214 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.91 150.95 21.12 Favored Glycine 0 N--CA 1.502 3.099 0 C-N-CA 119.366 -1.397 . . . . 0.28000000000000003 111.667 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.591 ' O ' ' N ' ' B' ' 41' ' ' ARG . 81.8 p -131.88 139.5 48.81 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.826 -0.808 . . . . 1.1100000000000001 112.174 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 35.79 -83.58 0.0 OUTLIER Glycine 0 N--CA 1.502 3.092 0 O-C-N 121.694 -0.629 . . . . 0.28999999999999998 111.983 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.668 ' N ' ' HE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -81.23 -54.61 5.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.084 -1.245 . . . . 3.6699999999999999 109.388 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.26 -20.55 43.22 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.155 -0.965 . . . . 1.3799999999999999 108.431 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 tt -55.25 -33.55 30.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.049 -1.032 . . . . 1.54 110.301 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.518 ' H ' ' HG ' ' B' ' 44' ' ' SER . 0.0 OUTLIER -83.38 -22.65 32.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.035 -1.04 . . . . 1.5600000000000001 108.858 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' B' ' 46' ' ' ALA . 0.0 OUTLIER -64.85 -68.73 0.34 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.533 -1.655 . . . . 2.4399999999999999 106.533 177.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -37.23 -46.15 0.7 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.378 0.608 . . . . 1.02 110.272 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.79 -66.3 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.185 -0.947 . . . . 1.1399999999999999 109.132 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ASP . . . . . 0.442 ' O ' ' OG ' ' B' ' 52' ' ' SER . 26.8 t0 -48.23 -46.6 35.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.919 . . . . 1.25 108.848 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' B' ' 48' ' ' ASP . 75.0 t -47.87 -54.91 3.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.011 -1.107 . . . . 1.77 108.011 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.462 ' O ' ' N ' ' B' ' 54' ' ' LYS . 1.3 t80 -59.47 -60.67 3.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 4.3499999999999996 110.611 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -48.13 -54.79 12.09 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.276 -0.89 . . . . 1.75 108.599 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.7 OUTLIER -60.25 -38.3 83.03 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.377 -0.929 . . . . 1.0600000000000001 109.378 -179.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 24.2 tp -73.32 -26.9 61.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.938 . . . . 1.22 109.276 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' B' ' 56' ' ' ARG . 1.6 tmtt? -75.03 -50.91 14.95 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.674 -1.602 . . . . 1.8300000000000001 106.674 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.41 -17.96 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.053 -1.43 . . . . 1.46 109.479 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' B' ' 54' ' ' LYS . 12.7 mmm180 -69.17 -38.44 78.72 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.13 -1.028 . . . . 1.99 109.845 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.6 mt -155.39 -13.13 0.11 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.091 -1.444 . . . . 2.5699999999999998 112.216 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.93 -67.81 0.05 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.228 -1.463 . . . . 0.39000000000000001 110.187 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.17 -35.71 76.59 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.407 -1.055 . . . . 1.3999999999999999 109.919 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.27 22.37 6.25 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.385 -1.486 . . . . 0.37 109.385 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 t -153.84 130.29 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.187 -1.184 . . . . 1.1799999999999999 107.872 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.5 mm100 -133.11 155.54 49.08 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.306 1.051 . . . . 2.1200000000000001 111.977 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 tt -94.85 118.97 32.65 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.517 -0.92 . . . . 1.3799999999999999 108.517 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.97 -14.94 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.399 -0.813 . . . . 2.0 109.906 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.407 ' O ' ' CG2' ' B' ' 66' ' ' VAL . 1.2 m-80 -177.53 152.07 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.732 -1.23 . . . . 1.8600000000000001 109.906 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' B' ' 65' ' ' ASN . 74.8 t -160.05 134.31 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.759 -0.83 . . . . 1.5700000000000001 108.759 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -145.59 162.42 37.51 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.123 0.963 . . . . 2.04 110.973 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.66 154.69 50.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.416 -0.957 . . . . 0.92000000000000004 108.416 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.656 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -177.98 155.9 18.26 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 107.443 -2.263 . . . . 0.34999999999999998 107.443 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.48 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 90.7 p -94.03 156.74 16.44 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.055 -1.262 . . . . 0.84999999999999998 108.959 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.419 ' OE1' ' C ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -147.0 164.71 32.12 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.939 -1.101 . . . . 1.49 110.141 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.419 ' C ' ' OE1' ' B' ' 71' ' ' GLU . 2.1 t -91.14 136.46 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 120.023 -0.671 . . . . 1.46 110.002 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 0.0 OUTLIER -148.51 106.66 3.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.416 -0.957 . . . . 2.8799999999999999 108.416 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.8 t0 79.74 35.53 0.15 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.258 -1.015 . . . . 1.3500000000000001 108.258 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.72 31.85 11.62 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.845 0.831 . . . . 3.3700000000000001 109.169 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -150.01 150.76 32.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.21 -0.931 . . . . 3.8999999999999999 109.298 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -88.4 138.5 31.38 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.393 1.092 . . . . 2.9700000000000002 112.429 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.34 154.09 27.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.045 -1.094 . . . . 1.3700000000000001 108.045 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' SER . . . . . 0.46 ' HG ' ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -85.81 150.19 24.73 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.146 -0.972 . . . . 1.04 109.912 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.656 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.9 p90 -144.42 149.93 36.87 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.929 0.871 . . . . 4.29 110.826 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 7.2 tt -125.35 134.04 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.59 0.709 . . . . 1.55 110.33 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 11.2 mt -108.31 119.93 40.93 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.591 -1.633 . . . . 1.1599999999999999 106.591 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.12 125.02 43.08 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.396 -0.922 . . . . 1.55 111.065 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 -100.35 167.98 10.06 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.975 -0.75 . . . . 0.70999999999999996 108.975 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tp -159.42 136.28 9.43 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.45 -0.9 . . . . 2.1200000000000001 110.448 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -118.0 143.01 46.76 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.285 -0.635 . . . . 2.0 109.285 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . 0.582 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 17.6 mmt85 -100.64 140.57 34.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.278 -0.889 . . . . 2.2999999999999998 109.997 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 t -119.0 -7.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.658 -0.867 . . . . 1.46 108.658 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.455 0 CA-C-O 118.003 -0.999 . . . . 2.6299999999999999 109.494 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.475 ' ND2' ' CG1' ' A' ' 8' ' ' ILE . 53.3 t30 . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.237 0.541 . . . . 1.8500000000000001 110.824 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.99 120.58 32.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.861 -1.149 . . . . 1.4399999999999999 108.36 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.475 ' CG1' ' ND2' ' A' ' 6' ' ' ASN . 3.5 mm -125.25 148.01 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-O 122.061 0.934 . . . . 1.8300000000000001 111.551 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.9 t -111.18 131.67 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.605 0.716 . . . . 2.0099999999999998 110.386 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.46 162.36 2.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.47 -0.937 . . . . 1.24 108.47 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.79 174.05 10.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 2.8500000000000001 110.221 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 -10.99 18.62 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.872 -0.788 . . . . 2.3399999999999999 108.872 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -8.82 57.95 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.45 -0.9 . . . . 1.6699999999999999 109.082 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HB3' ' H ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -100.3 -121.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.353 -1.351 . . . . 1.8600000000000001 107.353 177.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.479 ' H ' ' HB3' ' A' ' 14' ' ' LYS . 5.4 m-80 -170.73 173.53 5.29 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.505 -1.372 . . . . 1.97 108.153 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.6 -31.57 51.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.073 -1.051 . . . . 1.29 108.214 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -79.21 -36.37 40.22 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.409 -0.917 . . . . 1.5600000000000001 109.965 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.73 -33.26 64.09 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 119.908 -1.745 . . . . 1.3799999999999999 110.814 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 10.5 m80 -94.52 -19.4 20.57 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.695 -1.253 . . . . 2.3500000000000001 109.021 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.74 -34.26 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 104.324 -2.473 . . . . 1.1299999999999999 104.324 176.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.9 mt -68.49 -54.68 15.33 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.59 -1.186 . . . . 1.1799999999999999 108.935 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -67.41 -26.6 66.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 1.22 110.061 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 35.3 t -72.41 -52.17 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.17 -0.957 . . . . 1.1399999999999999 108.7 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 tt -61.86 -19.16 20.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.209 -0.932 . . . . 1.3 108.58 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.52 -44.71 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.244 -0.91 . . . . 1.1499999999999999 109.221 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mt -64.94 -34.67 78.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.814 -1.179 . . . . 1.8700000000000001 110.673 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -65.91 -24.47 66.85 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.534 -1.284 . . . . 2.3599999999999999 107.534 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.36 -24.97 67.83 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.452 -0.795 . . . . 1.71 109.796 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -92.07 1.18 57.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.794 -1.191 . . . . 1.8799999999999999 109.189 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.65 12.37 30.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.585 -1.406 . . . . 0.47999999999999998 109.585 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.3 mm -74.35 108.96 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -1.184 . . . . 1.0900000000000001 108.248 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -93.31 -41.18 10.0 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.443 -0.786 . . . . 1.55 110.57 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -94.96 142.15 27.82 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.357 -0.839 . . . . 1.5800000000000001 109.902 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.76 137.78 11.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.049 -1.06 . . . . 1.28 110.57 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -116.83 122.1 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.977 -0.556 . . . . 1.0900000000000001 110.284 -178.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 mp -104.33 120.71 41.81 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 120.115 -0.634 . . . . 1.0800000000000001 109.379 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.88 134.97 50.84 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.681 -0.859 . . . . 3.21 108.681 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -152.48 164.7 30.71 Favored Glycine 0 N--CA 1.508 3.435 0 C-N-CA 119.763 -1.208 . . . . 0.28000000000000003 111.603 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -145.69 152.33 39.44 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.391 -1.064 . . . . 1.1399999999999999 113.649 -177.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.41 ' O ' ' CG2' ' A' ' 43' ' ' ILE . . . 38.13 -86.29 0.01 OUTLIER Glycine 0 N--CA 1.499 2.838 0 N-CA-C 111.254 -0.739 . . . . 0.34999999999999998 111.254 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.657 ' N ' ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -82.46 -54.32 5.29 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.224 -1.162 . . . . 3.6000000000000001 109.485 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -20.63 58.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 109.148 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -52.78 -38.04 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.004 . . . . 1.6599999999999999 110.759 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -82.38 -25.37 33.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.745 -1.222 . . . . 1.51 108.871 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' O ' ' C ' ' A' ' 46' ' ' ALA . 3.2 mptt -62.06 -69.4 0.25 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.675 -1.972 . . . . 2.4399999999999999 105.675 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -34.22 -47.56 0.29 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.139 0.495 . . . . 1.1000000000000001 110.276 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 48' ' ' ASP . 68.9 t -62.19 -68.14 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.111 -0.993 . . . . 1.01 109.537 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.442 ' O ' ' OG ' ' A' ' 52' ' ' SER . 0.7 OUTLIER -45.49 -49.61 13.47 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.793 -0.818 . . . . 1.26 108.793 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' ASP . 47.7 t -45.59 -57.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.582 -0.896 . . . . 1.78 108.582 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -62.99 -58.21 8.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.299 -0.875 . . . . 4.2999999999999998 110.153 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.538 ' CG ' ' H ' ' B' ' 70' ' ' SER . 1.3 t30 -46.97 -54.72 9.51 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.97 -1.122 . . . . 1.8500000000000001 107.97 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 1.7 m -59.49 -34.72 72.93 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.596 -0.89 . . . . 1.1799999999999999 108.596 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.1 tp -76.85 -21.76 54.53 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.227 -1.027 . . . . 1.1499999999999999 108.227 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -78.26 -46.28 20.69 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.091 -1.818 . . . . 1.6599999999999999 106.091 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -58.49 -5.86 0.6 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.025 -1.102 . . . . 1.5800000000000001 108.025 178.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' A' ' 54' ' ' LYS . 3.4 tpt85 -75.87 -47.35 25.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.722 0.772 . . . . 1.99 109.639 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.617 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.4 tp -152.14 -27.08 0.17 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.663 -0.815 . . . . 2.48 109.88 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.62 -47.93 0.08 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.149 -1.181 . . . . 0.41999999999999998 110.149 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.617 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.6 OUTLIER -74.8 -44.28 50.26 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.484 -1.009 . . . . 1.3799999999999999 109.772 -179.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.93 27.04 5.63 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.007 -1.637 . . . . 0.29999999999999999 109.007 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.7 t -154.75 129.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.339 -1.356 . . . . 1.22 107.339 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 86' ' ' LYS . 0.8 OUTLIER -136.39 157.01 47.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.122 0.963 . . . . 2.0699999999999998 111.594 -177.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.1 tt -93.13 112.16 24.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.845 -0.798 . . . . 1.3100000000000001 108.845 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.35 -27.7 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.175 -0.953 . . . . 2.0299999999999998 109.902 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.416 ' O ' ' CG2' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -169.88 156.29 6.15 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.612 -1.305 . . . . 1.76 109.694 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 65' ' ' ASN . 68.2 t -159.52 131.34 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.596 0.712 . . . . 1.49 109.343 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.506 ' CG ' ' N ' ' A' ' 68' ' ' THR . 30.6 tt0 -144.21 163.15 34.48 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.166 0.984 . . . . 2.02 109.985 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.506 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -139.65 149.8 44.17 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.569 -0.901 . . . . 1.1000000000000001 108.569 -178.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.95 148.43 13.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.621 -2.192 . . . . 0.51000000000000001 107.621 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.528 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 28.1 p -95.55 162.53 13.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.98 -1.306 . . . . 0.82999999999999996 109.008 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -164.36 178.96 7.09 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.293 -0.963 . . . . 1.29 110.131 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.403 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -89.05 135.44 25.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 119.609 -0.836 . . . . 1.54 109.77 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 17.8 ttt85 -151.57 102.46 2.88 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.546 -0.909 . . . . 2.96 108.546 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.3 t70 88.5 33.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.114 0.483 . . . . 1.3799999999999999 109.721 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.93 34.18 5.45 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.201 1.001 . . . . 3.4300000000000002 109.364 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.25 153.64 27.85 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.14 -0.975 . . . . 3.9100000000000001 109.534 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -84.85 137.97 32.83 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.381 1.086 . . . . 2.9900000000000002 109.14 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.415 ' CG1' ' N ' ' A' ' 79' ' ' SER . 4.2 tt -146.18 159.87 11.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.324 -0.853 . . . . 1.0700000000000001 108.851 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.415 ' N ' ' CG1' ' A' ' 78' ' ' ILE . 5.1 p -86.58 149.84 24.65 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.076 0.941 . . . . 1.03 109.864 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.428 ' CE2' ' CG2' ' A' ' 39' ' ' THR . 0.6 OUTLIER -133.15 141.21 48.01 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.507 -0.769 . . . . 4.2599999999999998 109.033 -178.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.8 tt -117.66 127.34 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.879 0.847 . . . . 1.5800000000000001 111.225 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 34.6 mt -107.35 115.95 31.08 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.287 -1.746 . . . . 1.05 106.287 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.52 127.2 40.29 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.011 -1.055 . . . . 1.6699999999999999 111.117 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -103.12 169.41 8.58 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.482 0.658 . . . . 0.65000000000000002 110.936 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.86 145.26 12.19 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.25 -0.58 . . . . 2.02 110.174 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 62' ' ' GLN . 1.5 tmtp? -127.35 145.51 50.78 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.53 -0.545 . . . . 2.02 109.53 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -96.87 138.98 33.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.455 -0.778 . . . . 2.2999999999999998 110.291 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.16 -6.52 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.6 -0.889 . . . . 1.3899999999999999 108.6 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.0 t80 . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 118.089 -0.957 . . . . 2.6200000000000001 109.511 179.772 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . 0.403 HD21 ' CG1' ' B' ' 8' ' ' ILE . 1.2 t30 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.574 0.226 . . . . 1.72 110.605 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -90.4 100.2 13.08 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.41 -1.431 . . . . 1.49 107.56 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.403 ' CG1' HD21 ' B' ' 6' ' ' ASN . 4.2 mm -111.3 140.72 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 109.336 -0.616 . . . . 1.8 109.336 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 63.5 t -104.29 131.45 53.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.69 0.757 . . . . 2.02 110.481 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.13 159.54 2.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.981 -1.118 . . . . 1.1699999999999999 107.981 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -134.68 169.19 17.7 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.024 0.916 . . . . 2.9399999999999999 111.025 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.439 ' C ' ' CD ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -97.55 -11.09 24.1 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.834 -0.802 . . . . 2.2999999999999998 108.834 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.38 -10.17 44.91 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.737 -0.785 . . . . 1.76 109.179 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -96.18 -127.78 0.14 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.999 -1.112 . . . . 1.8999999999999999 107.999 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.405 ' O ' ' ND1' ' B' ' 19' ' ' HIS . 5.2 m-80 -167.02 162.69 15.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -0.942 . . . . 1.96 109.331 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -63.25 -38.65 82.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 122.001 0.905 . . . . 1.29 108.959 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.455 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 7.3 pt-20 -71.94 -32.75 67.63 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.625 -0.88 . . . . 1.7 108.625 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -63.43 -31.01 72.05 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.349 -0.844 . . . . 1.46 112.402 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.468 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 23.0 m80 -94.54 -20.87 19.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 119.822 -1.799 . . . . 2.3100000000000001 108.383 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.99 -38.98 82.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 104.275 -2.491 . . . . 1.2 104.275 176.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 48.9 mt -65.73 -49.22 69.23 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.435 -1.257 . . . . 1.1899999999999999 108.689 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.5 -31.64 68.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.227 -0.921 . . . . 1.21 109.779 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 55.5 t -68.79 -57.32 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.947 -1.096 . . . . 1.1299999999999999 108.92 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 tt -56.6 -24.67 19.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.336 -0.853 . . . . 1.3999999999999999 108.937 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.08 -40.65 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.132 -0.98 . . . . 1.27 109.661 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -67.45 -44.37 78.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.723 -1.236 . . . . 1.8300000000000001 110.185 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -57.24 -30.77 64.9 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.139 -1.43 . . . . 2.3500000000000001 107.139 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -24.1 61.6 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.49 -0.777 . . . . 1.6799999999999999 109.2 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -92.95 -3.39 54.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 1.9399999999999999 109.151 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.64 14.51 19.46 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.304 -1.518 . . . . 0.42999999999999999 109.304 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.425 HG23 HD12 ' B' ' 31' ' ' ILE . 42.4 mm -77.42 107.82 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.111 -1.229 . . . . 1.3400000000000001 108.503 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -91.18 -36.82 13.72 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.477 -0.765 . . . . 1.46 111.415 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -107.1 136.47 46.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.542 -0.723 . . . . 1.2 111.135 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.4 p -145.94 145.39 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 119.706 -0.798 . . . . 1.27 111.171 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.69 119.49 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.261 0.553 . . . . 1.1599999999999999 110.439 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mp -95.47 121.88 37.61 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.268 -0.895 . . . . 1.22 110.918 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -102.88 125.73 49.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.488 -0.758 . . . . 3.2200000000000002 109.33 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.4 156.85 26.98 Favored Glycine 0 N--CA 1.507 3.407 0 C-N-CA 119.362 -1.399 . . . . 0.28000000000000003 111.942 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 17.1 p -142.48 149.79 39.67 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.008 0.909 . . . . 1.1100000000000001 113.309 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.441 ' O ' ' CG2' ' B' ' 43' ' ' ILE . . . 34.28 -85.51 0.01 OUTLIER Glycine 0 N--CA 1.498 2.773 0 N-CA-C 111.144 -0.782 . . . . 0.28999999999999998 111.144 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.652 ' NE ' ' N ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -81.22 -53.08 6.67 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.417 -1.049 . . . . 3.6699999999999999 109.267 -179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.02 -17.73 53.86 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.068 -1.02 . . . . 1.3799999999999999 108.254 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.441 ' CG2' ' O ' ' B' ' 40' ' ' GLY . 0.2 OUTLIER -53.28 -35.54 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.351 -0.843 . . . . 1.54 110.358 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.408 ' N ' HG23 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -82.65 -24.86 33.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.717 -1.239 . . . . 1.5600000000000001 109.036 -179.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.499 ' CD ' ' N ' ' B' ' 45' ' ' LYS . 5.4 mptt -66.44 -68.58 0.36 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.692 -1.595 . . . . 2.4399999999999999 106.692 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -36.44 -49.13 0.71 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.056 0.455 . . . . 1.02 110.671 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' B' ' 48' ' ' ASP . 79.7 t -66.89 -64.89 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.083 -1.011 . . . . 1.1399999999999999 109.8 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' B' ' 47' ' ' VAL . 4.5 t70 -46.59 -48.81 19.58 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.442 -0.947 . . . . 1.25 108.442 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -45.98 -52.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.389 -0.967 . . . . 1.77 108.389 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.547 ' C ' ' CD1' ' B' ' 50' ' ' TYR . 0.2 OUTLIER -66.78 -60.25 2.84 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.377 -0.827 . . . . 4.3499999999999996 110.26 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . 0.528 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -45.13 -50.53 11.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.155 -1.018 . . . . 1.75 108.539 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -64.97 -34.63 78.88 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.349 -0.94 . . . . 1.0600000000000001 109.882 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 tp -69.98 -23.99 63.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.976 -1.078 . . . . 1.22 109.921 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -28.41 33.47 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.095 -1.628 . . . . 1.8300000000000001 106.683 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -16.3 12.16 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.978 -1.119 . . . . 1.46 107.978 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -78.39 -40.04 37.29 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 120.222 -0.591 . . . . 1.99 110.073 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.2 tp -153.53 -24.7 0.14 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 118.329 -1.348 . . . . 2.5699999999999998 112.118 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.29 -60.88 0.06 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.367 -1.397 . . . . 0.39000000000000001 109.914 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -67.71 -37.66 82.56 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.351 -1.088 . . . . 1.3999999999999999 109.764 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.93 28.34 7.99 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.534 -1.426 . . . . 0.37 109.534 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -158.57 92.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -1.177 . . . . 1.1799999999999999 108.791 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER -97.42 161.64 13.69 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.252 1.025 . . . . 2.1200000000000001 112.094 -178.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 tt -97.27 121.15 38.84 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.104 -1.073 . . . . 1.3799999999999999 108.104 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.37 -18.21 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.248 -0.907 . . . . 2.0 110.865 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -178.5 153.49 0.72 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.52 -1.362 . . . . 1.8600000000000001 109.907 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 87.5 t -158.19 136.56 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.93 -0.767 . . . . 1.5700000000000001 108.93 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . 0.422 ' CG ' ' N ' ' B' ' 68' ' ' THR . 24.0 tt0 -147.16 164.87 31.74 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.253 1.025 . . . . 2.04 110.663 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' THR . . . . . 0.422 ' N ' ' CG ' ' B' ' 67' ' ' GLN . 0.5 OUTLIER -143.0 158.42 43.62 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.426 -0.953 . . . . 0.92000000000000004 108.426 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.67 151.84 11.78 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 106.934 -2.467 . . . . 0.34999999999999998 106.934 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.538 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 39.9 p -93.28 160.21 14.93 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.909 -1.348 . . . . 0.84999999999999998 108.535 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -159.09 174.62 14.62 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.925 -1.109 . . . . 1.49 110.061 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.432 ' O ' ' OE1' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -90.64 130.47 39.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 119.767 -0.773 . . . . 1.46 109.858 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.2 ttt85 -148.14 104.88 3.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.041 -0.726 . . . . 2.8799999999999999 109.041 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.2 t70 82.59 39.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.611 -0.515 . . . . 1.3500000000000001 109.611 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.62 31.86 20.26 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.063 0.935 . . . . 3.3700000000000001 108.793 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -154.86 152.75 30.17 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.056 -0.72 . . . . 3.8999999999999999 109.056 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -88.18 136.77 32.82 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.857 -1.137 . . . . 2.9700000000000002 110.734 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 tt -138.87 157.26 29.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.713 0.768 . . . . 1.3700000000000001 109.38 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.37 146.75 28.3 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.904 -1.146 . . . . 1.04 107.904 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.618 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 2.3 t80 -136.98 139.78 41.72 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.961 -0.755 . . . . 4.29 108.961 -175.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . 0.428 ' O ' HG21 ' B' ' 81' ' ' ILE . 12.9 tt -122.78 132.27 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 121.996 0.903 . . . . 1.55 113.236 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.81 108.08 18.75 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 105.999 -1.852 . . . . 1.1599999999999999 105.999 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.73 121.26 43.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.227 -0.921 . . . . 1.55 110.139 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -97.28 168.26 10.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.873 -0.731 . . . . 0.70999999999999996 109.61 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.97 144.17 13.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.653 -0.819 . . . . 2.1200000000000001 109.99 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' B' ' 62' ' ' GLN . 1.8 tmtp? -125.64 147.27 49.38 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.542 -0.54 . . . . 2.0 109.542 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -101.48 136.6 41.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.262 -0.898 . . . . 2.2999999999999998 109.845 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.94 -8.97 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.626 -0.879 . . . . 1.46 108.626 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 21.0 t80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 118.017 -0.992 . . . . 2.6299999999999999 109.564 179.659 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.025 -0.731 . . . . 1.8500000000000001 109.025 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 6.7 pt-20 -93.32 117.88 30.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.289 -0.882 . . . . 1.4399999999999999 109.671 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 35' ' ' ILE . 53.5 mt -128.89 153.22 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 CA-C-O 122.189 0.995 . . . . 1.8300000000000001 112.384 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.3 131.22 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.626 0.727 . . . . 2.0099999999999998 110.252 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 11' ' ' ARG . 4.7 p -88.95 165.12 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.206 -1.035 . . . . 1.24 108.206 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.36 172.47 12.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.967 . . . . 2.8500000000000001 110.002 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.554 ' NZ ' ' CZ ' ' A' ' 41' ' ' ARG . 6.1 pttp -98.06 -4.23 36.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.979 -0.748 . . . . 2.3399999999999999 108.979 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.01 0.33 55.93 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.429 -1.323 . . . . 1.6699999999999999 107.429 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.95 131.25 56.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.362 -1.348 . . . . 1.8600000000000001 107.362 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -67.88 173.17 4.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.751 -1.218 . . . . 1.97 110.435 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.49 -35.65 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.361 -0.977 . . . . 1.29 108.361 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 9.2 pt-20 -69.76 -39.88 76.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.649 -0.871 . . . . 1.5600000000000001 108.649 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' N ' ' CG ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -48.5 -37.93 18.82 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.671 -1.268 . . . . 1.3799999999999999 111.93 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.485 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 1.4 m80 -93.87 -19.56 20.86 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.321 -1.487 . . . . 2.3500000000000001 108.667 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.68 -34.53 47.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 104.482 -2.414 . . . . 1.1299999999999999 104.482 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 71.6 mt -69.07 -55.68 10.02 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.033 -0.985 . . . . 1.1799999999999999 108.556 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.68 -29.95 71.03 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.311 -0.868 . . . . 1.22 109.668 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 24.9 t -70.42 -54.82 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 1.1399999999999999 108.953 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 tt -61.73 -15.18 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.165 -0.959 . . . . 1.3 108.839 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.4 t -81.42 -47.32 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 1.1499999999999999 109.458 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mt -65.84 -35.12 79.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.789 -1.194 . . . . 1.8700000000000001 110.017 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.597 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 3.1 t80 -62.39 -23.83 67.05 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.919 -1.511 . . . . 2.3599999999999999 106.919 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.29 -29.54 70.84 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.338 -0.846 . . . . 1.71 109.153 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -87.26 -14.08 41.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.945 -1.097 . . . . 1.8799999999999999 109.121 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.68 11.25 5.04 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.378 -1.089 . . . . 0.47999999999999998 110.378 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.3 mm -74.99 98.92 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.985 -1.303 . . . . 1.0900000000000001 109.172 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.11 -34.27 20.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.551 -0.907 . . . . 1.55 108.551 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 1.7 mt-10 -102.85 141.55 35.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.56 0.695 . . . . 1.5800000000000001 110.259 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -151.77 144.18 16.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.397 -0.921 . . . . 1.28 109.859 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -121.63 128.54 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.38 0.609 . . . . 1.0900000000000001 109.94 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 mp -111.78 123.56 50.5 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.236 0.541 . . . . 1.0800000000000001 110.241 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -102.9 128.82 49.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.246 -1.39 . . . . 3.21 107.246 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.44 154.11 23.37 Favored Glycine 0 N--CA 1.501 3.029 0 C-N-CA 119.525 -1.321 . . . . 0.28000000000000003 111.031 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 41' ' ' ARG . 30.1 p -135.88 141.15 44.55 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.801 0.81 . . . . 1.1399999999999999 112.678 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 39.46 -84.26 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.728 -0.608 . . . . 0.34999999999999998 111.637 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -84.89 -51.14 6.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.157 -1.202 . . . . 3.6000000000000001 110.096 -178.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -25.07 64.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.624 -1.298 . . . . 1.0900000000000001 108.763 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' A' ' 44' ' ' SER . 5.7 tt -51.93 -36.66 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.628 -0.67 . . . . 1.6599999999999999 111.335 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.448 ' CB ' ' HG ' ' B' ' 79' ' ' SER . 0.0 OUTLIER -84.7 -21.18 30.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.718 -1.239 . . . . 1.51 109.133 -179.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 46' ' ' ALA . 8.0 mmtp -62.08 -71.67 0.15 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.819 -1.919 . . . . 2.4399999999999999 105.819 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -32.88 -45.37 0.13 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.267 0.556 . . . . 1.1000000000000001 111.167 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.02 -70.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.986 -1.071 . . . . 1.01 110.267 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -44.49 -44.29 8.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.556 -0.715 . . . . 1.26 109.971 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.6 t -46.81 -57.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 119.967 -0.693 . . . . 1.78 109.556 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 54' ' ' LYS . 64.8 m-85 -65.13 -51.23 62.49 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.039 -1.038 . . . . 4.2999999999999998 112.668 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' ND2' ' N ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -51.05 -47.98 61.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.546 -1.346 . . . . 1.8500000000000001 107.55 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.514 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 11.1 p -65.45 -33.84 76.89 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.799 -0.761 . . . . 1.1799999999999999 109.527 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 tp -84.13 -24.18 30.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.68 -1.263 . . . . 1.1499999999999999 108.846 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.607 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.92 -48.81 12.83 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 104.756 -2.313 . . . . 1.6599999999999999 104.756 177.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 32.0 t0 -50.1 -12.93 0.09 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.185 -1.37 . . . . 1.5800000000000001 107.786 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.0 tpt85 -64.7 -46.95 80.16 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.682 0.753 . . . . 1.99 109.887 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 tp -155.35 -7.44 0.13 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.515 -0.874 . . . . 2.48 110.388 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.27 -59.81 0.06 OUTLIER Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.594 -1.289 . . . . 0.41999999999999998 109.887 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -72.09 -35.83 69.33 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.808 -0.819 . . . . 1.3799999999999999 110.212 -178.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.75 20.54 9.16 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.364 -1.494 . . . . 0.29999999999999999 109.364 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t -154.63 133.26 2.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.54 -1.282 . . . . 1.22 107.54 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.9 mm-40 -137.57 150.73 47.69 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.482 1.134 . . . . 2.0699999999999998 112.249 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.4 tt -94.31 108.7 20.58 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.537 -1.282 . . . . 1.3100000000000001 107.537 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.89 -23.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.305 -0.872 . . . . 2.0299999999999998 110.369 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.431 ' O ' ' CG2' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -162.38 153.82 18.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.172 -1.58 . . . . 1.76 109.348 177.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 65' ' ' ASN . 46.3 t -162.32 129.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.406 -0.809 . . . . 1.49 109.485 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -140.78 157.15 45.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.107 0.955 . . . . 2.02 110.606 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.42 143.89 42.1 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.178 -0.675 . . . . 1.1000000000000001 109.178 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.674 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -167.35 159.94 33.43 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.384 -2.286 . . . . 0.51000000000000001 107.384 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.468 ' HG ' ' ND2' ' B' ' 51' ' ' ASN . 31.4 p -98.53 161.15 13.82 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 118.984 1.392 . . . . 0.82999999999999996 110.745 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -156.05 175.6 13.75 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.111 -0.993 . . . . 1.29 110.568 178.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.62 137.34 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.6 0.714 . . . . 1.54 110.553 -179.245 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 27.5 ttt-85 -148.41 102.58 3.35 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.567 -0.901 . . . . 2.96 108.567 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.9 t70 87.91 35.07 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.204 0.526 . . . . 1.3799999999999999 109.646 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 63.66 37.62 10.0 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.356 1.074 . . . . 3.4300000000000002 109.21 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -157.52 153.35 26.86 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.41 -0.806 . . . . 3.9100000000000001 108.837 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -86.31 135.19 33.63 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.775 1.274 . . . . 2.9900000000000002 110.662 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -141.31 155.12 20.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.604 -1.258 . . . . 1.0700000000000001 107.604 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -87.44 159.99 18.47 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.227 -0.921 . . . . 1.03 111.116 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.674 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.1 p90 -145.08 153.25 41.23 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.87 0.843 . . . . 4.2599999999999998 110.581 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -125.96 131.84 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.778 0.799 . . . . 1.5800000000000001 109.416 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.5 mt -109.5 122.56 47.69 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.695 -1.594 . . . . 1.05 106.695 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.95 129.13 37.87 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.255 1.026 . . . . 1.6699999999999999 110.737 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -99.25 172.25 7.47 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.128 -0.942 . . . . 0.65000000000000002 110.074 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -157.18 137.79 13.11 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.2 -1.0 . . . . 2.02 108.85 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -125.78 140.69 52.47 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.399 0.618 . . . . 2.02 109.468 179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.597 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 16.6 mmt85 -99.41 136.02 39.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.533 -0.73 . . . . 2.2999999999999998 109.979 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 88' ' ' VAL . 48.2 t -113.54 -0.97 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.496 -0.927 . . . . 1.3899999999999999 108.496 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.7 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.988 -1.006 . . . . 2.6200000000000001 109.415 178.901 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.243 0.544 . . . . 1.72 111.965 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 7.0 pt-20 -93.41 116.45 28.99 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.524 -1.287 . . . . 1.49 107.524 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 75.6 mt -128.96 153.15 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.526 -0.734 . . . . 1.8 110.815 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -105.79 126.81 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.451 0.643 . . . . 2.02 110.169 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' B' ' 11' ' ' ARG . 3.7 p -86.86 166.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.834 -1.173 . . . . 1.1699999999999999 107.834 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.471 ' N ' ' CG2' ' B' ' 10' ' ' VAL . 0.0 OUTLIER -138.78 174.31 10.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 2.9399999999999999 110.902 -178.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.545 ' NZ ' ' CZ ' ' B' ' 41' ' ' ARG . 6.6 pttp -102.49 -12.88 17.49 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.171 -1.048 . . . . 2.2999999999999998 108.171 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.72 -9.44 58.21 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.948 -1.13 . . . . 1.76 107.948 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -92.56 -129.74 0.11 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.451 -1.314 . . . . 1.8999999999999999 107.451 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.15 158.89 10.55 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.09 -1.006 . . . . 1.96 109.37 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 12.9 m -57.69 -39.84 72.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.116 -1.068 . . . . 1.29 108.116 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.482 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 6.5 pt-20 -75.58 -34.04 60.63 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.916 -0.772 . . . . 1.7 108.916 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -63.49 -32.84 74.4 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.852 -1.155 . . . . 1.46 111.6 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.476 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 0.3 OUTLIER -91.96 -16.06 27.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.051 -1.656 . . . . 2.3100000000000001 108.032 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.14 -35.49 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 104.499 -2.408 . . . . 1.2 104.499 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 43.3 mt -67.87 -50.56 55.75 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.785 -1.098 . . . . 1.1899999999999999 109.33 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.34 -33.57 75.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.978 -1.077 . . . . 1.21 109.307 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 34.7 t -66.29 -52.76 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 1.1299999999999999 109.42 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.7 tt -65.3 -19.71 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.99 -1.069 . . . . 1.3999999999999999 109.025 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 41.8 t -75.17 -45.51 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.203 -0.936 . . . . 1.27 109.822 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mt -68.02 -36.94 80.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.699 -1.251 . . . . 1.8300000000000001 109.829 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . 0.559 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 4.6 t80 -58.03 -29.84 65.65 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.229 -1.767 . . . . 2.3500000000000001 106.229 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -26.74 66.57 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.818 -1.083 . . . . 1.6799999999999999 109.176 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -92.2 -1.09 57.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.008 . . . . 1.9399999999999999 109.337 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.02 13.9 18.48 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.765 -0.934 . . . . 0.42999999999999999 110.765 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 12.9 mm -78.2 105.01 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.697 -1.473 . . . . 1.3400000000000001 107.987 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -91.3 -38.87 12.38 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.19 -0.944 . . . . 1.46 109.186 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.7 135.21 43.61 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.278 0.561 . . . . 1.2 110.159 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.41 130.94 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.578 -0.849 . . . . 1.27 110.397 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -106.34 124.37 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.686 -0.634 . . . . 1.1599999999999999 110.069 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.449 ' CD1' ' OH ' ' B' ' 50' ' ' TYR . 2.6 mp -107.94 129.73 55.08 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.451 -0.78 . . . . 1.22 110.887 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -106.11 126.18 51.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.177 -1.046 . . . . 3.2200000000000002 108.177 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.63 153.23 20.96 Favored Glycine 0 N--CA 1.505 3.241 0 C-N-CA 119.873 -1.156 . . . . 0.28000000000000003 110.799 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.635 ' O ' ' N ' ' B' ' 41' ' ' ARG . 24.9 p -133.87 142.65 47.88 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.785 -0.833 . . . . 1.1100000000000001 112.095 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 33.8 -79.23 0.0 OUTLIER Glycine 0 N--CA 1.505 3.277 0 N-CA-C 111.932 -0.467 . . . . 0.28999999999999998 111.932 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.635 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -84.04 -55.4 4.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.037 -1.272 . . . . 3.6699999999999999 109.377 -179.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -17.7 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.024 -1.048 . . . . 1.3799999999999999 109.852 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 6.7 tt -61.64 -22.41 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 1.54 109.913 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.41 -29.72 17.82 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.353 -0.98 . . . . 1.5600000000000001 108.353 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' B' ' 46' ' ' ALA . 7.5 mmtp -60.19 -67.18 0.42 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.332 -1.729 . . . . 2.4399999999999999 106.332 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -32.4 -47.01 0.14 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 116.082 -0.508 . . . . 1.02 111.823 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' B' ' 48' ' ' ASP . 84.9 t -66.4 -61.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.837 -1.164 . . . . 1.1399999999999999 111.3 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' B' ' 49' ' ' VAL . 9.2 t70 -45.54 -51.08 12.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.216 -0.928 . . . . 1.25 109.348 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' B' ' 48' ' ' ASP . 64.3 t -41.71 -54.22 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.751 -0.463 . . . . 1.77 109.751 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' B' ' 54' ' ' LYS . 59.5 m-85 -68.12 -53.56 24.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -0.987 . . . . 4.3499999999999996 111.627 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' B' ' 52' ' ' SER . 0.0 OUTLIER -46.77 -55.76 7.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.858 -1.164 . . . . 1.75 107.858 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.557 ' N ' ' ND2' ' B' ' 51' ' ' ASN . 0.7 OUTLIER -61.17 -39.68 91.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.628 -0.829 . . . . 1.0600000000000001 109.714 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 tp -71.2 -23.96 62.13 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.79 -1.194 . . . . 1.22 108.614 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 50' ' ' TYR . 0.0 OUTLIER -76.5 -47.83 21.53 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.789 -1.56 . . . . 1.8300000000000001 106.789 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -44.67 -17.47 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.993 -1.003 . . . . 1.46 109.276 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' B' ' 54' ' ' LYS . 21.9 mmm180 -65.87 -39.8 91.03 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.38 -0.928 . . . . 1.99 109.997 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.3 tp -156.7 -12.46 0.09 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.429 -1.308 . . . . 2.5699999999999998 111.528 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 67.3 -65.24 0.24 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.849 -1.7 . . . . 0.39000000000000001 108.849 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.5 -41.24 76.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.632 -0.922 . . . . 1.3999999999999999 109.704 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.16 17.07 2.51 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.543 -1.423 . . . . 0.37 109.543 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' B' ' 59' ' ' ASP . 2.5 t -152.32 130.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.05 -1.463 . . . . 1.1799999999999999 107.05 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' B' ' 86' ' ' LYS . 5.4 mm-40 -137.94 152.01 48.54 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.303 1.049 . . . . 2.1200000000000001 112.455 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 tt -94.37 119.12 32.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.906 -1.146 . . . . 1.3799999999999999 107.906 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.49 ' O ' ' ND2' ' B' ' 65' ' ' ASN . 6.9 p -116.32 -13.39 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.337 -0.852 . . . . 2.0 110.853 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' B' ' 64' ' ' VAL . 0.3 OUTLIER -171.23 143.66 1.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.399 -1.438 . . . . 1.8600000000000001 109.482 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 96.7 t -156.83 133.92 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.054 -0.721 . . . . 1.5700000000000001 109.054 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -142.21 159.75 41.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.092 0.949 . . . . 2.04 110.446 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.0 156.14 48.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.78 -0.822 . . . . 0.92000000000000004 108.78 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.681 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -179.74 157.98 21.33 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.745 -2.142 . . . . 0.34999999999999998 107.745 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 68.8 p -96.44 154.63 17.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.051 -1.264 . . . . 0.84999999999999998 109.44 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -153.17 170.7 19.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.827 -1.171 . . . . 1.49 110.446 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.418 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -89.02 137.09 21.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.852 0.834 . . . . 1.46 111.284 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 7.5 ttt-85 -149.78 97.87 2.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.08 -0.711 . . . . 2.8799999999999999 109.08 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 4.0 t0 88.34 36.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.427 -0.583 . . . . 1.3500000000000001 109.427 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 65.01 34.48 8.84 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.214 1.007 . . . . 3.3700000000000001 109.463 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -156.52 154.52 30.44 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.791 -0.818 . . . . 3.8999999999999999 108.791 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -88.11 145.77 25.77 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.585 1.183 . . . . 2.9700000000000002 111.842 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tt -144.36 159.49 15.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.871 -1.058 . . . . 1.3700000000000001 108.194 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' SER . . . . . 0.448 ' HG ' ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -88.09 151.08 22.99 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 121.372 -0.83 . . . . 1.04 109.036 -178.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.681 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.2 p90 -143.83 151.91 40.51 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.615 -0.834 . . . . 4.29 110.37 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 20.4 tt -128.71 135.02 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.643 0.735 . . . . 1.55 111.27 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 7.7 mt -110.69 124.31 51.7 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.69 -1.596 . . . . 1.1599999999999999 106.69 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.67 127.15 39.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.143 -0.973 . . . . 1.55 111.275 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' B' ' 65' ' ' ASN . 17.4 ttt180 -108.26 110.17 21.71 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.557 0.694 . . . . 0.70999999999999996 111.159 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' B' ' 86' ' ' LYS . 1.3 tm? -96.42 140.46 31.04 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.986 -0.746 . . . . 2.1200000000000001 108.986 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -122.35 136.03 54.82 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.406 -0.591 . . . . 2.0 109.406 179.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . 0.559 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 16.4 mmt85 -96.12 140.26 31.09 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.33 -0.856 . . . . 2.2999999999999998 110.296 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . 0.427 ' O ' ' CG1' ' B' ' 88' ' ' VAL . 36.2 t -118.08 -6.77 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.706 -0.85 . . . . 1.46 108.706 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 74.8 t80 . . . . . 0 C--N 1.303 -1.432 0 CA-C-O 117.979 -1.01 . . . . 2.6299999999999999 109.423 179.26 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.576 0.227 . . . . 1.8500000000000001 110.621 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 3.8 pt-20 -89.34 112.23 23.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.066 -1.646 . . . . 1.4399999999999999 108.262 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 35' ' ' ILE . 5.6 mt -128.74 147.25 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 CA-C-O 122.189 0.995 . . . . 1.8300000000000001 112.195 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.91 129.52 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.606 0.717 . . . . 2.0099999999999998 110.336 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 p -87.65 167.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.055 -1.091 . . . . 1.24 108.055 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.91 167.88 20.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 2.8500000000000001 109.977 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -20.65 27.61 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.386 -0.968 . . . . 2.3399999999999999 108.386 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -69.4 -65.41 0.72 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.761 -1.57 . . . . 1.6699999999999999 106.761 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.524 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.4 mtmm -58.24 144.07 42.23 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.216 1.007 . . . . 1.8600000000000001 110.347 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.87 178.86 4.61 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.696 -0.684 . . . . 1.97 110.067 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.61 -28.79 25.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.254 -1.017 . . . . 1.29 108.254 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.4 -33.85 61.01 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.484 -0.886 . . . . 1.5600000000000001 109.119 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.2 -31.59 69.16 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 120.396 -1.44 . . . . 1.3799999999999999 110.925 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.491 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -95.64 -18.3 20.64 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.692 -1.255 . . . . 2.3500000000000001 108.459 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -34.72 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 104.513 -2.403 . . . . 1.1299999999999999 104.513 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 mt -68.33 -52.57 31.97 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.495 -1.23 . . . . 1.1799999999999999 108.771 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -66.34 -29.34 69.51 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.114 -0.991 . . . . 1.22 109.437 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 19.7 t -69.79 -53.24 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 1.1399999999999999 109.453 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.23 -18.03 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.895 -1.128 . . . . 1.3 108.617 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.0 t -75.98 -43.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 119.335 -0.946 . . . . 1.1499999999999999 108.573 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mt -64.79 -33.4 75.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.825 -1.172 . . . . 1.8700000000000001 110.029 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -65.87 -23.0 66.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.877 -1.527 . . . . 2.3599999999999999 106.877 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -61.74 -30.77 70.99 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.123 -0.944 . . . . 1.71 108.811 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -87.82 -6.34 58.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.27 -0.894 . . . . 1.8799999999999999 109.244 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.73 12.45 18.74 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.913 -1.275 . . . . 0.47999999999999998 109.913 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.6 mm -73.88 109.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.138 -1.213 . . . . 1.0900000000000001 109.25 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.22 -37.22 11.66 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.423 -0.798 . . . . 1.55 110.721 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 1.9 mt-10 -97.73 137.85 36.0 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.601 0.715 . . . . 1.5800000000000001 110.793 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.87 137.29 16.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.66 -0.816 . . . . 1.28 109.826 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -117.08 126.04 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.753 -0.658 . . . . 1.0900000000000001 109.591 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 mp -111.76 119.56 39.04 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 120.262 -0.575 . . . . 1.0800000000000001 109.519 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -105.26 132.67 51.17 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.02 -1.104 . . . . 3.21 108.02 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.19 151.79 21.6 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.748 -1.215 . . . . 0.28000000000000003 110.926 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 41' ' ' ARG . 64.3 p -126.01 134.03 51.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.986 -0.714 . . . . 1.1399999999999999 111.673 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 38.4 -83.56 0.0 OUTLIER Glycine 0 N--CA 1.495 2.632 0 O-C-N 121.615 -0.678 . . . . 0.34999999999999998 112.286 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.673 ' HE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.31 -54.2 6.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.127 -1.219 . . . . 3.6000000000000001 110.087 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.38 -20.99 63.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.64 -1.244 . . . . 1.0900000000000001 107.64 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 tt -53.18 -36.46 25.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.233 -0.917 . . . . 1.6599999999999999 110.858 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.61 -20.39 31.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.678 -1.264 . . . . 1.51 108.747 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 46' ' ' ALA . 1.5 mptt -64.32 -71.02 0.19 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.518 -2.03 . . . . 2.4399999999999999 105.518 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -30.44 -48.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.403 0.621 . . . . 1.1000000000000001 110.37 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.94 -71.68 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.378 -0.826 . . . . 1.01 109.995 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.433 ' O ' ' OG ' ' A' ' 52' ' ' SER . 8.4 t70 -42.52 -46.72 4.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.755 -0.59 . . . . 1.26 110.05 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.2 t -48.75 -57.52 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.483 -0.887 . . . . 1.78 108.82 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.571 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -61.03 -55.58 31.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 4.2999999999999998 110.978 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.528 ' ND2' ' OG ' ' B' ' 70' ' ' SER . 4.7 t30 -52.1 -51.14 59.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.873 -1.142 . . . . 1.8500000000000001 107.985 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 5.7 m -60.38 -34.15 73.49 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.528 -0.915 . . . . 1.1799999999999999 108.528 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.1 tp -82.13 -21.64 36.56 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.078 -1.014 . . . . 1.1499999999999999 108.389 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.29 -49.34 12.61 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.701 -1.963 . . . . 1.6599999999999999 105.701 177.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 1.7 t0 -54.43 -8.64 0.23 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.754 -1.202 . . . . 1.5800000000000001 107.754 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.544 ' H ' ' C ' ' A' ' 54' ' ' LYS . 4.6 tpt85 -68.7 -52.88 26.04 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.487 -0.758 . . . . 1.99 109.196 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -153.14 -13.29 0.15 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.347 -0.941 . . . . 2.48 110.948 179.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.94 -47.44 0.07 OUTLIER Glycine 0 N--CA 1.494 2.509 0 C-N-CA 120.043 -1.075 . . . . 0.41999999999999998 110.842 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -72.72 -41.71 64.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.252 -1.146 . . . . 1.3799999999999999 109.986 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.15 22.91 12.7 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.94 -1.264 . . . . 0.29999999999999999 109.94 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t -149.37 132.5 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.979 -1.306 . . . . 1.22 107.705 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.605 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.7 mm-40 -135.51 155.74 50.02 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.034 0.921 . . . . 2.0699999999999998 111.575 -177.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.42 110.01 21.57 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.486 -0.931 . . . . 1.3100000000000001 108.486 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.8 -22.91 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.065 -1.022 . . . . 2.0299999999999998 109.775 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.85 152.56 2.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.699 -1.25 . . . . 1.76 109.759 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.0 t -159.28 128.29 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.863 -0.792 . . . . 1.49 108.863 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 68' ' ' THR . 31.9 tt0 -142.09 157.05 45.35 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.086 0.946 . . . . 2.02 110.531 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.479 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -124.2 150.81 44.8 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.239 -0.892 . . . . 1.1000000000000001 108.737 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.683 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -175.89 148.88 9.57 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 107.607 -2.197 . . . . 0.51000000000000001 107.607 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.613 ' HG ' ' ND2' ' B' ' 51' ' ' ASN . 37.1 p -95.75 158.01 15.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.703 -1.469 . . . . 0.82999999999999996 110.996 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' OE2' ' C ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -150.51 167.63 26.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.162 -0.961 . . . . 1.29 110.073 178.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.403 ' C ' ' OE2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -91.91 141.94 13.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.644 0.735 . . . . 1.54 111.044 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 7.5 ttt-85 -149.25 103.44 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.165 -0.68 . . . . 2.96 109.165 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.4 t70 86.38 36.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.049 0.452 . . . . 1.3799999999999999 110.339 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.29 32.71 12.08 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.174 0.988 . . . . 3.4300000000000002 109.045 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.19 146.12 26.67 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.284 -1.006 . . . . 3.9100000000000001 108.284 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.622 ' NH2' ' ND2' ' B' ' 51' ' ' ASN . 8.1 ttt180 -85.91 139.73 30.98 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.893 1.33 . . . . 2.9900000000000002 110.614 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.6 tt -142.71 154.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 114.276 -1.329 . . . . 1.0700000000000001 107.986 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.8 p -88.37 161.64 16.98 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 119.335 -0.946 . . . . 1.03 110.444 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.683 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.4 p90 -148.35 156.4 42.46 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.313 -0.955 . . . . 4.2599999999999998 110.244 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.3 tt -129.68 139.05 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.746 0.784 . . . . 1.5800000000000001 110.485 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.7 mt -111.32 124.0 51.35 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.952 -1.129 . . . . 1.05 107.952 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 tt -131.64 126.52 34.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.122 -0.987 . . . . 1.6699999999999999 110.61 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -102.88 172.42 6.84 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.315 0.578 . . . . 0.65000000000000002 109.789 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 1.9 tp -160.82 144.93 13.7 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 118.679 -1.208 . . . . 2.02 110.999 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.605 ' O ' ' N ' ' A' ' 62' ' ' GLN . 14.0 tptt -125.57 136.35 53.2 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.574 0.702 . . . . 2.02 109.936 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.406 ' N ' ' HD2' ' A' ' 86' ' ' LYS . 22.6 mmt180 -94.41 136.4 34.75 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.059 -1.026 . . . . 2.2999999999999998 109.663 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 88' ' ' VAL . 69.4 t -121.62 1.21 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.824 -0.806 . . . . 1.3899999999999999 108.824 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.424 ' CD2' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.383 0 CA-C-O 118.001 -0.999 . . . . 2.6200000000000001 109.512 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 110.214 -0.291 . . . . 1.72 110.214 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.8 pt-20 -90.12 110.32 21.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.165 -1.585 . . . . 1.49 108.897 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.41 142.52 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.848 0.832 . . . . 1.8 110.677 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 63.2 t -104.22 130.47 54.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.49 0.662 . . . . 2.02 109.581 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.49 166.13 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.516 -0.92 . . . . 1.1699999999999999 108.516 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.414 ' NE ' ' CE ' ' B' ' 14' ' ' LYS . 6.7 mtt180 -139.09 171.58 14.1 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.01 0.909 . . . . 2.9399999999999999 110.507 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.04 -11.52 20.5 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.187 -1.042 . . . . 2.2999999999999998 108.187 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.86 -14.35 54.44 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.637 -0.825 . . . . 1.76 109.758 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' B' ' 15' ' ' ASN . 1.2 mttm -98.57 -120.65 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.281 -1.007 . . . . 1.8999999999999999 108.281 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' B' ' 14' ' ' LYS . 0.7 OUTLIER -170.94 172.44 5.53 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.097 -1.002 . . . . 1.96 109.15 179.306 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -72.38 -35.25 51.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.115 -1.069 . . . . 1.29 108.115 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 10.0 pt-20 -72.46 -41.67 65.82 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.495 -0.928 . . . . 1.7 108.495 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . 0.464 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 68.2 t0 -62.49 -30.81 71.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.141 -0.974 . . . . 1.46 112.082 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 0.1 OUTLIER -91.34 -16.46 27.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 119.892 -1.755 . . . . 2.3100000000000001 108.289 178.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 t -75.19 -40.11 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 105.152 -2.166 . . . . 1.2 105.152 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.31 -49.46 75.54 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.909 -1.041 . . . . 1.1899999999999999 108.481 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -67.3 -32.13 72.9 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.565 -0.854 . . . . 1.21 109.685 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 41.0 t -69.57 -54.55 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.291 -0.881 . . . . 1.1299999999999999 110.068 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 20.4 tt -61.15 -24.05 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.893 -1.129 . . . . 1.3999999999999999 108.864 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -68.19 -41.5 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -0.922 . . . . 1.27 108.951 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -66.52 -43.12 86.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.121 -0.987 . . . . 1.8300000000000001 109.7 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -55.19 -31.49 61.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.735 -1.58 . . . . 2.3500000000000001 106.735 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -55.69 -30.69 61.53 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.273 -0.876 . . . . 1.6799999999999999 108.777 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -87.96 -3.02 58.95 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.809 -0.811 . . . . 1.9399999999999999 108.809 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.19 15.98 22.14 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.608 -1.397 . . . . 0.42999999999999999 109.608 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.405 HG23 HD12 ' B' ' 31' ' ' ILE . 36.8 mm -77.36 111.42 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.148 -1.207 . . . . 1.3400000000000001 108.421 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.39 -35.83 12.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.272 -0.893 . . . . 1.46 111.015 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -101.64 141.6 34.25 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.626 0.727 . . . . 1.2 110.954 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' B' ' 34' ' ' VAL . 0.8 OUTLIER -149.5 122.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.146 0.974 . . . . 1.27 111.096 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.21 122.91 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.613 -0.679 . . . . 1.1599999999999999 109.254 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mp -105.57 121.76 44.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.431 -0.793 . . . . 1.22 110.087 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -103.34 128.41 50.43 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.736 -0.839 . . . . 3.2200000000000002 108.736 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.51 150.83 20.64 Favored Glycine 0 N--CA 1.502 3.037 0 C-N-CA 119.572 -1.299 . . . . 0.28000000000000003 110.805 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.613 ' O ' ' N ' ' B' ' 41' ' ' ARG . 47.3 p -129.86 141.24 50.85 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.888 -0.772 . . . . 1.1100000000000001 111.841 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 32.84 -82.0 0.0 OUTLIER Glycine 0 N--CA 1.504 3.195 0 N-CA-C 111.785 -0.526 . . . . 0.28999999999999998 111.785 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.645 ' N ' ' HE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -80.14 -53.13 6.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.087 -1.243 . . . . 3.6699999999999999 110.057 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -13.7 57.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.945 -1.097 . . . . 1.3799999999999999 109.296 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.407 ' CG2' ' O ' ' B' ' 40' ' ' GLY . 8.1 tt -60.65 -26.03 36.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.26 -0.9 . . . . 1.54 109.711 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.58 -25.95 23.34 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.29 -1.004 . . . . 1.5600000000000001 108.29 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' B' ' 46' ' ' ALA . 2.6 mptt -63.75 -70.54 0.21 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.5 -1.667 . . . . 2.4399999999999999 106.5 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -32.97 -41.17 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.217 0.532 . . . . 1.02 110.99 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.63 -64.9 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.142 -0.974 . . . . 1.1399999999999999 109.567 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' B' ' 49' ' ' VAL . 5.8 t70 -48.47 -50.72 30.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.189 -0.944 . . . . 1.25 109.276 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' B' ' 48' ' ' ASP . 38.0 t -42.39 -56.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.96 -0.755 . . . . 1.77 108.96 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' B' ' 50' ' ' TYR . 0.0 OUTLIER -67.66 -54.33 20.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.447 -0.783 . . . . 4.3499999999999996 110.564 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . 0.622 ' ND2' ' NH2' ' A' ' 77' ' ' ARG . 2.8 t30 -48.5 -57.98 5.35 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.119 -1.032 . . . . 1.75 108.531 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -57.95 -30.81 66.27 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.172 -1.011 . . . . 1.0600000000000001 109.649 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 46.0 tp -75.05 -21.74 58.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 1.22 110.287 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.46 -27.95 25.35 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.373 -1.714 . . . . 1.8300000000000001 106.373 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.412 ' OD2' ' NH2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -59.08 -14.52 10.17 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.686 -1.227 . . . . 1.46 107.686 177.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -75.74 -43.92 44.34 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.618 -0.833 . . . . 1.99 109.487 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' B' ' 59' ' ' ASP . 0.2 OUTLIER -152.1 -20.71 0.18 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.624 -1.23 . . . . 2.5699999999999998 112.291 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.66 -56.02 0.14 Allowed Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.275 -1.441 . . . . 0.39000000000000001 110.035 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.58 -43.27 73.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.295 -1.121 . . . . 1.3999999999999999 109.989 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.52 24.97 4.66 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.9 -1.28 . . . . 0.37 109.9 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.24 130.25 4.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.478 -1.304 . . . . 1.1799999999999999 107.478 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' B' ' 86' ' ' LYS . 4.0 mm-40 -132.27 159.21 39.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.002 0.906 . . . . 2.1200000000000001 111.471 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.34 112.72 25.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.473 -0.936 . . . . 1.3799999999999999 108.473 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -23.51 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.161 -0.962 . . . . 2.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' B' ' 84' ' ' ARG . 0.3 OUTLIER -174.21 151.03 1.59 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.491 -1.38 . . . . 1.8600000000000001 109.457 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 96.6 t -156.85 132.74 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.722 -0.844 . . . . 1.5700000000000001 108.722 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . 0.467 ' CG ' ' N ' ' B' ' 68' ' ' THR . 28.4 tt0 -145.94 165.21 29.62 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.282 1.039 . . . . 2.04 110.823 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' THR . . . . . 0.467 ' N ' ' CG ' ' B' ' 67' ' ' GLN . 0.8 OUTLIER -135.72 154.8 51.14 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.221 -0.9 . . . . 0.92000000000000004 108.699 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.711 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -176.71 153.2 13.52 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 107.767 -2.133 . . . . 0.34999999999999998 107.767 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.534 ' OG ' ' NH2' ' B' ' 77' ' ' ARG . 6.0 p -96.57 155.98 16.54 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.882 1.341 . . . . 0.84999999999999998 109.382 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -148.98 166.75 27.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.946 -1.096 . . . . 1.49 110.05 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.42 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.2 OUTLIER -90.03 136.95 22.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.845 -0.742 . . . . 1.46 110.542 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.8 ttt-85 -147.17 101.52 3.41 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.337 -0.616 . . . . 2.8799999999999999 109.337 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 1.8 t70 83.02 39.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.427 -0.583 . . . . 1.3500000000000001 109.427 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.17 32.61 14.96 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.915 0.864 . . . . 3.3700000000000001 109.273 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.32 153.88 36.87 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.453 -0.779 . . . . 3.8999999999999999 109.207 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.534 ' NH2' ' OG ' ' B' ' 70' ' ' SER . 1.3 tpt180 -88.36 136.28 33.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.729 0.776 . . . . 2.9700000000000002 110.922 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 11.9 tt -136.31 153.54 31.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.743 -0.836 . . . . 1.3700000000000001 108.743 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 151.59 22.81 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.332 -0.855 . . . . 1.04 109.039 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.711 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.0 p90 -144.35 150.86 38.48 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.467 -0.893 . . . . 4.29 110.313 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 tt -126.12 135.83 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.53 0.681 . . . . 1.55 109.972 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 12.2 mt -109.23 121.19 44.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.168 -1.419 . . . . 1.1599999999999999 107.168 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.25 121.23 35.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.111 -0.993 . . . . 1.55 110.338 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' B' ' 65' ' ' ASN . 19.9 ttt180 -110.12 107.02 16.7 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.264 0.554 . . . . 0.70999999999999996 110.259 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 tp -104.01 151.54 23.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.591 -0.693 . . . . 2.1200000000000001 110.609 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.1 OUTLIER -126.65 157.27 39.42 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.757 -0.46 . . . . 2.0 109.757 -179.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -109.98 141.94 42.06 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.225 -0.922 . . . . 2.2999999999999998 110.037 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' B' ' 88' ' ' VAL . 18.8 t -121.94 -9.98 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.907 -0.775 . . . . 1.46 108.907 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 118.066 -0.969 . . . . 2.6299999999999999 109.537 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.426 ' ND2' ' CD1' ' A' ' 8' ' ' ILE . 47.3 t30 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 121.33 0.586 . . . . 1.8500000000000001 111.193 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -93.82 123.47 37.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 1.4399999999999999 108.384 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.426 ' CD1' ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -130.38 151.81 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 122.632 1.206 . . . . 1.8300000000000001 113.356 -177.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -104.7 127.11 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.317 -0.856 . . . . 2.0099999999999998 109.585 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.93 166.63 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.899 . . . . 1.24 108.777 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.1 174.17 10.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.176 -0.952 . . . . 2.8500000000000001 110.462 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.661 ' HZ2' ' HE ' ' A' ' 41' ' ' ARG . 12.4 pttt -94.99 -13.66 25.08 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.66 -0.867 . . . . 2.3399999999999999 108.66 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 t -86.58 1.33 52.09 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.727 -1.212 . . . . 1.6699999999999999 107.727 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.75 128.59 53.06 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.964 -1.495 . . . . 1.8600000000000001 106.964 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.28 -178.4 1.68 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.831 -0.748 . . . . 1.97 109.865 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 m -79.93 -27.96 12.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 106.796 -1.557 . . . . 1.29 106.796 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.72 -46.88 28.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.626 -0.716 . . . . 1.5600000000000001 109.369 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.79 -28.64 69.6 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.915 -1.115 . . . . 1.3799999999999999 110.957 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.464 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -92.08 -15.65 27.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.426 -1.421 . . . . 2.3500000000000001 109.688 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.91 -30.39 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 105.197 -2.149 . . . . 1.1299999999999999 105.197 176.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.5 mt -70.12 -53.51 16.98 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.866 -1.061 . . . . 1.1799999999999999 108.834 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -65.2 -26.32 68.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 1.22 109.728 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 38.6 t -73.64 -50.14 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.59 -0.893 . . . . 1.1399999999999999 108.59 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.75 -23.59 23.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.543 -0.91 . . . . 1.3 108.543 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.71 -42.81 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.247 -0.908 . . . . 1.1499999999999999 109.913 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.408 ' CD2' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -68.53 -33.64 74.47 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.447 -1.408 . . . . 1.8700000000000001 109.805 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.75 -27.13 68.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.166 -1.42 . . . . 2.3599999999999999 107.166 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.97 -26.27 68.5 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.239 -0.891 . . . . 1.71 109.887 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -88.97 -1.98 58.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.841 -1.162 . . . . 1.8799999999999999 109.267 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.5 14.52 19.7 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.766 -1.334 . . . . 0.47999999999999998 109.766 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 20.7 mm -75.92 107.49 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -1.147 . . . . 1.0900000000000001 108.298 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 33' ' ' GLU . 1.6 p30 -93.65 -38.59 11.26 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.433 -0.792 . . . . 1.55 110.594 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 7.7 mt-10 -97.69 142.02 29.99 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.561 -0.712 . . . . 1.5800000000000001 110.189 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.32 139.98 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.041 -1.064 . . . . 1.28 111.157 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.55 129.28 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 122.054 -0.404 . . . . 1.0900000000000001 110.077 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mp -115.21 126.31 54.41 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.599 0.714 . . . . 1.0800000000000001 110.277 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.41 127.19 45.43 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.905 -1.146 . . . . 3.21 107.905 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.54 143.31 14.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.725 -1.226 . . . . 0.28000000000000003 110.51 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 41' ' ' ARG . 31.8 p -131.07 138.45 49.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.922 -0.752 . . . . 1.1399999999999999 111.643 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' THR . . . 35.41 -83.11 0.0 OUTLIER Glycine 0 N--CA 1.501 3.008 0 O-C-N 121.735 -0.603 . . . . 0.34999999999999998 112.247 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.661 ' HE ' ' HZ2' ' A' ' 12' ' ' LYS . 0.2 OUTLIER -82.97 -56.32 3.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.249 . . . . 3.6000000000000001 109.886 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -15.17 8.71 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.99 -1.115 . . . . 1.0900000000000001 107.99 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.416 ' CG2' ' CG2' ' B' ' 43' ' ' ILE . 0.1 OUTLIER -55.5 -32.89 31.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.408 -0.807 . . . . 1.6599999999999999 111.131 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.678 ' HG ' ' HG ' ' B' ' 79' ' ' SER . 0.5 OUTLIER -88.17 -22.9 23.79 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.963 -1.086 . . . . 1.51 108.221 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 46' ' ' ALA . 2.7 mptt -62.35 -72.39 0.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.747 -1.946 . . . . 2.4399999999999999 105.747 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -33.24 -46.72 0.18 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.094 0.473 . . . . 1.1000000000000001 110.673 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.51 -61.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.003 . . . . 1.01 109.297 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 49' ' ' VAL . 10.5 t70 -51.33 -54.4 26.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 1.26 108.847 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 48' ' ' ASP . 46.7 t -42.66 -58.24 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.543 -0.91 . . . . 1.78 108.543 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 54' ' ' LYS . 3.0 m-30 -62.14 -50.6 71.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.85 -0.531 . . . . 4.2999999999999998 110.982 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.527 ' ND2' ' OG ' ' B' ' 70' ' ' SER . 0.8 OUTLIER -56.07 -49.69 73.08 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.78 -1.193 . . . . 1.8500000000000001 107.78 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 4.3 p -59.96 -33.86 72.51 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.423 -0.954 . . . . 1.1799999999999999 108.423 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 57.0 tp -79.06 -19.86 50.3 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.985 -1.117 . . . . 1.1499999999999999 107.985 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.58 -44.47 17.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.539 -2.022 . . . . 1.6599999999999999 105.539 177.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -59.34 -5.98 0.88 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.565 -1.272 . . . . 1.5800000000000001 107.565 177.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 54' ' ' LYS . 4.6 tpt85 -71.05 -49.13 48.11 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.58 -0.7 . . . . 1.99 109.247 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.2 mt -151.64 -21.86 0.19 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.437 -0.905 . . . . 2.48 110.302 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.15 -49.44 0.09 OUTLIER Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.847 -1.168 . . . . 0.41999999999999998 110.431 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -73.84 -45.41 51.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -1.202 . . . . 1.3799999999999999 109.929 -178.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.2 27.68 4.97 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.846 -1.702 . . . . 0.29999999999999999 108.846 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.475 ' CG2' ' NH1' ' A' ' 87' ' ' ARG . 5.7 t -151.84 129.39 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 107.525 -1.287 . . . . 1.22 107.525 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.0 mm100 -134.39 157.79 45.52 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.964 0.888 . . . . 2.0699999999999998 111.577 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tt -97.57 113.45 25.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.45 -0.944 . . . . 1.3100000000000001 108.45 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -23.31 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.122 -0.986 . . . . 2.0299999999999998 109.318 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.11 157.2 5.07 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.676 -1.21 . . . . 1.76 109.718 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.9 p -163.42 133.11 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.356 -0.84 . . . . 1.49 109.614 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.464 ' CG ' ' N ' ' A' ' 68' ' ' THR . 32.7 tt0 -145.9 163.12 36.11 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.271 1.034 . . . . 2.02 111.271 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.464 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -138.74 149.0 44.58 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.654 -0.869 . . . . 1.1000000000000001 108.654 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.662 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -174.42 160.42 29.89 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 107.701 -2.16 . . . . 0.51000000000000001 107.701 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.533 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 40.0 p -102.02 158.85 15.85 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.777 1.288 . . . . 0.82999999999999996 110.583 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.8 OUTLIER -154.23 173.96 15.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 1.29 110.312 178.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.9 138.45 19.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.611 0.72 . . . . 1.54 111.262 -178.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 1.0 OUTLIER -148.16 101.77 3.3 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.045 -0.724 . . . . 2.96 109.045 177.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.0 t70 86.41 36.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.181 0.515 . . . . 1.3799999999999999 110.144 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.68 30.7 6.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.25 -0.906 . . . . 3.4300000000000002 109.338 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.18 151.62 32.15 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.244 -0.91 . . . . 3.9100000000000001 109.477 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -85.3 137.98 32.61 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.566 1.174 . . . . 2.9900000000000002 109.598 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 tt -143.35 155.91 16.8 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 114.925 -1.034 . . . . 1.0700000000000001 108.549 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.607 ' HG ' ' HG ' ' B' ' 44' ' ' SER . 14.0 p -90.35 155.8 18.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.986 0.898 . . . . 1.03 111.44 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.662 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 6.1 p90 -142.48 148.38 37.6 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.79 -0.641 . . . . 4.2599999999999998 109.977 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 pp -123.12 133.72 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.184 -1.043 . . . . 1.5800000000000001 108.184 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 67' ' ' GLN . 16.2 mt -106.89 126.06 51.82 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.437 -0.949 . . . . 1.05 108.437 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.454 ' CD1' ' OG1' ' B' ' 68' ' ' THR . 0.5 OUTLIER -131.52 123.7 28.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.981 -1.075 . . . . 1.6699999999999999 111.025 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -102.46 165.58 11.02 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.197 -0.91 . . . . 0.65000000000000002 110.372 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 2.5 tp -157.67 144.68 18.18 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 119.302 -0.959 . . . . 2.02 111.423 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -126.4 143.69 51.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.17 0.509 . . . . 2.02 110.326 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.475 ' NH1' ' CG2' ' A' ' 61' ' ' VAL . 20.3 mmt180 -96.9 139.05 33.51 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.379 -0.826 . . . . 2.2999999999999998 110.049 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 51.4 t -117.14 -9.66 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.791 -0.818 . . . . 1.3899999999999999 108.791 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 117.977 -1.011 . . . . 2.6200000000000001 109.511 179.577 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 120.878 0.37 . . . . 1.72 110.664 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.0 pt-20 -94.01 107.37 19.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.661 -1.274 . . . . 1.49 107.724 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.44 146.33 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 122.205 1.002 . . . . 1.8 110.884 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.19 124.53 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.86 -0.609 . . . . 2.02 109.375 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.43 166.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.376 -0.972 . . . . 1.1699999999999999 108.376 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -136.9 168.34 19.75 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.815 0.817 . . . . 2.9399999999999999 110.927 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.636 ' HZ2' ' HE ' ' B' ' 41' ' ' ARG . 14.2 pttt -87.62 -11.36 48.75 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.899 -0.778 . . . . 2.2999999999999998 108.899 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' THR . . . . . 0.403 HG21 ' H ' ' B' ' 14' ' ' LYS . 0.1 OUTLIER -76.23 -64.21 1.15 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.436 -1.306 . . . . 1.76 107.806 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.403 ' H ' HG21 ' B' ' 13' ' ' THR . 0.0 OUTLIER -58.08 146.72 32.06 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.906 -1.121 . . . . 1.8999999999999999 109.813 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.91 -179.8 6.26 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.049 -0.723 . . . . 1.96 109.049 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -76.75 -32.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.335 -0.987 . . . . 1.29 108.335 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -81.04 -33.71 33.33 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.648 -0.871 . . . . 1.7 108.648 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -67.32 -28.32 67.89 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.742 -1.224 . . . . 1.46 109.843 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.419 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 0.1 OUTLIER -91.37 -18.18 24.67 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.385 -1.447 . . . . 2.3100000000000001 108.644 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.96 -29.39 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 104.98 -2.23 . . . . 1.2 104.98 176.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 34.9 mt -69.78 -50.75 40.1 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.498 -1.228 . . . . 1.1899999999999999 108.52 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -65.82 -26.37 67.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.796 -1.19 . . . . 1.21 109.335 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 77.2 t -74.71 -54.76 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.945 . . . . 1.1299999999999999 109.719 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.542 ' CD1' HH22 ' B' ' 87' ' ' ARG . 3.9 tp -57.72 -19.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.064 -1.022 . . . . 1.3999999999999999 108.574 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 50.4 t -70.83 -41.59 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.185 -0.947 . . . . 1.27 109.48 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' B' ' 26' ' ' LEU . 0.3 OUTLIER -70.06 -37.99 75.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.539 -1.35 . . . . 1.8300000000000001 109.766 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.08 -29.36 67.28 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.608 -1.627 . . . . 2.3500000000000001 106.608 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -25.59 65.98 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.035 -0.984 . . . . 1.6799999999999999 108.986 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -90.41 -7.17 53.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.959 . . . . 1.9399999999999999 109.194 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.01 15.07 10.27 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.287 -1.125 . . . . 0.42999999999999999 110.287 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 40.4 mm -76.74 106.26 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.781 -1.423 . . . . 1.3400000000000001 108.471 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.7 -36.46 14.32 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.36 -0.838 . . . . 1.46 110.178 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -102.49 141.72 34.86 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.55 0.69 . . . . 1.2 110.582 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.66 141.94 15.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 119.504 -0.878 . . . . 1.27 110.72 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.2 120.96 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 109.613 -0.514 . . . . 1.1599999999999999 109.613 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.65 131.96 53.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.565 -0.71 . . . . 1.22 110.529 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.31 127.15 49.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.338 -0.986 . . . . 3.2200000000000002 108.338 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.28 141.64 12.82 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.993 -1.099 . . . . 0.28000000000000003 110.443 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.57 ' O ' ' N ' ' B' ' 41' ' ' ARG . 62.4 p -131.68 137.14 48.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.636 -0.92 . . . . 1.1100000000000001 111.42 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 35.81 -84.9 0.01 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 111.793 -0.523 . . . . 0.28999999999999998 111.793 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.636 ' HE ' ' HZ2' ' B' ' 12' ' ' LYS . 0.1 OUTLIER -82.3 -54.69 5.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.917 -1.343 . . . . 3.6699999999999999 109.767 -178.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -16.66 11.65 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.574 -1.269 . . . . 1.3799999999999999 107.574 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.416 ' CG2' ' CG2' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -55.64 -33.46 33.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.214 -0.929 . . . . 1.54 110.368 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.607 ' HG ' ' HG ' ' A' ' 79' ' ' SER . 0.5 OUTLIER -82.17 -22.44 36.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.121 -0.987 . . . . 1.5600000000000001 108.648 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' B' ' 46' ' ' ALA . 1.2 mptt -68.07 -71.86 0.2 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.326 -1.361 . . . . 2.4399999999999999 107.326 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -37.12 -47.56 0.76 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.05 0.452 . . . . 1.02 110.555 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.11 -61.35 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.096 -1.003 . . . . 1.1399999999999999 109.034 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ASP . . . . . 0.445 ' O ' ' OG ' ' B' ' 52' ' ' SER . 10.7 t70 -56.4 -49.73 73.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.291 -0.881 . . . . 1.25 109.149 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -46.2 -56.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.411 -0.959 . . . . 1.77 108.411 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -64.54 -54.45 31.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.5 -0.75 . . . . 4.3499999999999996 110.75 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . 0.533 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -50.77 -52.52 40.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.616 -1.303 . . . . 1.75 108.398 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 1.1 m -59.88 -30.21 68.84 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.649 -0.82 . . . . 1.0600000000000001 109.522 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 27.7 tp -74.07 -23.62 59.39 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.966 -1.084 . . . . 1.22 109.55 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . 0.407 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -82.26 -30.47 30.66 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.664 -1.606 . . . . 1.8300000000000001 106.664 178.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -14.67 6.31 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.752 -1.203 . . . . 1.46 107.752 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.407 ' N ' ' C ' ' B' ' 54' ' ' LYS . 20.5 mmm180 -73.29 -42.85 61.95 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.587 -0.845 . . . . 1.99 109.626 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.7 mt -153.32 -21.05 0.15 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.117 -1.433 . . . . 2.5699999999999998 112.678 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.21 -62.0 0.06 OUTLIER Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.187 -1.482 . . . . 0.39000000000000001 110.212 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -67.74 -38.39 83.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.259 -1.142 . . . . 1.3999999999999999 109.555 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.83 28.2 6.7 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.07 -1.612 . . . . 0.37 109.07 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.437 ' CG2' ' NH1' ' B' ' 87' ' ' ARG . 4.0 t -153.96 132.31 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.554 -1.276 . . . . 1.1799999999999999 107.554 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.7 mm100 -135.55 154.16 51.46 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.876 0.846 . . . . 2.1200000000000001 111.608 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 tt -94.43 118.57 31.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.482 -0.933 . . . . 1.3799999999999999 108.482 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.66 -17.82 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.815 . . . . 2.0 110.551 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -178.4 157.29 1.01 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.651 -1.281 . . . . 1.8600000000000001 109.458 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -165.26 136.83 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.408 -0.807 . . . . 1.5700000000000001 109.353 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . 0.436 ' CG ' ' N ' ' B' ' 68' ' ' THR . 33.1 tt0 -148.48 165.17 31.99 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.424 1.107 . . . . 2.04 111.546 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' THR . . . . . 0.454 ' OG1' ' CD1' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -138.44 152.02 47.97 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.207 -0.906 . . . . 0.92000000000000004 108.56 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.66 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -176.96 157.36 22.35 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.261 -2.336 . . . . 0.34999999999999998 107.261 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.527 ' OG ' ' ND2' ' A' ' 51' ' ' ASN . 59.6 p -96.1 159.05 15.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.903 -1.351 . . . . 0.84999999999999998 109.41 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -154.03 172.39 17.57 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.002 -1.061 . . . . 1.49 109.95 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.52 134.02 29.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.768 -0.773 . . . . 1.46 110.64 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 0.0 OUTLIER -143.58 100.4 3.59 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.303 -0.628 . . . . 2.8799999999999999 109.303 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.7 t70 79.82 41.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.825 -0.547 . . . . 1.3500000000000001 109.888 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.14 26.31 10.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.34 -0.85 . . . . 3.3700000000000001 109.267 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.18 154.93 38.85 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.426 -0.796 . . . . 3.8999999999999999 109.341 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -88.72 136.53 32.96 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.209 -0.996 . . . . 2.9700000000000002 111.29 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.74 154.02 33.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.104 -1.073 . . . . 1.3700000000000001 108.104 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' SER . . . . . 0.678 ' HG ' ' HG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -86.32 152.57 22.64 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.552 -0.717 . . . . 1.04 109.809 -177.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.66 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 5.8 p90 -142.51 146.67 34.94 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.768 -0.773 . . . . 4.29 109.992 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.64 133.59 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.016 -1.105 . . . . 1.55 108.016 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 13.2 mt -109.24 122.74 47.98 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.336 -1.357 . . . . 1.1599999999999999 107.336 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.429 ' CD1' ' OG1' ' A' ' 68' ' ' THR . 0.4 OUTLIER -128.67 127.22 41.72 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.088 -1.045 . . . . 1.55 110.921 -178.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -102.02 169.32 8.83 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.494 -0.775 . . . . 0.70999999999999996 109.456 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tp -160.45 140.22 11.12 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.288 -0.965 . . . . 2.1200000000000001 110.24 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.1 OUTLIER -123.11 146.39 47.76 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.528 -0.545 . . . . 2.0 109.528 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . 0.542 HH22 ' CD1' ' B' ' 24' ' ' ILE . 20.4 mmt180 -98.48 136.2 38.95 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.836 . . . . 2.2999999999999998 110.216 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . 0.441 ' O ' ' CG1' ' B' ' 88' ' ' VAL . 23.2 t -113.4 -7.61 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.587 -0.894 . . . . 1.46 108.587 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 117.941 -1.028 . . . . 2.6299999999999999 109.48 179.559 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.49 ' ND2' ' CG1' ' A' ' 8' ' ' ILE . 50.0 t30 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 121.252 0.548 . . . . 1.8500000000000001 111.123 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 7' ' ' GLU . 9.9 pt-20 -91.91 119.47 31.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.893 -1.13 . . . . 1.4399999999999999 109.045 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.49 ' CG1' ' ND2' ' A' ' 6' ' ' ASN . 3.5 mm -124.42 147.99 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 CA-C-O 122.32 1.057 . . . . 1.8300000000000001 112.091 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.3 t -111.6 130.31 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.783 0.801 . . . . 2.0099999999999998 109.959 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -88.33 161.47 2.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.257 -1.016 . . . . 1.24 108.257 -178.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -132.9 166.41 22.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.234 -0.916 . . . . 2.8500000000000001 110.321 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -25.26 39.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.739 -0.837 . . . . 2.3399999999999999 108.739 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.8 p -68.61 -63.04 1.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.224 -1.769 . . . . 1.6699999999999999 106.224 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.507 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 11.9 mptt -55.42 131.93 47.07 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.068 0.937 . . . . 1.8600000000000001 110.123 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -72.12 180.0 3.07 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.592 0.71 . . . . 1.97 110.002 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 17' ' ' GLU . 4.0 m -73.45 -33.68 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.443 -1.317 . . . . 1.29 107.443 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 3.7 tt0 -72.65 -37.48 67.97 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.358 -0.979 . . . . 1.5600000000000001 108.358 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -31.42 67.14 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.035 -1.041 . . . . 1.3799999999999999 111.439 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.485 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 54.3 m-70 -93.69 -17.33 23.33 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.217 -1.552 . . . . 2.3500000000000001 108.66 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -34.14 59.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 104.296 -2.483 . . . . 1.1299999999999999 104.296 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.6 mt -70.45 -51.14 31.45 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.72 -1.127 . . . . 1.1799999999999999 109.362 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.86 -30.94 71.24 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.888 -1.133 . . . . 1.22 109.298 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 53.4 t -70.62 -55.22 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -0.86 . . . . 1.1399999999999999 109.822 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.3 tt -60.85 -19.77 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.939 -1.101 . . . . 1.3 108.594 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -73.39 -42.99 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.211 -0.931 . . . . 1.1499999999999999 108.961 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -65.61 -34.88 79.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.773 -1.204 . . . . 1.8700000000000001 110.102 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -64.39 -26.22 68.37 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.319 -1.363 . . . . 2.3599999999999999 107.319 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -26.92 68.71 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.309 -0.86 . . . . 1.71 109.646 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -90.26 1.77 56.15 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.909 -1.119 . . . . 1.8799999999999999 109.402 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.65 13.81 31.38 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.201 -1.559 . . . . 0.47999999999999998 109.201 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mm -75.57 109.27 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.252 -1.146 . . . . 1.0900000000000001 108.007 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -99.87 6.51 45.3 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.251 -0.906 . . . . 1.55 110.736 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -146.43 147.1 30.89 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.929 -1.107 . . . . 1.5800000000000001 108.936 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.53 142.02 11.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 118.786 -1.166 . . . . 1.28 111.017 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -114.42 120.61 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.634 -0.712 . . . . 1.0900000000000001 109.312 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mp -105.21 121.31 43.58 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.978 -0.689 . . . . 1.0800000000000001 109.812 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -108.03 133.18 52.7 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.89 -0.782 . . . . 3.21 108.89 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.488 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -144.31 157.19 27.1 Favored Glycine 0 N--CA 1.503 3.114 0 C-N-CA 119.879 -1.153 . . . . 0.28000000000000003 111.539 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.56 ' CG2' ' CD2' ' A' ' 80' ' ' TYR . 10.2 p -137.88 145.23 41.9 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.582 -0.952 . . . . 1.1399999999999999 112.856 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 38.38 -87.26 0.01 OUTLIER Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.687 -0.965 . . . . 0.34999999999999998 110.687 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.664 ' HE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -80.22 -52.59 7.56 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.327 -1.102 . . . . 3.6000000000000001 109.829 -178.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.75 -19.61 64.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.892 -1.13 . . . . 1.0900000000000001 109.145 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 44' ' ' SER . 7.1 tt -54.71 -35.49 33.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.142 -0.974 . . . . 1.6599999999999999 111.202 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.432 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.32 -22.71 32.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.953 -1.092 . . . . 1.51 108.875 -178.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.475 ' O ' ' C ' ' A' ' 46' ' ' ALA . 1.3 mptt -63.47 -69.34 0.28 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.069 -2.196 . . . . 2.4399999999999999 105.069 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -34.22 -38.1 0.06 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.479 0.657 . . . . 1.1000000000000001 109.843 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' LYS . 99.0 t -74.01 -73.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.243 -0.91 . . . . 1.01 109.546 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.409 ' O ' ' OG ' ' A' ' 52' ' ' SER . 6.7 t70 -40.41 -53.21 2.66 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.351 0.596 . . . . 1.26 111.103 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' LEU . 13.2 p -55.7 -47.64 78.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.318 -0.864 . . . . 1.78 109.486 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.633 ' CD2' ' N ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -61.37 -54.86 38.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.665 -1.272 . . . . 4.2999999999999998 109.284 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.633 ' N ' ' CD2' ' A' ' 50' ' ' TYR . 27.9 t-20 -56.22 -48.55 76.24 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.546 -1.279 . . . . 1.8500000000000001 107.546 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 14.6 m -60.72 -32.7 71.95 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.915 -1.143 . . . . 1.1799999999999999 107.915 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 49' ' ' VAL . 10.5 tp -80.69 -20.85 42.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.64 -1.244 . . . . 1.1499999999999999 107.64 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.14 -46.49 14.83 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.906 -1.887 . . . . 1.6599999999999999 105.906 177.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -57.66 -6.53 0.52 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.772 -1.195 . . . . 1.5800000000000001 107.772 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.53 ' H ' ' C ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -70.1 -50.42 41.01 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 121.427 -0.796 . . . . 1.99 109.251 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.2 mt -152.19 -16.71 0.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.169 -1.013 . . . . 2.48 110.748 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.53 -50.48 0.07 OUTLIER Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.75 -1.214 . . . . 0.41999999999999998 110.609 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -74.62 -47.1 34.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -1.176 . . . . 1.3799999999999999 110.35 -178.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.68 27.17 3.41 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.748 -1.741 . . . . 0.29999999999999999 108.748 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' H ' ' C ' ' A' ' 59' ' ' ASP . 42.9 t -154.23 136.25 6.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.26 -1.141 . . . . 1.22 108.267 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 86' ' ' LYS . 6.0 mm-40 -138.91 153.92 48.3 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 122.465 1.126 . . . . 2.0699999999999998 112.257 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 tt -95.85 109.15 21.54 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.155 -1.424 . . . . 1.3100000000000001 107.155 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.01 -23.79 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.163 -0.961 . . . . 2.0299999999999998 110.045 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 84' ' ' ARG . 0.5 OUTLIER -168.61 156.26 7.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.31 -1.494 . . . . 1.76 109.513 177.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 65' ' ' ASN . 74.1 t -161.15 131.49 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.91 -0.774 . . . . 1.49 108.91 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 82' ' ' LEU . 19.1 tt0 -143.2 158.38 43.67 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.998 0.904 . . . . 2.02 110.612 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.469 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -109.25 165.54 11.54 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.578 0.704 . . . . 1.1000000000000001 109.356 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 80' ' ' TYR . . . -169.83 176.38 43.67 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.729 -1.348 . . . . 0.51000000000000001 109.729 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.502 ' HG ' ' CG ' ' B' ' 51' ' ' ASN . 10.9 p -153.0 152.9 31.91 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.906 -1.146 . . . . 0.82999999999999996 107.906 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -160.24 176.91 11.19 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.045 -1.034 . . . . 1.29 109.908 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -89.34 139.91 16.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 119.589 -0.844 . . . . 1.54 110.435 -178.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 52.1 ttt180 -146.23 98.89 3.16 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.805 -0.813 . . . . 2.96 108.805 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 8.3 t0 88.87 34.58 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.334 0.588 . . . . 1.3799999999999999 109.562 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.93 38.87 6.18 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.293 1.044 . . . . 3.4300000000000002 109.367 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -157.66 151.63 24.32 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.594 -0.891 . . . . 3.9100000000000001 108.594 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -84.77 138.55 32.54 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.848 1.308 . . . . 2.9900000000000002 110.757 -177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -139.07 152.63 24.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 114.271 -1.332 . . . . 1.0700000000000001 107.592 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 p -88.33 162.87 16.33 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.204 1.002 . . . . 1.03 111.53 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.56 ' CD2' ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -139.72 138.52 36.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.38 -0.827 . . . . 4.2599999999999998 109.692 -177.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 81' ' ' ILE . 1.7 tt -119.04 129.48 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.858 -1.164 . . . . 1.5800000000000001 107.858 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' GLN . 14.9 mt -108.71 119.17 38.75 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.929 -1.508 . . . . 1.05 106.929 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.1 tt -127.02 127.16 44.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.235 -0.916 . . . . 1.6699999999999999 110.647 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 14.4 ttt180 -99.92 172.21 7.37 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.98 -0.554 . . . . 0.65000000000000002 109.681 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mt -161.24 145.03 13.07 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.555 -0.858 . . . . 2.02 110.094 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 62' ' ' GLN . 5.3 tmtm? -131.21 157.39 43.34 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.565 -0.531 . . . . 2.02 109.565 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -113.56 139.41 49.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.438 -0.789 . . . . 2.2999999999999998 109.72 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.8 t -116.2 -5.09 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.038 -0.727 . . . . 1.3899999999999999 109.038 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 118.043 -0.979 . . . . 2.6200000000000001 109.597 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.51 0.195 . . . . 1.72 110.772 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -89.7 103.55 16.19 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.339 -1.475 . . . . 1.49 107.875 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mm -114.34 139.86 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.738 0.78 . . . . 1.8 109.78 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 66.9 t -104.19 129.0 57.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.594 0.711 . . . . 2.02 109.614 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.403 HG12 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -88.38 162.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.148 -1.056 . . . . 1.1699999999999999 108.148 -178.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -138.0 171.79 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 2.9399999999999999 110.183 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -9.64 39.74 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.463 -0.94 . . . . 2.2999999999999998 108.463 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 33.5 p -89.41 -6.1 56.84 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.739 -0.785 . . . . 1.76 109.038 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -97.6 -132.92 0.22 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.627 -1.249 . . . . 1.8999999999999999 107.627 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -168.15 167.07 12.61 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.882 -0.784 . . . . 1.96 108.882 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.422 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.0 m -66.43 -36.6 77.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.754 -1.202 . . . . 1.29 107.754 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 4.8 mm-40 -73.73 -39.94 63.92 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.328 -0.99 . . . . 1.7 108.328 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -60.87 -31.95 71.4 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.173 -0.954 . . . . 1.46 111.917 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.475 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 49.1 m-70 -92.99 -17.54 23.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 119.835 -1.791 . . . . 2.3100000000000001 108.907 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -33.84 55.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 104.427 -2.435 . . . . 1.2 104.427 176.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 52.6 mt -68.72 -51.7 38.64 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.648 -1.16 . . . . 1.1899999999999999 109.058 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.04 -31.48 72.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 1.21 109.729 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 52.9 t -69.68 -55.91 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 1.1299999999999999 109.837 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 20.9 tt -61.32 -20.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.067 -1.021 . . . . 1.3999999999999999 108.873 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 4.8 t -71.11 -42.95 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 1.27 109.098 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mt -65.73 -41.44 92.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.854 -1.154 . . . . 1.8300000000000001 109.739 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -58.05 -29.95 65.79 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.211 -1.403 . . . . 2.3500000000000001 107.211 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -28.34 65.43 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.477 -0.783 . . . . 1.6799999999999999 108.899 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -89.55 -1.23 57.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 1.9399999999999999 109.368 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.92 15.01 23.39 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.57 -1.412 . . . . 0.42999999999999999 109.57 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 45.6 mm -78.56 108.17 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -1.162 . . . . 1.3400000000000001 108.82 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -92.77 -36.5 12.85 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.26 -0.9 . . . . 1.46 110.226 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -101.54 143.37 31.61 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.577 0.703 . . . . 1.2 110.905 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.57 143.04 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 119.554 -0.858 . . . . 1.27 111.026 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.54 123.2 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.223 0.535 . . . . 1.1599999999999999 109.87 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.95 121.08 42.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.738 -0.602 . . . . 1.22 109.991 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -106.75 129.84 54.56 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.37 -0.604 . . . . 3.2200000000000002 109.37 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -143.49 156.43 26.57 Favored Glycine 0 N--CA 1.507 3.385 0 C-N-CA 119.662 -1.256 . . . . 0.28000000000000003 111.76 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.602 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 1.8 p -137.95 145.97 42.65 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.481 -1.011 . . . . 1.1100000000000001 112.916 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 37.68 -86.1 0.01 OUTLIER Glycine 0 N--CA 1.499 2.869 0 N-CA-C 110.571 -1.012 . . . . 0.28999999999999998 110.571 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.642 ' N ' ' HE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -80.71 -52.99 6.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.359 -1.083 . . . . 3.6699999999999999 109.792 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -19.53 65.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.956 -1.09 . . . . 1.3799999999999999 109.535 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 7.1 tt -56.01 -31.6 31.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.905 -1.122 . . . . 1.54 109.818 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -24.6 33.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 1.5600000000000001 108.656 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' B' ' 46' ' ' ALA . 2.2 mptt -65.04 -70.84 0.21 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.642 -1.985 . . . . 2.4399999999999999 105.642 177.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -32.37 -40.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.25 0.548 . . . . 1.02 110.527 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' B' ' 45' ' ' LYS . 94.6 t -79.13 -64.5 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.111 -0.993 . . . . 1.1399999999999999 110.011 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' ASP . . . . . 0.417 ' O ' ' OG ' ' B' ' 52' ' ' SER . 6.0 t0 -44.97 -52.95 8.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.347 -0.846 . . . . 1.25 109.952 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' B' ' 50' ' ' TYR . 11.1 p -55.58 -46.62 79.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.576 -0.849 . . . . 1.77 109.204 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.643 ' CD2' ' N ' ' B' ' 51' ' ' ASN . 0.0 OUTLIER -62.81 -54.89 32.0 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.91 -1.119 . . . . 4.3499999999999996 109.162 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . 0.643 ' N ' ' CD2' ' B' ' 50' ' ' TYR . 23.3 t-20 -53.83 -47.64 70.71 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.271 -1.381 . . . . 1.75 107.271 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 2.6 m -63.62 -31.57 72.77 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.194 -1.002 . . . . 1.0600000000000001 109.141 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' B' ' 49' ' ' VAL . 13.7 tp -73.49 -23.2 60.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.054 -1.029 . . . . 1.22 109.774 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' LYS . . . . . 0.407 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -83.18 -30.57 27.69 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.47 -1.678 . . . . 1.8300000000000001 106.47 177.435 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.46 -14.6 3.17 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.745 -1.206 . . . . 1.46 107.745 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.407 ' N ' ' C ' ' B' ' 54' ' ' LYS . 1.0 OUTLIER -71.61 -47.41 54.85 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.532 -0.867 . . . . 1.99 109.559 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' LEU . . . . . 0.605 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.7 mt -155.11 -15.24 0.11 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.99 -1.484 . . . . 2.5699999999999998 112.638 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.33 -57.52 0.07 OUTLIER Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.22 -1.466 . . . . 0.39000000000000001 110.219 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.605 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -71.05 -44.24 66.19 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.298 -1.119 . . . . 1.3999999999999999 110.089 -179.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.65 25.74 5.01 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.231 -1.548 . . . . 0.37 109.231 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 22.6 t -154.6 135.42 4.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.0 -1.111 . . . . 1.1799999999999999 108.0 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' B' ' 86' ' ' LYS . 5.4 mm-40 -140.86 154.39 46.16 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.534 1.159 . . . . 2.1200000000000001 112.422 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tt -96.16 114.48 26.18 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.898 -1.047 . . . . 1.3799999999999999 108.285 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.88 -13.69 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 119.54 -0.864 . . . . 2.0 110.763 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -177.69 151.43 0.72 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.06 -1.65 . . . . 1.8600000000000001 110.63 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 63.1 t -158.22 135.43 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.554 -0.717 . . . . 1.5700000000000001 109.341 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -143.99 160.14 41.37 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.016 0.913 . . . . 2.04 111.579 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 50' ' ' TYR . 6.5 p -117.87 163.7 16.14 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.459 -0.791 . . . . 0.92000000000000004 109.025 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' B' ' 80' ' ' TYR . . . 177.76 134.61 2.08 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.717 -1.353 . . . . 0.34999999999999998 109.717 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.606 ' CB ' ' HE ' ' B' ' 77' ' ' ARG . 65.3 p -91.95 156.3 17.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.292 -1.711 . . . . 0.84999999999999998 109.513 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -150.65 164.48 35.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 1.49 110.088 -179.066 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.568 ' N ' ' OE1' ' B' ' 71' ' ' GLU . 0.1 OUTLIER -88.74 136.23 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.185 -0.947 . . . . 1.46 110.295 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 49.2 ttt180 -148.06 101.93 3.33 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.187 -0.946 . . . . 2.8799999999999999 109.661 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 6.7 t0 86.13 34.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.694 -0.854 . . . . 1.3500000000000001 108.694 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.7 34.47 9.62 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.094 0.949 . . . . 3.3700000000000001 108.601 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -152.98 150.28 29.06 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.601 -0.888 . . . . 3.8999999999999999 108.601 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.606 ' HE ' ' CB ' ' B' ' 70' ' ' SER . 4.2 ttt85 -87.04 140.67 29.32 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.525 1.155 . . . . 2.9700000000000002 111.218 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 10.3 tt -136.79 153.68 30.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.713 -1.218 . . . . 1.3700000000000001 107.713 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' SER . . . . . 0.48 ' H ' ' HG ' ' B' ' 79' ' ' SER . 0.0 OUTLIER -85.32 155.49 21.31 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.221 -0.924 . . . . 1.04 109.711 -176.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.602 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.1 OUTLIER -137.56 138.03 39.17 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.209 -0.663 . . . . 4.29 109.209 -177.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' B' ' 81' ' ' ILE . 1.3 tt -120.56 130.59 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.297 -1.001 . . . . 1.55 108.297 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mt -108.28 119.21 38.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.469 -1.678 . . . . 1.1599999999999999 106.469 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tt -124.63 126.09 45.19 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.511 -0.876 . . . . 1.55 110.721 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -97.14 171.54 8.39 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.757 -0.831 . . . . 0.70999999999999996 108.757 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mt -160.41 141.6 12.16 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.559 -0.857 . . . . 2.1200000000000001 109.352 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' B' ' 62' ' ' GLN . 9.2 tttm -127.26 148.11 50.22 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.019 0.437 . . . . 2.0 110.188 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -106.0 137.76 43.36 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.505 -0.747 . . . . 2.2999999999999998 109.421 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 75.7 t -116.2 -4.45 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.061 -0.718 . . . . 1.46 109.061 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 118.077 -0.963 . . . . 2.6299999999999999 109.473 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.51 -0.552 . . . . 6.7999999999999998 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.49 66.69 1.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.717 0.77 . . . . 2.7799999999999998 109.069 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' O ' ' O ' ' A' ' 30' ' ' GLY . 6.9 mt-10 -76.95 -29.62 55.66 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.606 -0.684 . . . . 1.8 110.08 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.59 59.14 1.2 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.479 -0.763 . . . . 2.8500000000000001 110.105 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.2 tp -172.51 52.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.684 -0.858 . . . . 2.2200000000000002 108.684 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -88.64 103.14 15.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.903 . . . . 1.8500000000000001 111.137 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -91.47 124.98 36.05 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.456 -0.942 . . . . 1.4399999999999999 108.456 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 35' ' ' ILE . 10.4 mt -137.12 154.4 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 119.918 -0.713 . . . . 1.8300000000000001 111.205 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.56 138.63 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.723 -0.843 . . . . 2.0099999999999998 108.723 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 p -91.06 163.5 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.942 -1.099 . . . . 1.24 108.683 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -129.67 163.65 25.63 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.836 0.827 . . . . 2.8500000000000001 109.986 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 -17.49 21.78 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.174 -1.047 . . . . 2.3399999999999999 108.174 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -73.42 -44.56 58.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.374 -0.973 . . . . 1.6699999999999999 108.374 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 146.51 39.08 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.236 -0.915 . . . . 1.8600000000000001 109.294 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -69.0 -179.44 1.5 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.099 -1.001 . . . . 1.97 108.632 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 17' ' ' GLU . 27.2 m -78.62 -50.2 19.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.872 -1.142 . . . . 1.29 109.458 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 4.1 pt-20 -57.88 -19.69 31.26 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.076 -1.015 . . . . 1.5600000000000001 110.529 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.61 -30.37 69.09 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.379 -1.451 . . . . 1.3799999999999999 108.239 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -23.57 22.28 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.845 -0.742 . . . . 2.3500000000000001 109.015 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.41 -27.8 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 106.532 -1.655 . . . . 1.1299999999999999 106.532 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.37 -48.94 20.65 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.117 -1.068 . . . . 1.1799999999999999 108.117 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -66.73 -22.01 66.06 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.537 -0.727 . . . . 1.22 109.597 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 t -78.79 -54.41 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.154 -0.966 . . . . 1.1399999999999999 109.783 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.1 tt -55.6 -28.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.147 -0.97 . . . . 1.3 108.924 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.67 -43.97 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.231 -1.026 . . . . 1.1499999999999999 108.231 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 28' ' ' ASN . 44.8 mt -63.8 -39.73 94.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.53 -0.731 . . . . 1.8700000000000001 109.692 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 3.2 t80 -69.77 -0.93 7.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 2.3599999999999999 108.786 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -90.72 -26.69 19.41 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.981 -1.118 . . . . 1.71 107.981 177.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -86.82 3.96 43.14 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.519 -0.738 . . . . 1.8799999999999999 109.648 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 106.64 6.84 34.95 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.171 -1.172 . . . . 0.47999999999999998 110.171 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -75.7 95.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -1.234 . . . . 1.0900000000000001 109.407 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -87.37 -33.95 18.97 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.232 -0.918 . . . . 1.55 108.82 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -99.5 147.71 25.02 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.366 0.603 . . . . 1.5800000000000001 109.807 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.15 149.07 10.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 119.163 -1.015 . . . . 1.28 109.488 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.1 mt -129.7 117.24 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.494 0.664 . . . . 1.0900000000000001 110.732 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mp -100.68 127.17 47.18 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.893 -0.781 . . . . 1.0800000000000001 108.893 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -115.3 139.93 49.55 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.015 -1.106 . . . . 3.21 108.015 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.81 163.96 28.83 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 119.379 -1.391 . . . . 0.28000000000000003 110.444 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 41' ' ' ARG . 36.4 p -137.46 148.1 45.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.503 -0.998 . . . . 1.1399999999999999 110.914 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 36.94 -85.65 0.01 OUTLIER Glycine 0 N--CA 1.5 2.947 0 O-C-N 122.0 -0.438 . . . . 0.34999999999999998 112.179 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -87.14 -42.87 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -1.174 . . . . 3.6000000000000001 110.34 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.58 -22.34 66.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.66 -1.275 . . . . 1.0900000000000001 109.511 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 44' ' ' SER . 8.3 tt -48.23 -54.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 1.6599999999999999 109.978 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.497 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.61 -26.57 65.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.906 -1.121 . . . . 1.51 110.903 -178.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -41.27 95.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.638 -1.289 . . . . 2.4399999999999999 109.066 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.83 -38.73 82.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 1.1000000000000001 109.245 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.75 -66.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.654 -0.654 . . . . 1.01 110.643 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 52' ' ' SER . 0.4 OUTLIER -44.52 -53.54 6.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.797 -0.564 . . . . 1.26 109.804 -178.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.0 t -46.15 -55.19 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.555 -0.715 . . . . 1.78 109.494 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -64.66 -44.68 89.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.395 -0.816 . . . . 2.1600000000000001 110.037 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.518 ' CG ' ' H ' ' B' ' 70' ' ' SER . 4.6 t30 -58.46 -48.33 81.08 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.094 -1.004 . . . . 1.8500000000000001 108.467 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 2.1 p -67.46 -29.18 68.57 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.942 -0.762 . . . . 1.1799999999999999 108.942 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.79 -25.39 44.29 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.385 -0.969 . . . . 1.1499999999999999 108.385 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -76.28 -46.32 28.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.007 -1.849 . . . . 1.6599999999999999 106.007 177.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 16.6 t0 -57.63 -6.96 0.56 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.827 -1.079 . . . . 1.5800000000000001 108.351 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' A' ' 54' ' ' LYS . 3.1 tpt85 -76.35 -46.53 27.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.727 -0.608 . . . . 1.99 110.148 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' ASP . 6.1 tp -152.42 -29.03 0.16 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.41 -0.916 . . . . 2.48 110.292 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.71 -49.32 0.64 Allowed Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.022 -1.561 . . . . 0.41999999999999998 109.229 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER -74.68 -49.79 20.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -1.223 . . . . 1.3799999999999999 109.055 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.97 23.36 1.36 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.79 -1.724 . . . . 0.29999999999999999 108.79 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.531 ' H ' ' C ' ' A' ' 59' ' ' ASP . 24.1 t -149.86 139.51 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 121.505 -0.997 . . . . 1.22 108.511 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.5 mm-40 -143.27 142.36 31.33 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.229 1.014 . . . . 2.0699999999999998 110.864 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 tt -93.84 94.26 8.41 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.471 -0.786 . . . . 1.3100000000000001 109.114 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.427 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -79.33 -35.37 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.904 -1.122 . . . . 2.0299999999999998 110.126 -179.138 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 64' ' ' VAL . 15.2 m-80 -165.99 157.63 13.94 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.139 -1.425 . . . . 1.76 112.155 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.1 t -158.16 145.37 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.397 -1.335 . . . . 1.49 107.397 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -148.11 165.23 31.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.754 -1.216 . . . . 2.02 108.896 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.36 129.64 15.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 1.1000000000000001 111.007 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -152.38 171.52 31.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.964 -1.655 . . . . 0.51000000000000001 108.964 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.523 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 9.9 p -112.08 156.45 22.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.693 0.759 . . . . 0.82999999999999996 110.366 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.29 175.84 13.03 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.511 -0.743 . . . . 1.29 109.552 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.4 t -87.99 132.78 32.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.388 -0.82 . . . . 1.54 110.651 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 34.4 ttt-85 -143.85 99.97 3.5 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.487 -0.931 . . . . 2.96 108.487 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.2 t70 85.69 40.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.205 0.526 . . . . 1.3799999999999999 109.643 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 60.32 37.68 20.11 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.379 1.085 . . . . 3.4300000000000002 108.897 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -155.51 149.0 25.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.111 -0.993 . . . . 3.9100000000000001 108.765 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -83.02 140.88 32.46 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.223 -0.991 . . . . 2.9900000000000002 109.626 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.3 tt -144.31 156.95 15.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.176 -0.676 . . . . 1.0700000000000001 109.176 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.415 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -87.9 152.79 21.81 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.394 -0.816 . . . . 1.03 109.4 -178.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 9.8 p90 -146.82 151.87 37.82 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.063 -1.023 . . . . 4.2599999999999998 110.348 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.75 137.53 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-N 115.667 -0.697 . . . . 1.5800000000000001 111.488 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.5 mt -110.23 104.71 13.57 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.076 -2.194 . . . . 1.05 105.076 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.436 ' CD1' ' HG1' ' B' ' 68' ' ' THR . 1.4 tp -106.82 120.47 42.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.878 -0.514 . . . . 1.6699999999999999 110.081 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -103.69 168.23 9.28 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.907 -0.775 . . . . 0.65000000000000002 108.907 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tp -160.57 160.11 31.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.951 -1.099 . . . . 2.02 109.999 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -142.15 145.26 34.01 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.52 -0.548 . . . . 2.02 109.52 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -105.08 136.62 44.24 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.55 -0.719 . . . . 2.2999999999999998 109.373 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 t -107.63 -7.55 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.878 -1.156 . . . . 1.3899999999999999 107.878 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 117.977 -1.011 . . . . 2.6200000000000001 109.437 179.591 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mmt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.326 -0.62 . . . . 6.8200000000000003 109.326 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.2 68.08 1.15 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 2.7799999999999998 109.562 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 30' ' ' GLY . 83.5 mt-10 -79.59 -20.79 46.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.211 -0.93 . . . . 1.6799999999999999 109.588 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 59.25 0.93 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.136 -0.978 . . . . 2.8999999999999999 110.338 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 18.0 tp -172.56 49.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.553 -0.906 . . . . 2.2599999999999998 108.553 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -89.23 101.84 14.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 1.72 111.387 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.1 pt-20 -93.1 121.88 34.9 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.38 -0.97 . . . . 1.49 108.38 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 40.1 mt -134.63 150.91 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.735 -0.603 . . . . 1.8 110.009 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.9 138.91 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.878 . . . . 2.02 108.909 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 p -90.26 160.1 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.967 -1.083 . . . . 1.1699999999999999 108.499 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 12.1 mtt-85 -130.74 167.7 18.41 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.874 0.845 . . . . 2.9399999999999999 110.505 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.25 -4.65 21.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.507 -0.923 . . . . 2.2999999999999998 108.507 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 2.8 t -83.49 -29.05 28.27 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.647 -0.821 . . . . 1.76 110.447 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.411 ' O ' ' OD1' ' B' ' 15' ' ' ASN . 7.5 mttm -83.8 -113.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.78 -1.2 . . . . 1.8999999999999999 109.415 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' B' ' 14' ' ' LYS . 2.6 m120 -166.18 173.63 10.02 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.393 -1.336 . . . . 1.96 107.393 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 22.1 m -70.9 -51.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.606 -1.309 . . . . 1.29 109.112 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 6.0 pt-20 -63.11 -24.94 68.13 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.147 -0.97 . . . . 1.7 110.106 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.42 -38.42 91.08 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.39 -1.444 . . . . 1.46 108.359 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.76 -22.3 31.94 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.894 -0.722 . . . . 2.3100000000000001 109.841 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.08 -31.05 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.074 -1.454 . . . . 1.2 107.074 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 37.4 mt -70.63 -48.64 53.98 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.264 -1.013 . . . . 1.1899999999999999 108.264 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -65.62 -26.04 67.65 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.477 -0.764 . . . . 1.21 109.906 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.57 -54.14 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.11 -0.994 . . . . 1.1299999999999999 110.026 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 5.5 tt -55.15 -28.54 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 1.3999999999999999 109.246 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 t -73.38 -43.32 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.198 -0.939 . . . . 1.27 108.631 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mt -62.37 -45.97 90.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.45 -0.781 . . . . 1.8300000000000001 109.524 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' B' ' 30' ' ' GLY . 3.0 t80 -53.92 -48.0 70.63 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.746 -1.205 . . . . 2.3500000000000001 107.746 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -31.01 2.16 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.208 -0.597 . . . . 1.6799999999999999 109.577 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -84.77 5.43 28.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.952 -1.093 . . . . 1.9399999999999999 110.031 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 100.25 6.08 53.85 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.924 -1.27 . . . . 0.42999999999999999 109.924 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 43.5 mm -76.17 88.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.067 -1.255 . . . . 1.3400000000000001 108.588 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -83.49 -39.08 20.95 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.21 -0.931 . . . . 1.46 109.152 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -93.58 142.11 27.71 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.643 -0.661 . . . . 1.2 109.592 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 p -155.57 151.03 10.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.546 -0.862 . . . . 1.27 109.683 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.56 112.81 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.439 0.638 . . . . 1.1599999999999999 110.055 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -95.53 133.05 39.98 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.542 -0.724 . . . . 1.22 109.187 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.99 140.03 52.96 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.463 -0.94 . . . . 3.2200000000000002 108.463 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.99 164.19 28.59 Favored Glycine 0 N--CA 1.502 3.089 0 C-N-CA 119.498 -1.334 . . . . 0.28000000000000003 110.232 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.548 ' O ' ' N ' ' B' ' 41' ' ' ARG . 76.9 p -135.87 146.37 47.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.701 -0.882 . . . . 1.1100000000000001 110.763 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 36.27 -84.02 0.0 OUTLIER Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.847 -0.533 . . . . 0.28999999999999998 112.615 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.0 OUTLIER -84.5 -45.31 12.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -1.187 . . . . 3.6699999999999999 110.443 -178.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.76 -23.92 66.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.727 -1.233 . . . . 1.3799999999999999 109.045 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 7.9 tt -53.85 -20.71 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 1.54 109.036 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.11 -34.58 13.59 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.279 0.562 . . . . 1.5600000000000001 110.196 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -25.38 66.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 2.4399999999999999 110.212 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.26 -45.74 54.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.962 -1.086 . . . . 1.02 109.975 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.88 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 1.1399999999999999 109.68 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' B' ' 52' ' ' SER . 2.7 t70 -57.43 -56.37 22.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 1.25 109.474 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 10.3 t -43.89 -49.48 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.672 -0.643 . . . . 1.77 110.006 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.446 ' C ' ' CD1' ' B' ' 50' ' ' TYR . 1.1 t80 -68.33 -53.18 25.92 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.426 -0.797 . . . . 2.1800000000000002 110.295 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.523 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 1.2 t30 -50.3 -45.88 54.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.032 -1.042 . . . . 1.75 108.527 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.6 OUTLIER -68.67 -37.15 79.39 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.559 -0.857 . . . . 1.0600000000000001 109.171 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 tp -65.89 -26.84 67.8 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.378 -0.826 . . . . 1.22 108.817 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -75.25 -38.69 60.43 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.664 -1.236 . . . . 1.8300000000000001 107.664 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.26 -7.78 0.41 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.036 -0.727 . . . . 1.46 109.036 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' B' ' 54' ' ' LYS . 21.1 mmm180 -82.66 -39.41 22.1 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.548 -0.72 . . . . 1.99 110.727 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.14 -35.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 117.928 -1.509 . . . . 2.5699999999999998 112.595 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.78 -55.03 2.57 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 118.548 -1.786 . . . . 0.39000000000000001 108.919 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' B' ' 61' ' ' VAL . 0.4 OUTLIER -72.16 -48.68 41.62 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.149 -1.206 . . . . 1.3999999999999999 108.575 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.79 25.11 1.81 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 108.969 -1.652 . . . . 0.37 108.969 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.487 ' H ' ' C ' ' B' ' 59' ' ' ASP . 13.0 t -153.07 140.2 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.392 -1.064 . . . . 1.1799999999999999 108.72 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.5 mm-40 -143.87 141.9 30.54 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.297 1.046 . . . . 2.1200000000000001 111.669 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.34 94.33 9.08 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.421 -0.809 . . . . 1.3799999999999999 109.346 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.429 ' O ' ' ND2' ' B' ' 65' ' ' ASN . 0.0 OUTLIER -74.53 -39.55 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.945 -1.097 . . . . 2.0 110.53 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' B' ' 64' ' ' VAL . 21.4 m-80 -164.46 164.69 21.88 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.336 -1.346 . . . . 1.8600000000000001 111.831 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 59.2 t -161.07 143.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.718 -1.216 . . . . 1.5700000000000001 107.718 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -147.76 165.13 31.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.899 -1.125 . . . . 2.04 108.645 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' THR . . . . . 0.436 ' HG1' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -148.78 129.48 14.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.088 -1.007 . . . . 0.92000000000000004 110.232 -178.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.551 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -149.29 169.58 29.61 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.061 -1.216 . . . . 0.34999999999999998 110.061 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.518 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 23.9 p -104.32 151.21 23.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 122.038 -0.684 . . . . 0.84999999999999998 109.986 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.65 172.01 16.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 1.49 110.224 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 67.9 t -87.58 133.95 29.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.474 -0.766 . . . . 1.46 110.692 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 17.7 ttt-85 -146.36 101.39 3.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.544 -0.722 . . . . 2.8799999999999999 109.301 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 1.6 t70 82.2 41.84 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.319 0.58 . . . . 1.3500000000000001 109.509 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 60.48 32.29 20.49 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.121 0.962 . . . . 3.3700000000000001 109.212 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -151.9 154.96 37.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.563 -0.903 . . . . 3.8999999999999999 108.563 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -87.37 142.17 28.08 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.389 -0.924 . . . . 2.9700000000000002 110.644 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 tt -142.56 157.33 18.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.404 -0.962 . . . . 1.3700000000000001 108.404 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.15 149.51 24.6 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.797 -0.816 . . . . 1.04 108.797 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.551 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 9.1 p90 -144.49 149.89 36.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.38 -0.825 . . . . 4.29 109.899 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 tt -122.08 138.95 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 115.899 -0.591 . . . . 1.55 111.766 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 21.0 mt -108.99 106.99 17.18 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.518 -2.03 . . . . 1.1599999999999999 105.518 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.5 119.48 39.52 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 118.343 0.519 . . . . 1.55 110.566 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -102.81 164.84 11.39 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.912 -0.773 . . . . 0.70999999999999996 108.912 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 tp -160.4 152.19 19.94 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.607 -0.837 . . . . 2.1200000000000001 109.708 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -136.86 136.07 38.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.452 -0.573 . . . . 2.0 109.452 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -95.18 137.17 34.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.48 -0.762 . . . . 2.2999999999999998 109.313 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 40.0 t -108.92 -6.85 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 1.46 108.21 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.964 -1.017 . . . . 2.6299999999999999 109.513 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.527 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.233 0.54 . . . . 6.7999999999999998 109.548 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.49 ' H ' ' HG1' ' A' ' 2' ' ' THR . 0.8 OUTLIER -78.56 103.67 8.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 2.7799999999999998 109.604 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 30' ' ' GLY . 1.6 mt-10 -165.69 -49.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.799 -0.815 . . . . 1.8 108.799 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.53 53.86 0.54 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.956 0.884 . . . . 2.8500000000000001 109.687 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -172.1 49.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.563 -1.336 . . . . 2.2200000000000002 110.15 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -91.78 111.77 23.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.048 -1.032 . . . . 1.8500000000000001 111.033 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 7.0 pt-20 -91.67 117.03 29.37 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.604 -1.258 . . . . 1.4399999999999999 107.604 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 35' ' ' ILE . 12.6 mt -122.43 147.98 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-O 121.889 0.852 . . . . 1.8300000000000001 112.062 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -111.78 128.17 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.65 0.738 . . . . 2.0099999999999998 109.796 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -88.4 164.9 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.398 -0.964 . . . . 1.24 108.398 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -138.0 174.9 10.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.439 -0.788 . . . . 2.8500000000000001 109.827 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -8.38 15.09 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.208 -1.034 . . . . 2.3399999999999999 108.208 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.44 -12.34 37.72 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.35 -1.352 . . . . 1.6699999999999999 107.35 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' CB ' ' HE2' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -90.44 -130.41 0.09 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.996 -1.483 . . . . 1.8600000000000001 106.996 178.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.79 155.21 21.12 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.803 -1.186 . . . . 1.97 108.925 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.5 m -62.7 -37.24 78.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 122.121 0.962 . . . . 1.29 108.859 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.86 -31.61 59.37 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.22 -0.925 . . . . 1.5600000000000001 108.523 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.33 -32.04 73.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.614 -1.304 . . . . 1.3799999999999999 111.452 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.47 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 85.2 m-70 -90.37 -18.63 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 119.806 -1.809 . . . . 2.3500000000000001 108.74 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.09 -32.15 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 105.147 -2.168 . . . . 1.1299999999999999 105.147 176.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.2 mt -69.53 -53.01 21.12 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.729 -1.123 . . . . 1.1799999999999999 109.294 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -65.86 -28.81 69.24 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.98 -1.075 . . . . 1.22 109.546 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 23.2 t -68.72 -54.42 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.421 -0.799 . . . . 1.1399999999999999 109.01 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 tt -63.5 -17.05 19.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.181 -0.949 . . . . 1.3 108.978 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -76.95 -46.7 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.064 -1.023 . . . . 1.1499999999999999 109.408 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.22 -33.13 75.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.614 -1.304 . . . . 1.8700000000000001 110.273 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 4.2 t80 -64.33 -24.73 67.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.79 -1.559 . . . . 2.3599999999999999 106.79 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -27.29 69.18 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.096 -0.956 . . . . 1.71 109.398 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -89.89 -4.69 57.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.901 -1.124 . . . . 1.8799999999999999 109.254 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 111.74 12.22 15.1 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.368 -1.093 . . . . 0.47999999999999998 110.368 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 31' ' ' ILE . 46.4 mm -75.16 106.46 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.038 -1.272 . . . . 1.0900000000000001 108.475 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.57 -36.91 15.06 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.339 -0.851 . . . . 1.55 110.306 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.95 143.32 31.24 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.827 0.822 . . . . 1.5800000000000001 110.456 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.67 141.46 14.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 119.555 -0.858 . . . . 1.28 109.942 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -120.81 126.37 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 115.887 -0.597 . . . . 1.0900000000000001 110.321 -178.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.81 125.13 51.63 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 120.2 -0.6 . . . . 1.0800000000000001 109.753 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -108.42 131.59 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.752 -1.203 . . . . 3.21 107.752 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.69 152.75 21.79 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 119.893 -1.146 . . . . 0.28000000000000003 110.717 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.595 ' O ' ' N ' ' A' ' 41' ' ' ARG . 18.0 p -132.3 139.61 48.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.842 -0.799 . . . . 1.1399999999999999 112.243 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 39.51 -85.08 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 N-CA-C 111.406 -0.677 . . . . 0.34999999999999998 111.406 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -82.09 -54.2 5.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.256 -1.143 . . . . 3.6000000000000001 109.913 -178.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -19.34 48.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.785 -1.197 . . . . 1.0900000000000001 108.564 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.9 tt -53.97 -30.91 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.388 -0.82 . . . . 1.6599999999999999 110.673 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.6 -22.53 27.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.563 -1.336 . . . . 1.51 108.54 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' VAL . 24.3 mmtp -63.33 -69.24 0.28 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.078 -1.823 . . . . 2.4399999999999999 106.078 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -29.22 -38.18 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.784 0.802 . . . . 1.1000000000000001 109.959 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' LYS . 65.8 t -73.64 -74.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.696 -0.627 . . . . 1.01 110.578 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -39.8 -56.55 1.73 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.412 0.625 . . . . 1.26 110.838 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.51 ' CG2' ' H ' ' A' ' 50' ' ' TYR . 31.2 m -47.19 -54.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.465 -0.772 . . . . 1.78 109.035 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER -58.34 -52.64 64.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 4.2999999999999998 109.634 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.648 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 2.5 t30 -53.21 -52.74 57.9 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.605 -1.257 . . . . 1.8500000000000001 107.605 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.5 p -59.44 -33.29 71.09 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.242 -1.022 . . . . 1.1799999999999999 108.242 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 tp -78.98 -25.13 43.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.111 -0.993 . . . . 1.1499999999999999 108.9 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -79.02 -45.19 20.69 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.216 -2.142 . . . . 1.6599999999999999 105.216 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.53 -7.9 0.47 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.817 -1.179 . . . . 1.5800000000000001 107.817 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.535 ' H ' ' C ' ' A' ' 54' ' ' LYS . 6.9 tpt180 -72.03 -48.74 42.39 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.589 0.709 . . . . 1.99 109.834 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.0 tp -153.73 -24.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.203 -0.999 . . . . 2.48 110.994 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.37 -48.94 0.07 OUTLIER Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.77 -1.205 . . . . 0.41999999999999998 110.181 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -72.3 -41.9 66.08 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.395 -1.062 . . . . 1.3799999999999999 109.548 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.65 28.96 8.34 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 108.844 -1.703 . . . . 0.29999999999999999 108.844 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.2 t -154.58 130.21 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.541 -1.281 . . . . 1.22 107.541 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 86' ' ' LYS . 1.7 mm100 -136.98 158.44 44.46 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.349 1.071 . . . . 2.0699999999999998 111.926 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.4 tt -94.73 114.6 26.54 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.495 -0.928 . . . . 1.3100000000000001 108.495 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -22.11 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.166 -0.959 . . . . 2.0299999999999998 109.712 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -173.57 157.02 3.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.549 -1.344 . . . . 1.76 109.835 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -159.78 130.94 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.703 -0.851 . . . . 1.49 108.703 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -142.0 157.63 44.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.131 0.967 . . . . 2.02 110.16 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -132.6 147.37 52.34 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.293 -1.002 . . . . 1.1000000000000001 108.293 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.631 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -175.27 154.34 17.73 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.414 -2.675 . . . . 0.51000000000000001 106.414 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.631 ' HG ' ' ND2' ' B' ' 51' ' ' ASN . 52.7 p -103.78 169.21 8.65 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 119.085 1.442 . . . . 0.82999999999999996 110.128 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.24 164.88 34.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 1.29 109.525 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.75 91.65 3.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.638 -0.825 . . . . 1.54 109.874 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 47.0 ttt-85 -95.02 112.06 23.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.991 -1.068 . . . . 2.96 110.048 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.1 t70 77.73 39.75 0.17 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.454 -0.573 . . . . 1.3799999999999999 109.454 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.417 ' CG ' HH11 ' A' ' 75' ' ' ARG . 0.0 OUTLIER 60.86 29.43 19.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.462 -0.774 . . . . 3.4300000000000002 108.954 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.66 144.99 30.74 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.026 -1.047 . . . . 3.9100000000000001 108.671 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -84.35 126.54 33.31 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.94 1.353 . . . . 2.9900000000000002 111.428 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 tt -136.4 147.53 27.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 106.943 -1.503 . . . . 1.0700000000000001 106.943 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.71 159.59 17.73 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.077 -1.014 . . . . 1.03 110.938 -176.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.631 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 6.4 p90 -145.91 153.32 40.71 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.869 0.842 . . . . 4.2599999999999998 110.608 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.4 tt -125.14 132.63 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.623 0.725 . . . . 1.5800000000000001 109.822 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.39 121.63 44.97 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.092 -1.448 . . . . 1.05 107.092 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.65 123.86 34.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.206 -0.934 . . . . 1.6699999999999999 111.072 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -97.7 169.68 9.52 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.437 0.637 . . . . 0.65000000000000002 110.11 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mt -159.68 140.04 11.99 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.362 -0.935 . . . . 2.02 110.349 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 62' ' ' GLN . 2.2 tmtp? -122.9 145.64 48.28 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.941 -0.475 . . . . 2.02 109.92 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.548 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 14.7 mmt85 -103.85 138.66 40.12 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.186 -0.946 . . . . 2.2999999999999998 109.863 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.78 -6.84 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.718 -0.845 . . . . 1.3899999999999999 108.718 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 CA-C-O 118.058 -0.972 . . . . 2.6200000000000001 109.573 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.486 -0.561 . . . . 6.8200000000000003 109.486 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.479 ' H ' ' HG1' ' B' ' 2' ' ' THR . 0.8 OUTLIER -74.95 104.51 5.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 2.7799999999999998 109.419 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' B' ' 30' ' ' GLY . 41.9 tt0 -165.82 -50.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.138 0.971 . . . . 1.6799999999999999 108.604 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.21 58.43 0.35 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.313 -0.867 . . . . 2.8999999999999999 109.323 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -175.91 46.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.187 -1.042 . . . . 2.2599999999999998 108.187 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -93.35 111.44 23.1 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.56 -0.712 . . . . 1.72 110.451 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.8 pt-20 -93.62 120.96 34.54 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.144 -0.973 . . . . 1.49 108.944 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 mt -123.58 146.0 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.971 0.891 . . . . 1.8 111.217 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 p -105.45 129.38 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.147 -0.686 . . . . 2.02 109.147 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -89.45 166.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.526 -0.87 . . . . 1.1699999999999999 108.749 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -141.18 175.78 9.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.431 -0.793 . . . . 2.9399999999999999 109.996 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.433 ' C ' ' CD ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -112.96 -4.82 13.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.074 -1.084 . . . . 2.2999999999999998 108.074 179.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -18.06 34.24 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.718 -0.845 . . . . 1.76 108.718 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -92.97 -115.91 0.09 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.443 -0.947 . . . . 1.8999999999999999 108.443 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.21 166.06 12.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.389 -0.82 . . . . 1.96 108.967 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.88 -35.12 73.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.043 0.925 . . . . 1.29 108.823 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 16.0 pt-20 -73.59 -37.97 65.28 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.03 -1.044 . . . . 1.7 108.8 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . 0.41 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 0.3 OUTLIER -54.41 -36.66 64.22 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.653 -1.28 . . . . 1.46 111.772 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.477 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 90.3 m-70 -91.39 -18.64 23.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.271 -1.518 . . . . 2.3100000000000001 109.105 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -36.61 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 105.158 -2.164 . . . . 1.2 105.158 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.15 -52.16 44.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.377 -0.829 . . . . 1.1899999999999999 108.983 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.89 -28.39 68.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -0.969 . . . . 1.21 109.844 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 18.4 t -69.4 -53.55 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 1.1299999999999999 108.951 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 tt -64.14 -18.92 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.197 -0.939 . . . . 1.3999999999999999 109.116 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 63.4 t -75.58 -46.68 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 1.27 109.244 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.33 -33.45 76.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.796 -1.19 . . . . 1.8300000000000001 110.073 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 0.517 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 4.9 t80 -64.92 -28.23 69.39 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.926 -1.509 . . . . 2.3500000000000001 106.926 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -29.24 68.38 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.321 -0.854 . . . . 1.6799999999999999 109.116 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -88.19 -0.59 57.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 1.9399999999999999 109.466 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 106.07 12.14 26.34 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.588 -1.005 . . . . 0.42999999999999999 110.588 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 33.6 mm -75.18 107.35 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.951 -1.323 . . . . 1.3400000000000001 107.863 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -91.48 -41.33 10.9 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.317 -0.865 . . . . 1.46 110.518 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -97.17 143.72 27.7 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.569 0.7 . . . . 1.2 110.217 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -153.16 136.94 8.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 119.006 -1.078 . . . . 1.27 111.111 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.4 128.58 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 115.958 -0.565 . . . . 1.1599999999999999 110.048 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.42 124.66 52.15 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.555 -0.716 . . . . 1.22 110.114 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -107.74 130.57 54.94 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.775 -0.578 . . . . 3.2200000000000002 109.449 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.12 153.51 23.4 Favored Glycine 0 N--CA 1.502 3.06 0 C-N-CA 119.502 -1.333 . . . . 0.28000000000000003 111.02 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.657 ' O ' ' N ' ' B' ' 41' ' ' ARG . 62.2 p -133.93 141.42 47.31 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.964 -0.727 . . . . 1.1100000000000001 112.558 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 34.98 -78.98 0.0 OUTLIER Glycine 0 N--CA 1.504 3.191 0 N-CA-C 111.873 -0.491 . . . . 0.28999999999999998 111.873 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.657 ' N ' ' O ' ' B' ' 39' ' ' THR . 1.4 mtp85 -83.3 -55.92 4.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.002 -1.293 . . . . 3.6699999999999999 109.374 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -16.41 59.96 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.995 -1.066 . . . . 1.3799999999999999 109.841 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 tt -59.69 -25.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.165 -0.959 . . . . 1.54 109.664 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.08 -25.86 27.3 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.89 -1.152 . . . . 1.5600000000000001 107.89 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 47' ' ' VAL . 24.3 mmtp -63.32 -71.33 0.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.597 -1.631 . . . . 2.4399999999999999 106.597 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -24.53 -43.29 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.375 0.607 . . . . 1.02 111.271 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' B' ' 45' ' ' LYS . 94.5 t -77.54 -60.32 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.168 -0.958 . . . . 1.1399999999999999 110.361 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . 0.427 ' O ' ' OG ' ' B' ' 52' ' ' SER . 1.9 t0 -46.37 -62.63 1.27 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.046 -1.034 . . . . 1.25 109.456 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' B' ' 50' ' ' TYR . 33.3 m -42.84 -51.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.824 -0.806 . . . . 1.77 108.824 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' B' ' 51' ' ' ASN . 0.1 OUTLIER -62.31 -50.53 71.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 4.3499999999999996 109.744 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.631 ' ND2' ' HG ' ' A' ' 70' ' ' SER . 1.3 t30 -54.57 -54.53 40.03 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.729 -1.188 . . . . 1.75 107.896 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.1 OUTLIER -59.01 -37.81 77.78 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.57 -0.852 . . . . 1.0600000000000001 108.832 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.1 tp -67.1 -23.48 65.84 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.128 -0.982 . . . . 1.22 108.379 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -39.38 50.12 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.769 -1.197 . . . . 1.8300000000000001 107.769 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.94 -12.72 2.15 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.384 -0.826 . . . . 1.46 109.227 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -73.58 -43.48 59.66 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.035 -1.066 . . . . 1.99 109.39 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.9 tp -154.61 -23.59 0.12 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.368 -1.333 . . . . 2.5699999999999998 112.209 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 65.15 -58.78 0.09 OUTLIER Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.224 -1.465 . . . . 0.39000000000000001 109.551 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.95 -42.59 73.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -1.1 . . . . 1.3999999999999999 109.773 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.42 25.42 5.66 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.896 -1.682 . . . . 0.37 108.896 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' B' ' 58' ' ' GLY . 73.5 t -154.65 131.65 2.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.318 -1.364 . . . . 1.1799999999999999 107.318 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.1 mm100 -135.28 153.07 52.02 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.148 0.975 . . . . 2.1200000000000001 112.273 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 7.4 tt -94.0 113.17 25.11 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.783 -1.191 . . . . 1.3799999999999999 107.783 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -16.43 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.205 -0.935 . . . . 2.0 110.302 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.415 ' O ' ' CG2' ' B' ' 66' ' ' VAL . 0.9 OUTLIER -176.35 156.69 1.62 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.642 -1.286 . . . . 1.8600000000000001 110.209 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' B' ' 65' ' ' ASN . 54.1 t -160.42 131.87 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.936 -0.764 . . . . 1.5700000000000001 108.936 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -142.48 160.23 40.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.947 0.879 . . . . 2.04 110.14 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.26 152.24 50.52 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.249 -1.019 . . . . 0.92000000000000004 108.249 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.638 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -175.03 154.16 17.52 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.391 -2.284 . . . . 0.34999999999999998 107.391 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.528 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 25.2 p -98.61 161.97 13.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.161 -1.199 . . . . 0.84999999999999998 109.343 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -146.05 159.19 43.61 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.035 -1.04 . . . . 1.49 109.95 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.38 90.6 3.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.325 -0.95 . . . . 1.46 109.55 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 53.8 ttt-85 -97.02 112.03 23.98 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.107 -0.996 . . . . 2.8799999999999999 109.846 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.2 t70 78.21 39.13 0.16 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.152 -0.685 . . . . 1.3500000000000001 109.152 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.27 26.79 16.05 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.288 -0.634 . . . . 3.3700000000000001 109.288 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -146.04 148.39 32.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.048 -1.032 . . . . 3.8999999999999999 108.509 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -87.02 134.62 33.47 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.913 1.339 . . . . 2.9700000000000002 112.508 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -137.76 150.18 25.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.291 -1.322 . . . . 1.3700000000000001 107.542 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.25 148.99 24.88 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.165 -0.96 . . . . 1.04 109.531 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.638 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.5 p90 -140.38 149.64 42.93 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.654 0.74 . . . . 4.29 110.598 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 tt -124.62 130.82 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 122.094 0.949 . . . . 1.55 110.463 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 12.0 mt -104.2 119.06 38.13 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.288 -1.745 . . . . 1.1599999999999999 106.288 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 tt -127.98 121.67 30.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 1.55 110.824 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -96.5 168.69 10.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.664 0.745 . . . . 0.70999999999999996 110.222 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 mt -159.78 136.78 9.41 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.891 -0.723 . . . . 2.1200000000000001 110.06 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' B' ' 62' ' ' GLN . 2.0 tmtp? -121.86 146.75 46.79 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.233 -0.655 . . . . 2.0 109.233 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.517 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 15.5 mmt85 -102.15 141.8 34.42 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.277 -0.89 . . . . 2.2999999999999998 110.465 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.23 -12.33 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.881 -0.785 . . . . 1.46 108.881 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 118.028 -0.987 . . . . 2.6299999999999999 109.558 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.522 -0.548 . . . . 6.7999999999999998 109.522 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.497 ' H ' ' HG1' ' A' ' 2' ' ' THR . 0.9 OUTLIER -89.04 110.74 21.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 2.7799999999999998 109.392 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 30' ' ' GLY . 38.2 tt0 -164.53 -53.83 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.294 -0.879 . . . . 1.8 108.809 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.63 57.67 0.44 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.91 0.862 . . . . 2.8500000000000001 109.26 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.21 46.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.115 -0.991 . . . . 2.2200000000000002 108.628 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -91.3 115.1 27.76 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.301 -0.874 . . . . 1.8500000000000001 110.441 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 6.8 pt-20 -93.03 117.6 30.24 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.271 -0.893 . . . . 1.4399999999999999 108.769 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 35' ' ' ILE . 20.6 mt -119.04 142.29 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-O 121.709 0.766 . . . . 1.8300000000000001 111.598 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.8 t -109.02 128.74 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.765 0.793 . . . . 2.0099999999999998 110.282 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 p -89.25 164.11 2.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.612 -0.885 . . . . 1.24 108.612 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.76 173.57 11.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.559 -0.713 . . . . 2.8500000000000001 109.758 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 pttt -92.85 -9.06 41.68 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.878 -0.786 . . . . 2.3399999999999999 108.878 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -91.28 -0.27 57.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.204 -1.035 . . . . 1.6699999999999999 108.204 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -118.28 134.14 55.29 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.462 -1.31 . . . . 1.8600000000000001 107.462 178.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -69.87 175.69 4.18 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.845 -1.159 . . . . 1.97 109.773 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.57 -31.86 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.355 -0.98 . . . . 1.29 108.355 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -74.75 -31.12 61.7 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.585 -0.846 . . . . 1.5600000000000001 108.95 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -33.88 70.01 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.644 -1.285 . . . . 1.3799999999999999 111.319 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 1.1 m80 -95.74 -19.34 19.74 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.448 -1.407 . . . . 2.3500000000000001 108.487 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -36.84 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 104.523 -2.399 . . . . 1.1299999999999999 104.523 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 mt -68.18 -51.27 47.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.708 -1.133 . . . . 1.1799999999999999 109.009 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -67.27 -31.77 72.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.17 -0.956 . . . . 1.22 109.442 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 32.5 t -68.55 -52.59 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -0.811 . . . . 1.1399999999999999 108.964 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 tt -61.31 -22.43 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.166 -0.959 . . . . 1.3 109.017 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.64 -41.67 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.165 -0.959 . . . . 1.1499999999999999 109.265 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mt -67.83 -37.3 81.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.874 -1.142 . . . . 1.8700000000000001 110.025 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 18.6 t80 -61.1 -28.26 68.96 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.994 -1.484 . . . . 2.3599999999999999 106.994 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.62 -25.68 66.46 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.42 -0.809 . . . . 1.71 109.02 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -89.88 -9.36 49.25 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.509 -0.923 . . . . 1.8799999999999999 108.509 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 113.47 14.07 10.01 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.193 -1.163 . . . . 0.47999999999999998 110.193 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -75.66 107.58 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.26 . . . . 1.0900000000000001 108.688 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.05 -37.66 12.66 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.418 -0.801 . . . . 1.55 109.97 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -96.89 139.92 32.21 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.401 0.62 . . . . 1.5800000000000001 109.614 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.39 136.66 12.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 119.279 -0.968 . . . . 1.28 110.086 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -116.1 124.75 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.229 0.537 . . . . 1.0900000000000001 110.682 -178.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.6 mp -104.38 116.65 32.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.971 -0.456 . . . . 1.0800000000000001 109.802 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.56 127.29 49.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.397 -0.964 . . . . 3.21 108.397 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.423 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -142.66 157.66 26.79 Favored Glycine 0 N--CA 1.508 3.44 0 O-C-N 121.093 -1.005 . . . . 0.28000000000000003 111.636 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.67 ' CG2' ' CD2' ' A' ' 80' ' ' TYR . 7.2 p -141.58 147.7 38.09 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.434 -1.039 . . . . 1.1399999999999999 112.84 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 38.67 -87.28 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.617 -0.993 . . . . 0.34999999999999998 110.617 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' THR . 2.9 mtp180 -82.68 -51.78 7.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.348 -1.089 . . . . 3.6000000000000001 109.506 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.56 -21.47 62.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.222 -0.924 . . . . 1.0900000000000001 109.028 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 44' ' ' SER . 6.5 tt -53.83 -33.81 24.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.579 -0.7 . . . . 1.6599999999999999 110.756 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.427 ' OG ' ' OG ' ' B' ' 79' ' ' SER . 0.0 OUTLIER -83.09 -23.45 33.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 1.51 108.91 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 14' ' ' LYS . 21.1 mmtp -65.18 -69.22 0.31 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.682 -1.97 . . . . 2.4399999999999999 105.682 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -34.31 -46.43 0.26 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.216 0.532 . . . . 1.1000000000000001 110.484 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.7 t -63.53 -66.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.076 -1.015 . . . . 1.01 109.694 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 52' ' ' SER . 13.1 t0 -44.76 -44.85 9.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.561 -0.712 . . . . 1.26 109.199 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' LEU . 60.5 t -50.11 -55.19 6.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.704 -0.798 . . . . 1.78 108.936 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.635 ' CD2' ' N ' ' A' ' 51' ' ' ASN . 1.1 t80 -58.5 -60.49 3.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.064 -1.022 . . . . 4.2999999999999998 110.607 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.635 ' N ' ' CD2' ' A' ' 50' ' ' TYR . 9.2 t-20 -49.11 -52.61 25.0 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.985 -1.117 . . . . 1.8500000000000001 107.985 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 48' ' ' ASP . 2.8 m -62.18 -39.02 91.29 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.847 -0.798 . . . . 1.1799999999999999 108.847 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 49' ' ' VAL . 12.5 tp -72.94 -24.06 60.76 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.067 -1.021 . . . . 1.1499999999999999 108.884 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' TYR . 4.1 tmtt? -81.34 -39.86 24.45 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.18 -1.575 . . . . 1.6599999999999999 107.227 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -52.68 -14.56 0.54 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.857 -1.164 . . . . 1.5800000000000001 107.857 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' N ' ' C ' ' A' ' 54' ' ' LYS . 11.5 mmm180 -56.15 -53.51 56.21 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.035 -0.666 . . . . 1.99 109.972 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.5 tp -161.83 -3.95 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 118.93 -1.108 . . . . 2.48 109.917 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.53 -50.94 0.1 OUTLIER Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.705 -1.236 . . . . 0.41999999999999998 110.392 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -71.91 -41.52 67.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.255 -1.144 . . . . 1.3799999999999999 110.521 -178.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.97 25.31 8.92 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.773 -1.331 . . . . 0.29999999999999999 109.773 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.8 t -155.27 133.6 2.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.944 -1.327 . . . . 1.22 108.29 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 86' ' ' LYS . 9.9 mm-40 -140.06 156.83 46.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.406 1.098 . . . . 2.0699999999999998 111.966 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.6 tt -97.08 118.45 33.53 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.044 -0.98 . . . . 1.3100000000000001 108.537 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.528 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -108.35 -17.13 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.813 -0.755 . . . . 2.0299999999999998 110.37 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 64' ' ' VAL . 0.2 OUTLIER -175.5 153.42 1.48 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.411 -1.431 . . . . 1.76 110.154 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.2 t -159.5 133.78 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.464 -0.939 . . . . 1.49 108.464 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 82' ' ' LEU . 19.7 tt0 -144.11 163.05 34.7 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.265 1.031 . . . . 2.02 110.6 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -136.51 157.18 47.39 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.751 -0.833 . . . . 1.1000000000000001 108.751 -178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.01 145.15 7.73 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 107.682 -2.167 . . . . 0.51000000000000001 107.682 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.67 ' H ' ' ND2' ' B' ' 51' ' ' ASN . 97.3 p -94.99 160.09 14.73 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.893 -1.357 . . . . 0.82999999999999996 109.356 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.12 176.63 11.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.823 -1.151 . . . . 1.29 111.118 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.24 131.4 37.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.503 0.668 . . . . 1.54 109.865 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 3.6 ttt85 -148.74 103.05 3.35 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.692 -0.855 . . . . 2.96 108.692 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.7 t0 87.19 36.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.062 0.458 . . . . 1.3799999999999999 110.117 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 65.6 33.55 8.43 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.083 0.944 . . . . 3.4300000000000002 109.363 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -158.3 155.24 28.47 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.234 -0.916 . . . . 3.9100000000000001 109.723 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -86.05 137.99 32.29 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.893 -1.123 . . . . 2.9900000000000002 109.982 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 tt -142.3 156.96 19.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-N 115.236 -0.893 . . . . 1.0700000000000001 109.489 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.05 151.6 23.1 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.958 0.885 . . . . 1.03 110.015 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.67 ' CD2' ' CG2' ' A' ' 39' ' ' THR . 0.4 OUTLIER -135.62 137.19 41.66 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.123 -1.066 . . . . 4.2599999999999998 108.123 -178.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 81' ' ' ILE . 5.1 tt -116.68 130.38 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.542 -0.91 . . . . 1.5800000000000001 108.542 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' GLN . 52.9 mt -110.22 120.54 42.78 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.145 -1.428 . . . . 1.05 107.145 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -127.46 128.27 45.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.161 -0.962 . . . . 1.6699999999999999 111.051 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -101.23 171.4 7.63 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.948 -0.569 . . . . 0.65000000000000002 109.548 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 mt -162.54 141.96 9.26 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.548 -0.861 . . . . 2.02 109.859 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -126.63 149.19 49.63 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.103 0.477 . . . . 2.02 110.593 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.459 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 17.9 mmt85 -108.06 139.99 41.89 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.627 -0.671 . . . . 2.2999999999999998 110.185 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.457 ' O ' ' CG1' ' A' ' 88' ' ' VAL . 4.3 t -115.01 -6.0 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.382 -0.969 . . . . 1.3899999999999999 108.382 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.48 0 CA-C-O 117.967 -1.016 . . . . 2.6200000000000001 109.497 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.462 -0.569 . . . . 6.8200000000000003 109.462 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.463 ' H ' ' HG1' ' B' ' 2' ' ' THR . 0.8 OUTLIER -91.83 111.71 23.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 2.7799999999999998 109.588 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' B' ' 30' ' ' GLY . 1.7 mt-10 -166.17 -51.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.35 -0.844 . . . . 1.6799999999999999 108.952 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.64 58.45 0.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.834 0.826 . . . . 2.8999999999999999 109.57 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.93 47.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.623 -1.298 . . . . 2.2599999999999998 109.479 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.36 113.58 25.88 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.226 -0.921 . . . . 1.72 112.251 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 5.8 pt-20 -93.03 111.93 23.72 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.204 -1.406 . . . . 1.49 107.204 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 18.7 mt -114.12 139.29 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.607 -0.683 . . . . 1.8 109.851 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 82.9 t -102.69 126.02 56.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.704 -0.623 . . . . 2.02 109.579 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.32 163.91 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.914 -1.143 . . . . 1.1699999999999999 107.914 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.2 173.98 10.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.314 -0.866 . . . . 2.9399999999999999 109.899 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.526 ' N ' ' OE1' ' B' ' 42' ' ' GLU . 7.6 pttt -96.65 -9.21 29.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.951 -0.759 . . . . 2.2999999999999998 108.951 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -89.72 -4.78 57.54 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.649 -0.871 . . . . 1.76 108.649 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -99.34 -131.0 0.22 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.694 -1.224 . . . . 1.8999999999999999 107.694 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -166.77 163.83 16.5 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.544 -0.91 . . . . 1.96 108.544 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -63.39 -37.41 79.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.179 -1.045 . . . . 1.29 108.179 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 6.8 pt-20 -76.24 -38.03 56.9 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.75 -0.78 . . . . 1.7 109.035 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . 0.436 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 10.4 t70 -59.41 -31.59 69.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.721 -1.237 . . . . 1.46 111.598 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.473 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 0.3 OUTLIER -93.41 -16.44 24.58 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.173 -1.58 . . . . 2.3100000000000001 108.222 178.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.06 -34.78 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 104.784 -2.302 . . . . 1.2 104.784 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 57.5 mt -68.81 -52.31 31.45 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.972 -1.013 . . . . 1.1899999999999999 109.191 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -66.49 -29.83 70.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.19 -0.944 . . . . 1.21 109.499 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 24.3 t -70.06 -53.39 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.845 . . . . 1.1299999999999999 109.202 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 tt -62.41 -20.47 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.076 -1.015 . . . . 1.3999999999999999 108.944 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -72.1 -42.55 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.233 -0.917 . . . . 1.27 109.035 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mt -67.01 -36.31 81.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.97 -1.081 . . . . 1.8300000000000001 109.569 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 0.511 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 23.3 t80 -61.16 -28.23 68.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.436 -1.32 . . . . 2.3500000000000001 107.436 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -26.17 67.64 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.64 -0.709 . . . . 1.6799999999999999 109.195 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -90.42 -1.98 57.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.173 -0.954 . . . . 1.9399999999999999 109.455 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 106.88 12.28 24.53 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.912 -1.275 . . . . 0.42999999999999999 109.912 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 mm -76.78 106.12 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.024 -1.28 . . . . 1.3400000000000001 108.545 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.85 -38.6 12.23 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.22 -0.925 . . . . 1.46 110.821 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -98.59 142.58 29.99 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.57 0.7 . . . . 1.2 110.24 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.41 137.11 11.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 119.221 -0.992 . . . . 1.27 110.802 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.61 125.63 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-N 116.089 -0.505 . . . . 1.1599999999999999 110.344 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 mp -105.36 120.21 41.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.67 -0.644 . . . . 1.22 110.696 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.43 124.36 46.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.612 -0.68 . . . . 3.2200000000000002 109.168 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.437 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -138.64 153.83 22.78 Favored Glycine 0 N--CA 1.51 3.592 0 O-C-N 121.041 -1.037 . . . . 0.28000000000000003 111.567 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.626 ' O ' ' N ' ' B' ' 41' ' ' ARG . 3.8 p -138.38 143.9 40.03 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.551 -0.97 . . . . 1.1100000000000001 112.794 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 36.26 -83.17 0.0 OUTLIER Glycine 0 N--CA 1.499 2.863 0 N-CA-C 111.15 -0.78 . . . . 0.28999999999999998 111.15 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.626 ' N ' ' O ' ' B' ' 39' ' ' THR . 5.2 mtp180 -82.03 -53.19 6.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.201 -1.176 . . . . 3.6699999999999999 110.072 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' B' ' 12' ' ' LYS . 1.3 pm0 -64.27 -18.39 64.52 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.55 -1.344 . . . . 1.3799999999999999 109.223 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 tt -54.4 -30.86 21.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.073 -1.017 . . . . 1.54 109.84 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -24.92 32.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 1.5600000000000001 108.948 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' B' ' 46' ' ' ALA . 17.1 mmtp -65.86 -68.59 0.36 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.621 -1.992 . . . . 2.4399999999999999 105.621 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -33.21 -50.64 0.31 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 116.163 -0.472 . . . . 1.02 111.281 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.01 -59.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.768 -1.208 . . . . 1.1399999999999999 109.68 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 21.3 t0 -48.51 -47.61 38.81 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.193 -0.942 . . . . 1.25 108.666 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' B' ' 53' ' ' LEU . 88.8 t -48.61 -53.6 6.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.776 -0.769 . . . . 1.77 109.038 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.614 ' CD2' ' N ' ' B' ' 51' ' ' ASN . 0.9 OUTLIER -59.67 -56.58 20.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.244 -0.91 . . . . 4.3499999999999996 111.304 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' ' 70' ' ' SER . 21.1 t-20 -54.76 -48.51 72.55 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.759 -1.2 . . . . 1.75 107.759 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 1.5 m -63.37 -39.58 94.9 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.534 -0.866 . . . . 1.0600000000000001 108.92 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.48 ' O ' ' CG ' ' B' ' 56' ' ' ARG . 10.0 tp -74.86 -26.32 59.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 1.22 109.04 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 50' ' ' TYR . 5.1 tmtt? -80.28 -46.1 16.77 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.069 -1.645 . . . . 1.8300000000000001 106.859 177.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -49.98 -11.84 0.07 Allowed 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.353 -1.294 . . . . 1.46 108.284 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.545 ' H ' ' C ' ' B' ' 54' ' ' LYS . 9.1 mmm180 -54.03 -54.5 38.33 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.827 0.822 . . . . 1.99 110.297 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.0 tp -159.83 -3.78 0.07 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.622 -0.881 . . . . 2.5699999999999998 108.622 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.69 -47.96 0.11 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.944 -1.122 . . . . 0.39000000000000001 110.561 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -73.77 -43.69 58.22 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.286 -1.126 . . . . 1.3999999999999999 110.398 -178.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.34 22.87 7.87 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 109.857 -1.297 . . . . 0.37 109.857 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -154.49 135.44 4.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 120.872 -1.37 . . . . 1.1799999999999999 108.455 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.6 tp60 -140.19 155.24 47.01 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.342 1.068 . . . . 2.1200000000000001 112.145 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.09 119.1 32.46 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.344 -0.844 . . . . 1.3799999999999999 108.88 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.4 ' O ' ' CG ' ' B' ' 65' ' ' ASN . 0.1 OUTLIER -102.09 -28.27 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.426 -0.796 . . . . 2.0 110.972 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' B' ' 64' ' ' VAL . 1.3 m120 -173.37 161.28 4.12 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.498 -1.377 . . . . 1.8600000000000001 109.41 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -159.47 132.82 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.636 -0.875 . . . . 1.5700000000000001 108.636 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' B' ' 82' ' ' LEU . 28.4 tt0 -142.46 161.74 37.27 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.988 0.899 . . . . 2.04 109.969 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -136.59 159.25 42.37 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.959 -0.756 . . . . 0.92000000000000004 108.959 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.4 144.19 7.09 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 107.926 -2.07 . . . . 0.34999999999999998 107.926 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.535 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 14.4 p -93.58 160.07 14.94 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.968 -1.313 . . . . 0.84999999999999998 108.39 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.83 175.92 12.04 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.744 -1.182 . . . . 1.49 110.941 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.47 132.28 34.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.85 -0.74 . . . . 1.46 109.283 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.3 ttt-85 -151.73 103.24 2.92 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.556 -0.715 . . . . 2.8799999999999999 109.158 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 3.7 t0 86.91 35.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.102 0.477 . . . . 1.3500000000000001 109.85 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.77 29.02 8.74 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.991 0.901 . . . . 3.3700000000000001 109.451 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -156.74 157.51 35.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.344 -0.848 . . . . 3.8999999999999999 109.601 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -87.51 139.85 30.12 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.987 -1.085 . . . . 2.9700000000000002 110.943 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 tt -142.22 158.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.571 -0.74 . . . . 1.3700000000000001 109.107 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.427 ' OG ' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -86.37 149.26 25.15 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.015 0.912 . . . . 1.04 110.198 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.615 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.4 OUTLIER -133.95 137.27 44.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.464 -0.939 . . . . 4.29 108.464 -179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' B' ' 81' ' ' ILE . 5.6 tt -118.02 129.6 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.866 -0.79 . . . . 1.55 108.866 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' B' ' 67' ' ' GLN . 6.3 mt -106.9 119.27 38.9 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.703 -1.591 . . . . 1.1599999999999999 106.703 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 3.7 tt -126.76 126.73 43.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.061 -1.024 . . . . 1.55 111.08 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -99.48 169.59 9.21 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.342 -0.614 . . . . 0.70999999999999996 109.342 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 mt -162.44 137.55 6.97 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.802 -0.759 . . . . 2.1200000000000001 109.395 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -124.97 151.6 45.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.793 -0.567 . . . . 2.0 109.492 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.511 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 19.0 mmt85 -107.5 141.23 39.25 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.469 0.652 . . . . 2.2999999999999998 110.275 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . 0.435 ' O ' ' CG1' ' B' ' 88' ' ' VAL . 13.7 t -115.18 -6.47 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.251 -1.018 . . . . 1.46 108.251 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.022 -0.989 . . . . 2.6299999999999999 109.528 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.546 -0.539 . . . . 6.7999999999999998 109.546 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.535 ' C ' ' H ' ' A' ' 4' ' ' LYS . 10.1 p -96.37 -72.11 0.65 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 2.7799999999999998 109.384 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 2' ' ' THR . 5.2 tt0 74.02 -32.93 0.24 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.988 -1.07 . . . . 1.8 109.809 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 2' ' ' THR . 7.4 mtmm -155.88 53.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.076 0.941 . . . . 2.8500000000000001 108.582 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 0.7 OUTLIER -161.31 151.61 17.57 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 104.146 -2.538 . . . . 2.2200000000000002 104.146 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.6 HD22 ' CG1' ' A' ' 8' ' ' ILE . 1.8 t-20 177.45 94.51 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 118.061 -1.456 . . . . 1.8500000000000001 110.131 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 112.34 23.6 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.524 -1.36 . . . . 1.4399999999999999 108.166 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.6 ' CG1' HD22 ' A' ' 6' ' ' ASN . 4.8 mm -125.13 148.88 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 122.288 1.042 . . . . 1.8300000000000001 111.79 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.7 t -111.94 129.82 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.537 0.684 . . . . 2.0099999999999998 110.485 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.2 162.9 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.866 -1.161 . . . . 1.24 107.866 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -131.66 167.2 19.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.344 -0.847 . . . . 2.8500000000000001 110.136 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.2 pttp -87.93 -16.31 34.2 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.806 -1.183 . . . . 2.3399999999999999 107.806 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -74.37 -67.5 0.62 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.542 -1.651 . . . . 1.6699999999999999 106.542 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.538 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.1 mtmm -58.0 143.44 43.21 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.241 -0.912 . . . . 1.8600000000000001 110.113 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -72.27 178.09 4.12 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.48 0.657 . . . . 1.97 110.342 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.51 -31.86 39.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.908 0.861 . . . . 1.29 108.715 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -73.77 -30.77 62.97 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.454 -0.899 . . . . 1.5600000000000001 109.219 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -30.51 69.63 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 120.445 -1.409 . . . . 1.3799999999999999 110.881 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.483 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 41.0 m80 -95.33 -19.75 19.71 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.585 -1.322 . . . . 2.3500000000000001 108.236 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.71 -35.63 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 104.896 -2.261 . . . . 1.1299999999999999 104.896 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.8 mt -69.04 -52.5 27.93 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.823 -1.08 . . . . 1.1799999999999999 108.703 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -66.76 -26.46 66.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 1.22 109.895 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 13.9 t -73.62 -53.14 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.256 -0.902 . . . . 1.1399999999999999 108.804 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tt -55.39 -24.57 15.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.503 -0.925 . . . . 1.3 108.503 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.8 t -69.25 -40.81 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.234 -0.987 . . . . 1.1499999999999999 109.443 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.51 -38.03 88.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.524 -1.36 . . . . 1.8700000000000001 109.613 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -28.61 69.68 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.071 -1.455 . . . . 2.3599999999999999 107.071 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.36 -28.43 59.09 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.29 -0.868 . . . . 1.71 108.729 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -90.43 -18.43 25.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 1.8799999999999999 109.222 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 114.43 17.22 7.21 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.793 -1.323 . . . . 0.47999999999999998 109.793 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mm -74.19 113.99 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.395 -1.062 . . . . 1.0900000000000001 108.793 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -93.38 -34.59 13.41 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 119.71 -0.796 . . . . 1.55 111.366 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.81 135.88 42.6 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.625 0.726 . . . . 1.5800000000000001 111.351 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 p -149.55 141.92 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.96 -0.696 . . . . 1.28 110.297 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -122.35 124.9 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 116.06 -0.518 . . . . 1.0900000000000001 110.767 -178.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mp -106.36 123.08 47.52 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.279 -0.568 . . . . 1.0800000000000001 110.042 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -99.75 125.73 45.69 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.29 -1.004 . . . . 3.21 108.29 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.17 142.34 13.58 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.562 -1.304 . . . . 0.28000000000000003 110.827 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 41' ' ' ARG . 54.1 p -126.31 135.72 51.86 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.878 0.846 . . . . 1.1399999999999999 111.908 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 37.97 -87.41 0.01 OUTLIER Glycine 0 N--CA 1.496 2.678 0 O-C-N 121.623 -0.673 . . . . 0.34999999999999998 111.815 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -80.11 -51.77 8.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.041 -1.27 . . . . 3.6000000000000001 109.901 -178.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.66 -19.28 37.85 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.611 -1.305 . . . . 1.0900000000000001 107.59 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' OG ' ' A' ' 79' ' ' SER . 2.2 tt -54.51 -33.66 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.719 -0.613 . . . . 1.6599999999999999 110.934 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.612 ' CB ' ' HG ' ' B' ' 79' ' ' SER . 0.6 OUTLIER -83.77 -21.92 32.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.857 -1.152 . . . . 1.51 108.615 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.533 ' NZ ' ' O ' ' A' ' 14' ' ' LYS . 22.8 mmtp -66.17 -70.43 0.24 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.368 -1.715 . . . . 2.4399999999999999 106.368 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -29.46 -51.34 0.11 Allowed 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.439 0.638 . . . . 1.1000000000000001 110.598 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.86 -68.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.37 -0.831 . . . . 1.01 109.937 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 52' ' ' SER . 12.8 t70 -45.54 -48.1 14.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.716 . . . . 1.26 109.584 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' A' ' 52' ' ' SER . 91.7 t -47.36 -58.56 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.936 -0.764 . . . . 1.78 108.936 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -61.84 -54.52 40.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.16 -0.963 . . . . 4.2999999999999998 111.432 -178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.575 ' ND2' ' HG ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -53.74 -48.27 69.82 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.691 -1.256 . . . . 1.8500000000000001 107.804 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.495 ' N ' ' CG ' ' A' ' 51' ' ' ASN . 22.1 p -59.43 -35.88 74.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.839 -1.171 . . . . 1.1799999999999999 107.839 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 tp -79.09 -22.12 45.71 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.095 -1.076 . . . . 1.1499999999999999 108.095 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.98 -43.96 21.09 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.506 -2.035 . . . . 1.6599999999999999 105.506 177.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -56.05 -9.21 0.57 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.562 -1.273 . . . . 1.5800000000000001 107.562 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 54' ' ' LYS . 8.8 tpt180 -70.83 -49.34 47.3 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.599 0.714 . . . . 1.99 109.559 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.1 tp -153.86 -15.45 0.14 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.381 -0.928 . . . . 2.48 110.794 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 61' ' ' VAL . . . 63.27 -55.62 0.05 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.004 -1.238 . . . . 0.41999999999999998 110.004 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -73.08 -40.09 65.3 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.633 -0.922 . . . . 1.3799999999999999 109.496 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.431 ' O ' ' CD ' ' A' ' 87' ' ' ARG . . . -83.34 23.57 6.19 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 108.883 -1.687 . . . . 0.29999999999999999 108.883 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' GLY . 2.8 t -155.15 131.71 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.57 -1.27 . . . . 1.22 107.57 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.7 mm-40 -138.09 157.4 46.4 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.427 1.108 . . . . 2.0699999999999998 111.796 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.5 tt -94.55 116.4 28.73 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.363 -0.835 . . . . 1.3100000000000001 109.504 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.34 -20.97 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.323 -0.861 . . . . 2.0299999999999998 109.396 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.59 148.61 1.98 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.232 -1.387 . . . . 1.76 110.323 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -157.63 134.09 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.755 -0.831 . . . . 1.49 108.755 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -144.92 159.9 42.17 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.077 0.942 . . . . 2.02 110.667 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -135.44 151.81 50.77 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.537 -0.912 . . . . 1.1000000000000001 108.537 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.69 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -176.47 157.23 22.6 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 106.512 -2.635 . . . . 0.51000000000000001 106.512 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.534 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 94.4 p -99.38 161.25 13.72 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 119.051 1.426 . . . . 0.82999999999999996 110.396 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -155.77 175.73 13.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.102 -0.999 . . . . 1.29 110.737 178.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.434 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.02 134.59 29.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.72 0.771 . . . . 1.54 110.799 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 25.2 ttt-85 -145.7 101.39 3.55 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.321 -0.992 . . . . 2.96 108.321 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.9 t0 85.96 36.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.224 0.535 . . . . 1.3799999999999999 109.766 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.1 32.36 12.78 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.967 0.889 . . . . 3.4300000000000002 109.304 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -150.57 149.84 30.43 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.66 -0.867 . . . . 3.9100000000000001 108.66 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -85.73 137.38 32.85 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.482 1.134 . . . . 2.9900000000000002 110.077 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 tt -142.9 156.52 17.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.072 -0.967 . . . . 1.0700000000000001 108.778 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.483 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -87.92 155.82 19.66 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.453 -0.779 . . . . 1.03 111.145 -176.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.69 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 7.7 p90 -146.47 153.75 40.79 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.774 0.797 . . . . 4.2599999999999998 110.466 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.34 132.49 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.419 0.628 . . . . 1.5800000000000001 109.993 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.3 mt -106.86 120.71 42.77 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.763 -1.569 . . . . 1.05 106.763 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 tt -128.99 124.84 36.02 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.313 -0.955 . . . . 1.6699999999999999 110.582 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -101.4 172.0 7.25 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.663 -0.699 . . . . 0.65000000000000002 109.465 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 tp -159.42 143.03 14.68 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 118.978 -1.089 . . . . 2.02 111.135 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -118.72 142.45 47.66 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.768 -0.827 . . . . 2.02 108.768 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' CD ' ' O ' ' A' ' 60' ' ' GLY . 16.2 tpp180 -104.16 138.81 40.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.326 -0.858 . . . . 2.2999999999999998 109.726 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.85 -7.18 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.052 -0.721 . . . . 1.3899999999999999 109.052 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 117.978 -1.01 . . . . 2.6200000000000001 109.587 179.422 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mtt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.533 -0.544 . . . . 6.8200000000000003 109.533 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 73.0 p -138.64 81.19 1.83 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.523 -0.735 . . . . 2.7799999999999998 109.775 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' B' ' 30' ' ' GLY . 12.1 mt-10 -78.64 -10.87 59.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.868 -1.145 . . . . 1.6799999999999999 108.747 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -152.18 60.59 0.84 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.533 -0.867 . . . . 2.8999999999999999 110.131 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.09 153.18 17.93 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.535 -2.024 . . . . 2.2599999999999998 105.535 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.457 ' OD1' ' CD1' ' B' ' 26' ' ' LEU . 1.0 OUTLIER -178.35 91.54 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.367 -1.333 . . . . 1.72 111.841 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.75 107.52 19.23 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.018 -1.676 . . . . 1.49 107.147 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.437 ' CG1' ' OD1' ' B' ' 6' ' ' ASN . 43.1 mm -122.13 141.75 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 122.06 0.933 . . . . 1.8 110.215 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.0 t -101.26 129.05 52.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.778 -0.647 . . . . 2.02 109.476 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.9 164.27 2.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.613 -1.254 . . . . 1.1699999999999999 107.613 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.451 ' HE ' ' CE ' ' B' ' 14' ' ' LYS . 11.6 mtt-85 -138.21 174.55 10.44 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.844 0.831 . . . . 2.9399999999999999 110.149 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -103.56 -8.56 19.95 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.014 -1.106 . . . . 2.2999999999999998 108.014 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.43 -14.9 41.92 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.741 -0.784 . . . . 1.76 109.616 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.451 ' CE ' ' HE ' ' B' ' 11' ' ' ARG . 0.5 OUTLIER -97.81 -118.79 0.13 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.409 -0.96 . . . . 1.8999999999999999 108.409 178.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.77 170.24 9.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.1 -1.0 . . . . 1.96 108.656 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.89 -32.85 45.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.187 -1.042 . . . . 1.29 108.187 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.455 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 7.3 pt-20 -77.1 -40.42 45.99 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.792 -0.763 . . . . 1.7 109.098 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . 0.455 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 66.4 t0 -58.45 -31.87 68.18 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.605 -1.31 . . . . 1.46 110.975 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.47 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 17.2 m80 -91.21 -16.89 26.92 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.137 -1.602 . . . . 2.3100000000000001 108.546 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.22 -34.88 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.322 -2.103 . . . . 1.2 105.322 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 72.4 mt -67.97 -52.97 29.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.144 -0.935 . . . . 1.1899999999999999 108.949 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.04 -25.88 68.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.3 -0.875 . . . . 1.21 109.755 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 20.1 t -74.57 -52.96 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.422 -0.798 . . . . 1.1299999999999999 109.282 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 tt -57.04 -24.83 21.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.562 -0.903 . . . . 1.3999999999999999 108.562 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.32 -41.78 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.323 -0.861 . . . . 1.27 109.248 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.457 ' CD1' ' OD1' ' B' ' 6' ' ' ASN . 4.5 mt -65.15 -39.63 93.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.681 -1.262 . . . . 1.8300000000000001 109.342 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -32.02 69.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.215 -1.402 . . . . 2.3500000000000001 107.215 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -30.8 54.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.769 -0.826 . . . . 1.6799999999999999 108.769 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -89.54 -6.36 56.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 1.9399999999999999 109.926 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 101.39 16.47 24.76 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.556 -1.418 . . . . 0.42999999999999999 109.556 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.9 113.88 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.814 -1.18 . . . . 1.3400000000000001 107.814 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -98.35 -40.4 8.33 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.37 -0.832 . . . . 1.46 112.211 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -96.11 137.59 34.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 1.2 111.307 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -152.52 141.17 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.985 -1.086 . . . . 1.27 111.57 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.55 128.32 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 115.589 -0.732 . . . . 1.1599999999999999 110.605 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.91 122.56 47.47 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.471 -0.768 . . . . 1.22 110.034 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -102.96 130.07 49.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.331 -0.856 . . . . 3.2200000000000002 108.851 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.16 147.65 19.26 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.654 -1.26 . . . . 0.28000000000000003 110.649 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.613 ' O ' ' N ' ' B' ' 41' ' ' ARG . 42.6 p -129.71 140.06 51.19 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.074 -0.662 . . . . 1.1100000000000001 112.117 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 33.51 -80.78 0.0 OUTLIER Glycine 0 N--CA 1.503 3.148 0 O-C-N 121.847 -0.533 . . . . 0.28999999999999998 112.325 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.0 OUTLIER -83.53 -54.04 5.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.968 -1.313 . . . . 3.6699999999999999 109.45 -178.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -15.84 36.83 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.845 -1.159 . . . . 1.3799999999999999 109.048 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.405 ' CG2' ' O ' ' B' ' 40' ' ' GLY . 10.1 tt -58.25 -26.24 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.334 -0.854 . . . . 1.54 110.027 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -26.22 22.13 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.456 -0.942 . . . . 1.5600000000000001 108.456 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' B' ' 46' ' ' ALA . 23.3 mmtp -63.18 -69.64 0.26 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.167 -1.79 . . . . 2.4399999999999999 106.167 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -29.71 -50.41 0.11 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 116.159 -0.473 . . . . 1.02 111.582 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.61 -59.33 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.802 -1.186 . . . . 1.1399999999999999 109.957 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' B' ' 52' ' ' SER . 12.3 t70 -52.19 -51.87 55.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.141 -0.975 . . . . 1.25 108.612 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' B' ' 48' ' ' ASP . 60.4 t -41.34 -61.33 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 109.028 -0.73 . . . . 1.77 109.028 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' B' ' 50' ' ' TYR . 0.1 OUTLIER -62.36 -50.75 70.33 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.515 -0.74 . . . . 4.3499999999999996 109.906 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.534 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -50.72 -55.22 17.63 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.975 -1.12 . . . . 1.75 107.975 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.477 ' N ' ' CG ' ' B' ' 51' ' ' ASN . 0.8 OUTLIER -59.9 -35.52 75.03 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.643 -0.823 . . . . 1.0600000000000001 109.256 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.1 tp -72.1 -24.15 61.44 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.892 -1.13 . . . . 1.22 109.417 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.07 -29.72 31.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.266 -1.521 . . . . 1.8300000000000001 107.277 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.0 -13.85 13.37 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.897 -1.149 . . . . 1.46 107.897 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -71.5 -42.66 67.76 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.492 -0.883 . . . . 1.99 109.342 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.3 tp -153.95 -18.21 0.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.532 -1.267 . . . . 2.5699999999999998 111.602 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 65.86 -62.88 0.13 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.365 -1.494 . . . . 0.39000000000000001 109.365 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -69.64 -41.61 75.36 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.387 -1.066 . . . . 1.3999999999999999 109.089 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' B' ' 87' ' ' ARG . . . -76.81 20.03 3.08 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.592 -1.403 . . . . 0.37 109.592 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' B' ' 59' ' ' ASP . 2.5 t -153.16 131.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.412 -1.329 . . . . 1.1799999999999999 107.412 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' B' ' 86' ' ' LYS . 3.0 mm-40 -134.0 153.35 51.84 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.048 0.928 . . . . 2.1200000000000001 112.207 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 7.6 tt -93.54 116.49 29.01 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.177 -1.045 . . . . 1.3799999999999999 108.177 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.83 -25.82 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.262 -0.899 . . . . 2.0 110.206 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -172.42 151.58 2.51 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.85 -1.156 . . . . 1.8600000000000001 109.284 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 96.1 t -154.53 133.82 3.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.193 -1.04 . . . . 1.5700000000000001 108.193 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -141.11 159.84 41.37 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.769 0.795 . . . . 2.04 109.47 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -138.98 151.85 47.2 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.109 -0.7 . . . . 0.92000000000000004 109.109 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.665 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -174.81 160.38 29.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.683 -1.767 . . . . 0.34999999999999998 108.683 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.575 ' HG ' ' ND2' ' A' ' 51' ' ' ASN . 89.9 p -98.35 155.11 17.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.275 -1.132 . . . . 0.84999999999999998 109.403 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -151.9 172.86 15.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.67 -1.269 . . . . 1.49 110.996 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.423 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -89.64 136.63 23.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.847 0.832 . . . . 1.46 110.917 -178.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 5.2 ttt-85 -148.96 100.21 3.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.973 -0.751 . . . . 2.8799999999999999 108.973 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 4.7 t0 85.07 36.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.246 -0.65 . . . . 1.3500000000000001 109.246 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.44 28.5 11.6 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.849 0.833 . . . . 3.3700000000000001 109.328 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.54 152.04 36.15 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.826 -0.805 . . . . 3.8999999999999999 108.826 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 9.6 ttm-85 -87.29 141.65 28.48 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.018 -1.073 . . . . 2.9700000000000002 111.099 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.91 158.58 23.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.635 -0.876 . . . . 1.3700000000000001 108.635 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.612 ' HG ' ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -87.84 148.14 24.8 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.514 -0.741 . . . . 1.04 109.553 -178.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.665 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.8 p90 -140.75 148.11 40.19 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.573 0.702 . . . . 4.29 109.948 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 6.4 tt -123.22 131.01 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.631 0.729 . . . . 1.55 110.037 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -105.98 123.06 47.38 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.149 -1.426 . . . . 1.1599999999999999 107.149 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -132.4 125.25 30.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.028 -1.045 . . . . 1.55 110.938 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -99.83 169.66 9.08 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.802 -0.635 . . . . 0.70999999999999996 109.933 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 tp -159.86 136.1 8.84 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.55 -0.86 . . . . 2.1200000000000001 110.661 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 62' ' ' GLN . 7.8 tmtt? -118.36 138.3 52.52 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.52 -0.919 . . . . 2.0 108.52 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.403 HH11 ' CG2' ' B' ' 61' ' ' VAL . 16.6 tpp180 -95.48 143.7 26.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.465 -0.772 . . . . 2.2999999999999998 110.753 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.22 -13.48 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.877 -0.786 . . . . 1.46 108.877 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.303 -1.428 0 CA-C-O 117.98 -1.009 . . . . 2.6299999999999999 109.534 179.781 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.627 ' N ' HD22 ' A' ' 6' ' ' ASN . 9.1 ttt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 6.7999999999999998 109.472 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 5' ' ' LEU . 6.7 p -144.64 17.8 1.65 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 2.7799999999999998 109.549 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 30' ' ' GLY . 2.2 tt0 67.74 -48.34 0.51 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.5 -0.75 . . . . 1.8 109.845 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.85 55.37 0.48 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.488 -0.885 . . . . 2.8500000000000001 110.355 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.496 ' N ' ' OG1' ' A' ' 2' ' ' THR . 1.1 tt -173.17 49.7 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.274 -0.971 . . . . 2.2200000000000002 109.728 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.627 HD22 ' N ' ' A' ' 1' ' ' MET . 2.4 m120 -91.0 116.0 28.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.8 -1.187 . . . . 1.8500000000000001 111.329 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 7.0 pt-20 -92.09 115.58 28.19 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.989 -1.485 . . . . 1.4399999999999999 106.989 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.0 mt -115.64 140.0 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-O 122.132 0.968 . . . . 1.8300000000000001 111.592 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.8 124.71 62.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.986 -0.552 . . . . 2.0099999999999998 109.83 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.53 165.07 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.631 -1.248 . . . . 1.24 107.631 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -140.19 175.43 9.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.913 . . . . 2.8500000000000001 109.671 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.1 pttm -101.83 -9.71 20.52 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.006 -0.739 . . . . 2.3399999999999999 109.006 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 t -90.71 -7.89 51.35 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.828 -1.175 . . . . 1.6699999999999999 107.828 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.15 -132.76 0.18 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.423 -1.325 . . . . 1.8600000000000001 107.423 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.81 159.65 21.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.557 -1.339 . . . . 1.97 109.4 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 17' ' ' GLU . 16.5 m -61.66 -40.97 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-O 121.869 0.842 . . . . 1.29 109.284 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 3.5 pt-20 -77.86 -32.35 52.0 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.265 -0.897 . . . . 1.5600000000000001 108.871 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 52.3 t0 -62.78 -31.07 71.96 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.63 -1.294 . . . . 1.3799999999999999 111.164 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.486 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 1.6 m-70 -95.23 -17.15 21.96 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.176 -1.578 . . . . 2.3500000000000001 108.389 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -31.89 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 104.436 -2.431 . . . . 1.1299999999999999 104.436 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 mt -70.43 -52.85 19.27 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.32 -1.309 . . . . 1.1799999999999999 109.057 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -67.38 -29.46 68.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 1.22 109.671 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 25.5 t -70.03 -54.29 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 1.1399999999999999 108.964 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 tt -60.89 -20.36 21.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.203 -0.935 . . . . 1.3 108.894 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -72.46 -40.83 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.095 -1.003 . . . . 1.1499999999999999 109.025 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.03 -36.78 80.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.784 -1.197 . . . . 1.8700000000000001 109.965 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -61.73 -24.72 66.99 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.237 -1.394 . . . . 2.3599999999999999 107.237 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -27.03 68.67 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.343 -0.844 . . . . 1.71 109.109 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -89.32 -2.31 58.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 1.8799999999999999 109.535 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 107.74 12.4 22.73 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.898 -1.281 . . . . 0.47999999999999998 109.898 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.456 HD13 HG23 ' A' ' 31' ' ' ILE . 50.0 mm -76.44 106.16 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.063 -1.257 . . . . 1.0900000000000001 108.927 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -92.52 -35.76 13.42 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.312 -0.867 . . . . 1.55 110.232 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -98.63 140.12 33.33 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.387 0.613 . . . . 1.5800000000000001 109.608 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.47 142.85 15.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 119.188 -1.005 . . . . 1.28 110.221 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.2 127.33 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.987 -0.551 . . . . 1.0900000000000001 110.477 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.71 118.37 35.43 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.501 0.667 . . . . 1.0800000000000001 109.322 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.32 134.36 49.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.667 -0.864 . . . . 3.21 108.667 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.5 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -145.14 157.28 27.29 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 120.036 -1.078 . . . . 0.28000000000000003 111.155 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 41' ' ' ARG . 14.9 p -139.0 146.92 41.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.466 -1.02 . . . . 1.1399999999999999 112.664 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 39.76 -86.92 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.628 -0.989 . . . . 0.34999999999999998 110.628 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -85.23 -51.86 6.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.32 -1.106 . . . . 3.6000000000000001 109.682 -178.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -25.51 60.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.819 -1.176 . . . . 1.0900000000000001 108.895 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 44' ' ' SER . 7.0 tt -49.74 -36.37 11.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.552 -0.717 . . . . 1.6599999999999999 110.83 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.494 ' H ' ' HG ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -83.54 -23.57 32.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.007 -1.058 . . . . 1.51 108.989 -178.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 46' ' ' ALA . 7.8 mmtt -62.29 -70.7 0.18 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 104.497 -2.409 . . . . 2.4399999999999999 104.497 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -31.47 -49.63 0.16 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.17 0.51 . . . . 1.1000000000000001 110.576 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.37 -69.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.225 -0.922 . . . . 1.01 109.549 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.424 ' O ' ' OG ' ' A' ' 52' ' ' SER . 3.6 t0 -45.81 -49.04 15.54 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.52 -0.738 . . . . 1.26 109.563 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.424 ' O ' ' OG ' ' A' ' 52' ' ' SER . 70.4 t -48.14 -59.64 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.646 -0.822 . . . . 1.78 109.105 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -60.06 -53.45 57.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 4.2999999999999998 110.228 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.48 ' CG ' ' H ' ' B' ' 70' ' ' SER . 0.5 OUTLIER -52.48 -49.82 63.95 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.662 -1.236 . . . . 1.8500000000000001 107.662 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 21.0 p -62.07 -35.04 77.45 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.73 -0.841 . . . . 1.1799999999999999 108.73 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.446 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 7.5 tp -77.34 -22.38 51.94 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.065 -1.022 . . . . 1.1499999999999999 108.737 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' C ' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -79.89 -42.5 24.04 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.172 -1.58 . . . . 1.6599999999999999 106.858 177.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.49 -16.11 0.1 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.783 -1.099 . . . . 1.5800000000000001 108.051 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.506 ' N ' ' C ' ' A' ' 54' ' ' LYS . 12.2 mmm180 -59.31 -55.7 31.49 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.356 0.598 . . . . 1.99 110.251 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 mt -159.16 0.58 0.09 Allowed 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 118.689 -1.204 . . . . 2.48 110.595 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 61' ' ' VAL . . . 64.92 -58.52 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.527 -1.321 . . . . 0.41999999999999998 110.209 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -70.96 -41.98 70.36 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.495 -1.003 . . . . 1.3799999999999999 110.49 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.49 17.64 3.24 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.414 -1.475 . . . . 0.29999999999999999 109.414 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.453 ' H ' ' C ' ' A' ' 59' ' ' ASP . 2.4 t -155.94 127.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.785 -1.191 . . . . 1.22 107.785 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.6 mm-40 -132.94 157.51 44.96 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.176 0.988 . . . . 2.0699999999999998 111.375 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.05 112.6 24.29 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.072 -0.714 . . . . 1.3100000000000001 109.072 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -20.86 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 2.0299999999999998 110.001 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.42 ' O ' ' CG2' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -167.86 153.23 7.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.18 -1.575 . . . . 1.76 109.784 177.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 65' ' ' ASN . 70.3 t -159.65 129.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.463 -0.773 . . . . 1.49 109.457 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 82' ' ' LEU . 12.9 tt0 -146.06 164.79 31.03 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.285 1.04 . . . . 2.02 110.902 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.6 p -139.27 158.06 44.82 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.894 -0.78 . . . . 1.1000000000000001 108.894 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 80' ' ' TYR . . . -174.55 147.38 9.12 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 107.195 -2.362 . . . . 0.51000000000000001 107.195 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.523 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 87.4 p -93.45 163.05 13.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.662 -1.493 . . . . 0.82999999999999996 110.175 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -147.85 159.88 43.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.237 -0.914 . . . . 1.29 110.648 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.17 87.71 2.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 118.991 -1.084 . . . . 1.54 109.226 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 46.1 ttt-85 -96.11 111.19 23.3 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.963 -1.086 . . . . 2.96 110.301 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.0 t70 80.64 37.25 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.888 -0.507 . . . . 1.3799999999999999 110.178 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.46 28.86 15.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.397 -0.815 . . . . 3.4300000000000002 109.129 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.26 146.14 28.51 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.083 -1.011 . . . . 3.9100000000000001 108.776 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.677 ' NH2' HD22 ' B' ' 51' ' ' ASN . 5.5 tpt180 -84.46 133.23 34.49 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.779 1.276 . . . . 2.9900000000000002 111.256 -177.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.5 tt -141.34 155.72 21.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.436 -1.256 . . . . 1.0700000000000001 108.831 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.55 151.71 23.24 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.139 0.971 . . . . 1.03 111.305 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.5 ' CD1' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -131.45 135.5 47.18 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.455 -0.943 . . . . 4.2599999999999998 108.455 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.441 ' CG2' ' O ' ' A' ' 81' ' ' ILE . 2.8 tt -117.11 126.79 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.168 -1.049 . . . . 1.5800000000000001 108.168 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 67' ' ' GLN . 16.8 mt -107.5 121.06 43.86 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.311 -1.366 . . . . 1.05 107.311 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 tt -131.89 126.12 33.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.035 . . . . 1.6699999999999999 111.123 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -100.56 171.61 7.62 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.784 -0.644 . . . . 0.65000000000000002 109.985 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 tp -159.49 142.38 14.07 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.112 -1.035 . . . . 2.02 110.72 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.59 ' O ' ' N ' ' A' ' 62' ' ' GLN . 13.7 tmtt? -121.85 141.21 51.48 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 116.073 -0.512 . . . . 2.02 110.442 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.1 mmt-85 -99.21 137.24 38.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.099 -1.001 . . . . 2.2999999999999998 109.705 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.31 -0.79 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.537 -0.912 . . . . 1.3899999999999999 108.537 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 t80 . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 118.028 -0.987 . . . . 2.6200000000000001 109.53 179.524 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.608 ' H3 ' HD21 ' B' ' 6' ' ' ASN . 9.1 ttt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.494 -0.558 . . . . 6.8200000000000003 109.494 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.479 ' O ' ' CB ' ' B' ' 3' ' ' GLU . 15.7 p -144.05 13.52 1.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 2.7799999999999998 109.93 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' B' ' 2' ' ' THR . 7.8 tt0 72.28 -50.73 0.7 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 1.6799999999999999 109.817 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 57.4 0.5 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.303 -0.873 . . . . 2.8999999999999999 109.857 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.433 ' N ' ' OG1' ' B' ' 2' ' ' THR . 1.1 tt -175.38 46.6 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.422 -0.955 . . . . 2.2599999999999998 108.422 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.608 HD21 ' H3 ' ' B' ' 1' ' ' MET . 13.8 t-20 -92.32 114.92 27.59 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.251 -0.906 . . . . 1.72 110.792 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.7 pt-20 -93.4 117.62 30.3 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.303 -0.999 . . . . 1.49 108.303 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 45.5 mt -113.23 133.9 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.741 0.782 . . . . 1.8 110.574 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -98.7 123.02 51.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.361 0.6 . . . . 2.02 109.703 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.92 165.38 2.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.163 -1.051 . . . . 1.1699999999999999 108.163 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 26.9 mtt-85 -141.79 175.33 9.79 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.431 -0.793 . . . . 2.9399999999999999 109.747 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -102.53 -9.09 20.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.38 -0.97 . . . . 2.2999999999999998 108.38 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -84.79 -14.49 47.99 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.478 -0.889 . . . . 1.76 109.614 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -94.95 -118.25 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.18 -0.95 . . . . 1.8999999999999999 108.944 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.5 168.6 9.29 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.396 -0.815 . . . . 1.96 109.06 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.429 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 15.1 m -68.25 -38.4 79.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.881 0.848 . . . . 1.29 109.097 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.429 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 8.0 pt-20 -76.7 -31.46 57.22 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.024 -1.048 . . . . 1.7 109.51 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -32.28 72.6 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.453 -1.404 . . . . 1.46 111.268 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.474 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 3.1 m-70 -94.96 -16.81 22.49 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.335 -1.478 . . . . 2.3100000000000001 108.409 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.15 -35.21 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 104.538 -2.393 . . . . 1.2 104.538 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.93 -49.07 61.29 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.649 -1.16 . . . . 1.1899999999999999 109.011 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -70.25 -32.06 69.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.153 -0.967 . . . . 1.21 109.536 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 25.0 t -68.11 -52.53 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 1.1299999999999999 109.165 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 tt -62.19 -23.31 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.217 -0.927 . . . . 1.3999999999999999 108.883 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 t -69.88 -39.91 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.111 -0.993 . . . . 1.27 109.27 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -68.71 -38.76 80.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.758 -1.214 . . . . 1.8300000000000001 109.822 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.2 -27.64 65.91 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.81 -1.552 . . . . 2.3500000000000001 106.81 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -25.25 68.28 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.235 -0.893 . . . . 1.6799999999999999 109.143 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -91.64 0.62 57.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 1.9399999999999999 109.351 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 103.68 14.25 25.8 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.034 -1.226 . . . . 0.42999999999999999 110.034 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.42 HD13 HG23 ' B' ' 31' ' ' ILE . 39.1 mm -78.08 108.49 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.931 -1.335 . . . . 1.3400000000000001 108.393 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.7 OUTLIER -94.38 -37.97 11.2 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.409 -0.807 . . . . 1.46 110.642 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -100.38 139.03 36.63 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.714 -0.616 . . . . 1.2 110.046 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.75 142.93 16.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.089 -1.044 . . . . 1.27 111.234 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.85 124.79 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-N 115.889 -0.596 . . . . 1.1599999999999999 110.405 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mp -103.19 114.21 28.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.305 -0.872 . . . . 1.22 109.848 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -98.66 122.97 42.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 3.2200000000000002 109.761 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.507 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -137.59 153.33 22.01 Favored Glycine 0 N--CA 1.505 3.266 0 C-N-CA 119.86 -1.162 . . . . 0.28000000000000003 111.357 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.61 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 1.4 p -139.79 147.28 40.56 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 122.174 0.987 . . . . 1.1100000000000001 112.949 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 36.93 -87.62 0.01 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.632 -0.987 . . . . 0.28999999999999998 110.632 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -82.63 -52.77 6.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -1.084 . . . . 3.6699999999999999 109.503 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -19.48 54.24 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.901 -1.124 . . . . 1.3799999999999999 109.224 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 6.6 tt -54.58 -28.61 19.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.267 -0.896 . . . . 1.54 109.618 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.501 ' H ' ' HG ' ' B' ' 44' ' ' SER . 0.2 OUTLIER -84.98 -26.83 26.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.5600000000000001 108.921 -178.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.452 ' O ' ' C ' ' B' ' 46' ' ' ALA . 9.9 mmtt -64.0 -69.62 0.27 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.819 -1.919 . . . . 2.4399999999999999 105.819 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -32.42 -49.69 0.22 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 116.123 -0.49 . . . . 1.02 111.166 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.91 -62.74 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.73 -1.231 . . . . 1.1399999999999999 109.884 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . 0.438 ' O ' ' OG ' ' B' ' 52' ' ' SER . 7.5 t0 -48.22 -52.57 20.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 1.25 108.646 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 54.2 t -44.42 -55.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.722 -0.844 . . . . 1.77 108.722 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' B' ' 54' ' ' LYS . 0.1 OUTLIER -63.97 -51.89 62.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.542 -0.724 . . . . 4.3499999999999996 110.503 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.677 HD22 ' NH2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -53.25 -51.08 63.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.311 -1.366 . . . . 1.75 107.311 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 3.8 p -59.18 -36.73 75.84 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.564 -0.902 . . . . 1.0600000000000001 108.564 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.473 ' O ' ' CG ' ' B' ' 56' ' ' ARG . 5.4 tp -77.13 -24.06 51.7 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.211 -0.931 . . . . 1.22 109.069 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . 0.564 ' C ' ' H ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -81.78 -44.57 16.81 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 119.843 -1.786 . . . . 1.8300000000000001 107.286 178.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' B' ' 55' ' ' ASP . 1.4 t0 -50.88 -11.22 0.08 Allowed 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.171 -1.377 . . . . 1.46 107.88 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.564 ' H ' ' C ' ' B' ' 54' ' ' LYS . 9.3 mmm180 -56.96 -57.25 13.36 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.119 0.961 . . . . 1.99 110.352 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.0 OUTLIER -156.53 -1.92 0.12 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.137 -1.061 . . . . 2.5699999999999998 108.137 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.0 -52.93 0.1 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.011 -1.09 . . . . 0.39000000000000001 110.427 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' B' ' 61' ' ' VAL . 0.3 OUTLIER -72.51 -45.44 59.36 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.473 -1.016 . . . . 1.3999999999999999 110.329 -178.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.93 21.08 0.82 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 109.395 -1.482 . . . . 0.37 109.395 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' B' ' 59' ' ' ASP . 2.5 t -156.65 130.76 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.032 -1.275 . . . . 1.1799999999999999 107.894 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.5 mm-40 -132.92 150.11 52.19 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.029 0.919 . . . . 2.1200000000000001 111.695 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' B' ' 63' ' ' LEU . 7.0 tt -94.23 114.83 27.0 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.84 -1.17 . . . . 1.3799999999999999 107.84 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.36 -11.77 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.419 -0.801 . . . . 2.0 110.729 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' B' ' 84' ' ' ARG . 0.5 OUTLIER -175.57 146.42 0.77 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.343 -1.473 . . . . 1.8600000000000001 109.655 178.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -156.79 134.29 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.507 -0.746 . . . . 1.5700000000000001 109.038 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . 0.483 ' O ' ' N ' ' B' ' 82' ' ' LEU . 23.6 tt0 -146.28 162.87 37.16 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.133 0.968 . . . . 2.04 110.943 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.74 164.86 20.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.303 -0.999 . . . . 0.92000000000000004 108.303 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.55 136.85 3.05 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.024 -1.63 . . . . 0.34999999999999998 109.024 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.609 ' HG ' ' CZ ' ' B' ' 77' ' ' ARG . 51.8 p -94.36 156.81 16.32 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.185 -1.185 . . . . 0.84999999999999998 108.231 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.83 173.09 17.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.805 -1.184 . . . . 1.49 110.605 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 t -89.54 137.75 20.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.805 -0.813 . . . . 1.46 108.805 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 27.3 ttt-85 -149.67 103.47 3.25 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.098 -1.075 . . . . 2.8799999999999999 108.098 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.3 t70 82.22 34.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.434 -0.95 . . . . 1.3500000000000001 108.434 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 66.45 25.84 10.15 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.727 0.775 . . . . 3.3700000000000001 109.12 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -147.32 152.22 37.87 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.412 -0.805 . . . . 3.8999999999999999 108.995 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.609 ' CZ ' ' HG ' ' B' ' 70' ' ' SER . 3.5 ttt180 -88.08 138.71 31.21 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.598 1.19 . . . . 2.9700000000000002 112.253 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.01 156.41 22.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.016 -1.105 . . . . 1.3700000000000001 108.016 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 2.8 m -86.68 151.52 23.34 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.203 -0.935 . . . . 1.04 110.372 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.61 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.2 OUTLIER -133.32 133.95 43.2 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.133 -1.062 . . . . 4.29 108.133 -178.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' B' ' 81' ' ' ILE . 3.5 tt -116.06 128.79 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.872 -0.788 . . . . 1.55 108.872 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' B' ' 67' ' ' GLN . 4.4 mt -106.64 118.44 36.67 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.631 -1.618 . . . . 1.1599999999999999 106.631 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tt -128.18 124.47 36.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 1.55 110.317 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' B' ' 65' ' ' ASN . 23.0 ttt180 -99.96 170.76 8.29 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.443 0.64 . . . . 0.70999999999999996 109.965 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 tp -162.47 127.56 3.28 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.363 -0.935 . . . . 2.1200000000000001 110.783 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 62' ' ' GLN . 12.6 tmtt? -109.1 148.65 30.5 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.199 -0.667 . . . . 2.0 109.199 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 29.3 mmt-85 -101.18 141.81 33.53 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.276 -0.89 . . . . 2.2999999999999998 110.416 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.74 -7.79 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.032 -0.729 . . . . 1.46 109.032 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 13.5 t80 . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 117.973 -1.013 . . . . 2.6299999999999999 109.54 179.438 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.438 -0.579 . . . . 6.7999999999999998 109.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.414 ' O ' ' CD1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -168.09 -162.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 2.7799999999999998 109.643 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.41 -57.31 4.56 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.509 -0.744 . . . . 1.8 109.827 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.72 63.81 0.61 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.626 -0.671 . . . . 2.8500000000000001 109.319 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.1 tp -165.0 156.27 14.74 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.17 -1.789 . . . . 2.2200000000000002 106.17 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.554 ' ND2' ' CG2' ' A' ' 34' ' ' VAL . 1.0 OUTLIER 175.84 96.13 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.683 -1.207 . . . . 1.8500000000000001 109.898 176.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 4.4 pt-20 -91.26 119.11 31.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.454 -1.404 . . . . 1.4399999999999999 108.793 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.462 ' CG1' ' OD1' ' A' ' 6' ' ' ASN . 2.7 mt -129.76 145.99 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 CA-C-O 122.242 1.02 . . . . 1.8300000000000001 111.732 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.7 t -107.96 130.27 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.585 0.707 . . . . 2.0099999999999998 109.632 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.47 162.98 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.244 -1.021 . . . . 1.24 108.244 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.23 175.01 9.99 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.276 1.036 . . . . 2.8500000000000001 111.216 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.91 -12.47 18.2 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.086 -1.079 . . . . 2.3399999999999999 108.086 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.512 ' C ' ' HZ1' ' A' ' 14' ' ' LYS . 30.0 p -86.42 -15.35 40.58 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.828 -0.749 . . . . 1.6699999999999999 109.437 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.512 ' HZ1' ' C ' ' A' ' 13' ' ' THR . 4.9 mmpm? -91.71 -123.55 0.08 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.118 -0.989 . . . . 1.8600000000000001 108.841 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.49 167.09 13.95 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.887 -1.153 . . . . 1.97 107.887 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.06 -30.12 46.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.897 -1.149 . . . . 1.29 107.897 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -79.46 -37.85 35.95 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.504 -0.878 . . . . 1.5600000000000001 109.328 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.29 -33.23 69.21 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 120.146 -1.596 . . . . 1.3799999999999999 110.899 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.491 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 70.4 m-70 -91.74 -16.87 26.25 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 120.379 -1.451 . . . . 2.3500000000000001 108.922 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.56 -32.73 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 105.294 -2.113 . . . . 1.1299999999999999 105.294 176.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.9 mt -70.36 -56.15 7.38 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.228 -0.896 . . . . 1.1799999999999999 109.517 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -64.79 -27.47 68.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 1.22 110.26 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 38.8 t -73.25 -50.26 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.235 -0.915 . . . . 1.1399999999999999 109.262 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 tt -64.52 -18.13 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.203 -0.935 . . . . 1.3 108.675 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 t -74.95 -44.62 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.293 -0.879 . . . . 1.1499999999999999 108.835 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -67.15 -31.95 72.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.008 -1.057 . . . . 1.8700000000000001 110.147 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.596 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 15.6 t80 -65.36 -24.87 67.35 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.225 -1.398 . . . . 2.3599999999999999 107.225 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -64.01 -27.32 69.04 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.36 -0.836 . . . . 1.71 109.318 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -89.41 -2.42 58.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.996 -1.065 . . . . 1.8799999999999999 109.317 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.17 15.8 13.6 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.088 -1.205 . . . . 0.47999999999999998 110.088 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.462 HG23 HD12 ' A' ' 31' ' ' ILE . 48.8 mm -79.54 105.98 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.02 -1.282 . . . . 1.0900000000000001 108.566 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -94.41 -37.77 11.28 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.337 -0.852 . . . . 1.55 110.482 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 3.4 mt-10 -95.08 135.27 36.84 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.297 -0.877 . . . . 1.5800000000000001 109.697 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.554 ' CG2' ' ND2' ' A' ' 6' ' ' ASN . 2.8 p -149.14 138.55 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.329 -0.948 . . . . 1.28 110.466 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.99 127.64 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 115.911 -0.586 . . . . 1.0900000000000001 110.865 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -112.75 122.28 47.21 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.291 -0.633 . . . . 1.0800000000000001 109.291 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.76 136.98 45.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.442 -0.947 . . . . 3.21 108.442 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.34 156.68 26.26 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 119.501 -1.333 . . . . 0.28000000000000003 111.32 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.671 ' O ' ' N ' ' A' ' 41' ' ' ARG . 43.4 p -134.02 142.84 47.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.907 -0.76 . . . . 1.1399999999999999 112.151 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 35.49 -77.19 0.0 OUTLIER Glycine 0 N--CA 1.503 3.122 0 CA-C-O 121.346 0.415 . . . . 0.34999999999999998 112.182 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.671 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -87.11 -58.37 2.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.249 . . . . 3.6000000000000001 109.429 -179.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -20.91 21.72 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.1 -1.0 . . . . 1.0900000000000001 108.933 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.4 tt -53.65 -33.84 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.152 -0.967 . . . . 1.6599999999999999 111.046 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.494 ' H ' ' HG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -87.14 -24.48 24.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.727 -1.233 . . . . 1.51 108.499 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -58.39 -67.7 0.33 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.206 -2.146 . . . . 2.4399999999999999 105.206 177.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -34.32 -48.01 0.32 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 120.998 0.428 . . . . 1.1000000000000001 110.556 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.62 -64.93 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.034 -1.041 . . . . 1.01 109.343 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' O ' ' OG ' ' A' ' 52' ' ' SER . 56.3 t0 -46.53 -51.81 14.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.436 -0.95 . . . . 1.26 108.436 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.5 t -46.93 -57.34 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.875 -1.157 . . . . 1.78 107.875 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -58.35 -57.5 12.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.401 -0.812 . . . . 4.2999999999999998 110.598 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.48 ' CG ' ' H ' ' B' ' 70' ' ' SER . 1.1 t30 -51.76 -53.44 39.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.899 -1.148 . . . . 1.8500000000000001 107.899 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 19.9 p -59.4 -39.03 82.1 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.434 -0.906 . . . . 1.1799999999999999 109.101 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -75.53 -24.33 56.74 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.993 -1.067 . . . . 1.1499999999999999 109.023 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' A' ' 56' ' ' ARG . 5.9 tmtt? -80.88 -40.97 23.87 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.738 -1.949 . . . . 1.6599999999999999 105.738 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -57.92 -7.18 0.69 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.331 -1.304 . . . . 1.5800000000000001 107.817 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.4 tpt180 -71.59 -46.07 60.35 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.624 0.726 . . . . 1.99 110.067 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 mt -154.44 -19.47 0.13 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.777 -0.769 . . . . 2.48 109.657 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.79 -50.34 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.321 -1.112 . . . . 0.41999999999999998 110.321 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -74.54 -41.73 60.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.347 -1.09 . . . . 1.3799999999999999 109.94 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.25 25.05 7.34 Favored Glycine 0 N--CA 1.48 1.62 0 N-CA-C 109.273 -1.531 . . . . 0.29999999999999999 109.273 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 t -151.97 119.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 106.943 -1.503 . . . . 1.22 106.943 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.1 mm100 -126.58 159.64 32.95 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.096 0.95 . . . . 2.0699999999999998 111.604 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 tt -94.67 116.69 29.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.923 -0.769 . . . . 1.3100000000000001 108.923 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -22.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.212 -0.93 . . . . 2.0299999999999998 109.482 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.402 ' O ' ' CG2' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -172.04 154.01 3.33 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.76 -1.176 . . . . 1.76 109.741 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 65' ' ' ASN . 77.7 t -159.46 130.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.41 -0.959 . . . . 1.49 108.41 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -141.38 162.0 36.53 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.985 0.898 . . . . 2.02 109.945 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.57 148.77 51.64 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.84 -0.8 . . . . 1.1000000000000001 108.84 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.637 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -172.04 155.35 23.53 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.602 -1.799 . . . . 0.51000000000000001 108.602 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.515 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 83.2 p -100.48 156.85 17.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.188 -1.184 . . . . 0.82999999999999996 109.907 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -144.18 160.27 41.22 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.085 -1.009 . . . . 1.29 110.278 179.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.43 91.07 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.808 -0.757 . . . . 1.54 111.141 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 9.0 ttt85 -96.07 107.84 20.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.064 -1.023 . . . . 2.96 110.18 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.8 t0 84.08 36.22 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.127 0.489 . . . . 1.3799999999999999 110.263 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.466 ' CG ' HH11 ' A' ' 75' ' ' ARG . 0.0 OUTLIER 62.6 29.82 16.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.378 -0.826 . . . . 3.4300000000000002 108.794 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -145.09 144.09 30.76 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.022 -1.103 . . . . 3.9100000000000001 108.022 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -84.25 136.28 34.0 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.822 1.296 . . . . 2.9900000000000002 110.84 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.0 tt -143.91 155.79 15.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-N 114.316 -1.311 . . . . 1.0700000000000001 108.156 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.402 ' HG ' ' CB ' ' B' ' 44' ' ' SER . 9.7 p -90.49 154.35 19.7 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 121.356 -0.84 . . . . 1.03 111.43 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.637 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.8 p90 -143.56 150.91 39.54 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.81 0.814 . . . . 4.2599999999999998 109.702 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 tt -124.51 133.61 68.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.724 0.773 . . . . 1.5800000000000001 109.582 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.2 mt -107.8 128.58 54.72 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.663 -1.236 . . . . 1.05 107.663 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 tt -137.13 127.43 26.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.976 -1.077 . . . . 1.6699999999999999 111.519 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -104.9 166.36 10.44 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.681 -0.69 . . . . 0.65000000000000002 110.295 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 4.7 tp -157.87 137.01 11.66 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.437 -0.905 . . . . 2.02 111.458 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -117.31 137.11 52.64 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.727 -0.471 . . . . 2.02 109.727 178.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 16.9 mmt85 -94.17 144.49 25.46 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.212 -0.93 . . . . 2.2999999999999998 109.721 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 t -123.63 -6.5 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.909 -0.774 . . . . 1.3899999999999999 108.909 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 118.049 -0.976 . . . . 2.6200000000000001 109.51 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mtt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.244 0.545 . . . . 6.8200000000000003 109.626 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -160.21 -167.92 2.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 2.7799999999999998 109.11 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 30' ' ' GLY . 1.5 mt-10 -83.84 7.33 18.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.113 -0.992 . . . . 1.6799999999999999 109.633 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.02 50.29 0.3 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.868 0.842 . . . . 2.8999999999999999 109.348 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 5.6 tp -162.85 155.98 19.61 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 105.545 -2.02 . . . . 2.2599999999999998 105.545 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.449 HD21 ' CD1' ' B' ' 8' ' ' ILE . 1.1 t30 -178.94 92.96 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 117.852 -1.539 . . . . 1.72 110.887 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.1 pt-20 -92.06 105.12 17.43 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.183 -1.573 . . . . 1.49 108.032 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.449 ' CD1' HD21 ' B' ' 6' ' ' ASN . 4.0 mt -116.33 135.05 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.698 0.761 . . . . 1.8 109.954 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -97.79 127.72 49.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.508 0.671 . . . . 2.02 109.483 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.33 160.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.946 -1.131 . . . . 1.1699999999999999 107.946 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 172.25 12.97 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.934 0.873 . . . . 2.9399999999999999 110.538 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.99 -13.02 39.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.705 -0.85 . . . . 2.2999999999999998 108.705 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 47.8 p -76.86 -70.27 0.47 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.885 -1.524 . . . . 1.76 106.885 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 139.9 33.93 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.386 -0.821 . . . . 1.8999999999999999 110.148 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -72.84 178.59 4.14 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.473 0.654 . . . . 1.96 109.843 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.11 -29.25 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.92 0.866 . . . . 1.29 108.795 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 13.0 pt-20 -74.62 -39.15 62.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.607 -0.886 . . . . 1.7 108.607 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 17.4 t0 -57.16 -29.54 63.72 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.088 -1.008 . . . . 1.46 111.375 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.482 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 52.4 m-70 -94.83 -19.51 20.26 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 119.977 -1.702 . . . . 2.3100000000000001 107.946 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -35.81 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 105.069 -2.197 . . . . 1.2 105.069 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -69.14 -51.92 33.38 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.204 -0.907 . . . . 1.1899999999999999 108.732 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -66.78 -30.73 71.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 1.21 110.126 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 42.2 t -71.71 -55.12 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.142 -0.974 . . . . 1.1299999999999999 109.41 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 tt -58.67 -21.97 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 1.3999999999999999 108.982 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 t -71.12 -39.86 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.179 -0.951 . . . . 1.27 108.95 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.44 -44.98 73.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 1.8300000000000001 109.942 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 0.582 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 18.4 t80 -54.42 -27.5 37.36 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.29 -1.374 . . . . 2.3500000000000001 107.29 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -62.76 -24.92 67.95 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.533 -0.758 . . . . 1.6799999999999999 109.575 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -91.6 -4.38 55.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.917 -1.114 . . . . 1.9399999999999999 109.083 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 110.16 14.13 14.01 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.429 -1.468 . . . . 0.42999999999999999 109.429 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' B' ' 2' ' ' THR . 32.6 mm -78.83 102.18 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.006 -1.291 . . . . 1.3400000000000001 108.666 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.15 -35.03 14.79 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.278 -0.889 . . . . 1.46 111.517 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.68 135.42 44.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.382 -0.824 . . . . 1.2 110.471 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.59 142.5 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.305 -0.958 . . . . 1.27 111.707 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.86 123.42 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 121.204 0.526 . . . . 1.1599999999999999 111.012 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 mp -102.5 121.89 43.26 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.439 -0.788 . . . . 1.22 110.141 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -103.01 128.56 49.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.223 -0.923 . . . . 3.2200000000000002 109.214 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.91 150.95 21.12 Favored Glycine 0 N--CA 1.502 3.099 0 C-N-CA 119.366 -1.397 . . . . 0.28000000000000003 111.667 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.591 ' O ' ' N ' ' B' ' 41' ' ' ARG . 81.8 p -131.88 139.5 48.81 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.826 -0.808 . . . . 1.1100000000000001 112.174 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 35.79 -83.58 0.0 OUTLIER Glycine 0 N--CA 1.502 3.092 0 O-C-N 121.694 -0.629 . . . . 0.28999999999999998 111.983 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.668 ' N ' ' HE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -81.23 -54.61 5.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.084 -1.245 . . . . 3.6699999999999999 109.388 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.26 -20.55 43.22 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.155 -0.965 . . . . 1.3799999999999999 108.431 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 tt -55.25 -33.55 30.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.049 -1.032 . . . . 1.54 110.301 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.518 ' H ' ' HG ' ' B' ' 44' ' ' SER . 0.0 OUTLIER -83.38 -22.65 32.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.035 -1.04 . . . . 1.5600000000000001 108.858 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' B' ' 46' ' ' ALA . 0.0 OUTLIER -64.85 -68.73 0.34 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.533 -1.655 . . . . 2.4399999999999999 106.533 177.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -37.23 -46.15 0.7 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.378 0.608 . . . . 1.02 110.272 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.79 -66.3 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.185 -0.947 . . . . 1.1399999999999999 109.132 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . 0.442 ' O ' ' OG ' ' B' ' 52' ' ' SER . 26.8 t0 -48.23 -46.6 35.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.919 . . . . 1.25 108.848 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' B' ' 48' ' ' ASP . 75.0 t -47.87 -54.91 3.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.011 -1.107 . . . . 1.77 108.011 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.462 ' O ' ' N ' ' B' ' 54' ' ' LYS . 1.3 t80 -59.47 -60.67 3.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 4.3499999999999996 110.611 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -48.13 -54.79 12.09 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.276 -0.89 . . . . 1.75 108.599 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.7 OUTLIER -60.25 -38.3 83.03 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.377 -0.929 . . . . 1.0600000000000001 109.378 -179.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 24.2 tp -73.32 -26.9 61.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.938 . . . . 1.22 109.276 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' B' ' 56' ' ' ARG . 1.6 tmtt? -75.03 -50.91 14.95 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.674 -1.602 . . . . 1.8300000000000001 106.674 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.41 -17.96 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.053 -1.43 . . . . 1.46 109.479 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' B' ' 54' ' ' LYS . 12.7 mmm180 -69.17 -38.44 78.72 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.13 -1.028 . . . . 1.99 109.845 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.6 mt -155.39 -13.13 0.11 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.091 -1.444 . . . . 2.5699999999999998 112.216 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.93 -67.81 0.05 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.228 -1.463 . . . . 0.39000000000000001 110.187 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.17 -35.71 76.59 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.407 -1.055 . . . . 1.3999999999999999 109.919 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.27 22.37 6.25 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.385 -1.486 . . . . 0.37 109.385 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 t -153.84 130.29 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.187 -1.184 . . . . 1.1799999999999999 107.872 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.5 mm100 -133.11 155.54 49.08 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.306 1.051 . . . . 2.1200000000000001 111.977 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 tt -94.85 118.97 32.65 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.517 -0.92 . . . . 1.3799999999999999 108.517 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.97 -14.94 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.399 -0.813 . . . . 2.0 109.906 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.407 ' O ' ' CG2' ' B' ' 66' ' ' VAL . 1.2 m-80 -177.53 152.07 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.732 -1.23 . . . . 1.8600000000000001 109.906 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' B' ' 65' ' ' ASN . 74.8 t -160.05 134.31 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.759 -0.83 . . . . 1.5700000000000001 108.759 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -145.59 162.42 37.51 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.123 0.963 . . . . 2.04 110.973 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.66 154.69 50.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.416 -0.957 . . . . 0.92000000000000004 108.416 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.656 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -177.98 155.9 18.26 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 107.443 -2.263 . . . . 0.34999999999999998 107.443 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.48 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 90.7 p -94.03 156.74 16.44 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.055 -1.262 . . . . 0.84999999999999998 108.959 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.419 ' OE1' ' C ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -147.0 164.71 32.12 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.939 -1.101 . . . . 1.49 110.141 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.419 ' C ' ' OE1' ' B' ' 71' ' ' GLU . 2.1 t -91.14 136.46 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 120.023 -0.671 . . . . 1.46 110.002 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 0.0 OUTLIER -148.51 106.66 3.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.416 -0.957 . . . . 2.8799999999999999 108.416 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.8 t0 79.74 35.53 0.15 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.258 -1.015 . . . . 1.3500000000000001 108.258 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.72 31.85 11.62 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.845 0.831 . . . . 3.3700000000000001 109.169 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -150.01 150.76 32.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.21 -0.931 . . . . 3.8999999999999999 109.298 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -88.4 138.5 31.38 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.393 1.092 . . . . 2.9700000000000002 112.429 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.34 154.09 27.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.045 -1.094 . . . . 1.3700000000000001 108.045 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.46 ' HG ' ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -85.81 150.19 24.73 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.146 -0.972 . . . . 1.04 109.912 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.656 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.9 p90 -144.42 149.93 36.87 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.929 0.871 . . . . 4.29 110.826 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 7.2 tt -125.35 134.04 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.59 0.709 . . . . 1.55 110.33 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 11.2 mt -108.31 119.93 40.93 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.591 -1.633 . . . . 1.1599999999999999 106.591 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.12 125.02 43.08 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.396 -0.922 . . . . 1.55 111.065 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 -100.35 167.98 10.06 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.975 -0.75 . . . . 0.70999999999999996 108.975 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tp -159.42 136.28 9.43 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.45 -0.9 . . . . 2.1200000000000001 110.448 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -118.0 143.01 46.76 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.285 -0.635 . . . . 2.0 109.285 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.582 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 17.6 mmt85 -100.64 140.57 34.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.278 -0.889 . . . . 2.2999999999999998 109.997 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 t -119.0 -7.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.658 -0.867 . . . . 1.46 108.658 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.455 0 CA-C-O 118.003 -0.999 . . . . 2.6299999999999999 109.494 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 mmt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.518 -0.549 . . . . 6.7999999999999998 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.481 ' O ' ' CD1' ' A' ' 31' ' ' ILE . 5.5 t -138.05 23.28 2.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.456 -0.778 . . . . 2.7799999999999998 109.803 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 30' ' ' GLY . 2.3 mt-10 -84.26 -2.72 57.46 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.746 -0.835 . . . . 1.8 108.746 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 53.84 0.38 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 2.8500000000000001 109.706 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -173.24 46.92 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.186 -1.042 . . . . 2.2200000000000002 108.186 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.475 ' ND2' ' CG1' ' A' ' 8' ' ' ILE . 53.3 t30 -91.38 110.52 21.83 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.313 -0.867 . . . . 1.8500000000000001 110.824 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.99 120.58 32.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.861 -1.149 . . . . 1.4399999999999999 108.36 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.475 ' CG1' ' ND2' ' A' ' 6' ' ' ASN . 3.5 mm -125.25 148.01 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-O 122.061 0.934 . . . . 1.8300000000000001 111.551 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.9 t -111.18 131.67 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.605 0.716 . . . . 2.0099999999999998 110.386 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.46 162.36 2.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.47 -0.937 . . . . 1.24 108.47 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.79 174.05 10.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 2.8500000000000001 110.221 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 -10.99 18.62 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.872 -0.788 . . . . 2.3399999999999999 108.872 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -8.82 57.95 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.45 -0.9 . . . . 1.6699999999999999 109.082 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HB3' ' H ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -100.3 -121.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.353 -1.351 . . . . 1.8600000000000001 107.353 177.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.479 ' H ' ' HB3' ' A' ' 14' ' ' LYS . 5.4 m-80 -170.73 173.53 5.29 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.505 -1.372 . . . . 1.97 108.153 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.6 -31.57 51.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.073 -1.051 . . . . 1.29 108.214 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -79.21 -36.37 40.22 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.409 -0.917 . . . . 1.5600000000000001 109.965 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.73 -33.26 64.09 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 119.908 -1.745 . . . . 1.3799999999999999 110.814 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 10.5 m80 -94.52 -19.4 20.57 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.695 -1.253 . . . . 2.3500000000000001 109.021 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.74 -34.26 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 104.324 -2.473 . . . . 1.1299999999999999 104.324 176.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.9 mt -68.49 -54.68 15.33 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.59 -1.186 . . . . 1.1799999999999999 108.935 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -67.41 -26.6 66.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 1.22 110.061 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 35.3 t -72.41 -52.17 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.17 -0.957 . . . . 1.1399999999999999 108.7 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 tt -61.86 -19.16 20.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.209 -0.932 . . . . 1.3 108.58 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.52 -44.71 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.244 -0.91 . . . . 1.1499999999999999 109.221 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mt -64.94 -34.67 78.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.814 -1.179 . . . . 1.8700000000000001 110.673 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -65.91 -24.47 66.85 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.534 -1.284 . . . . 2.3599999999999999 107.534 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.36 -24.97 67.83 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.452 -0.795 . . . . 1.71 109.796 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -92.07 1.18 57.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.794 -1.191 . . . . 1.8799999999999999 109.189 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 103.65 12.37 30.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.585 -1.406 . . . . 0.47999999999999998 109.585 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 2' ' ' THR . 19.3 mm -74.35 108.96 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -1.184 . . . . 1.0900000000000001 108.248 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -93.31 -41.18 10.0 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.443 -0.786 . . . . 1.55 110.57 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -94.96 142.15 27.82 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.357 -0.839 . . . . 1.5800000000000001 109.902 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.76 137.78 11.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.049 -1.06 . . . . 1.28 110.57 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -116.83 122.1 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.977 -0.556 . . . . 1.0900000000000001 110.284 -178.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 mp -104.33 120.71 41.81 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 120.115 -0.634 . . . . 1.0800000000000001 109.379 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.88 134.97 50.84 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.681 -0.859 . . . . 3.21 108.681 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -152.48 164.7 30.71 Favored Glycine 0 N--CA 1.508 3.435 0 C-N-CA 119.763 -1.208 . . . . 0.28000000000000003 111.603 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -145.69 152.33 39.44 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.391 -1.064 . . . . 1.1399999999999999 113.649 -177.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.41 ' O ' ' CG2' ' A' ' 43' ' ' ILE . . . 38.13 -86.29 0.01 OUTLIER Glycine 0 N--CA 1.499 2.838 0 N-CA-C 111.254 -0.739 . . . . 0.34999999999999998 111.254 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.657 ' N ' ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -82.46 -54.32 5.29 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.224 -1.162 . . . . 3.6000000000000001 109.485 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -20.63 58.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 109.148 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -52.78 -38.04 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.004 . . . . 1.6599999999999999 110.759 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -82.38 -25.37 33.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.745 -1.222 . . . . 1.51 108.871 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' O ' ' C ' ' A' ' 46' ' ' ALA . 3.2 mptt -62.06 -69.4 0.25 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.675 -1.972 . . . . 2.4399999999999999 105.675 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -34.22 -47.56 0.29 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.139 0.495 . . . . 1.1000000000000001 110.276 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 48' ' ' ASP . 68.9 t -62.19 -68.14 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.111 -0.993 . . . . 1.01 109.537 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.442 ' O ' ' OG ' ' A' ' 52' ' ' SER . 0.7 OUTLIER -45.49 -49.61 13.47 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.793 -0.818 . . . . 1.26 108.793 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' ASP . 47.7 t -45.59 -57.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.582 -0.896 . . . . 1.78 108.582 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -62.99 -58.21 8.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.299 -0.875 . . . . 4.2999999999999998 110.153 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.538 ' CG ' ' H ' ' B' ' 70' ' ' SER . 1.3 t30 -46.97 -54.72 9.51 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.97 -1.122 . . . . 1.8500000000000001 107.97 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 1.7 m -59.49 -34.72 72.93 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.596 -0.89 . . . . 1.1799999999999999 108.596 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.1 tp -76.85 -21.76 54.53 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.227 -1.027 . . . . 1.1499999999999999 108.227 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -78.26 -46.28 20.69 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.091 -1.818 . . . . 1.6599999999999999 106.091 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -58.49 -5.86 0.6 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.025 -1.102 . . . . 1.5800000000000001 108.025 178.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' A' ' 54' ' ' LYS . 3.4 tpt85 -75.87 -47.35 25.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.722 0.772 . . . . 1.99 109.639 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.617 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.4 tp -152.14 -27.08 0.17 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.663 -0.815 . . . . 2.48 109.88 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.62 -47.93 0.08 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.149 -1.181 . . . . 0.41999999999999998 110.149 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.617 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.6 OUTLIER -74.8 -44.28 50.26 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.484 -1.009 . . . . 1.3799999999999999 109.772 -179.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.93 27.04 5.63 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.007 -1.637 . . . . 0.29999999999999999 109.007 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.7 t -154.75 129.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.339 -1.356 . . . . 1.22 107.339 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 86' ' ' LYS . 0.8 OUTLIER -136.39 157.01 47.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.122 0.963 . . . . 2.0699999999999998 111.594 -177.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.1 tt -93.13 112.16 24.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.845 -0.798 . . . . 1.3100000000000001 108.845 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.35 -27.7 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.175 -0.953 . . . . 2.0299999999999998 109.902 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.416 ' O ' ' CG2' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -169.88 156.29 6.15 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.612 -1.305 . . . . 1.76 109.694 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 65' ' ' ASN . 68.2 t -159.52 131.34 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.596 0.712 . . . . 1.49 109.343 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.506 ' CG ' ' N ' ' A' ' 68' ' ' THR . 30.6 tt0 -144.21 163.15 34.48 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.166 0.984 . . . . 2.02 109.985 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.506 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -139.65 149.8 44.17 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.569 -0.901 . . . . 1.1000000000000001 108.569 -178.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.95 148.43 13.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.621 -2.192 . . . . 0.51000000000000001 107.621 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.528 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 28.1 p -95.55 162.53 13.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.98 -1.306 . . . . 0.82999999999999996 109.008 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -164.36 178.96 7.09 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.293 -0.963 . . . . 1.29 110.131 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.403 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -89.05 135.44 25.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 119.609 -0.836 . . . . 1.54 109.77 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 17.8 ttt85 -151.57 102.46 2.88 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.546 -0.909 . . . . 2.96 108.546 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.3 t70 88.5 33.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.114 0.483 . . . . 1.3799999999999999 109.721 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.93 34.18 5.45 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.201 1.001 . . . . 3.4300000000000002 109.364 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.25 153.64 27.85 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.14 -0.975 . . . . 3.9100000000000001 109.534 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -84.85 137.97 32.83 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.381 1.086 . . . . 2.9900000000000002 109.14 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.415 ' CG1' ' N ' ' A' ' 79' ' ' SER . 4.2 tt -146.18 159.87 11.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.324 -0.853 . . . . 1.0700000000000001 108.851 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.415 ' N ' ' CG1' ' A' ' 78' ' ' ILE . 5.1 p -86.58 149.84 24.65 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.076 0.941 . . . . 1.03 109.864 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.428 ' CE2' ' CG2' ' A' ' 39' ' ' THR . 0.6 OUTLIER -133.15 141.21 48.01 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.507 -0.769 . . . . 4.2599999999999998 109.033 -178.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.8 tt -117.66 127.34 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.879 0.847 . . . . 1.5800000000000001 111.225 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 34.6 mt -107.35 115.95 31.08 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.287 -1.746 . . . . 1.05 106.287 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.52 127.2 40.29 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.011 -1.055 . . . . 1.6699999999999999 111.117 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -103.12 169.41 8.58 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.482 0.658 . . . . 0.65000000000000002 110.936 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.86 145.26 12.19 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.25 -0.58 . . . . 2.02 110.174 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 62' ' ' GLN . 1.5 tmtp? -127.35 145.51 50.78 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.53 -0.545 . . . . 2.02 109.53 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -96.87 138.98 33.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.455 -0.778 . . . . 2.2999999999999998 110.291 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.16 -6.52 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.6 -0.889 . . . . 1.3899999999999999 108.6 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.0 t80 . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 118.089 -0.957 . . . . 2.6200000000000001 109.511 179.772 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.355 -0.609 . . . . 6.8200000000000003 109.355 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 5.6 t -96.36 24.03 6.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 2.7799999999999998 109.007 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.58 -72.51 0.2 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.599 -0.688 . . . . 1.6799999999999999 110.159 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.73 62.12 4.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.446 -1.409 . . . . 2.8999999999999999 110.124 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.11 154.08 19.01 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.959 -1.497 . . . . 2.2599999999999998 106.959 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.403 HD21 ' CG1' ' B' ' 8' ' ' ILE . 1.2 t30 179.06 93.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.718 -1.239 . . . . 1.72 110.605 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -90.4 100.2 13.08 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.41 -1.431 . . . . 1.49 107.56 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.403 ' CG1' HD21 ' B' ' 6' ' ' ASN . 4.2 mm -111.3 140.72 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 109.336 -0.616 . . . . 1.8 109.336 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 63.5 t -104.29 131.45 53.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.69 0.757 . . . . 2.02 110.481 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.13 159.54 2.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.981 -1.118 . . . . 1.1699999999999999 107.981 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -134.68 169.19 17.7 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.024 0.916 . . . . 2.9399999999999999 111.025 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.439 ' C ' ' CD ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -97.55 -11.09 24.1 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.834 -0.802 . . . . 2.2999999999999998 108.834 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.38 -10.17 44.91 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.737 -0.785 . . . . 1.76 109.179 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -96.18 -127.78 0.14 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.999 -1.112 . . . . 1.8999999999999999 107.999 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.405 ' O ' ' ND1' ' B' ' 19' ' ' HIS . 5.2 m-80 -167.02 162.69 15.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -0.942 . . . . 1.96 109.331 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -63.25 -38.65 82.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 122.001 0.905 . . . . 1.29 108.959 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.455 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 7.3 pt-20 -71.94 -32.75 67.63 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.625 -0.88 . . . . 1.7 108.625 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -63.43 -31.01 72.05 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.349 -0.844 . . . . 1.46 112.402 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.468 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 23.0 m80 -94.54 -20.87 19.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 119.822 -1.799 . . . . 2.3100000000000001 108.383 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.99 -38.98 82.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 104.275 -2.491 . . . . 1.2 104.275 176.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 48.9 mt -65.73 -49.22 69.23 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.435 -1.257 . . . . 1.1899999999999999 108.689 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.5 -31.64 68.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.227 -0.921 . . . . 1.21 109.779 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 55.5 t -68.79 -57.32 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.947 -1.096 . . . . 1.1299999999999999 108.92 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 tt -56.6 -24.67 19.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.336 -0.853 . . . . 1.3999999999999999 108.937 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.08 -40.65 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.132 -0.98 . . . . 1.27 109.661 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -67.45 -44.37 78.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.723 -1.236 . . . . 1.8300000000000001 110.185 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -57.24 -30.77 64.9 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.139 -1.43 . . . . 2.3500000000000001 107.139 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -24.1 61.6 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.49 -0.777 . . . . 1.6799999999999999 109.2 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -92.95 -3.39 54.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 1.9399999999999999 109.151 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.64 14.51 19.46 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.304 -1.518 . . . . 0.42999999999999999 109.304 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.425 HG23 HD12 ' B' ' 31' ' ' ILE . 42.4 mm -77.42 107.82 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.111 -1.229 . . . . 1.3400000000000001 108.503 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -91.18 -36.82 13.72 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.477 -0.765 . . . . 1.46 111.415 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -107.1 136.47 46.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.542 -0.723 . . . . 1.2 111.135 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.4 p -145.94 145.39 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 119.706 -0.798 . . . . 1.27 111.171 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.69 119.49 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.261 0.553 . . . . 1.1599999999999999 110.439 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mp -95.47 121.88 37.61 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.268 -0.895 . . . . 1.22 110.918 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -102.88 125.73 49.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.488 -0.758 . . . . 3.2200000000000002 109.33 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.4 156.85 26.98 Favored Glycine 0 N--CA 1.507 3.407 0 C-N-CA 119.362 -1.399 . . . . 0.28000000000000003 111.942 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 17.1 p -142.48 149.79 39.67 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.008 0.909 . . . . 1.1100000000000001 113.309 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.441 ' O ' ' CG2' ' B' ' 43' ' ' ILE . . . 34.28 -85.51 0.01 OUTLIER Glycine 0 N--CA 1.498 2.773 0 N-CA-C 111.144 -0.782 . . . . 0.28999999999999998 111.144 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.652 ' NE ' ' N ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -81.22 -53.08 6.67 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.417 -1.049 . . . . 3.6699999999999999 109.267 -179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.02 -17.73 53.86 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.068 -1.02 . . . . 1.3799999999999999 108.254 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.441 ' CG2' ' O ' ' B' ' 40' ' ' GLY . 0.2 OUTLIER -53.28 -35.54 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.351 -0.843 . . . . 1.54 110.358 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.408 ' N ' HG23 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -82.65 -24.86 33.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.717 -1.239 . . . . 1.5600000000000001 109.036 -179.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.499 ' CD ' ' N ' ' B' ' 45' ' ' LYS . 5.4 mptt -66.44 -68.58 0.36 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.692 -1.595 . . . . 2.4399999999999999 106.692 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -36.44 -49.13 0.71 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.056 0.455 . . . . 1.02 110.671 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' B' ' 48' ' ' ASP . 79.7 t -66.89 -64.89 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.083 -1.011 . . . . 1.1399999999999999 109.8 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' B' ' 47' ' ' VAL . 4.5 t70 -46.59 -48.81 19.58 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.442 -0.947 . . . . 1.25 108.442 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -45.98 -52.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.389 -0.967 . . . . 1.77 108.389 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.547 ' C ' ' CD1' ' B' ' 50' ' ' TYR . 0.2 OUTLIER -66.78 -60.25 2.84 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.377 -0.827 . . . . 4.3499999999999996 110.26 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.528 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -45.13 -50.53 11.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.155 -1.018 . . . . 1.75 108.539 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -64.97 -34.63 78.88 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.349 -0.94 . . . . 1.0600000000000001 109.882 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 tp -69.98 -23.99 63.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.976 -1.078 . . . . 1.22 109.921 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -28.41 33.47 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.095 -1.628 . . . . 1.8300000000000001 106.683 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -16.3 12.16 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.978 -1.119 . . . . 1.46 107.978 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -78.39 -40.04 37.29 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 120.222 -0.591 . . . . 1.99 110.073 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.2 tp -153.53 -24.7 0.14 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 118.329 -1.348 . . . . 2.5699999999999998 112.118 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.29 -60.88 0.06 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.367 -1.397 . . . . 0.39000000000000001 109.914 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -67.71 -37.66 82.56 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.351 -1.088 . . . . 1.3999999999999999 109.764 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.93 28.34 7.99 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.534 -1.426 . . . . 0.37 109.534 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -158.57 92.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -1.177 . . . . 1.1799999999999999 108.791 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER -97.42 161.64 13.69 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.252 1.025 . . . . 2.1200000000000001 112.094 -178.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 tt -97.27 121.15 38.84 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.104 -1.073 . . . . 1.3799999999999999 108.104 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.37 -18.21 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.248 -0.907 . . . . 2.0 110.865 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -178.5 153.49 0.72 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.52 -1.362 . . . . 1.8600000000000001 109.907 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 87.5 t -158.19 136.56 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.93 -0.767 . . . . 1.5700000000000001 108.93 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . 0.422 ' CG ' ' N ' ' B' ' 68' ' ' THR . 24.0 tt0 -147.16 164.87 31.74 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.253 1.025 . . . . 2.04 110.663 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' THR . . . . . 0.422 ' N ' ' CG ' ' B' ' 67' ' ' GLN . 0.5 OUTLIER -143.0 158.42 43.62 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.426 -0.953 . . . . 0.92000000000000004 108.426 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.67 151.84 11.78 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 106.934 -2.467 . . . . 0.34999999999999998 106.934 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.538 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 39.9 p -93.28 160.21 14.93 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.909 -1.348 . . . . 0.84999999999999998 108.535 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -159.09 174.62 14.62 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.925 -1.109 . . . . 1.49 110.061 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.432 ' O ' ' OE1' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -90.64 130.47 39.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 119.767 -0.773 . . . . 1.46 109.858 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.2 ttt85 -148.14 104.88 3.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.041 -0.726 . . . . 2.8799999999999999 109.041 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.2 t70 82.59 39.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.611 -0.515 . . . . 1.3500000000000001 109.611 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.62 31.86 20.26 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.063 0.935 . . . . 3.3700000000000001 108.793 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -154.86 152.75 30.17 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.056 -0.72 . . . . 3.8999999999999999 109.056 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -88.18 136.77 32.82 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.857 -1.137 . . . . 2.9700000000000002 110.734 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 tt -138.87 157.26 29.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.713 0.768 . . . . 1.3700000000000001 109.38 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.37 146.75 28.3 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.904 -1.146 . . . . 1.04 107.904 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.618 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 2.3 t80 -136.98 139.78 41.72 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.961 -0.755 . . . . 4.29 108.961 -175.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.428 ' O ' HG21 ' B' ' 81' ' ' ILE . 12.9 tt -122.78 132.27 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 121.996 0.903 . . . . 1.55 113.236 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.81 108.08 18.75 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 105.999 -1.852 . . . . 1.1599999999999999 105.999 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.73 121.26 43.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.227 -0.921 . . . . 1.55 110.139 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -97.28 168.26 10.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.873 -0.731 . . . . 0.70999999999999996 109.61 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.97 144.17 13.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.653 -0.819 . . . . 2.1200000000000001 109.99 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' B' ' 62' ' ' GLN . 1.8 tmtp? -125.64 147.27 49.38 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.542 -0.54 . . . . 2.0 109.542 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -101.48 136.6 41.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.262 -0.898 . . . . 2.2999999999999998 109.845 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.94 -8.97 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.626 -0.879 . . . . 1.46 108.626 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 21.0 t80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 118.017 -0.992 . . . . 2.6299999999999999 109.564 179.659 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.34 -0.615 . . . . 6.7999999999999998 109.34 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -42.67 135.14 2.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.571 -0.706 . . . . 2.7799999999999998 109.887 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' GLY . 4.6 mt-10 -76.33 -20.48 57.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.373 -0.829 . . . . 1.8 109.828 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 5' ' ' LEU . 5.3 ptpt -156.09 149.53 24.69 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.848 -1.158 . . . . 2.8500000000000001 109.585 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 1.9 tt 89.32 49.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.372 -0.973 . . . . 2.2200000000000002 108.372 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -90.89 116.78 28.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.025 -0.731 . . . . 1.8500000000000001 109.025 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 6.7 pt-20 -93.32 117.88 30.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.289 -0.882 . . . . 1.4399999999999999 109.671 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 35' ' ' ILE . 53.5 mt -128.89 153.22 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 CA-C-O 122.189 0.995 . . . . 1.8300000000000001 112.384 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.3 131.22 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.626 0.727 . . . . 2.0099999999999998 110.252 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 11' ' ' ARG . 4.7 p -88.95 165.12 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.206 -1.035 . . . . 1.24 108.206 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.36 172.47 12.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.967 . . . . 2.8500000000000001 110.002 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.554 ' NZ ' ' CZ ' ' A' ' 41' ' ' ARG . 6.1 pttp -98.06 -4.23 36.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.979 -0.748 . . . . 2.3399999999999999 108.979 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.01 0.33 55.93 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.429 -1.323 . . . . 1.6699999999999999 107.429 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.95 131.25 56.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.362 -1.348 . . . . 1.8600000000000001 107.362 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -67.88 173.17 4.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.751 -1.218 . . . . 1.97 110.435 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.49 -35.65 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.361 -0.977 . . . . 1.29 108.361 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 9.2 pt-20 -69.76 -39.88 76.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.649 -0.871 . . . . 1.5600000000000001 108.649 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' N ' ' CG ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -48.5 -37.93 18.82 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.671 -1.268 . . . . 1.3799999999999999 111.93 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.485 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 1.4 m80 -93.87 -19.56 20.86 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.321 -1.487 . . . . 2.3500000000000001 108.667 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.68 -34.53 47.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 104.482 -2.414 . . . . 1.1299999999999999 104.482 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 71.6 mt -69.07 -55.68 10.02 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.033 -0.985 . . . . 1.1799999999999999 108.556 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.68 -29.95 71.03 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.311 -0.868 . . . . 1.22 109.668 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 24.9 t -70.42 -54.82 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 1.1399999999999999 108.953 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 tt -61.73 -15.18 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.165 -0.959 . . . . 1.3 108.839 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.4 t -81.42 -47.32 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 1.1499999999999999 109.458 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mt -65.84 -35.12 79.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.789 -1.194 . . . . 1.8700000000000001 110.017 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.597 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 3.1 t80 -62.39 -23.83 67.05 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.919 -1.511 . . . . 2.3599999999999999 106.919 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.29 -29.54 70.84 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.338 -0.846 . . . . 1.71 109.153 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -87.26 -14.08 41.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.945 -1.097 . . . . 1.8799999999999999 109.121 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 123.68 11.25 5.04 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.378 -1.089 . . . . 0.47999999999999998 110.378 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.3 mm -74.99 98.92 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.985 -1.303 . . . . 1.0900000000000001 109.172 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.11 -34.27 20.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.551 -0.907 . . . . 1.55 108.551 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 1.7 mt-10 -102.85 141.55 35.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.56 0.695 . . . . 1.5800000000000001 110.259 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -151.77 144.18 16.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.397 -0.921 . . . . 1.28 109.859 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -121.63 128.54 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.38 0.609 . . . . 1.0900000000000001 109.94 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 mp -111.78 123.56 50.5 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.236 0.541 . . . . 1.0800000000000001 110.241 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -102.9 128.82 49.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.246 -1.39 . . . . 3.21 107.246 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.44 154.11 23.37 Favored Glycine 0 N--CA 1.501 3.029 0 C-N-CA 119.525 -1.321 . . . . 0.28000000000000003 111.031 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 41' ' ' ARG . 30.1 p -135.88 141.15 44.55 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.801 0.81 . . . . 1.1399999999999999 112.678 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 39.46 -84.26 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.728 -0.608 . . . . 0.34999999999999998 111.637 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -84.89 -51.14 6.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.157 -1.202 . . . . 3.6000000000000001 110.096 -178.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -25.07 64.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.624 -1.298 . . . . 1.0900000000000001 108.763 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' A' ' 44' ' ' SER . 5.7 tt -51.93 -36.66 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.628 -0.67 . . . . 1.6599999999999999 111.335 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.448 ' CB ' ' HG ' ' B' ' 79' ' ' SER . 0.0 OUTLIER -84.7 -21.18 30.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.718 -1.239 . . . . 1.51 109.133 -179.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 46' ' ' ALA . 8.0 mmtp -62.08 -71.67 0.15 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.819 -1.919 . . . . 2.4399999999999999 105.819 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -32.88 -45.37 0.13 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.267 0.556 . . . . 1.1000000000000001 111.167 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.02 -70.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.986 -1.071 . . . . 1.01 110.267 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -44.49 -44.29 8.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.556 -0.715 . . . . 1.26 109.971 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.6 t -46.81 -57.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 119.967 -0.693 . . . . 1.78 109.556 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 54' ' ' LYS . 64.8 m-85 -65.13 -51.23 62.49 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.039 -1.038 . . . . 4.2999999999999998 112.668 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' ND2' ' N ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -51.05 -47.98 61.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.546 -1.346 . . . . 1.8500000000000001 107.55 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.514 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 11.1 p -65.45 -33.84 76.89 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.799 -0.761 . . . . 1.1799999999999999 109.527 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 tp -84.13 -24.18 30.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.68 -1.263 . . . . 1.1499999999999999 108.846 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.607 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.92 -48.81 12.83 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 104.756 -2.313 . . . . 1.6599999999999999 104.756 177.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 32.0 t0 -50.1 -12.93 0.09 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.185 -1.37 . . . . 1.5800000000000001 107.786 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.0 tpt85 -64.7 -46.95 80.16 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.682 0.753 . . . . 1.99 109.887 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 tp -155.35 -7.44 0.13 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.515 -0.874 . . . . 2.48 110.388 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.27 -59.81 0.06 OUTLIER Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.594 -1.289 . . . . 0.41999999999999998 109.887 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -72.09 -35.83 69.33 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.808 -0.819 . . . . 1.3799999999999999 110.212 -178.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.75 20.54 9.16 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.364 -1.494 . . . . 0.29999999999999999 109.364 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t -154.63 133.26 2.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.54 -1.282 . . . . 1.22 107.54 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.9 mm-40 -137.57 150.73 47.69 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.482 1.134 . . . . 2.0699999999999998 112.249 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.4 tt -94.31 108.7 20.58 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.537 -1.282 . . . . 1.3100000000000001 107.537 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.89 -23.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.305 -0.872 . . . . 2.0299999999999998 110.369 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.431 ' O ' ' CG2' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -162.38 153.82 18.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.172 -1.58 . . . . 1.76 109.348 177.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 65' ' ' ASN . 46.3 t -162.32 129.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.406 -0.809 . . . . 1.49 109.485 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -140.78 157.15 45.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.107 0.955 . . . . 2.02 110.606 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.42 143.89 42.1 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.178 -0.675 . . . . 1.1000000000000001 109.178 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.674 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -167.35 159.94 33.43 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.384 -2.286 . . . . 0.51000000000000001 107.384 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.468 ' HG ' ' ND2' ' B' ' 51' ' ' ASN . 31.4 p -98.53 161.15 13.82 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 118.984 1.392 . . . . 0.82999999999999996 110.745 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -156.05 175.6 13.75 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.111 -0.993 . . . . 1.29 110.568 178.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.62 137.34 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.6 0.714 . . . . 1.54 110.553 -179.245 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 27.5 ttt-85 -148.41 102.58 3.35 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.567 -0.901 . . . . 2.96 108.567 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.9 t70 87.91 35.07 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.204 0.526 . . . . 1.3799999999999999 109.646 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 63.66 37.62 10.0 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.356 1.074 . . . . 3.4300000000000002 109.21 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -157.52 153.35 26.86 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.41 -0.806 . . . . 3.9100000000000001 108.837 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -86.31 135.19 33.63 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.775 1.274 . . . . 2.9900000000000002 110.662 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -141.31 155.12 20.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.604 -1.258 . . . . 1.0700000000000001 107.604 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -87.44 159.99 18.47 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.227 -0.921 . . . . 1.03 111.116 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.674 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.1 p90 -145.08 153.25 41.23 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.87 0.843 . . . . 4.2599999999999998 110.581 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -125.96 131.84 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.778 0.799 . . . . 1.5800000000000001 109.416 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.5 mt -109.5 122.56 47.69 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.695 -1.594 . . . . 1.05 106.695 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.95 129.13 37.87 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.255 1.026 . . . . 1.6699999999999999 110.737 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -99.25 172.25 7.47 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.128 -0.942 . . . . 0.65000000000000002 110.074 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -157.18 137.79 13.11 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.2 -1.0 . . . . 2.02 108.85 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -125.78 140.69 52.47 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.399 0.618 . . . . 2.02 109.468 179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.597 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 16.6 mmt85 -99.41 136.02 39.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.533 -0.73 . . . . 2.2999999999999998 109.979 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 88' ' ' VAL . 48.2 t -113.54 -0.97 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.496 -0.927 . . . . 1.3899999999999999 108.496 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.7 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.988 -1.006 . . . . 2.6200000000000001 109.415 178.901 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.653 -0.499 . . . . 6.8200000000000003 109.653 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 29.8 p 42.92 -149.76 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.747 . . . . 2.7799999999999998 109.886 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' B' ' 30' ' ' GLY . 3.3 mt-10 -164.14 -41.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.386 -0.968 . . . . 1.6799999999999999 108.386 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -148.74 65.93 1.05 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.618 -0.676 . . . . 2.8999999999999999 109.855 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -178.41 54.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.375 -0.972 . . . . 2.2599999999999998 108.375 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.44 107.29 19.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.951 -1.093 . . . . 1.72 111.965 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 7.0 pt-20 -93.41 116.45 28.99 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.524 -1.287 . . . . 1.49 107.524 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 75.6 mt -128.96 153.15 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.526 -0.734 . . . . 1.8 110.815 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -105.79 126.81 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.451 0.643 . . . . 2.02 110.169 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' B' ' 11' ' ' ARG . 3.7 p -86.86 166.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.834 -1.173 . . . . 1.1699999999999999 107.834 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.471 ' N ' ' CG2' ' B' ' 10' ' ' VAL . 0.0 OUTLIER -138.78 174.31 10.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 2.9399999999999999 110.902 -178.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.545 ' NZ ' ' CZ ' ' B' ' 41' ' ' ARG . 6.6 pttp -102.49 -12.88 17.49 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.171 -1.048 . . . . 2.2999999999999998 108.171 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.72 -9.44 58.21 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.948 -1.13 . . . . 1.76 107.948 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -92.56 -129.74 0.11 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.451 -1.314 . . . . 1.8999999999999999 107.451 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.15 158.89 10.55 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.09 -1.006 . . . . 1.96 109.37 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 12.9 m -57.69 -39.84 72.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.116 -1.068 . . . . 1.29 108.116 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.482 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 6.5 pt-20 -75.58 -34.04 60.63 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.916 -0.772 . . . . 1.7 108.916 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -63.49 -32.84 74.4 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.852 -1.155 . . . . 1.46 111.6 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.476 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 0.3 OUTLIER -91.96 -16.06 27.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.051 -1.656 . . . . 2.3100000000000001 108.032 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.14 -35.49 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 104.499 -2.408 . . . . 1.2 104.499 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 43.3 mt -67.87 -50.56 55.75 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.785 -1.098 . . . . 1.1899999999999999 109.33 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.34 -33.57 75.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.978 -1.077 . . . . 1.21 109.307 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 34.7 t -66.29 -52.76 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 1.1299999999999999 109.42 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.7 tt -65.3 -19.71 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.99 -1.069 . . . . 1.3999999999999999 109.025 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 41.8 t -75.17 -45.51 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.203 -0.936 . . . . 1.27 109.822 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mt -68.02 -36.94 80.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.699 -1.251 . . . . 1.8300000000000001 109.829 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . 0.559 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 4.6 t80 -58.03 -29.84 65.65 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.229 -1.767 . . . . 2.3500000000000001 106.229 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -26.74 66.57 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.818 -1.083 . . . . 1.6799999999999999 109.176 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -92.2 -1.09 57.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.008 . . . . 1.9399999999999999 109.337 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 108.02 13.9 18.48 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.765 -0.934 . . . . 0.42999999999999999 110.765 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 12.9 mm -78.2 105.01 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.697 -1.473 . . . . 1.3400000000000001 107.987 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -91.3 -38.87 12.38 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.19 -0.944 . . . . 1.46 109.186 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.7 135.21 43.61 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.278 0.561 . . . . 1.2 110.159 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.41 130.94 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.578 -0.849 . . . . 1.27 110.397 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -106.34 124.37 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.686 -0.634 . . . . 1.1599999999999999 110.069 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.449 ' CD1' ' OH ' ' B' ' 50' ' ' TYR . 2.6 mp -107.94 129.73 55.08 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.451 -0.78 . . . . 1.22 110.887 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -106.11 126.18 51.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.177 -1.046 . . . . 3.2200000000000002 108.177 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.63 153.23 20.96 Favored Glycine 0 N--CA 1.505 3.241 0 C-N-CA 119.873 -1.156 . . . . 0.28000000000000003 110.799 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.635 ' O ' ' N ' ' B' ' 41' ' ' ARG . 24.9 p -133.87 142.65 47.88 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.785 -0.833 . . . . 1.1100000000000001 112.095 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 33.8 -79.23 0.0 OUTLIER Glycine 0 N--CA 1.505 3.277 0 N-CA-C 111.932 -0.467 . . . . 0.28999999999999998 111.932 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.635 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -84.04 -55.4 4.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.037 -1.272 . . . . 3.6699999999999999 109.377 -179.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -17.7 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.024 -1.048 . . . . 1.3799999999999999 109.852 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 6.7 tt -61.64 -22.41 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 1.54 109.913 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.41 -29.72 17.82 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.353 -0.98 . . . . 1.5600000000000001 108.353 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' B' ' 46' ' ' ALA . 7.5 mmtp -60.19 -67.18 0.42 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.332 -1.729 . . . . 2.4399999999999999 106.332 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -32.4 -47.01 0.14 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 116.082 -0.508 . . . . 1.02 111.823 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' B' ' 48' ' ' ASP . 84.9 t -66.4 -61.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.837 -1.164 . . . . 1.1399999999999999 111.3 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' B' ' 49' ' ' VAL . 9.2 t70 -45.54 -51.08 12.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.216 -0.928 . . . . 1.25 109.348 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' B' ' 48' ' ' ASP . 64.3 t -41.71 -54.22 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.751 -0.463 . . . . 1.77 109.751 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' B' ' 54' ' ' LYS . 59.5 m-85 -68.12 -53.56 24.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -0.987 . . . . 4.3499999999999996 111.627 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' B' ' 52' ' ' SER . 0.0 OUTLIER -46.77 -55.76 7.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.858 -1.164 . . . . 1.75 107.858 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.557 ' N ' ' ND2' ' B' ' 51' ' ' ASN . 0.7 OUTLIER -61.17 -39.68 91.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.628 -0.829 . . . . 1.0600000000000001 109.714 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 tp -71.2 -23.96 62.13 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.79 -1.194 . . . . 1.22 108.614 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 50' ' ' TYR . 0.0 OUTLIER -76.5 -47.83 21.53 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.789 -1.56 . . . . 1.8300000000000001 106.789 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -44.67 -17.47 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.993 -1.003 . . . . 1.46 109.276 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' B' ' 54' ' ' LYS . 21.9 mmm180 -65.87 -39.8 91.03 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.38 -0.928 . . . . 1.99 109.997 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.3 tp -156.7 -12.46 0.09 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.429 -1.308 . . . . 2.5699999999999998 111.528 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 67.3 -65.24 0.24 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.849 -1.7 . . . . 0.39000000000000001 108.849 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.5 -41.24 76.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.632 -0.922 . . . . 1.3999999999999999 109.704 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.16 17.07 2.51 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.543 -1.423 . . . . 0.37 109.543 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' B' ' 59' ' ' ASP . 2.5 t -152.32 130.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.05 -1.463 . . . . 1.1799999999999999 107.05 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' B' ' 86' ' ' LYS . 5.4 mm-40 -137.94 152.01 48.54 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.303 1.049 . . . . 2.1200000000000001 112.455 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 tt -94.37 119.12 32.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.906 -1.146 . . . . 1.3799999999999999 107.906 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.49 ' O ' ' ND2' ' B' ' 65' ' ' ASN . 6.9 p -116.32 -13.39 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.337 -0.852 . . . . 2.0 110.853 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' B' ' 64' ' ' VAL . 0.3 OUTLIER -171.23 143.66 1.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.399 -1.438 . . . . 1.8600000000000001 109.482 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 96.7 t -156.83 133.92 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.054 -0.721 . . . . 1.5700000000000001 109.054 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -142.21 159.75 41.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.092 0.949 . . . . 2.04 110.446 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.0 156.14 48.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.78 -0.822 . . . . 0.92000000000000004 108.78 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.681 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -179.74 157.98 21.33 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.745 -2.142 . . . . 0.34999999999999998 107.745 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 68.8 p -96.44 154.63 17.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.051 -1.264 . . . . 0.84999999999999998 109.44 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -153.17 170.7 19.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.827 -1.171 . . . . 1.49 110.446 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.418 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -89.02 137.09 21.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.852 0.834 . . . . 1.46 111.284 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 7.5 ttt-85 -149.78 97.87 2.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.08 -0.711 . . . . 2.8799999999999999 109.08 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 4.0 t0 88.34 36.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.427 -0.583 . . . . 1.3500000000000001 109.427 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 65.01 34.48 8.84 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.214 1.007 . . . . 3.3700000000000001 109.463 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -156.52 154.52 30.44 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.791 -0.818 . . . . 3.8999999999999999 108.791 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -88.11 145.77 25.77 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.585 1.183 . . . . 2.9700000000000002 111.842 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tt -144.36 159.49 15.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.871 -1.058 . . . . 1.3700000000000001 108.194 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.448 ' HG ' ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -88.09 151.08 22.99 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 121.372 -0.83 . . . . 1.04 109.036 -178.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.681 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.2 p90 -143.83 151.91 40.51 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.615 -0.834 . . . . 4.29 110.37 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 20.4 tt -128.71 135.02 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.643 0.735 . . . . 1.55 111.27 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 7.7 mt -110.69 124.31 51.7 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.69 -1.596 . . . . 1.1599999999999999 106.69 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.67 127.15 39.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.143 -0.973 . . . . 1.55 111.275 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' B' ' 65' ' ' ASN . 17.4 ttt180 -108.26 110.17 21.71 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.557 0.694 . . . . 0.70999999999999996 111.159 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' B' ' 86' ' ' LYS . 1.3 tm? -96.42 140.46 31.04 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.986 -0.746 . . . . 2.1200000000000001 108.986 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -122.35 136.03 54.82 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.406 -0.591 . . . . 2.0 109.406 179.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.559 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 16.4 mmt85 -96.12 140.26 31.09 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.33 -0.856 . . . . 2.2999999999999998 110.296 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . 0.427 ' O ' ' CG1' ' B' ' 88' ' ' VAL . 36.2 t -118.08 -6.77 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.706 -0.85 . . . . 1.46 108.706 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 74.8 t80 . . . . . 0 C--N 1.303 -1.432 0 CA-C-O 117.979 -1.01 . . . . 2.6299999999999999 109.423 179.26 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.562 -0.533 . . . . 6.7999999999999998 109.562 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.503 ' O ' ' CD1' ' A' ' 31' ' ' ILE . 5.1 t -108.28 19.91 19.3 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.13 -0.692 . . . . 2.7799999999999998 109.13 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 30' ' ' GLY . 2.6 mt-10 -75.61 -30.48 59.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.684 -0.635 . . . . 1.8 110.232 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.91 57.51 1.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.8 0.81 . . . . 2.8500000000000001 109.476 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -161.84 152.38 17.46 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 104.469 -2.419 . . . . 2.2200000000000002 104.469 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -179.4 93.68 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 117.928 -1.509 . . . . 1.8500000000000001 110.621 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 3.8 pt-20 -89.34 112.23 23.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.066 -1.646 . . . . 1.4399999999999999 108.262 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 35' ' ' ILE . 5.6 mt -128.74 147.25 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 CA-C-O 122.189 0.995 . . . . 1.8300000000000001 112.195 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.91 129.52 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.606 0.717 . . . . 2.0099999999999998 110.336 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 p -87.65 167.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.055 -1.091 . . . . 1.24 108.055 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.91 167.88 20.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 2.8500000000000001 109.977 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -20.65 27.61 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.386 -0.968 . . . . 2.3399999999999999 108.386 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -69.4 -65.41 0.72 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.761 -1.57 . . . . 1.6699999999999999 106.761 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.524 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.4 mtmm -58.24 144.07 42.23 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.216 1.007 . . . . 1.8600000000000001 110.347 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.87 178.86 4.61 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.696 -0.684 . . . . 1.97 110.067 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.61 -28.79 25.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.254 -1.017 . . . . 1.29 108.254 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.4 -33.85 61.01 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.484 -0.886 . . . . 1.5600000000000001 109.119 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.2 -31.59 69.16 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 120.396 -1.44 . . . . 1.3799999999999999 110.925 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.491 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -95.64 -18.3 20.64 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.692 -1.255 . . . . 2.3500000000000001 108.459 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -34.72 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 104.513 -2.403 . . . . 1.1299999999999999 104.513 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 mt -68.33 -52.57 31.97 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.495 -1.23 . . . . 1.1799999999999999 108.771 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -66.34 -29.34 69.51 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.114 -0.991 . . . . 1.22 109.437 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 19.7 t -69.79 -53.24 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 1.1399999999999999 109.453 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.23 -18.03 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.895 -1.128 . . . . 1.3 108.617 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.0 t -75.98 -43.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 119.335 -0.946 . . . . 1.1499999999999999 108.573 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mt -64.79 -33.4 75.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.825 -1.172 . . . . 1.8700000000000001 110.029 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -65.87 -23.0 66.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.877 -1.527 . . . . 2.3599999999999999 106.877 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -61.74 -30.77 70.99 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.123 -0.944 . . . . 1.71 108.811 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -87.82 -6.34 58.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.27 -0.894 . . . . 1.8799999999999999 109.244 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 109.73 12.45 18.74 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.913 -1.275 . . . . 0.47999999999999998 109.913 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.503 ' CD1' ' O ' ' A' ' 2' ' ' THR . 47.6 mm -73.88 109.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.138 -1.213 . . . . 1.0900000000000001 109.25 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.22 -37.22 11.66 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.423 -0.798 . . . . 1.55 110.721 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 1.9 mt-10 -97.73 137.85 36.0 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.601 0.715 . . . . 1.5800000000000001 110.793 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.87 137.29 16.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.66 -0.816 . . . . 1.28 109.826 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -117.08 126.04 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.753 -0.658 . . . . 1.0900000000000001 109.591 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 mp -111.76 119.56 39.04 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 120.262 -0.575 . . . . 1.0800000000000001 109.519 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -105.26 132.67 51.17 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.02 -1.104 . . . . 3.21 108.02 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.19 151.79 21.6 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.748 -1.215 . . . . 0.28000000000000003 110.926 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 41' ' ' ARG . 64.3 p -126.01 134.03 51.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.986 -0.714 . . . . 1.1399999999999999 111.673 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 38.4 -83.56 0.0 OUTLIER Glycine 0 N--CA 1.495 2.632 0 O-C-N 121.615 -0.678 . . . . 0.34999999999999998 112.286 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.673 ' HE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.31 -54.2 6.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.127 -1.219 . . . . 3.6000000000000001 110.087 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.38 -20.99 63.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.64 -1.244 . . . . 1.0900000000000001 107.64 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 tt -53.18 -36.46 25.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.233 -0.917 . . . . 1.6599999999999999 110.858 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.61 -20.39 31.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.678 -1.264 . . . . 1.51 108.747 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 46' ' ' ALA . 1.5 mptt -64.32 -71.02 0.19 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.518 -2.03 . . . . 2.4399999999999999 105.518 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -30.44 -48.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.403 0.621 . . . . 1.1000000000000001 110.37 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.94 -71.68 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.378 -0.826 . . . . 1.01 109.995 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.433 ' O ' ' OG ' ' A' ' 52' ' ' SER . 8.4 t70 -42.52 -46.72 4.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.755 -0.59 . . . . 1.26 110.05 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.2 t -48.75 -57.52 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.483 -0.887 . . . . 1.78 108.82 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.571 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -61.03 -55.58 31.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 4.2999999999999998 110.978 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.528 ' ND2' ' OG ' ' B' ' 70' ' ' SER . 4.7 t30 -52.1 -51.14 59.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.873 -1.142 . . . . 1.8500000000000001 107.985 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 5.7 m -60.38 -34.15 73.49 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.528 -0.915 . . . . 1.1799999999999999 108.528 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.1 tp -82.13 -21.64 36.56 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.078 -1.014 . . . . 1.1499999999999999 108.389 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.29 -49.34 12.61 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.701 -1.963 . . . . 1.6599999999999999 105.701 177.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 1.7 t0 -54.43 -8.64 0.23 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.754 -1.202 . . . . 1.5800000000000001 107.754 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.544 ' H ' ' C ' ' A' ' 54' ' ' LYS . 4.6 tpt85 -68.7 -52.88 26.04 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.487 -0.758 . . . . 1.99 109.196 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -153.14 -13.29 0.15 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.347 -0.941 . . . . 2.48 110.948 179.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.94 -47.44 0.07 OUTLIER Glycine 0 N--CA 1.494 2.509 0 C-N-CA 120.043 -1.075 . . . . 0.41999999999999998 110.842 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -72.72 -41.71 64.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.252 -1.146 . . . . 1.3799999999999999 109.986 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.15 22.91 12.7 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.94 -1.264 . . . . 0.29999999999999999 109.94 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t -149.37 132.5 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.979 -1.306 . . . . 1.22 107.705 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.605 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.7 mm-40 -135.51 155.74 50.02 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.034 0.921 . . . . 2.0699999999999998 111.575 -177.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.42 110.01 21.57 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.486 -0.931 . . . . 1.3100000000000001 108.486 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.8 -22.91 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.065 -1.022 . . . . 2.0299999999999998 109.775 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.85 152.56 2.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.699 -1.25 . . . . 1.76 109.759 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.0 t -159.28 128.29 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.863 -0.792 . . . . 1.49 108.863 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 68' ' ' THR . 31.9 tt0 -142.09 157.05 45.35 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.086 0.946 . . . . 2.02 110.531 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.479 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -124.2 150.81 44.8 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.239 -0.892 . . . . 1.1000000000000001 108.737 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.683 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -175.89 148.88 9.57 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 107.607 -2.197 . . . . 0.51000000000000001 107.607 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.613 ' HG ' ' ND2' ' B' ' 51' ' ' ASN . 37.1 p -95.75 158.01 15.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.703 -1.469 . . . . 0.82999999999999996 110.996 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' OE2' ' C ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -150.51 167.63 26.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.162 -0.961 . . . . 1.29 110.073 178.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.403 ' C ' ' OE2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -91.91 141.94 13.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.644 0.735 . . . . 1.54 111.044 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 7.5 ttt-85 -149.25 103.44 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.165 -0.68 . . . . 2.96 109.165 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.4 t70 86.38 36.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.049 0.452 . . . . 1.3799999999999999 110.339 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.29 32.71 12.08 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.174 0.988 . . . . 3.4300000000000002 109.045 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.19 146.12 26.67 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.284 -1.006 . . . . 3.9100000000000001 108.284 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.622 ' NH2' ' ND2' ' B' ' 51' ' ' ASN . 8.1 ttt180 -85.91 139.73 30.98 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.893 1.33 . . . . 2.9900000000000002 110.614 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.6 tt -142.71 154.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 114.276 -1.329 . . . . 1.0700000000000001 107.986 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.8 p -88.37 161.64 16.98 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 119.335 -0.946 . . . . 1.03 110.444 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.683 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.4 p90 -148.35 156.4 42.46 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.313 -0.955 . . . . 4.2599999999999998 110.244 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.3 tt -129.68 139.05 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.746 0.784 . . . . 1.5800000000000001 110.485 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.7 mt -111.32 124.0 51.35 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.952 -1.129 . . . . 1.05 107.952 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 tt -131.64 126.52 34.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.122 -0.987 . . . . 1.6699999999999999 110.61 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -102.88 172.42 6.84 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.315 0.578 . . . . 0.65000000000000002 109.789 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 1.9 tp -160.82 144.93 13.7 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 118.679 -1.208 . . . . 2.02 110.999 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.605 ' O ' ' N ' ' A' ' 62' ' ' GLN . 14.0 tptt -125.57 136.35 53.2 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.574 0.702 . . . . 2.02 109.936 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.406 ' N ' ' HD2' ' A' ' 86' ' ' LYS . 22.6 mmt180 -94.41 136.4 34.75 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.059 -1.026 . . . . 2.2999999999999998 109.663 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 88' ' ' VAL . 69.4 t -121.62 1.21 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.824 -0.806 . . . . 1.3899999999999999 108.824 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.424 ' CD2' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.383 0 CA-C-O 118.001 -0.999 . . . . 2.6200000000000001 109.512 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.438 -0.578 . . . . 6.8200000000000003 109.438 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.51 ' O ' ' CD1' ' B' ' 31' ' ' ILE . 4.6 t -135.85 21.39 3.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.484 -0.76 . . . . 2.7799999999999998 109.692 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' B' ' 30' ' ' GLY . 4.9 mt-10 -84.12 -4.54 58.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.337 -0.852 . . . . 1.6799999999999999 109.147 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.437 ' O ' ' OE1' ' B' ' 33' ' ' GLU . 0.0 OUTLIER -155.95 58.31 0.6 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.034 -1.042 . . . . 2.8999999999999999 108.801 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -165.74 151.4 9.12 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 103.097 -2.927 . . . . 2.2599999999999998 103.097 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.95 93.12 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 117.703 -1.599 . . . . 1.72 110.214 177.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.8 pt-20 -90.12 110.32 21.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.165 -1.585 . . . . 1.49 108.897 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.41 142.52 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.848 0.832 . . . . 1.8 110.677 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 63.2 t -104.22 130.47 54.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.49 0.662 . . . . 2.02 109.581 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.49 166.13 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.516 -0.92 . . . . 1.1699999999999999 108.516 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.414 ' NE ' ' CE ' ' B' ' 14' ' ' LYS . 6.7 mtt180 -139.09 171.58 14.1 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.01 0.909 . . . . 2.9399999999999999 110.507 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.04 -11.52 20.5 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.187 -1.042 . . . . 2.2999999999999998 108.187 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.86 -14.35 54.44 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.637 -0.825 . . . . 1.76 109.758 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' B' ' 15' ' ' ASN . 1.2 mttm -98.57 -120.65 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.281 -1.007 . . . . 1.8999999999999999 108.281 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' B' ' 14' ' ' LYS . 0.7 OUTLIER -170.94 172.44 5.53 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.097 -1.002 . . . . 1.96 109.15 179.306 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -72.38 -35.25 51.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.115 -1.069 . . . . 1.29 108.115 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 10.0 pt-20 -72.46 -41.67 65.82 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.495 -0.928 . . . . 1.7 108.495 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . 0.464 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 68.2 t0 -62.49 -30.81 71.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.141 -0.974 . . . . 1.46 112.082 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 0.1 OUTLIER -91.34 -16.46 27.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 119.892 -1.755 . . . . 2.3100000000000001 108.289 178.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 t -75.19 -40.11 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 105.152 -2.166 . . . . 1.2 105.152 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.31 -49.46 75.54 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.909 -1.041 . . . . 1.1899999999999999 108.481 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -67.3 -32.13 72.9 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.565 -0.854 . . . . 1.21 109.685 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 41.0 t -69.57 -54.55 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.291 -0.881 . . . . 1.1299999999999999 110.068 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 20.4 tt -61.15 -24.05 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.893 -1.129 . . . . 1.3999999999999999 108.864 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -68.19 -41.5 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -0.922 . . . . 1.27 108.951 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -66.52 -43.12 86.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.121 -0.987 . . . . 1.8300000000000001 109.7 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -55.19 -31.49 61.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.735 -1.58 . . . . 2.3500000000000001 106.735 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -55.69 -30.69 61.53 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.273 -0.876 . . . . 1.6799999999999999 108.777 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -87.96 -3.02 58.95 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.809 -0.811 . . . . 1.9399999999999999 108.809 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 103.19 15.98 22.14 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.608 -1.397 . . . . 0.42999999999999999 109.608 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' B' ' 2' ' ' THR . 36.8 mm -77.36 111.42 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.148 -1.207 . . . . 1.3400000000000001 108.421 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.39 -35.83 12.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.272 -0.893 . . . . 1.46 111.015 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' B' ' 4' ' ' LYS . 11.4 mt-10 -101.64 141.6 34.25 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.626 0.727 . . . . 1.2 110.954 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' B' ' 34' ' ' VAL . 0.8 OUTLIER -149.5 122.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.146 0.974 . . . . 1.27 111.096 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.21 122.91 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.613 -0.679 . . . . 1.1599999999999999 109.254 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mp -105.57 121.76 44.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.431 -0.793 . . . . 1.22 110.087 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -103.34 128.41 50.43 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.736 -0.839 . . . . 3.2200000000000002 108.736 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.51 150.83 20.64 Favored Glycine 0 N--CA 1.502 3.037 0 C-N-CA 119.572 -1.299 . . . . 0.28000000000000003 110.805 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.613 ' O ' ' N ' ' B' ' 41' ' ' ARG . 47.3 p -129.86 141.24 50.85 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.888 -0.772 . . . . 1.1100000000000001 111.841 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 32.84 -82.0 0.0 OUTLIER Glycine 0 N--CA 1.504 3.195 0 N-CA-C 111.785 -0.526 . . . . 0.28999999999999998 111.785 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.645 ' N ' ' HE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -80.14 -53.13 6.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.087 -1.243 . . . . 3.6699999999999999 110.057 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -13.7 57.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.945 -1.097 . . . . 1.3799999999999999 109.296 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.407 ' CG2' ' O ' ' B' ' 40' ' ' GLY . 8.1 tt -60.65 -26.03 36.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.26 -0.9 . . . . 1.54 109.711 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.58 -25.95 23.34 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.29 -1.004 . . . . 1.5600000000000001 108.29 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' B' ' 46' ' ' ALA . 2.6 mptt -63.75 -70.54 0.21 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.5 -1.667 . . . . 2.4399999999999999 106.5 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -32.97 -41.17 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.217 0.532 . . . . 1.02 110.99 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.63 -64.9 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.142 -0.974 . . . . 1.1399999999999999 109.567 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' B' ' 49' ' ' VAL . 5.8 t70 -48.47 -50.72 30.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.189 -0.944 . . . . 1.25 109.276 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' B' ' 48' ' ' ASP . 38.0 t -42.39 -56.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.96 -0.755 . . . . 1.77 108.96 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' B' ' 50' ' ' TYR . 0.0 OUTLIER -67.66 -54.33 20.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.447 -0.783 . . . . 4.3499999999999996 110.564 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.622 ' ND2' ' NH2' ' A' ' 77' ' ' ARG . 2.8 t30 -48.5 -57.98 5.35 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.119 -1.032 . . . . 1.75 108.531 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -57.95 -30.81 66.27 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.172 -1.011 . . . . 1.0600000000000001 109.649 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 46.0 tp -75.05 -21.74 58.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 1.22 110.287 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.46 -27.95 25.35 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.373 -1.714 . . . . 1.8300000000000001 106.373 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.412 ' OD2' ' NH2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -59.08 -14.52 10.17 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.686 -1.227 . . . . 1.46 107.686 177.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -75.74 -43.92 44.34 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.618 -0.833 . . . . 1.99 109.487 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' B' ' 59' ' ' ASP . 0.2 OUTLIER -152.1 -20.71 0.18 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.624 -1.23 . . . . 2.5699999999999998 112.291 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.66 -56.02 0.14 Allowed Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.275 -1.441 . . . . 0.39000000000000001 110.035 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.58 -43.27 73.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.295 -1.121 . . . . 1.3999999999999999 109.989 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.52 24.97 4.66 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.9 -1.28 . . . . 0.37 109.9 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.24 130.25 4.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.478 -1.304 . . . . 1.1799999999999999 107.478 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' B' ' 86' ' ' LYS . 4.0 mm-40 -132.27 159.21 39.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.002 0.906 . . . . 2.1200000000000001 111.471 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.34 112.72 25.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.473 -0.936 . . . . 1.3799999999999999 108.473 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -23.51 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.161 -0.962 . . . . 2.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' B' ' 84' ' ' ARG . 0.3 OUTLIER -174.21 151.03 1.59 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.491 -1.38 . . . . 1.8600000000000001 109.457 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 96.6 t -156.85 132.74 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.722 -0.844 . . . . 1.5700000000000001 108.722 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . 0.467 ' CG ' ' N ' ' B' ' 68' ' ' THR . 28.4 tt0 -145.94 165.21 29.62 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.282 1.039 . . . . 2.04 110.823 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' THR . . . . . 0.467 ' N ' ' CG ' ' B' ' 67' ' ' GLN . 0.8 OUTLIER -135.72 154.8 51.14 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.221 -0.9 . . . . 0.92000000000000004 108.699 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.711 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -176.71 153.2 13.52 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 107.767 -2.133 . . . . 0.34999999999999998 107.767 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.534 ' OG ' ' NH2' ' B' ' 77' ' ' ARG . 6.0 p -96.57 155.98 16.54 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.882 1.341 . . . . 0.84999999999999998 109.382 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -148.98 166.75 27.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.946 -1.096 . . . . 1.49 110.05 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.42 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.2 OUTLIER -90.03 136.95 22.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.845 -0.742 . . . . 1.46 110.542 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.8 ttt-85 -147.17 101.52 3.41 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.337 -0.616 . . . . 2.8799999999999999 109.337 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 1.8 t70 83.02 39.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.427 -0.583 . . . . 1.3500000000000001 109.427 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.17 32.61 14.96 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.915 0.864 . . . . 3.3700000000000001 109.273 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.32 153.88 36.87 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.453 -0.779 . . . . 3.8999999999999999 109.207 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.534 ' NH2' ' OG ' ' B' ' 70' ' ' SER . 1.3 tpt180 -88.36 136.28 33.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.729 0.776 . . . . 2.9700000000000002 110.922 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 11.9 tt -136.31 153.54 31.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.743 -0.836 . . . . 1.3700000000000001 108.743 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 151.59 22.81 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.332 -0.855 . . . . 1.04 109.039 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.711 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.0 p90 -144.35 150.86 38.48 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.467 -0.893 . . . . 4.29 110.313 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 tt -126.12 135.83 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.53 0.681 . . . . 1.55 109.972 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 12.2 mt -109.23 121.19 44.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.168 -1.419 . . . . 1.1599999999999999 107.168 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.25 121.23 35.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.111 -0.993 . . . . 1.55 110.338 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' B' ' 65' ' ' ASN . 19.9 ttt180 -110.12 107.02 16.7 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.264 0.554 . . . . 0.70999999999999996 110.259 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 tp -104.01 151.54 23.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.591 -0.693 . . . . 2.1200000000000001 110.609 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.1 OUTLIER -126.65 157.27 39.42 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.757 -0.46 . . . . 2.0 109.757 -179.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -109.98 141.94 42.06 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.225 -0.922 . . . . 2.2999999999999998 110.037 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' B' ' 88' ' ' VAL . 18.8 t -121.94 -9.98 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.907 -0.775 . . . . 1.46 108.907 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 118.066 -0.969 . . . . 2.6299999999999999 109.537 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mtt . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.484 -0.562 . . . . 6.7999999999999998 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.8 133.36 6.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 2.7799999999999998 109.632 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -165.81 -39.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.023 -1.103 . . . . 1.8 108.023 178.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -156.09 54.37 0.57 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.267 -0.896 . . . . 2.8500000000000001 109.754 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 tp -174.74 50.89 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.531 -0.915 . . . . 2.2200000000000002 108.531 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.426 ' ND2' ' CD1' ' A' ' 8' ' ' ILE . 47.3 t30 -91.62 105.18 17.55 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.298 -0.876 . . . . 1.8500000000000001 111.193 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -93.82 123.47 37.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 1.4399999999999999 108.384 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.426 ' CD1' ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -130.38 151.81 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 122.632 1.206 . . . . 1.8300000000000001 113.356 -177.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -104.7 127.11 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.317 -0.856 . . . . 2.0099999999999998 109.585 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.93 166.63 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.899 . . . . 1.24 108.777 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.1 174.17 10.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.176 -0.952 . . . . 2.8500000000000001 110.462 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.661 ' HZ2' ' HE ' ' A' ' 41' ' ' ARG . 12.4 pttt -94.99 -13.66 25.08 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.66 -0.867 . . . . 2.3399999999999999 108.66 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 t -86.58 1.33 52.09 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.727 -1.212 . . . . 1.6699999999999999 107.727 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.75 128.59 53.06 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.964 -1.495 . . . . 1.8600000000000001 106.964 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.28 -178.4 1.68 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.831 -0.748 . . . . 1.97 109.865 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 m -79.93 -27.96 12.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 106.796 -1.557 . . . . 1.29 106.796 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.72 -46.88 28.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.626 -0.716 . . . . 1.5600000000000001 109.369 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.79 -28.64 69.6 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.915 -1.115 . . . . 1.3799999999999999 110.957 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.464 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -92.08 -15.65 27.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.426 -1.421 . . . . 2.3500000000000001 109.688 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.91 -30.39 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 105.197 -2.149 . . . . 1.1299999999999999 105.197 176.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.5 mt -70.12 -53.51 16.98 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.866 -1.061 . . . . 1.1799999999999999 108.834 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -65.2 -26.32 68.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 1.22 109.728 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 38.6 t -73.64 -50.14 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.59 -0.893 . . . . 1.1399999999999999 108.59 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.75 -23.59 23.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.543 -0.91 . . . . 1.3 108.543 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.71 -42.81 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.247 -0.908 . . . . 1.1499999999999999 109.913 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.408 ' CD2' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -68.53 -33.64 74.47 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.447 -1.408 . . . . 1.8700000000000001 109.805 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.75 -27.13 68.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.166 -1.42 . . . . 2.3599999999999999 107.166 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.97 -26.27 68.5 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.239 -0.891 . . . . 1.71 109.887 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -88.97 -1.98 58.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.841 -1.162 . . . . 1.8799999999999999 109.267 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 106.5 14.52 19.7 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.766 -1.334 . . . . 0.47999999999999998 109.766 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 20.7 mm -75.92 107.49 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -1.147 . . . . 1.0900000000000001 108.298 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 33' ' ' GLU . 1.6 p30 -93.65 -38.59 11.26 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.433 -0.792 . . . . 1.55 110.594 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 7.7 mt-10 -97.69 142.02 29.99 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.561 -0.712 . . . . 1.5800000000000001 110.189 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.32 139.98 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.041 -1.064 . . . . 1.28 111.157 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.55 129.28 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 122.054 -0.404 . . . . 1.0900000000000001 110.077 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mp -115.21 126.31 54.41 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.599 0.714 . . . . 1.0800000000000001 110.277 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.41 127.19 45.43 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.905 -1.146 . . . . 3.21 107.905 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.54 143.31 14.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.725 -1.226 . . . . 0.28000000000000003 110.51 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 41' ' ' ARG . 31.8 p -131.07 138.45 49.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.922 -0.752 . . . . 1.1399999999999999 111.643 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' THR . . . 35.41 -83.11 0.0 OUTLIER Glycine 0 N--CA 1.501 3.008 0 O-C-N 121.735 -0.603 . . . . 0.34999999999999998 112.247 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.661 ' HE ' ' HZ2' ' A' ' 12' ' ' LYS . 0.2 OUTLIER -82.97 -56.32 3.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.249 . . . . 3.6000000000000001 109.886 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -15.17 8.71 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.99 -1.115 . . . . 1.0900000000000001 107.99 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.416 ' CG2' ' CG2' ' B' ' 43' ' ' ILE . 0.1 OUTLIER -55.5 -32.89 31.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.408 -0.807 . . . . 1.6599999999999999 111.131 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.678 ' HG ' ' HG ' ' B' ' 79' ' ' SER . 0.5 OUTLIER -88.17 -22.9 23.79 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.963 -1.086 . . . . 1.51 108.221 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 46' ' ' ALA . 2.7 mptt -62.35 -72.39 0.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.747 -1.946 . . . . 2.4399999999999999 105.747 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -33.24 -46.72 0.18 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.094 0.473 . . . . 1.1000000000000001 110.673 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.51 -61.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.003 . . . . 1.01 109.297 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 49' ' ' VAL . 10.5 t70 -51.33 -54.4 26.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 1.26 108.847 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 48' ' ' ASP . 46.7 t -42.66 -58.24 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.543 -0.91 . . . . 1.78 108.543 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 54' ' ' LYS . 3.0 m-30 -62.14 -50.6 71.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.85 -0.531 . . . . 4.2999999999999998 110.982 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.527 ' ND2' ' OG ' ' B' ' 70' ' ' SER . 0.8 OUTLIER -56.07 -49.69 73.08 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.78 -1.193 . . . . 1.8500000000000001 107.78 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 4.3 p -59.96 -33.86 72.51 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.423 -0.954 . . . . 1.1799999999999999 108.423 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 57.0 tp -79.06 -19.86 50.3 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.985 -1.117 . . . . 1.1499999999999999 107.985 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.58 -44.47 17.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.539 -2.022 . . . . 1.6599999999999999 105.539 177.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -59.34 -5.98 0.88 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.565 -1.272 . . . . 1.5800000000000001 107.565 177.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 54' ' ' LYS . 4.6 tpt85 -71.05 -49.13 48.11 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.58 -0.7 . . . . 1.99 109.247 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.2 mt -151.64 -21.86 0.19 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.437 -0.905 . . . . 2.48 110.302 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.15 -49.44 0.09 OUTLIER Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.847 -1.168 . . . . 0.41999999999999998 110.431 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -73.84 -45.41 51.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -1.202 . . . . 1.3799999999999999 109.929 -178.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.2 27.68 4.97 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.846 -1.702 . . . . 0.29999999999999999 108.846 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.475 ' CG2' ' NH1' ' A' ' 87' ' ' ARG . 5.7 t -151.84 129.39 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 107.525 -1.287 . . . . 1.22 107.525 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.0 mm100 -134.39 157.79 45.52 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.964 0.888 . . . . 2.0699999999999998 111.577 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tt -97.57 113.45 25.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.45 -0.944 . . . . 1.3100000000000001 108.45 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -23.31 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.122 -0.986 . . . . 2.0299999999999998 109.318 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.11 157.2 5.07 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.676 -1.21 . . . . 1.76 109.718 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.9 p -163.42 133.11 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.356 -0.84 . . . . 1.49 109.614 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.464 ' CG ' ' N ' ' A' ' 68' ' ' THR . 32.7 tt0 -145.9 163.12 36.11 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.271 1.034 . . . . 2.02 111.271 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.464 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -138.74 149.0 44.58 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.654 -0.869 . . . . 1.1000000000000001 108.654 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.662 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -174.42 160.42 29.89 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 107.701 -2.16 . . . . 0.51000000000000001 107.701 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.533 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 40.0 p -102.02 158.85 15.85 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.777 1.288 . . . . 0.82999999999999996 110.583 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.8 OUTLIER -154.23 173.96 15.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 1.29 110.312 178.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.9 138.45 19.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.611 0.72 . . . . 1.54 111.262 -178.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 1.0 OUTLIER -148.16 101.77 3.3 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.045 -0.724 . . . . 2.96 109.045 177.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.0 t70 86.41 36.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.181 0.515 . . . . 1.3799999999999999 110.144 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.68 30.7 6.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.25 -0.906 . . . . 3.4300000000000002 109.338 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.18 151.62 32.15 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.244 -0.91 . . . . 3.9100000000000001 109.477 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -85.3 137.98 32.61 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.566 1.174 . . . . 2.9900000000000002 109.598 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 tt -143.35 155.91 16.8 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 114.925 -1.034 . . . . 1.0700000000000001 108.549 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.607 ' HG ' ' HG ' ' B' ' 44' ' ' SER . 14.0 p -90.35 155.8 18.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.986 0.898 . . . . 1.03 111.44 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.662 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 6.1 p90 -142.48 148.38 37.6 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.79 -0.641 . . . . 4.2599999999999998 109.977 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 pp -123.12 133.72 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.184 -1.043 . . . . 1.5800000000000001 108.184 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 67' ' ' GLN . 16.2 mt -106.89 126.06 51.82 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.437 -0.949 . . . . 1.05 108.437 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.454 ' CD1' ' OG1' ' B' ' 68' ' ' THR . 0.5 OUTLIER -131.52 123.7 28.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.981 -1.075 . . . . 1.6699999999999999 111.025 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -102.46 165.58 11.02 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.197 -0.91 . . . . 0.65000000000000002 110.372 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 2.5 tp -157.67 144.68 18.18 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 119.302 -0.959 . . . . 2.02 111.423 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -126.4 143.69 51.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.17 0.509 . . . . 2.02 110.326 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' NH1' ' CG2' ' A' ' 61' ' ' VAL . 20.3 mmt180 -96.9 139.05 33.51 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.379 -0.826 . . . . 2.2999999999999998 110.049 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 51.4 t -117.14 -9.66 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.791 -0.818 . . . . 1.3899999999999999 108.791 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 117.977 -1.011 . . . . 2.6200000000000001 109.511 179.577 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.376 0.607 . . . . 6.8200000000000003 109.515 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.07 136.57 21.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 2.7799999999999998 109.153 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -157.77 -84.9 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.993 -1.114 . . . . 1.6799999999999999 107.993 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.0 58.1 0.6 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.518 -0.919 . . . . 2.8999999999999999 108.518 178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 8.1 tp -163.92 157.65 18.88 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.357 -1.349 . . . . 2.2599999999999998 107.357 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.4 t30 179.12 91.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.574 -1.329 . . . . 1.72 110.664 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.0 pt-20 -94.01 107.37 19.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.661 -1.274 . . . . 1.49 107.724 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.44 146.33 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 122.205 1.002 . . . . 1.8 110.884 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.19 124.53 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.86 -0.609 . . . . 2.02 109.375 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.43 166.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.376 -0.972 . . . . 1.1699999999999999 108.376 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -136.9 168.34 19.75 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.815 0.817 . . . . 2.9399999999999999 110.927 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.636 ' HZ2' ' HE ' ' B' ' 41' ' ' ARG . 14.2 pttt -87.62 -11.36 48.75 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.899 -0.778 . . . . 2.2999999999999998 108.899 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' THR . . . . . 0.403 HG21 ' H ' ' B' ' 14' ' ' LYS . 0.1 OUTLIER -76.23 -64.21 1.15 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.436 -1.306 . . . . 1.76 107.806 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.403 ' H ' HG21 ' B' ' 13' ' ' THR . 0.0 OUTLIER -58.08 146.72 32.06 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.906 -1.121 . . . . 1.8999999999999999 109.813 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.91 -179.8 6.26 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.049 -0.723 . . . . 1.96 109.049 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -76.75 -32.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.335 -0.987 . . . . 1.29 108.335 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -81.04 -33.71 33.33 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.648 -0.871 . . . . 1.7 108.648 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -67.32 -28.32 67.89 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.742 -1.224 . . . . 1.46 109.843 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.419 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 0.1 OUTLIER -91.37 -18.18 24.67 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.385 -1.447 . . . . 2.3100000000000001 108.644 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.96 -29.39 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 104.98 -2.23 . . . . 1.2 104.98 176.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 34.9 mt -69.78 -50.75 40.1 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.498 -1.228 . . . . 1.1899999999999999 108.52 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -65.82 -26.37 67.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.796 -1.19 . . . . 1.21 109.335 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 77.2 t -74.71 -54.76 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.945 . . . . 1.1299999999999999 109.719 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.542 ' CD1' HH22 ' B' ' 87' ' ' ARG . 3.9 tp -57.72 -19.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.064 -1.022 . . . . 1.3999999999999999 108.574 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 50.4 t -70.83 -41.59 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.185 -0.947 . . . . 1.27 109.48 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' B' ' 26' ' ' LEU . 0.3 OUTLIER -70.06 -37.99 75.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.539 -1.35 . . . . 1.8300000000000001 109.766 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.08 -29.36 67.28 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.608 -1.627 . . . . 2.3500000000000001 106.608 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -25.59 65.98 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.035 -0.984 . . . . 1.6799999999999999 108.986 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -90.41 -7.17 53.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.959 . . . . 1.9399999999999999 109.194 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.01 15.07 10.27 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.287 -1.125 . . . . 0.42999999999999999 110.287 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 40.4 mm -76.74 106.26 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.781 -1.423 . . . . 1.3400000000000001 108.471 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.7 -36.46 14.32 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.36 -0.838 . . . . 1.46 110.178 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -102.49 141.72 34.86 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.55 0.69 . . . . 1.2 110.582 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.66 141.94 15.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 119.504 -0.878 . . . . 1.27 110.72 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.2 120.96 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 109.613 -0.514 . . . . 1.1599999999999999 109.613 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.65 131.96 53.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.565 -0.71 . . . . 1.22 110.529 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.31 127.15 49.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.338 -0.986 . . . . 3.2200000000000002 108.338 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.28 141.64 12.82 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.993 -1.099 . . . . 0.28000000000000003 110.443 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.57 ' O ' ' N ' ' B' ' 41' ' ' ARG . 62.4 p -131.68 137.14 48.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.636 -0.92 . . . . 1.1100000000000001 111.42 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 35.81 -84.9 0.01 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 111.793 -0.523 . . . . 0.28999999999999998 111.793 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.636 ' HE ' ' HZ2' ' B' ' 12' ' ' LYS . 0.1 OUTLIER -82.3 -54.69 5.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.917 -1.343 . . . . 3.6699999999999999 109.767 -178.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -16.66 11.65 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.574 -1.269 . . . . 1.3799999999999999 107.574 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.416 ' CG2' ' CG2' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -55.64 -33.46 33.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.214 -0.929 . . . . 1.54 110.368 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.607 ' HG ' ' HG ' ' A' ' 79' ' ' SER . 0.5 OUTLIER -82.17 -22.44 36.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.121 -0.987 . . . . 1.5600000000000001 108.648 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' B' ' 46' ' ' ALA . 1.2 mptt -68.07 -71.86 0.2 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.326 -1.361 . . . . 2.4399999999999999 107.326 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -37.12 -47.56 0.76 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.05 0.452 . . . . 1.02 110.555 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.11 -61.35 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.096 -1.003 . . . . 1.1399999999999999 109.034 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . 0.445 ' O ' ' OG ' ' B' ' 52' ' ' SER . 10.7 t70 -56.4 -49.73 73.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.291 -0.881 . . . . 1.25 109.149 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -46.2 -56.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.411 -0.959 . . . . 1.77 108.411 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -64.54 -54.45 31.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.5 -0.75 . . . . 4.3499999999999996 110.75 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.533 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -50.77 -52.52 40.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.616 -1.303 . . . . 1.75 108.398 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 1.1 m -59.88 -30.21 68.84 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.649 -0.82 . . . . 1.0600000000000001 109.522 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 27.7 tp -74.07 -23.62 59.39 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.966 -1.084 . . . . 1.22 109.55 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . 0.407 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -82.26 -30.47 30.66 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.664 -1.606 . . . . 1.8300000000000001 106.664 178.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -14.67 6.31 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.752 -1.203 . . . . 1.46 107.752 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.407 ' N ' ' C ' ' B' ' 54' ' ' LYS . 20.5 mmm180 -73.29 -42.85 61.95 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.587 -0.845 . . . . 1.99 109.626 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.7 mt -153.32 -21.05 0.15 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.117 -1.433 . . . . 2.5699999999999998 112.678 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.21 -62.0 0.06 OUTLIER Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.187 -1.482 . . . . 0.39000000000000001 110.212 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -67.74 -38.39 83.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.259 -1.142 . . . . 1.3999999999999999 109.555 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.83 28.2 6.7 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.07 -1.612 . . . . 0.37 109.07 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.437 ' CG2' ' NH1' ' B' ' 87' ' ' ARG . 4.0 t -153.96 132.31 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.554 -1.276 . . . . 1.1799999999999999 107.554 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.7 mm100 -135.55 154.16 51.46 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.876 0.846 . . . . 2.1200000000000001 111.608 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 tt -94.43 118.57 31.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.482 -0.933 . . . . 1.3799999999999999 108.482 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.66 -17.82 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.815 . . . . 2.0 110.551 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -178.4 157.29 1.01 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.651 -1.281 . . . . 1.8600000000000001 109.458 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -165.26 136.83 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.408 -0.807 . . . . 1.5700000000000001 109.353 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . 0.436 ' CG ' ' N ' ' B' ' 68' ' ' THR . 33.1 tt0 -148.48 165.17 31.99 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.424 1.107 . . . . 2.04 111.546 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' THR . . . . . 0.454 ' OG1' ' CD1' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -138.44 152.02 47.97 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.207 -0.906 . . . . 0.92000000000000004 108.56 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.66 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -176.96 157.36 22.35 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.261 -2.336 . . . . 0.34999999999999998 107.261 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.527 ' OG ' ' ND2' ' A' ' 51' ' ' ASN . 59.6 p -96.1 159.05 15.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.903 -1.351 . . . . 0.84999999999999998 109.41 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -154.03 172.39 17.57 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.002 -1.061 . . . . 1.49 109.95 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.52 134.02 29.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.768 -0.773 . . . . 1.46 110.64 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 0.0 OUTLIER -143.58 100.4 3.59 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.303 -0.628 . . . . 2.8799999999999999 109.303 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.7 t70 79.82 41.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.825 -0.547 . . . . 1.3500000000000001 109.888 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.14 26.31 10.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.34 -0.85 . . . . 3.3700000000000001 109.267 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.18 154.93 38.85 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.426 -0.796 . . . . 3.8999999999999999 109.341 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -88.72 136.53 32.96 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.209 -0.996 . . . . 2.9700000000000002 111.29 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.74 154.02 33.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.104 -1.073 . . . . 1.3700000000000001 108.104 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.678 ' HG ' ' HG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -86.32 152.57 22.64 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.552 -0.717 . . . . 1.04 109.809 -177.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.66 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 5.8 p90 -142.51 146.67 34.94 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.768 -0.773 . . . . 4.29 109.992 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.64 133.59 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.016 -1.105 . . . . 1.55 108.016 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 13.2 mt -109.24 122.74 47.98 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.336 -1.357 . . . . 1.1599999999999999 107.336 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.429 ' CD1' ' OG1' ' A' ' 68' ' ' THR . 0.4 OUTLIER -128.67 127.22 41.72 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.088 -1.045 . . . . 1.55 110.921 -178.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -102.02 169.32 8.83 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.494 -0.775 . . . . 0.70999999999999996 109.456 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tp -160.45 140.22 11.12 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.288 -0.965 . . . . 2.1200000000000001 110.24 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.1 OUTLIER -123.11 146.39 47.76 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.528 -0.545 . . . . 2.0 109.528 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.542 HH22 ' CD1' ' B' ' 24' ' ' ILE . 20.4 mmt180 -98.48 136.2 38.95 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.836 . . . . 2.2999999999999998 110.216 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . 0.441 ' O ' ' CG1' ' B' ' 88' ' ' VAL . 23.2 t -113.4 -7.61 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.587 -0.894 . . . . 1.46 108.587 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 117.941 -1.028 . . . . 2.6299999999999999 109.48 179.559 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtt . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.321 -0.622 . . . . 6.7999999999999998 109.321 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.444 ' O ' ' CD1' ' A' ' 31' ' ' ILE . 14.7 m -133.18 33.25 3.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.616 -0.677 . . . . 2.7799999999999998 109.708 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 30' ' ' GLY . 1.5 mt-10 -83.31 -4.21 58.23 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.243 -0.911 . . . . 1.8 109.29 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 1.8 ptmt -160.62 55.61 0.32 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.103 -0.998 . . . . 2.8500000000000001 109.103 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tp -174.01 46.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.312 -0.868 . . . . 2.2200000000000002 109.087 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.49 ' ND2' ' CG1' ' A' ' 8' ' ' ILE . 50.0 t30 -90.55 112.2 23.8 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.188 -0.945 . . . . 1.8500000000000001 111.123 -177.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 7' ' ' GLU . 9.9 pt-20 -91.91 119.47 31.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.893 -1.13 . . . . 1.4399999999999999 109.045 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.49 ' CG1' ' ND2' ' A' ' 6' ' ' ASN . 3.5 mm -124.42 147.99 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 CA-C-O 122.32 1.057 . . . . 1.8300000000000001 112.091 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.3 t -111.6 130.31 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.783 0.801 . . . . 2.0099999999999998 109.959 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -88.33 161.47 2.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.257 -1.016 . . . . 1.24 108.257 -178.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -132.9 166.41 22.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.234 -0.916 . . . . 2.8500000000000001 110.321 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -25.26 39.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.739 -0.837 . . . . 2.3399999999999999 108.739 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.8 p -68.61 -63.04 1.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.224 -1.769 . . . . 1.6699999999999999 106.224 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.507 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 11.9 mptt -55.42 131.93 47.07 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.068 0.937 . . . . 1.8600000000000001 110.123 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -72.12 180.0 3.07 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.592 0.71 . . . . 1.97 110.002 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 17' ' ' GLU . 4.0 m -73.45 -33.68 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.443 -1.317 . . . . 1.29 107.443 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 3.7 tt0 -72.65 -37.48 67.97 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.358 -0.979 . . . . 1.5600000000000001 108.358 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -31.42 67.14 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.035 -1.041 . . . . 1.3799999999999999 111.439 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.485 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 54.3 m-70 -93.69 -17.33 23.33 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.217 -1.552 . . . . 2.3500000000000001 108.66 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -34.14 59.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 104.296 -2.483 . . . . 1.1299999999999999 104.296 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.6 mt -70.45 -51.14 31.45 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.72 -1.127 . . . . 1.1799999999999999 109.362 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.86 -30.94 71.24 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.888 -1.133 . . . . 1.22 109.298 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 53.4 t -70.62 -55.22 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -0.86 . . . . 1.1399999999999999 109.822 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.3 tt -60.85 -19.77 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.939 -1.101 . . . . 1.3 108.594 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -73.39 -42.99 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.211 -0.931 . . . . 1.1499999999999999 108.961 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -65.61 -34.88 79.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.773 -1.204 . . . . 1.8700000000000001 110.102 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -64.39 -26.22 68.37 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.319 -1.363 . . . . 2.3599999999999999 107.319 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -26.92 68.71 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.309 -0.86 . . . . 1.71 109.646 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -90.26 1.77 56.15 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.909 -1.119 . . . . 1.8799999999999999 109.402 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 101.65 13.81 31.38 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.201 -1.559 . . . . 0.47999999999999998 109.201 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.444 ' CD1' ' O ' ' A' ' 2' ' ' THR . 10.7 mm -75.57 109.27 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.252 -1.146 . . . . 1.0900000000000001 108.007 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -99.87 6.51 45.3 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.251 -0.906 . . . . 1.55 110.736 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' A' ' 4' ' ' LYS . 7.6 mt-10 -146.43 147.1 30.89 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.929 -1.107 . . . . 1.5800000000000001 108.936 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.53 142.02 11.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 118.786 -1.166 . . . . 1.28 111.017 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -114.42 120.61 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.634 -0.712 . . . . 1.0900000000000001 109.312 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mp -105.21 121.31 43.58 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.978 -0.689 . . . . 1.0800000000000001 109.812 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -108.03 133.18 52.7 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.89 -0.782 . . . . 3.21 108.89 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -144.31 157.19 27.1 Favored Glycine 0 N--CA 1.503 3.114 0 C-N-CA 119.879 -1.153 . . . . 0.28000000000000003 111.539 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.56 ' CG2' ' CD2' ' A' ' 80' ' ' TYR . 10.2 p -137.88 145.23 41.9 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.582 -0.952 . . . . 1.1399999999999999 112.856 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 38.38 -87.26 0.01 OUTLIER Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.687 -0.965 . . . . 0.34999999999999998 110.687 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.664 ' HE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -80.22 -52.59 7.56 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.327 -1.102 . . . . 3.6000000000000001 109.829 -178.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.75 -19.61 64.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.892 -1.13 . . . . 1.0900000000000001 109.145 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 44' ' ' SER . 7.1 tt -54.71 -35.49 33.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.142 -0.974 . . . . 1.6599999999999999 111.202 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.432 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.32 -22.71 32.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.953 -1.092 . . . . 1.51 108.875 -178.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.475 ' O ' ' C ' ' A' ' 46' ' ' ALA . 1.3 mptt -63.47 -69.34 0.28 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.069 -2.196 . . . . 2.4399999999999999 105.069 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -34.22 -38.1 0.06 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.479 0.657 . . . . 1.1000000000000001 109.843 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' LYS . 99.0 t -74.01 -73.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.243 -0.91 . . . . 1.01 109.546 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.409 ' O ' ' OG ' ' A' ' 52' ' ' SER . 6.7 t70 -40.41 -53.21 2.66 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.351 0.596 . . . . 1.26 111.103 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' LEU . 13.2 p -55.7 -47.64 78.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.318 -0.864 . . . . 1.78 109.486 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.633 ' CD2' ' N ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -61.37 -54.86 38.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.665 -1.272 . . . . 4.2999999999999998 109.284 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.633 ' N ' ' CD2' ' A' ' 50' ' ' TYR . 27.9 t-20 -56.22 -48.55 76.24 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.546 -1.279 . . . . 1.8500000000000001 107.546 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 14.6 m -60.72 -32.7 71.95 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.915 -1.143 . . . . 1.1799999999999999 107.915 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 49' ' ' VAL . 10.5 tp -80.69 -20.85 42.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.64 -1.244 . . . . 1.1499999999999999 107.64 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.14 -46.49 14.83 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.906 -1.887 . . . . 1.6599999999999999 105.906 177.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -57.66 -6.53 0.52 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.772 -1.195 . . . . 1.5800000000000001 107.772 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.53 ' H ' ' C ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -70.1 -50.42 41.01 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 121.427 -0.796 . . . . 1.99 109.251 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.2 mt -152.19 -16.71 0.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.169 -1.013 . . . . 2.48 110.748 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.53 -50.48 0.07 OUTLIER Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.75 -1.214 . . . . 0.41999999999999998 110.609 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -74.62 -47.1 34.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -1.176 . . . . 1.3799999999999999 110.35 -178.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.68 27.17 3.41 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.748 -1.741 . . . . 0.29999999999999999 108.748 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' H ' ' C ' ' A' ' 59' ' ' ASP . 42.9 t -154.23 136.25 6.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.26 -1.141 . . . . 1.22 108.267 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 86' ' ' LYS . 6.0 mm-40 -138.91 153.92 48.3 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 122.465 1.126 . . . . 2.0699999999999998 112.257 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 tt -95.85 109.15 21.54 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.155 -1.424 . . . . 1.3100000000000001 107.155 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.01 -23.79 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.163 -0.961 . . . . 2.0299999999999998 110.045 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 84' ' ' ARG . 0.5 OUTLIER -168.61 156.26 7.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.31 -1.494 . . . . 1.76 109.513 177.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 65' ' ' ASN . 74.1 t -161.15 131.49 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.91 -0.774 . . . . 1.49 108.91 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 82' ' ' LEU . 19.1 tt0 -143.2 158.38 43.67 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.998 0.904 . . . . 2.02 110.612 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.469 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -109.25 165.54 11.54 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.578 0.704 . . . . 1.1000000000000001 109.356 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 80' ' ' TYR . . . -169.83 176.38 43.67 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.729 -1.348 . . . . 0.51000000000000001 109.729 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.502 ' HG ' ' CG ' ' B' ' 51' ' ' ASN . 10.9 p -153.0 152.9 31.91 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.906 -1.146 . . . . 0.82999999999999996 107.906 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -160.24 176.91 11.19 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.045 -1.034 . . . . 1.29 109.908 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -89.34 139.91 16.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 119.589 -0.844 . . . . 1.54 110.435 -178.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 52.1 ttt180 -146.23 98.89 3.16 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.805 -0.813 . . . . 2.96 108.805 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 8.3 t0 88.87 34.58 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.334 0.588 . . . . 1.3799999999999999 109.562 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.93 38.87 6.18 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.293 1.044 . . . . 3.4300000000000002 109.367 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -157.66 151.63 24.32 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.594 -0.891 . . . . 3.9100000000000001 108.594 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -84.77 138.55 32.54 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.848 1.308 . . . . 2.9900000000000002 110.757 -177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -139.07 152.63 24.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 114.271 -1.332 . . . . 1.0700000000000001 107.592 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 p -88.33 162.87 16.33 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.204 1.002 . . . . 1.03 111.53 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.56 ' CD2' ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -139.72 138.52 36.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.38 -0.827 . . . . 4.2599999999999998 109.692 -177.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 81' ' ' ILE . 1.7 tt -119.04 129.48 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.858 -1.164 . . . . 1.5800000000000001 107.858 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' GLN . 14.9 mt -108.71 119.17 38.75 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.929 -1.508 . . . . 1.05 106.929 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.1 tt -127.02 127.16 44.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.235 -0.916 . . . . 1.6699999999999999 110.647 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 14.4 ttt180 -99.92 172.21 7.37 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.98 -0.554 . . . . 0.65000000000000002 109.681 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 mt -161.24 145.03 13.07 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.555 -0.858 . . . . 2.02 110.094 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 62' ' ' GLN . 5.3 tmtm? -131.21 157.39 43.34 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.565 -0.531 . . . . 2.02 109.565 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -113.56 139.41 49.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.438 -0.789 . . . . 2.2999999999999998 109.72 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.8 t -116.2 -5.09 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.038 -0.727 . . . . 1.3899999999999999 109.038 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 118.043 -0.979 . . . . 2.6200000000000001 109.597 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.52 -0.548 . . . . 6.8200000000000003 109.52 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 10.3 m -95.69 34.78 1.45 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 2.7799999999999998 109.079 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.99 -73.63 0.17 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.385 -0.822 . . . . 1.6799999999999999 109.974 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.423 ' O ' ' OE1' ' B' ' 33' ' ' GLU . 0.0 OUTLIER -93.64 63.41 3.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.632 -1.293 . . . . 2.8999999999999999 109.543 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -161.62 153.77 19.63 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.68 -1.6 . . . . 2.2599999999999998 106.68 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 179.76 93.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.623 -1.298 . . . . 1.72 110.772 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -89.7 103.55 16.19 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.339 -1.475 . . . . 1.49 107.875 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mm -114.34 139.86 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.738 0.78 . . . . 1.8 109.78 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 66.9 t -104.19 129.0 57.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.594 0.711 . . . . 2.02 109.614 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.403 HG12 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -88.38 162.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.148 -1.056 . . . . 1.1699999999999999 108.148 -178.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -138.0 171.79 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 2.9399999999999999 110.183 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -9.64 39.74 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.463 -0.94 . . . . 2.2999999999999998 108.463 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 33.5 p -89.41 -6.1 56.84 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.739 -0.785 . . . . 1.76 109.038 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -97.6 -132.92 0.22 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.627 -1.249 . . . . 1.8999999999999999 107.627 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -168.15 167.07 12.61 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.882 -0.784 . . . . 1.96 108.882 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.422 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.0 m -66.43 -36.6 77.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.754 -1.202 . . . . 1.29 107.754 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 4.8 mm-40 -73.73 -39.94 63.92 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.328 -0.99 . . . . 1.7 108.328 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -60.87 -31.95 71.4 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.173 -0.954 . . . . 1.46 111.917 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.475 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 49.1 m-70 -92.99 -17.54 23.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 119.835 -1.791 . . . . 2.3100000000000001 108.907 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -33.84 55.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 104.427 -2.435 . . . . 1.2 104.427 176.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 52.6 mt -68.72 -51.7 38.64 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.648 -1.16 . . . . 1.1899999999999999 109.058 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.04 -31.48 72.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 1.21 109.729 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' B' ' 19' ' ' HIS . 52.9 t -69.68 -55.91 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 1.1299999999999999 109.837 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 20.9 tt -61.32 -20.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.067 -1.021 . . . . 1.3999999999999999 108.873 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 4.8 t -71.11 -42.95 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 1.27 109.098 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mt -65.73 -41.44 92.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.854 -1.154 . . . . 1.8300000000000001 109.739 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -58.05 -29.95 65.79 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.211 -1.403 . . . . 2.3500000000000001 107.211 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -28.34 65.43 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.477 -0.783 . . . . 1.6799999999999999 108.899 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -89.55 -1.23 57.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 1.9399999999999999 109.368 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.92 15.01 23.39 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.57 -1.412 . . . . 0.42999999999999999 109.57 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 45.6 mm -78.56 108.17 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -1.162 . . . . 1.3400000000000001 108.82 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -92.77 -36.5 12.85 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.26 -0.9 . . . . 1.46 110.226 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' B' ' 4' ' ' LYS . 6.5 mt-10 -101.54 143.37 31.61 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.577 0.703 . . . . 1.2 110.905 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.57 143.04 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 119.554 -0.858 . . . . 1.27 111.026 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.54 123.2 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.223 0.535 . . . . 1.1599999999999999 109.87 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.95 121.08 42.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.738 -0.602 . . . . 1.22 109.991 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -106.75 129.84 54.56 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.37 -0.604 . . . . 3.2200000000000002 109.37 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -143.49 156.43 26.57 Favored Glycine 0 N--CA 1.507 3.385 0 C-N-CA 119.662 -1.256 . . . . 0.28000000000000003 111.76 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.602 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 1.8 p -137.95 145.97 42.65 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.481 -1.011 . . . . 1.1100000000000001 112.916 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 37.68 -86.1 0.01 OUTLIER Glycine 0 N--CA 1.499 2.869 0 N-CA-C 110.571 -1.012 . . . . 0.28999999999999998 110.571 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.642 ' N ' ' HE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -80.71 -52.99 6.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.359 -1.083 . . . . 3.6699999999999999 109.792 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -19.53 65.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.956 -1.09 . . . . 1.3799999999999999 109.535 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 7.1 tt -56.01 -31.6 31.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.905 -1.122 . . . . 1.54 109.818 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -24.6 33.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 1.5600000000000001 108.656 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' B' ' 46' ' ' ALA . 2.2 mptt -65.04 -70.84 0.21 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.642 -1.985 . . . . 2.4399999999999999 105.642 177.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -32.37 -40.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.25 0.548 . . . . 1.02 110.527 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' B' ' 45' ' ' LYS . 94.6 t -79.13 -64.5 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.111 -0.993 . . . . 1.1399999999999999 110.011 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . 0.417 ' O ' ' OG ' ' B' ' 52' ' ' SER . 6.0 t0 -44.97 -52.95 8.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.347 -0.846 . . . . 1.25 109.952 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' B' ' 50' ' ' TYR . 11.1 p -55.58 -46.62 79.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.576 -0.849 . . . . 1.77 109.204 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.643 ' CD2' ' N ' ' B' ' 51' ' ' ASN . 0.0 OUTLIER -62.81 -54.89 32.0 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.91 -1.119 . . . . 4.3499999999999996 109.162 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.643 ' N ' ' CD2' ' B' ' 50' ' ' TYR . 23.3 t-20 -53.83 -47.64 70.71 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.271 -1.381 . . . . 1.75 107.271 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 2.6 m -63.62 -31.57 72.77 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.194 -1.002 . . . . 1.0600000000000001 109.141 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' B' ' 49' ' ' VAL . 13.7 tp -73.49 -23.2 60.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.054 -1.029 . . . . 1.22 109.774 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . 0.407 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -83.18 -30.57 27.69 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.47 -1.678 . . . . 1.8300000000000001 106.47 177.435 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.46 -14.6 3.17 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.745 -1.206 . . . . 1.46 107.745 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.407 ' N ' ' C ' ' B' ' 54' ' ' LYS . 1.0 OUTLIER -71.61 -47.41 54.85 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.532 -0.867 . . . . 1.99 109.559 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' LEU . . . . . 0.605 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.7 mt -155.11 -15.24 0.11 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.99 -1.484 . . . . 2.5699999999999998 112.638 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.33 -57.52 0.07 OUTLIER Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.22 -1.466 . . . . 0.39000000000000001 110.219 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.605 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -71.05 -44.24 66.19 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.298 -1.119 . . . . 1.3999999999999999 110.089 -179.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.65 25.74 5.01 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.231 -1.548 . . . . 0.37 109.231 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 22.6 t -154.6 135.42 4.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.0 -1.111 . . . . 1.1799999999999999 108.0 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' B' ' 86' ' ' LYS . 5.4 mm-40 -140.86 154.39 46.16 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.534 1.159 . . . . 2.1200000000000001 112.422 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tt -96.16 114.48 26.18 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.898 -1.047 . . . . 1.3799999999999999 108.285 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.88 -13.69 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 119.54 -0.864 . . . . 2.0 110.763 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -177.69 151.43 0.72 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.06 -1.65 . . . . 1.8600000000000001 110.63 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 63.1 t -158.22 135.43 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.554 -0.717 . . . . 1.5700000000000001 109.341 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -143.99 160.14 41.37 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.016 0.913 . . . . 2.04 111.579 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 50' ' ' TYR . 6.5 p -117.87 163.7 16.14 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.459 -0.791 . . . . 0.92000000000000004 109.025 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' B' ' 80' ' ' TYR . . . 177.76 134.61 2.08 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.717 -1.353 . . . . 0.34999999999999998 109.717 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.606 ' CB ' ' HE ' ' B' ' 77' ' ' ARG . 65.3 p -91.95 156.3 17.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.292 -1.711 . . . . 0.84999999999999998 109.513 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -150.65 164.48 35.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 1.49 110.088 -179.066 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.568 ' N ' ' OE1' ' B' ' 71' ' ' GLU . 0.1 OUTLIER -88.74 136.23 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.185 -0.947 . . . . 1.46 110.295 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 49.2 ttt180 -148.06 101.93 3.33 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.187 -0.946 . . . . 2.8799999999999999 109.661 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 6.7 t0 86.13 34.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.694 -0.854 . . . . 1.3500000000000001 108.694 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.7 34.47 9.62 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.094 0.949 . . . . 3.3700000000000001 108.601 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -152.98 150.28 29.06 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.601 -0.888 . . . . 3.8999999999999999 108.601 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.606 ' HE ' ' CB ' ' B' ' 70' ' ' SER . 4.2 ttt85 -87.04 140.67 29.32 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.525 1.155 . . . . 2.9700000000000002 111.218 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 10.3 tt -136.79 153.68 30.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.713 -1.218 . . . . 1.3700000000000001 107.713 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.48 ' H ' ' HG ' ' B' ' 79' ' ' SER . 0.0 OUTLIER -85.32 155.49 21.31 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.221 -0.924 . . . . 1.04 109.711 -176.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.602 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.1 OUTLIER -137.56 138.03 39.17 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.209 -0.663 . . . . 4.29 109.209 -177.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' B' ' 81' ' ' ILE . 1.3 tt -120.56 130.59 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.297 -1.001 . . . . 1.55 108.297 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mt -108.28 119.21 38.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.469 -1.678 . . . . 1.1599999999999999 106.469 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tt -124.63 126.09 45.19 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.511 -0.876 . . . . 1.55 110.721 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -97.14 171.54 8.39 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.757 -0.831 . . . . 0.70999999999999996 108.757 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mt -160.41 141.6 12.16 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.559 -0.857 . . . . 2.1200000000000001 109.352 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' B' ' 62' ' ' GLN . 9.2 tttm -127.26 148.11 50.22 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.019 0.437 . . . . 2.0 110.188 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -106.0 137.76 43.36 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.505 -0.747 . . . . 2.2999999999999998 109.421 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 75.7 t -116.2 -4.45 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.061 -0.718 . . . . 1.46 109.061 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 118.077 -0.963 . . . . 2.6299999999999999 109.473 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.672 ' OD1' HD11 ' A' ' 8' ' ' ILE . 1.3 t-20 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.176 0.512 . . . . 1.72 111.137 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -91.47 124.98 36.05 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.456 -0.942 . . . . 1.4399999999999999 108.456 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.672 HD11 ' OD1' ' A' ' 6' ' ' ASN . 10.4 mt -137.12 154.4 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 119.918 -0.713 . . . . 1.1100000000000001 111.205 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.56 138.63 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.723 -0.843 . . . . 1.3500000000000001 108.723 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 p -91.06 163.5 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.942 -1.099 . . . . 0.39000000000000001 108.683 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -129.67 163.65 25.63 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.836 0.827 . . . . 2.27 109.986 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -95.11 -17.49 21.78 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.174 -1.047 . . . . 1.78 108.174 178.591 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -73.42 -44.56 58.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.374 -0.973 . . . . 1.24 108.374 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 146.51 39.08 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.236 -0.915 . . . . 1.4099999999999999 109.294 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -69.0 -179.44 1.5 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.099 -1.001 . . . . 1.25 108.632 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.638 HG23 ' N ' ' A' ' 17' ' ' GLU . 27.2 m -78.62 -50.2 19.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.872 -1.142 . . . . 0.48999999999999999 109.458 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.638 ' N ' HG23 ' A' ' 16' ' ' VAL . 4.1 pt-20 -57.88 -19.69 31.26 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.076 -1.015 . . . . 1.5600000000000001 110.529 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.61 -30.37 69.09 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.379 -1.451 . . . . 1.3799999999999999 108.239 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -89.27 -23.57 22.28 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.845 -0.742 . . . . 1.4299999999999999 109.015 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.41 -27.8 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 106.532 -1.655 . . . . 0.28999999999999998 106.532 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 25' ' ' VAL . 27.2 mt -75.37 -48.94 20.65 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.117 -1.068 . . . . 0.40999999999999998 108.117 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -66.73 -22.01 66.06 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.537 -0.727 . . . . 1.22 109.597 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 19' ' ' HIS . 11.9 t -78.79 -54.41 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.154 -0.966 . . . . 0.32000000000000001 109.783 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.1 tt -55.6 -28.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.147 -0.97 . . . . 0.57999999999999996 108.924 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 21' ' ' LEU . 58.0 t -72.67 -43.97 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.231 -1.026 . . . . 0.40999999999999998 108.231 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.465 HD13 ' OD1' ' A' ' 6' ' ' ASN . 44.8 mt -63.8 -39.73 94.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.53 -0.731 . . . . 1.1899999999999999 109.692 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 3.2 t80 -69.77 -0.93 7.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 1.46 108.786 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.72 -26.69 19.41 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.981 -1.118 . . . . 1.1499999999999999 107.981 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -86.82 3.96 43.14 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.519 -0.738 . . . . 1.1699999999999999 109.648 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.64 6.84 34.95 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.171 -1.172 . . . . 0.41999999999999998 110.171 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -75.7 95.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -1.234 . . . . 0.34999999999999998 109.407 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -87.37 -33.95 18.97 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.232 -0.918 . . . . 1.55 108.82 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -99.5 147.71 25.02 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.366 0.603 . . . . 1.5800000000000001 109.807 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.15 149.07 10.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 119.163 -1.015 . . . . 0.54000000000000004 109.488 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.1 mt -129.7 117.24 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.494 0.664 . . . . 0.25 110.732 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 46' ' ' ALA . 4.6 mp -100.68 127.17 47.18 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.893 -0.781 . . . . 0.40000000000000002 108.893 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -115.3 139.93 49.55 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.015 -1.106 . . . . 2.7400000000000002 108.015 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.81 163.96 28.83 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 119.379 -1.391 . . . . 0.20999999999999999 110.444 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 41' ' ' ARG . 36.4 p -137.46 148.1 45.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.503 -0.998 . . . . 0.56000000000000005 110.914 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 36.94 -85.65 0.01 OUTLIER Glycine 0 N--CA 1.5 2.947 0 O-C-N 122.0 -0.438 . . . . 0.33000000000000002 112.179 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -87.14 -42.87 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -1.174 . . . . 3.0899999999999999 110.34 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.58 -22.34 66.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.66 -1.275 . . . . 1.0900000000000001 109.511 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.539 HG13 HG22 ' A' ' 81' ' ' ILE . 8.3 tt -48.23 -54.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.87 109.978 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.497 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.61 -26.57 65.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.906 -1.121 . . . . 1.1399999999999999 110.903 -178.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -41.27 95.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.638 -1.289 . . . . 1.8600000000000001 109.066 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -59.83 -38.73 82.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.28999999999999998 109.245 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.668 HG13 ' HB ' ' B' ' 68' ' ' THR . 48.5 t -59.75 -66.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.654 -0.654 . . . . 0.22 110.643 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -53.54 6.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.797 -0.564 . . . . 1.26 109.804 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG21 ' CB ' ' A' ' 19' ' ' HIS . 9.0 t -46.15 -55.19 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.555 -0.715 . . . . 1.0600000000000001 109.494 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -64.66 -44.68 89.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.395 -0.816 . . . . 1.27 110.037 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.57 ' CG ' ' H ' ' B' ' 70' ' ' SER . 4.6 t30 -58.46 -48.33 81.08 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.094 -1.004 . . . . 1.3400000000000001 108.467 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 p -67.46 -29.18 68.57 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.942 -0.762 . . . . 1.04 108.942 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.79 -25.39 44.29 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.385 -0.969 . . . . 0.44 108.385 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -76.28 -46.32 28.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.007 -1.849 . . . . 1.0 106.007 177.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 16.6 t0 -57.63 -6.96 0.56 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.827 -1.079 . . . . 1.5800000000000001 108.351 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 54' ' ' LYS . 3.1 tpt85 -76.35 -46.53 27.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.727 -0.608 . . . . 1.6899999999999999 110.148 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' ASP . 6.1 tp -152.42 -29.03 0.16 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.41 -0.916 . . . . 1.6599999999999999 110.292 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.71 -49.32 0.64 Allowed Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.022 -1.561 . . . . 0.39000000000000001 109.229 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.502 ' C ' ' H ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER -74.68 -49.79 20.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -1.223 . . . . 1.3799999999999999 109.055 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.97 23.36 1.36 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.79 -1.724 . . . . 0.26000000000000001 108.79 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 59' ' ' ASP . 24.1 t -149.86 139.51 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 121.505 -0.997 . . . . 0.38 108.511 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.5 mm-40 -143.27 142.36 31.33 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.229 1.014 . . . . 1.3100000000000001 110.864 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 tt -93.84 94.26 8.41 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.471 -0.786 . . . . 0.48999999999999999 109.114 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.33 -35.37 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.904 -1.122 . . . . 1.3500000000000001 110.126 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -165.99 157.63 13.94 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.139 -1.425 . . . . 1.2 112.155 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.1 t -158.16 145.37 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.397 -1.335 . . . . 0.84999999999999998 107.397 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -148.11 165.23 31.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.754 -1.216 . . . . 1.4099999999999999 108.896 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.4 ' HB ' HG13 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -147.36 129.64 15.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.52000000000000002 111.007 -178.393 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -152.38 171.52 31.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.964 -1.655 . . . . 0.40000000000000002 108.964 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.523 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 9.9 p -112.08 156.45 22.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.693 0.759 . . . . 0.41999999999999998 110.366 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.29 175.84 13.03 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.511 -0.743 . . . . 1.29 109.552 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.4 t -87.99 132.78 32.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.388 -0.82 . . . . 1.02 110.651 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 34.4 ttt-85 -143.85 99.97 3.5 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.487 -0.931 . . . . 2.23 108.487 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.2 t70 85.69 40.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.205 0.526 . . . . 1.3799999999999999 109.643 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 60.32 37.68 20.11 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.379 1.085 . . . . 2.6200000000000001 108.897 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -155.51 149.0 25.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.111 -0.993 . . . . 3.1499999999999999 108.765 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -83.02 140.88 32.46 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.223 -0.991 . . . . 2.4399999999999999 109.626 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.3 tt -144.31 156.95 15.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.176 -0.676 . . . . 0.23000000000000001 109.176 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -87.9 152.79 21.81 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.394 -0.816 . . . . 0.73999999999999999 109.4 -178.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 9.8 p90 -146.82 151.87 37.82 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.063 -1.023 . . . . 4.1600000000000001 110.348 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.539 HG22 HG13 ' A' ' 43' ' ' ILE . 10.6 tt -121.75 137.53 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-N 115.667 -0.697 . . . . 0.92000000000000004 111.488 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.5 mt -110.23 104.71 13.57 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.076 -2.194 . . . . 0.35999999999999999 105.076 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 tp -106.82 120.47 42.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.878 -0.514 . . . . 0.97999999999999998 110.081 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -103.69 168.23 9.28 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.907 -0.775 . . . . 0.57999999999999996 108.907 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.459 HD21 HG13 ' A' ' 61' ' ' VAL . 1.3 tp -160.57 160.11 31.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.951 -1.099 . . . . 1.3899999999999999 109.999 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -142.15 145.26 34.01 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.52 -0.548 . . . . 1.4199999999999999 109.52 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -105.08 136.62 44.24 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.55 -0.719 . . . . 1.6399999999999999 109.373 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 t -107.63 -7.55 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.878 -1.156 . . . . 0.63 107.878 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 117.977 -1.011 . . . . 1.76 109.437 179.591 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.609 ' OD1' HD11 ' B' ' 8' ' ' ILE . 1.1 t-20 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.421 0.629 . . . . 1.46 111.387 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.1 pt-20 -93.1 121.88 34.9 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.38 -0.97 . . . . 1.49 108.38 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.609 HD11 ' OD1' ' B' ' 6' ' ' ASN . 40.1 mt -134.63 150.91 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.735 -0.603 . . . . 1.1699999999999999 110.009 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.9 138.91 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.878 . . . . 1.3700000000000001 108.909 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.445 HG23 ' CD2' ' B' ' 19' ' ' HIS . 1.4 p -90.26 160.1 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.967 -1.083 . . . . 0.37 108.499 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.403 ' HE ' ' HE3' ' B' ' 14' ' ' LYS . 12.1 mtt-85 -130.74 167.7 18.41 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.874 0.845 . . . . 2.3700000000000001 110.505 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.25 -4.65 21.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.507 -0.923 . . . . 1.75 108.507 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' THR . . . . . 0.406 ' H ' HG22 ' B' ' 13' ' ' THR . 2.8 t -83.49 -29.05 28.27 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.647 -0.821 . . . . 1.1899999999999999 110.447 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.411 ' O ' ' OD1' ' B' ' 15' ' ' ASN . 7.5 mttm -83.8 -113.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.78 -1.2 . . . . 1.47 109.415 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' B' ' 14' ' ' LYS . 2.6 m120 -166.18 173.63 10.02 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.393 -1.336 . . . . 1.22 107.393 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.63 HG23 ' N ' ' B' ' 17' ' ' GLU . 22.1 m -70.9 -51.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.606 -1.309 . . . . 0.45000000000000001 109.112 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.63 ' N ' HG23 ' B' ' 16' ' ' VAL . 6.0 pt-20 -63.11 -24.94 68.13 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.147 -0.97 . . . . 1.7 110.106 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.42 -38.42 91.08 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.39 -1.444 . . . . 1.46 108.359 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.448 ' HB3' HG21 ' B' ' 49' ' ' VAL . 0.7 OUTLIER -83.76 -22.3 31.94 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.894 -0.722 . . . . 1.3999999999999999 109.841 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.08 -31.05 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.074 -1.454 . . . . 0.34000000000000002 107.074 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 37.4 mt -70.63 -48.64 53.98 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.264 -1.013 . . . . 0.38 108.264 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -65.62 -26.04 67.65 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.477 -0.764 . . . . 1.21 109.906 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.57 -54.14 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.11 -0.994 . . . . 0.29999999999999999 110.026 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 5.5 tt -55.15 -28.54 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.68999999999999995 109.246 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 t -73.38 -43.32 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.198 -0.939 . . . . 0.41999999999999998 108.631 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mt -62.37 -45.97 90.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.45 -0.781 . . . . 1.1499999999999999 109.524 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -53.92 -48.0 70.63 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.746 -1.205 . . . . 1.46 107.746 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -31.01 2.16 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.208 -0.597 . . . . 1.1699999999999999 109.577 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.77 5.43 28.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.952 -1.093 . . . . 1.1699999999999999 110.031 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.08 53.85 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.924 -1.27 . . . . 0.38 109.924 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 43.5 mm -76.17 88.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.067 -1.255 . . . . 0.58999999999999997 108.588 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -83.49 -39.08 20.95 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.21 -0.931 . . . . 1.46 109.152 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -93.58 142.11 27.71 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.643 -0.661 . . . . 1.2 109.592 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 p -155.57 151.03 10.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.546 -0.862 . . . . 0.48999999999999999 109.683 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.56 112.81 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.439 0.638 . . . . 0.31 110.055 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -95.53 133.05 39.98 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.542 -0.724 . . . . 0.47999999999999998 109.187 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.99 140.03 52.96 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.463 -0.94 . . . . 2.7400000000000002 108.463 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.99 164.19 28.59 Favored Glycine 0 N--CA 1.502 3.089 0 C-N-CA 119.498 -1.334 . . . . 0.23999999999999999 110.232 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.548 ' O ' ' N ' ' B' ' 41' ' ' ARG . 76.9 p -135.87 146.37 47.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.701 -0.882 . . . . 0.48999999999999999 110.763 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.503 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 36.27 -84.02 0.0 OUTLIER Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.847 -0.533 . . . . 0.28000000000000003 112.615 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.0 OUTLIER -84.5 -45.31 12.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -1.187 . . . . 3.1600000000000001 110.443 -178.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.2 OUTLIER -66.76 -23.92 66.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.727 -1.233 . . . . 1.3799999999999999 109.045 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.558 HG13 HG22 ' B' ' 81' ' ' ILE . 7.9 tt -53.85 -20.71 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.84999999999999998 109.036 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.11 -34.58 13.59 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.279 0.562 . . . . 1.1200000000000001 110.196 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -25.38 66.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 1.8700000000000001 110.212 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.435 ' HB2' HG11 ' B' ' 10' ' ' VAL . . . -73.26 -45.74 54.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.962 -1.086 . . . . 0.26000000000000001 109.975 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.4 HG13 ' HB ' ' A' ' 68' ' ' THR . 88.5 t -61.88 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.28000000000000003 109.68 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' B' ' 52' ' ' SER . 2.7 t70 -57.43 -56.37 22.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 1.25 109.474 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' B' ' 19' ' ' HIS . 10.3 t -43.89 -49.48 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.672 -0.643 . . . . 1.0600000000000001 110.006 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.504 ' CE1' HD11 ' B' ' 85' ' ' LEU . 1.1 t80 -68.33 -53.18 25.92 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.426 -0.797 . . . . 1.28 110.295 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ASN . . . . . 0.523 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 1.2 t30 -50.3 -45.88 54.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.032 -1.042 . . . . 1.4099999999999999 108.527 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.6 OUTLIER -68.67 -37.15 79.39 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.559 -0.857 . . . . 0.65000000000000002 109.171 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 tp -65.89 -26.84 67.8 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.378 -0.826 . . . . 0.53000000000000003 108.817 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -75.25 -38.69 60.43 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.664 -1.236 . . . . 0.98999999999999999 107.664 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.26 -7.78 0.41 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.036 -0.727 . . . . 1.46 109.036 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.472 ' H ' ' C ' ' B' ' 54' ' ' LYS . 21.1 mmm180 -82.66 -39.41 22.1 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.548 -0.72 . . . . 1.71 110.727 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' LEU . . . . . 0.425 HD23 ' H ' ' B' ' 60' ' ' GLY . 1.0 OUTLIER -157.14 -35.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 117.928 -1.509 . . . . 1.77 112.595 -179.308 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.78 -55.03 2.57 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 118.548 -1.786 . . . . 0.39000000000000001 108.919 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' B' ' 61' ' ' VAL . 0.4 OUTLIER -72.16 -48.68 41.62 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.149 -1.206 . . . . 1.3999999999999999 108.575 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.425 ' H ' HD23 ' B' ' 57' ' ' LEU . . . -76.79 25.11 1.81 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 108.969 -1.652 . . . . 0.34000000000000002 108.969 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' B' ' 59' ' ' ASP . 13.0 t -153.07 140.2 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.392 -1.064 . . . . 0.46000000000000002 108.72 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.5 mm-40 -143.87 141.9 30.54 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.297 1.046 . . . . 1.4199999999999999 111.669 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.34 94.33 9.08 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.421 -0.809 . . . . 0.54000000000000004 109.346 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.44 HG22 ' H ' ' B' ' 64' ' ' VAL . 0.0 OUTLIER -74.53 -39.55 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.945 -1.097 . . . . 1.4299999999999999 110.53 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.491 ' O ' HG23 ' B' ' 66' ' ' VAL . 6.3 m120 -164.46 164.69 21.88 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.336 -1.346 . . . . 1.28 111.831 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 65' ' ' ASN . 59.2 t -161.07 143.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.718 -1.216 . . . . 0.90000000000000002 107.718 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -147.76 165.13 31.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.899 -1.125 . . . . 1.4399999999999999 108.645 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.668 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -148.78 129.48 14.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.088 -1.007 . . . . 0.45000000000000001 110.232 -178.575 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.551 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -149.29 169.58 29.61 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.061 -1.216 . . . . 0.28999999999999998 110.061 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.57 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 23.9 p -104.32 151.21 23.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 122.038 -0.684 . . . . 0.39000000000000001 109.986 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.65 172.01 16.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 1.49 110.224 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 67.9 t -87.58 133.95 29.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.474 -0.766 . . . . 0.87 110.692 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 17.7 ttt-85 -146.36 101.39 3.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.544 -0.722 . . . . 2.1800000000000002 109.301 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 1.6 t70 82.2 41.84 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.319 0.58 . . . . 1.3500000000000001 109.509 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 60.48 32.29 20.49 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.121 0.962 . . . . 2.5699999999999998 109.212 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -151.9 154.96 37.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.563 -0.903 . . . . 3.1400000000000001 108.563 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -87.37 142.17 28.08 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.389 -0.924 . . . . 2.3900000000000001 110.644 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 tt -142.56 157.33 18.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.404 -0.962 . . . . 0.57999999999999996 108.404 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.15 149.51 24.6 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.797 -0.816 . . . . 0.60999999999999999 108.797 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.551 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 9.1 p90 -144.49 149.89 36.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.38 -0.825 . . . . 4.0800000000000001 109.899 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.558 HG22 HG13 ' B' ' 43' ' ' ILE . 2.9 tt -122.08 138.95 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 115.899 -0.591 . . . . 0.90000000000000002 111.766 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 21.0 mt -108.99 106.99 17.18 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.518 -2.03 . . . . 0.37 105.518 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.5 119.48 39.52 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 118.343 0.519 . . . . 0.97999999999999998 110.566 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -102.81 164.84 11.39 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.912 -0.773 . . . . 0.70999999999999996 108.912 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.504 HD11 ' CE1' ' B' ' 50' ' ' TYR . 1.9 tp -160.4 152.19 19.94 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.607 -0.837 . . . . 1.4399999999999999 109.708 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -136.86 136.07 38.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.452 -0.573 . . . . 1.3100000000000001 109.452 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -95.18 137.17 34.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.48 -0.762 . . . . 1.6399999999999999 109.313 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 40.0 t -108.92 -6.85 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 0.68000000000000005 108.21 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.964 -1.017 . . . . 1.77 109.513 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.978 0.418 . . . . 1.72 111.033 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 7.0 pt-20 -91.67 117.03 29.37 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.604 -1.258 . . . . 1.4399999999999999 107.604 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 35' ' ' ILE . 12.6 mt -122.43 147.98 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-O 121.889 0.852 . . . . 1.1100000000000001 112.062 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -111.78 128.17 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.65 0.738 . . . . 1.3500000000000001 109.796 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -88.4 164.9 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.398 -0.964 . . . . 0.39000000000000001 108.398 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -138.0 174.9 10.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.439 -0.788 . . . . 2.27 109.827 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -8.38 15.09 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.208 -1.034 . . . . 1.78 108.208 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.423 ' H ' HG22 ' A' ' 13' ' ' THR . 1.0 OUTLIER -90.44 -12.34 37.72 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.35 -1.352 . . . . 1.24 107.35 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -130.41 0.09 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.996 -1.483 . . . . 1.4099999999999999 106.996 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.79 155.21 21.12 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.803 -1.186 . . . . 1.25 108.925 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 49' ' ' VAL . 11.5 m -62.7 -37.24 78.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 122.121 0.962 . . . . 0.48999999999999999 108.859 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.86 -31.61 59.37 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.22 -0.925 . . . . 1.5600000000000001 108.523 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.33 -32.04 73.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.614 -1.304 . . . . 1.3799999999999999 111.452 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.71 ' O ' HG23 ' A' ' 23' ' ' VAL . 85.2 m-70 -90.37 -18.63 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 119.806 -1.809 . . . . 1.4299999999999999 108.74 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.09 -32.15 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 105.147 -2.168 . . . . 0.28999999999999998 105.147 176.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.816 ' O ' HG23 ' A' ' 25' ' ' VAL . 34.2 mt -69.53 -53.01 21.12 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 109.294 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -65.86 -28.81 69.24 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.98 -1.075 . . . . 1.22 109.546 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 19' ' ' HIS . 23.2 t -68.72 -54.42 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.421 -0.799 . . . . 0.32000000000000001 109.01 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 tt -63.5 -17.05 19.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.181 -0.949 . . . . 0.57999999999999996 108.978 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 21' ' ' LEU . 53.6 t -76.95 -46.7 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.064 -1.023 . . . . 0.40999999999999998 109.408 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.22 -33.13 75.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.614 -1.304 . . . . 1.1899999999999999 110.273 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 4.2 t80 -64.33 -24.73 67.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.79 -1.559 . . . . 1.46 106.79 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -27.29 69.18 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.096 -0.956 . . . . 1.1499999999999999 109.398 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -89.89 -4.69 57.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.901 -1.124 . . . . 1.1699999999999999 109.254 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.74 12.22 15.1 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.368 -1.093 . . . . 0.41999999999999998 110.368 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.4 mm -75.16 106.46 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.038 -1.272 . . . . 0.34999999999999998 108.475 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.57 -36.91 15.06 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.339 -0.851 . . . . 1.55 110.306 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.95 143.32 31.24 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.827 0.822 . . . . 1.5800000000000001 110.456 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.67 141.46 14.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 119.555 -0.858 . . . . 0.54000000000000004 109.942 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -120.81 126.37 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 115.887 -0.597 . . . . 0.25 110.321 -178.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.465 ' CD2' HG21 ' A' ' 49' ' ' VAL . 6.9 mp -108.81 125.13 51.63 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 120.2 -0.6 . . . . 0.40000000000000002 109.753 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -108.42 131.59 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.752 -1.203 . . . . 2.7400000000000002 107.752 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.69 152.75 21.79 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 119.893 -1.146 . . . . 0.20999999999999999 110.717 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.595 ' O ' ' N ' ' A' ' 41' ' ' ARG . 18.0 p -132.3 139.61 48.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.842 -0.799 . . . . 0.56000000000000005 112.243 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.542 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 39.51 -85.08 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 N-CA-C 111.406 -0.677 . . . . 0.33000000000000002 111.406 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -82.09 -54.2 5.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.256 -1.143 . . . . 3.0899999999999999 109.913 -178.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -19.34 48.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.785 -1.197 . . . . 1.0900000000000001 108.564 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 40' ' ' GLY . 4.9 tt -53.97 -30.91 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.388 -0.82 . . . . 0.87 110.673 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.41 ' HA ' HD13 ' B' ' 43' ' ' ILE . 0.8 OUTLIER -85.6 -22.53 27.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.563 -1.336 . . . . 1.1399999999999999 108.54 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' VAL . 24.3 mmtp -63.33 -69.24 0.28 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.078 -1.823 . . . . 1.8600000000000001 106.078 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -29.22 -38.18 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.784 0.802 . . . . 0.28999999999999998 109.959 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.693 HG13 ' HB ' ' B' ' 68' ' ' THR . 65.8 t -73.64 -74.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.696 -0.627 . . . . 0.22 110.578 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -39.8 -56.55 1.73 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.412 0.625 . . . . 1.26 110.838 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.713 HG23 ' N ' ' A' ' 50' ' ' TYR . 31.2 m -47.19 -54.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.465 -0.772 . . . . 1.0600000000000001 109.035 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.713 ' N ' HG23 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -58.34 -52.64 64.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 4.0199999999999996 109.634 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.648 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 2.5 t30 -53.21 -52.74 57.9 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.605 -1.257 . . . . 1.3400000000000001 107.605 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.5 p -59.44 -33.29 71.09 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.242 -1.022 . . . . 1.04 108.242 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.416 HD22 HG11 ' A' ' 23' ' ' VAL . 7.3 tp -78.98 -25.13 43.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.111 -0.993 . . . . 0.44 108.9 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.02 -45.19 20.69 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.216 -2.142 . . . . 1.0 105.216 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.418 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 9.9 t70 -56.53 -7.9 0.47 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.817 -1.179 . . . . 1.5800000000000001 107.817 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 54' ' ' LYS . 6.9 tpt180 -72.03 -48.74 42.39 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.589 0.709 . . . . 1.6899999999999999 109.834 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.0 tp -153.73 -24.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.203 -0.999 . . . . 1.6599999999999999 110.994 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.37 -48.94 0.07 OUTLIER Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.77 -1.205 . . . . 0.39000000000000001 110.181 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -72.3 -41.9 66.08 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.395 -1.062 . . . . 1.3799999999999999 109.548 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.598 ' H ' HD23 ' A' ' 57' ' ' LEU . . . -92.65 28.96 8.34 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 108.844 -1.703 . . . . 0.26000000000000001 108.844 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.2 t -154.58 130.21 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.541 -1.281 . . . . 0.38 107.541 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.733 ' O ' HD23 ' A' ' 85' ' ' LEU . 1.7 mm100 -136.98 158.44 44.46 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.349 1.071 . . . . 1.3100000000000001 111.926 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.563 HD11 HG21 ' A' ' 66' ' ' VAL . 7.4 tt -94.73 114.6 26.54 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.495 -0.928 . . . . 0.48999999999999999 108.495 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -22.11 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.166 -0.959 . . . . 1.3500000000000001 109.712 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -173.57 157.02 3.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.549 -1.344 . . . . 1.2 109.835 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.563 HG21 HD11 ' A' ' 63' ' ' LEU . 58.0 t -159.78 130.94 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.703 -0.851 . . . . 0.84999999999999998 108.703 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -142.0 157.63 44.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.131 0.967 . . . . 1.4099999999999999 110.16 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.596 ' HB ' HG13 ' B' ' 47' ' ' VAL . 1.3 p -132.6 147.37 52.34 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.293 -1.002 . . . . 0.52000000000000002 108.293 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.631 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -175.27 154.34 17.73 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.414 -2.675 . . . . 0.40000000000000002 106.414 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.526 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 52.7 p -103.78 169.21 8.65 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 119.085 1.442 . . . . 0.41999999999999998 110.128 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.24 164.88 34.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 1.29 109.525 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.75 91.65 3.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.638 -0.825 . . . . 1.02 109.874 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 47.0 ttt-85 -95.02 112.06 23.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.991 -1.068 . . . . 2.23 110.048 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.1 t70 77.73 39.75 0.17 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.454 -0.573 . . . . 1.3799999999999999 109.454 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.426 ' CG ' HH11 ' A' ' 75' ' ' ARG . 0.0 OUTLIER 60.86 29.43 19.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.462 -0.774 . . . . 2.6200000000000001 108.954 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.66 144.99 30.74 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.026 -1.047 . . . . 3.1499999999999999 108.671 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -84.35 126.54 33.31 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.94 1.353 . . . . 2.4399999999999999 111.428 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 tt -136.4 147.53 27.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 106.943 -1.503 . . . . 0.23000000000000001 106.943 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.71 159.59 17.73 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.077 -1.014 . . . . 0.73999999999999999 110.938 -176.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.631 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 6.4 p90 -145.91 153.32 40.71 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.869 0.842 . . . . 4.1600000000000001 110.608 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 81' ' ' ILE . 10.4 tt -125.14 132.63 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.623 0.725 . . . . 0.92000000000000004 109.822 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.39 121.63 44.97 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.092 -1.448 . . . . 0.35999999999999999 107.092 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.65 123.86 34.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.206 -0.934 . . . . 0.97999999999999998 111.072 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -97.7 169.68 9.52 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.437 0.637 . . . . 0.57999999999999996 110.11 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 62' ' ' GLN . 2.8 mt -159.68 140.04 11.99 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.362 -0.935 . . . . 1.3899999999999999 110.349 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 62' ' ' GLN . 2.2 tmtp? -122.9 145.64 48.28 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.941 -0.475 . . . . 1.4199999999999999 109.92 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.548 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 14.7 mmt85 -103.85 138.66 40.12 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.186 -0.946 . . . . 1.6399999999999999 109.863 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.78 -6.84 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.718 -0.845 . . . . 0.63 108.718 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 CA-C-O 118.058 -0.972 . . . . 1.76 109.573 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.822 ' ND2' HD13 ' B' ' 26' ' ' LEU . 32.9 t-20 . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 121.264 0.554 . . . . 1.46 110.451 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.8 pt-20 -93.62 120.96 34.54 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.144 -0.973 . . . . 1.49 108.944 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.419 HD13 HG21 ' B' ' 8' ' ' ILE . 7.8 mt -123.58 146.0 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.971 0.891 . . . . 1.1699999999999999 111.217 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.453 HG13 ' O ' ' B' ' 9' ' ' VAL . 9.8 p -105.45 129.38 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.147 -0.686 . . . . 1.3700000000000001 109.147 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -89.45 166.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.526 -0.87 . . . . 0.37 108.749 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -141.18 175.78 9.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.431 -0.793 . . . . 2.3700000000000001 109.996 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.433 ' C ' ' CD ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -112.96 -4.82 13.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.074 -1.084 . . . . 1.75 108.074 179.039 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 13' ' ' THR . . . . . 0.419 ' H ' HG22 ' B' ' 13' ' ' THR . 0.0 OUTLIER -85.68 -18.06 34.24 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.718 -0.845 . . . . 1.1899999999999999 108.718 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -92.97 -115.91 0.09 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.443 -0.947 . . . . 1.47 108.443 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.21 166.06 12.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.389 -0.82 . . . . 1.22 108.967 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.436 ' H ' HG22 ' B' ' 16' ' ' VAL . 5.0 m -66.88 -35.12 73.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.043 0.925 . . . . 0.45000000000000001 108.823 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 16.0 pt-20 -73.59 -37.97 65.28 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.03 -1.044 . . . . 1.7 108.8 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.41 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 0.3 OUTLIER -54.41 -36.66 64.22 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.653 -1.28 . . . . 1.46 111.772 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.711 ' O ' HG23 ' B' ' 23' ' ' VAL . 90.3 m-70 -91.39 -18.64 23.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.271 -1.518 . . . . 1.3999999999999999 109.105 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -36.61 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 105.158 -2.164 . . . . 0.34000000000000002 105.158 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.823 ' O ' HG23 ' B' ' 25' ' ' VAL . 69.2 mt -67.15 -52.16 44.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.377 -0.829 . . . . 0.38 108.983 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.89 -28.39 68.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -0.969 . . . . 1.21 109.844 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 19' ' ' HIS . 18.4 t -69.4 -53.55 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.29999999999999999 108.951 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 tt -64.14 -18.92 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.197 -0.939 . . . . 0.68999999999999995 109.116 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.823 HG23 ' O ' ' B' ' 21' ' ' LEU . 63.4 t -75.58 -46.68 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.41999999999999998 109.244 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.822 HD13 ' ND2' ' B' ' 6' ' ' ASN . 12.7 mt -65.33 -33.45 76.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.796 -1.19 . . . . 1.1499999999999999 110.073 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.517 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 4.9 t80 -64.92 -28.23 69.39 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.926 -1.509 . . . . 1.46 106.926 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -29.24 68.38 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.321 -0.854 . . . . 1.1699999999999999 109.116 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -88.19 -0.59 57.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 1.1699999999999999 109.466 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.07 12.14 26.34 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.588 -1.005 . . . . 0.38 110.588 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 33.6 mm -75.18 107.35 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.951 -1.323 . . . . 0.58999999999999997 107.863 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -91.48 -41.33 10.9 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.317 -0.865 . . . . 1.46 110.518 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -97.17 143.72 27.7 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.569 0.7 . . . . 1.2 110.217 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -153.16 136.94 8.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 119.006 -1.078 . . . . 0.48999999999999999 111.111 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.4 128.58 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 115.958 -0.565 . . . . 0.31 110.048 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.42 124.66 52.15 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.555 -0.716 . . . . 0.47999999999999998 110.114 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -107.74 130.57 54.94 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.775 -0.578 . . . . 2.7400000000000002 109.449 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.12 153.51 23.4 Favored Glycine 0 N--CA 1.502 3.06 0 C-N-CA 119.502 -1.333 . . . . 0.23999999999999999 111.02 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.657 ' O ' ' N ' ' B' ' 41' ' ' ARG . 62.2 p -133.93 141.42 47.31 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.964 -0.727 . . . . 0.48999999999999999 112.558 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.685 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 34.98 -78.98 0.0 OUTLIER Glycine 0 N--CA 1.504 3.191 0 N-CA-C 111.873 -0.491 . . . . 0.28000000000000003 111.873 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.657 ' N ' ' O ' ' B' ' 39' ' ' THR . 1.4 mtp85 -83.3 -55.92 4.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.002 -1.293 . . . . 3.1600000000000001 109.374 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.5 OUTLIER -63.13 -16.41 59.96 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.995 -1.066 . . . . 1.3799999999999999 109.841 -178.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.685 HG22 ' O ' ' B' ' 40' ' ' GLY . 9.6 tt -59.69 -25.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.165 -0.959 . . . . 0.84999999999999998 109.664 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.08 -25.86 27.3 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.89 -1.152 . . . . 1.1200000000000001 107.89 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 47' ' ' VAL . 24.3 mmtp -63.32 -71.33 0.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.597 -1.631 . . . . 1.8700000000000001 106.597 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -24.53 -43.29 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.375 0.607 . . . . 0.26000000000000001 111.271 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.596 HG13 ' HB ' ' A' ' 68' ' ' THR . 94.5 t -77.54 -60.32 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.168 -0.958 . . . . 0.28000000000000003 110.361 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ASP . . . . . 0.417 ' O ' ' OG ' ' B' ' 52' ' ' SER . 1.9 t0 -46.37 -62.63 1.27 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.046 -1.034 . . . . 1.25 109.456 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.674 HG23 ' N ' ' B' ' 50' ' ' TYR . 33.3 m -42.84 -51.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.824 -0.806 . . . . 1.0600000000000001 108.824 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.674 ' N ' HG23 ' B' ' 49' ' ' VAL . 0.1 OUTLIER -62.31 -50.53 71.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 4.1100000000000003 109.744 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ASN . . . . . 0.619 ' N ' ' CD1' ' B' ' 50' ' ' TYR . 1.3 t30 -54.57 -54.53 40.03 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.729 -1.188 . . . . 1.4099999999999999 107.896 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.1 OUTLIER -59.01 -37.81 77.78 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.57 -0.852 . . . . 0.65000000000000002 108.832 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.408 HD22 HG11 ' B' ' 23' ' ' VAL . 10.1 tp -67.1 -23.48 65.84 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.128 -0.982 . . . . 0.53000000000000003 108.379 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -39.38 50.12 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.769 -1.197 . . . . 0.98999999999999999 107.769 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.94 -12.72 2.15 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.384 -0.826 . . . . 1.46 109.227 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -73.58 -43.48 59.66 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.035 -1.066 . . . . 1.71 109.39 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.9 tp -154.61 -23.59 0.12 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.368 -1.333 . . . . 1.77 112.209 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 65.15 -58.78 0.09 OUTLIER Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.224 -1.465 . . . . 0.39000000000000001 109.551 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.95 -42.59 73.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -1.1 . . . . 1.3999999999999999 109.773 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.475 ' H ' HD23 ' B' ' 57' ' ' LEU . . . -84.42 25.42 5.66 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.896 -1.682 . . . . 0.34000000000000002 108.896 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' B' ' 58' ' ' GLY . 73.5 t -154.65 131.65 2.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.318 -1.364 . . . . 0.46000000000000002 107.318 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.694 ' O ' HD23 ' B' ' 85' ' ' LEU . 1.1 mm100 -135.28 153.07 52.02 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.148 0.975 . . . . 1.4199999999999999 112.273 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.585 HD11 HG21 ' B' ' 66' ' ' VAL . 7.4 tt -94.0 113.17 25.11 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.783 -1.191 . . . . 0.54000000000000004 107.783 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -16.43 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.205 -0.935 . . . . 1.4299999999999999 110.302 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.52 ' O ' HG23 ' B' ' 66' ' ' VAL . 0.9 OUTLIER -176.35 156.69 1.62 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.642 -1.286 . . . . 1.28 110.209 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.585 HG21 HD11 ' B' ' 63' ' ' LEU . 54.1 t -160.42 131.87 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.936 -0.764 . . . . 0.90000000000000002 108.936 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' GLN . . . . . 0.501 ' HB3' HD12 ' B' ' 82' ' ' LEU . 20.1 tt0 -142.48 160.23 40.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.947 0.879 . . . . 1.4399999999999999 110.14 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.693 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -136.26 152.24 50.52 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.249 -1.019 . . . . 0.45000000000000001 108.249 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.638 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -175.03 154.16 17.52 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.391 -2.284 . . . . 0.28999999999999998 107.391 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.593 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 25.2 p -98.61 161.97 13.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.161 -1.199 . . . . 0.39000000000000001 109.343 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -146.05 159.19 43.61 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.035 -1.04 . . . . 1.49 109.95 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.38 90.6 3.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.325 -0.95 . . . . 0.87 109.55 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 53.8 ttt-85 -97.02 112.03 23.98 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.107 -0.996 . . . . 2.1800000000000002 109.846 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.2 t70 78.21 39.13 0.16 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.152 -0.685 . . . . 1.3500000000000001 109.152 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.27 26.79 16.05 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.288 -0.634 . . . . 2.5699999999999998 109.288 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -146.04 148.39 32.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.048 -1.032 . . . . 3.1400000000000001 108.509 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -87.02 134.62 33.47 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.913 1.339 . . . . 2.3900000000000001 112.508 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -137.76 150.18 25.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.291 -1.322 . . . . 0.57999999999999996 107.542 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.25 148.99 24.88 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.165 -0.96 . . . . 0.60999999999999999 109.531 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.638 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.5 p90 -140.38 149.64 42.93 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.654 0.74 . . . . 4.0800000000000001 110.598 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.52 HG23 ' O ' ' B' ' 81' ' ' ILE . 10.2 tt -124.62 130.82 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 122.094 0.949 . . . . 0.90000000000000002 110.463 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' B' ' 67' ' ' GLN . 12.0 mt -104.2 119.06 38.13 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.288 -1.745 . . . . 0.37 106.288 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 tt -127.98 121.67 30.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.97999999999999998 110.824 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -96.5 168.69 10.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.664 0.745 . . . . 0.70999999999999996 110.222 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.694 HD23 ' O ' ' B' ' 62' ' ' GLN . 2.9 mt -159.78 136.78 9.41 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.891 -0.723 . . . . 1.4399999999999999 110.06 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' B' ' 62' ' ' GLN . 2.0 tmtp? -121.86 146.75 46.79 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.233 -0.655 . . . . 1.3100000000000001 109.233 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ARG . . . . . 0.517 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 15.5 mmt85 -102.15 141.8 34.42 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.277 -0.89 . . . . 1.6399999999999999 110.465 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.23 -12.33 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.881 -0.785 . . . . 0.68000000000000005 108.881 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 118.028 -0.987 . . . . 1.77 109.558 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.45 ' OD1' HD13 ' A' ' 26' ' ' LEU . 5.5 t-20 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.436 0.636 . . . . 1.72 110.441 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 6.8 pt-20 -93.03 117.6 30.24 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.271 -0.893 . . . . 1.4399999999999999 108.769 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 35' ' ' ILE . 20.6 mt -119.04 142.29 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-O 121.709 0.766 . . . . 1.1100000000000001 111.598 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.556 HG22 ' CG ' ' A' ' 37' ' ' LYS . 87.8 t -109.02 128.74 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.765 0.793 . . . . 1.3500000000000001 110.282 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.513 HG11 ' H ' ' A' ' 46' ' ' ALA . 2.2 p -89.25 164.11 2.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.612 -0.885 . . . . 0.39000000000000001 108.612 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.437 ' HE ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -138.76 173.57 11.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.559 -0.713 . . . . 2.27 109.758 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 pttt -92.85 -9.06 41.68 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.878 -0.786 . . . . 1.78 108.878 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -91.28 -0.27 57.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.204 -1.035 . . . . 1.24 108.204 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.527 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -118.28 134.14 55.29 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.462 -1.31 . . . . 1.4099999999999999 107.462 178.431 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -69.87 175.69 4.18 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.845 -1.159 . . . . 1.25 109.773 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.57 -31.86 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.355 -0.98 . . . . 0.48999999999999999 108.355 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -74.75 -31.12 61.7 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.585 -0.846 . . . . 1.5600000000000001 108.95 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -33.88 70.01 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.644 -1.285 . . . . 1.3799999999999999 111.319 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.696 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.1 m80 -95.74 -19.34 19.74 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.448 -1.407 . . . . 1.4299999999999999 108.487 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -36.84 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 104.523 -2.399 . . . . 0.28999999999999998 104.523 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 mt -68.18 -51.27 47.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.708 -1.133 . . . . 0.40999999999999998 109.009 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -67.27 -31.77 72.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.17 -0.956 . . . . 1.22 109.442 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 19' ' ' HIS . 32.5 t -68.55 -52.59 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -0.811 . . . . 0.32000000000000001 108.964 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 tt -61.31 -22.43 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.166 -0.959 . . . . 0.57999999999999996 109.017 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.64 -41.67 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.165 -0.959 . . . . 0.40999999999999998 109.265 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.45 HD13 ' OD1' ' A' ' 6' ' ' ASN . 4.2 mt -67.83 -37.3 81.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.874 -1.142 . . . . 1.1899999999999999 110.025 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 18.6 t80 -61.1 -28.26 68.96 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.994 -1.484 . . . . 1.46 106.994 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.62 -25.68 66.46 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.42 -0.809 . . . . 1.1499999999999999 109.02 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -89.88 -9.36 49.25 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.509 -0.923 . . . . 1.1699999999999999 108.509 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.47 14.07 10.01 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.193 -1.163 . . . . 0.41999999999999998 110.193 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -75.66 107.58 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.26 . . . . 0.34999999999999998 108.688 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.05 -37.66 12.66 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.418 -0.801 . . . . 1.55 109.97 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -96.89 139.92 32.21 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.401 0.62 . . . . 1.5800000000000001 109.614 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.39 136.66 12.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 119.279 -0.968 . . . . 0.54000000000000004 110.086 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -116.1 124.75 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.229 0.537 . . . . 0.25 110.682 -178.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.731 HD21 HG11 ' A' ' 49' ' ' VAL . 5.6 mp -104.38 116.65 32.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.971 -0.456 . . . . 0.40000000000000002 109.802 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.556 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -102.56 127.29 49.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.397 -0.964 . . . . 2.7400000000000002 108.397 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.423 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -142.66 157.66 26.79 Favored Glycine 0 N--CA 1.508 3.44 0 O-C-N 121.093 -1.005 . . . . 0.20999999999999999 111.636 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.67 ' CG2' ' CD2' ' A' ' 80' ' ' TYR . 7.2 p -141.58 147.7 38.09 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.434 -1.039 . . . . 0.56000000000000005 112.84 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.566 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 38.67 -87.28 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.617 -0.993 . . . . 0.33000000000000002 110.617 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' THR . 2.9 mtp180 -82.68 -51.78 7.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.348 -1.089 . . . . 3.0899999999999999 109.506 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.56 -21.47 62.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.222 -0.924 . . . . 1.0900000000000001 109.028 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 40' ' ' GLY . 6.5 tt -53.83 -33.81 24.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.579 -0.7 . . . . 0.87 110.756 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.492 ' HG ' ' HG ' ' B' ' 79' ' ' SER . 0.0 OUTLIER -83.09 -23.45 33.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 1.1399999999999999 108.91 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.537 ' O ' HG23 ' A' ' 49' ' ' VAL . 21.1 mmtp -65.18 -69.22 0.31 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.682 -1.97 . . . . 1.8600000000000001 105.682 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.69 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -34.31 -46.43 0.26 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.216 0.532 . . . . 0.28999999999999998 110.484 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' B' ' 68' ' ' THR . 56.7 t -63.53 -66.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.076 -1.015 . . . . 0.22 109.694 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 52' ' ' SER . 13.1 t0 -44.76 -44.85 9.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.561 -0.712 . . . . 1.26 109.199 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.731 HG11 HD21 ' A' ' 36' ' ' LEU . 60.5 t -50.11 -55.19 6.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.704 -0.798 . . . . 1.0600000000000001 108.936 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.635 ' CD2' ' N ' ' A' ' 51' ' ' ASN . 1.1 t80 -58.5 -60.49 3.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.064 -1.022 . . . . 4.0199999999999996 110.607 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.635 ' N ' ' CD2' ' A' ' 50' ' ' TYR . 9.2 t-20 -49.11 -52.61 25.0 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.985 -1.117 . . . . 1.3400000000000001 107.985 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 48' ' ' ASP . 2.8 m -62.18 -39.02 91.29 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.847 -0.798 . . . . 1.04 108.847 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.786 HD23 HD13 ' A' ' 85' ' ' LEU . 12.5 tp -72.94 -24.06 60.76 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.067 -1.021 . . . . 0.44 108.884 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' TYR . 4.1 tmtt? -81.34 -39.86 24.45 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.18 -1.575 . . . . 1.0 107.227 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -52.68 -14.56 0.54 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.857 -1.164 . . . . 1.5800000000000001 107.857 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.483 ' N ' ' C ' ' A' ' 54' ' ' LYS . 11.5 mmm180 -56.15 -53.51 56.21 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.035 -0.666 . . . . 1.6899999999999999 109.972 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.5 tp -161.83 -3.95 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 118.93 -1.108 . . . . 1.6599999999999999 109.917 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.53 -50.94 0.1 OUTLIER Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.705 -1.236 . . . . 0.39000000000000001 110.392 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -71.91 -41.52 67.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.255 -1.144 . . . . 1.3799999999999999 110.521 -178.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 61' ' ' VAL . . . -87.97 25.31 8.92 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.773 -1.331 . . . . 0.26000000000000001 109.773 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' GLY . 43.8 t -155.27 133.6 2.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.944 -1.327 . . . . 0.38 108.29 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.741 ' O ' HD23 ' A' ' 85' ' ' LEU . 11.4 mm100 -140.06 156.83 46.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.406 1.098 . . . . 1.3100000000000001 111.966 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.51 HD11 HG21 ' A' ' 66' ' ' VAL . 6.6 tt -97.08 118.45 33.53 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.044 -0.98 . . . . 0.48999999999999999 108.537 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.528 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -108.35 -17.13 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.813 -0.755 . . . . 1.3500000000000001 110.37 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 64' ' ' VAL . 0.2 OUTLIER -175.5 153.42 1.48 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.411 -1.431 . . . . 1.2 110.154 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.51 HG21 HD11 ' A' ' 63' ' ' LEU . 94.2 t -159.5 133.78 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.464 -0.939 . . . . 0.84999999999999998 108.464 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' LEU . 19.7 tt0 -144.11 163.05 34.7 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.265 1.031 . . . . 1.4099999999999999 110.6 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.629 ' HB ' HG13 ' B' ' 47' ' ' VAL . 1.3 p -136.51 157.18 47.39 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.751 -0.833 . . . . 0.52000000000000002 108.751 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.01 145.15 7.73 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 107.682 -2.167 . . . . 0.40000000000000002 107.682 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.602 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 97.3 p -94.99 160.09 14.73 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.893 -1.357 . . . . 0.41999999999999998 109.356 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.12 176.63 11.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.823 -1.151 . . . . 1.29 111.118 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.451 ' H ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -90.24 131.4 37.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.503 0.668 . . . . 1.02 109.865 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 3.6 ttt85 -148.74 103.05 3.35 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.692 -0.855 . . . . 2.23 108.692 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.7 t0 87.19 36.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.062 0.458 . . . . 1.3799999999999999 110.117 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 65.6 33.55 8.43 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.083 0.944 . . . . 2.6200000000000001 109.363 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -158.3 155.24 28.47 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.234 -0.916 . . . . 3.1499999999999999 109.723 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -86.05 137.99 32.29 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.893 -1.123 . . . . 2.4399999999999999 109.982 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.481 HG21 ' CB ' ' A' ' 73' ' ' ARG . 5.5 tt -142.3 156.96 19.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-N 115.236 -0.893 . . . . 0.23000000000000001 109.489 -178.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.05 151.6 23.1 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.958 0.885 . . . . 0.73999999999999999 110.015 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.67 ' CD2' ' CG2' ' A' ' 39' ' ' THR . 0.4 OUTLIER -135.62 137.19 41.66 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.123 -1.066 . . . . 4.1600000000000001 108.123 -178.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 81' ' ' ILE . 5.1 tt -116.68 130.38 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.542 -0.91 . . . . 0.92000000000000004 108.542 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 67' ' ' GLN . 52.9 mt -110.22 120.54 42.78 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.145 -1.428 . . . . 0.35999999999999999 107.145 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -127.46 128.27 45.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.161 -0.962 . . . . 0.97999999999999998 111.051 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -101.23 171.4 7.63 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.948 -0.569 . . . . 0.57999999999999996 109.548 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.786 HD13 HD23 ' A' ' 53' ' ' LEU . 2.2 mt -162.54 141.96 9.26 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.548 -0.861 . . . . 1.3899999999999999 109.859 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -126.63 149.19 49.63 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.103 0.477 . . . . 1.4199999999999999 110.593 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.459 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 17.9 mmt85 -108.06 139.99 41.89 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.627 -0.671 . . . . 1.6399999999999999 110.185 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.457 ' O ' ' CG1' ' A' ' 88' ' ' VAL . 4.3 t -115.01 -6.0 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.382 -0.969 . . . . 0.63 108.382 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.48 0 CA-C-O 117.967 -1.016 . . . . 1.76 109.497 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.24 0.543 . . . . 1.46 112.251 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 5.8 pt-20 -93.03 111.93 23.72 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.204 -1.406 . . . . 1.49 107.204 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 18.7 mt -114.12 139.29 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.607 -0.683 . . . . 1.1699999999999999 109.851 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 82.9 t -102.69 126.02 56.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.704 -0.623 . . . . 1.3700000000000001 109.579 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.32 163.91 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.914 -1.143 . . . . 0.37 107.914 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.2 173.98 10.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.314 -0.866 . . . . 2.3700000000000001 109.899 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.526 ' N ' ' OE1' ' B' ' 42' ' ' GLU . 7.6 pttt -96.65 -9.21 29.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.951 -0.759 . . . . 1.75 108.951 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -89.72 -4.78 57.54 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.649 -0.871 . . . . 1.1899999999999999 108.649 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -99.34 -131.0 0.22 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.694 -1.224 . . . . 1.47 107.694 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -166.77 163.83 16.5 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.544 -0.91 . . . . 1.22 108.544 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -63.39 -37.41 79.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.179 -1.045 . . . . 0.45000000000000001 108.179 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 6.8 pt-20 -76.24 -38.03 56.9 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.75 -0.78 . . . . 1.7 109.035 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.436 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 10.4 t70 -59.41 -31.59 69.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.721 -1.237 . . . . 1.46 111.598 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.667 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.3 OUTLIER -93.41 -16.44 24.58 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.173 -1.58 . . . . 1.3999999999999999 108.222 178.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.06 -34.78 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 104.784 -2.302 . . . . 0.34000000000000002 104.784 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.465 ' O ' HG23 ' B' ' 25' ' ' VAL . 57.5 mt -68.81 -52.31 31.45 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.972 -1.013 . . . . 0.38 109.191 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -66.49 -29.83 70.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.19 -0.944 . . . . 1.21 109.499 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.667 HG23 ' O ' ' B' ' 19' ' ' HIS . 24.3 t -70.06 -53.39 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.845 . . . . 0.29999999999999999 109.202 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 tt -62.41 -20.47 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.076 -1.015 . . . . 0.68999999999999995 108.944 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 21' ' ' LEU . 6.2 t -72.1 -42.55 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.233 -0.917 . . . . 0.41999999999999998 109.035 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mt -67.01 -36.31 81.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.97 -1.081 . . . . 1.1499999999999999 109.569 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.511 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 23.3 t80 -61.16 -28.23 68.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.436 -1.32 . . . . 1.46 107.436 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -26.17 67.64 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.64 -0.709 . . . . 1.1699999999999999 109.195 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -90.42 -1.98 57.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.173 -0.954 . . . . 1.1699999999999999 109.455 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.88 12.28 24.53 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.912 -1.275 . . . . 0.38 109.912 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 mm -76.78 106.12 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.024 -1.28 . . . . 0.58999999999999997 108.545 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.85 -38.6 12.23 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.22 -0.925 . . . . 1.46 110.821 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -98.59 142.58 29.99 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.57 0.7 . . . . 1.2 110.24 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.41 137.11 11.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 119.221 -0.992 . . . . 0.48999999999999999 110.802 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.61 125.63 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-N 116.089 -0.505 . . . . 0.31 110.344 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' B' ' 46' ' ' ALA . 3.7 mp -105.36 120.21 41.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.67 -0.644 . . . . 0.47999999999999998 110.696 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.43 124.36 46.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.612 -0.68 . . . . 2.7400000000000002 109.168 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.437 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -138.64 153.83 22.78 Favored Glycine 0 N--CA 1.51 3.592 0 O-C-N 121.041 -1.037 . . . . 0.23999999999999999 111.567 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.626 ' O ' ' N ' ' B' ' 41' ' ' ARG . 3.8 p -138.38 143.9 40.03 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.551 -0.97 . . . . 0.48999999999999999 112.794 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.516 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 36.26 -83.17 0.0 OUTLIER Glycine 0 N--CA 1.499 2.863 0 N-CA-C 111.15 -0.78 . . . . 0.28000000000000003 111.15 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.626 ' N ' ' O ' ' B' ' 39' ' ' THR . 5.2 mtp180 -82.03 -53.19 6.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.201 -1.176 . . . . 3.1600000000000001 110.072 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' B' ' 12' ' ' LYS . 1.3 pm0 -64.27 -18.39 64.52 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.55 -1.344 . . . . 1.3799999999999999 109.223 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.516 HG22 ' O ' ' B' ' 40' ' ' GLY . 5.6 tt -54.4 -30.86 21.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.073 -1.017 . . . . 0.84999999999999998 109.84 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -24.92 32.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 1.1200000000000001 108.948 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.48 ' O ' HG23 ' B' ' 49' ' ' VAL . 17.1 mmtp -65.86 -68.59 0.36 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.621 -1.992 . . . . 1.8700000000000001 105.621 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.656 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -33.21 -50.64 0.31 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 116.163 -0.472 . . . . 0.26000000000000001 111.281 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.629 HG13 ' HB ' ' A' ' 68' ' ' THR . 77.8 t -65.01 -59.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.768 -1.208 . . . . 0.28000000000000003 109.68 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 21.3 t0 -48.51 -47.61 38.81 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.193 -0.942 . . . . 1.25 108.666 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.573 HG11 HD21 ' B' ' 36' ' ' LEU . 88.8 t -48.61 -53.6 6.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.776 -0.769 . . . . 1.0600000000000001 109.038 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.614 ' CD2' ' N ' ' B' ' 51' ' ' ASN . 0.9 OUTLIER -59.67 -56.58 20.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.244 -0.91 . . . . 4.1100000000000003 111.304 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ASN . . . . . 0.614 ' N ' ' CD2' ' B' ' 50' ' ' TYR . 3.4 t30 -54.76 -48.51 72.55 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.759 -1.2 . . . . 1.4099999999999999 107.759 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 1.5 m -63.37 -39.58 94.9 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.534 -0.866 . . . . 0.65000000000000002 108.92 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.806 HD23 HD13 ' B' ' 85' ' ' LEU . 10.0 tp -74.86 -26.32 59.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.53000000000000003 109.04 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' B' ' 56' ' ' ARG . 5.1 tmtt? -80.28 -46.1 16.77 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.069 -1.645 . . . . 0.98999999999999999 106.859 177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -49.98 -11.84 0.07 Allowed 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.353 -1.294 . . . . 1.46 108.284 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' B' ' 54' ' ' LYS . 9.1 mmm180 -54.03 -54.5 38.33 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.827 0.822 . . . . 1.71 110.297 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.0 tp -159.83 -3.78 0.07 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.622 -0.881 . . . . 1.77 108.622 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.425 ' H ' ' H ' ' B' ' 57' ' ' LEU . . . 64.69 -47.96 0.11 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.944 -1.122 . . . . 0.39000000000000001 110.561 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -73.77 -43.69 58.22 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.286 -1.126 . . . . 1.3999999999999999 110.398 -178.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.424 ' O ' HG23 ' B' ' 61' ' ' VAL . . . -84.34 22.87 7.87 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 109.857 -1.297 . . . . 0.34000000000000002 109.857 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' B' ' 54' ' ' LYS . 39.4 t -154.49 135.44 4.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 120.872 -1.37 . . . . 0.46000000000000002 108.455 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.773 ' O ' HD23 ' B' ' 85' ' ' LEU . 1.1 tp-100 -140.19 155.24 47.01 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.342 1.068 . . . . 1.4199999999999999 112.145 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.09 119.1 32.46 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.344 -0.844 . . . . 0.54000000000000004 108.88 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.4 ' O ' ' CG ' ' B' ' 65' ' ' ASN . 0.1 OUTLIER -102.09 -28.27 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.426 -0.796 . . . . 1.4299999999999999 110.972 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.437 ' O ' HG23 ' B' ' 66' ' ' VAL . 19.5 m-20 -173.37 161.28 4.12 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.498 -1.377 . . . . 1.28 109.41 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.437 HG23 ' O ' ' B' ' 65' ' ' ASN . 74.1 t -159.47 132.82 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.636 -0.875 . . . . 0.90000000000000002 108.636 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' GLN . . . . . 0.665 ' HB3' HD12 ' B' ' 82' ' ' LEU . 28.4 tt0 -142.46 161.74 37.27 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.988 0.899 . . . . 1.4399999999999999 109.969 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.706 ' HB ' HG13 ' A' ' 47' ' ' VAL . 1.8 p -136.59 159.25 42.37 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.959 -0.756 . . . . 0.45000000000000001 108.959 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.4 144.19 7.09 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 107.926 -2.07 . . . . 0.28999999999999998 107.926 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.582 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 14.4 p -93.58 160.07 14.94 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.968 -1.313 . . . . 0.39000000000000001 108.39 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.83 175.92 12.04 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.744 -1.182 . . . . 1.49 110.941 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.47 132.28 34.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.85 -0.74 . . . . 0.87 109.283 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.3 ttt-85 -151.73 103.24 2.92 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.556 -0.715 . . . . 2.1800000000000002 109.158 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 3.7 t0 86.91 35.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.102 0.477 . . . . 1.3500000000000001 109.85 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.77 29.02 8.74 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.991 0.901 . . . . 2.5699999999999998 109.451 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -156.74 157.51 35.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.344 -0.848 . . . . 3.1400000000000001 109.601 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -87.51 139.85 30.12 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.987 -1.085 . . . . 2.3900000000000001 110.943 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 tt -142.22 158.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.571 -0.74 . . . . 0.57999999999999996 109.107 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' SER . . . . . 0.492 ' HG ' ' HG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -86.37 149.26 25.15 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.015 0.912 . . . . 0.60999999999999999 110.198 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.615 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.4 OUTLIER -133.95 137.27 44.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.464 -0.939 . . . . 4.0800000000000001 108.464 -179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.554 HG23 ' O ' ' B' ' 81' ' ' ILE . 5.6 tt -118.02 129.6 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.866 -0.79 . . . . 0.90000000000000002 108.866 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' B' ' 67' ' ' GLN . 6.3 mt -106.9 119.27 38.9 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.703 -1.591 . . . . 0.37 106.703 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 3.7 tt -126.76 126.73 43.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.061 -1.024 . . . . 0.97999999999999998 111.08 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -99.48 169.59 9.21 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.342 -0.614 . . . . 0.70999999999999996 109.342 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.806 HD13 HD23 ' B' ' 53' ' ' LEU . 2.1 mt -162.44 137.55 6.97 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.802 -0.759 . . . . 1.4399999999999999 109.395 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -124.97 151.6 45.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.793 -0.567 . . . . 1.3100000000000001 109.492 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ARG . . . . . 0.511 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 19.0 mmt85 -107.5 141.23 39.25 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.469 0.652 . . . . 1.6399999999999999 110.275 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.489 ' O ' HG12 ' B' ' 88' ' ' VAL . 13.7 t -115.18 -6.47 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.251 -1.018 . . . . 0.68000000000000005 108.251 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.022 -0.989 . . . . 1.77 109.528 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.855 ' OD1' HG23 ' A' ' 34' ' ' VAL . 1.8 t-20 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.131 -0.322 . . . . 1.72 110.131 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 112.34 23.6 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.524 -1.36 . . . . 1.4399999999999999 108.166 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.623 ' CG1' HD21 ' A' ' 6' ' ' ASN . 4.8 mm -125.13 148.88 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 122.288 1.042 . . . . 1.1100000000000001 111.79 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.564 HG13 ' HG2' ' A' ' 37' ' ' LYS . 66.7 t -111.94 129.82 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.537 0.684 . . . . 1.3500000000000001 110.485 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.52 HG23 ' ND1' ' A' ' 19' ' ' HIS . 1.3 p -88.2 162.9 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.866 -1.161 . . . . 0.39000000000000001 107.866 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.442 ' HE ' ' HE3' ' A' ' 14' ' ' LYS . 1.9 mtt-85 -131.66 167.2 19.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.344 -0.847 . . . . 2.27 110.136 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.2 pttp -87.93 -16.31 34.2 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.806 -1.183 . . . . 1.78 107.806 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -74.37 -67.5 0.62 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.542 -1.651 . . . . 1.24 106.542 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.538 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.1 mtmm -58.0 143.44 43.21 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.241 -0.912 . . . . 1.4099999999999999 110.113 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -72.27 178.09 4.12 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.48 0.657 . . . . 1.25 110.342 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.511 HG21 ' OD1' ' A' ' 48' ' ' ASP . 3.7 m -72.51 -31.86 39.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.908 0.861 . . . . 0.48999999999999999 108.715 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -73.77 -30.77 62.97 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.454 -0.899 . . . . 1.5600000000000001 109.219 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -30.51 69.63 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 120.445 -1.409 . . . . 1.3799999999999999 110.881 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.681 ' O ' HG23 ' A' ' 23' ' ' VAL . 41.0 m80 -95.33 -19.75 19.71 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.585 -1.322 . . . . 1.4299999999999999 108.236 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.71 -35.63 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 104.896 -2.261 . . . . 0.28999999999999998 104.896 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 25' ' ' VAL . 46.8 mt -69.04 -52.5 27.93 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.823 -1.08 . . . . 0.40999999999999998 108.703 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -66.76 -26.46 66.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 1.22 109.895 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 19' ' ' HIS . 13.9 t -73.62 -53.14 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.256 -0.902 . . . . 0.32000000000000001 108.804 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tt -55.39 -24.57 15.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.503 -0.925 . . . . 0.57999999999999996 108.503 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 21' ' ' LEU . 41.8 t -69.25 -40.81 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.234 -0.987 . . . . 0.40999999999999998 109.443 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.452 HD13 ' ND2' ' A' ' 6' ' ' ASN . 7.1 mt -65.51 -38.03 88.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.524 -1.36 . . . . 1.1899999999999999 109.613 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -28.61 69.68 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.071 -1.455 . . . . 1.46 107.071 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.36 -28.43 59.09 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.29 -0.868 . . . . 1.1499999999999999 108.729 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -90.43 -18.43 25.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 1.1699999999999999 109.222 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.43 17.22 7.21 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.793 -1.323 . . . . 0.41999999999999998 109.793 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mm -74.19 113.99 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.395 -1.062 . . . . 0.34999999999999998 108.793 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -93.38 -34.59 13.41 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 119.71 -0.796 . . . . 1.55 111.366 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 4.1 mt-10 -101.81 135.88 42.6 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.625 0.726 . . . . 1.5800000000000001 111.351 -177.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.855 HG23 ' OD1' ' A' ' 6' ' ' ASN . 3.8 p -149.55 141.92 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.96 -0.696 . . . . 0.54000000000000004 110.297 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -122.35 124.9 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 116.06 -0.518 . . . . 0.25 110.767 -178.016 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.8 mp -106.36 123.08 47.52 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.279 -0.568 . . . . 0.40000000000000002 110.042 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HG2' HG13 ' A' ' 9' ' ' VAL . 15.8 tttt -99.75 125.73 45.69 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.29 -1.004 . . . . 2.7400000000000002 108.29 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.17 142.34 13.58 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.562 -1.304 . . . . 0.20999999999999999 110.827 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 41' ' ' ARG . 54.1 p -126.31 135.72 51.86 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.878 0.846 . . . . 0.56000000000000005 111.908 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' A' ' 78' ' ' ILE . . . 37.97 -87.41 0.01 OUTLIER Glycine 0 N--CA 1.496 2.678 0 O-C-N 121.623 -0.673 . . . . 0.33000000000000002 111.815 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -80.11 -51.77 8.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.041 -1.27 . . . . 3.0899999999999999 109.901 -178.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.66 -19.28 37.85 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.611 -1.305 . . . . 1.0900000000000001 107.59 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' OG ' ' A' ' 79' ' ' SER . 2.2 tt -54.51 -33.66 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.719 -0.613 . . . . 0.87 110.934 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.77 -21.92 32.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.857 -1.152 . . . . 1.1399999999999999 108.615 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.533 ' NZ ' ' O ' ' A' ' 14' ' ' LYS . 22.8 mmtp -66.17 -70.43 0.24 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.368 -1.715 . . . . 1.8600000000000001 106.368 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.649 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -29.46 -51.34 0.11 Allowed 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.439 0.638 . . . . 0.28999999999999998 110.598 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.697 HG13 ' HB ' ' B' ' 68' ' ' THR . 89.8 t -57.86 -68.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.37 -0.831 . . . . 0.22 109.937 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.511 ' OD1' HG21 ' A' ' 16' ' ' VAL . 12.8 t70 -45.54 -48.1 14.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.716 . . . . 1.26 109.584 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.572 HG11 HD21 ' A' ' 36' ' ' LEU . 91.7 t -47.36 -58.56 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.936 -0.764 . . . . 1.0600000000000001 108.936 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -61.84 -54.52 40.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.16 -0.963 . . . . 4.0199999999999996 111.432 -178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.524 ' ND2' ' OG ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -53.74 -48.27 69.82 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.691 -1.256 . . . . 1.3400000000000001 107.804 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.495 ' N ' ' CG ' ' A' ' 51' ' ' ASN . 22.1 p -59.43 -35.88 74.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.839 -1.171 . . . . 1.04 107.839 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.721 HD21 HH12 ' A' ' 87' ' ' ARG . 6.8 tp -79.09 -22.12 45.71 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.095 -1.076 . . . . 0.44 108.095 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.98 -43.96 21.09 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.506 -2.035 . . . . 1.0 105.506 177.512 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -56.05 -9.21 0.57 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.562 -1.273 . . . . 1.5800000000000001 107.562 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.498 ' H ' ' C ' ' A' ' 54' ' ' LYS . 8.8 tpt180 -70.83 -49.34 47.3 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.599 0.714 . . . . 1.6899999999999999 109.559 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.639 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.1 tp -153.86 -15.45 0.14 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.381 -0.928 . . . . 1.6599999999999999 110.794 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 61' ' ' VAL . . . 63.27 -55.62 0.05 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.004 -1.238 . . . . 0.39000000000000001 110.004 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.639 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -73.08 -40.09 65.3 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.633 -0.922 . . . . 1.3799999999999999 109.496 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.522 ' H ' HD23 ' A' ' 57' ' ' LEU . . . -83.34 23.57 6.19 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 108.883 -1.687 . . . . 0.26000000000000001 108.883 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.609 HG13 HD21 ' A' ' 85' ' ' LEU . 2.8 t -155.15 131.71 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.57 -1.27 . . . . 0.38 107.57 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.597 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.7 mm-40 -138.09 157.4 46.4 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.427 1.108 . . . . 1.3100000000000001 111.796 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.637 HD11 HG21 ' A' ' 66' ' ' VAL . 7.5 tt -94.55 116.4 28.73 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.363 -0.835 . . . . 0.48999999999999999 109.504 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -105.34 -20.97 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.323 -0.861 . . . . 1.3500000000000001 109.396 179.315 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.59 148.61 1.98 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.232 -1.387 . . . . 1.2 110.323 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.637 HG21 HD11 ' A' ' 63' ' ' LEU . 94.9 t -157.63 134.09 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.755 -0.831 . . . . 0.84999999999999998 108.755 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.53 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -144.92 159.9 42.17 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.077 0.942 . . . . 1.4099999999999999 110.667 -179.181 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.54 ' HB ' HG13 ' B' ' 47' ' ' VAL . 1.2 p -135.44 151.81 50.77 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.537 -0.912 . . . . 0.52000000000000002 108.537 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.69 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -176.47 157.23 22.6 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 106.512 -2.635 . . . . 0.40000000000000002 106.512 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.534 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 94.4 p -99.38 161.25 13.72 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 119.051 1.426 . . . . 0.41999999999999998 110.396 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -155.77 175.73 13.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.102 -0.999 . . . . 1.29 110.737 178.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.434 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.02 134.59 29.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.72 0.771 . . . . 1.02 110.799 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 25.2 ttt-85 -145.7 101.39 3.55 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.321 -0.992 . . . . 2.23 108.321 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.9 t0 85.96 36.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.224 0.535 . . . . 1.3799999999999999 109.766 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.1 32.36 12.78 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.967 0.889 . . . . 2.6200000000000001 109.304 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -150.57 149.84 30.43 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.66 -0.867 . . . . 3.1499999999999999 108.66 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -85.73 137.38 32.85 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.482 1.134 . . . . 2.4399999999999999 110.077 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.558 HD11 ' HA3' ' A' ' 40' ' ' GLY . 4.7 tt -142.9 156.52 17.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.072 -0.967 . . . . 0.23000000000000001 108.778 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.483 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -87.92 155.82 19.66 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.453 -0.779 . . . . 0.73999999999999999 111.145 -176.399 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.69 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 7.7 p90 -146.47 153.75 40.79 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.774 0.797 . . . . 4.1600000000000001 110.466 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.684 HD11 HG21 ' B' ' 68' ' ' THR . 13.2 tt -125.34 132.49 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.419 0.628 . . . . 0.92000000000000004 109.993 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.53 HD12 ' HB3' ' A' ' 67' ' ' GLN . 12.3 mt -106.86 120.71 42.77 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.763 -1.569 . . . . 0.35999999999999999 106.763 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 tt -128.99 124.84 36.02 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.313 -0.955 . . . . 0.97999999999999998 110.582 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -101.4 172.0 7.25 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.663 -0.699 . . . . 0.57999999999999996 109.465 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.609 HD21 HG13 ' A' ' 61' ' ' VAL . 1.6 tp -159.42 143.03 14.68 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 118.978 -1.089 . . . . 1.3899999999999999 111.135 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -118.72 142.45 47.66 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.768 -0.827 . . . . 1.4199999999999999 108.768 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.721 HH12 HD21 ' A' ' 53' ' ' LEU . 16.2 tpp180 -104.16 138.81 40.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.326 -0.858 . . . . 1.6399999999999999 109.726 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.85 -7.18 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.052 -0.721 . . . . 0.63 109.052 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 117.978 -1.01 . . . . 1.76 109.587 179.422 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.457 ' OD1' ' CD1' ' B' ' 26' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 111.841 0.311 . . . . 1.46 111.841 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.75 107.52 19.23 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.018 -1.676 . . . . 1.49 107.147 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.437 ' CG1' ' OD1' ' B' ' 6' ' ' ASN . 43.1 mm -122.13 141.75 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 122.06 0.933 . . . . 1.1699999999999999 110.215 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.634 HG13 ' HG2' ' B' ' 37' ' ' LYS . 59.0 t -101.26 129.05 52.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.778 -0.647 . . . . 1.3700000000000001 109.476 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.9 164.27 2.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.613 -1.254 . . . . 0.37 107.613 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.479 ' HE ' ' CE ' ' B' ' 14' ' ' LYS . 11.6 mtt-85 -138.21 174.55 10.44 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.844 0.831 . . . . 2.3700000000000001 110.149 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -103.56 -8.56 19.95 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.014 -1.106 . . . . 1.75 108.014 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' THR . . . . . 0.417 ' H ' HG23 ' B' ' 13' ' ' THR . 0.3 OUTLIER -86.43 -14.9 41.92 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.741 -0.784 . . . . 1.1899999999999999 109.616 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.479 ' CE ' ' HE ' ' B' ' 11' ' ' ARG . 0.5 OUTLIER -97.81 -118.79 0.13 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.409 -0.96 . . . . 1.47 108.409 178.393 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.77 170.24 9.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.1 -1.0 . . . . 1.22 108.656 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.89 -32.85 45.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.187 -1.042 . . . . 0.45000000000000001 108.187 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.455 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 7.3 pt-20 -77.1 -40.42 45.99 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.792 -0.763 . . . . 1.7 109.098 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.455 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 66.4 t0 -58.45 -31.87 68.18 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.605 -1.31 . . . . 1.46 110.975 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.691 ' O ' HG23 ' B' ' 23' ' ' VAL . 17.2 m80 -91.21 -16.89 26.92 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.137 -1.602 . . . . 1.3999999999999999 108.546 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.22 -34.88 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.322 -2.103 . . . . 0.34000000000000002 105.322 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.526 ' O ' HG23 ' B' ' 25' ' ' VAL . 72.4 mt -67.97 -52.97 29.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.144 -0.935 . . . . 0.38 108.949 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.04 -25.88 68.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.3 -0.875 . . . . 1.21 109.755 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.691 HG23 ' O ' ' B' ' 19' ' ' HIS . 20.1 t -74.57 -52.96 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.422 -0.798 . . . . 0.29999999999999999 109.282 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 tt -57.04 -24.83 21.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.562 -0.903 . . . . 0.68999999999999995 108.562 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 21' ' ' LEU . 40.8 t -67.32 -41.78 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.323 -0.861 . . . . 0.41999999999999998 109.248 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.457 ' CD1' ' OD1' ' B' ' 6' ' ' ASN . 4.5 mt -65.15 -39.63 93.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.681 -1.262 . . . . 1.1499999999999999 109.342 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -32.02 69.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.215 -1.402 . . . . 1.46 107.215 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -30.8 54.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.769 -0.826 . . . . 1.1699999999999999 108.769 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -89.54 -6.36 56.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 1.1699999999999999 109.926 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.39 16.47 24.76 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.556 -1.418 . . . . 0.38 109.556 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.9 113.88 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.814 -1.18 . . . . 0.58999999999999997 107.814 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -98.35 -40.4 8.33 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.37 -0.832 . . . . 1.46 112.211 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -96.11 137.59 34.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 1.2 111.307 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' B' ' 6' ' ' ASN . 5.8 p -152.52 141.17 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.985 -1.086 . . . . 0.48999999999999999 111.57 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.55 128.32 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 115.589 -0.732 . . . . 0.31 110.605 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.632 HD23 ' HA ' ' B' ' 46' ' ' ALA . 1.7 mp -108.91 122.56 47.47 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.471 -0.768 . . . . 0.47999999999999998 110.034 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.634 ' HG2' HG13 ' B' ' 9' ' ' VAL . 6.7 tttt -102.96 130.07 49.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.331 -0.856 . . . . 2.7400000000000002 108.851 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.16 147.65 19.26 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.654 -1.26 . . . . 0.23999999999999999 110.649 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.613 ' O ' ' N ' ' B' ' 41' ' ' ARG . 42.6 p -129.71 140.06 51.19 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.074 -0.662 . . . . 0.48999999999999999 112.117 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.631 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 33.51 -80.78 0.0 OUTLIER Glycine 0 N--CA 1.503 3.148 0 O-C-N 121.847 -0.533 . . . . 0.28000000000000003 112.325 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.0 OUTLIER -83.53 -54.04 5.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.968 -1.313 . . . . 3.1600000000000001 109.45 -178.663 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -15.84 36.83 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.845 -1.159 . . . . 1.3799999999999999 109.048 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.631 HG22 ' O ' ' B' ' 40' ' ' GLY . 10.1 tt -58.25 -26.24 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.334 -0.854 . . . . 0.84999999999999998 110.027 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -26.22 22.13 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.456 -0.942 . . . . 1.1200000000000001 108.456 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' B' ' 46' ' ' ALA . 23.3 mmtp -63.18 -69.64 0.26 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.167 -1.79 . . . . 1.8700000000000001 106.167 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.632 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -29.71 -50.41 0.11 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 116.159 -0.473 . . . . 0.26000000000000001 111.582 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.54 HG13 ' HB ' ' A' ' 68' ' ' THR . 94.7 t -62.61 -59.33 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.802 -1.186 . . . . 0.28000000000000003 109.957 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ASP . . . . . 0.418 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 12.3 t70 -52.19 -51.87 55.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.141 -0.975 . . . . 1.25 108.612 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.528 HG11 HD21 ' B' ' 36' ' ' LEU . 60.4 t -41.34 -61.33 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 109.028 -0.73 . . . . 1.0600000000000001 109.028 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.506 ' CD1' HD11 ' B' ' 85' ' ' LEU . 0.1 OUTLIER -62.36 -50.75 70.33 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.515 -0.74 . . . . 4.1100000000000003 109.906 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ASN . . . . . 0.534 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -50.72 -55.22 17.63 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.975 -1.12 . . . . 1.4099999999999999 107.975 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.477 ' N ' ' CG ' ' B' ' 51' ' ' ASN . 0.8 OUTLIER -59.9 -35.52 75.03 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.643 -0.823 . . . . 0.65000000000000002 109.256 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.598 HD21 HH12 ' B' ' 87' ' ' ARG . 8.1 tp -72.1 -24.15 61.44 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.892 -1.13 . . . . 0.53000000000000003 109.417 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.07 -29.72 31.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.266 -1.521 . . . . 0.98999999999999999 107.277 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.0 -13.85 13.37 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.897 -1.149 . . . . 1.46 107.897 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -71.5 -42.66 67.76 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.492 -0.883 . . . . 1.71 109.342 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.3 tp -153.95 -18.21 0.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.532 -1.267 . . . . 1.77 111.602 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 65.86 -62.88 0.13 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.365 -1.494 . . . . 0.39000000000000001 109.365 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -69.64 -41.61 75.36 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.387 -1.066 . . . . 1.3999999999999999 109.089 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' B' ' 87' ' ' ARG . . . -76.81 20.03 3.08 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.592 -1.403 . . . . 0.34000000000000002 109.592 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.559 HG13 HD21 ' B' ' 85' ' ' LEU . 2.5 t -153.16 131.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.412 -1.329 . . . . 0.46000000000000002 107.412 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' B' ' 86' ' ' LYS . 3.0 mm-40 -134.0 153.35 51.84 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.048 0.928 . . . . 1.4199999999999999 112.207 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.651 HD11 HG21 ' B' ' 66' ' ' VAL . 7.6 tt -93.54 116.49 29.01 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.177 -1.045 . . . . 0.54000000000000004 108.177 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.83 -25.82 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.262 -0.899 . . . . 1.4299999999999999 110.206 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -172.42 151.58 2.51 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.85 -1.156 . . . . 1.28 109.284 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.651 HG21 HD11 ' B' ' 63' ' ' LEU . 96.1 t -154.53 133.82 3.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.193 -1.04 . . . . 0.90000000000000002 108.193 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' GLN . . . . . 0.636 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -141.11 159.84 41.37 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.769 0.795 . . . . 1.4399999999999999 109.47 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.697 ' HB ' HG13 ' A' ' 47' ' ' VAL . 1.3 p -138.98 151.85 47.2 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.109 -0.7 . . . . 0.45000000000000001 109.109 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.665 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -174.81 160.38 29.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.683 -1.767 . . . . 0.28999999999999998 108.683 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.524 ' OG ' ' ND2' ' A' ' 51' ' ' ASN . 89.9 p -98.35 155.11 17.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.275 -1.132 . . . . 0.39000000000000001 109.403 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -151.9 172.86 15.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.67 -1.269 . . . . 1.49 110.996 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.423 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -89.64 136.63 23.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.847 0.832 . . . . 0.87 110.917 -178.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 5.2 ttt-85 -148.96 100.21 3.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.973 -0.751 . . . . 2.1800000000000002 108.973 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 4.7 t0 85.07 36.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.246 -0.65 . . . . 1.3500000000000001 109.246 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.44 28.5 11.6 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.849 0.833 . . . . 2.5699999999999998 109.328 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.54 152.04 36.15 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.826 -0.805 . . . . 3.1400000000000001 108.826 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 9.6 ttm-85 -87.29 141.65 28.48 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.018 -1.073 . . . . 2.3900000000000001 111.099 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.91 158.58 23.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.635 -0.876 . . . . 0.57999999999999996 108.635 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.84 148.14 24.8 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.514 -0.741 . . . . 0.60999999999999999 109.553 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.665 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.8 p90 -140.75 148.11 40.19 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.573 0.702 . . . . 4.0800000000000001 109.948 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.511 HG23 ' O ' ' B' ' 81' ' ' ILE . 6.4 tt -123.22 131.01 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.631 0.729 . . . . 0.90000000000000002 110.037 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.636 HD12 ' HB3' ' B' ' 67' ' ' GLN . 11.7 mt -105.98 123.06 47.38 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.149 -1.426 . . . . 0.37 107.149 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -132.4 125.25 30.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.028 -1.045 . . . . 0.97999999999999998 110.938 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -99.83 169.66 9.08 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.802 -0.635 . . . . 0.70999999999999996 109.933 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.559 HD21 HG13 ' B' ' 61' ' ' VAL . 1.6 tp -159.86 136.1 8.84 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.55 -0.86 . . . . 1.4399999999999999 110.661 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 62' ' ' GLN . 7.8 tmtt? -118.36 138.3 52.52 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.52 -0.919 . . . . 1.3100000000000001 108.52 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ARG . . . . . 0.598 HH12 HD21 ' B' ' 53' ' ' LEU . 16.6 tpp180 -95.48 143.7 26.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.465 -0.772 . . . . 1.6399999999999999 110.753 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.22 -13.48 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.877 -0.786 . . . . 0.68000000000000005 108.877 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.303 -1.428 0 CA-C-O 117.98 -1.009 . . . . 1.77 109.534 179.781 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.674 ' OD1' HD12 ' A' ' 31' ' ' ILE . 2.4 m120 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.023 0.44 . . . . 1.72 111.329 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 7.0 pt-20 -92.09 115.58 28.19 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.989 -1.485 . . . . 1.4399999999999999 106.989 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.0 mt -115.64 140.0 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-O 122.132 0.968 . . . . 1.1100000000000001 111.592 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.8 124.71 62.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.986 -0.552 . . . . 1.3500000000000001 109.83 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.509 HG11 ' H ' ' A' ' 46' ' ' ALA . 2.1 p -89.53 165.07 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.631 -1.248 . . . . 0.39000000000000001 107.631 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -140.19 175.43 9.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.913 . . . . 2.27 109.671 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.1 pttm -101.83 -9.71 20.52 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.006 -0.739 . . . . 1.78 109.006 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 t -90.71 -7.89 51.35 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.828 -1.175 . . . . 1.24 107.828 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.15 -132.76 0.18 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.423 -1.325 . . . . 1.4099999999999999 107.423 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.81 159.65 21.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.557 -1.339 . . . . 1.25 109.4 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.569 HG23 ' N ' ' A' ' 17' ' ' GLU . 16.5 m -61.66 -40.97 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-O 121.869 0.842 . . . . 0.48999999999999999 109.284 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 16' ' ' VAL . 3.5 pt-20 -77.86 -32.35 52.0 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.265 -0.897 . . . . 1.5600000000000001 108.871 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 52.3 t0 -62.78 -31.07 71.96 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.63 -1.294 . . . . 1.3799999999999999 111.164 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.672 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.6 m-70 -95.23 -17.15 21.96 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.176 -1.578 . . . . 1.4299999999999999 108.389 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -31.89 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 104.436 -2.431 . . . . 0.28999999999999998 104.436 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 25' ' ' VAL . 31.6 mt -70.43 -52.85 19.27 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.32 -1.309 . . . . 0.40999999999999998 109.057 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -67.38 -29.46 68.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 1.22 109.671 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 19' ' ' HIS . 25.5 t -70.03 -54.29 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.32000000000000001 108.964 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 tt -60.89 -20.36 21.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.203 -0.935 . . . . 0.57999999999999996 108.894 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 21' ' ' LEU . 11.0 t -72.46 -40.83 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.095 -1.003 . . . . 0.40999999999999998 109.025 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.03 -36.78 80.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.784 -1.197 . . . . 1.1899999999999999 109.965 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -61.73 -24.72 66.99 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.237 -1.394 . . . . 1.46 107.237 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -27.03 68.67 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.343 -0.844 . . . . 1.1499999999999999 109.109 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -89.32 -2.31 58.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 1.1699999999999999 109.535 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.409 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . 107.74 12.4 22.73 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.898 -1.281 . . . . 0.41999999999999998 109.898 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.674 HD12 ' OD1' ' A' ' 6' ' ' ASN . 50.0 mm -76.44 106.16 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.063 -1.257 . . . . 0.34999999999999998 108.927 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -92.52 -35.76 13.42 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.312 -0.867 . . . . 1.55 110.232 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -98.63 140.12 33.33 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.387 0.613 . . . . 1.5800000000000001 109.608 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.47 142.85 15.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 119.188 -1.005 . . . . 0.54000000000000004 110.221 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.2 127.33 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.987 -0.551 . . . . 0.25 110.477 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.8 mp -111.71 118.37 35.43 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.501 0.667 . . . . 0.40000000000000002 109.322 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.32 134.36 49.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.667 -0.864 . . . . 2.7400000000000002 108.667 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.5 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -145.14 157.28 27.29 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 120.036 -1.078 . . . . 0.20999999999999999 111.155 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 41' ' ' ARG . 14.9 p -139.0 146.92 41.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.466 -1.02 . . . . 0.56000000000000005 112.664 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.526 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 39.76 -86.92 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.628 -0.989 . . . . 0.33000000000000002 110.628 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -85.23 -51.86 6.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.32 -1.106 . . . . 3.0899999999999999 109.682 -178.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -25.51 60.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.819 -1.176 . . . . 1.0900000000000001 108.895 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 40' ' ' GLY . 7.0 tt -49.74 -36.37 11.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.552 -0.717 . . . . 0.87 110.83 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.45 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -83.54 -23.57 32.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.007 -1.058 . . . . 1.1399999999999999 108.989 -178.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 46' ' ' ALA . 7.8 mmtt -62.29 -70.7 0.18 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 104.497 -2.409 . . . . 1.8600000000000001 104.497 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.637 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -31.47 -49.63 0.16 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.17 0.51 . . . . 0.28999999999999998 110.576 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.7 HG13 ' HB ' ' B' ' 68' ' ' THR . 97.4 t -59.37 -69.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.225 -0.922 . . . . 0.22 109.549 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 52' ' ' SER . 3.6 t0 -45.81 -49.04 15.54 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.52 -0.738 . . . . 1.26 109.563 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.485 HG11 HD21 ' A' ' 36' ' ' LEU . 70.4 t -48.14 -59.64 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.646 -0.822 . . . . 1.0600000000000001 109.105 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -60.06 -53.45 57.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 4.0199999999999996 110.228 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 1.09 ' ND2' ' H ' ' B' ' 70' ' ' SER . 14.5 t-20 -52.48 -49.82 63.95 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.662 -1.236 . . . . 1.3400000000000001 107.662 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 49' ' ' VAL . 21.0 p -62.07 -35.04 77.45 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.73 -0.841 . . . . 1.04 108.73 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.474 HD23 ' CD2' ' A' ' 85' ' ' LEU . 7.5 tp -77.34 -22.38 51.94 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.065 -1.022 . . . . 0.44 108.737 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' C ' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -79.89 -42.5 24.04 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.172 -1.58 . . . . 1.0 106.858 177.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.49 -16.11 0.1 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.783 -1.099 . . . . 1.5800000000000001 108.051 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.506 ' N ' ' C ' ' A' ' 54' ' ' LYS . 12.2 mmm180 -59.31 -55.7 31.49 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.356 0.598 . . . . 1.6899999999999999 110.251 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 mt -159.16 0.58 0.09 Allowed 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 118.689 -1.204 . . . . 1.6599999999999999 110.595 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 61' ' ' VAL . . . 64.92 -58.52 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.527 -1.321 . . . . 0.39000000000000001 110.209 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -70.96 -41.98 70.36 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.495 -1.003 . . . . 1.3799999999999999 110.49 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.49 17.64 3.24 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.414 -1.475 . . . . 0.26000000000000001 109.414 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.681 HG13 HD21 ' A' ' 85' ' ' LEU . 2.4 t -155.94 127.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.785 -1.191 . . . . 0.38 107.785 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.6 mm-40 -132.94 157.51 44.96 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.176 0.988 . . . . 1.3100000000000001 111.375 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.724 HD11 HG21 ' A' ' 66' ' ' VAL . 8.3 tt -96.05 112.6 24.29 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.072 -0.714 . . . . 0.48999999999999999 109.072 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -20.86 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 1.3500000000000001 110.001 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.477 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -167.86 153.23 7.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.18 -1.575 . . . . 1.2 109.784 177.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.724 HG21 HD11 ' A' ' 63' ' ' LEU . 70.3 t -159.65 129.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.463 -0.773 . . . . 0.84999999999999998 109.457 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 82' ' ' LEU . 12.9 tt0 -146.06 164.79 31.03 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.285 1.04 . . . . 1.4099999999999999 110.902 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.613 HG22 ' HA ' ' A' ' 81' ' ' ILE . 1.6 p -139.27 158.06 44.82 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.894 -0.78 . . . . 0.52000000000000002 108.894 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.463 ' HA2' HD21 ' B' ' 51' ' ' ASN . . . -174.55 147.38 9.12 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 107.195 -2.362 . . . . 0.40000000000000002 107.195 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 1.132 ' H ' ' ND2' ' B' ' 51' ' ' ASN . 87.4 p -93.45 163.05 13.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.662 -1.493 . . . . 0.41999999999999998 110.175 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -147.85 159.88 43.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.237 -0.914 . . . . 1.29 110.648 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.17 87.71 2.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 118.991 -1.084 . . . . 1.02 109.226 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 46.1 ttt-85 -96.11 111.19 23.3 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.963 -1.086 . . . . 2.23 110.301 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.0 t70 80.64 37.25 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.888 -0.507 . . . . 1.3799999999999999 110.178 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.46 28.86 15.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.397 -0.815 . . . . 2.6200000000000001 109.129 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.26 146.14 28.51 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.083 -1.011 . . . . 3.1499999999999999 108.776 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.5 ' NH2' ' OG ' ' A' ' 70' ' ' SER . 5.5 tpt180 -84.46 133.23 34.49 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.779 1.276 . . . . 2.4399999999999999 111.256 -177.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.462 HD11 ' HA3' ' A' ' 40' ' ' GLY . 13.5 tt -141.34 155.72 21.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.436 -1.256 . . . . 0.23000000000000001 108.831 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.55 151.71 23.24 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.139 0.971 . . . . 0.73999999999999999 111.305 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.5 ' CD1' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -131.45 135.5 47.18 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.455 -0.943 . . . . 4.1600000000000001 108.455 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.613 ' HA ' HG22 ' A' ' 68' ' ' THR . 2.8 tt -117.11 126.79 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.168 -1.049 . . . . 0.92000000000000004 108.168 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' GLN . 16.8 mt -107.5 121.06 43.86 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.311 -1.366 . . . . 0.35999999999999999 107.311 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 tt -131.89 126.12 33.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.035 . . . . 0.97999999999999998 111.123 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -100.56 171.61 7.62 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.784 -0.644 . . . . 0.57999999999999996 109.985 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 61' ' ' VAL . 1.4 tp -159.49 142.38 14.07 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.112 -1.035 . . . . 1.3899999999999999 110.72 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.59 ' O ' ' N ' ' A' ' 62' ' ' GLN . 13.7 tmtt? -121.85 141.21 51.48 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 116.073 -0.512 . . . . 1.4199999999999999 110.442 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.1 mmt-85 -99.21 137.24 38.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.099 -1.001 . . . . 1.6399999999999999 109.705 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.31 -0.79 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.537 -0.912 . . . . 0.63 108.537 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 t80 . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 118.028 -0.987 . . . . 1.76 109.53 179.524 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.442 0.639 . . . . 1.46 110.792 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.7 pt-20 -93.4 117.62 30.3 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.303 -0.999 . . . . 1.49 108.303 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 45.5 mt -113.23 133.9 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.741 0.782 . . . . 1.1699999999999999 110.574 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -98.7 123.02 51.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.361 0.6 . . . . 1.3700000000000001 109.703 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.421 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.4 OUTLIER -88.92 165.38 2.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.163 -1.051 . . . . 0.37 108.163 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.448 ' HE ' ' HE3' ' B' ' 14' ' ' LYS . 26.9 mtt-85 -141.79 175.33 9.79 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.431 -0.793 . . . . 2.3700000000000001 109.747 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -102.53 -9.09 20.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.38 -0.97 . . . . 1.75 108.38 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -84.79 -14.49 47.99 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.478 -0.889 . . . . 1.1899999999999999 109.614 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.448 ' HE3' ' HE ' ' B' ' 11' ' ' ARG . 12.7 mttm -94.95 -118.25 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.18 -0.95 . . . . 1.47 108.944 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.5 168.6 9.29 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.396 -0.815 . . . . 1.22 109.06 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.517 HG23 ' N ' ' B' ' 17' ' ' GLU . 15.1 m -68.25 -38.4 79.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.881 0.848 . . . . 0.45000000000000001 109.097 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.517 ' N ' HG23 ' B' ' 16' ' ' VAL . 8.0 pt-20 -76.7 -31.46 57.22 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.024 -1.048 . . . . 1.7 109.51 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -32.28 72.6 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.453 -1.404 . . . . 1.46 111.268 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.66 ' O ' HG23 ' B' ' 23' ' ' VAL . 3.1 m-70 -94.96 -16.81 22.49 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.335 -1.478 . . . . 1.3999999999999999 108.409 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.15 -35.21 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 104.538 -2.393 . . . . 0.34000000000000002 104.538 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.57 ' O ' HG23 ' B' ' 25' ' ' VAL . 43.7 mt -68.93 -49.07 61.29 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.649 -1.16 . . . . 0.38 109.011 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -70.25 -32.06 69.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.153 -0.967 . . . . 1.21 109.536 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.66 HG23 ' O ' ' B' ' 19' ' ' HIS . 25.0 t -68.11 -52.53 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.29999999999999999 109.165 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 tt -62.19 -23.31 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.217 -0.927 . . . . 0.68999999999999995 108.883 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.57 HG23 ' O ' ' B' ' 21' ' ' LEU . 11.3 t -69.88 -39.91 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.111 -0.993 . . . . 0.41999999999999998 109.27 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -68.71 -38.76 80.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.758 -1.214 . . . . 1.1499999999999999 109.822 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.2 -27.64 65.91 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.81 -1.552 . . . . 1.46 106.81 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -25.25 68.28 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.235 -0.893 . . . . 1.1699999999999999 109.143 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -91.64 0.62 57.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 1.1699999999999999 109.351 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.25 25.8 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.034 -1.226 . . . . 0.38 110.034 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -78.08 108.49 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.931 -1.335 . . . . 0.58999999999999997 108.393 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.7 OUTLIER -94.38 -37.97 11.2 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.409 -0.807 . . . . 1.46 110.642 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -100.38 139.03 36.63 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.714 -0.616 . . . . 1.2 110.046 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.75 142.93 16.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.089 -1.044 . . . . 0.48999999999999999 111.234 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.85 124.79 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-N 115.889 -0.596 . . . . 0.31 110.405 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' B' ' 46' ' ' ALA . 2.8 mp -103.19 114.21 28.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.305 -0.872 . . . . 0.47999999999999998 109.848 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -98.66 122.97 42.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 2.7400000000000002 109.761 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.507 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -137.59 153.33 22.01 Favored Glycine 0 N--CA 1.505 3.266 0 C-N-CA 119.86 -1.162 . . . . 0.23999999999999999 111.357 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.61 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 1.4 p -139.79 147.28 40.56 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 122.174 0.987 . . . . 0.48999999999999999 112.949 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.531 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 36.93 -87.62 0.01 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.632 -0.987 . . . . 0.28000000000000003 110.632 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -82.63 -52.77 6.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -1.084 . . . . 3.1600000000000001 109.503 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -19.48 54.24 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.901 -1.124 . . . . 1.3799999999999999 109.224 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.531 HG22 ' O ' ' B' ' 40' ' ' GLY . 6.6 tt -54.58 -28.61 19.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.267 -0.896 . . . . 0.84999999999999998 109.618 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.98 -26.83 26.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.1200000000000001 108.921 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.452 ' O ' ' C ' ' B' ' 46' ' ' ALA . 9.9 mmtt -64.0 -69.62 0.27 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.819 -1.919 . . . . 1.8700000000000001 105.819 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.648 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -32.42 -49.69 0.22 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 116.123 -0.49 . . . . 0.26000000000000001 111.166 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.583 HG13 ' HB ' ' A' ' 68' ' ' THR . 69.9 t -66.91 -62.74 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.73 -1.231 . . . . 0.28000000000000003 109.884 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ASP . . . . . 0.438 ' O ' ' OG ' ' B' ' 52' ' ' SER . 7.5 t0 -48.22 -52.57 20.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 1.25 108.646 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 54.2 t -44.42 -55.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.722 -0.844 . . . . 1.0600000000000001 108.722 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' B' ' 54' ' ' LYS . 0.1 OUTLIER -63.97 -51.89 62.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.542 -0.724 . . . . 4.1100000000000003 110.503 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ASN . . . . . 1.132 ' ND2' ' H ' ' A' ' 70' ' ' SER . 15.2 t-20 -53.25 -51.08 63.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.311 -1.366 . . . . 1.4099999999999999 107.311 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 3.8 p -59.18 -36.73 75.84 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.564 -0.902 . . . . 0.65000000000000002 108.564 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.473 ' O ' ' CG ' ' B' ' 56' ' ' ARG . 5.4 tp -77.13 -24.06 51.7 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.211 -0.931 . . . . 0.53000000000000003 109.069 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' LYS . . . . . 0.531 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -81.78 -44.57 16.81 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 119.843 -1.786 . . . . 0.98999999999999999 107.286 178.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' B' ' 55' ' ' ASP . 1.4 t0 -50.88 -11.22 0.08 Allowed 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.171 -1.377 . . . . 1.46 107.88 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.531 ' N ' ' C ' ' B' ' 54' ' ' LYS . 9.3 mmm180 -56.96 -57.25 13.36 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.119 0.961 . . . . 1.71 110.352 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.0 OUTLIER -156.53 -1.92 0.12 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.137 -1.061 . . . . 1.77 108.137 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.0 -52.93 0.1 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.011 -1.09 . . . . 0.39000000000000001 110.427 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -72.51 -45.44 59.36 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.473 -1.016 . . . . 1.3999999999999999 110.329 -178.47 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.417 ' O ' HG23 ' B' ' 61' ' ' VAL . . . -71.93 21.08 0.82 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 109.395 -1.482 . . . . 0.34000000000000002 109.395 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.651 HG13 HD21 ' B' ' 85' ' ' LEU . 2.5 t -156.65 130.76 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.032 -1.275 . . . . 0.46000000000000002 107.894 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.5 mm-40 -132.92 150.11 52.19 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.029 0.919 . . . . 1.4199999999999999 111.695 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.667 ' C ' HD23 ' B' ' 63' ' ' LEU . 7.0 tt -94.23 114.83 27.0 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.84 -1.17 . . . . 0.54000000000000004 107.84 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.36 -11.77 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.419 -0.801 . . . . 1.4299999999999999 110.729 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' B' ' 84' ' ' ARG . 0.5 OUTLIER -175.57 146.42 0.77 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.343 -1.473 . . . . 1.28 109.655 178.237 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.661 HG21 HD11 ' B' ' 63' ' ' LEU . 87.2 t -156.79 134.29 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.507 -0.746 . . . . 0.90000000000000002 109.038 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' GLN . . . . . 0.667 ' HB3' HD12 ' B' ' 82' ' ' LEU . 23.6 tt0 -146.28 162.87 37.16 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.133 0.968 . . . . 1.4399999999999999 110.943 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.7 ' HB ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -126.74 164.86 20.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.303 -0.999 . . . . 0.45000000000000001 108.303 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.613 ' HA2' HD21 ' A' ' 51' ' ' ASN . . . -178.55 136.85 3.05 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.024 -1.63 . . . . 0.28999999999999998 109.024 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' SER . . . . . 1.09 ' H ' ' ND2' ' A' ' 51' ' ' ASN . 51.8 p -94.36 156.81 16.32 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.185 -1.185 . . . . 0.39000000000000001 108.231 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.83 173.09 17.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.805 -1.184 . . . . 1.49 110.605 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 t -89.54 137.75 20.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.805 -0.813 . . . . 0.87 108.805 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 27.3 ttt-85 -149.67 103.47 3.25 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.098 -1.075 . . . . 2.1800000000000002 108.098 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.3 t70 82.22 34.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.434 -0.95 . . . . 1.3500000000000001 108.434 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 66.45 25.84 10.15 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.727 0.775 . . . . 2.5699999999999998 109.12 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -147.32 152.22 37.87 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.412 -0.805 . . . . 3.1400000000000001 108.995 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.469 ' NH2' ' OG ' ' B' ' 70' ' ' SER . 3.5 ttt180 -88.08 138.71 31.21 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.598 1.19 . . . . 2.3900000000000001 112.253 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.01 156.41 22.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.016 -1.105 . . . . 0.57999999999999996 108.016 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 2.8 m -86.68 151.52 23.34 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.203 -0.935 . . . . 0.60999999999999999 110.372 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.61 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.2 OUTLIER -133.32 133.95 43.2 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.133 -1.062 . . . . 4.0800000000000001 108.133 -178.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.532 HG23 ' O ' ' B' ' 81' ' ' ILE . 3.5 tt -116.06 128.79 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.872 -0.788 . . . . 0.90000000000000002 108.872 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' B' ' 67' ' ' GLN . 4.4 mt -106.64 118.44 36.67 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.631 -1.618 . . . . 0.37 106.631 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tt -128.18 124.47 36.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.97999999999999998 110.317 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' B' ' 65' ' ' ASN . 23.0 ttt180 -99.96 170.76 8.29 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.443 0.64 . . . . 0.70999999999999996 109.965 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.651 HD21 HG13 ' B' ' 61' ' ' VAL . 1.5 tp -162.47 127.56 3.28 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.363 -0.935 . . . . 1.4399999999999999 110.783 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 62' ' ' GLN . 12.6 tmtt? -109.1 148.65 30.5 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.199 -0.667 . . . . 1.3100000000000001 109.199 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 29.3 mmt-85 -101.18 141.81 33.53 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.276 -0.89 . . . . 1.6399999999999999 110.416 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.74 -7.79 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.032 -0.729 . . . . 0.68000000000000005 109.032 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 13.5 t80 . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 117.973 -1.013 . . . . 1.77 109.54 179.438 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.851 ' ND2' HG23 ' A' ' 34' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.898 -0.408 . . . . 1.72 109.898 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 4.4 pt-20 -91.26 119.11 31.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.454 -1.404 . . . . 1.4399999999999999 108.793 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.462 ' CG1' ' OD1' ' A' ' 6' ' ' ASN . 2.7 mt -129.76 145.99 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 CA-C-O 122.242 1.02 . . . . 1.1100000000000001 111.732 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 37' ' ' LYS . 3.7 t -107.96 130.27 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.585 0.707 . . . . 1.3500000000000001 109.632 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.408 HG11 ' H ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -88.47 162.98 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.244 -1.021 . . . . 0.39000000000000001 108.244 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.23 175.01 9.99 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.276 1.036 . . . . 2.27 111.216 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' H ' ' HG3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -101.91 -12.47 18.2 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.086 -1.079 . . . . 1.78 108.086 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.587 ' C ' ' HZ3' ' A' ' 14' ' ' LYS . 30.0 p -86.42 -15.35 40.58 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.828 -0.749 . . . . 1.24 109.437 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HZ3' ' C ' ' A' ' 13' ' ' THR . 4.9 mmpm? -91.71 -123.55 0.08 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.118 -0.989 . . . . 1.4099999999999999 108.841 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.49 167.09 13.95 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.887 -1.153 . . . . 1.25 107.887 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 16' ' ' VAL . 1.5 m -68.06 -30.12 46.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.897 -1.149 . . . . 0.48999999999999999 107.897 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.5 pt-20 -79.46 -37.85 35.95 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.504 -0.878 . . . . 1.5600000000000001 109.328 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -58.29 -33.23 69.21 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 120.146 -1.596 . . . . 1.3799999999999999 110.899 -179.04 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.638 ' O ' HG23 ' A' ' 23' ' ' VAL . 70.4 m-70 -91.74 -16.87 26.25 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 120.379 -1.451 . . . . 1.4299999999999999 108.922 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.56 -32.73 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 105.294 -2.113 . . . . 0.28999999999999998 105.294 176.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 25' ' ' VAL . 65.9 mt -70.36 -56.15 7.38 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.228 -0.896 . . . . 0.40999999999999998 109.517 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -64.79 -27.47 68.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 1.22 110.26 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 19' ' ' HIS . 38.8 t -73.25 -50.26 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.235 -0.915 . . . . 0.32000000000000001 109.262 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 tt -64.52 -18.13 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.203 -0.935 . . . . 0.57999999999999996 108.675 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 21' ' ' LEU . 9.0 t -74.95 -44.62 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.293 -0.879 . . . . 0.40999999999999998 108.835 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -67.15 -31.95 72.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.008 -1.057 . . . . 1.1899999999999999 110.147 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.596 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 15.6 t80 -65.36 -24.87 67.35 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.225 -1.398 . . . . 1.46 107.225 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -64.01 -27.32 69.04 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.36 -0.836 . . . . 1.1499999999999999 109.318 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -89.41 -2.42 58.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.996 -1.065 . . . . 1.1699999999999999 109.317 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.17 15.8 13.6 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.088 -1.205 . . . . 0.41999999999999998 110.088 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -79.54 105.98 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.02 -1.282 . . . . 0.34999999999999998 108.566 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -94.41 -37.77 11.28 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.337 -0.852 . . . . 1.55 110.482 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 3.4 mt-10 -95.08 135.27 36.84 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.297 -0.877 . . . . 1.5800000000000001 109.697 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.851 HG23 ' ND2' ' A' ' 6' ' ' ASN . 2.8 p -149.14 138.55 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.329 -0.948 . . . . 0.54000000000000004 110.466 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.99 127.64 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 115.911 -0.586 . . . . 0.25 110.865 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.2 mp -112.75 122.28 47.21 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.291 -0.633 . . . . 0.40000000000000002 109.291 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -106.76 136.98 45.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.442 -0.947 . . . . 2.7400000000000002 108.442 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.34 156.68 26.26 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 119.501 -1.333 . . . . 0.20999999999999999 111.32 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.671 ' O ' ' N ' ' A' ' 41' ' ' ARG . 43.4 p -134.02 142.84 47.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.907 -0.76 . . . . 0.56000000000000005 112.151 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.565 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 35.49 -77.19 0.0 OUTLIER Glycine 0 N--CA 1.503 3.122 0 CA-C-O 121.346 0.415 . . . . 0.33000000000000002 112.182 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.671 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -87.11 -58.37 2.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.249 . . . . 3.0899999999999999 109.429 -179.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -20.91 21.72 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.1 -1.0 . . . . 1.0900000000000001 108.933 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 40' ' ' GLY . 8.4 tt -53.65 -33.84 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.152 -0.967 . . . . 0.87 111.046 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.14 -24.48 24.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.727 -1.233 . . . . 1.1399999999999999 108.499 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -58.39 -67.7 0.33 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.206 -2.146 . . . . 1.8600000000000001 105.206 177.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.561 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -34.32 -48.01 0.32 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 120.998 0.428 . . . . 0.28999999999999998 110.556 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.661 HG13 ' HB ' ' B' ' 68' ' ' THR . 97.1 t -60.62 -64.93 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.034 -1.041 . . . . 0.22 109.343 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -46.53 -51.81 14.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.436 -0.95 . . . . 1.26 108.436 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.467 HG11 HD21 ' A' ' 36' ' ' LEU . 74.5 t -46.93 -57.34 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.875 -1.157 . . . . 1.0600000000000001 107.875 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -58.35 -57.5 12.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.401 -0.812 . . . . 4.0199999999999996 110.598 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.544 ' CG ' ' H ' ' B' ' 70' ' ' SER . 1.1 t30 -51.76 -53.44 39.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.899 -1.148 . . . . 1.3400000000000001 107.899 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.9 p -59.4 -39.03 82.1 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.434 -0.906 . . . . 1.04 109.101 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.445 HD22 HG11 ' A' ' 23' ' ' VAL . 38.0 tp -75.53 -24.33 56.74 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.993 -1.067 . . . . 0.44 109.023 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' TYR . 5.9 tmtt? -80.88 -40.97 23.87 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.738 -1.949 . . . . 1.0 105.738 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -57.92 -7.18 0.69 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.331 -1.304 . . . . 1.5800000000000001 107.817 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.4 tpt180 -71.59 -46.07 60.35 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.624 0.726 . . . . 1.6899999999999999 110.067 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 mt -154.44 -19.47 0.13 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.777 -0.769 . . . . 1.6599999999999999 109.657 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.79 -50.34 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.321 -1.112 . . . . 0.39000000000000001 110.321 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -74.54 -41.73 60.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.347 -1.09 . . . . 1.3799999999999999 109.94 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.25 25.05 7.34 Favored Glycine 0 N--CA 1.48 1.62 0 N-CA-C 109.273 -1.531 . . . . 0.26000000000000001 109.273 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.562 HG13 HD21 ' A' ' 85' ' ' LEU . 4.0 t -151.97 119.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 106.943 -1.503 . . . . 0.38 106.943 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.1 mm100 -126.58 159.64 32.95 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.096 0.95 . . . . 1.3100000000000001 111.604 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.709 HD11 HG21 ' A' ' 66' ' ' VAL . 8.4 tt -94.67 116.69 29.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.923 -0.769 . . . . 0.48999999999999999 108.923 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -22.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.212 -0.93 . . . . 1.3500000000000001 109.482 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.459 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -172.04 154.01 3.33 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.76 -1.176 . . . . 1.2 109.741 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.709 HG21 HD11 ' A' ' 63' ' ' LEU . 77.7 t -159.46 130.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.41 -0.959 . . . . 0.84999999999999998 108.41 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -141.38 162.0 36.53 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.985 0.898 . . . . 1.4099999999999999 109.945 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.57 148.77 51.64 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.84 -0.8 . . . . 0.52000000000000002 108.84 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.637 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -172.04 155.35 23.53 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.602 -1.799 . . . . 0.40000000000000002 108.602 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.578 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 83.2 p -100.48 156.85 17.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.188 -1.184 . . . . 0.41999999999999998 109.907 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -144.18 160.27 41.22 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.085 -1.009 . . . . 1.29 110.278 179.445 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.43 91.07 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.808 -0.757 . . . . 1.02 111.141 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 9.0 ttt85 -96.07 107.84 20.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.064 -1.023 . . . . 2.23 110.18 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.8 t0 84.08 36.22 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.127 0.489 . . . . 1.3799999999999999 110.263 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.478 ' CG ' HH11 ' A' ' 75' ' ' ARG . 0.0 OUTLIER 62.6 29.82 16.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.378 -0.826 . . . . 2.6200000000000001 108.794 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -145.09 144.09 30.76 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.022 -1.103 . . . . 3.1499999999999999 108.022 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -84.25 136.28 34.0 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.822 1.296 . . . . 2.4399999999999999 110.84 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.0 tt -143.91 155.79 15.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-N 114.316 -1.311 . . . . 0.23000000000000001 108.156 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 p -90.49 154.35 19.7 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 121.356 -0.84 . . . . 0.73999999999999999 111.43 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.637 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.8 p90 -143.56 150.91 39.54 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.81 0.814 . . . . 4.1600000000000001 109.702 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 81' ' ' ILE . 6.0 tt -124.51 133.61 68.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.724 0.773 . . . . 0.92000000000000004 109.582 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.2 mt -107.8 128.58 54.72 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.663 -1.236 . . . . 0.35999999999999999 107.663 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 tt -137.13 127.43 26.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.976 -1.077 . . . . 0.97999999999999998 111.519 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -104.9 166.36 10.44 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.681 -0.69 . . . . 0.57999999999999996 110.295 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.562 HD21 HG13 ' A' ' 61' ' ' VAL . 4.7 tp -157.87 137.01 11.66 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.437 -0.905 . . . . 1.3899999999999999 111.458 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -117.31 137.11 52.64 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.727 -0.471 . . . . 1.4199999999999999 109.727 178.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 16.9 mmt85 -94.17 144.49 25.46 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.212 -0.93 . . . . 1.6399999999999999 109.721 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 88' ' ' VAL . 27.1 t -123.63 -6.5 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.909 -0.774 . . . . 0.63 108.909 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 118.049 -0.976 . . . . 1.76 109.51 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.563 HD22 HD22 ' B' ' 26' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.361 0.124 . . . . 1.46 110.887 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.1 pt-20 -92.06 105.12 17.43 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.183 -1.573 . . . . 1.49 108.032 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.437 HD11 ' OD1' ' B' ' 6' ' ' ASN . 4.0 mt -116.33 135.05 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.698 0.761 . . . . 1.1699999999999999 109.954 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.646 HG13 ' HB2' ' B' ' 37' ' ' LYS . 11.9 t -97.79 127.72 49.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.508 0.671 . . . . 1.3700000000000001 109.483 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.495 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -88.33 160.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.946 -1.131 . . . . 0.37 107.946 -179.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 172.25 12.97 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.934 0.873 . . . . 2.3700000000000001 110.538 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.99 -13.02 39.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.705 -0.85 . . . . 1.75 108.705 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 47.8 p -76.86 -70.27 0.47 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.885 -1.524 . . . . 1.1899999999999999 106.885 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 139.9 33.93 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.386 -0.821 . . . . 1.47 110.148 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -72.84 178.59 4.14 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.473 0.654 . . . . 1.22 109.843 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.11 -29.25 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.92 0.866 . . . . 0.45000000000000001 108.795 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 13.0 pt-20 -74.62 -39.15 62.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.607 -0.886 . . . . 1.7 108.607 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 17.4 t0 -57.16 -29.54 63.72 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.088 -1.008 . . . . 1.46 111.375 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.687 ' O ' HG23 ' B' ' 23' ' ' VAL . 52.4 m-70 -94.83 -19.51 20.26 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 119.977 -1.702 . . . . 1.3999999999999999 107.946 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -35.81 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 105.069 -2.197 . . . . 0.34000000000000002 105.069 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.488 ' O ' HG23 ' B' ' 25' ' ' VAL . 68.9 mt -69.14 -51.92 33.38 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.204 -0.907 . . . . 0.38 108.732 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -66.78 -30.73 71.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 1.21 110.126 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.687 HG23 ' O ' ' B' ' 19' ' ' HIS . 42.2 t -71.71 -55.12 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.142 -0.974 . . . . 0.29999999999999999 109.41 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 tt -58.67 -21.97 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.68999999999999995 108.982 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 21' ' ' LEU . 5.6 t -71.12 -39.86 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.179 -0.951 . . . . 0.41999999999999998 108.95 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.563 HD22 HD22 ' B' ' 6' ' ' ASN . 4.9 mt -68.44 -44.98 73.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 1.1499999999999999 109.942 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.582 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 18.4 t80 -54.42 -27.5 37.36 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.29 -1.374 . . . . 1.46 107.29 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -62.76 -24.92 67.95 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.533 -0.758 . . . . 1.1699999999999999 109.575 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -91.6 -4.38 55.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.917 -1.114 . . . . 1.1699999999999999 109.083 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.16 14.13 14.01 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.429 -1.468 . . . . 0.38 109.429 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.535 HG21 ' ND2' ' B' ' 6' ' ' ASN . 32.6 mm -78.83 102.18 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.006 -1.291 . . . . 0.58999999999999997 108.666 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.15 -35.03 14.79 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.278 -0.889 . . . . 1.46 111.517 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.68 135.42 44.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.382 -0.824 . . . . 1.2 110.471 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.59 142.5 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.305 -0.958 . . . . 0.48999999999999999 111.707 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.86 123.42 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 121.204 0.526 . . . . 0.31 111.012 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.646 HD23 ' HA ' ' B' ' 46' ' ' ALA . 3.3 mp -102.5 121.89 43.26 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.439 -0.788 . . . . 0.47999999999999998 110.141 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.646 ' HB2' HG13 ' B' ' 9' ' ' VAL . 4.0 mttt -103.01 128.56 49.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.223 -0.923 . . . . 2.7400000000000002 109.214 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.91 150.95 21.12 Favored Glycine 0 N--CA 1.502 3.099 0 C-N-CA 119.366 -1.397 . . . . 0.23999999999999999 111.667 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.591 ' O ' ' N ' ' B' ' 41' ' ' ARG . 81.8 p -131.88 139.5 48.81 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.826 -0.808 . . . . 0.48999999999999999 112.174 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.451 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 35.79 -83.58 0.0 OUTLIER Glycine 0 N--CA 1.502 3.092 0 O-C-N 121.694 -0.629 . . . . 0.28000000000000003 111.983 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.69 ' N ' ' HE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -81.23 -54.61 5.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.084 -1.245 . . . . 3.1600000000000001 109.388 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.26 -20.55 43.22 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.155 -0.965 . . . . 1.3799999999999999 108.431 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.451 HG22 ' O ' ' B' ' 40' ' ' GLY . 3.7 tt -55.25 -33.55 30.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.049 -1.032 . . . . 0.84999999999999998 110.301 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -22.65 32.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.035 -1.04 . . . . 1.1200000000000001 108.858 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' B' ' 46' ' ' ALA . 0.0 OUTLIER -64.85 -68.73 0.34 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.533 -1.655 . . . . 1.8700000000000001 106.533 177.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.646 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -37.23 -46.15 0.7 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.378 0.608 . . . . 0.26000000000000001 110.272 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 43' ' ' ILE . 74.0 t -60.79 -66.3 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.185 -0.947 . . . . 0.28000000000000003 109.132 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ASP . . . . . 0.438 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 26.8 t0 -48.23 -46.6 35.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.919 . . . . 1.25 108.848 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.608 HG11 HD21 ' B' ' 36' ' ' LEU . 75.0 t -47.87 -54.91 3.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.011 -1.107 . . . . 1.0600000000000001 108.011 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.473 ' CE1' HD11 ' B' ' 85' ' ' LEU . 1.3 t80 -59.47 -60.67 3.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 4.1100000000000003 110.611 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ASN . . . . . 0.578 ' CG ' ' H ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -48.13 -54.79 12.09 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.276 -0.89 . . . . 1.4099999999999999 108.599 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.438 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 0.7 OUTLIER -60.25 -38.3 83.03 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.377 -0.929 . . . . 0.65000000000000002 109.378 -179.06 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.477 HD22 HG11 ' B' ' 23' ' ' VAL . 24.2 tp -73.32 -26.9 61.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.938 . . . . 0.53000000000000003 109.276 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' B' ' 56' ' ' ARG . 1.6 tmtt? -75.03 -50.91 14.95 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.674 -1.602 . . . . 0.98999999999999999 106.674 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.41 -17.96 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.053 -1.43 . . . . 1.46 109.479 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' B' ' 54' ' ' LYS . 12.7 mmm180 -69.17 -38.44 78.72 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.13 -1.028 . . . . 1.71 109.845 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.6 mt -155.39 -13.13 0.11 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.091 -1.444 . . . . 1.77 112.216 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.93 -67.81 0.05 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.228 -1.463 . . . . 0.39000000000000001 110.187 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.17 -35.71 76.59 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.407 -1.055 . . . . 1.3999999999999999 109.919 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.27 22.37 6.25 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.385 -1.486 . . . . 0.34000000000000002 109.385 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.603 HG13 HD21 ' B' ' 85' ' ' LEU . 7.2 t -153.84 130.29 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.187 -1.184 . . . . 0.46000000000000002 107.872 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.5 mm100 -133.11 155.54 49.08 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.306 1.051 . . . . 1.4199999999999999 111.977 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.611 HD11 HG21 ' B' ' 66' ' ' VAL . 8.4 tt -94.85 118.97 32.65 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.517 -0.92 . . . . 0.54000000000000004 108.517 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.97 -14.94 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.399 -0.813 . . . . 1.4299999999999999 109.906 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.475 ' O ' HG23 ' B' ' 66' ' ' VAL . 0.5 OUTLIER -177.53 152.07 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.732 -1.23 . . . . 1.28 109.906 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.611 HG21 HD11 ' B' ' 63' ' ' LEU . 74.8 t -160.05 134.31 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.759 -0.83 . . . . 0.90000000000000002 108.759 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' GLN . . . . . 0.422 ' HB3' HD12 ' B' ' 82' ' ' LEU . 32.1 tt0 -145.59 162.42 37.51 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.123 0.963 . . . . 1.4399999999999999 110.973 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.661 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -136.66 154.69 50.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.416 -0.957 . . . . 0.45000000000000001 108.416 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.656 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -177.98 155.9 18.26 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 107.443 -2.263 . . . . 0.28999999999999998 107.443 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.544 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 90.7 p -94.03 156.74 16.44 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.055 -1.262 . . . . 0.39000000000000001 108.959 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.419 ' OE1' ' C ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -147.0 164.71 32.12 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.939 -1.101 . . . . 1.49 110.141 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.419 ' C ' ' OE1' ' B' ' 71' ' ' GLU . 2.1 t -91.14 136.46 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 120.023 -0.671 . . . . 0.87 110.002 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 0.0 OUTLIER -148.51 106.66 3.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.416 -0.957 . . . . 2.1800000000000002 108.416 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.8 t0 79.74 35.53 0.15 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.258 -1.015 . . . . 1.3500000000000001 108.258 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.72 31.85 11.62 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.845 0.831 . . . . 2.5699999999999998 109.169 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -150.01 150.76 32.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.21 -0.931 . . . . 3.1400000000000001 109.298 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -88.4 138.5 31.38 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.393 1.092 . . . . 2.3900000000000001 112.429 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.34 154.09 27.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.045 -1.094 . . . . 0.57999999999999996 108.045 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 150.19 24.73 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.146 -0.972 . . . . 0.60999999999999999 109.912 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.656 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.9 p90 -144.42 149.93 36.87 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.929 0.871 . . . . 4.0800000000000001 110.826 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.483 HG23 ' O ' ' B' ' 81' ' ' ILE . 7.2 tt -125.35 134.04 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.59 0.709 . . . . 0.90000000000000002 110.33 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.422 HD12 ' HB3' ' B' ' 67' ' ' GLN . 11.2 mt -108.31 119.93 40.93 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.591 -1.633 . . . . 0.37 106.591 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.12 125.02 43.08 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.396 -0.922 . . . . 0.97999999999999998 111.065 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 -100.35 167.98 10.06 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.975 -0.75 . . . . 0.70999999999999996 108.975 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.603 HD21 HG13 ' B' ' 61' ' ' VAL . 2.2 tp -159.42 136.28 9.43 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.45 -0.9 . . . . 1.4399999999999999 110.448 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -118.0 143.01 46.76 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.285 -0.635 . . . . 1.3100000000000001 109.285 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ARG . . . . . 0.582 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 17.6 mmt85 -100.64 140.57 34.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.278 -0.889 . . . . 1.6399999999999999 109.997 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 t -119.0 -7.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.658 -0.867 . . . . 0.68000000000000005 108.658 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.455 0 CA-C-O 118.003 -0.999 . . . . 1.77 109.494 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.554 ' OD1' HD13 ' A' ' 26' ' ' LEU . 12.3 t-20 . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.237 0.541 . . . . 1.72 110.824 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.99 120.58 32.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.861 -1.149 . . . . 1.4399999999999999 108.36 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 35' ' ' ILE . 3.5 mm -125.25 148.01 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-O 122.061 0.934 . . . . 1.1100000000000001 111.551 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.9 t -111.18 131.67 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.605 0.716 . . . . 1.3500000000000001 110.386 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.477 HG11 ' H ' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -90.46 162.36 2.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.47 -0.937 . . . . 0.39000000000000001 108.47 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.435 ' HE ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -137.79 174.05 10.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 2.27 110.221 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 -10.99 18.62 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.872 -0.788 . . . . 1.78 108.872 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.419 ' H ' HG22 ' A' ' 13' ' ' THR . 0.5 OUTLIER -85.71 -8.82 57.95 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.45 -0.9 . . . . 1.24 109.082 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HD3' ' HE ' ' A' ' 11' ' ' ARG . 0.1 OUTLIER -100.3 -121.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.353 -1.351 . . . . 1.4099999999999999 107.353 177.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.473 ' O ' ' ND1' ' A' ' 19' ' ' HIS . 5.4 m-80 -170.73 173.53 5.29 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.505 -1.372 . . . . 1.25 108.153 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.6 -31.57 51.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.073 -1.051 . . . . 0.48999999999999999 108.214 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.6 pt-20 -79.21 -36.37 40.22 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.409 -0.917 . . . . 1.5600000000000001 109.965 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.408 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -55.73 -33.26 64.09 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 119.908 -1.745 . . . . 1.3799999999999999 110.814 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.709 ' O ' HG23 ' A' ' 23' ' ' VAL . 10.5 m80 -94.52 -19.4 20.57 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.695 -1.253 . . . . 1.4299999999999999 109.021 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.74 -34.26 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 104.324 -2.473 . . . . 0.28999999999999998 104.324 176.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.653 ' O ' HG23 ' A' ' 25' ' ' VAL . 51.9 mt -68.49 -54.68 15.33 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.59 -1.186 . . . . 0.40999999999999998 108.935 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -67.41 -26.6 66.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 1.22 110.061 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 19' ' ' HIS . 35.3 t -72.41 -52.17 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.17 -0.957 . . . . 0.32000000000000001 108.7 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 tt -61.86 -19.16 20.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.209 -0.932 . . . . 0.57999999999999996 108.58 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 21' ' ' LEU . 40.2 t -75.52 -44.71 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.244 -0.91 . . . . 0.40999999999999998 109.221 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.554 HD13 ' OD1' ' A' ' 6' ' ' ASN . 4.5 mt -64.94 -34.67 78.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.814 -1.179 . . . . 1.1899999999999999 110.673 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -65.91 -24.47 66.85 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.534 -1.284 . . . . 1.46 107.534 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.36 -24.97 67.83 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.452 -0.795 . . . . 1.1499999999999999 109.796 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -92.07 1.18 57.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.794 -1.191 . . . . 1.1699999999999999 109.189 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.65 12.37 30.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.585 -1.406 . . . . 0.41999999999999998 109.585 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.3 mm -74.35 108.96 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -1.184 . . . . 0.34999999999999998 108.248 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -93.31 -41.18 10.0 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.443 -0.786 . . . . 1.55 110.57 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -94.96 142.15 27.82 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.357 -0.839 . . . . 1.5800000000000001 109.902 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.76 137.78 11.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.049 -1.06 . . . . 0.54000000000000004 110.57 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -116.83 122.1 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.977 -0.556 . . . . 0.25 110.284 -178.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 46' ' ' ALA . 2.3 mp -104.33 120.71 41.81 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 120.115 -0.634 . . . . 0.40000000000000002 109.379 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.88 134.97 50.84 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.681 -0.859 . . . . 2.7400000000000002 108.681 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -152.48 164.7 30.71 Favored Glycine 0 N--CA 1.508 3.435 0 C-N-CA 119.763 -1.208 . . . . 0.20999999999999999 111.603 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -145.69 152.33 39.44 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.391 -1.064 . . . . 0.56000000000000005 113.649 -177.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.593 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 38.13 -86.29 0.01 OUTLIER Glycine 0 N--CA 1.499 2.838 0 N-CA-C 111.254 -0.739 . . . . 0.33000000000000002 111.254 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.657 ' N ' ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -82.46 -54.32 5.29 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.224 -1.162 . . . . 3.0899999999999999 109.485 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -20.63 58.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 109.148 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.705 HD12 HD12 ' B' ' 43' ' ' ILE . 0.2 OUTLIER -52.78 -38.04 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.004 . . . . 0.87 110.759 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -82.38 -25.37 33.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.745 -1.222 . . . . 1.1399999999999999 108.871 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' O ' ' C ' ' A' ' 46' ' ' ALA . 3.2 mptt -62.06 -69.4 0.25 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.675 -1.972 . . . . 1.8600000000000001 105.675 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.637 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -34.22 -47.56 0.29 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.139 0.495 . . . . 0.28999999999999998 110.276 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.628 HG13 ' HB ' ' B' ' 68' ' ' THR . 68.9 t -62.19 -68.14 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.111 -0.993 . . . . 0.22 109.537 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 49' ' ' VAL . 0.7 OUTLIER -45.49 -49.61 13.47 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.793 -0.818 . . . . 1.26 108.793 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 36' ' ' LEU . 47.7 t -45.59 -57.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.582 -0.896 . . . . 1.0600000000000001 108.582 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -62.99 -58.21 8.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.299 -0.875 . . . . 4.0199999999999996 110.153 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.617 ' CG ' ' H ' ' B' ' 70' ' ' SER . 1.3 t30 -46.97 -54.72 9.51 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.97 -1.122 . . . . 1.3400000000000001 107.97 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -59.49 -34.72 72.93 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.596 -0.89 . . . . 1.04 108.596 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 23' ' ' VAL . 10.1 tp -76.85 -21.76 54.53 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.227 -1.027 . . . . 0.44 108.227 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -78.26 -46.28 20.69 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.091 -1.818 . . . . 1.0 106.091 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -58.49 -5.86 0.6 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.025 -1.102 . . . . 1.5800000000000001 108.025 178.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 54' ' ' LYS . 3.4 tpt85 -75.87 -47.35 25.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.722 0.772 . . . . 1.6899999999999999 109.639 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.629 HD23 ' H ' ' A' ' 60' ' ' GLY . 2.4 tp -152.14 -27.08 0.17 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.663 -0.815 . . . . 1.6599999999999999 109.88 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.62 -47.93 0.08 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.149 -1.181 . . . . 0.39000000000000001 110.149 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.617 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.6 OUTLIER -74.8 -44.28 50.26 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.484 -1.009 . . . . 1.3799999999999999 109.772 -179.153 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.629 ' H ' HD23 ' A' ' 57' ' ' LEU . . . -85.93 27.04 5.63 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.007 -1.637 . . . . 0.26000000000000001 109.007 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.7 t -154.75 129.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.339 -1.356 . . . . 0.38 107.339 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 86' ' ' LYS . 0.8 OUTLIER -136.39 157.01 47.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.122 0.963 . . . . 1.3100000000000001 111.594 -177.295 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.554 HD11 HG21 ' A' ' 66' ' ' VAL . 7.1 tt -93.13 112.16 24.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.845 -0.798 . . . . 0.48999999999999999 108.845 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.35 -27.7 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.175 -0.953 . . . . 1.3500000000000001 109.902 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.494 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -169.88 156.29 6.15 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.612 -1.305 . . . . 1.2 109.694 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 63' ' ' LEU . 68.2 t -159.52 131.34 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.596 0.712 . . . . 0.84999999999999998 109.343 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.506 ' CG ' ' N ' ' A' ' 68' ' ' THR . 30.6 tt0 -144.21 163.15 34.48 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.166 0.984 . . . . 1.4099999999999999 109.985 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.506 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -139.65 149.8 44.17 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.569 -0.901 . . . . 0.52000000000000002 108.569 -178.125 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.95 148.43 13.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.621 -2.192 . . . . 0.40000000000000002 107.621 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.59 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 28.1 p -95.55 162.53 13.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.98 -1.306 . . . . 0.41999999999999998 109.008 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -164.36 178.96 7.09 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.293 -0.963 . . . . 1.29 110.131 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.446 HG23 ' H ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -89.05 135.44 25.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 119.609 -0.836 . . . . 1.02 109.77 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 17.8 ttt85 -151.57 102.46 2.88 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.546 -0.909 . . . . 2.23 108.546 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.3 t70 88.5 33.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.114 0.483 . . . . 1.3799999999999999 109.721 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.93 34.18 5.45 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.201 1.001 . . . . 2.6200000000000001 109.364 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.25 153.64 27.85 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.14 -0.975 . . . . 3.1499999999999999 109.534 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -84.85 137.97 32.83 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.381 1.086 . . . . 2.4399999999999999 109.14 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.415 ' CG1' ' N ' ' A' ' 79' ' ' SER . 4.2 tt -146.18 159.87 11.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.324 -0.853 . . . . 0.23000000000000001 108.851 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.415 ' N ' ' CG1' ' A' ' 78' ' ' ILE . 5.1 p -86.58 149.84 24.65 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.076 0.941 . . . . 0.73999999999999999 109.864 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' CD2' HG22 ' A' ' 39' ' ' THR . 0.6 OUTLIER -133.15 141.21 48.01 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.507 -0.769 . . . . 4.1600000000000001 109.033 -178.357 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 81' ' ' ILE . 8.8 tt -117.66 127.34 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.879 0.847 . . . . 0.92000000000000004 111.225 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 34.6 mt -107.35 115.95 31.08 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.287 -1.746 . . . . 0.35999999999999999 106.287 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.52 127.2 40.29 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.011 -1.055 . . . . 0.97999999999999998 111.117 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.604 ' O ' HD12 ' A' ' 85' ' ' LEU . 10.1 ttt180 -103.12 169.41 8.58 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.482 0.658 . . . . 0.57999999999999996 110.936 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 84' ' ' ARG . 0.9 OUTLIER -161.86 145.26 12.19 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.25 -0.58 . . . . 1.3899999999999999 110.174 178.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 62' ' ' GLN . 1.5 tmtp? -127.35 145.51 50.78 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.53 -0.545 . . . . 1.4199999999999999 109.53 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -96.87 138.98 33.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.455 -0.778 . . . . 1.6399999999999999 110.291 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.16 -6.52 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.6 -0.889 . . . . 0.63 108.6 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.0 t80 . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 118.089 -0.957 . . . . 1.76 109.511 179.772 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.569 ' OD1' HD13 ' B' ' 26' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.574 0.226 . . . . 1.46 110.605 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -90.4 100.2 13.08 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.41 -1.431 . . . . 1.49 107.56 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 4.2 mm -111.3 140.72 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 109.336 -0.616 . . . . 1.1699999999999999 109.336 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' B' ' 37' ' ' LYS . 63.5 t -104.29 131.45 53.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.69 0.757 . . . . 1.3700000000000001 110.481 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.573 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -89.13 159.54 2.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.981 -1.118 . . . . 0.37 107.981 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -134.68 169.19 17.7 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.024 0.916 . . . . 2.3700000000000001 111.025 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.439 ' C ' ' CD ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -97.55 -11.09 24.1 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.834 -0.802 . . . . 1.75 108.834 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.38 -10.17 44.91 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.737 -0.785 . . . . 1.1899999999999999 109.179 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -96.18 -127.78 0.14 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.999 -1.112 . . . . 1.47 107.999 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ASN . . . . . 0.405 ' O ' ' ND1' ' B' ' 19' ' ' HIS . 5.2 m-80 -167.02 162.69 15.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -0.942 . . . . 1.22 109.331 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -63.25 -38.65 82.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 122.001 0.905 . . . . 0.45000000000000001 108.959 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.455 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 7.3 pt-20 -71.94 -32.75 67.63 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.625 -0.88 . . . . 1.7 108.625 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -63.43 -31.01 72.05 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.349 -0.844 . . . . 1.46 112.402 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.759 ' O ' HG23 ' B' ' 23' ' ' VAL . 23.0 m80 -94.54 -20.87 19.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 119.822 -1.799 . . . . 1.3999999999999999 108.383 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.99 -38.98 82.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 104.275 -2.491 . . . . 0.34000000000000002 104.275 176.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.722 ' O ' HG23 ' B' ' 25' ' ' VAL . 48.9 mt -65.73 -49.22 69.23 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.435 -1.257 . . . . 0.38 108.689 178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.5 -31.64 68.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.227 -0.921 . . . . 1.21 109.779 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.759 HG23 ' O ' ' B' ' 19' ' ' HIS . 55.5 t -68.79 -57.32 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.947 -1.096 . . . . 0.29999999999999999 108.92 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 tt -56.6 -24.67 19.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.336 -0.853 . . . . 0.68999999999999995 108.937 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.722 HG23 ' O ' ' B' ' 21' ' ' LEU . 25.2 t -70.08 -40.65 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.132 -0.98 . . . . 0.41999999999999998 109.661 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.569 HD13 ' OD1' ' B' ' 6' ' ' ASN . 4.7 mt -67.45 -44.37 78.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.723 -1.236 . . . . 1.1499999999999999 110.185 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -57.24 -30.77 64.9 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.139 -1.43 . . . . 1.46 107.139 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -24.1 61.6 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.49 -0.777 . . . . 1.1699999999999999 109.2 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -92.95 -3.39 54.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 1.1699999999999999 109.151 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.64 14.51 19.46 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.304 -1.518 . . . . 0.38 109.304 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.42 107.82 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.111 -1.229 . . . . 0.58999999999999997 108.503 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -91.18 -36.82 13.72 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.477 -0.765 . . . . 1.46 111.415 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' B' ' 85' ' ' LEU . 7.3 mt-10 -107.1 136.47 46.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.542 -0.723 . . . . 1.2 111.135 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' B' ' 6' ' ' ASN . 13.4 p -145.94 145.39 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 119.706 -0.798 . . . . 0.48999999999999999 111.171 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.69 119.49 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.261 0.553 . . . . 0.31 110.439 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' B' ' 46' ' ' ALA . 2.7 mp -95.47 121.88 37.61 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.268 -0.895 . . . . 0.47999999999999998 110.918 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.477 ' HB2' HG13 ' B' ' 9' ' ' VAL . 2.8 mtpp -102.88 125.73 49.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.488 -0.758 . . . . 2.7400000000000002 109.33 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.4 156.85 26.98 Favored Glycine 0 N--CA 1.507 3.407 0 C-N-CA 119.362 -1.399 . . . . 0.23999999999999999 111.942 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 17.1 p -142.48 149.79 39.67 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.008 0.909 . . . . 0.48999999999999999 113.309 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.543 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 34.28 -85.51 0.01 OUTLIER Glycine 0 N--CA 1.498 2.773 0 N-CA-C 111.144 -0.782 . . . . 0.28000000000000003 111.144 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.652 ' NE ' ' N ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -81.22 -53.08 6.67 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.417 -1.049 . . . . 3.1600000000000001 109.267 -179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.452 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.4 OUTLIER -61.02 -17.73 53.86 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.068 -1.02 . . . . 1.3799999999999999 108.254 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -53.28 -35.54 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.351 -0.843 . . . . 0.84999999999999998 110.358 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -24.86 33.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.717 -1.239 . . . . 1.1200000000000001 109.036 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.499 ' CD ' ' N ' ' B' ' 45' ' ' LYS . 5.4 mptt -66.44 -68.58 0.36 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.692 -1.595 . . . . 1.8700000000000001 106.692 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.654 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -36.44 -49.13 0.71 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.056 0.455 . . . . 0.26000000000000001 110.671 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 68' ' ' THR . 79.7 t -66.89 -64.89 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.083 -1.011 . . . . 0.28000000000000003 109.8 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' B' ' 47' ' ' VAL . 4.5 t70 -46.59 -48.81 19.58 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.442 -0.947 . . . . 1.25 108.442 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.604 HG11 HD21 ' B' ' 36' ' ' LEU . 25.5 t -45.98 -52.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.389 -0.967 . . . . 1.0600000000000001 108.389 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.547 ' C ' ' CD1' ' B' ' 50' ' ' TYR . 0.2 OUTLIER -66.78 -60.25 2.84 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.377 -0.827 . . . . 4.1100000000000003 110.26 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ASN . . . . . 0.59 ' CG ' ' H ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -45.13 -50.53 11.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.155 -1.018 . . . . 1.4099999999999999 108.539 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -64.97 -34.63 78.88 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.349 -0.94 . . . . 0.65000000000000002 109.882 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.449 HD22 HG11 ' B' ' 23' ' ' VAL . 11.2 tp -69.98 -23.99 63.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.976 -1.078 . . . . 0.53000000000000003 109.921 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -28.41 33.47 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.095 -1.628 . . . . 0.98999999999999999 106.683 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -16.3 12.16 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.978 -1.119 . . . . 1.46 107.978 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -78.39 -40.04 37.29 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 120.222 -0.591 . . . . 1.71 110.073 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.2 tp -153.53 -24.7 0.14 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 118.329 -1.348 . . . . 1.77 112.118 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.29 -60.88 0.06 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.367 -1.397 . . . . 0.39000000000000001 109.914 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -67.71 -37.66 82.56 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.351 -1.088 . . . . 1.3999999999999999 109.764 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.508 ' O ' HG23 ' B' ' 61' ' ' VAL . . . -90.93 28.34 7.99 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.534 -1.426 . . . . 0.34000000000000002 109.534 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 60' ' ' GLY . 48.6 t -158.57 92.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -1.177 . . . . 0.46000000000000002 108.791 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER -97.42 161.64 13.69 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.252 1.025 . . . . 1.4199999999999999 112.094 -178.397 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 tt -97.27 121.15 38.84 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.104 -1.073 . . . . 0.54000000000000004 108.104 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.37 -18.21 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.248 -0.907 . . . . 1.4299999999999999 110.865 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.4 ' O ' HG23 ' B' ' 66' ' ' VAL . 1.9 m-20 -178.5 153.49 0.72 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.52 -1.362 . . . . 1.28 109.907 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 65' ' ' ASN . 87.5 t -158.19 136.56 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.93 -0.767 . . . . 0.90000000000000002 108.93 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' GLN . . . . . 0.648 ' HB3' HD12 ' B' ' 82' ' ' LEU . 24.0 tt0 -147.16 164.87 31.74 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.253 1.025 . . . . 1.4399999999999999 110.663 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.628 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -143.0 158.42 43.62 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.426 -0.953 . . . . 0.45000000000000001 108.426 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.67 151.84 11.78 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 106.934 -2.467 . . . . 0.28999999999999998 106.934 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.617 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 39.9 p -93.28 160.21 14.93 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.909 -1.348 . . . . 0.39000000000000001 108.535 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -159.09 174.62 14.62 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.925 -1.109 . . . . 1.49 110.061 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.432 ' O ' ' OE1' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -90.64 130.47 39.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 119.767 -0.773 . . . . 0.87 109.858 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.2 ttt85 -148.14 104.88 3.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.041 -0.726 . . . . 2.1800000000000002 109.041 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.2 t70 82.59 39.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.611 -0.515 . . . . 1.3500000000000001 109.611 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.62 31.86 20.26 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.063 0.935 . . . . 2.5699999999999998 108.793 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -154.86 152.75 30.17 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.056 -0.72 . . . . 3.1400000000000001 109.056 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -88.18 136.77 32.82 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.857 -1.137 . . . . 2.3900000000000001 110.734 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 tt -138.87 157.26 29.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.713 0.768 . . . . 0.57999999999999996 109.38 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.37 146.75 28.3 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.904 -1.146 . . . . 0.60999999999999999 107.904 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.618 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 2.3 t80 -136.98 139.78 41.72 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.961 -0.755 . . . . 4.0800000000000001 108.961 -175.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 12.9 tt -122.78 132.27 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 121.996 0.903 . . . . 0.90000000000000002 113.236 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' B' ' 67' ' ' GLN . 0.9 OUTLIER -108.81 108.08 18.75 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 105.999 -1.852 . . . . 0.37 105.999 177.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.73 121.26 43.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.227 -0.921 . . . . 0.97999999999999998 110.139 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ARG . . . . . 0.581 ' O ' HD12 ' B' ' 85' ' ' LEU . 33.9 ttt180 -97.28 168.26 10.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.873 -0.731 . . . . 0.70999999999999996 109.61 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.581 HD12 ' O ' ' B' ' 84' ' ' ARG . 1.0 OUTLIER -160.97 144.17 13.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.653 -0.819 . . . . 1.4399999999999999 109.99 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' B' ' 62' ' ' GLN . 1.8 tmtp? -125.64 147.27 49.38 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.542 -0.54 . . . . 1.3100000000000001 109.542 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -101.48 136.6 41.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.262 -0.898 . . . . 1.6399999999999999 109.845 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.94 -8.97 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.626 -0.879 . . . . 0.68000000000000005 108.626 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 21.0 t80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 118.017 -0.992 . . . . 1.77 109.564 179.659 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.723 ' ND2' HD13 ' A' ' 26' ' ' LEU . 48.0 t-20 . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.025 -0.731 . . . . 1.72 109.025 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 6.7 pt-20 -93.32 117.88 30.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.289 -0.882 . . . . 1.4399999999999999 109.671 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.645 HD11 ' ND2' ' A' ' 6' ' ' ASN . 53.5 mt -128.89 153.22 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 CA-C-O 122.189 0.995 . . . . 1.1100000000000001 112.384 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 37' ' ' LYS . 12.2 p -112.3 131.22 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.626 0.727 . . . . 1.3500000000000001 110.252 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.685 HG11 ' HB2' ' A' ' 46' ' ' ALA . 4.7 p -88.95 165.12 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.206 -1.035 . . . . 0.39000000000000001 108.206 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.53 ' N ' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.36 172.47 12.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.967 . . . . 2.27 110.002 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.554 ' NZ ' ' CZ ' ' A' ' 41' ' ' ARG . 6.1 pttp -98.06 -4.23 36.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.979 -0.748 . . . . 1.78 108.979 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.01 0.33 55.93 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.429 -1.323 . . . . 1.24 107.429 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -117.95 131.25 56.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.362 -1.348 . . . . 1.4099999999999999 107.362 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -67.88 173.17 4.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.751 -1.218 . . . . 1.25 110.435 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 17' ' ' GLU . 33.5 m -62.49 -35.65 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.361 -0.977 . . . . 0.48999999999999999 108.361 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' N ' HG23 ' A' ' 16' ' ' VAL . 9.2 pt-20 -69.76 -39.88 76.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.649 -0.871 . . . . 1.5600000000000001 108.649 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' N ' ' CG ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -48.5 -37.93 18.82 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.671 -1.268 . . . . 1.3799999999999999 111.93 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.689 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.4 m80 -93.87 -19.56 20.86 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.321 -1.487 . . . . 1.4299999999999999 108.667 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.68 -34.53 47.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 104.482 -2.414 . . . . 0.28999999999999998 104.482 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.791 ' O ' HG23 ' A' ' 25' ' ' VAL . 71.6 mt -69.07 -55.68 10.02 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.033 -0.985 . . . . 0.40999999999999998 108.556 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.68 -29.95 71.03 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.311 -0.868 . . . . 1.22 109.668 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 19' ' ' HIS . 24.9 t -70.42 -54.82 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.32000000000000001 108.953 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 24' ' ' ILE . 2.9 tt -61.73 -15.18 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.165 -0.959 . . . . 0.57999999999999996 108.839 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 21' ' ' LEU . 55.4 t -81.42 -47.32 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.40999999999999998 109.458 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.723 HD13 ' ND2' ' A' ' 6' ' ' ASN . 3.9 mt -65.84 -35.12 79.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.789 -1.194 . . . . 1.1899999999999999 110.017 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.597 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 3.1 t80 -62.39 -23.83 67.05 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.919 -1.511 . . . . 1.46 106.919 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.29 -29.54 70.84 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.338 -0.846 . . . . 1.1499999999999999 109.153 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -87.26 -14.08 41.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.945 -1.097 . . . . 1.1699999999999999 109.121 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.68 11.25 5.04 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.378 -1.089 . . . . 0.41999999999999998 110.378 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 6' ' ' ASN . 32.3 mm -74.99 98.92 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.985 -1.303 . . . . 0.34999999999999998 109.172 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.11 -34.27 20.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.551 -0.907 . . . . 1.55 108.551 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 1.7 mt-10 -102.85 141.55 35.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.56 0.695 . . . . 1.5800000000000001 110.259 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -151.77 144.18 16.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.397 -0.921 . . . . 0.54000000000000004 109.859 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -121.63 128.54 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.38 0.609 . . . . 0.25 109.94 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.753 HD13 ' OH ' ' A' ' 50' ' ' TYR . 3.4 mp -111.78 123.56 50.5 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.236 0.541 . . . . 0.40000000000000002 110.241 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.626 ' O ' HG12 ' A' ' 10' ' ' VAL . 3.3 mtpt -102.9 128.82 49.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.246 -1.39 . . . . 2.7400000000000002 107.246 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.44 154.11 23.37 Favored Glycine 0 N--CA 1.501 3.029 0 C-N-CA 119.525 -1.321 . . . . 0.20999999999999999 111.031 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 41' ' ' ARG . 30.1 p -135.88 141.15 44.55 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.801 0.81 . . . . 0.56000000000000005 112.678 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.604 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 39.46 -84.26 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.728 -0.608 . . . . 0.33000000000000002 111.637 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -84.89 -51.14 6.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.157 -1.202 . . . . 3.0899999999999999 110.096 -178.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -25.07 64.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.624 -1.298 . . . . 1.0900000000000001 108.763 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 40' ' ' GLY . 5.7 tt -51.93 -36.66 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.628 -0.67 . . . . 0.87 111.335 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.402 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -84.7 -21.18 30.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.718 -1.239 . . . . 1.1399999999999999 109.133 -179.187 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 46' ' ' ALA . 8.0 mmtp -62.08 -71.67 0.15 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.819 -1.919 . . . . 1.8600000000000001 105.819 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.685 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -32.88 -45.37 0.13 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.267 0.556 . . . . 0.28999999999999998 111.167 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.708 HG13 ' HB ' ' B' ' 68' ' ' THR . 72.0 t -57.02 -70.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.986 -1.071 . . . . 0.22 110.267 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -44.49 -44.29 8.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.556 -0.715 . . . . 1.26 109.971 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.6 t -46.81 -57.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 119.967 -0.693 . . . . 1.0600000000000001 109.556 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.753 ' OH ' HD13 ' A' ' 36' ' ' LEU . 64.8 m-85 -65.13 -51.23 62.49 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.039 -1.038 . . . . 4.0199999999999996 112.668 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' ND2' ' N ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -51.05 -47.98 61.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.546 -1.346 . . . . 1.3400000000000001 107.55 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.514 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 11.1 p -65.45 -33.84 76.89 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.799 -0.761 . . . . 1.04 109.527 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.456 HD22 HG11 ' A' ' 23' ' ' VAL . 5.9 tp -84.13 -24.18 30.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.68 -1.263 . . . . 0.44 108.846 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.607 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.92 -48.81 12.83 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 104.756 -2.313 . . . . 1.0 104.756 177.606 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 32.0 t0 -50.1 -12.93 0.09 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.185 -1.37 . . . . 1.5800000000000001 107.786 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' N ' ' C ' ' A' ' 54' ' ' LYS . 5.0 tpt85 -64.7 -46.95 80.16 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.682 0.753 . . . . 1.6899999999999999 109.887 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 tp -155.35 -7.44 0.13 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.515 -0.874 . . . . 1.6599999999999999 110.388 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.27 -59.81 0.06 OUTLIER Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.594 -1.289 . . . . 0.39000000000000001 109.887 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -72.09 -35.83 69.33 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.808 -0.819 . . . . 1.3799999999999999 110.212 -178.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.75 20.54 9.16 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.364 -1.494 . . . . 0.26000000000000001 109.364 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.628 HG13 HD11 ' A' ' 85' ' ' LEU . 2.4 t -154.63 133.26 2.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.54 -1.282 . . . . 0.38 107.54 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.9 mm-40 -137.57 150.73 47.69 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.482 1.134 . . . . 1.3100000000000001 112.249 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 66' ' ' VAL . 7.4 tt -94.31 108.7 20.58 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.537 -1.282 . . . . 0.48999999999999999 107.537 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.89 -23.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.305 -0.872 . . . . 1.3500000000000001 110.369 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.578 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -162.38 153.82 18.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.172 -1.58 . . . . 1.2 109.348 177.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 63' ' ' LEU . 46.3 t -162.32 129.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.406 -0.809 . . . . 0.84999999999999998 109.485 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -140.78 157.15 45.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.107 0.955 . . . . 1.4099999999999999 110.606 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.432 ' HB ' HG13 ' B' ' 47' ' ' VAL . 0.7 OUTLIER -137.42 143.89 42.1 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.178 -0.675 . . . . 0.52000000000000002 109.178 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.674 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -167.35 159.94 33.43 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.384 -2.286 . . . . 0.40000000000000002 107.384 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.4 p -98.53 161.15 13.82 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 118.984 1.392 . . . . 0.41999999999999998 110.745 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -156.05 175.6 13.75 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.111 -0.993 . . . . 1.29 110.568 178.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.62 137.34 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.6 0.714 . . . . 1.02 110.553 -179.245 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 27.5 ttt-85 -148.41 102.58 3.35 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.567 -0.901 . . . . 2.23 108.567 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.9 t70 87.91 35.07 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.204 0.526 . . . . 1.3799999999999999 109.646 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 63.66 37.62 10.0 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.356 1.074 . . . . 2.6200000000000001 109.21 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -157.52 153.35 26.86 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.41 -0.806 . . . . 3.1499999999999999 108.837 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -86.31 135.19 33.63 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.775 1.274 . . . . 2.4399999999999999 110.662 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.409 HD11 ' HA3' ' A' ' 40' ' ' GLY . 4.8 tt -141.31 155.12 20.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.604 -1.258 . . . . 0.23000000000000001 107.604 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -87.44 159.99 18.47 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.227 -0.921 . . . . 0.73999999999999999 111.116 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.674 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.1 p90 -145.08 153.25 41.23 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.87 0.843 . . . . 4.1600000000000001 110.581 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -125.96 131.84 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.778 0.799 . . . . 0.92000000000000004 109.416 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.5 mt -109.5 122.56 47.69 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.695 -1.594 . . . . 0.35999999999999999 106.695 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.517 HD11 ' OG1' ' B' ' 68' ' ' THR . 0.5 OUTLIER -132.95 129.13 37.87 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.255 1.026 . . . . 0.97999999999999998 110.737 -177.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -99.25 172.25 7.47 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.128 -0.942 . . . . 0.57999999999999996 110.074 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.815 HD13 ' N ' ' A' ' 86' ' ' LYS . 1.0 OUTLIER -157.18 137.79 13.11 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.2 -1.0 . . . . 1.3899999999999999 108.85 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.815 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -125.78 140.69 52.47 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.399 0.618 . . . . 1.4199999999999999 109.468 179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.597 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 16.6 mmt85 -99.41 136.02 39.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.533 -0.73 . . . . 1.6399999999999999 109.979 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 88' ' ' VAL . 48.2 t -113.54 -0.97 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.496 -0.927 . . . . 0.63 108.496 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.7 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.988 -1.006 . . . . 1.76 109.415 178.901 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.504 ' OD1' HD13 ' B' ' 26' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.243 0.544 . . . . 1.46 111.965 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 7.0 pt-20 -93.41 116.45 28.99 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.524 -1.287 . . . . 1.49 107.524 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 75.6 mt -128.96 153.15 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.526 -0.734 . . . . 1.1699999999999999 110.815 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.553 HG23 ' HB2' ' B' ' 37' ' ' LYS . 7.9 p -105.79 126.81 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.451 0.643 . . . . 1.3700000000000001 110.169 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' B' ' 46' ' ' ALA . 3.7 p -86.86 166.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.834 -1.173 . . . . 0.37 107.834 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.596 ' N ' HG22 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -138.78 174.31 10.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 2.3700000000000001 110.902 -178.234 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.545 ' NZ ' ' CZ ' ' B' ' 41' ' ' ARG . 6.6 pttp -102.49 -12.88 17.49 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.171 -1.048 . . . . 1.75 108.171 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.72 -9.44 58.21 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.948 -1.13 . . . . 1.1899999999999999 107.948 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' B' ' 15' ' ' ASN . 11.4 mmpt? -92.56 -129.74 0.11 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.451 -1.314 . . . . 1.47 107.451 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' B' ' 14' ' ' LYS . 0.4 OUTLIER -168.15 158.89 10.55 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.09 -1.006 . . . . 1.22 109.37 178.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.547 HG23 ' N ' ' B' ' 17' ' ' GLU . 12.9 m -57.69 -39.84 72.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.116 -1.068 . . . . 0.45000000000000001 108.116 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.547 ' N ' HG23 ' B' ' 16' ' ' VAL . 6.5 pt-20 -75.58 -34.04 60.63 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.916 -0.772 . . . . 1.7 108.916 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -63.49 -32.84 74.4 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.852 -1.155 . . . . 1.46 111.6 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.7 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.3 OUTLIER -91.96 -16.06 27.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.051 -1.656 . . . . 1.3999999999999999 108.032 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.14 -35.49 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 104.499 -2.408 . . . . 0.34000000000000002 104.499 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.788 ' O ' HG23 ' B' ' 25' ' ' VAL . 43.3 mt -67.87 -50.56 55.75 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.785 -1.098 . . . . 0.38 109.33 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.34 -33.57 75.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.978 -1.077 . . . . 1.21 109.307 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 19' ' ' HIS . 34.7 t -66.29 -52.76 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.29999999999999999 109.42 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.7 tt -65.3 -19.71 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.99 -1.069 . . . . 0.68999999999999995 109.025 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.788 HG23 ' O ' ' B' ' 21' ' ' LEU . 41.8 t -75.17 -45.51 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.203 -0.936 . . . . 0.41999999999999998 109.822 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.538 HD22 HG13 ' B' ' 31' ' ' ILE . 4.1 mt -68.02 -36.94 80.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.699 -1.251 . . . . 1.1499999999999999 109.829 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' PHE . . . . . 0.559 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 4.6 t80 -58.03 -29.84 65.65 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.229 -1.767 . . . . 1.46 106.229 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -26.74 66.57 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.818 -1.083 . . . . 1.1699999999999999 109.176 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.437 ' OE1' HD23 ' B' ' 26' ' ' LEU . 80.1 mt-30 -92.2 -1.09 57.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.008 . . . . 1.1699999999999999 109.337 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.02 13.9 18.48 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.765 -0.934 . . . . 0.38 110.765 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.538 HG13 HD22 ' B' ' 26' ' ' LEU . 12.9 mm -78.2 105.01 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.697 -1.473 . . . . 0.58999999999999997 107.987 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -91.3 -38.87 12.38 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.19 -0.944 . . . . 1.46 109.186 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.7 135.21 43.61 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.278 0.561 . . . . 1.2 110.159 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' B' ' 6' ' ' ASN . 0.3 OUTLIER -145.41 130.94 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.578 -0.849 . . . . 0.48999999999999999 110.397 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -106.34 124.37 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.686 -0.634 . . . . 0.31 110.069 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.901 HD13 ' OH ' ' B' ' 50' ' ' TYR . 2.6 mp -107.94 129.73 55.08 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.451 -0.78 . . . . 0.47999999999999998 110.887 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.592 ' O ' HG12 ' B' ' 10' ' ' VAL . 5.0 mtpt -106.11 126.18 51.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.177 -1.046 . . . . 2.7400000000000002 108.177 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.63 153.23 20.96 Favored Glycine 0 N--CA 1.505 3.241 0 C-N-CA 119.873 -1.156 . . . . 0.23999999999999999 110.799 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.635 ' O ' ' N ' ' B' ' 41' ' ' ARG . 24.9 p -133.87 142.65 47.88 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.785 -0.833 . . . . 0.48999999999999999 112.095 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.661 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 33.8 -79.23 0.0 OUTLIER Glycine 0 N--CA 1.505 3.277 0 N-CA-C 111.932 -0.467 . . . . 0.28000000000000003 111.932 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.635 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -84.04 -55.4 4.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.037 -1.272 . . . . 3.1600000000000001 109.377 -179.465 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -17.7 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.024 -1.048 . . . . 1.3799999999999999 109.852 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.661 HG22 ' O ' ' B' ' 40' ' ' GLY . 6.7 tt -61.64 -22.41 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.84999999999999998 109.913 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.41 -29.72 17.82 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.353 -0.98 . . . . 1.1200000000000001 108.353 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' B' ' 46' ' ' ALA . 7.5 mmtp -60.19 -67.18 0.42 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.332 -1.729 . . . . 1.8700000000000001 106.332 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.784 ' HB2' HG11 ' B' ' 10' ' ' VAL . . . -32.4 -47.01 0.14 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 116.082 -0.508 . . . . 0.26000000000000001 111.823 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.432 HG13 ' HB ' ' A' ' 68' ' ' THR . 84.9 t -66.4 -61.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.837 -1.164 . . . . 0.28000000000000003 111.3 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' B' ' 49' ' ' VAL . 9.2 t70 -45.54 -51.08 12.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.216 -0.928 . . . . 1.25 109.348 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' B' ' 48' ' ' ASP . 64.3 t -41.71 -54.22 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.751 -0.463 . . . . 1.0600000000000001 109.751 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.901 ' OH ' HD13 ' B' ' 36' ' ' LEU . 59.5 m-85 -68.12 -53.56 24.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -0.987 . . . . 4.1100000000000003 111.627 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' B' ' 52' ' ' SER . 0.0 OUTLIER -46.77 -55.76 7.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.858 -1.164 . . . . 1.4099999999999999 107.858 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.557 ' N ' ' ND2' ' B' ' 51' ' ' ASN . 0.7 OUTLIER -61.17 -39.68 91.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.628 -0.829 . . . . 0.65000000000000002 109.714 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.461 HD22 HG11 ' B' ' 23' ' ' VAL . 5.8 tp -71.2 -23.96 62.13 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.79 -1.194 . . . . 0.53000000000000003 108.614 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 50' ' ' TYR . 0.0 OUTLIER -76.5 -47.83 21.53 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.789 -1.56 . . . . 0.98999999999999999 106.789 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -44.67 -17.47 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.993 -1.003 . . . . 1.46 109.276 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' B' ' 54' ' ' LYS . 21.9 mmm180 -65.87 -39.8 91.03 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.38 -0.928 . . . . 1.71 109.997 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.3 tp -156.7 -12.46 0.09 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.429 -1.308 . . . . 1.77 111.528 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 67.3 -65.24 0.24 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.849 -1.7 . . . . 0.39000000000000001 108.849 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.5 -41.24 76.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.632 -0.922 . . . . 1.3999999999999999 109.704 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.16 17.07 2.51 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.543 -1.423 . . . . 0.34000000000000002 109.543 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.68 HG13 HD11 ' B' ' 85' ' ' LEU . 2.5 t -152.32 130.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.05 -1.463 . . . . 0.46000000000000002 107.05 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' B' ' 86' ' ' LYS . 5.4 mm-40 -137.94 152.01 48.54 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.303 1.049 . . . . 1.4199999999999999 112.455 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.578 HD11 HG21 ' B' ' 66' ' ' VAL . 8.4 tt -94.37 119.12 32.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.906 -1.146 . . . . 0.54000000000000004 107.906 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.49 ' O ' ' ND2' ' B' ' 65' ' ' ASN . 6.9 p -116.32 -13.39 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.337 -0.852 . . . . 1.4299999999999999 110.853 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' B' ' 64' ' ' VAL . 0.3 OUTLIER -171.23 143.66 1.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.399 -1.438 . . . . 1.28 109.482 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.578 HG21 HD11 ' B' ' 63' ' ' LEU . 96.7 t -156.83 133.92 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.054 -0.721 . . . . 0.90000000000000002 109.054 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' GLN . . . . . 0.611 ' HB3' HD12 ' B' ' 82' ' ' LEU . 48.5 tt0 -142.21 159.75 41.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.092 0.949 . . . . 1.4399999999999999 110.446 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.708 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -137.0 156.14 48.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.78 -0.822 . . . . 0.45000000000000001 108.78 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.681 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -179.74 157.98 21.33 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.745 -2.142 . . . . 0.28999999999999998 107.745 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 68.8 p -96.44 154.63 17.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.051 -1.264 . . . . 0.39000000000000001 109.44 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -153.17 170.7 19.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.827 -1.171 . . . . 1.49 110.446 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.418 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -89.02 137.09 21.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.852 0.834 . . . . 0.87 111.284 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 7.5 ttt-85 -149.78 97.87 2.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.08 -0.711 . . . . 2.1800000000000002 109.08 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 4.0 t0 88.34 36.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.427 -0.583 . . . . 1.3500000000000001 109.427 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 65.01 34.48 8.84 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.214 1.007 . . . . 2.5699999999999998 109.463 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -156.52 154.52 30.44 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.791 -0.818 . . . . 3.1400000000000001 108.791 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -88.11 145.77 25.77 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.585 1.183 . . . . 2.3900000000000001 111.842 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tt -144.36 159.49 15.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.871 -1.058 . . . . 0.57999999999999996 108.194 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.09 151.08 22.99 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 121.372 -0.83 . . . . 0.60999999999999999 109.036 -178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.681 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.2 p90 -143.83 151.91 40.51 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.615 -0.834 . . . . 4.0800000000000001 110.37 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.498 HG23 ' O ' ' B' ' 81' ' ' ILE . 20.4 tt -128.71 135.02 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.643 0.735 . . . . 0.90000000000000002 111.27 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' B' ' 67' ' ' GLN . 7.7 mt -110.69 124.31 51.7 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.69 -1.596 . . . . 0.37 106.69 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.67 127.15 39.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.143 -0.973 . . . . 0.97999999999999998 111.275 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -108.26 110.17 21.71 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.557 0.694 . . . . 0.70999999999999996 111.159 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.864 HD13 ' N ' ' B' ' 86' ' ' LYS . 1.3 tm? -96.42 140.46 31.04 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.986 -0.746 . . . . 1.4399999999999999 108.986 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.864 ' N ' HD13 ' B' ' 85' ' ' LEU . 0.0 OUTLIER -122.35 136.03 54.82 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.406 -0.591 . . . . 1.3100000000000001 109.406 179.297 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ARG . . . . . 0.559 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 16.4 mmt85 -96.12 140.26 31.09 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.33 -0.856 . . . . 1.6399999999999999 110.296 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.49 ' O ' HG12 ' B' ' 88' ' ' VAL . 36.2 t -118.08 -6.77 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.706 -0.85 . . . . 0.68000000000000005 108.706 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 74.8 t80 . . . . . 0 C--N 1.303 -1.432 0 CA-C-O 117.979 -1.01 . . . . 1.77 109.423 179.26 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.63 ' OD1' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.576 0.227 . . . . 1.72 110.621 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 3.8 pt-20 -89.34 112.23 23.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.066 -1.646 . . . . 1.4399999999999999 108.262 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.63 HD11 ' OD1' ' A' ' 6' ' ' ASN . 5.6 mt -128.74 147.25 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 CA-C-O 122.189 0.995 . . . . 1.1100000000000001 112.195 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 37' ' ' LYS . 61.1 t -112.91 129.52 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.606 0.717 . . . . 1.3500000000000001 110.336 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.532 HG11 ' H ' ' A' ' 46' ' ' ALA . 1.7 p -87.65 167.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.055 -1.091 . . . . 0.39000000000000001 108.055 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.91 167.88 20.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 2.27 109.977 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -20.65 27.61 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.386 -0.968 . . . . 1.78 108.386 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -69.4 -65.41 0.72 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.761 -1.57 . . . . 1.24 106.761 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.524 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.4 mtmm -58.24 144.07 42.23 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.216 1.007 . . . . 1.4099999999999999 110.347 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.87 178.86 4.61 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.696 -0.684 . . . . 1.25 110.067 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.61 -28.79 25.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.254 -1.017 . . . . 0.48999999999999999 108.254 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.4 -33.85 61.01 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.484 -0.886 . . . . 1.5600000000000001 109.119 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.2 -31.59 69.16 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 120.396 -1.44 . . . . 1.3799999999999999 110.925 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.709 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -95.64 -18.3 20.64 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.692 -1.255 . . . . 1.4299999999999999 108.459 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -34.72 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 104.513 -2.403 . . . . 0.28999999999999998 104.513 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.773 ' O ' HG23 ' A' ' 25' ' ' VAL . 38.5 mt -68.33 -52.57 31.97 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.495 -1.23 . . . . 0.40999999999999998 108.771 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -66.34 -29.34 69.51 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.114 -0.991 . . . . 1.22 109.437 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 19' ' ' HIS . 19.7 t -69.79 -53.24 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.32000000000000001 109.453 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.23 -18.03 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.895 -1.128 . . . . 0.57999999999999996 108.617 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 21' ' ' LEU . 54.0 t -75.98 -43.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 119.335 -0.946 . . . . 0.40999999999999998 108.573 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.415 HD13 HD11 ' A' ' 8' ' ' ILE . 4.2 mt -64.79 -33.4 75.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.825 -1.172 . . . . 1.1899999999999999 110.029 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -65.87 -23.0 66.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.877 -1.527 . . . . 1.46 106.877 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -61.74 -30.77 70.99 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.123 -0.944 . . . . 1.1499999999999999 108.811 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -87.82 -6.34 58.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.27 -0.894 . . . . 1.1699999999999999 109.244 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.73 12.45 18.74 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.913 -1.275 . . . . 0.41999999999999998 109.913 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.6 mm -73.88 109.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.138 -1.213 . . . . 0.34999999999999998 109.25 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.22 -37.22 11.66 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.423 -0.798 . . . . 1.55 110.721 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 1.9 mt-10 -97.73 137.85 36.0 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.601 0.715 . . . . 1.5800000000000001 110.793 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -147.87 137.29 16.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.66 -0.816 . . . . 0.54000000000000004 109.826 -179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -117.08 126.04 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.753 -0.658 . . . . 0.25 109.591 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.4 mp -111.76 119.56 39.04 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 120.262 -0.575 . . . . 0.40000000000000002 109.519 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 9' ' ' VAL . 2.4 mttt -105.26 132.67 51.17 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.02 -1.104 . . . . 2.7400000000000002 108.02 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.19 151.79 21.6 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.748 -1.215 . . . . 0.20999999999999999 110.926 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 41' ' ' ARG . 64.3 p -126.01 134.03 51.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.986 -0.714 . . . . 0.56000000000000005 111.673 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 38.4 -83.56 0.0 OUTLIER Glycine 0 N--CA 1.495 2.632 0 O-C-N 121.615 -0.678 . . . . 0.33000000000000002 112.286 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.686 ' HE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.31 -54.2 6.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.127 -1.219 . . . . 3.0899999999999999 110.087 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.38 -20.99 63.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.64 -1.244 . . . . 1.0900000000000001 107.64 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 43' ' ' ILE . 1.5 tt -53.18 -36.46 25.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.233 -0.917 . . . . 0.87 110.858 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.61 -20.39 31.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.678 -1.264 . . . . 1.1399999999999999 108.747 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 46' ' ' ALA . 1.5 mptt -64.32 -71.02 0.19 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.518 -2.03 . . . . 1.8600000000000001 105.518 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.663 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -30.44 -48.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.403 0.621 . . . . 0.28999999999999998 110.37 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.691 HG13 ' HB ' ' B' ' 68' ' ' THR . 92.0 t -57.94 -71.68 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.378 -0.826 . . . . 0.22 109.995 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' OG ' ' A' ' 52' ' ' SER . 8.4 t70 -42.52 -46.72 4.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.755 -0.59 . . . . 1.26 110.05 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.2 t -48.75 -57.52 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.483 -0.887 . . . . 1.0600000000000001 108.82 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.571 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -61.03 -55.58 31.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 4.0199999999999996 110.978 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.681 HD21 ' HA2' ' B' ' 69' ' ' GLY . 14.0 t-20 -52.1 -51.14 59.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.873 -1.142 . . . . 1.3400000000000001 107.985 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 5.7 m -60.38 -34.15 73.49 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.528 -0.915 . . . . 1.04 108.528 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.434 HD22 HG11 ' A' ' 23' ' ' VAL . 7.1 tp -82.13 -21.64 36.56 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.078 -1.014 . . . . 0.44 108.389 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.29 -49.34 12.61 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.701 -1.963 . . . . 1.0 105.701 177.134 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 1.7 t0 -54.43 -8.64 0.23 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.754 -1.202 . . . . 1.5800000000000001 107.754 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 54' ' ' LYS . 4.6 tpt85 -68.7 -52.88 26.04 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.487 -0.758 . . . . 1.6899999999999999 109.196 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -153.14 -13.29 0.15 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.347 -0.941 . . . . 1.6599999999999999 110.948 179.307 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.441 ' N ' HD12 ' A' ' 57' ' ' LEU . . . 62.94 -47.44 0.07 OUTLIER Glycine 0 N--CA 1.494 2.509 0 C-N-CA 120.043 -1.075 . . . . 0.39000000000000001 110.842 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -72.72 -41.71 64.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.252 -1.146 . . . . 1.3799999999999999 109.986 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.482 ' H ' HD13 ' A' ' 57' ' ' LEU . . . -87.15 22.91 12.7 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.94 -1.264 . . . . 0.26000000000000001 109.94 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.577 HG13 HD21 ' A' ' 85' ' ' LEU . 2.4 t -149.37 132.5 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.979 -1.306 . . . . 0.38 107.705 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.605 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.7 mm-40 -135.51 155.74 50.02 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.034 0.921 . . . . 1.3100000000000001 111.575 -177.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.42 110.01 21.57 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.486 -0.931 . . . . 0.48999999999999999 108.486 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.8 -22.91 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.065 -1.022 . . . . 1.3500000000000001 109.775 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -172.85 152.56 2.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.699 -1.25 . . . . 1.2 109.759 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 65' ' ' ASN . 72.0 t -159.28 128.29 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.863 -0.792 . . . . 0.84999999999999998 108.863 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 68' ' ' THR . 31.9 tt0 -142.09 157.05 45.35 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.086 0.946 . . . . 1.4099999999999999 110.531 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.479 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -124.2 150.81 44.8 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.239 -0.892 . . . . 0.52000000000000002 108.737 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.683 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -175.89 148.88 9.57 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 107.607 -2.197 . . . . 0.40000000000000002 107.607 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 1.133 ' H ' ' ND2' ' B' ' 51' ' ' ASN . 37.1 p -95.75 158.01 15.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.703 -1.469 . . . . 0.41999999999999998 110.996 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' OE2' ' C ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -150.51 167.63 26.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.162 -0.961 . . . . 1.29 110.073 178.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.403 ' C ' ' OE2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -91.91 141.94 13.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.644 0.735 . . . . 1.02 111.044 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 7.5 ttt-85 -149.25 103.44 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.165 -0.68 . . . . 2.23 109.165 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.4 t70 86.38 36.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.049 0.452 . . . . 1.3799999999999999 110.339 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.29 32.71 12.08 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.174 0.988 . . . . 2.6200000000000001 109.045 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.19 146.12 26.67 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.284 -1.006 . . . . 3.1499999999999999 108.284 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.473 ' NH2' ' OD1' ' B' ' 51' ' ' ASN . 8.1 ttt180 -85.91 139.73 30.98 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.893 1.33 . . . . 2.4399999999999999 110.614 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.6 tt -142.71 154.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 114.276 -1.329 . . . . 0.23000000000000001 107.986 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.8 p -88.37 161.64 16.98 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 119.335 -0.946 . . . . 0.73999999999999999 110.444 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.683 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.4 p90 -148.35 156.4 42.46 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.313 -0.955 . . . . 4.1600000000000001 110.244 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 81' ' ' ILE . 10.3 tt -129.68 139.05 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.746 0.784 . . . . 0.92000000000000004 110.485 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.7 mt -111.32 124.0 51.35 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.952 -1.129 . . . . 0.35999999999999999 107.952 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 tt -131.64 126.52 34.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.122 -0.987 . . . . 0.97999999999999998 110.61 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -102.88 172.42 6.84 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.315 0.578 . . . . 0.57999999999999996 109.789 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.577 HD21 HG13 ' A' ' 61' ' ' VAL . 1.9 tp -160.82 144.93 13.7 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 118.679 -1.208 . . . . 1.3899999999999999 110.999 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.605 ' O ' ' N ' ' A' ' 62' ' ' GLN . 14.0 tptt -125.57 136.35 53.2 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.574 0.702 . . . . 1.4199999999999999 109.936 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.425 ' N ' ' HD2' ' A' ' 86' ' ' LYS . 22.6 mmt180 -94.41 136.4 34.75 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.059 -1.026 . . . . 1.6399999999999999 109.663 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.602 ' O ' HG12 ' A' ' 88' ' ' VAL . 69.4 t -121.62 1.21 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.824 -0.806 . . . . 0.63 108.824 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.424 ' CD2' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.383 0 CA-C-O 118.001 -0.999 . . . . 1.76 109.512 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.523 ' OD1' HD11 ' B' ' 8' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 110.214 -0.291 . . . . 1.46 110.214 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.8 pt-20 -90.12 110.32 21.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.165 -1.585 . . . . 1.49 108.897 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.523 HD11 ' OD1' ' B' ' 6' ' ' ASN . 4.1 mt -126.41 142.52 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.848 0.832 . . . . 1.1699999999999999 110.677 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' B' ' 37' ' ' LYS . 63.2 t -104.22 130.47 54.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.49 0.662 . . . . 1.3700000000000001 109.581 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.538 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.4 OUTLIER -87.49 166.13 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.516 -0.92 . . . . 0.37 108.516 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.414 ' NE ' ' CE ' ' B' ' 14' ' ' LYS . 6.7 mtt180 -139.09 171.58 14.1 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.01 0.909 . . . . 2.3700000000000001 110.507 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.04 -11.52 20.5 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.187 -1.042 . . . . 1.75 108.187 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.86 -14.35 54.44 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.637 -0.825 . . . . 1.1899999999999999 109.758 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.574 ' O ' ' ND2' ' B' ' 15' ' ' ASN . 1.2 mttm -98.57 -120.65 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.281 -1.007 . . . . 1.47 108.281 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ASN . . . . . 0.574 ' ND2' ' O ' ' B' ' 14' ' ' LYS . 0.5 OUTLIER -170.94 172.44 5.53 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.097 -1.002 . . . . 1.22 109.15 179.306 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -72.38 -35.25 51.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.115 -1.069 . . . . 0.45000000000000001 108.115 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 10.0 pt-20 -72.46 -41.67 65.82 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.495 -0.928 . . . . 1.7 108.495 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.464 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 68.2 t0 -62.49 -30.81 71.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.141 -0.974 . . . . 1.46 112.082 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.759 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.1 OUTLIER -91.34 -16.46 27.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 119.892 -1.755 . . . . 1.3999999999999999 108.289 178.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 t -75.19 -40.11 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 105.152 -2.166 . . . . 0.34000000000000002 105.152 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.773 ' O ' HG23 ' B' ' 25' ' ' VAL . 59.1 mt -62.31 -49.46 75.54 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.909 -1.041 . . . . 0.38 108.481 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -67.3 -32.13 72.9 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.565 -0.854 . . . . 1.21 109.685 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.759 HG23 ' O ' ' B' ' 19' ' ' HIS . 41.0 t -69.57 -54.55 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.291 -0.881 . . . . 0.29999999999999999 110.068 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 20.4 tt -61.15 -24.05 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.893 -1.129 . . . . 0.68999999999999995 108.864 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.773 HG23 ' O ' ' B' ' 21' ' ' LEU . 39.3 t -68.19 -41.5 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -0.922 . . . . 0.41999999999999998 108.951 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.402 HD13 HD11 ' B' ' 8' ' ' ILE . 4.8 mt -66.52 -43.12 86.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.121 -0.987 . . . . 1.1499999999999999 109.7 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -55.19 -31.49 61.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.735 -1.58 . . . . 1.46 106.735 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -55.69 -30.69 61.53 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.273 -0.876 . . . . 1.1699999999999999 108.777 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -87.96 -3.02 58.95 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.809 -0.811 . . . . 1.1699999999999999 108.809 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.19 15.98 22.14 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.608 -1.397 . . . . 0.38 109.608 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 36.8 mm -77.36 111.42 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.148 -1.207 . . . . 0.58999999999999997 108.421 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.39 -35.83 12.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.272 -0.893 . . . . 1.46 111.015 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -101.64 141.6 34.25 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.626 0.727 . . . . 1.2 110.954 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' B' ' 6' ' ' ASN . 0.8 OUTLIER -149.5 122.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.146 0.974 . . . . 0.48999999999999999 111.096 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.21 122.91 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.613 -0.679 . . . . 0.31 109.254 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' B' ' 46' ' ' ALA . 2.4 mp -105.57 121.76 44.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.431 -0.793 . . . . 0.47999999999999998 110.087 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.506 ' HB2' HG13 ' B' ' 9' ' ' VAL . 7.4 mttt -103.34 128.41 50.43 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.736 -0.839 . . . . 2.7400000000000002 108.736 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.51 150.83 20.64 Favored Glycine 0 N--CA 1.502 3.037 0 C-N-CA 119.572 -1.299 . . . . 0.23999999999999999 110.805 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.613 ' O ' ' N ' ' B' ' 41' ' ' ARG . 47.3 p -129.86 141.24 50.85 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.888 -0.772 . . . . 0.48999999999999999 111.841 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.666 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 32.84 -82.0 0.0 OUTLIER Glycine 0 N--CA 1.504 3.195 0 N-CA-C 111.785 -0.526 . . . . 0.28000000000000003 111.785 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.664 ' N ' ' HE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -80.14 -53.13 6.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.087 -1.243 . . . . 3.1600000000000001 110.057 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.3 OUTLIER -64.93 -13.7 57.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.945 -1.097 . . . . 1.3799999999999999 109.296 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.666 HG22 ' O ' ' B' ' 40' ' ' GLY . 8.1 tt -60.65 -26.03 36.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.26 -0.9 . . . . 0.84999999999999998 109.711 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.58 -25.95 23.34 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.29 -1.004 . . . . 1.1200000000000001 108.29 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' B' ' 46' ' ' ALA . 2.6 mptt -63.75 -70.54 0.21 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.5 -1.667 . . . . 1.8700000000000001 106.5 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.677 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -32.97 -41.17 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.217 0.532 . . . . 0.26000000000000001 110.99 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.63 -64.9 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.142 -0.974 . . . . 0.28000000000000003 109.567 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' B' ' 49' ' ' VAL . 5.8 t70 -48.47 -50.72 30.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.189 -0.944 . . . . 1.25 109.276 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.658 HG11 HD21 ' B' ' 36' ' ' LEU . 38.0 t -42.39 -56.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.96 -0.755 . . . . 1.0600000000000001 108.96 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.568 ' CD1' HD13 ' B' ' 85' ' ' LEU . 0.0 OUTLIER -67.66 -54.33 20.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.447 -0.783 . . . . 4.1100000000000003 110.564 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ASN . . . . . 1.133 ' ND2' ' H ' ' A' ' 70' ' ' SER . 24.7 t-20 -48.5 -57.98 5.35 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.119 -1.032 . . . . 1.4099999999999999 108.531 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -57.95 -30.81 66.27 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.172 -1.011 . . . . 0.65000000000000002 109.649 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.505 HD22 HG11 ' B' ' 23' ' ' VAL . 46.0 tp -75.05 -21.74 58.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.53000000000000003 110.287 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.46 -27.95 25.35 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.373 -1.714 . . . . 0.98999999999999999 106.373 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.412 ' OD2' ' NH2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -59.08 -14.52 10.17 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.686 -1.227 . . . . 1.46 107.686 177.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -75.74 -43.92 44.34 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.618 -0.833 . . . . 1.71 109.487 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' B' ' 59' ' ' ASP . 0.2 OUTLIER -152.1 -20.71 0.18 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.624 -1.23 . . . . 1.77 112.291 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.66 -56.02 0.14 Allowed Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.275 -1.441 . . . . 0.39000000000000001 110.035 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.58 -43.27 73.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.295 -1.121 . . . . 1.3999999999999999 109.989 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.418 ' HA3' HD22 ' B' ' 57' ' ' LEU . . . -82.52 24.97 4.66 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.9 -1.28 . . . . 0.34000000000000002 109.9 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.453 HG13 HD21 ' B' ' 85' ' ' LEU . 1.0 OUTLIER -149.24 130.25 4.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.478 -1.304 . . . . 0.46000000000000002 107.478 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' B' ' 86' ' ' LYS . 4.0 mm-40 -132.27 159.21 39.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.002 0.906 . . . . 1.4199999999999999 111.471 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.34 112.72 25.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.473 -0.936 . . . . 0.54000000000000004 108.473 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -23.51 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.161 -0.962 . . . . 1.4299999999999999 110.391 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.21 151.03 1.59 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.491 -1.38 . . . . 1.28 109.457 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 96.6 t -156.85 132.74 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.722 -0.844 . . . . 0.90000000000000002 108.722 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' GLN . . . . . 0.467 ' CG ' ' N ' ' B' ' 68' ' ' THR . 28.4 tt0 -145.94 165.21 29.62 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.282 1.039 . . . . 1.4399999999999999 110.823 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.691 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -135.72 154.8 51.14 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.221 -0.9 . . . . 0.45000000000000001 108.699 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.711 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -176.71 153.2 13.52 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 107.767 -2.133 . . . . 0.28999999999999998 107.767 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.549 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 6.0 p -96.57 155.98 16.54 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.882 1.341 . . . . 0.39000000000000001 109.382 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -148.98 166.75 27.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.946 -1.096 . . . . 1.49 110.05 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.42 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.2 OUTLIER -90.03 136.95 22.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.845 -0.742 . . . . 0.87 110.542 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.8 ttt-85 -147.17 101.52 3.41 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.337 -0.616 . . . . 2.1800000000000002 109.337 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 1.8 t70 83.02 39.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.427 -0.583 . . . . 1.3500000000000001 109.427 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.17 32.61 14.96 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.915 0.864 . . . . 2.5699999999999998 109.273 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.32 153.88 36.87 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.453 -0.779 . . . . 3.1400000000000001 109.207 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.534 ' NH2' ' OG ' ' B' ' 70' ' ' SER . 1.3 tpt180 -88.36 136.28 33.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.729 0.776 . . . . 2.3900000000000001 110.922 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 11.9 tt -136.31 153.54 31.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.743 -0.836 . . . . 0.57999999999999996 108.743 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 151.59 22.81 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.332 -0.855 . . . . 0.60999999999999999 109.039 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.711 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.0 p90 -144.35 150.86 38.48 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.467 -0.893 . . . . 4.0800000000000001 110.313 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.453 HD11 HG21 ' A' ' 68' ' ' THR . 6.0 tt -126.12 135.83 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.53 0.681 . . . . 0.90000000000000002 109.972 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' B' ' 80' ' ' TYR . 12.2 mt -109.23 121.19 44.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.168 -1.419 . . . . 0.37 107.168 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.517 HD11 ' CD2' ' B' ' 50' ' ' TYR . 6.1 tt -123.25 121.23 35.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.111 -0.993 . . . . 0.97999999999999998 110.338 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -110.12 107.02 16.7 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.264 0.554 . . . . 0.70999999999999996 110.259 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.568 HD13 ' CD1' ' B' ' 50' ' ' TYR . 8.7 tp -104.01 151.54 23.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.591 -0.693 . . . . 1.4399999999999999 110.609 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.1 OUTLIER -126.65 157.27 39.42 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.757 -0.46 . . . . 1.3100000000000001 109.757 -179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ARG . . . . . 0.497 HH22 HD11 ' B' ' 53' ' ' LEU . 22.2 mmt180 -109.98 141.94 42.06 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.225 -0.922 . . . . 1.6399999999999999 110.037 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.452 ' O ' HG12 ' B' ' 88' ' ' VAL . 18.8 t -121.94 -9.98 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.907 -0.775 . . . . 0.68000000000000005 108.907 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 118.066 -0.969 . . . . 1.77 109.537 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.421 ' HB2' HD12 ' A' ' 31' ' ' ILE . 3.2 t-20 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 121.33 0.586 . . . . 1.72 111.193 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -93.82 123.47 37.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 1.4399999999999999 108.384 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -130.38 151.81 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 122.632 1.206 . . . . 1.1100000000000001 113.356 -177.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.4 p -104.7 127.11 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.317 -0.856 . . . . 1.3500000000000001 109.585 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.93 166.63 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.899 . . . . 0.39000000000000001 108.777 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.1 174.17 10.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.176 -0.952 . . . . 2.27 110.462 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' NZ ' ' HE ' ' A' ' 41' ' ' ARG . 12.4 pttt -94.99 -13.66 25.08 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.66 -0.867 . . . . 1.78 108.66 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 t -86.58 1.33 52.09 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.727 -1.212 . . . . 1.24 107.727 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.75 128.59 53.06 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.964 -1.495 . . . . 1.4099999999999999 106.964 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.28 -178.4 1.68 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.831 -0.748 . . . . 1.25 109.865 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 49' ' ' VAL . 1.8 m -79.93 -27.96 12.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 106.796 -1.557 . . . . 0.48999999999999999 106.796 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.72 -46.88 28.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.626 -0.716 . . . . 1.5600000000000001 109.369 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.79 -28.64 69.6 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.915 -1.115 . . . . 1.3799999999999999 110.957 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.708 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -92.08 -15.65 27.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.426 -1.421 . . . . 1.4299999999999999 109.688 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.91 -30.39 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 105.197 -2.149 . . . . 0.28999999999999998 105.197 176.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.555 ' O ' HG23 ' A' ' 25' ' ' VAL . 64.5 mt -70.12 -53.51 16.98 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.866 -1.061 . . . . 0.40999999999999998 108.834 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -65.2 -26.32 68.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 1.22 109.728 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 19' ' ' HIS . 38.6 t -73.64 -50.14 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.59 -0.893 . . . . 0.32000000000000001 108.59 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.75 -23.59 23.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.543 -0.91 . . . . 0.57999999999999996 108.543 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 21' ' ' LEU . 48.8 t -70.71 -42.81 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.247 -0.908 . . . . 0.40999999999999998 109.913 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -68.53 -33.64 74.47 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.447 -1.408 . . . . 1.1899999999999999 109.805 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.75 -27.13 68.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.166 -1.42 . . . . 1.46 107.166 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.97 -26.27 68.5 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.239 -0.891 . . . . 1.1499999999999999 109.887 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -88.97 -1.98 58.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.841 -1.162 . . . . 1.1699999999999999 109.267 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.5 14.52 19.7 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.766 -1.334 . . . . 0.41999999999999998 109.766 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 6' ' ' ASN . 20.7 mm -75.92 107.49 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -1.147 . . . . 0.34999999999999998 108.298 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 33' ' ' GLU . 1.6 p30 -93.65 -38.59 11.26 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.433 -0.792 . . . . 1.55 110.594 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 7.7 mt-10 -97.69 142.02 29.99 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.561 -0.712 . . . . 1.5800000000000001 110.189 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.439 HG13 ' OH ' ' A' ' 50' ' ' TYR . 14.6 p -152.32 139.98 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.041 -1.064 . . . . 0.54000000000000004 111.157 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.55 129.28 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 122.054 -0.404 . . . . 0.25 110.077 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 50' ' ' TYR . 1.8 mp -115.21 126.31 54.41 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.599 0.714 . . . . 0.40000000000000002 110.277 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.438 ' HG2' HG23 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -99.41 127.19 45.43 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.905 -1.146 . . . . 2.7400000000000002 107.905 177.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.54 143.31 14.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.725 -1.226 . . . . 0.20999999999999999 110.51 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 41' ' ' ARG . 31.8 p -131.07 138.45 49.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.922 -0.752 . . . . 0.56000000000000005 111.643 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' THR . . . 35.41 -83.11 0.0 OUTLIER Glycine 0 N--CA 1.501 3.008 0 O-C-N 121.735 -0.603 . . . . 0.33000000000000002 112.247 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -82.97 -56.32 3.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.249 . . . . 3.0899999999999999 109.886 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -15.17 8.71 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.99 -1.115 . . . . 1.0900000000000001 107.99 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.536 HG12 HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -55.5 -32.89 31.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.408 -0.807 . . . . 0.87 111.131 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.17 -22.9 23.79 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.963 -1.086 . . . . 1.1399999999999999 108.221 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 49' ' ' VAL . 2.7 mptt -62.35 -72.39 0.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.747 -1.946 . . . . 1.8600000000000001 105.747 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.638 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -33.24 -46.72 0.18 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.094 0.473 . . . . 0.28999999999999998 110.673 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.602 HG13 ' HB ' ' B' ' 68' ' ' THR . 98.5 t -66.51 -61.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.003 . . . . 0.22 109.297 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.458 ' OD1' HG21 ' A' ' 16' ' ' VAL . 10.5 t70 -51.33 -54.4 26.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 1.26 108.847 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 45' ' ' LYS . 46.7 t -42.66 -58.24 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.543 -0.91 . . . . 1.0600000000000001 108.543 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.655 ' CE1' HD22 ' A' ' 36' ' ' LEU . 3.0 m-30 -62.14 -50.6 71.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.85 -0.531 . . . . 4.0199999999999996 110.982 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.583 ' CG ' ' H ' ' B' ' 70' ' ' SER . 0.8 OUTLIER -56.07 -49.69 73.08 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.78 -1.193 . . . . 1.3400000000000001 107.78 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 4.3 p -59.96 -33.86 72.51 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.423 -0.954 . . . . 1.04 108.423 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.431 HD22 HG11 ' A' ' 23' ' ' VAL . 57.0 tp -79.06 -19.86 50.3 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.985 -1.117 . . . . 0.44 107.985 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.58 -44.47 17.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.539 -2.022 . . . . 1.0 105.539 177.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -59.34 -5.98 0.88 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.565 -1.272 . . . . 1.5800000000000001 107.565 177.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 54' ' ' LYS . 4.6 tpt85 -71.05 -49.13 48.11 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.58 -0.7 . . . . 1.6899999999999999 109.247 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.2 mt -151.64 -21.86 0.19 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.437 -0.905 . . . . 1.6599999999999999 110.302 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.15 -49.44 0.09 OUTLIER Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.847 -1.168 . . . . 0.39000000000000001 110.431 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -73.84 -45.41 51.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -1.202 . . . . 1.3799999999999999 109.929 -178.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.2 27.68 4.97 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.846 -1.702 . . . . 0.26000000000000001 108.846 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.475 ' CG2' ' NH1' ' A' ' 87' ' ' ARG . 5.7 t -151.84 129.39 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 107.525 -1.287 . . . . 0.38 107.525 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.0 mm100 -134.39 157.79 45.52 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.964 0.888 . . . . 1.3100000000000001 111.577 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tt -97.57 113.45 25.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.45 -0.944 . . . . 0.48999999999999999 108.45 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -23.31 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.122 -0.986 . . . . 1.3500000000000001 109.318 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.11 157.2 5.07 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.676 -1.21 . . . . 1.2 109.718 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.746 HG13 HG13 ' B' ' 66' ' ' VAL . 7.9 p -163.42 133.11 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.356 -0.84 . . . . 0.84999999999999998 109.614 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.464 ' CG ' ' N ' ' A' ' 68' ' ' THR . 32.7 tt0 -145.9 163.12 36.11 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.271 1.034 . . . . 1.4099999999999999 111.271 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.68 ' OG1' HD11 ' B' ' 83' ' ' LEU . 0.0 OUTLIER -138.74 149.0 44.58 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.654 -0.869 . . . . 0.52000000000000002 108.654 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.662 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -174.42 160.42 29.89 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 107.701 -2.16 . . . . 0.40000000000000002 107.701 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.533 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 40.0 p -102.02 158.85 15.85 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.777 1.288 . . . . 0.41999999999999998 110.583 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.8 OUTLIER -154.23 173.96 15.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 1.29 110.312 178.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.9 138.45 19.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.611 0.72 . . . . 1.02 111.262 -178.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 1.0 OUTLIER -148.16 101.77 3.3 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.045 -0.724 . . . . 2.23 109.045 177.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.0 t70 86.41 36.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.181 0.515 . . . . 1.3799999999999999 110.144 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.68 30.7 6.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.25 -0.906 . . . . 2.6200000000000001 109.338 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.18 151.62 32.15 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.244 -0.91 . . . . 3.1499999999999999 109.477 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -85.3 137.98 32.61 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.566 1.174 . . . . 2.4399999999999999 109.598 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 tt -143.35 155.91 16.8 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 114.925 -1.034 . . . . 0.23000000000000001 108.549 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.0 p -90.35 155.8 18.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.986 0.898 . . . . 0.73999999999999999 111.44 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.662 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 6.1 p90 -142.48 148.38 37.6 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.79 -0.641 . . . . 4.1600000000000001 109.977 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.662 HG21 HG21 ' B' ' 81' ' ' ILE . 2.0 pp -123.12 133.72 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.184 -1.043 . . . . 0.92000000000000004 108.184 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 80' ' ' TYR . 16.2 mt -106.89 126.06 51.82 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.437 -0.949 . . . . 0.35999999999999999 108.437 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.818 HD11 ' OG1' ' B' ' 68' ' ' THR . 0.5 OUTLIER -131.52 123.7 28.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.981 -1.075 . . . . 0.97999999999999998 111.025 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -102.46 165.58 11.02 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.197 -0.91 . . . . 0.57999999999999996 110.372 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 50' ' ' TYR . 2.5 tp -157.67 144.68 18.18 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 119.302 -0.959 . . . . 1.3899999999999999 111.423 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -126.4 143.69 51.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.17 0.509 . . . . 1.4199999999999999 110.326 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.475 ' NH1' ' CG2' ' A' ' 61' ' ' VAL . 20.3 mmt180 -96.9 139.05 33.51 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.379 -0.826 . . . . 1.6399999999999999 110.049 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 88' ' ' VAL . 51.4 t -117.14 -9.66 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.791 -0.818 . . . . 0.63 108.791 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 117.977 -1.011 . . . . 1.76 109.511 179.577 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 120.878 0.37 . . . . 1.46 110.664 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.0 pt-20 -94.01 107.37 19.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.661 -1.274 . . . . 1.49 107.724 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.44 146.33 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 122.205 1.002 . . . . 1.1699999999999999 110.884 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.491 HG13 ' O ' ' B' ' 9' ' ' VAL . 10.0 p -99.19 124.53 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.86 -0.609 . . . . 1.3700000000000001 109.375 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.43 166.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.376 -0.972 . . . . 0.37 108.376 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -136.9 168.34 19.75 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.815 0.817 . . . . 2.3700000000000001 110.927 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -87.62 -11.36 48.75 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.899 -0.778 . . . . 1.75 108.899 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' THR . . . . . 0.416 HG22 ' H ' ' B' ' 13' ' ' THR . 0.1 OUTLIER -76.23 -64.21 1.15 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.436 -1.306 . . . . 1.1899999999999999 107.806 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.408 ' H ' HG23 ' B' ' 13' ' ' THR . 0.0 OUTLIER -58.08 146.72 32.06 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.906 -1.121 . . . . 1.47 109.813 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.91 -179.8 6.26 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.049 -0.723 . . . . 1.22 109.049 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.474 ' HA ' HG22 ' B' ' 49' ' ' VAL . 2.4 m -76.75 -32.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.335 -0.987 . . . . 0.45000000000000001 108.335 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -81.04 -33.71 33.33 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.648 -0.871 . . . . 1.7 108.648 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -67.32 -28.32 67.89 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.742 -1.224 . . . . 1.46 109.843 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.789 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.1 OUTLIER -91.37 -18.18 24.67 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.385 -1.447 . . . . 1.3999999999999999 108.644 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.96 -29.39 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 104.98 -2.23 . . . . 0.34000000000000002 104.98 176.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.704 ' O ' HG23 ' B' ' 25' ' ' VAL . 34.9 mt -69.78 -50.75 40.1 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.498 -1.228 . . . . 0.38 108.52 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -65.82 -26.37 67.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.796 -1.19 . . . . 1.21 109.335 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.789 HG23 ' O ' ' B' ' 19' ' ' HIS . 77.2 t -74.71 -54.76 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.945 . . . . 0.29999999999999999 109.719 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.649 HD12 ' NH2' ' B' ' 87' ' ' ARG . 3.9 tp -57.72 -19.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.064 -1.022 . . . . 0.68999999999999995 108.574 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 21' ' ' LEU . 50.4 t -70.83 -41.59 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.185 -0.947 . . . . 0.41999999999999998 109.48 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.597 HD23 ' N ' ' B' ' 26' ' ' LEU . 0.3 OUTLIER -70.06 -37.99 75.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.539 -1.35 . . . . 1.1499999999999999 109.766 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.08 -29.36 67.28 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.608 -1.627 . . . . 1.46 106.608 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -25.59 65.98 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.035 -0.984 . . . . 1.1699999999999999 108.986 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -90.41 -7.17 53.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.959 . . . . 1.1699999999999999 109.194 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.01 15.07 10.27 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.287 -1.125 . . . . 0.38 110.287 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 40.4 mm -76.74 106.26 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.781 -1.423 . . . . 0.58999999999999997 108.471 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.7 -36.46 14.32 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.36 -0.838 . . . . 1.46 110.178 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -102.49 141.72 34.86 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.55 0.69 . . . . 1.2 110.582 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.415 HG13 ' OH ' ' B' ' 50' ' ' TYR . 11.6 p -151.66 141.94 15.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 119.504 -0.878 . . . . 0.48999999999999999 110.72 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.2 120.96 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 109.613 -0.514 . . . . 0.31 109.613 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.672 HD22 ' CE1' ' B' ' 50' ' ' TYR . 1.4 mp -106.65 131.96 53.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.565 -0.71 . . . . 0.47999999999999998 110.529 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.31 127.15 49.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.338 -0.986 . . . . 2.7400000000000002 108.338 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.28 141.64 12.82 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.993 -1.099 . . . . 0.23999999999999999 110.443 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.57 ' O ' ' N ' ' B' ' 41' ' ' ARG . 62.4 p -131.68 137.14 48.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.636 -0.92 . . . . 0.48999999999999999 111.42 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 35.81 -84.9 0.01 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 111.793 -0.523 . . . . 0.28000000000000003 111.793 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -82.3 -54.69 5.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.917 -1.343 . . . . 3.1600000000000001 109.767 -178.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -16.66 11.65 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.574 -1.269 . . . . 1.3799999999999999 107.574 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.6 HG12 HG23 ' B' ' 81' ' ' ILE . 0.3 OUTLIER -55.64 -33.46 33.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.214 -0.929 . . . . 0.84999999999999998 110.368 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.17 -22.44 36.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.121 -0.987 . . . . 1.1200000000000001 108.648 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.703 ' O ' HG23 ' B' ' 49' ' ' VAL . 1.2 mptt -68.07 -71.86 0.2 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.326 -1.361 . . . . 1.8700000000000001 107.326 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.589 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -37.12 -47.56 0.76 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.05 0.452 . . . . 0.26000000000000001 110.555 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.11 -61.35 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.096 -1.003 . . . . 0.28000000000000003 109.034 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ASP . . . . . 0.46 ' OD1' HG21 ' B' ' 16' ' ' VAL . 10.7 t70 -56.4 -49.73 73.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.291 -0.881 . . . . 1.25 109.149 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 45' ' ' LYS . 61.3 t -46.2 -56.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.411 -0.959 . . . . 1.0600000000000001 108.411 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.672 ' CE1' HD22 ' B' ' 36' ' ' LEU . 2.9 m-30 -64.54 -54.45 31.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.5 -0.75 . . . . 4.1100000000000003 110.75 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ASN . . . . . 0.533 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -50.77 -52.52 40.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.616 -1.303 . . . . 1.4099999999999999 108.398 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.42 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 1.1 m -59.88 -30.21 68.84 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.649 -0.82 . . . . 0.65000000000000002 109.522 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.453 HD11 ' NH2' ' B' ' 87' ' ' ARG . 27.7 tp -74.07 -23.62 59.39 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.966 -1.084 . . . . 0.53000000000000003 109.55 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' LYS . . . . . 0.407 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -82.26 -30.47 30.66 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.664 -1.606 . . . . 0.98999999999999999 106.664 178.303 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -14.67 6.31 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.752 -1.203 . . . . 1.46 107.752 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.407 ' N ' ' C ' ' B' ' 54' ' ' LYS . 20.5 mmm180 -73.29 -42.85 61.95 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.587 -0.845 . . . . 1.71 109.626 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.7 mt -153.32 -21.05 0.15 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.117 -1.433 . . . . 1.77 112.678 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.21 -62.0 0.06 OUTLIER Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.187 -1.482 . . . . 0.39000000000000001 110.212 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -67.74 -38.39 83.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.259 -1.142 . . . . 1.3999999999999999 109.555 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.83 28.2 6.7 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.07 -1.612 . . . . 0.34000000000000002 109.07 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.541 HG13 HD21 ' B' ' 85' ' ' LEU . 4.0 t -153.96 132.31 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.554 -1.276 . . . . 0.46000000000000002 107.554 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.7 mm100 -135.55 154.16 51.46 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.876 0.846 . . . . 1.4199999999999999 111.608 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 tt -94.43 118.57 31.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.482 -0.933 . . . . 0.54000000000000004 108.482 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.66 -17.82 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.815 . . . . 1.4299999999999999 110.551 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -178.4 157.29 1.01 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.651 -1.281 . . . . 1.28 109.458 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.746 HG13 HG13 ' A' ' 66' ' ' VAL . 2.6 p -165.26 136.83 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.408 -0.807 . . . . 0.90000000000000002 109.353 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' GLN . . . . . 0.436 ' CG ' ' N ' ' B' ' 68' ' ' THR . 33.1 tt0 -148.48 165.17 31.99 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.424 1.107 . . . . 1.4399999999999999 111.546 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.818 ' OG1' HD11 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -138.44 152.02 47.97 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.207 -0.906 . . . . 0.45000000000000001 108.56 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.66 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -176.96 157.36 22.35 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.261 -2.336 . . . . 0.28999999999999998 107.261 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.583 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 59.6 p -96.1 159.05 15.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.903 -1.351 . . . . 0.39000000000000001 109.41 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -154.03 172.39 17.57 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.002 -1.061 . . . . 1.49 109.95 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.448 HG23 ' H ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -89.52 134.02 29.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.768 -0.773 . . . . 0.87 110.64 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 0.0 OUTLIER -143.58 100.4 3.59 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.303 -0.628 . . . . 2.1800000000000002 109.303 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.7 t70 79.82 41.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.825 -0.547 . . . . 1.3500000000000001 109.888 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.14 26.31 10.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.34 -0.85 . . . . 2.5699999999999998 109.267 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.18 154.93 38.85 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.426 -0.796 . . . . 3.1400000000000001 109.341 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -88.72 136.53 32.96 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.209 -0.996 . . . . 2.3900000000000001 111.29 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.74 154.02 33.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.104 -1.073 . . . . 0.57999999999999996 108.104 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.32 152.57 22.64 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.552 -0.717 . . . . 0.60999999999999999 109.809 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.66 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 5.8 p90 -142.51 146.67 34.94 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.768 -0.773 . . . . 4.0800000000000001 109.992 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 81' ' ' ILE . 2.0 pp -120.64 133.59 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.016 -1.105 . . . . 0.90000000000000002 108.016 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' B' ' 80' ' ' TYR . 13.2 mt -109.24 122.74 47.98 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.336 -1.357 . . . . 0.37 107.336 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.68 HD11 ' OG1' ' A' ' 68' ' ' THR . 0.4 OUTLIER -128.67 127.22 41.72 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.088 -1.045 . . . . 0.97999999999999998 110.921 -178.567 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -102.02 169.32 8.83 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.494 -0.775 . . . . 0.70999999999999996 109.456 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.541 HD21 HG13 ' B' ' 61' ' ' VAL . 1.7 tp -160.45 140.22 11.12 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.288 -0.965 . . . . 1.4399999999999999 110.24 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.1 OUTLIER -123.11 146.39 47.76 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.528 -0.545 . . . . 1.3100000000000001 109.528 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ARG . . . . . 0.649 ' NH2' HD12 ' B' ' 24' ' ' ILE . 20.4 mmt180 -98.48 136.2 38.95 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.836 . . . . 1.6399999999999999 110.216 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.511 ' O ' HG12 ' B' ' 88' ' ' VAL . 23.2 t -113.4 -7.61 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.587 -0.894 . . . . 0.68000000000000005 108.587 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 117.941 -1.028 . . . . 1.77 109.48 179.559 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.584 ' OD1' HD13 ' A' ' 26' ' ' LEU . 13.0 t-20 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 121.252 0.548 . . . . 1.72 111.123 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 7' ' ' GLU . 9.9 pt-20 -91.91 119.47 31.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.893 -1.13 . . . . 1.4399999999999999 109.045 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 35' ' ' ILE . 3.5 mm -124.42 147.99 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 CA-C-O 122.32 1.057 . . . . 1.1100000000000001 112.091 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.3 t -111.6 130.31 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.783 0.801 . . . . 1.3500000000000001 109.959 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.585 HG11 ' H ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -88.33 161.47 2.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.257 -1.016 . . . . 0.39000000000000001 108.257 -178.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HD2' ' HZ3' ' A' ' 14' ' ' LYS . 1.5 mtt-85 -132.9 166.41 22.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.234 -0.916 . . . . 2.27 110.321 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -25.26 39.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.739 -0.837 . . . . 1.78 108.739 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.8 p -68.61 -63.04 1.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.224 -1.769 . . . . 1.24 106.224 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 11.9 mptt -55.42 131.93 47.07 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.068 0.937 . . . . 1.4099999999999999 110.123 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -72.12 180.0 3.07 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.592 0.71 . . . . 1.25 110.002 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 17' ' ' GLU . 4.0 m -73.45 -33.68 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.443 -1.317 . . . . 0.48999999999999999 107.443 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 3.7 tt0 -72.65 -37.48 67.97 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.358 -0.979 . . . . 1.5600000000000001 108.358 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -31.42 67.14 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.035 -1.041 . . . . 1.3799999999999999 111.439 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.735 ' O ' HG23 ' A' ' 23' ' ' VAL . 54.3 m-70 -93.69 -17.33 23.33 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.217 -1.552 . . . . 1.4299999999999999 108.66 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -34.14 59.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 104.296 -2.483 . . . . 0.28999999999999998 104.296 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 25' ' ' VAL . 66.6 mt -70.45 -51.14 31.45 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.72 -1.127 . . . . 0.40999999999999998 109.362 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.86 -30.94 71.24 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.888 -1.133 . . . . 1.22 109.298 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 19' ' ' HIS . 53.4 t -70.62 -55.22 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -0.86 . . . . 0.32000000000000001 109.822 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.3 tt -60.85 -19.77 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.939 -1.101 . . . . 0.57999999999999996 108.594 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 21' ' ' LEU . 5.2 t -73.39 -42.99 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.211 -0.931 . . . . 0.40999999999999998 108.961 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.584 HD13 ' OD1' ' A' ' 6' ' ' ASN . 4.3 mt -65.61 -34.88 79.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.773 -1.204 . . . . 1.1899999999999999 110.102 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -64.39 -26.22 68.37 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.319 -1.363 . . . . 1.46 107.319 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -26.92 68.71 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.309 -0.86 . . . . 1.1499999999999999 109.646 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -90.26 1.77 56.15 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.909 -1.119 . . . . 1.1699999999999999 109.402 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.65 13.81 31.38 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.201 -1.559 . . . . 0.41999999999999998 109.201 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mm -75.57 109.27 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.252 -1.146 . . . . 0.34999999999999998 108.007 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -99.87 6.51 45.3 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.251 -0.906 . . . . 1.55 110.736 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -146.43 147.1 30.89 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.929 -1.107 . . . . 1.5800000000000001 108.936 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.53 142.02 11.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 118.786 -1.166 . . . . 0.54000000000000004 111.017 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -114.42 120.61 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.634 -0.712 . . . . 0.25 109.312 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 46' ' ' ALA . 4.2 mp -105.21 121.31 43.58 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.978 -0.689 . . . . 0.40000000000000002 109.812 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -108.03 133.18 52.7 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.89 -0.782 . . . . 2.7400000000000002 108.89 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.488 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -144.31 157.19 27.1 Favored Glycine 0 N--CA 1.503 3.114 0 C-N-CA 119.879 -1.153 . . . . 0.20999999999999999 111.539 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.56 ' CG2' ' CD2' ' A' ' 80' ' ' TYR . 10.2 p -137.88 145.23 41.9 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.582 -0.952 . . . . 0.56000000000000005 112.856 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.562 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 38.38 -87.26 0.01 OUTLIER Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.687 -0.965 . . . . 0.33000000000000002 110.687 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.675 ' HE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -80.22 -52.59 7.56 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.327 -1.102 . . . . 3.0899999999999999 109.829 -178.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.75 -19.61 64.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.892 -1.13 . . . . 1.0900000000000001 109.145 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 40' ' ' GLY . 7.1 tt -54.71 -35.49 33.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.142 -0.974 . . . . 0.87 111.202 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.432 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.32 -22.71 32.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.953 -1.092 . . . . 1.1399999999999999 108.875 -178.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' O ' HG12 ' A' ' 49' ' ' VAL . 1.3 mptt -63.47 -69.34 0.28 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.069 -2.196 . . . . 1.8600000000000001 105.069 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' H ' HG11 ' A' ' 10' ' ' VAL . . . -34.22 -38.1 0.06 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.479 0.657 . . . . 0.28999999999999998 109.843 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.764 HG13 ' HB ' ' B' ' 68' ' ' THR . 99.0 t -74.01 -73.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.243 -0.91 . . . . 0.22 109.546 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -40.41 -53.21 2.66 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.351 0.596 . . . . 1.26 111.103 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 50' ' ' TYR . 13.2 p -55.7 -47.64 78.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.318 -0.864 . . . . 1.0600000000000001 109.486 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.633 ' CD2' ' N ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -61.37 -54.86 38.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.665 -1.272 . . . . 4.0199999999999996 109.284 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.633 ' N ' ' CD2' ' A' ' 50' ' ' TYR . 27.9 t-20 -56.22 -48.55 76.24 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.546 -1.279 . . . . 1.3400000000000001 107.546 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.6 m -60.72 -32.7 71.95 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.915 -1.143 . . . . 1.04 107.915 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.548 HD22 HG11 ' A' ' 23' ' ' VAL . 10.5 tp -80.69 -20.85 42.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.64 -1.244 . . . . 0.44 107.64 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.14 -46.49 14.83 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.906 -1.887 . . . . 1.0 105.906 177.062 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -57.66 -6.53 0.52 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.772 -1.195 . . . . 1.5800000000000001 107.772 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -70.1 -50.42 41.01 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 121.427 -0.796 . . . . 1.6899999999999999 109.251 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.2 mt -152.19 -16.71 0.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.169 -1.013 . . . . 1.6599999999999999 110.748 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.53 -50.48 0.07 OUTLIER Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.75 -1.214 . . . . 0.39000000000000001 110.609 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -74.62 -47.1 34.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -1.176 . . . . 1.3799999999999999 110.35 -178.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.68 27.17 3.41 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.748 -1.741 . . . . 0.26000000000000001 108.748 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -154.23 136.25 6.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.26 -1.141 . . . . 0.38 108.267 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.718 ' O ' HD23 ' A' ' 85' ' ' LEU . 6.0 mm-40 -138.91 153.92 48.3 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 122.465 1.126 . . . . 1.3100000000000001 112.257 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.561 HD11 HG21 ' A' ' 66' ' ' VAL . 6.9 tt -95.85 109.15 21.54 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.155 -1.424 . . . . 0.48999999999999999 107.155 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.01 -23.79 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.163 -0.961 . . . . 1.3500000000000001 110.045 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -168.61 156.26 7.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.31 -1.494 . . . . 1.2 109.513 177.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 63' ' ' LEU . 74.1 t -161.15 131.49 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.91 -0.774 . . . . 0.84999999999999998 108.91 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 68' ' ' THR . 19.1 tt0 -143.2 158.38 43.67 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.998 0.904 . . . . 1.4099999999999999 110.612 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.469 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -109.25 165.54 11.54 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.578 0.704 . . . . 0.52000000000000002 109.356 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 80' ' ' TYR . . . -169.83 176.38 43.67 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.729 -1.348 . . . . 0.40000000000000002 109.729 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.434 ' OG ' ' OD1' ' B' ' 51' ' ' ASN . 10.9 p -153.0 152.9 31.91 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.906 -1.146 . . . . 0.41999999999999998 107.906 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -160.24 176.91 11.19 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.045 -1.034 . . . . 1.29 109.908 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -89.34 139.91 16.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 119.589 -0.844 . . . . 1.02 110.435 -178.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 52.1 ttt180 -146.23 98.89 3.16 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.805 -0.813 . . . . 2.23 108.805 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 8.3 t0 88.87 34.58 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.334 0.588 . . . . 1.3799999999999999 109.562 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.93 38.87 6.18 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.293 1.044 . . . . 2.6200000000000001 109.367 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -157.66 151.63 24.32 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.594 -0.891 . . . . 3.1499999999999999 108.594 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -84.77 138.55 32.54 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.848 1.308 . . . . 2.4399999999999999 110.757 -177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -139.07 152.63 24.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 114.271 -1.332 . . . . 0.23000000000000001 107.592 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 p -88.33 162.87 16.33 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.204 1.002 . . . . 0.73999999999999999 111.53 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.56 ' CD2' ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -139.72 138.52 36.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.38 -0.827 . . . . 4.1600000000000001 109.692 -177.206 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 81' ' ' ILE . 1.7 tt -119.04 129.48 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.858 -1.164 . . . . 0.92000000000000004 107.858 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 67' ' ' GLN . 14.9 mt -108.71 119.17 38.75 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.929 -1.508 . . . . 0.35999999999999999 106.929 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.1 tt -127.02 127.16 44.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.235 -0.916 . . . . 0.97999999999999998 110.647 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 14.4 ttt180 -99.92 172.21 7.37 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.98 -0.554 . . . . 0.57999999999999996 109.681 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 62' ' ' GLN . 3.0 mt -161.24 145.03 13.07 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.555 -0.858 . . . . 1.3899999999999999 110.094 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 62' ' ' GLN . 5.3 tmtm? -131.21 157.39 43.34 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.565 -0.531 . . . . 1.4199999999999999 109.565 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -113.56 139.41 49.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.438 -0.789 . . . . 1.6399999999999999 109.72 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 88' ' ' VAL . 48.8 t -116.2 -5.09 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.038 -0.727 . . . . 0.63 109.038 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 118.043 -0.979 . . . . 1.76 109.597 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.62 ' HB3' HG23 ' B' ' 34' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.51 0.195 . . . . 1.46 110.772 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -89.7 103.55 16.19 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.339 -1.475 . . . . 1.49 107.875 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mm -114.34 139.86 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.738 0.78 . . . . 1.1699999999999999 109.78 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 66.9 t -104.19 129.0 57.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.594 0.711 . . . . 1.3700000000000001 109.614 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.554 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -88.38 162.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.148 -1.056 . . . . 0.37 108.148 -178.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -138.0 171.79 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 2.3700000000000001 110.183 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -9.64 39.74 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.463 -0.94 . . . . 1.75 108.463 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 33.5 p -89.41 -6.1 56.84 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.739 -0.785 . . . . 1.1899999999999999 109.038 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -97.6 -132.92 0.22 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.627 -1.249 . . . . 1.47 107.627 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -168.15 167.07 12.61 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.882 -0.784 . . . . 1.22 108.882 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.422 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.0 m -66.43 -36.6 77.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.754 -1.202 . . . . 0.45000000000000001 107.754 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 4.8 mm-40 -73.73 -39.94 63.92 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.328 -0.99 . . . . 1.7 108.328 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -60.87 -31.95 71.4 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.173 -0.954 . . . . 1.46 111.917 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.744 ' O ' HG23 ' B' ' 23' ' ' VAL . 49.1 m-70 -92.99 -17.54 23.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 119.835 -1.791 . . . . 1.3999999999999999 108.907 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -33.84 55.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 104.427 -2.435 . . . . 0.34000000000000002 104.427 176.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.553 ' O ' HG23 ' B' ' 25' ' ' VAL . 52.6 mt -68.72 -51.7 38.64 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.648 -1.16 . . . . 0.38 109.058 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.04 -31.48 72.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 1.21 109.729 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.744 HG23 ' O ' ' B' ' 19' ' ' HIS . 52.9 t -69.68 -55.91 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.29999999999999999 109.837 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 20.9 tt -61.32 -20.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.067 -1.021 . . . . 0.68999999999999995 108.873 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 21' ' ' LEU . 4.8 t -71.11 -42.95 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.41999999999999998 109.098 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.596 HD13 ' OD1' ' B' ' 6' ' ' ASN . 5.0 mt -65.73 -41.44 92.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.854 -1.154 . . . . 1.1499999999999999 109.739 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -58.05 -29.95 65.79 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.211 -1.403 . . . . 1.46 107.211 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -28.34 65.43 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.477 -0.783 . . . . 1.1699999999999999 108.899 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -89.55 -1.23 57.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 1.1699999999999999 109.368 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.92 15.01 23.39 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.57 -1.412 . . . . 0.38 109.57 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 45.6 mm -78.56 108.17 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -1.162 . . . . 0.58999999999999997 108.82 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -92.77 -36.5 12.85 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.26 -0.9 . . . . 1.46 110.226 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -101.54 143.37 31.61 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.577 0.703 . . . . 1.2 110.905 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' B' ' 6' ' ' ASN . 9.8 p -154.57 143.04 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 119.554 -0.858 . . . . 0.48999999999999999 111.026 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.54 123.2 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.223 0.535 . . . . 0.31 109.87 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.95 121.08 42.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.738 -0.602 . . . . 0.47999999999999998 109.991 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -106.75 129.84 54.56 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.37 -0.604 . . . . 2.7400000000000002 109.37 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -143.49 156.43 26.57 Favored Glycine 0 N--CA 1.507 3.385 0 C-N-CA 119.662 -1.256 . . . . 0.23999999999999999 111.76 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.602 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 1.8 p -137.95 145.97 42.65 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.481 -1.011 . . . . 0.48999999999999999 112.916 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.566 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 37.68 -86.1 0.01 OUTLIER Glycine 0 N--CA 1.499 2.869 0 N-CA-C 110.571 -1.012 . . . . 0.28000000000000003 110.571 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.67 ' N ' ' HE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -80.71 -52.99 6.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.359 -1.083 . . . . 3.1600000000000001 109.792 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -19.53 65.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.956 -1.09 . . . . 1.3799999999999999 109.535 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.566 HG22 ' O ' ' B' ' 40' ' ' GLY . 7.1 tt -56.01 -31.6 31.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.905 -1.122 . . . . 0.84999999999999998 109.818 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -24.6 33.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 1.1200000000000001 108.656 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.492 ' O ' HG12 ' B' ' 49' ' ' VAL . 2.2 mptt -65.04 -70.84 0.21 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.642 -1.985 . . . . 1.8700000000000001 105.642 177.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.554 ' H ' HG11 ' B' ' 10' ' ' VAL . . . -32.37 -40.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.25 0.548 . . . . 0.26000000000000001 110.527 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 43' ' ' ILE . 94.6 t -79.13 -64.5 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.111 -0.993 . . . . 0.28000000000000003 110.011 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -44.97 -52.95 8.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.347 -0.846 . . . . 1.25 109.952 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.583 HG13 ' N ' ' B' ' 50' ' ' TYR . 11.1 p -55.58 -46.62 79.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.576 -0.849 . . . . 1.0600000000000001 109.204 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.643 ' CD2' ' N ' ' B' ' 51' ' ' ASN . 0.0 OUTLIER -62.81 -54.89 32.0 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.91 -1.119 . . . . 4.1100000000000003 109.162 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 51' ' ' ASN . . . . . 0.643 ' N ' ' CD2' ' B' ' 50' ' ' TYR . 23.3 t-20 -53.83 -47.64 70.71 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.271 -1.381 . . . . 1.4099999999999999 107.271 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -63.62 -31.57 72.77 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.194 -1.002 . . . . 0.65000000000000002 109.141 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.494 HD22 HG11 ' B' ' 23' ' ' VAL . 13.7 tp -73.49 -23.2 60.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.054 -1.029 . . . . 0.53000000000000003 109.774 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' LYS . . . . . 0.407 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -83.18 -30.57 27.69 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.47 -1.678 . . . . 0.98999999999999999 106.47 177.435 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.46 -14.6 3.17 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.745 -1.206 . . . . 1.46 107.745 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.407 ' N ' ' C ' ' B' ' 54' ' ' LYS . 1.0 OUTLIER -71.61 -47.41 54.85 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.532 -0.867 . . . . 1.71 109.559 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 57' ' ' LEU . . . . . 0.605 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.7 mt -155.11 -15.24 0.11 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.99 -1.484 . . . . 1.77 112.638 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.33 -57.52 0.07 OUTLIER Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.22 -1.466 . . . . 0.39000000000000001 110.219 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.605 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -71.05 -44.24 66.19 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.298 -1.119 . . . . 1.3999999999999999 110.089 -179.307 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.65 25.74 5.01 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.231 -1.548 . . . . 0.34000000000000002 109.231 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 22.6 t -154.6 135.42 4.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.0 -1.111 . . . . 0.46000000000000002 108.0 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.719 ' O ' HD23 ' B' ' 85' ' ' LEU . 5.4 mm-40 -140.86 154.39 46.16 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.534 1.159 . . . . 1.4199999999999999 112.422 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.446 HD11 HG21 ' B' ' 66' ' ' VAL . 6.5 tt -96.16 114.48 26.18 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.898 -1.047 . . . . 0.54000000000000004 108.285 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.88 -13.69 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 119.54 -0.864 . . . . 1.4299999999999999 110.763 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -177.69 151.43 0.72 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.06 -1.65 . . . . 1.28 110.63 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.446 HG21 HD11 ' B' ' 63' ' ' LEU . 63.1 t -158.22 135.43 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.554 -0.717 . . . . 0.90000000000000002 109.341 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 67' ' ' GLN . . . . . 0.508 ' HB3' HD12 ' B' ' 82' ' ' LEU . 36.0 tt0 -143.99 160.14 41.37 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.016 0.913 . . . . 1.4399999999999999 111.579 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.764 ' HB ' HG13 ' A' ' 47' ' ' VAL . 6.5 p -117.87 163.7 16.14 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.459 -0.791 . . . . 0.45000000000000001 109.025 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' B' ' 80' ' ' TYR . . . 177.76 134.61 2.08 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.717 -1.353 . . . . 0.28999999999999998 109.717 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.645 ' CB ' ' HE ' ' B' ' 77' ' ' ARG . 65.3 p -91.95 156.3 17.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.292 -1.711 . . . . 0.39000000000000001 109.513 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -150.65 164.48 35.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 1.49 110.088 -179.066 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.568 ' N ' ' OE1' ' B' ' 71' ' ' GLU . 0.1 OUTLIER -88.74 136.23 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.185 -0.947 . . . . 0.87 110.295 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 49.2 ttt180 -148.06 101.93 3.33 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.187 -0.946 . . . . 2.1800000000000002 109.661 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 6.7 t0 86.13 34.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.694 -0.854 . . . . 1.3500000000000001 108.694 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.7 34.47 9.62 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.094 0.949 . . . . 2.5699999999999998 108.601 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -152.98 150.28 29.06 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.601 -0.888 . . . . 3.1400000000000001 108.601 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.645 ' HE ' ' CB ' ' B' ' 70' ' ' SER . 4.2 ttt85 -87.04 140.67 29.32 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.525 1.155 . . . . 2.3900000000000001 111.218 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 10.3 tt -136.79 153.68 30.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.713 -1.218 . . . . 0.57999999999999996 107.713 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.32 155.49 21.31 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.221 -0.924 . . . . 0.60999999999999999 109.711 -176.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.602 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.1 OUTLIER -137.56 138.03 39.17 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.209 -0.663 . . . . 4.0800000000000001 109.209 -177.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.525 HG23 ' O ' ' B' ' 81' ' ' ILE . 1.3 tt -120.56 130.59 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.297 -1.001 . . . . 0.90000000000000002 108.297 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' B' ' 67' ' ' GLN . 3.7 mt -108.28 119.21 38.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.469 -1.678 . . . . 0.37 106.469 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tt -124.63 126.09 45.19 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.511 -0.876 . . . . 0.97999999999999998 110.721 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -97.14 171.54 8.39 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.757 -0.831 . . . . 0.70999999999999996 108.757 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.719 HD23 ' O ' ' B' ' 62' ' ' GLN . 2.4 mt -160.41 141.6 12.16 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.559 -0.857 . . . . 1.4399999999999999 109.352 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' B' ' 62' ' ' GLN . 9.2 tttm -127.26 148.11 50.22 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.019 0.437 . . . . 1.3100000000000001 110.188 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -106.0 137.76 43.36 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.505 -0.747 . . . . 1.6399999999999999 109.421 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.489 ' O ' HG12 ' B' ' 88' ' ' VAL . 75.7 t -116.2 -4.45 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.061 -0.718 . . . . 0.68000000000000005 109.061 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 118.077 -0.963 . . . . 1.77 109.473 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.51 -0.552 . . . . 6.3300000000000001 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.49 66.69 1.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.717 0.77 . . . . 2.5299999999999998 109.069 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' O ' ' O ' ' A' ' 30' ' ' GLY . 6.9 mt-10 -76.95 -29.62 55.66 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.606 -0.684 . . . . 1.75 110.08 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.59 59.14 1.2 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.479 -0.763 . . . . 2.2400000000000002 110.105 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.2 tp -172.51 52.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.684 -0.858 . . . . 1.6699999999999999 108.684 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.672 ' OD1' HD11 ' A' ' 8' ' ' ILE . 1.3 t-20 -88.64 103.14 15.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.903 . . . . 1.72 111.137 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -91.47 124.98 36.05 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.456 -0.942 . . . . 1.4399999999999999 108.456 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.672 HD11 ' OD1' ' A' ' 6' ' ' ASN . 10.4 mt -137.12 154.4 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 119.918 -0.713 . . . . 1.1100000000000001 111.205 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.56 138.63 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.723 -0.843 . . . . 1.3500000000000001 108.723 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 p -91.06 163.5 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.942 -1.099 . . . . 0.39000000000000001 108.683 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -129.67 163.65 25.63 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.836 0.827 . . . . 2.27 109.986 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -95.11 -17.49 21.78 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.174 -1.047 . . . . 1.78 108.174 178.591 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -73.42 -44.56 58.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.374 -0.973 . . . . 1.24 108.374 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 146.51 39.08 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.236 -0.915 . . . . 1.4099999999999999 109.294 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -69.0 -179.44 1.5 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.099 -1.001 . . . . 1.25 108.632 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.638 HG23 ' N ' ' A' ' 17' ' ' GLU . 27.2 m -78.62 -50.2 19.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.872 -1.142 . . . . 0.48999999999999999 109.458 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.638 ' N ' HG23 ' A' ' 16' ' ' VAL . 4.1 pt-20 -57.88 -19.69 31.26 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.076 -1.015 . . . . 1.5600000000000001 110.529 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.61 -30.37 69.09 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.379 -1.451 . . . . 1.3799999999999999 108.239 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -89.27 -23.57 22.28 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.845 -0.742 . . . . 1.4299999999999999 109.015 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.41 -27.8 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 106.532 -1.655 . . . . 0.28999999999999998 106.532 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 25' ' ' VAL . 27.2 mt -75.37 -48.94 20.65 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.117 -1.068 . . . . 0.40999999999999998 108.117 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -66.73 -22.01 66.06 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.537 -0.727 . . . . 1.22 109.597 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 19' ' ' HIS . 11.9 t -78.79 -54.41 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.154 -0.966 . . . . 0.32000000000000001 109.783 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.1 tt -55.6 -28.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.147 -0.97 . . . . 0.57999999999999996 108.924 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 21' ' ' LEU . 58.0 t -72.67 -43.97 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.231 -1.026 . . . . 0.40999999999999998 108.231 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.465 HD13 ' OD1' ' A' ' 6' ' ' ASN . 44.8 mt -63.8 -39.73 94.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.53 -0.731 . . . . 1.1899999999999999 109.692 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 3.2 t80 -69.77 -0.93 7.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 1.46 108.786 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.72 -26.69 19.41 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.981 -1.118 . . . . 1.1499999999999999 107.981 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -86.82 3.96 43.14 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.519 -0.738 . . . . 1.1699999999999999 109.648 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 106.64 6.84 34.95 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.171 -1.172 . . . . 0.41999999999999998 110.171 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -75.7 95.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -1.234 . . . . 0.34999999999999998 109.407 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -87.37 -33.95 18.97 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.232 -0.918 . . . . 1.55 108.82 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -99.5 147.71 25.02 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.366 0.603 . . . . 1.5800000000000001 109.807 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.15 149.07 10.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 119.163 -1.015 . . . . 0.54000000000000004 109.488 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.1 mt -129.7 117.24 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.494 0.664 . . . . 0.25 110.732 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 46' ' ' ALA . 4.6 mp -100.68 127.17 47.18 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.893 -0.781 . . . . 0.40000000000000002 108.893 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -115.3 139.93 49.55 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.015 -1.106 . . . . 2.7400000000000002 108.015 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.81 163.96 28.83 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 119.379 -1.391 . . . . 0.20999999999999999 110.444 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 41' ' ' ARG . 36.4 p -137.46 148.1 45.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.503 -0.998 . . . . 0.56000000000000005 110.914 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 36.94 -85.65 0.01 OUTLIER Glycine 0 N--CA 1.5 2.947 0 O-C-N 122.0 -0.438 . . . . 0.33000000000000002 112.179 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -87.14 -42.87 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -1.174 . . . . 3.0899999999999999 110.34 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.58 -22.34 66.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.66 -1.275 . . . . 1.0900000000000001 109.511 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.539 HG13 HG22 ' A' ' 81' ' ' ILE . 8.3 tt -48.23 -54.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.87 109.978 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.497 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.61 -26.57 65.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.906 -1.121 . . . . 1.1399999999999999 110.903 -178.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -41.27 95.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.638 -1.289 . . . . 1.8600000000000001 109.066 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -59.83 -38.73 82.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.28999999999999998 109.245 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.668 HG13 ' HB ' ' B' ' 68' ' ' THR . 48.5 t -59.75 -66.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.654 -0.654 . . . . 0.22 110.643 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -53.54 6.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.797 -0.564 . . . . 1.26 109.804 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG21 ' CB ' ' A' ' 19' ' ' HIS . 9.0 t -46.15 -55.19 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.555 -0.715 . . . . 1.0600000000000001 109.494 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -64.66 -44.68 89.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.395 -0.816 . . . . 1.27 110.037 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.57 ' CG ' ' H ' ' B' ' 70' ' ' SER . 4.6 t30 -58.46 -48.33 81.08 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.094 -1.004 . . . . 1.3400000000000001 108.467 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 p -67.46 -29.18 68.57 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.942 -0.762 . . . . 1.04 108.942 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.79 -25.39 44.29 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.385 -0.969 . . . . 0.44 108.385 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -76.28 -46.32 28.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.007 -1.849 . . . . 1.0 106.007 177.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 16.6 t0 -57.63 -6.96 0.56 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.827 -1.079 . . . . 1.5800000000000001 108.351 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 54' ' ' LYS . 3.1 tpt85 -76.35 -46.53 27.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.727 -0.608 . . . . 1.6899999999999999 110.148 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' ASP . 6.1 tp -152.42 -29.03 0.16 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.41 -0.916 . . . . 1.6599999999999999 110.292 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.71 -49.32 0.64 Allowed Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.022 -1.561 . . . . 0.39000000000000001 109.229 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.502 ' C ' ' H ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER -74.68 -49.79 20.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -1.223 . . . . 1.3799999999999999 109.055 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.97 23.36 1.36 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.79 -1.724 . . . . 0.26000000000000001 108.79 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 59' ' ' ASP . 24.1 t -149.86 139.51 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 121.505 -0.997 . . . . 0.38 108.511 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.5 mm-40 -143.27 142.36 31.33 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.229 1.014 . . . . 1.3100000000000001 110.864 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 tt -93.84 94.26 8.41 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.471 -0.786 . . . . 0.48999999999999999 109.114 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.33 -35.37 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.904 -1.122 . . . . 1.3500000000000001 110.126 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -165.99 157.63 13.94 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.139 -1.425 . . . . 1.2 112.155 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.1 t -158.16 145.37 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.397 -1.335 . . . . 0.84999999999999998 107.397 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -148.11 165.23 31.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.754 -1.216 . . . . 1.4099999999999999 108.896 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.4 ' HB ' HG13 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -147.36 129.64 15.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.52000000000000002 111.007 -178.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -152.38 171.52 31.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.964 -1.655 . . . . 0.40000000000000002 108.964 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.523 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 9.9 p -112.08 156.45 22.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.693 0.759 . . . . 0.41999999999999998 110.366 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.29 175.84 13.03 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.511 -0.743 . . . . 1.29 109.552 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.4 t -87.99 132.78 32.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.388 -0.82 . . . . 1.02 110.651 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 34.4 ttt-85 -143.85 99.97 3.5 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.487 -0.931 . . . . 2.23 108.487 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.2 t70 85.69 40.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.205 0.526 . . . . 1.3799999999999999 109.643 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 60.32 37.68 20.11 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.379 1.085 . . . . 2.6200000000000001 108.897 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -155.51 149.0 25.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.111 -0.993 . . . . 3.1499999999999999 108.765 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -83.02 140.88 32.46 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.223 -0.991 . . . . 2.4399999999999999 109.626 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.3 tt -144.31 156.95 15.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.176 -0.676 . . . . 0.23000000000000001 109.176 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -87.9 152.79 21.81 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.394 -0.816 . . . . 0.73999999999999999 109.4 -178.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 9.8 p90 -146.82 151.87 37.82 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.063 -1.023 . . . . 4.1600000000000001 110.348 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.539 HG22 HG13 ' A' ' 43' ' ' ILE . 10.6 tt -121.75 137.53 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-N 115.667 -0.697 . . . . 0.92000000000000004 111.488 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.5 mt -110.23 104.71 13.57 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.076 -2.194 . . . . 0.35999999999999999 105.076 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 tp -106.82 120.47 42.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.878 -0.514 . . . . 0.97999999999999998 110.081 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -103.69 168.23 9.28 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.907 -0.775 . . . . 0.57999999999999996 108.907 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.459 HD21 HG13 ' A' ' 61' ' ' VAL . 1.3 tp -160.57 160.11 31.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.951 -1.099 . . . . 1.3899999999999999 109.999 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -142.15 145.26 34.01 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.52 -0.548 . . . . 1.4199999999999999 109.52 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -105.08 136.62 44.24 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.55 -0.719 . . . . 1.6399999999999999 109.373 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 t -107.63 -7.55 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.878 -1.156 . . . . 0.63 107.878 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 117.977 -1.011 . . . . 1.76 109.437 179.591 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mmt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.326 -0.62 . . . . 6.3499999999999996 109.326 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.2 68.08 1.15 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 2.4199999999999999 109.562 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 30' ' ' GLY . 83.5 mt-10 -79.59 -20.79 46.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.211 -0.93 . . . . 1.6799999999999999 109.588 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 59.25 0.93 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.136 -0.978 . . . . 2.3100000000000001 110.338 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 18.0 tp -172.56 49.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.553 -0.906 . . . . 1.6200000000000001 108.553 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.609 ' OD1' HD11 ' B' ' 8' ' ' ILE . 1.1 t-20 -89.23 101.84 14.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 1.46 111.387 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.1 pt-20 -93.1 121.88 34.9 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.38 -0.97 . . . . 1.49 108.38 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.609 HD11 ' OD1' ' B' ' 6' ' ' ASN . 40.1 mt -134.63 150.91 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.735 -0.603 . . . . 1.1699999999999999 110.009 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.9 138.91 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.878 . . . . 1.3700000000000001 108.909 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.445 HG23 ' CD2' ' B' ' 19' ' ' HIS . 1.4 p -90.26 160.1 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.967 -1.083 . . . . 0.37 108.499 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.403 ' HE ' ' HE3' ' B' ' 14' ' ' LYS . 12.1 mtt-85 -130.74 167.7 18.41 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.874 0.845 . . . . 2.3700000000000001 110.505 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.25 -4.65 21.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.507 -0.923 . . . . 1.75 108.507 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' THR . . . . . 0.406 ' H ' HG22 ' B' ' 13' ' ' THR . 2.8 t -83.49 -29.05 28.27 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.647 -0.821 . . . . 1.1899999999999999 110.447 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.411 ' O ' ' OD1' ' B' ' 15' ' ' ASN . 7.5 mttm -83.8 -113.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.78 -1.2 . . . . 1.47 109.415 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' B' ' 14' ' ' LYS . 2.6 m120 -166.18 173.63 10.02 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.393 -1.336 . . . . 1.22 107.393 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.63 HG23 ' N ' ' B' ' 17' ' ' GLU . 22.1 m -70.9 -51.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.606 -1.309 . . . . 0.45000000000000001 109.112 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.63 ' N ' HG23 ' B' ' 16' ' ' VAL . 6.0 pt-20 -63.11 -24.94 68.13 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.147 -0.97 . . . . 1.7 110.106 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.42 -38.42 91.08 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.39 -1.444 . . . . 1.46 108.359 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.448 ' HB3' HG21 ' B' ' 49' ' ' VAL . 0.7 OUTLIER -83.76 -22.3 31.94 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.894 -0.722 . . . . 1.3999999999999999 109.841 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.08 -31.05 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.074 -1.454 . . . . 0.34000000000000002 107.074 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 37.4 mt -70.63 -48.64 53.98 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.264 -1.013 . . . . 0.38 108.264 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -65.62 -26.04 67.65 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.477 -0.764 . . . . 1.21 109.906 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.57 -54.14 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.11 -0.994 . . . . 0.29999999999999999 110.026 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 5.5 tt -55.15 -28.54 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.68999999999999995 109.246 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 t -73.38 -43.32 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.198 -0.939 . . . . 0.41999999999999998 108.631 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mt -62.37 -45.97 90.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.45 -0.781 . . . . 1.1499999999999999 109.524 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -53.92 -48.0 70.63 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.746 -1.205 . . . . 1.46 107.746 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -31.01 2.16 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.208 -0.597 . . . . 1.1699999999999999 109.577 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.77 5.43 28.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.952 -1.093 . . . . 1.1699999999999999 110.031 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 100.25 6.08 53.85 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.924 -1.27 . . . . 0.38 109.924 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 43.5 mm -76.17 88.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.067 -1.255 . . . . 0.58999999999999997 108.588 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -83.49 -39.08 20.95 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.21 -0.931 . . . . 1.46 109.152 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -93.58 142.11 27.71 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.643 -0.661 . . . . 1.2 109.592 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 p -155.57 151.03 10.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.546 -0.862 . . . . 0.48999999999999999 109.683 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.56 112.81 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.439 0.638 . . . . 0.31 110.055 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -95.53 133.05 39.98 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.542 -0.724 . . . . 0.47999999999999998 109.187 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.99 140.03 52.96 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.463 -0.94 . . . . 2.7400000000000002 108.463 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.99 164.19 28.59 Favored Glycine 0 N--CA 1.502 3.089 0 C-N-CA 119.498 -1.334 . . . . 0.23999999999999999 110.232 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.548 ' O ' ' N ' ' B' ' 41' ' ' ARG . 76.9 p -135.87 146.37 47.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.701 -0.882 . . . . 0.48999999999999999 110.763 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.503 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 36.27 -84.02 0.0 OUTLIER Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.847 -0.533 . . . . 0.28000000000000003 112.615 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.0 OUTLIER -84.5 -45.31 12.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -1.187 . . . . 3.1600000000000001 110.443 -178.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.2 OUTLIER -66.76 -23.92 66.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.727 -1.233 . . . . 1.3799999999999999 109.045 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.558 HG13 HG22 ' B' ' 81' ' ' ILE . 7.9 tt -53.85 -20.71 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.84999999999999998 109.036 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.11 -34.58 13.59 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.279 0.562 . . . . 1.1200000000000001 110.196 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -25.38 66.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 1.8700000000000001 110.212 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.435 ' HB2' HG11 ' B' ' 10' ' ' VAL . . . -73.26 -45.74 54.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.962 -1.086 . . . . 0.26000000000000001 109.975 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.4 HG13 ' HB ' ' A' ' 68' ' ' THR . 88.5 t -61.88 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.28000000000000003 109.68 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' B' ' 52' ' ' SER . 2.7 t70 -57.43 -56.37 22.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 1.25 109.474 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' B' ' 19' ' ' HIS . 10.3 t -43.89 -49.48 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.672 -0.643 . . . . 1.0600000000000001 110.006 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.504 ' CE1' HD11 ' B' ' 85' ' ' LEU . 1.1 t80 -68.33 -53.18 25.92 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.426 -0.797 . . . . 1.28 110.295 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 0.523 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 1.2 t30 -50.3 -45.88 54.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.032 -1.042 . . . . 1.4099999999999999 108.527 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.6 OUTLIER -68.67 -37.15 79.39 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.559 -0.857 . . . . 0.65000000000000002 109.171 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 tp -65.89 -26.84 67.8 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.378 -0.826 . . . . 0.53000000000000003 108.817 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -75.25 -38.69 60.43 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.664 -1.236 . . . . 0.98999999999999999 107.664 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.26 -7.78 0.41 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.036 -0.727 . . . . 1.46 109.036 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.472 ' H ' ' C ' ' B' ' 54' ' ' LYS . 21.1 mmm180 -82.66 -39.41 22.1 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.548 -0.72 . . . . 1.71 110.727 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' LEU . . . . . 0.425 HD23 ' H ' ' B' ' 60' ' ' GLY . 1.0 OUTLIER -157.14 -35.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 117.928 -1.509 . . . . 1.77 112.595 -179.308 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.78 -55.03 2.57 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 118.548 -1.786 . . . . 0.39000000000000001 108.919 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' B' ' 61' ' ' VAL . 0.4 OUTLIER -72.16 -48.68 41.62 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.149 -1.206 . . . . 1.3999999999999999 108.575 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.425 ' H ' HD23 ' B' ' 57' ' ' LEU . . . -76.79 25.11 1.81 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 108.969 -1.652 . . . . 0.34000000000000002 108.969 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' B' ' 59' ' ' ASP . 13.0 t -153.07 140.2 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.392 -1.064 . . . . 0.46000000000000002 108.72 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.5 mm-40 -143.87 141.9 30.54 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.297 1.046 . . . . 1.4199999999999999 111.669 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.34 94.33 9.08 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.421 -0.809 . . . . 0.54000000000000004 109.346 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.44 HG22 ' H ' ' B' ' 64' ' ' VAL . 0.0 OUTLIER -74.53 -39.55 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.945 -1.097 . . . . 1.4299999999999999 110.53 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.491 ' O ' HG23 ' B' ' 66' ' ' VAL . 6.3 m120 -164.46 164.69 21.88 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.336 -1.346 . . . . 1.28 111.831 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 65' ' ' ASN . 59.2 t -161.07 143.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.718 -1.216 . . . . 0.90000000000000002 107.718 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -147.76 165.13 31.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.899 -1.125 . . . . 1.4399999999999999 108.645 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.668 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -148.78 129.48 14.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.088 -1.007 . . . . 0.45000000000000001 110.232 -178.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.551 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -149.29 169.58 29.61 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.061 -1.216 . . . . 0.28999999999999998 110.061 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.57 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 23.9 p -104.32 151.21 23.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 122.038 -0.684 . . . . 0.39000000000000001 109.986 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.65 172.01 16.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 1.49 110.224 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 67.9 t -87.58 133.95 29.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.474 -0.766 . . . . 0.87 110.692 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 17.7 ttt-85 -146.36 101.39 3.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.544 -0.722 . . . . 2.1800000000000002 109.301 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 1.6 t70 82.2 41.84 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.319 0.58 . . . . 1.3500000000000001 109.509 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 60.48 32.29 20.49 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.121 0.962 . . . . 2.5699999999999998 109.212 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -151.9 154.96 37.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.563 -0.903 . . . . 3.1400000000000001 108.563 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -87.37 142.17 28.08 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.389 -0.924 . . . . 2.3900000000000001 110.644 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 tt -142.56 157.33 18.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.404 -0.962 . . . . 0.57999999999999996 108.404 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.15 149.51 24.6 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.797 -0.816 . . . . 0.60999999999999999 108.797 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.551 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 9.1 p90 -144.49 149.89 36.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.38 -0.825 . . . . 4.0800000000000001 109.899 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.558 HG22 HG13 ' B' ' 43' ' ' ILE . 2.9 tt -122.08 138.95 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 115.899 -0.591 . . . . 0.90000000000000002 111.766 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 21.0 mt -108.99 106.99 17.18 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.518 -2.03 . . . . 0.37 105.518 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.5 119.48 39.52 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 118.343 0.519 . . . . 0.97999999999999998 110.566 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -102.81 164.84 11.39 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.912 -0.773 . . . . 0.70999999999999996 108.912 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.504 HD11 ' CE1' ' B' ' 50' ' ' TYR . 1.9 tp -160.4 152.19 19.94 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.607 -0.837 . . . . 1.4399999999999999 109.708 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -136.86 136.07 38.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.452 -0.573 . . . . 1.3100000000000001 109.452 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -95.18 137.17 34.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.48 -0.762 . . . . 1.6399999999999999 109.313 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 40.0 t -108.92 -6.85 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 0.68000000000000005 108.21 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.964 -1.017 . . . . 1.77 109.513 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.498 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.233 0.54 . . . . 6.3300000000000001 109.548 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.492 HG22 HD22 ' A' ' 6' ' ' ASN . 0.8 OUTLIER -78.56 103.67 8.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 2.5299999999999998 109.604 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 30' ' ' GLY . 1.6 mt-10 -165.69 -49.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.799 -0.815 . . . . 1.75 108.799 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.53 53.86 0.54 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.956 0.884 . . . . 2.2400000000000002 109.687 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -172.1 49.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.563 -1.336 . . . . 1.6699999999999999 110.15 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.492 HD22 HG22 ' A' ' 2' ' ' THR . 0.6 OUTLIER -91.78 111.77 23.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.048 -1.032 . . . . 1.72 111.033 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 7.0 pt-20 -91.67 117.03 29.37 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.604 -1.258 . . . . 1.4399999999999999 107.604 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 35' ' ' ILE . 12.6 mt -122.43 147.98 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-O 121.889 0.852 . . . . 1.1100000000000001 112.062 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -111.78 128.17 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.65 0.738 . . . . 1.3500000000000001 109.796 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -88.4 164.9 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.398 -0.964 . . . . 0.39000000000000001 108.398 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -138.0 174.9 10.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.439 -0.788 . . . . 2.27 109.827 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -8.38 15.09 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.208 -1.034 . . . . 1.78 108.208 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.423 ' H ' HG22 ' A' ' 13' ' ' THR . 1.0 OUTLIER -90.44 -12.34 37.72 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.35 -1.352 . . . . 1.24 107.35 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -130.41 0.09 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.996 -1.483 . . . . 1.4099999999999999 106.996 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.79 155.21 21.12 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.803 -1.186 . . . . 1.25 108.925 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 49' ' ' VAL . 11.5 m -62.7 -37.24 78.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 122.121 0.962 . . . . 0.48999999999999999 108.859 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.86 -31.61 59.37 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.22 -0.925 . . . . 1.5600000000000001 108.523 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.33 -32.04 73.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.614 -1.304 . . . . 1.3799999999999999 111.452 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.71 ' O ' HG23 ' A' ' 23' ' ' VAL . 85.2 m-70 -90.37 -18.63 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 119.806 -1.809 . . . . 1.4299999999999999 108.74 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.09 -32.15 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 105.147 -2.168 . . . . 0.28999999999999998 105.147 176.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.816 ' O ' HG23 ' A' ' 25' ' ' VAL . 34.2 mt -69.53 -53.01 21.12 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 109.294 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -65.86 -28.81 69.24 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.98 -1.075 . . . . 1.22 109.546 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 19' ' ' HIS . 23.2 t -68.72 -54.42 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.421 -0.799 . . . . 0.32000000000000001 109.01 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 tt -63.5 -17.05 19.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.181 -0.949 . . . . 0.57999999999999996 108.978 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 21' ' ' LEU . 53.6 t -76.95 -46.7 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.064 -1.023 . . . . 0.40999999999999998 109.408 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.22 -33.13 75.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.614 -1.304 . . . . 1.1899999999999999 110.273 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 4.2 t80 -64.33 -24.73 67.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.79 -1.559 . . . . 1.46 106.79 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -27.29 69.18 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.096 -0.956 . . . . 1.1499999999999999 109.398 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -89.89 -4.69 57.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.901 -1.124 . . . . 1.1699999999999999 109.254 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 111.74 12.22 15.1 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.368 -1.093 . . . . 0.41999999999999998 110.368 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.4 mm -75.16 106.46 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.038 -1.272 . . . . 0.34999999999999998 108.475 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.57 -36.91 15.06 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.339 -0.851 . . . . 1.55 110.306 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.95 143.32 31.24 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.827 0.822 . . . . 1.5800000000000001 110.456 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.67 141.46 14.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 119.555 -0.858 . . . . 0.54000000000000004 109.942 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -120.81 126.37 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 115.887 -0.597 . . . . 0.25 110.321 -178.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.465 ' CD2' HG21 ' A' ' 49' ' ' VAL . 6.9 mp -108.81 125.13 51.63 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 120.2 -0.6 . . . . 0.40000000000000002 109.753 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -108.42 131.59 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.752 -1.203 . . . . 2.7400000000000002 107.752 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.69 152.75 21.79 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 119.893 -1.146 . . . . 0.20999999999999999 110.717 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.595 ' O ' ' N ' ' A' ' 41' ' ' ARG . 18.0 p -132.3 139.61 48.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.842 -0.799 . . . . 0.56000000000000005 112.243 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.542 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 39.51 -85.08 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 N-CA-C 111.406 -0.677 . . . . 0.33000000000000002 111.406 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -82.09 -54.2 5.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.256 -1.143 . . . . 3.0899999999999999 109.913 -178.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -19.34 48.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.785 -1.197 . . . . 1.0900000000000001 108.564 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 40' ' ' GLY . 4.9 tt -53.97 -30.91 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.388 -0.82 . . . . 0.87 110.673 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.41 ' HA ' HD13 ' B' ' 43' ' ' ILE . 0.8 OUTLIER -85.6 -22.53 27.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.563 -1.336 . . . . 1.1399999999999999 108.54 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' VAL . 24.3 mmtp -63.33 -69.24 0.28 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.078 -1.823 . . . . 1.8600000000000001 106.078 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -29.22 -38.18 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.784 0.802 . . . . 0.28999999999999998 109.959 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.693 HG13 ' HB ' ' B' ' 68' ' ' THR . 65.8 t -73.64 -74.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.696 -0.627 . . . . 0.22 110.578 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -39.8 -56.55 1.73 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.412 0.625 . . . . 1.26 110.838 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.713 HG23 ' N ' ' A' ' 50' ' ' TYR . 31.2 m -47.19 -54.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.465 -0.772 . . . . 1.0600000000000001 109.035 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.713 ' N ' HG23 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -58.34 -52.64 64.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 4.0199999999999996 109.634 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.648 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 2.5 t30 -53.21 -52.74 57.9 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.605 -1.257 . . . . 1.3400000000000001 107.605 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.5 p -59.44 -33.29 71.09 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.242 -1.022 . . . . 1.04 108.242 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.416 HD22 HG11 ' A' ' 23' ' ' VAL . 7.3 tp -78.98 -25.13 43.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.111 -0.993 . . . . 0.44 108.9 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.02 -45.19 20.69 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.216 -2.142 . . . . 1.0 105.216 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.418 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 9.9 t70 -56.53 -7.9 0.47 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.817 -1.179 . . . . 1.5800000000000001 107.817 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 54' ' ' LYS . 6.9 tpt180 -72.03 -48.74 42.39 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.589 0.709 . . . . 1.6899999999999999 109.834 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.0 tp -153.73 -24.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.203 -0.999 . . . . 1.6599999999999999 110.994 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.37 -48.94 0.07 OUTLIER Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.77 -1.205 . . . . 0.39000000000000001 110.181 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -72.3 -41.9 66.08 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.395 -1.062 . . . . 1.3799999999999999 109.548 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.598 ' H ' HD23 ' A' ' 57' ' ' LEU . . . -92.65 28.96 8.34 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 108.844 -1.703 . . . . 0.26000000000000001 108.844 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.2 t -154.58 130.21 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.541 -1.281 . . . . 0.38 107.541 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.733 ' O ' HD23 ' A' ' 85' ' ' LEU . 1.7 mm100 -136.98 158.44 44.46 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.349 1.071 . . . . 1.3100000000000001 111.926 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.563 HD11 HG21 ' A' ' 66' ' ' VAL . 7.4 tt -94.73 114.6 26.54 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.495 -0.928 . . . . 0.48999999999999999 108.495 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -22.11 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.166 -0.959 . . . . 1.3500000000000001 109.712 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -173.57 157.02 3.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.549 -1.344 . . . . 1.2 109.835 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.563 HG21 HD11 ' A' ' 63' ' ' LEU . 58.0 t -159.78 130.94 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.703 -0.851 . . . . 0.84999999999999998 108.703 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -142.0 157.63 44.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.131 0.967 . . . . 1.4099999999999999 110.16 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.596 ' HB ' HG13 ' B' ' 47' ' ' VAL . 1.3 p -132.6 147.37 52.34 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.293 -1.002 . . . . 0.52000000000000002 108.293 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.631 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -175.27 154.34 17.73 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.414 -2.675 . . . . 0.40000000000000002 106.414 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.526 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 52.7 p -103.78 169.21 8.65 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 119.085 1.442 . . . . 0.41999999999999998 110.128 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.24 164.88 34.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 1.29 109.525 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.75 91.65 3.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.638 -0.825 . . . . 1.02 109.874 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 47.0 ttt-85 -95.02 112.06 23.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.991 -1.068 . . . . 2.23 110.048 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.1 t70 77.73 39.75 0.17 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.454 -0.573 . . . . 1.3799999999999999 109.454 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.426 ' CG ' HH11 ' A' ' 75' ' ' ARG . 0.0 OUTLIER 60.86 29.43 19.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.462 -0.774 . . . . 2.6200000000000001 108.954 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.66 144.99 30.74 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.026 -1.047 . . . . 3.1499999999999999 108.671 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -84.35 126.54 33.31 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.94 1.353 . . . . 2.4399999999999999 111.428 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 tt -136.4 147.53 27.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 106.943 -1.503 . . . . 0.23000000000000001 106.943 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.71 159.59 17.73 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.077 -1.014 . . . . 0.73999999999999999 110.938 -176.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.631 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 6.4 p90 -145.91 153.32 40.71 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.869 0.842 . . . . 4.1600000000000001 110.608 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 81' ' ' ILE . 10.4 tt -125.14 132.63 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.623 0.725 . . . . 0.92000000000000004 109.822 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.39 121.63 44.97 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.092 -1.448 . . . . 0.35999999999999999 107.092 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.65 123.86 34.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.206 -0.934 . . . . 0.97999999999999998 111.072 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -97.7 169.68 9.52 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.437 0.637 . . . . 0.57999999999999996 110.11 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 62' ' ' GLN . 2.8 mt -159.68 140.04 11.99 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.362 -0.935 . . . . 1.3899999999999999 110.349 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 62' ' ' GLN . 2.2 tmtp? -122.9 145.64 48.28 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.941 -0.475 . . . . 1.4199999999999999 109.92 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.548 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 14.7 mmt85 -103.85 138.66 40.12 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.186 -0.946 . . . . 1.6399999999999999 109.863 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.78 -6.84 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.718 -0.845 . . . . 0.63 108.718 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 CA-C-O 118.058 -0.972 . . . . 1.76 109.573 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.502 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.486 -0.561 . . . . 6.3499999999999996 109.486 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.95 104.51 5.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 2.4199999999999999 109.419 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' B' ' 30' ' ' GLY . 41.9 tt0 -165.82 -50.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.138 0.971 . . . . 1.6799999999999999 108.604 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.21 58.43 0.35 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.313 -0.867 . . . . 2.3100000000000001 109.323 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -175.91 46.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.187 -1.042 . . . . 1.6200000000000001 108.187 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.822 ' ND2' HD13 ' B' ' 26' ' ' LEU . 32.9 t-20 -93.35 111.44 23.1 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.56 -0.712 . . . . 1.46 110.451 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.8 pt-20 -93.62 120.96 34.54 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.144 -0.973 . . . . 1.49 108.944 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.419 HD13 HG21 ' B' ' 8' ' ' ILE . 7.8 mt -123.58 146.0 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.971 0.891 . . . . 1.1699999999999999 111.217 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.453 HG13 ' O ' ' B' ' 9' ' ' VAL . 9.8 p -105.45 129.38 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.147 -0.686 . . . . 1.3700000000000001 109.147 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -89.45 166.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.526 -0.87 . . . . 0.37 108.749 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -141.18 175.78 9.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.431 -0.793 . . . . 2.3700000000000001 109.996 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.433 ' C ' ' CD ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -112.96 -4.82 13.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.074 -1.084 . . . . 1.75 108.074 179.039 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 13' ' ' THR . . . . . 0.419 ' H ' HG22 ' B' ' 13' ' ' THR . 0.0 OUTLIER -85.68 -18.06 34.24 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.718 -0.845 . . . . 1.1899999999999999 108.718 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -92.97 -115.91 0.09 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.443 -0.947 . . . . 1.47 108.443 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.21 166.06 12.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.389 -0.82 . . . . 1.22 108.967 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.436 ' H ' HG22 ' B' ' 16' ' ' VAL . 5.0 m -66.88 -35.12 73.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.043 0.925 . . . . 0.45000000000000001 108.823 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 16.0 pt-20 -73.59 -37.97 65.28 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.03 -1.044 . . . . 1.7 108.8 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.41 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 0.3 OUTLIER -54.41 -36.66 64.22 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.653 -1.28 . . . . 1.46 111.772 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.711 ' O ' HG23 ' B' ' 23' ' ' VAL . 90.3 m-70 -91.39 -18.64 23.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.271 -1.518 . . . . 1.3999999999999999 109.105 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -36.61 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 105.158 -2.164 . . . . 0.34000000000000002 105.158 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.823 ' O ' HG23 ' B' ' 25' ' ' VAL . 69.2 mt -67.15 -52.16 44.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.377 -0.829 . . . . 0.38 108.983 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.89 -28.39 68.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -0.969 . . . . 1.21 109.844 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 19' ' ' HIS . 18.4 t -69.4 -53.55 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.29999999999999999 108.951 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 tt -64.14 -18.92 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.197 -0.939 . . . . 0.68999999999999995 109.116 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.823 HG23 ' O ' ' B' ' 21' ' ' LEU . 63.4 t -75.58 -46.68 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.41999999999999998 109.244 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.822 HD13 ' ND2' ' B' ' 6' ' ' ASN . 12.7 mt -65.33 -33.45 76.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.796 -1.19 . . . . 1.1499999999999999 110.073 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.517 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 4.9 t80 -64.92 -28.23 69.39 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.926 -1.509 . . . . 1.46 106.926 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -29.24 68.38 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.321 -0.854 . . . . 1.1699999999999999 109.116 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -88.19 -0.59 57.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 1.1699999999999999 109.466 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 106.07 12.14 26.34 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.588 -1.005 . . . . 0.38 110.588 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 33.6 mm -75.18 107.35 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.951 -1.323 . . . . 0.58999999999999997 107.863 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -91.48 -41.33 10.9 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.317 -0.865 . . . . 1.46 110.518 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -97.17 143.72 27.7 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.569 0.7 . . . . 1.2 110.217 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -153.16 136.94 8.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 119.006 -1.078 . . . . 0.48999999999999999 111.111 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.4 128.58 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 115.958 -0.565 . . . . 0.31 110.048 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.42 124.66 52.15 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.555 -0.716 . . . . 0.47999999999999998 110.114 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -107.74 130.57 54.94 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.775 -0.578 . . . . 2.7400000000000002 109.449 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.12 153.51 23.4 Favored Glycine 0 N--CA 1.502 3.06 0 C-N-CA 119.502 -1.333 . . . . 0.23999999999999999 111.02 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.657 ' O ' ' N ' ' B' ' 41' ' ' ARG . 62.2 p -133.93 141.42 47.31 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.964 -0.727 . . . . 0.48999999999999999 112.558 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.685 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 34.98 -78.98 0.0 OUTLIER Glycine 0 N--CA 1.504 3.191 0 N-CA-C 111.873 -0.491 . . . . 0.28000000000000003 111.873 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.657 ' N ' ' O ' ' B' ' 39' ' ' THR . 1.4 mtp85 -83.3 -55.92 4.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.002 -1.293 . . . . 3.1600000000000001 109.374 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.5 OUTLIER -63.13 -16.41 59.96 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.995 -1.066 . . . . 1.3799999999999999 109.841 -178.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.685 HG22 ' O ' ' B' ' 40' ' ' GLY . 9.6 tt -59.69 -25.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.165 -0.959 . . . . 0.84999999999999998 109.664 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.08 -25.86 27.3 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.89 -1.152 . . . . 1.1200000000000001 107.89 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 47' ' ' VAL . 24.3 mmtp -63.32 -71.33 0.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.597 -1.631 . . . . 1.8700000000000001 106.597 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -24.53 -43.29 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.375 0.607 . . . . 0.26000000000000001 111.271 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.596 HG13 ' HB ' ' A' ' 68' ' ' THR . 94.5 t -77.54 -60.32 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.168 -0.958 . . . . 0.28000000000000003 110.361 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ASP . . . . . 0.417 ' O ' ' OG ' ' B' ' 52' ' ' SER . 1.9 t0 -46.37 -62.63 1.27 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.046 -1.034 . . . . 1.25 109.456 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.674 HG23 ' N ' ' B' ' 50' ' ' TYR . 33.3 m -42.84 -51.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.824 -0.806 . . . . 1.0600000000000001 108.824 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.674 ' N ' HG23 ' B' ' 49' ' ' VAL . 0.1 OUTLIER -62.31 -50.53 71.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 4.1100000000000003 109.744 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 0.619 ' N ' ' CD1' ' B' ' 50' ' ' TYR . 1.3 t30 -54.57 -54.53 40.03 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.729 -1.188 . . . . 1.4099999999999999 107.896 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.1 OUTLIER -59.01 -37.81 77.78 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.57 -0.852 . . . . 0.65000000000000002 108.832 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.408 HD22 HG11 ' B' ' 23' ' ' VAL . 10.1 tp -67.1 -23.48 65.84 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.128 -0.982 . . . . 0.53000000000000003 108.379 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -39.38 50.12 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.769 -1.197 . . . . 0.98999999999999999 107.769 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.94 -12.72 2.15 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.384 -0.826 . . . . 1.46 109.227 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -73.58 -43.48 59.66 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.035 -1.066 . . . . 1.71 109.39 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.9 tp -154.61 -23.59 0.12 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.368 -1.333 . . . . 1.77 112.209 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 65.15 -58.78 0.09 OUTLIER Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.224 -1.465 . . . . 0.39000000000000001 109.551 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.95 -42.59 73.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -1.1 . . . . 1.3999999999999999 109.773 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.475 ' H ' HD23 ' B' ' 57' ' ' LEU . . . -84.42 25.42 5.66 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.896 -1.682 . . . . 0.34000000000000002 108.896 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' B' ' 58' ' ' GLY . 73.5 t -154.65 131.65 2.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.318 -1.364 . . . . 0.46000000000000002 107.318 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.694 ' O ' HD23 ' B' ' 85' ' ' LEU . 1.1 mm100 -135.28 153.07 52.02 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.148 0.975 . . . . 1.4199999999999999 112.273 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.585 HD11 HG21 ' B' ' 66' ' ' VAL . 7.4 tt -94.0 113.17 25.11 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.783 -1.191 . . . . 0.54000000000000004 107.783 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -16.43 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.205 -0.935 . . . . 1.4299999999999999 110.302 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.52 ' O ' HG23 ' B' ' 66' ' ' VAL . 0.9 OUTLIER -176.35 156.69 1.62 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.642 -1.286 . . . . 1.28 110.209 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.585 HG21 HD11 ' B' ' 63' ' ' LEU . 54.1 t -160.42 131.87 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.936 -0.764 . . . . 0.90000000000000002 108.936 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLN . . . . . 0.501 ' HB3' HD12 ' B' ' 82' ' ' LEU . 20.1 tt0 -142.48 160.23 40.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.947 0.879 . . . . 1.4399999999999999 110.14 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.693 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -136.26 152.24 50.52 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.249 -1.019 . . . . 0.45000000000000001 108.249 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.638 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -175.03 154.16 17.52 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.391 -2.284 . . . . 0.28999999999999998 107.391 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.593 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 25.2 p -98.61 161.97 13.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.161 -1.199 . . . . 0.39000000000000001 109.343 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -146.05 159.19 43.61 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.035 -1.04 . . . . 1.49 109.95 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.38 90.6 3.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.325 -0.95 . . . . 0.87 109.55 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 53.8 ttt-85 -97.02 112.03 23.98 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.107 -0.996 . . . . 2.1800000000000002 109.846 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.2 t70 78.21 39.13 0.16 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.152 -0.685 . . . . 1.3500000000000001 109.152 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.27 26.79 16.05 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.288 -0.634 . . . . 2.5699999999999998 109.288 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -146.04 148.39 32.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.048 -1.032 . . . . 3.1400000000000001 108.509 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -87.02 134.62 33.47 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.913 1.339 . . . . 2.3900000000000001 112.508 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -137.76 150.18 25.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.291 -1.322 . . . . 0.57999999999999996 107.542 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.25 148.99 24.88 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.165 -0.96 . . . . 0.60999999999999999 109.531 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.638 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.5 p90 -140.38 149.64 42.93 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.654 0.74 . . . . 4.0800000000000001 110.598 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.52 HG23 ' O ' ' B' ' 81' ' ' ILE . 10.2 tt -124.62 130.82 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 122.094 0.949 . . . . 0.90000000000000002 110.463 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' B' ' 67' ' ' GLN . 12.0 mt -104.2 119.06 38.13 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.288 -1.745 . . . . 0.37 106.288 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 tt -127.98 121.67 30.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.97999999999999998 110.824 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -96.5 168.69 10.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.664 0.745 . . . . 0.70999999999999996 110.222 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.694 HD23 ' O ' ' B' ' 62' ' ' GLN . 2.9 mt -159.78 136.78 9.41 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.891 -0.723 . . . . 1.4399999999999999 110.06 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' B' ' 62' ' ' GLN . 2.0 tmtp? -121.86 146.75 46.79 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.233 -0.655 . . . . 1.3100000000000001 109.233 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.517 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 15.5 mmt85 -102.15 141.8 34.42 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.277 -0.89 . . . . 1.6399999999999999 110.465 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.23 -12.33 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.881 -0.785 . . . . 0.68000000000000005 108.881 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 118.028 -0.987 . . . . 1.77 109.558 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.522 -0.548 . . . . 6.3300000000000001 109.522 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.04 110.74 21.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 2.5299999999999998 109.392 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 30' ' ' GLY . 38.2 tt0 -164.53 -53.83 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.294 -0.879 . . . . 1.75 108.809 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.63 57.67 0.44 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.91 0.862 . . . . 2.2400000000000002 109.26 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.21 46.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.115 -0.991 . . . . 1.6699999999999999 108.628 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' OD1' HD13 ' A' ' 26' ' ' LEU . 5.5 t-20 -91.3 115.1 27.76 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.301 -0.874 . . . . 1.72 110.441 -178.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 6.8 pt-20 -93.03 117.6 30.24 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.271 -0.893 . . . . 1.4399999999999999 108.769 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 35' ' ' ILE . 20.6 mt -119.04 142.29 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-O 121.709 0.766 . . . . 1.1100000000000001 111.598 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.556 HG22 ' CG ' ' A' ' 37' ' ' LYS . 87.8 t -109.02 128.74 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.765 0.793 . . . . 1.3500000000000001 110.282 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.513 HG11 ' H ' ' A' ' 46' ' ' ALA . 2.2 p -89.25 164.11 2.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.612 -0.885 . . . . 0.39000000000000001 108.612 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.437 ' HE ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -138.76 173.57 11.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.559 -0.713 . . . . 2.27 109.758 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 pttt -92.85 -9.06 41.68 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.878 -0.786 . . . . 1.78 108.878 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -91.28 -0.27 57.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.204 -1.035 . . . . 1.24 108.204 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -118.28 134.14 55.29 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.462 -1.31 . . . . 1.4099999999999999 107.462 178.431 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -69.87 175.69 4.18 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.845 -1.159 . . . . 1.25 109.773 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.57 -31.86 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.355 -0.98 . . . . 0.48999999999999999 108.355 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -74.75 -31.12 61.7 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.585 -0.846 . . . . 1.5600000000000001 108.95 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -33.88 70.01 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.644 -1.285 . . . . 1.3799999999999999 111.319 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.696 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.1 m80 -95.74 -19.34 19.74 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.448 -1.407 . . . . 1.4299999999999999 108.487 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -36.84 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 104.523 -2.399 . . . . 0.28999999999999998 104.523 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 mt -68.18 -51.27 47.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.708 -1.133 . . . . 0.40999999999999998 109.009 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -67.27 -31.77 72.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.17 -0.956 . . . . 1.22 109.442 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 19' ' ' HIS . 32.5 t -68.55 -52.59 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -0.811 . . . . 0.32000000000000001 108.964 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 tt -61.31 -22.43 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.166 -0.959 . . . . 0.57999999999999996 109.017 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.64 -41.67 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.165 -0.959 . . . . 0.40999999999999998 109.265 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.45 HD13 ' OD1' ' A' ' 6' ' ' ASN . 4.2 mt -67.83 -37.3 81.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.874 -1.142 . . . . 1.1899999999999999 110.025 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 18.6 t80 -61.1 -28.26 68.96 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.994 -1.484 . . . . 1.46 106.994 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.62 -25.68 66.46 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.42 -0.809 . . . . 1.1499999999999999 109.02 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -89.88 -9.36 49.25 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.509 -0.923 . . . . 1.1699999999999999 108.509 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 113.47 14.07 10.01 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.193 -1.163 . . . . 0.41999999999999998 110.193 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -75.66 107.58 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.26 . . . . 0.34999999999999998 108.688 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.05 -37.66 12.66 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.418 -0.801 . . . . 1.55 109.97 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -96.89 139.92 32.21 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.401 0.62 . . . . 1.5800000000000001 109.614 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.39 136.66 12.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 119.279 -0.968 . . . . 0.54000000000000004 110.086 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -116.1 124.75 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.229 0.537 . . . . 0.25 110.682 -178.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.731 HD21 HG11 ' A' ' 49' ' ' VAL . 5.6 mp -104.38 116.65 32.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.971 -0.456 . . . . 0.40000000000000002 109.802 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.556 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -102.56 127.29 49.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.397 -0.964 . . . . 2.7400000000000002 108.397 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.423 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -142.66 157.66 26.79 Favored Glycine 0 N--CA 1.508 3.44 0 O-C-N 121.093 -1.005 . . . . 0.20999999999999999 111.636 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.67 ' CG2' ' CD2' ' A' ' 80' ' ' TYR . 7.2 p -141.58 147.7 38.09 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.434 -1.039 . . . . 0.56000000000000005 112.84 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.566 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 38.67 -87.28 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.617 -0.993 . . . . 0.33000000000000002 110.617 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' THR . 2.9 mtp180 -82.68 -51.78 7.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.348 -1.089 . . . . 3.0899999999999999 109.506 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.56 -21.47 62.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.222 -0.924 . . . . 1.0900000000000001 109.028 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 40' ' ' GLY . 6.5 tt -53.83 -33.81 24.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.579 -0.7 . . . . 0.87 110.756 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.492 ' HG ' ' HG ' ' B' ' 79' ' ' SER . 0.0 OUTLIER -83.09 -23.45 33.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 1.1399999999999999 108.91 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.537 ' O ' HG23 ' A' ' 49' ' ' VAL . 21.1 mmtp -65.18 -69.22 0.31 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.682 -1.97 . . . . 1.8600000000000001 105.682 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.69 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -34.31 -46.43 0.26 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.216 0.532 . . . . 0.28999999999999998 110.484 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' B' ' 68' ' ' THR . 56.7 t -63.53 -66.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.076 -1.015 . . . . 0.22 109.694 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 52' ' ' SER . 13.1 t0 -44.76 -44.85 9.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.561 -0.712 . . . . 1.26 109.199 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.731 HG11 HD21 ' A' ' 36' ' ' LEU . 60.5 t -50.11 -55.19 6.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.704 -0.798 . . . . 1.0600000000000001 108.936 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.635 ' CD2' ' N ' ' A' ' 51' ' ' ASN . 1.1 t80 -58.5 -60.49 3.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.064 -1.022 . . . . 4.0199999999999996 110.607 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.635 ' N ' ' CD2' ' A' ' 50' ' ' TYR . 9.2 t-20 -49.11 -52.61 25.0 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.985 -1.117 . . . . 1.3400000000000001 107.985 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 48' ' ' ASP . 2.8 m -62.18 -39.02 91.29 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.847 -0.798 . . . . 1.04 108.847 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.786 HD23 HD13 ' A' ' 85' ' ' LEU . 12.5 tp -72.94 -24.06 60.76 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.067 -1.021 . . . . 0.44 108.884 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' TYR . 4.1 tmtt? -81.34 -39.86 24.45 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.18 -1.575 . . . . 1.0 107.227 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -52.68 -14.56 0.54 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.857 -1.164 . . . . 1.5800000000000001 107.857 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' N ' ' C ' ' A' ' 54' ' ' LYS . 11.5 mmm180 -56.15 -53.51 56.21 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.035 -0.666 . . . . 1.6899999999999999 109.972 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.5 tp -161.83 -3.95 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 118.93 -1.108 . . . . 1.6599999999999999 109.917 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.53 -50.94 0.1 OUTLIER Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.705 -1.236 . . . . 0.39000000000000001 110.392 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -71.91 -41.52 67.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.255 -1.144 . . . . 1.3799999999999999 110.521 -178.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 61' ' ' VAL . . . -87.97 25.31 8.92 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.773 -1.331 . . . . 0.26000000000000001 109.773 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' GLY . 43.8 t -155.27 133.6 2.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.944 -1.327 . . . . 0.38 108.29 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.741 ' O ' HD23 ' A' ' 85' ' ' LEU . 11.4 mm100 -140.06 156.83 46.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.406 1.098 . . . . 1.3100000000000001 111.966 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.51 HD11 HG21 ' A' ' 66' ' ' VAL . 6.6 tt -97.08 118.45 33.53 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.044 -0.98 . . . . 0.48999999999999999 108.537 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.528 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -108.35 -17.13 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.813 -0.755 . . . . 1.3500000000000001 110.37 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 64' ' ' VAL . 0.2 OUTLIER -175.5 153.42 1.48 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.411 -1.431 . . . . 1.2 110.154 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.51 HG21 HD11 ' A' ' 63' ' ' LEU . 94.2 t -159.5 133.78 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.464 -0.939 . . . . 0.84999999999999998 108.464 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' LEU . 19.7 tt0 -144.11 163.05 34.7 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.265 1.031 . . . . 1.4099999999999999 110.6 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.629 ' HB ' HG13 ' B' ' 47' ' ' VAL . 1.3 p -136.51 157.18 47.39 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.751 -0.833 . . . . 0.52000000000000002 108.751 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.01 145.15 7.73 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 107.682 -2.167 . . . . 0.40000000000000002 107.682 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.602 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 97.3 p -94.99 160.09 14.73 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.893 -1.357 . . . . 0.41999999999999998 109.356 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.12 176.63 11.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.823 -1.151 . . . . 1.29 111.118 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.451 ' H ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -90.24 131.4 37.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.503 0.668 . . . . 1.02 109.865 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 3.6 ttt85 -148.74 103.05 3.35 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.692 -0.855 . . . . 2.23 108.692 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.7 t0 87.19 36.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.062 0.458 . . . . 1.3799999999999999 110.117 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 65.6 33.55 8.43 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.083 0.944 . . . . 2.6200000000000001 109.363 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -158.3 155.24 28.47 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.234 -0.916 . . . . 3.1499999999999999 109.723 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -86.05 137.99 32.29 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.893 -1.123 . . . . 2.4399999999999999 109.982 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.481 HG21 ' CB ' ' A' ' 73' ' ' ARG . 5.5 tt -142.3 156.96 19.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-N 115.236 -0.893 . . . . 0.23000000000000001 109.489 -178.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.05 151.6 23.1 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.958 0.885 . . . . 0.73999999999999999 110.015 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.67 ' CD2' ' CG2' ' A' ' 39' ' ' THR . 0.4 OUTLIER -135.62 137.19 41.66 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.123 -1.066 . . . . 4.1600000000000001 108.123 -178.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 81' ' ' ILE . 5.1 tt -116.68 130.38 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.542 -0.91 . . . . 0.92000000000000004 108.542 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 67' ' ' GLN . 52.9 mt -110.22 120.54 42.78 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.145 -1.428 . . . . 0.35999999999999999 107.145 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -127.46 128.27 45.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.161 -0.962 . . . . 0.97999999999999998 111.051 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -101.23 171.4 7.63 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.948 -0.569 . . . . 0.57999999999999996 109.548 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.786 HD13 HD23 ' A' ' 53' ' ' LEU . 2.2 mt -162.54 141.96 9.26 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.548 -0.861 . . . . 1.3899999999999999 109.859 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -126.63 149.19 49.63 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.103 0.477 . . . . 1.4199999999999999 110.593 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.459 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 17.9 mmt85 -108.06 139.99 41.89 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.627 -0.671 . . . . 1.6399999999999999 110.185 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.457 ' O ' ' CG1' ' A' ' 88' ' ' VAL . 4.3 t -115.01 -6.0 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.382 -0.969 . . . . 0.63 108.382 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.48 0 CA-C-O 117.967 -1.016 . . . . 1.76 109.497 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.462 -0.569 . . . . 6.3499999999999996 109.462 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.83 111.71 23.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 2.4199999999999999 109.588 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' B' ' 30' ' ' GLY . 1.7 mt-10 -166.17 -51.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.35 -0.844 . . . . 1.6799999999999999 108.952 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.64 58.45 0.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.834 0.826 . . . . 2.3100000000000001 109.57 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.93 47.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.623 -1.298 . . . . 1.6200000000000001 109.479 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.36 113.58 25.88 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.226 -0.921 . . . . 1.46 112.251 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 5.8 pt-20 -93.03 111.93 23.72 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.204 -1.406 . . . . 1.49 107.204 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 18.7 mt -114.12 139.29 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.607 -0.683 . . . . 1.1699999999999999 109.851 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 82.9 t -102.69 126.02 56.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.704 -0.623 . . . . 1.3700000000000001 109.579 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.32 163.91 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.914 -1.143 . . . . 0.37 107.914 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.2 173.98 10.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.314 -0.866 . . . . 2.3700000000000001 109.899 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.526 ' N ' ' OE1' ' B' ' 42' ' ' GLU . 7.6 pttt -96.65 -9.21 29.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.951 -0.759 . . . . 1.75 108.951 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -89.72 -4.78 57.54 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.649 -0.871 . . . . 1.1899999999999999 108.649 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -99.34 -131.0 0.22 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.694 -1.224 . . . . 1.47 107.694 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -166.77 163.83 16.5 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.544 -0.91 . . . . 1.22 108.544 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -63.39 -37.41 79.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.179 -1.045 . . . . 0.45000000000000001 108.179 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 6.8 pt-20 -76.24 -38.03 56.9 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.75 -0.78 . . . . 1.7 109.035 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.436 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 10.4 t70 -59.41 -31.59 69.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.721 -1.237 . . . . 1.46 111.598 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.667 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.3 OUTLIER -93.41 -16.44 24.58 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.173 -1.58 . . . . 1.3999999999999999 108.222 178.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.06 -34.78 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 104.784 -2.302 . . . . 0.34000000000000002 104.784 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.465 ' O ' HG23 ' B' ' 25' ' ' VAL . 57.5 mt -68.81 -52.31 31.45 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.972 -1.013 . . . . 0.38 109.191 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -66.49 -29.83 70.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.19 -0.944 . . . . 1.21 109.499 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.667 HG23 ' O ' ' B' ' 19' ' ' HIS . 24.3 t -70.06 -53.39 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.845 . . . . 0.29999999999999999 109.202 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 tt -62.41 -20.47 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.076 -1.015 . . . . 0.68999999999999995 108.944 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 21' ' ' LEU . 6.2 t -72.1 -42.55 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.233 -0.917 . . . . 0.41999999999999998 109.035 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mt -67.01 -36.31 81.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.97 -1.081 . . . . 1.1499999999999999 109.569 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.511 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 23.3 t80 -61.16 -28.23 68.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.436 -1.32 . . . . 1.46 107.436 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -26.17 67.64 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.64 -0.709 . . . . 1.1699999999999999 109.195 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -90.42 -1.98 57.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.173 -0.954 . . . . 1.1699999999999999 109.455 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 106.88 12.28 24.53 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.912 -1.275 . . . . 0.38 109.912 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 mm -76.78 106.12 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.024 -1.28 . . . . 0.58999999999999997 108.545 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.85 -38.6 12.23 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.22 -0.925 . . . . 1.46 110.821 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -98.59 142.58 29.99 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.57 0.7 . . . . 1.2 110.24 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.41 137.11 11.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 119.221 -0.992 . . . . 0.48999999999999999 110.802 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.61 125.63 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-N 116.089 -0.505 . . . . 0.31 110.344 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' B' ' 46' ' ' ALA . 3.7 mp -105.36 120.21 41.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.67 -0.644 . . . . 0.47999999999999998 110.696 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.43 124.36 46.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.612 -0.68 . . . . 2.7400000000000002 109.168 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.437 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -138.64 153.83 22.78 Favored Glycine 0 N--CA 1.51 3.592 0 O-C-N 121.041 -1.037 . . . . 0.23999999999999999 111.567 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.626 ' O ' ' N ' ' B' ' 41' ' ' ARG . 3.8 p -138.38 143.9 40.03 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.551 -0.97 . . . . 0.48999999999999999 112.794 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.516 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 36.26 -83.17 0.0 OUTLIER Glycine 0 N--CA 1.499 2.863 0 N-CA-C 111.15 -0.78 . . . . 0.28000000000000003 111.15 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.626 ' N ' ' O ' ' B' ' 39' ' ' THR . 5.2 mtp180 -82.03 -53.19 6.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.201 -1.176 . . . . 3.1600000000000001 110.072 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' B' ' 12' ' ' LYS . 1.3 pm0 -64.27 -18.39 64.52 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.55 -1.344 . . . . 1.3799999999999999 109.223 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.516 HG22 ' O ' ' B' ' 40' ' ' GLY . 5.6 tt -54.4 -30.86 21.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.073 -1.017 . . . . 0.84999999999999998 109.84 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -24.92 32.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 1.1200000000000001 108.948 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.48 ' O ' HG23 ' B' ' 49' ' ' VAL . 17.1 mmtp -65.86 -68.59 0.36 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.621 -1.992 . . . . 1.8700000000000001 105.621 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.656 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -33.21 -50.64 0.31 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 116.163 -0.472 . . . . 0.26000000000000001 111.281 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.629 HG13 ' HB ' ' A' ' 68' ' ' THR . 77.8 t -65.01 -59.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.768 -1.208 . . . . 0.28000000000000003 109.68 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 21.3 t0 -48.51 -47.61 38.81 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.193 -0.942 . . . . 1.25 108.666 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.573 HG11 HD21 ' B' ' 36' ' ' LEU . 88.8 t -48.61 -53.6 6.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.776 -0.769 . . . . 1.0600000000000001 109.038 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.614 ' CD2' ' N ' ' B' ' 51' ' ' ASN . 0.9 OUTLIER -59.67 -56.58 20.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.244 -0.91 . . . . 4.1100000000000003 111.304 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 0.614 ' N ' ' CD2' ' B' ' 50' ' ' TYR . 3.4 t30 -54.76 -48.51 72.55 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.759 -1.2 . . . . 1.4099999999999999 107.759 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 1.5 m -63.37 -39.58 94.9 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.534 -0.866 . . . . 0.65000000000000002 108.92 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.806 HD23 HD13 ' B' ' 85' ' ' LEU . 10.0 tp -74.86 -26.32 59.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.53000000000000003 109.04 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' B' ' 56' ' ' ARG . 5.1 tmtt? -80.28 -46.1 16.77 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.069 -1.645 . . . . 0.98999999999999999 106.859 177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -49.98 -11.84 0.07 Allowed 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.353 -1.294 . . . . 1.46 108.284 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' B' ' 54' ' ' LYS . 9.1 mmm180 -54.03 -54.5 38.33 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.827 0.822 . . . . 1.71 110.297 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.0 tp -159.83 -3.78 0.07 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.622 -0.881 . . . . 1.77 108.622 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.425 ' H ' ' H ' ' B' ' 57' ' ' LEU . . . 64.69 -47.96 0.11 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.944 -1.122 . . . . 0.39000000000000001 110.561 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -73.77 -43.69 58.22 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.286 -1.126 . . . . 1.3999999999999999 110.398 -178.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.424 ' O ' HG23 ' B' ' 61' ' ' VAL . . . -84.34 22.87 7.87 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 109.857 -1.297 . . . . 0.34000000000000002 109.857 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' B' ' 54' ' ' LYS . 39.4 t -154.49 135.44 4.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 120.872 -1.37 . . . . 0.46000000000000002 108.455 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.773 ' O ' HD23 ' B' ' 85' ' ' LEU . 1.1 tp-100 -140.19 155.24 47.01 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.342 1.068 . . . . 1.4199999999999999 112.145 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.09 119.1 32.46 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.344 -0.844 . . . . 0.54000000000000004 108.88 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.4 ' O ' ' CG ' ' B' ' 65' ' ' ASN . 0.1 OUTLIER -102.09 -28.27 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.426 -0.796 . . . . 1.4299999999999999 110.972 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.437 ' O ' HG23 ' B' ' 66' ' ' VAL . 19.5 m-20 -173.37 161.28 4.12 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.498 -1.377 . . . . 1.28 109.41 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.437 HG23 ' O ' ' B' ' 65' ' ' ASN . 74.1 t -159.47 132.82 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.636 -0.875 . . . . 0.90000000000000002 108.636 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLN . . . . . 0.665 ' HB3' HD12 ' B' ' 82' ' ' LEU . 28.4 tt0 -142.46 161.74 37.27 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.988 0.899 . . . . 1.4399999999999999 109.969 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.706 ' HB ' HG13 ' A' ' 47' ' ' VAL . 1.8 p -136.59 159.25 42.37 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.959 -0.756 . . . . 0.45000000000000001 108.959 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.4 144.19 7.09 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 107.926 -2.07 . . . . 0.28999999999999998 107.926 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.582 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 14.4 p -93.58 160.07 14.94 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.968 -1.313 . . . . 0.39000000000000001 108.39 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.83 175.92 12.04 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.744 -1.182 . . . . 1.49 110.941 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.47 132.28 34.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.85 -0.74 . . . . 0.87 109.283 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.3 ttt-85 -151.73 103.24 2.92 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.556 -0.715 . . . . 2.1800000000000002 109.158 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 3.7 t0 86.91 35.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.102 0.477 . . . . 1.3500000000000001 109.85 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.77 29.02 8.74 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.991 0.901 . . . . 2.5699999999999998 109.451 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -156.74 157.51 35.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.344 -0.848 . . . . 3.1400000000000001 109.601 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -87.51 139.85 30.12 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.987 -1.085 . . . . 2.3900000000000001 110.943 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 tt -142.22 158.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.571 -0.74 . . . . 0.57999999999999996 109.107 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' SER . . . . . 0.492 ' HG ' ' HG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -86.37 149.26 25.15 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.015 0.912 . . . . 0.60999999999999999 110.198 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.615 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.4 OUTLIER -133.95 137.27 44.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.464 -0.939 . . . . 4.0800000000000001 108.464 -179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.554 HG23 ' O ' ' B' ' 81' ' ' ILE . 5.6 tt -118.02 129.6 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.866 -0.79 . . . . 0.90000000000000002 108.866 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' B' ' 67' ' ' GLN . 6.3 mt -106.9 119.27 38.9 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.703 -1.591 . . . . 0.37 106.703 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 3.7 tt -126.76 126.73 43.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.061 -1.024 . . . . 0.97999999999999998 111.08 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -99.48 169.59 9.21 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.342 -0.614 . . . . 0.70999999999999996 109.342 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.806 HD13 HD23 ' B' ' 53' ' ' LEU . 2.1 mt -162.44 137.55 6.97 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.802 -0.759 . . . . 1.4399999999999999 109.395 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -124.97 151.6 45.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.793 -0.567 . . . . 1.3100000000000001 109.492 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.511 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 19.0 mmt85 -107.5 141.23 39.25 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.469 0.652 . . . . 1.6399999999999999 110.275 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.489 ' O ' HG12 ' B' ' 88' ' ' VAL . 13.7 t -115.18 -6.47 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.251 -1.018 . . . . 0.68000000000000005 108.251 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.022 -0.989 . . . . 1.77 109.528 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.546 -0.539 . . . . 6.3300000000000001 109.546 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.479 ' C ' ' H ' ' A' ' 4' ' ' LYS . 10.1 p -96.37 -72.11 0.65 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 2.5299999999999998 109.384 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 2' ' ' THR . 5.2 tt0 74.02 -32.93 0.24 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.988 -1.07 . . . . 1.75 109.809 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 2' ' ' THR . 7.4 mtmm -155.88 53.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.076 0.941 . . . . 2.2400000000000002 108.582 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 6' ' ' ASN . 0.7 OUTLIER -161.31 151.61 17.57 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 104.146 -2.538 . . . . 1.6699999999999999 104.146 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.855 ' OD1' HG23 ' A' ' 34' ' ' VAL . 1.8 t-20 177.45 94.51 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 118.061 -1.456 . . . . 1.72 110.131 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 112.34 23.6 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.524 -1.36 . . . . 1.4399999999999999 108.166 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.623 ' CG1' HD21 ' A' ' 6' ' ' ASN . 4.8 mm -125.13 148.88 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 122.288 1.042 . . . . 1.1100000000000001 111.79 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.564 HG13 ' HG2' ' A' ' 37' ' ' LYS . 66.7 t -111.94 129.82 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.537 0.684 . . . . 1.3500000000000001 110.485 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.52 HG23 ' ND1' ' A' ' 19' ' ' HIS . 1.3 p -88.2 162.9 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.866 -1.161 . . . . 0.39000000000000001 107.866 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.442 ' HE ' ' HE3' ' A' ' 14' ' ' LYS . 1.9 mtt-85 -131.66 167.2 19.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.344 -0.847 . . . . 2.27 110.136 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.2 pttp -87.93 -16.31 34.2 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.806 -1.183 . . . . 1.78 107.806 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -74.37 -67.5 0.62 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.542 -1.651 . . . . 1.24 106.542 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.538 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.1 mtmm -58.0 143.44 43.21 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.241 -0.912 . . . . 1.4099999999999999 110.113 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -72.27 178.09 4.12 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.48 0.657 . . . . 1.25 110.342 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.511 HG21 ' OD1' ' A' ' 48' ' ' ASP . 3.7 m -72.51 -31.86 39.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.908 0.861 . . . . 0.48999999999999999 108.715 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -73.77 -30.77 62.97 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.454 -0.899 . . . . 1.5600000000000001 109.219 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -30.51 69.63 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 120.445 -1.409 . . . . 1.3799999999999999 110.881 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.681 ' O ' HG23 ' A' ' 23' ' ' VAL . 41.0 m80 -95.33 -19.75 19.71 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.585 -1.322 . . . . 1.4299999999999999 108.236 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.71 -35.63 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 104.896 -2.261 . . . . 0.28999999999999998 104.896 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 25' ' ' VAL . 46.8 mt -69.04 -52.5 27.93 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.823 -1.08 . . . . 0.40999999999999998 108.703 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -66.76 -26.46 66.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 1.22 109.895 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 19' ' ' HIS . 13.9 t -73.62 -53.14 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.256 -0.902 . . . . 0.32000000000000001 108.804 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tt -55.39 -24.57 15.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.503 -0.925 . . . . 0.57999999999999996 108.503 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 21' ' ' LEU . 41.8 t -69.25 -40.81 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.234 -0.987 . . . . 0.40999999999999998 109.443 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.452 HD13 ' ND2' ' A' ' 6' ' ' ASN . 7.1 mt -65.51 -38.03 88.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.524 -1.36 . . . . 1.1899999999999999 109.613 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -28.61 69.68 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.071 -1.455 . . . . 1.46 107.071 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.36 -28.43 59.09 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.29 -0.868 . . . . 1.1499999999999999 108.729 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -90.43 -18.43 25.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 1.1699999999999999 109.222 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 114.43 17.22 7.21 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.793 -1.323 . . . . 0.41999999999999998 109.793 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mm -74.19 113.99 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.395 -1.062 . . . . 0.34999999999999998 108.793 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -93.38 -34.59 13.41 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 119.71 -0.796 . . . . 1.55 111.366 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 4.1 mt-10 -101.81 135.88 42.6 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.625 0.726 . . . . 1.5800000000000001 111.351 -177.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.855 HG23 ' OD1' ' A' ' 6' ' ' ASN . 3.8 p -149.55 141.92 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.96 -0.696 . . . . 0.54000000000000004 110.297 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -122.35 124.9 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 116.06 -0.518 . . . . 0.25 110.767 -178.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.8 mp -106.36 123.08 47.52 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.279 -0.568 . . . . 0.40000000000000002 110.042 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HG2' HG13 ' A' ' 9' ' ' VAL . 15.8 tttt -99.75 125.73 45.69 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.29 -1.004 . . . . 2.7400000000000002 108.29 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.17 142.34 13.58 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.562 -1.304 . . . . 0.20999999999999999 110.827 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 41' ' ' ARG . 54.1 p -126.31 135.72 51.86 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.878 0.846 . . . . 0.56000000000000005 111.908 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' A' ' 78' ' ' ILE . . . 37.97 -87.41 0.01 OUTLIER Glycine 0 N--CA 1.496 2.678 0 O-C-N 121.623 -0.673 . . . . 0.33000000000000002 111.815 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -80.11 -51.77 8.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.041 -1.27 . . . . 3.0899999999999999 109.901 -178.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.66 -19.28 37.85 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.611 -1.305 . . . . 1.0900000000000001 107.59 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' OG ' ' A' ' 79' ' ' SER . 2.2 tt -54.51 -33.66 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.719 -0.613 . . . . 0.87 110.934 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.77 -21.92 32.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.857 -1.152 . . . . 1.1399999999999999 108.615 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.533 ' NZ ' ' O ' ' A' ' 14' ' ' LYS . 22.8 mmtp -66.17 -70.43 0.24 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.368 -1.715 . . . . 1.8600000000000001 106.368 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.649 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -29.46 -51.34 0.11 Allowed 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.439 0.638 . . . . 0.28999999999999998 110.598 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.697 HG13 ' HB ' ' B' ' 68' ' ' THR . 89.8 t -57.86 -68.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.37 -0.831 . . . . 0.22 109.937 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.511 ' OD1' HG21 ' A' ' 16' ' ' VAL . 12.8 t70 -45.54 -48.1 14.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.716 . . . . 1.26 109.584 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.572 HG11 HD21 ' A' ' 36' ' ' LEU . 91.7 t -47.36 -58.56 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.936 -0.764 . . . . 1.0600000000000001 108.936 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -61.84 -54.52 40.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.16 -0.963 . . . . 4.0199999999999996 111.432 -178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.524 ' ND2' ' OG ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -53.74 -48.27 69.82 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.691 -1.256 . . . . 1.3400000000000001 107.804 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.495 ' N ' ' CG ' ' A' ' 51' ' ' ASN . 22.1 p -59.43 -35.88 74.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.839 -1.171 . . . . 1.04 107.839 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.721 HD21 HH12 ' A' ' 87' ' ' ARG . 6.8 tp -79.09 -22.12 45.71 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.095 -1.076 . . . . 0.44 108.095 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.98 -43.96 21.09 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.506 -2.035 . . . . 1.0 105.506 177.512 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -56.05 -9.21 0.57 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.562 -1.273 . . . . 1.5800000000000001 107.562 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.498 ' H ' ' C ' ' A' ' 54' ' ' LYS . 8.8 tpt180 -70.83 -49.34 47.3 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.599 0.714 . . . . 1.6899999999999999 109.559 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.639 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.1 tp -153.86 -15.45 0.14 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.381 -0.928 . . . . 1.6599999999999999 110.794 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 61' ' ' VAL . . . 63.27 -55.62 0.05 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.004 -1.238 . . . . 0.39000000000000001 110.004 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.639 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -73.08 -40.09 65.3 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.633 -0.922 . . . . 1.3799999999999999 109.496 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.522 ' H ' HD23 ' A' ' 57' ' ' LEU . . . -83.34 23.57 6.19 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 108.883 -1.687 . . . . 0.26000000000000001 108.883 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.609 HG13 HD21 ' A' ' 85' ' ' LEU . 2.8 t -155.15 131.71 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.57 -1.27 . . . . 0.38 107.57 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.597 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.7 mm-40 -138.09 157.4 46.4 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.427 1.108 . . . . 1.3100000000000001 111.796 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.637 HD11 HG21 ' A' ' 66' ' ' VAL . 7.5 tt -94.55 116.4 28.73 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.363 -0.835 . . . . 0.48999999999999999 109.504 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -105.34 -20.97 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.323 -0.861 . . . . 1.3500000000000001 109.396 179.315 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.59 148.61 1.98 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.232 -1.387 . . . . 1.2 110.323 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.637 HG21 HD11 ' A' ' 63' ' ' LEU . 94.9 t -157.63 134.09 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.755 -0.831 . . . . 0.84999999999999998 108.755 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.53 ' HB3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -144.92 159.9 42.17 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.077 0.942 . . . . 1.4099999999999999 110.667 -179.181 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.54 ' HB ' HG13 ' B' ' 47' ' ' VAL . 1.2 p -135.44 151.81 50.77 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.537 -0.912 . . . . 0.52000000000000002 108.537 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.69 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -176.47 157.23 22.6 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 106.512 -2.635 . . . . 0.40000000000000002 106.512 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.534 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 94.4 p -99.38 161.25 13.72 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 119.051 1.426 . . . . 0.41999999999999998 110.396 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -155.77 175.73 13.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.102 -0.999 . . . . 1.29 110.737 178.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.434 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.02 134.59 29.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.72 0.771 . . . . 1.02 110.799 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 25.2 ttt-85 -145.7 101.39 3.55 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.321 -0.992 . . . . 2.23 108.321 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.9 t0 85.96 36.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.224 0.535 . . . . 1.3799999999999999 109.766 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.1 32.36 12.78 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.967 0.889 . . . . 2.6200000000000001 109.304 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -150.57 149.84 30.43 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.66 -0.867 . . . . 3.1499999999999999 108.66 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -85.73 137.38 32.85 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.482 1.134 . . . . 2.4399999999999999 110.077 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.558 HD11 ' HA3' ' A' ' 40' ' ' GLY . 4.7 tt -142.9 156.52 17.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.072 -0.967 . . . . 0.23000000000000001 108.778 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.483 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -87.92 155.82 19.66 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.453 -0.779 . . . . 0.73999999999999999 111.145 -176.399 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.69 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 7.7 p90 -146.47 153.75 40.79 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.774 0.797 . . . . 4.1600000000000001 110.466 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.684 HD11 HG21 ' B' ' 68' ' ' THR . 13.2 tt -125.34 132.49 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.419 0.628 . . . . 0.92000000000000004 109.993 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.53 HD12 ' HB3' ' A' ' 67' ' ' GLN . 12.3 mt -106.86 120.71 42.77 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.763 -1.569 . . . . 0.35999999999999999 106.763 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 tt -128.99 124.84 36.02 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.313 -0.955 . . . . 0.97999999999999998 110.582 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -101.4 172.0 7.25 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.663 -0.699 . . . . 0.57999999999999996 109.465 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.609 HD21 HG13 ' A' ' 61' ' ' VAL . 1.6 tp -159.42 143.03 14.68 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 118.978 -1.089 . . . . 1.3899999999999999 111.135 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -118.72 142.45 47.66 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.768 -0.827 . . . . 1.4199999999999999 108.768 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.721 HH12 HD21 ' A' ' 53' ' ' LEU . 16.2 tpp180 -104.16 138.81 40.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.326 -0.858 . . . . 1.6399999999999999 109.726 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.85 -7.18 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.052 -0.721 . . . . 0.63 109.052 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 117.978 -1.01 . . . . 1.76 109.587 179.422 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mtt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.533 -0.544 . . . . 6.3499999999999996 109.533 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 73.0 p -138.64 81.19 1.83 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.523 -0.735 . . . . 2.4199999999999999 109.775 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' B' ' 30' ' ' GLY . 12.1 mt-10 -78.64 -10.87 59.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.868 -1.145 . . . . 1.6799999999999999 108.747 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.42 ' HA ' ' H ' ' B' ' 32' ' ' ASP . 12.5 mtmm -152.18 60.59 0.84 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.533 -0.867 . . . . 2.3100000000000001 110.131 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.609 HD23 ' H ' ' B' ' 6' ' ' ASN . 0.6 OUTLIER -162.09 153.18 17.93 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.535 -2.024 . . . . 1.6200000000000001 105.535 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.609 ' H ' HD23 ' B' ' 5' ' ' LEU . 1.0 OUTLIER -178.35 91.54 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.367 -1.333 . . . . 1.46 111.841 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.75 107.52 19.23 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.018 -1.676 . . . . 1.49 107.147 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.437 ' CG1' ' OD1' ' B' ' 6' ' ' ASN . 43.1 mm -122.13 141.75 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 122.06 0.933 . . . . 1.1699999999999999 110.215 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.634 HG13 ' HG2' ' B' ' 37' ' ' LYS . 59.0 t -101.26 129.05 52.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.778 -0.647 . . . . 1.3700000000000001 109.476 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.9 164.27 2.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.613 -1.254 . . . . 0.37 107.613 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.479 ' HE ' ' CE ' ' B' ' 14' ' ' LYS . 11.6 mtt-85 -138.21 174.55 10.44 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.844 0.831 . . . . 2.3700000000000001 110.149 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -103.56 -8.56 19.95 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.014 -1.106 . . . . 1.75 108.014 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' THR . . . . . 0.417 ' H ' HG23 ' B' ' 13' ' ' THR . 0.3 OUTLIER -86.43 -14.9 41.92 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.741 -0.784 . . . . 1.1899999999999999 109.616 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.479 ' CE ' ' HE ' ' B' ' 11' ' ' ARG . 0.5 OUTLIER -97.81 -118.79 0.13 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.409 -0.96 . . . . 1.47 108.409 178.393 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.77 170.24 9.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.1 -1.0 . . . . 1.22 108.656 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.89 -32.85 45.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.187 -1.042 . . . . 0.45000000000000001 108.187 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.455 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 7.3 pt-20 -77.1 -40.42 45.99 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.792 -0.763 . . . . 1.7 109.098 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.455 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 66.4 t0 -58.45 -31.87 68.18 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.605 -1.31 . . . . 1.46 110.975 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.691 ' O ' HG23 ' B' ' 23' ' ' VAL . 17.2 m80 -91.21 -16.89 26.92 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.137 -1.602 . . . . 1.3999999999999999 108.546 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.22 -34.88 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.322 -2.103 . . . . 0.34000000000000002 105.322 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.526 ' O ' HG23 ' B' ' 25' ' ' VAL . 72.4 mt -67.97 -52.97 29.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.144 -0.935 . . . . 0.38 108.949 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.04 -25.88 68.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.3 -0.875 . . . . 1.21 109.755 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.691 HG23 ' O ' ' B' ' 19' ' ' HIS . 20.1 t -74.57 -52.96 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.422 -0.798 . . . . 0.29999999999999999 109.282 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 tt -57.04 -24.83 21.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.562 -0.903 . . . . 0.68999999999999995 108.562 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 21' ' ' LEU . 40.8 t -67.32 -41.78 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.323 -0.861 . . . . 0.41999999999999998 109.248 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.457 ' CD1' ' OD1' ' B' ' 6' ' ' ASN . 4.5 mt -65.15 -39.63 93.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.681 -1.262 . . . . 1.1499999999999999 109.342 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -32.02 69.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.215 -1.402 . . . . 1.46 107.215 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -30.8 54.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.769 -0.826 . . . . 1.1699999999999999 108.769 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -89.54 -6.36 56.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 1.1699999999999999 109.926 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 101.39 16.47 24.76 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.556 -1.418 . . . . 0.38 109.556 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.9 113.88 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.814 -1.18 . . . . 0.58999999999999997 107.814 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.42 ' H ' ' HA ' ' B' ' 4' ' ' LYS . 5.6 m-20 -98.35 -40.4 8.33 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.37 -0.832 . . . . 1.46 112.211 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -96.11 137.59 34.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 1.2 111.307 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' B' ' 6' ' ' ASN . 5.8 p -152.52 141.17 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.985 -1.086 . . . . 0.48999999999999999 111.57 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.55 128.32 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 115.589 -0.732 . . . . 0.31 110.605 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.632 HD23 ' HA ' ' B' ' 46' ' ' ALA . 1.7 mp -108.91 122.56 47.47 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.471 -0.768 . . . . 0.47999999999999998 110.034 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.634 ' HG2' HG13 ' B' ' 9' ' ' VAL . 6.7 tttt -102.96 130.07 49.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.331 -0.856 . . . . 2.7400000000000002 108.851 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.16 147.65 19.26 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.654 -1.26 . . . . 0.23999999999999999 110.649 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.613 ' O ' ' N ' ' B' ' 41' ' ' ARG . 42.6 p -129.71 140.06 51.19 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.074 -0.662 . . . . 0.48999999999999999 112.117 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.631 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 33.51 -80.78 0.0 OUTLIER Glycine 0 N--CA 1.503 3.148 0 O-C-N 121.847 -0.533 . . . . 0.28000000000000003 112.325 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.0 OUTLIER -83.53 -54.04 5.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.968 -1.313 . . . . 3.1600000000000001 109.45 -178.663 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -15.84 36.83 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.845 -1.159 . . . . 1.3799999999999999 109.048 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.631 HG22 ' O ' ' B' ' 40' ' ' GLY . 10.1 tt -58.25 -26.24 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.334 -0.854 . . . . 0.84999999999999998 110.027 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -26.22 22.13 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.456 -0.942 . . . . 1.1200000000000001 108.456 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' B' ' 46' ' ' ALA . 23.3 mmtp -63.18 -69.64 0.26 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.167 -1.79 . . . . 1.8700000000000001 106.167 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.632 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -29.71 -50.41 0.11 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 116.159 -0.473 . . . . 0.26000000000000001 111.582 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.54 HG13 ' HB ' ' A' ' 68' ' ' THR . 94.7 t -62.61 -59.33 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.802 -1.186 . . . . 0.28000000000000003 109.957 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ASP . . . . . 0.418 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 12.3 t70 -52.19 -51.87 55.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.141 -0.975 . . . . 1.25 108.612 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.528 HG11 HD21 ' B' ' 36' ' ' LEU . 60.4 t -41.34 -61.33 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 109.028 -0.73 . . . . 1.0600000000000001 109.028 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.506 ' CD1' HD11 ' B' ' 85' ' ' LEU . 0.1 OUTLIER -62.36 -50.75 70.33 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.515 -0.74 . . . . 4.1100000000000003 109.906 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 0.534 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -50.72 -55.22 17.63 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.975 -1.12 . . . . 1.4099999999999999 107.975 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.477 ' N ' ' CG ' ' B' ' 51' ' ' ASN . 0.8 OUTLIER -59.9 -35.52 75.03 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.643 -0.823 . . . . 0.65000000000000002 109.256 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.598 HD21 HH12 ' B' ' 87' ' ' ARG . 8.1 tp -72.1 -24.15 61.44 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.892 -1.13 . . . . 0.53000000000000003 109.417 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.07 -29.72 31.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.266 -1.521 . . . . 0.98999999999999999 107.277 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.0 -13.85 13.37 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.897 -1.149 . . . . 1.46 107.897 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -71.5 -42.66 67.76 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.492 -0.883 . . . . 1.71 109.342 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.3 tp -153.95 -18.21 0.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.532 -1.267 . . . . 1.77 111.602 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 65.86 -62.88 0.13 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.365 -1.494 . . . . 0.39000000000000001 109.365 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -69.64 -41.61 75.36 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.387 -1.066 . . . . 1.3999999999999999 109.089 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' B' ' 87' ' ' ARG . . . -76.81 20.03 3.08 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.592 -1.403 . . . . 0.34000000000000002 109.592 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.559 HG13 HD21 ' B' ' 85' ' ' LEU . 2.5 t -153.16 131.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.412 -1.329 . . . . 0.46000000000000002 107.412 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' B' ' 86' ' ' LYS . 3.0 mm-40 -134.0 153.35 51.84 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.048 0.928 . . . . 1.4199999999999999 112.207 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.651 HD11 HG21 ' B' ' 66' ' ' VAL . 7.6 tt -93.54 116.49 29.01 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.177 -1.045 . . . . 0.54000000000000004 108.177 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.83 -25.82 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.262 -0.899 . . . . 1.4299999999999999 110.206 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -172.42 151.58 2.51 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.85 -1.156 . . . . 1.28 109.284 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.651 HG21 HD11 ' B' ' 63' ' ' LEU . 96.1 t -154.53 133.82 3.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.193 -1.04 . . . . 0.90000000000000002 108.193 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLN . . . . . 0.636 ' HB3' HD12 ' B' ' 82' ' ' LEU . 0.0 OUTLIER -141.11 159.84 41.37 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.769 0.795 . . . . 1.4399999999999999 109.47 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.697 ' HB ' HG13 ' A' ' 47' ' ' VAL . 1.3 p -138.98 151.85 47.2 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.109 -0.7 . . . . 0.45000000000000001 109.109 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.665 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -174.81 160.38 29.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.683 -1.767 . . . . 0.28999999999999998 108.683 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.524 ' OG ' ' ND2' ' A' ' 51' ' ' ASN . 89.9 p -98.35 155.11 17.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.275 -1.132 . . . . 0.39000000000000001 109.403 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -151.9 172.86 15.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.67 -1.269 . . . . 1.49 110.996 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.423 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -89.64 136.63 23.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.847 0.832 . . . . 0.87 110.917 -178.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 5.2 ttt-85 -148.96 100.21 3.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.973 -0.751 . . . . 2.1800000000000002 108.973 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 4.7 t0 85.07 36.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.246 -0.65 . . . . 1.3500000000000001 109.246 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.44 28.5 11.6 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.849 0.833 . . . . 2.5699999999999998 109.328 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.54 152.04 36.15 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.826 -0.805 . . . . 3.1400000000000001 108.826 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 9.6 ttm-85 -87.29 141.65 28.48 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.018 -1.073 . . . . 2.3900000000000001 111.099 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.91 158.58 23.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.635 -0.876 . . . . 0.57999999999999996 108.635 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.84 148.14 24.8 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.514 -0.741 . . . . 0.60999999999999999 109.553 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.665 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.8 p90 -140.75 148.11 40.19 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.573 0.702 . . . . 4.0800000000000001 109.948 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.511 HG23 ' O ' ' B' ' 81' ' ' ILE . 6.4 tt -123.22 131.01 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.631 0.729 . . . . 0.90000000000000002 110.037 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.636 HD12 ' HB3' ' B' ' 67' ' ' GLN . 11.7 mt -105.98 123.06 47.38 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.149 -1.426 . . . . 0.37 107.149 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -132.4 125.25 30.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.028 -1.045 . . . . 0.97999999999999998 110.938 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -99.83 169.66 9.08 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.802 -0.635 . . . . 0.70999999999999996 109.933 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.559 HD21 HG13 ' B' ' 61' ' ' VAL . 1.6 tp -159.86 136.1 8.84 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.55 -0.86 . . . . 1.4399999999999999 110.661 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 62' ' ' GLN . 7.8 tmtt? -118.36 138.3 52.52 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.52 -0.919 . . . . 1.3100000000000001 108.52 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.598 HH12 HD21 ' B' ' 53' ' ' LEU . 16.6 tpp180 -95.48 143.7 26.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.465 -0.772 . . . . 1.6399999999999999 110.753 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.22 -13.48 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.877 -0.786 . . . . 0.68000000000000005 108.877 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.303 -1.428 0 CA-C-O 117.98 -1.009 . . . . 1.77 109.534 179.781 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ttt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 6.3300000000000001 109.472 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 4' ' ' LYS . 6.7 p -144.64 17.8 1.65 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 2.5299999999999998 109.549 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 30' ' ' GLY . 2.2 tt0 67.74 -48.34 0.51 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.5 -0.75 . . . . 1.75 109.845 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -157.85 55.37 0.48 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.488 -0.885 . . . . 2.2400000000000002 110.355 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.496 ' N ' ' OG1' ' A' ' 2' ' ' THR . 1.1 tt -173.17 49.7 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.274 -0.971 . . . . 1.6699999999999999 109.728 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.894 HD21 HD12 ' A' ' 31' ' ' ILE . 6.7 m-80 -91.0 116.0 28.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.8 -1.187 . . . . 1.72 111.329 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 7.0 pt-20 -92.09 115.58 28.19 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.989 -1.485 . . . . 1.4399999999999999 106.989 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.0 mt -115.64 140.0 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-O 122.132 0.968 . . . . 1.1100000000000001 111.592 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.8 124.71 62.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.986 -0.552 . . . . 1.3500000000000001 109.83 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.509 HG11 ' H ' ' A' ' 46' ' ' ALA . 2.1 p -89.53 165.07 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.631 -1.248 . . . . 0.39000000000000001 107.631 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -140.19 175.43 9.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.913 . . . . 2.27 109.671 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.1 pttm -101.83 -9.71 20.52 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.006 -0.739 . . . . 1.78 109.006 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 t -90.71 -7.89 51.35 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.828 -1.175 . . . . 1.24 107.828 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.15 -132.76 0.18 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.423 -1.325 . . . . 1.4099999999999999 107.423 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.81 159.65 21.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.557 -1.339 . . . . 1.25 109.4 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.569 HG23 ' N ' ' A' ' 17' ' ' GLU . 16.5 m -61.66 -40.97 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-O 121.869 0.842 . . . . 0.48999999999999999 109.284 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 16' ' ' VAL . 3.5 pt-20 -77.86 -32.35 52.0 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.265 -0.897 . . . . 1.5600000000000001 108.871 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 52.3 t0 -62.78 -31.07 71.96 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.63 -1.294 . . . . 1.3799999999999999 111.164 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.672 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.6 m-70 -95.23 -17.15 21.96 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.176 -1.578 . . . . 1.4299999999999999 108.389 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -31.89 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 104.436 -2.431 . . . . 0.28999999999999998 104.436 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 25' ' ' VAL . 31.6 mt -70.43 -52.85 19.27 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.32 -1.309 . . . . 0.40999999999999998 109.057 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -67.38 -29.46 68.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 1.22 109.671 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 19' ' ' HIS . 25.5 t -70.03 -54.29 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.32000000000000001 108.964 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 tt -60.89 -20.36 21.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.203 -0.935 . . . . 0.57999999999999996 108.894 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 21' ' ' LEU . 11.0 t -72.46 -40.83 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.095 -1.003 . . . . 0.40999999999999998 109.025 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.03 -36.78 80.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.784 -1.197 . . . . 1.1899999999999999 109.965 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -61.73 -24.72 66.99 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.237 -1.394 . . . . 1.46 107.237 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -27.03 68.67 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.343 -0.844 . . . . 1.1499999999999999 109.109 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -89.32 -2.31 58.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 1.1699999999999999 109.535 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 107.74 12.4 22.73 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.898 -1.281 . . . . 0.41999999999999998 109.898 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.894 HD12 HD21 ' A' ' 6' ' ' ASN . 50.0 mm -76.44 106.16 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.063 -1.257 . . . . 0.34999999999999998 108.927 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -92.52 -35.76 13.42 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.312 -0.867 . . . . 1.55 110.232 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -98.63 140.12 33.33 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.387 0.613 . . . . 1.5800000000000001 109.608 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.47 142.85 15.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 119.188 -1.005 . . . . 0.54000000000000004 110.221 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.2 127.33 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.987 -0.551 . . . . 0.25 110.477 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.8 mp -111.71 118.37 35.43 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.501 0.667 . . . . 0.40000000000000002 109.322 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.32 134.36 49.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.667 -0.864 . . . . 2.7400000000000002 108.667 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.5 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -145.14 157.28 27.29 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 120.036 -1.078 . . . . 0.20999999999999999 111.155 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 41' ' ' ARG . 14.9 p -139.0 146.92 41.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.466 -1.02 . . . . 0.56000000000000005 112.664 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.526 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 39.76 -86.92 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.628 -0.989 . . . . 0.33000000000000002 110.628 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -85.23 -51.86 6.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.32 -1.106 . . . . 3.0899999999999999 109.682 -178.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -25.51 60.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.819 -1.176 . . . . 1.0900000000000001 108.895 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 40' ' ' GLY . 7.0 tt -49.74 -36.37 11.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.552 -0.717 . . . . 0.87 110.83 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.45 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -83.54 -23.57 32.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.007 -1.058 . . . . 1.1399999999999999 108.989 -178.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 46' ' ' ALA . 7.8 mmtt -62.29 -70.7 0.18 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 104.497 -2.409 . . . . 1.8600000000000001 104.497 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.637 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -31.47 -49.63 0.16 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.17 0.51 . . . . 0.28999999999999998 110.576 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.7 HG13 ' HB ' ' B' ' 68' ' ' THR . 97.4 t -59.37 -69.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.225 -0.922 . . . . 0.22 109.549 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 52' ' ' SER . 3.6 t0 -45.81 -49.04 15.54 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.52 -0.738 . . . . 1.26 109.563 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.485 HG11 HD21 ' A' ' 36' ' ' LEU . 70.4 t -48.14 -59.64 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.646 -0.822 . . . . 1.0600000000000001 109.105 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -60.06 -53.45 57.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 4.0199999999999996 110.228 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 1.09 ' ND2' ' H ' ' B' ' 70' ' ' SER . 14.5 t-20 -52.48 -49.82 63.95 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.662 -1.236 . . . . 1.3400000000000001 107.662 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 49' ' ' VAL . 21.0 p -62.07 -35.04 77.45 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.73 -0.841 . . . . 1.04 108.73 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.474 HD23 ' CD2' ' A' ' 85' ' ' LEU . 7.5 tp -77.34 -22.38 51.94 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.065 -1.022 . . . . 0.44 108.737 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' C ' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -79.89 -42.5 24.04 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.172 -1.58 . . . . 1.0 106.858 177.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.49 -16.11 0.1 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.783 -1.099 . . . . 1.5800000000000001 108.051 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.506 ' N ' ' C ' ' A' ' 54' ' ' LYS . 12.2 mmm180 -59.31 -55.7 31.49 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.356 0.598 . . . . 1.6899999999999999 110.251 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 mt -159.16 0.58 0.09 Allowed 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 118.689 -1.204 . . . . 1.6599999999999999 110.595 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 61' ' ' VAL . . . 64.92 -58.52 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.527 -1.321 . . . . 0.39000000000000001 110.209 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -70.96 -41.98 70.36 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.495 -1.003 . . . . 1.3799999999999999 110.49 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.49 17.64 3.24 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.414 -1.475 . . . . 0.26000000000000001 109.414 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.681 HG13 HD21 ' A' ' 85' ' ' LEU . 2.4 t -155.94 127.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.785 -1.191 . . . . 0.38 107.785 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.6 mm-40 -132.94 157.51 44.96 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.176 0.988 . . . . 1.3100000000000001 111.375 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.724 HD11 HG21 ' A' ' 66' ' ' VAL . 8.3 tt -96.05 112.6 24.29 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.072 -0.714 . . . . 0.48999999999999999 109.072 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -20.86 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 1.3500000000000001 110.001 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.477 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -167.86 153.23 7.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.18 -1.575 . . . . 1.2 109.784 177.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.724 HG21 HD11 ' A' ' 63' ' ' LEU . 70.3 t -159.65 129.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.463 -0.773 . . . . 0.84999999999999998 109.457 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 82' ' ' LEU . 12.9 tt0 -146.06 164.79 31.03 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.285 1.04 . . . . 1.4099999999999999 110.902 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.613 HG22 ' HA ' ' A' ' 81' ' ' ILE . 1.6 p -139.27 158.06 44.82 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.894 -0.78 . . . . 0.52000000000000002 108.894 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.463 ' HA2' HD21 ' B' ' 51' ' ' ASN . . . -174.55 147.38 9.12 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 107.195 -2.362 . . . . 0.40000000000000002 107.195 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 1.132 ' H ' ' ND2' ' B' ' 51' ' ' ASN . 87.4 p -93.45 163.05 13.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.662 -1.493 . . . . 0.41999999999999998 110.175 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -147.85 159.88 43.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.237 -0.914 . . . . 1.29 110.648 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.17 87.71 2.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 118.991 -1.084 . . . . 1.02 109.226 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 46.1 ttt-85 -96.11 111.19 23.3 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.963 -1.086 . . . . 2.23 110.301 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.0 t70 80.64 37.25 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.888 -0.507 . . . . 1.3799999999999999 110.178 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.46 28.86 15.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.397 -0.815 . . . . 2.6200000000000001 109.129 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.26 146.14 28.51 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.083 -1.011 . . . . 3.1499999999999999 108.776 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.5 ' NH2' ' OG ' ' A' ' 70' ' ' SER . 5.5 tpt180 -84.46 133.23 34.49 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.779 1.276 . . . . 2.4399999999999999 111.256 -177.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.462 HD11 ' HA3' ' A' ' 40' ' ' GLY . 13.5 tt -141.34 155.72 21.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.436 -1.256 . . . . 0.23000000000000001 108.831 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.55 151.71 23.24 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.139 0.971 . . . . 0.73999999999999999 111.305 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.5 ' CD1' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -131.45 135.5 47.18 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.455 -0.943 . . . . 4.1600000000000001 108.455 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.613 ' HA ' HG22 ' A' ' 68' ' ' THR . 2.8 tt -117.11 126.79 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.168 -1.049 . . . . 0.92000000000000004 108.168 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' GLN . 16.8 mt -107.5 121.06 43.86 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.311 -1.366 . . . . 0.35999999999999999 107.311 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 tt -131.89 126.12 33.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.035 . . . . 0.97999999999999998 111.123 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -100.56 171.61 7.62 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.784 -0.644 . . . . 0.57999999999999996 109.985 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 61' ' ' VAL . 1.4 tp -159.49 142.38 14.07 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.112 -1.035 . . . . 1.3899999999999999 110.72 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.59 ' O ' ' N ' ' A' ' 62' ' ' GLN . 13.7 tmtt? -121.85 141.21 51.48 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 116.073 -0.512 . . . . 1.4199999999999999 110.442 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.1 mmt-85 -99.21 137.24 38.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.099 -1.001 . . . . 1.6399999999999999 109.705 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.31 -0.79 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.537 -0.912 . . . . 0.63 108.537 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 t80 . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 118.028 -0.987 . . . . 1.76 109.53 179.524 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ttt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.494 -0.558 . . . . 6.3499999999999996 109.494 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.479 ' O ' ' CB ' ' B' ' 3' ' ' GLU . 15.7 p -144.05 13.52 1.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 2.4199999999999999 109.93 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' B' ' 2' ' ' THR . 7.8 tt0 72.28 -50.73 0.7 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 1.6799999999999999 109.817 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 57.4 0.5 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.303 -0.873 . . . . 2.3100000000000001 109.857 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.433 ' N ' ' OG1' ' B' ' 2' ' ' THR . 1.1 tt -175.38 46.6 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.422 -0.955 . . . . 1.6200000000000001 108.422 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.473 HD21 ' CG1' ' B' ' 8' ' ' ILE . 9.5 t30 -92.32 114.92 27.59 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.251 -0.906 . . . . 1.46 110.792 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.7 pt-20 -93.4 117.62 30.3 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.303 -0.999 . . . . 1.49 108.303 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.473 ' CG1' HD21 ' B' ' 6' ' ' ASN . 45.5 mt -113.23 133.9 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.741 0.782 . . . . 1.1699999999999999 110.574 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -98.7 123.02 51.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.361 0.6 . . . . 1.3700000000000001 109.703 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.421 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.4 OUTLIER -88.92 165.38 2.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.163 -1.051 . . . . 0.37 108.163 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.448 ' HE ' ' HE3' ' B' ' 14' ' ' LYS . 26.9 mtt-85 -141.79 175.33 9.79 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.431 -0.793 . . . . 2.3700000000000001 109.747 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -102.53 -9.09 20.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.38 -0.97 . . . . 1.75 108.38 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -84.79 -14.49 47.99 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.478 -0.889 . . . . 1.1899999999999999 109.614 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.448 ' HE3' ' HE ' ' B' ' 11' ' ' ARG . 12.7 mttm -94.95 -118.25 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.18 -0.95 . . . . 1.47 108.944 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.5 168.6 9.29 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.396 -0.815 . . . . 1.22 109.06 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.517 HG23 ' N ' ' B' ' 17' ' ' GLU . 15.1 m -68.25 -38.4 79.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.881 0.848 . . . . 0.45000000000000001 109.097 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.517 ' N ' HG23 ' B' ' 16' ' ' VAL . 8.0 pt-20 -76.7 -31.46 57.22 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.024 -1.048 . . . . 1.7 109.51 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -32.28 72.6 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.453 -1.404 . . . . 1.46 111.268 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.66 ' O ' HG23 ' B' ' 23' ' ' VAL . 3.1 m-70 -94.96 -16.81 22.49 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.335 -1.478 . . . . 1.3999999999999999 108.409 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.15 -35.21 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 104.538 -2.393 . . . . 0.34000000000000002 104.538 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.57 ' O ' HG23 ' B' ' 25' ' ' VAL . 43.7 mt -68.93 -49.07 61.29 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.649 -1.16 . . . . 0.38 109.011 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -70.25 -32.06 69.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.153 -0.967 . . . . 1.21 109.536 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.66 HG23 ' O ' ' B' ' 19' ' ' HIS . 25.0 t -68.11 -52.53 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.29999999999999999 109.165 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 tt -62.19 -23.31 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.217 -0.927 . . . . 0.68999999999999995 108.883 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.57 HG23 ' O ' ' B' ' 21' ' ' LEU . 11.3 t -69.88 -39.91 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.111 -0.993 . . . . 0.41999999999999998 109.27 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -68.71 -38.76 80.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.758 -1.214 . . . . 1.1499999999999999 109.822 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.2 -27.64 65.91 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.81 -1.552 . . . . 1.46 106.81 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -25.25 68.28 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.235 -0.893 . . . . 1.1699999999999999 109.143 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -91.64 0.62 57.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 1.1699999999999999 109.351 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 103.68 14.25 25.8 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.034 -1.226 . . . . 0.38 110.034 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -78.08 108.49 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.931 -1.335 . . . . 0.58999999999999997 108.393 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.7 OUTLIER -94.38 -37.97 11.2 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.409 -0.807 . . . . 1.46 110.642 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -100.38 139.03 36.63 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.714 -0.616 . . . . 1.2 110.046 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.75 142.93 16.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.089 -1.044 . . . . 0.48999999999999999 111.234 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.85 124.79 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-N 115.889 -0.596 . . . . 0.31 110.405 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' B' ' 46' ' ' ALA . 2.8 mp -103.19 114.21 28.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.305 -0.872 . . . . 0.47999999999999998 109.848 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -98.66 122.97 42.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 2.7400000000000002 109.761 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.507 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -137.59 153.33 22.01 Favored Glycine 0 N--CA 1.505 3.266 0 C-N-CA 119.86 -1.162 . . . . 0.23999999999999999 111.357 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.61 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 1.4 p -139.79 147.28 40.56 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 122.174 0.987 . . . . 0.48999999999999999 112.949 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.531 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 36.93 -87.62 0.01 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.632 -0.987 . . . . 0.28000000000000003 110.632 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -82.63 -52.77 6.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -1.084 . . . . 3.1600000000000001 109.503 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -19.48 54.24 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.901 -1.124 . . . . 1.3799999999999999 109.224 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.531 HG22 ' O ' ' B' ' 40' ' ' GLY . 6.6 tt -54.58 -28.61 19.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.267 -0.896 . . . . 0.84999999999999998 109.618 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.98 -26.83 26.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.1200000000000001 108.921 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.452 ' O ' ' C ' ' B' ' 46' ' ' ALA . 9.9 mmtt -64.0 -69.62 0.27 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.819 -1.919 . . . . 1.8700000000000001 105.819 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.648 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -32.42 -49.69 0.22 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 116.123 -0.49 . . . . 0.26000000000000001 111.166 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.583 HG13 ' HB ' ' A' ' 68' ' ' THR . 69.9 t -66.91 -62.74 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.73 -1.231 . . . . 0.28000000000000003 109.884 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ASP . . . . . 0.438 ' O ' ' OG ' ' B' ' 52' ' ' SER . 7.5 t0 -48.22 -52.57 20.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 1.25 108.646 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 54.2 t -44.42 -55.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.722 -0.844 . . . . 1.0600000000000001 108.722 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' B' ' 54' ' ' LYS . 0.1 OUTLIER -63.97 -51.89 62.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.542 -0.724 . . . . 4.1100000000000003 110.503 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 1.132 ' ND2' ' H ' ' A' ' 70' ' ' SER . 15.2 t-20 -53.25 -51.08 63.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.311 -1.366 . . . . 1.4099999999999999 107.311 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 3.8 p -59.18 -36.73 75.84 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.564 -0.902 . . . . 0.65000000000000002 108.564 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.473 ' O ' ' CG ' ' B' ' 56' ' ' ARG . 5.4 tp -77.13 -24.06 51.7 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.211 -0.931 . . . . 0.53000000000000003 109.069 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' LYS . . . . . 0.531 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -81.78 -44.57 16.81 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 119.843 -1.786 . . . . 0.98999999999999999 107.286 178.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' B' ' 55' ' ' ASP . 1.4 t0 -50.88 -11.22 0.08 Allowed 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.171 -1.377 . . . . 1.46 107.88 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.531 ' N ' ' C ' ' B' ' 54' ' ' LYS . 9.3 mmm180 -56.96 -57.25 13.36 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.119 0.961 . . . . 1.71 110.352 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.0 OUTLIER -156.53 -1.92 0.12 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.137 -1.061 . . . . 1.77 108.137 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.0 -52.93 0.1 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.011 -1.09 . . . . 0.39000000000000001 110.427 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -72.51 -45.44 59.36 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.473 -1.016 . . . . 1.3999999999999999 110.329 -178.47 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.417 ' O ' HG23 ' B' ' 61' ' ' VAL . . . -71.93 21.08 0.82 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 109.395 -1.482 . . . . 0.34000000000000002 109.395 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.651 HG13 HD21 ' B' ' 85' ' ' LEU . 2.5 t -156.65 130.76 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.032 -1.275 . . . . 0.46000000000000002 107.894 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.5 mm-40 -132.92 150.11 52.19 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.029 0.919 . . . . 1.4199999999999999 111.695 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.667 ' C ' HD23 ' B' ' 63' ' ' LEU . 7.0 tt -94.23 114.83 27.0 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.84 -1.17 . . . . 0.54000000000000004 107.84 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.36 -11.77 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.419 -0.801 . . . . 1.4299999999999999 110.729 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' B' ' 84' ' ' ARG . 0.5 OUTLIER -175.57 146.42 0.77 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.343 -1.473 . . . . 1.28 109.655 178.237 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.661 HG21 HD11 ' B' ' 63' ' ' LEU . 87.2 t -156.79 134.29 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.507 -0.746 . . . . 0.90000000000000002 109.038 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLN . . . . . 0.667 ' HB3' HD12 ' B' ' 82' ' ' LEU . 23.6 tt0 -146.28 162.87 37.16 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.133 0.968 . . . . 1.4399999999999999 110.943 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.7 ' HB ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -126.74 164.86 20.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.303 -0.999 . . . . 0.45000000000000001 108.303 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.613 ' HA2' HD21 ' A' ' 51' ' ' ASN . . . -178.55 136.85 3.05 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.024 -1.63 . . . . 0.28999999999999998 109.024 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' SER . . . . . 1.09 ' H ' ' ND2' ' A' ' 51' ' ' ASN . 51.8 p -94.36 156.81 16.32 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.185 -1.185 . . . . 0.39000000000000001 108.231 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.83 173.09 17.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.805 -1.184 . . . . 1.49 110.605 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 t -89.54 137.75 20.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.805 -0.813 . . . . 0.87 108.805 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 27.3 ttt-85 -149.67 103.47 3.25 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.098 -1.075 . . . . 2.1800000000000002 108.098 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.3 t70 82.22 34.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.434 -0.95 . . . . 1.3500000000000001 108.434 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 66.45 25.84 10.15 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.727 0.775 . . . . 2.5699999999999998 109.12 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -147.32 152.22 37.87 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.412 -0.805 . . . . 3.1400000000000001 108.995 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.469 ' NH2' ' OG ' ' B' ' 70' ' ' SER . 3.5 ttt180 -88.08 138.71 31.21 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.598 1.19 . . . . 2.3900000000000001 112.253 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.01 156.41 22.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.016 -1.105 . . . . 0.57999999999999996 108.016 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 2.8 m -86.68 151.52 23.34 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.203 -0.935 . . . . 0.60999999999999999 110.372 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.61 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.2 OUTLIER -133.32 133.95 43.2 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.133 -1.062 . . . . 4.0800000000000001 108.133 -178.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.532 HG23 ' O ' ' B' ' 81' ' ' ILE . 3.5 tt -116.06 128.79 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.872 -0.788 . . . . 0.90000000000000002 108.872 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' B' ' 67' ' ' GLN . 4.4 mt -106.64 118.44 36.67 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.631 -1.618 . . . . 0.37 106.631 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tt -128.18 124.47 36.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.97999999999999998 110.317 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' B' ' 65' ' ' ASN . 23.0 ttt180 -99.96 170.76 8.29 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.443 0.64 . . . . 0.70999999999999996 109.965 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.651 HD21 HG13 ' B' ' 61' ' ' VAL . 1.5 tp -162.47 127.56 3.28 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.363 -0.935 . . . . 1.4399999999999999 110.783 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 62' ' ' GLN . 12.6 tmtt? -109.1 148.65 30.5 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.199 -0.667 . . . . 1.3100000000000001 109.199 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 29.3 mmt-85 -101.18 141.81 33.53 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.276 -0.89 . . . . 1.6399999999999999 110.416 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.74 -7.79 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.032 -0.729 . . . . 0.68000000000000005 109.032 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 13.5 t80 . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 117.973 -1.013 . . . . 1.77 109.54 179.438 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.438 -0.579 . . . . 6.3300000000000001 109.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.414 ' O ' ' CD1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -168.09 -162.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 2.5299999999999998 109.643 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.509 ' O ' HD13 ' A' ' 31' ' ' ILE . 1.4 mm-40 -71.41 -57.31 4.56 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.509 -0.744 . . . . 1.75 109.827 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.72 63.81 0.61 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.626 -0.671 . . . . 2.2400000000000002 109.319 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.1 tp -165.0 156.27 14.74 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.17 -1.789 . . . . 1.6699999999999999 106.17 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.851 ' ND2' HG23 ' A' ' 34' ' ' VAL . 1.0 OUTLIER 175.84 96.13 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.683 -1.207 . . . . 1.72 109.898 176.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 4.4 pt-20 -91.26 119.11 31.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.454 -1.404 . . . . 1.4399999999999999 108.793 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.462 ' CG1' ' OD1' ' A' ' 6' ' ' ASN . 2.7 mt -129.76 145.99 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 CA-C-O 122.242 1.02 . . . . 1.1100000000000001 111.732 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 37' ' ' LYS . 3.7 t -107.96 130.27 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.585 0.707 . . . . 1.3500000000000001 109.632 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.408 HG11 ' H ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -88.47 162.98 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.244 -1.021 . . . . 0.39000000000000001 108.244 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.23 175.01 9.99 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.276 1.036 . . . . 2.27 111.216 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.46 ' H ' ' HG3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -101.91 -12.47 18.2 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.086 -1.079 . . . . 1.78 108.086 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.587 ' C ' ' HZ3' ' A' ' 14' ' ' LYS . 30.0 p -86.42 -15.35 40.58 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.828 -0.749 . . . . 1.24 109.437 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HZ3' ' C ' ' A' ' 13' ' ' THR . 4.9 mmpm? -91.71 -123.55 0.08 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.118 -0.989 . . . . 1.4099999999999999 108.841 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.49 167.09 13.95 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.887 -1.153 . . . . 1.25 107.887 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 16' ' ' VAL . 1.5 m -68.06 -30.12 46.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.897 -1.149 . . . . 0.48999999999999999 107.897 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.5 pt-20 -79.46 -37.85 35.95 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.504 -0.878 . . . . 1.5600000000000001 109.328 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.418 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -58.29 -33.23 69.21 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 120.146 -1.596 . . . . 1.3799999999999999 110.899 -179.04 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.638 ' O ' HG23 ' A' ' 23' ' ' VAL . 70.4 m-70 -91.74 -16.87 26.25 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 120.379 -1.451 . . . . 1.4299999999999999 108.922 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.56 -32.73 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 105.294 -2.113 . . . . 0.28999999999999998 105.294 176.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 25' ' ' VAL . 65.9 mt -70.36 -56.15 7.38 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.228 -0.896 . . . . 0.40999999999999998 109.517 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -64.79 -27.47 68.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 1.22 110.26 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 19' ' ' HIS . 38.8 t -73.25 -50.26 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.235 -0.915 . . . . 0.32000000000000001 109.262 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 tt -64.52 -18.13 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.203 -0.935 . . . . 0.57999999999999996 108.675 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 21' ' ' LEU . 9.0 t -74.95 -44.62 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.293 -0.879 . . . . 0.40999999999999998 108.835 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -67.15 -31.95 72.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.008 -1.057 . . . . 1.1899999999999999 110.147 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.596 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 15.6 t80 -65.36 -24.87 67.35 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.225 -1.398 . . . . 1.46 107.225 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -64.01 -27.32 69.04 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.36 -0.836 . . . . 1.1499999999999999 109.318 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -89.41 -2.42 58.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.996 -1.065 . . . . 1.1699999999999999 109.317 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.17 15.8 13.6 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.088 -1.205 . . . . 0.41999999999999998 110.088 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.509 HD13 ' O ' ' A' ' 3' ' ' GLU . 48.8 mm -79.54 105.98 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.02 -1.282 . . . . 0.34999999999999998 108.566 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -94.41 -37.77 11.28 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.337 -0.852 . . . . 1.55 110.482 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 3.4 mt-10 -95.08 135.27 36.84 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.297 -0.877 . . . . 1.5800000000000001 109.697 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.851 HG23 ' ND2' ' A' ' 6' ' ' ASN . 2.8 p -149.14 138.55 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.329 -0.948 . . . . 0.54000000000000004 110.466 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.99 127.64 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 115.911 -0.586 . . . . 0.25 110.865 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.2 mp -112.75 122.28 47.21 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.291 -0.633 . . . . 0.40000000000000002 109.291 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -106.76 136.98 45.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.442 -0.947 . . . . 2.7400000000000002 108.442 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.34 156.68 26.26 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 119.501 -1.333 . . . . 0.20999999999999999 111.32 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.671 ' O ' ' N ' ' A' ' 41' ' ' ARG . 43.4 p -134.02 142.84 47.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.907 -0.76 . . . . 0.56000000000000005 112.151 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.565 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 35.49 -77.19 0.0 OUTLIER Glycine 0 N--CA 1.503 3.122 0 CA-C-O 121.346 0.415 . . . . 0.33000000000000002 112.182 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.671 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -87.11 -58.37 2.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.249 . . . . 3.0899999999999999 109.429 -179.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -20.91 21.72 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.1 -1.0 . . . . 1.0900000000000001 108.933 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 40' ' ' GLY . 8.4 tt -53.65 -33.84 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.152 -0.967 . . . . 0.87 111.046 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.14 -24.48 24.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.727 -1.233 . . . . 1.1399999999999999 108.499 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -58.39 -67.7 0.33 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.206 -2.146 . . . . 1.8600000000000001 105.206 177.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.561 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -34.32 -48.01 0.32 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 120.998 0.428 . . . . 0.28999999999999998 110.556 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.661 HG13 ' HB ' ' B' ' 68' ' ' THR . 97.1 t -60.62 -64.93 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.034 -1.041 . . . . 0.22 109.343 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -46.53 -51.81 14.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.436 -0.95 . . . . 1.26 108.436 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.467 HG11 HD21 ' A' ' 36' ' ' LEU . 74.5 t -46.93 -57.34 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.875 -1.157 . . . . 1.0600000000000001 107.875 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -58.35 -57.5 12.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.401 -0.812 . . . . 4.0199999999999996 110.598 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.544 ' CG ' ' H ' ' B' ' 70' ' ' SER . 1.1 t30 -51.76 -53.44 39.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.899 -1.148 . . . . 1.3400000000000001 107.899 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.9 p -59.4 -39.03 82.1 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.434 -0.906 . . . . 1.04 109.101 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.445 HD22 HG11 ' A' ' 23' ' ' VAL . 38.0 tp -75.53 -24.33 56.74 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.993 -1.067 . . . . 0.44 109.023 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' TYR . 5.9 tmtt? -80.88 -40.97 23.87 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.738 -1.949 . . . . 1.0 105.738 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -57.92 -7.18 0.69 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.331 -1.304 . . . . 1.5800000000000001 107.817 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.4 tpt180 -71.59 -46.07 60.35 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.624 0.726 . . . . 1.6899999999999999 110.067 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 mt -154.44 -19.47 0.13 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.777 -0.769 . . . . 1.6599999999999999 109.657 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.79 -50.34 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.321 -1.112 . . . . 0.39000000000000001 110.321 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -74.54 -41.73 60.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.347 -1.09 . . . . 1.3799999999999999 109.94 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.25 25.05 7.34 Favored Glycine 0 N--CA 1.48 1.62 0 N-CA-C 109.273 -1.531 . . . . 0.26000000000000001 109.273 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.562 HG13 HD21 ' A' ' 85' ' ' LEU . 4.0 t -151.97 119.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 106.943 -1.503 . . . . 0.38 106.943 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.1 mm100 -126.58 159.64 32.95 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.096 0.95 . . . . 1.3100000000000001 111.604 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.709 HD11 HG21 ' A' ' 66' ' ' VAL . 8.4 tt -94.67 116.69 29.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.923 -0.769 . . . . 0.48999999999999999 108.923 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -22.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.212 -0.93 . . . . 1.3500000000000001 109.482 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.459 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -172.04 154.01 3.33 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.76 -1.176 . . . . 1.2 109.741 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.709 HG21 HD11 ' A' ' 63' ' ' LEU . 77.7 t -159.46 130.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.41 -0.959 . . . . 0.84999999999999998 108.41 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -141.38 162.0 36.53 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.985 0.898 . . . . 1.4099999999999999 109.945 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.57 148.77 51.64 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.84 -0.8 . . . . 0.52000000000000002 108.84 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.637 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -172.04 155.35 23.53 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.602 -1.799 . . . . 0.40000000000000002 108.602 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.578 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 83.2 p -100.48 156.85 17.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.188 -1.184 . . . . 0.41999999999999998 109.907 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -144.18 160.27 41.22 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.085 -1.009 . . . . 1.29 110.278 179.445 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.43 91.07 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.808 -0.757 . . . . 1.02 111.141 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 9.0 ttt85 -96.07 107.84 20.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.064 -1.023 . . . . 2.23 110.18 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.8 t0 84.08 36.22 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.127 0.489 . . . . 1.3799999999999999 110.263 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.478 ' CG ' HH11 ' A' ' 75' ' ' ARG . 0.0 OUTLIER 62.6 29.82 16.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.378 -0.826 . . . . 2.6200000000000001 108.794 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -145.09 144.09 30.76 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.022 -1.103 . . . . 3.1499999999999999 108.022 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -84.25 136.28 34.0 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.822 1.296 . . . . 2.4399999999999999 110.84 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.0 tt -143.91 155.79 15.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-N 114.316 -1.311 . . . . 0.23000000000000001 108.156 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 p -90.49 154.35 19.7 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 121.356 -0.84 . . . . 0.73999999999999999 111.43 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.637 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.8 p90 -143.56 150.91 39.54 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.81 0.814 . . . . 4.1600000000000001 109.702 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 81' ' ' ILE . 6.0 tt -124.51 133.61 68.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.724 0.773 . . . . 0.92000000000000004 109.582 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.2 mt -107.8 128.58 54.72 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.663 -1.236 . . . . 0.35999999999999999 107.663 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 tt -137.13 127.43 26.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.976 -1.077 . . . . 0.97999999999999998 111.519 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -104.9 166.36 10.44 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.681 -0.69 . . . . 0.57999999999999996 110.295 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.562 HD21 HG13 ' A' ' 61' ' ' VAL . 4.7 tp -157.87 137.01 11.66 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.437 -0.905 . . . . 1.3899999999999999 111.458 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -117.31 137.11 52.64 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.727 -0.471 . . . . 1.4199999999999999 109.727 178.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 16.9 mmt85 -94.17 144.49 25.46 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.212 -0.93 . . . . 1.6399999999999999 109.721 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 88' ' ' VAL . 27.1 t -123.63 -6.5 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.909 -0.774 . . . . 0.63 108.909 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 118.049 -0.976 . . . . 1.76 109.51 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mtt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.244 0.545 . . . . 6.3499999999999996 109.626 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -160.21 -167.92 2.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 2.4199999999999999 109.11 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 30' ' ' GLY . 1.5 mt-10 -83.84 7.33 18.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.113 -0.992 . . . . 1.6799999999999999 109.633 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.02 50.29 0.3 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.868 0.842 . . . . 2.3100000000000001 109.348 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 5.6 tp -162.85 155.98 19.61 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 105.545 -2.02 . . . . 1.6200000000000001 105.545 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.563 HD22 HD22 ' B' ' 26' ' ' LEU . 0.4 OUTLIER -178.94 92.96 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 117.852 -1.539 . . . . 1.46 110.887 177.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.1 pt-20 -92.06 105.12 17.43 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.183 -1.573 . . . . 1.49 108.032 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.437 HD11 ' OD1' ' B' ' 6' ' ' ASN . 4.0 mt -116.33 135.05 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.698 0.761 . . . . 1.1699999999999999 109.954 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.646 HG13 ' HB2' ' B' ' 37' ' ' LYS . 11.9 t -97.79 127.72 49.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.508 0.671 . . . . 1.3700000000000001 109.483 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.495 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -88.33 160.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.946 -1.131 . . . . 0.37 107.946 -179.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 172.25 12.97 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.934 0.873 . . . . 2.3700000000000001 110.538 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.99 -13.02 39.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.705 -0.85 . . . . 1.75 108.705 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 47.8 p -76.86 -70.27 0.47 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.885 -1.524 . . . . 1.1899999999999999 106.885 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 139.9 33.93 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.386 -0.821 . . . . 1.47 110.148 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -72.84 178.59 4.14 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.473 0.654 . . . . 1.22 109.843 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.11 -29.25 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.92 0.866 . . . . 0.45000000000000001 108.795 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 13.0 pt-20 -74.62 -39.15 62.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.607 -0.886 . . . . 1.7 108.607 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 17.4 t0 -57.16 -29.54 63.72 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.088 -1.008 . . . . 1.46 111.375 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.687 ' O ' HG23 ' B' ' 23' ' ' VAL . 52.4 m-70 -94.83 -19.51 20.26 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 119.977 -1.702 . . . . 1.3999999999999999 107.946 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -35.81 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 105.069 -2.197 . . . . 0.34000000000000002 105.069 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.488 ' O ' HG23 ' B' ' 25' ' ' VAL . 68.9 mt -69.14 -51.92 33.38 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.204 -0.907 . . . . 0.38 108.732 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -66.78 -30.73 71.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 1.21 110.126 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.687 HG23 ' O ' ' B' ' 19' ' ' HIS . 42.2 t -71.71 -55.12 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.142 -0.974 . . . . 0.29999999999999999 109.41 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 tt -58.67 -21.97 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.68999999999999995 108.982 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 21' ' ' LEU . 5.6 t -71.12 -39.86 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.179 -0.951 . . . . 0.41999999999999998 108.95 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.563 HD22 HD22 ' B' ' 6' ' ' ASN . 4.9 mt -68.44 -44.98 73.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 1.1499999999999999 109.942 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.582 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 18.4 t80 -54.42 -27.5 37.36 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.29 -1.374 . . . . 1.46 107.29 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -62.76 -24.92 67.95 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.533 -0.758 . . . . 1.1699999999999999 109.575 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -91.6 -4.38 55.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.917 -1.114 . . . . 1.1699999999999999 109.083 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 110.16 14.13 14.01 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.429 -1.468 . . . . 0.38 109.429 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.535 HG21 ' ND2' ' B' ' 6' ' ' ASN . 32.6 mm -78.83 102.18 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.006 -1.291 . . . . 0.58999999999999997 108.666 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.15 -35.03 14.79 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.278 -0.889 . . . . 1.46 111.517 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.68 135.42 44.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.382 -0.824 . . . . 1.2 110.471 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.59 142.5 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.305 -0.958 . . . . 0.48999999999999999 111.707 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.86 123.42 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 121.204 0.526 . . . . 0.31 111.012 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.646 HD23 ' HA ' ' B' ' 46' ' ' ALA . 3.3 mp -102.5 121.89 43.26 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.439 -0.788 . . . . 0.47999999999999998 110.141 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.646 ' HB2' HG13 ' B' ' 9' ' ' VAL . 4.0 mttt -103.01 128.56 49.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.223 -0.923 . . . . 2.7400000000000002 109.214 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.91 150.95 21.12 Favored Glycine 0 N--CA 1.502 3.099 0 C-N-CA 119.366 -1.397 . . . . 0.23999999999999999 111.667 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.591 ' O ' ' N ' ' B' ' 41' ' ' ARG . 81.8 p -131.88 139.5 48.81 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.826 -0.808 . . . . 0.48999999999999999 112.174 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.451 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 35.79 -83.58 0.0 OUTLIER Glycine 0 N--CA 1.502 3.092 0 O-C-N 121.694 -0.629 . . . . 0.28000000000000003 111.983 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.69 ' N ' ' HE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -81.23 -54.61 5.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.084 -1.245 . . . . 3.1600000000000001 109.388 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.26 -20.55 43.22 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.155 -0.965 . . . . 1.3799999999999999 108.431 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.451 HG22 ' O ' ' B' ' 40' ' ' GLY . 3.7 tt -55.25 -33.55 30.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.049 -1.032 . . . . 0.84999999999999998 110.301 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -22.65 32.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.035 -1.04 . . . . 1.1200000000000001 108.858 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' B' ' 46' ' ' ALA . 0.0 OUTLIER -64.85 -68.73 0.34 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.533 -1.655 . . . . 1.8700000000000001 106.533 177.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.646 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -37.23 -46.15 0.7 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.378 0.608 . . . . 0.26000000000000001 110.272 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 43' ' ' ILE . 74.0 t -60.79 -66.3 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.185 -0.947 . . . . 0.28000000000000003 109.132 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ASP . . . . . 0.438 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 26.8 t0 -48.23 -46.6 35.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.919 . . . . 1.25 108.848 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.608 HG11 HD21 ' B' ' 36' ' ' LEU . 75.0 t -47.87 -54.91 3.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.011 -1.107 . . . . 1.0600000000000001 108.011 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.473 ' CE1' HD11 ' B' ' 85' ' ' LEU . 1.3 t80 -59.47 -60.67 3.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 4.1100000000000003 110.611 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 0.578 ' CG ' ' H ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -48.13 -54.79 12.09 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.276 -0.89 . . . . 1.4099999999999999 108.599 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.438 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 0.7 OUTLIER -60.25 -38.3 83.03 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.377 -0.929 . . . . 0.65000000000000002 109.378 -179.06 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.477 HD22 HG11 ' B' ' 23' ' ' VAL . 24.2 tp -73.32 -26.9 61.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.938 . . . . 0.53000000000000003 109.276 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' B' ' 56' ' ' ARG . 1.6 tmtt? -75.03 -50.91 14.95 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.674 -1.602 . . . . 0.98999999999999999 106.674 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.41 -17.96 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.053 -1.43 . . . . 1.46 109.479 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' B' ' 54' ' ' LYS . 12.7 mmm180 -69.17 -38.44 78.72 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.13 -1.028 . . . . 1.71 109.845 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.6 mt -155.39 -13.13 0.11 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.091 -1.444 . . . . 1.77 112.216 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.93 -67.81 0.05 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.228 -1.463 . . . . 0.39000000000000001 110.187 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.17 -35.71 76.59 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.407 -1.055 . . . . 1.3999999999999999 109.919 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.27 22.37 6.25 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.385 -1.486 . . . . 0.34000000000000002 109.385 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.603 HG13 HD21 ' B' ' 85' ' ' LEU . 7.2 t -153.84 130.29 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.187 -1.184 . . . . 0.46000000000000002 107.872 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.5 mm100 -133.11 155.54 49.08 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.306 1.051 . . . . 1.4199999999999999 111.977 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.611 HD11 HG21 ' B' ' 66' ' ' VAL . 8.4 tt -94.85 118.97 32.65 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.517 -0.92 . . . . 0.54000000000000004 108.517 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.97 -14.94 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.399 -0.813 . . . . 1.4299999999999999 109.906 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.475 ' O ' HG23 ' B' ' 66' ' ' VAL . 0.5 OUTLIER -177.53 152.07 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.732 -1.23 . . . . 1.28 109.906 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.611 HG21 HD11 ' B' ' 63' ' ' LEU . 74.8 t -160.05 134.31 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.759 -0.83 . . . . 0.90000000000000002 108.759 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLN . . . . . 0.422 ' HB3' HD12 ' B' ' 82' ' ' LEU . 32.1 tt0 -145.59 162.42 37.51 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.123 0.963 . . . . 1.4399999999999999 110.973 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.661 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -136.66 154.69 50.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.416 -0.957 . . . . 0.45000000000000001 108.416 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.656 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -177.98 155.9 18.26 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 107.443 -2.263 . . . . 0.28999999999999998 107.443 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.544 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 90.7 p -94.03 156.74 16.44 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.055 -1.262 . . . . 0.39000000000000001 108.959 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.419 ' OE1' ' C ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -147.0 164.71 32.12 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.939 -1.101 . . . . 1.49 110.141 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.419 ' C ' ' OE1' ' B' ' 71' ' ' GLU . 2.1 t -91.14 136.46 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 120.023 -0.671 . . . . 0.87 110.002 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 0.0 OUTLIER -148.51 106.66 3.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.416 -0.957 . . . . 2.1800000000000002 108.416 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.8 t0 79.74 35.53 0.15 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.258 -1.015 . . . . 1.3500000000000001 108.258 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.72 31.85 11.62 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.845 0.831 . . . . 2.5699999999999998 109.169 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -150.01 150.76 32.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.21 -0.931 . . . . 3.1400000000000001 109.298 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -88.4 138.5 31.38 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.393 1.092 . . . . 2.3900000000000001 112.429 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.34 154.09 27.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.045 -1.094 . . . . 0.57999999999999996 108.045 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 150.19 24.73 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.146 -0.972 . . . . 0.60999999999999999 109.912 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.656 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.9 p90 -144.42 149.93 36.87 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.929 0.871 . . . . 4.0800000000000001 110.826 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.483 HG23 ' O ' ' B' ' 81' ' ' ILE . 7.2 tt -125.35 134.04 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.59 0.709 . . . . 0.90000000000000002 110.33 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.422 HD12 ' HB3' ' B' ' 67' ' ' GLN . 11.2 mt -108.31 119.93 40.93 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.591 -1.633 . . . . 0.37 106.591 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.12 125.02 43.08 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.396 -0.922 . . . . 0.97999999999999998 111.065 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 -100.35 167.98 10.06 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.975 -0.75 . . . . 0.70999999999999996 108.975 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.603 HD21 HG13 ' B' ' 61' ' ' VAL . 2.2 tp -159.42 136.28 9.43 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.45 -0.9 . . . . 1.4399999999999999 110.448 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -118.0 143.01 46.76 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.285 -0.635 . . . . 1.3100000000000001 109.285 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.582 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 17.6 mmt85 -100.64 140.57 34.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.278 -0.889 . . . . 1.6399999999999999 109.997 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 t -119.0 -7.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.658 -0.867 . . . . 0.68000000000000005 108.658 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.455 0 CA-C-O 118.003 -0.999 . . . . 1.77 109.494 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 mmt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.518 -0.549 . . . . 6.3300000000000001 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.481 ' O ' ' CD1' ' A' ' 31' ' ' ILE . 5.5 t -138.05 23.28 2.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.456 -0.778 . . . . 2.5299999999999998 109.803 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 30' ' ' GLY . 2.3 mt-10 -84.26 -2.72 57.46 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.746 -0.835 . . . . 1.75 108.746 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 53.84 0.38 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 2.2400000000000002 109.706 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -173.24 46.92 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.186 -1.042 . . . . 1.6699999999999999 108.186 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.554 ' OD1' HD13 ' A' ' 26' ' ' LEU . 12.3 t-20 -91.38 110.52 21.83 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.313 -0.867 . . . . 1.72 110.824 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.99 120.58 32.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.861 -1.149 . . . . 1.4399999999999999 108.36 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 35' ' ' ILE . 3.5 mm -125.25 148.01 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-O 122.061 0.934 . . . . 1.1100000000000001 111.551 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.9 t -111.18 131.67 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.605 0.716 . . . . 1.3500000000000001 110.386 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.477 HG11 ' H ' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -90.46 162.36 2.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.47 -0.937 . . . . 0.39000000000000001 108.47 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.435 ' HE ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -137.79 174.05 10.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 2.27 110.221 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 -10.99 18.62 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.872 -0.788 . . . . 1.78 108.872 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.419 ' H ' HG22 ' A' ' 13' ' ' THR . 0.5 OUTLIER -85.71 -8.82 57.95 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.45 -0.9 . . . . 1.24 109.082 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HD3' ' HE ' ' A' ' 11' ' ' ARG . 0.1 OUTLIER -100.3 -121.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.353 -1.351 . . . . 1.4099999999999999 107.353 177.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.473 ' O ' ' ND1' ' A' ' 19' ' ' HIS . 5.4 m-80 -170.73 173.53 5.29 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.505 -1.372 . . . . 1.25 108.153 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.6 -31.57 51.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.073 -1.051 . . . . 0.48999999999999999 108.214 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.6 pt-20 -79.21 -36.37 40.22 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.409 -0.917 . . . . 1.5600000000000001 109.965 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -55.73 -33.26 64.09 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 119.908 -1.745 . . . . 1.3799999999999999 110.814 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.709 ' O ' HG23 ' A' ' 23' ' ' VAL . 10.5 m80 -94.52 -19.4 20.57 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.695 -1.253 . . . . 1.4299999999999999 109.021 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.74 -34.26 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 104.324 -2.473 . . . . 0.28999999999999998 104.324 176.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.653 ' O ' HG23 ' A' ' 25' ' ' VAL . 51.9 mt -68.49 -54.68 15.33 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.59 -1.186 . . . . 0.40999999999999998 108.935 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -67.41 -26.6 66.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 1.22 110.061 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 19' ' ' HIS . 35.3 t -72.41 -52.17 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.17 -0.957 . . . . 0.32000000000000001 108.7 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 tt -61.86 -19.16 20.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.209 -0.932 . . . . 0.57999999999999996 108.58 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 21' ' ' LEU . 40.2 t -75.52 -44.71 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.244 -0.91 . . . . 0.40999999999999998 109.221 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.554 HD13 ' OD1' ' A' ' 6' ' ' ASN . 4.5 mt -64.94 -34.67 78.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.814 -1.179 . . . . 1.1899999999999999 110.673 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -65.91 -24.47 66.85 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.534 -1.284 . . . . 1.46 107.534 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.36 -24.97 67.83 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.452 -0.795 . . . . 1.1499999999999999 109.796 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -92.07 1.18 57.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.794 -1.191 . . . . 1.1699999999999999 109.189 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 103.65 12.37 30.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.585 -1.406 . . . . 0.41999999999999998 109.585 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 2' ' ' THR . 19.3 mm -74.35 108.96 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -1.184 . . . . 0.34999999999999998 108.248 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -93.31 -41.18 10.0 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.443 -0.786 . . . . 1.55 110.57 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -94.96 142.15 27.82 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.357 -0.839 . . . . 1.5800000000000001 109.902 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.76 137.78 11.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.049 -1.06 . . . . 0.54000000000000004 110.57 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -116.83 122.1 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.977 -0.556 . . . . 0.25 110.284 -178.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 46' ' ' ALA . 2.3 mp -104.33 120.71 41.81 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 120.115 -0.634 . . . . 0.40000000000000002 109.379 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.88 134.97 50.84 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.681 -0.859 . . . . 2.7400000000000002 108.681 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -152.48 164.7 30.71 Favored Glycine 0 N--CA 1.508 3.435 0 C-N-CA 119.763 -1.208 . . . . 0.20999999999999999 111.603 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -145.69 152.33 39.44 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.391 -1.064 . . . . 0.56000000000000005 113.649 -177.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.593 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 38.13 -86.29 0.01 OUTLIER Glycine 0 N--CA 1.499 2.838 0 N-CA-C 111.254 -0.739 . . . . 0.33000000000000002 111.254 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.657 ' N ' ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -82.46 -54.32 5.29 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.224 -1.162 . . . . 3.0899999999999999 109.485 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -20.63 58.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 109.148 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.705 HD12 HD12 ' B' ' 43' ' ' ILE . 0.2 OUTLIER -52.78 -38.04 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.004 . . . . 0.87 110.759 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -82.38 -25.37 33.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.745 -1.222 . . . . 1.1399999999999999 108.871 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' O ' ' C ' ' A' ' 46' ' ' ALA . 3.2 mptt -62.06 -69.4 0.25 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.675 -1.972 . . . . 1.8600000000000001 105.675 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.637 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -34.22 -47.56 0.29 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.139 0.495 . . . . 0.28999999999999998 110.276 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.628 HG13 ' HB ' ' B' ' 68' ' ' THR . 68.9 t -62.19 -68.14 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.111 -0.993 . . . . 0.22 109.537 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 49' ' ' VAL . 0.7 OUTLIER -45.49 -49.61 13.47 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.793 -0.818 . . . . 1.26 108.793 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 36' ' ' LEU . 47.7 t -45.59 -57.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.582 -0.896 . . . . 1.0600000000000001 108.582 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -62.99 -58.21 8.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.299 -0.875 . . . . 4.0199999999999996 110.153 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.617 ' CG ' ' H ' ' B' ' 70' ' ' SER . 1.3 t30 -46.97 -54.72 9.51 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.97 -1.122 . . . . 1.3400000000000001 107.97 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -59.49 -34.72 72.93 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.596 -0.89 . . . . 1.04 108.596 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 23' ' ' VAL . 10.1 tp -76.85 -21.76 54.53 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.227 -1.027 . . . . 0.44 108.227 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -78.26 -46.28 20.69 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.091 -1.818 . . . . 1.0 106.091 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -58.49 -5.86 0.6 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.025 -1.102 . . . . 1.5800000000000001 108.025 178.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 54' ' ' LYS . 3.4 tpt85 -75.87 -47.35 25.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.722 0.772 . . . . 1.6899999999999999 109.639 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.629 HD23 ' H ' ' A' ' 60' ' ' GLY . 2.4 tp -152.14 -27.08 0.17 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.663 -0.815 . . . . 1.6599999999999999 109.88 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.62 -47.93 0.08 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.149 -1.181 . . . . 0.39000000000000001 110.149 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.617 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.6 OUTLIER -74.8 -44.28 50.26 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.484 -1.009 . . . . 1.3799999999999999 109.772 -179.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.629 ' H ' HD23 ' A' ' 57' ' ' LEU . . . -85.93 27.04 5.63 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.007 -1.637 . . . . 0.26000000000000001 109.007 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.7 t -154.75 129.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.339 -1.356 . . . . 0.38 107.339 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 86' ' ' LYS . 0.8 OUTLIER -136.39 157.01 47.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.122 0.963 . . . . 1.3100000000000001 111.594 -177.295 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.554 HD11 HG21 ' A' ' 66' ' ' VAL . 7.1 tt -93.13 112.16 24.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.845 -0.798 . . . . 0.48999999999999999 108.845 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.35 -27.7 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.175 -0.953 . . . . 1.3500000000000001 109.902 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.494 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -169.88 156.29 6.15 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.612 -1.305 . . . . 1.2 109.694 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 63' ' ' LEU . 68.2 t -159.52 131.34 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.596 0.712 . . . . 0.84999999999999998 109.343 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.506 ' CG ' ' N ' ' A' ' 68' ' ' THR . 30.6 tt0 -144.21 163.15 34.48 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.166 0.984 . . . . 1.4099999999999999 109.985 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.506 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -139.65 149.8 44.17 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.569 -0.901 . . . . 0.52000000000000002 108.569 -178.125 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.95 148.43 13.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.621 -2.192 . . . . 0.40000000000000002 107.621 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.59 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 28.1 p -95.55 162.53 13.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.98 -1.306 . . . . 0.41999999999999998 109.008 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -164.36 178.96 7.09 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.293 -0.963 . . . . 1.29 110.131 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.446 HG23 ' H ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -89.05 135.44 25.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 119.609 -0.836 . . . . 1.02 109.77 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 17.8 ttt85 -151.57 102.46 2.88 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.546 -0.909 . . . . 2.23 108.546 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.3 t70 88.5 33.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.114 0.483 . . . . 1.3799999999999999 109.721 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.93 34.18 5.45 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.201 1.001 . . . . 2.6200000000000001 109.364 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.25 153.64 27.85 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.14 -0.975 . . . . 3.1499999999999999 109.534 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -84.85 137.97 32.83 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.381 1.086 . . . . 2.4399999999999999 109.14 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.415 ' CG1' ' N ' ' A' ' 79' ' ' SER . 4.2 tt -146.18 159.87 11.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.324 -0.853 . . . . 0.23000000000000001 108.851 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.415 ' N ' ' CG1' ' A' ' 78' ' ' ILE . 5.1 p -86.58 149.84 24.65 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.076 0.941 . . . . 0.73999999999999999 109.864 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.44 ' CD2' HG22 ' A' ' 39' ' ' THR . 0.6 OUTLIER -133.15 141.21 48.01 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.507 -0.769 . . . . 4.1600000000000001 109.033 -178.357 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 81' ' ' ILE . 8.8 tt -117.66 127.34 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.879 0.847 . . . . 0.92000000000000004 111.225 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 34.6 mt -107.35 115.95 31.08 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.287 -1.746 . . . . 0.35999999999999999 106.287 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.52 127.2 40.29 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.011 -1.055 . . . . 0.97999999999999998 111.117 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.604 ' O ' HD12 ' A' ' 85' ' ' LEU . 10.1 ttt180 -103.12 169.41 8.58 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.482 0.658 . . . . 0.57999999999999996 110.936 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 84' ' ' ARG . 0.9 OUTLIER -161.86 145.26 12.19 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.25 -0.58 . . . . 1.3899999999999999 110.174 178.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 62' ' ' GLN . 1.5 tmtp? -127.35 145.51 50.78 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.53 -0.545 . . . . 1.4199999999999999 109.53 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -96.87 138.98 33.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.455 -0.778 . . . . 1.6399999999999999 110.291 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.16 -6.52 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.6 -0.889 . . . . 0.63 108.6 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.0 t80 . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 118.089 -0.957 . . . . 1.76 109.511 179.772 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.355 -0.609 . . . . 6.3499999999999996 109.355 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.485 HG23 ' O ' ' B' ' 2' ' ' THR . 5.6 t -96.36 24.03 6.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 2.4199999999999999 109.007 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.58 -72.51 0.2 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.599 -0.688 . . . . 1.6799999999999999 110.159 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.73 62.12 4.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.446 -1.409 . . . . 2.3100000000000001 110.124 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.11 154.08 19.01 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.959 -1.497 . . . . 1.6200000000000001 106.959 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.569 ' OD1' HD13 ' B' ' 26' ' ' LEU . 0.4 OUTLIER 179.06 93.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.718 -1.239 . . . . 1.46 110.605 177.24 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -90.4 100.2 13.08 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.41 -1.431 . . . . 1.49 107.56 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 4.2 mm -111.3 140.72 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 109.336 -0.616 . . . . 1.1699999999999999 109.336 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' B' ' 37' ' ' LYS . 63.5 t -104.29 131.45 53.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.69 0.757 . . . . 1.3700000000000001 110.481 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.573 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -89.13 159.54 2.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.981 -1.118 . . . . 0.37 107.981 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -134.68 169.19 17.7 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.024 0.916 . . . . 2.3700000000000001 111.025 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.439 ' C ' ' CD ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -97.55 -11.09 24.1 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.834 -0.802 . . . . 1.75 108.834 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.38 -10.17 44.91 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.737 -0.785 . . . . 1.1899999999999999 109.179 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -96.18 -127.78 0.14 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.999 -1.112 . . . . 1.47 107.999 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ASN . . . . . 0.405 ' O ' ' ND1' ' B' ' 19' ' ' HIS . 5.2 m-80 -167.02 162.69 15.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -0.942 . . . . 1.22 109.331 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -63.25 -38.65 82.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 122.001 0.905 . . . . 0.45000000000000001 108.959 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.455 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 7.3 pt-20 -71.94 -32.75 67.63 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.625 -0.88 . . . . 1.7 108.625 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -63.43 -31.01 72.05 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.349 -0.844 . . . . 1.46 112.402 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.759 ' O ' HG23 ' B' ' 23' ' ' VAL . 23.0 m80 -94.54 -20.87 19.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 119.822 -1.799 . . . . 1.3999999999999999 108.383 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.99 -38.98 82.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 104.275 -2.491 . . . . 0.34000000000000002 104.275 176.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.722 ' O ' HG23 ' B' ' 25' ' ' VAL . 48.9 mt -65.73 -49.22 69.23 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.435 -1.257 . . . . 0.38 108.689 178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.5 -31.64 68.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.227 -0.921 . . . . 1.21 109.779 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.759 HG23 ' O ' ' B' ' 19' ' ' HIS . 55.5 t -68.79 -57.32 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.947 -1.096 . . . . 0.29999999999999999 108.92 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 tt -56.6 -24.67 19.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.336 -0.853 . . . . 0.68999999999999995 108.937 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.722 HG23 ' O ' ' B' ' 21' ' ' LEU . 25.2 t -70.08 -40.65 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.132 -0.98 . . . . 0.41999999999999998 109.661 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.569 HD13 ' OD1' ' B' ' 6' ' ' ASN . 4.7 mt -67.45 -44.37 78.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.723 -1.236 . . . . 1.1499999999999999 110.185 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -57.24 -30.77 64.9 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.139 -1.43 . . . . 1.46 107.139 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -24.1 61.6 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.49 -0.777 . . . . 1.1699999999999999 109.2 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -92.95 -3.39 54.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 1.1699999999999999 109.151 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.64 14.51 19.46 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.304 -1.518 . . . . 0.38 109.304 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.42 107.82 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.111 -1.229 . . . . 0.58999999999999997 108.503 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -91.18 -36.82 13.72 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.477 -0.765 . . . . 1.46 111.415 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' B' ' 85' ' ' LEU . 7.3 mt-10 -107.1 136.47 46.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.542 -0.723 . . . . 1.2 111.135 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' B' ' 6' ' ' ASN . 13.4 p -145.94 145.39 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 119.706 -0.798 . . . . 0.48999999999999999 111.171 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.69 119.49 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.261 0.553 . . . . 0.31 110.439 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' B' ' 46' ' ' ALA . 2.7 mp -95.47 121.88 37.61 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.268 -0.895 . . . . 0.47999999999999998 110.918 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.477 ' HB2' HG13 ' B' ' 9' ' ' VAL . 2.8 mtpp -102.88 125.73 49.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.488 -0.758 . . . . 2.7400000000000002 109.33 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.4 156.85 26.98 Favored Glycine 0 N--CA 1.507 3.407 0 C-N-CA 119.362 -1.399 . . . . 0.23999999999999999 111.942 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 17.1 p -142.48 149.79 39.67 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.008 0.909 . . . . 0.48999999999999999 113.309 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.543 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 34.28 -85.51 0.01 OUTLIER Glycine 0 N--CA 1.498 2.773 0 N-CA-C 111.144 -0.782 . . . . 0.28000000000000003 111.144 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.652 ' NE ' ' N ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -81.22 -53.08 6.67 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.417 -1.049 . . . . 3.1600000000000001 109.267 -179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.452 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.4 OUTLIER -61.02 -17.73 53.86 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.068 -1.02 . . . . 1.3799999999999999 108.254 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -53.28 -35.54 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.351 -0.843 . . . . 0.84999999999999998 110.358 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -24.86 33.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.717 -1.239 . . . . 1.1200000000000001 109.036 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.499 ' CD ' ' N ' ' B' ' 45' ' ' LYS . 5.4 mptt -66.44 -68.58 0.36 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.692 -1.595 . . . . 1.8700000000000001 106.692 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.654 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -36.44 -49.13 0.71 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.056 0.455 . . . . 0.26000000000000001 110.671 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 68' ' ' THR . 79.7 t -66.89 -64.89 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.083 -1.011 . . . . 0.28000000000000003 109.8 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' B' ' 47' ' ' VAL . 4.5 t70 -46.59 -48.81 19.58 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.442 -0.947 . . . . 1.25 108.442 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.604 HG11 HD21 ' B' ' 36' ' ' LEU . 25.5 t -45.98 -52.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.389 -0.967 . . . . 1.0600000000000001 108.389 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.547 ' C ' ' CD1' ' B' ' 50' ' ' TYR . 0.2 OUTLIER -66.78 -60.25 2.84 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.377 -0.827 . . . . 4.1100000000000003 110.26 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 0.59 ' CG ' ' H ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -45.13 -50.53 11.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.155 -1.018 . . . . 1.4099999999999999 108.539 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -64.97 -34.63 78.88 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.349 -0.94 . . . . 0.65000000000000002 109.882 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.449 HD22 HG11 ' B' ' 23' ' ' VAL . 11.2 tp -69.98 -23.99 63.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.976 -1.078 . . . . 0.53000000000000003 109.921 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -28.41 33.47 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.095 -1.628 . . . . 0.98999999999999999 106.683 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -16.3 12.16 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.978 -1.119 . . . . 1.46 107.978 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -78.39 -40.04 37.29 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 120.222 -0.591 . . . . 1.71 110.073 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.2 tp -153.53 -24.7 0.14 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 118.329 -1.348 . . . . 1.77 112.118 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.29 -60.88 0.06 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.367 -1.397 . . . . 0.39000000000000001 109.914 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -67.71 -37.66 82.56 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.351 -1.088 . . . . 1.3999999999999999 109.764 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.508 ' O ' HG23 ' B' ' 61' ' ' VAL . . . -90.93 28.34 7.99 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.534 -1.426 . . . . 0.34000000000000002 109.534 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 60' ' ' GLY . 48.6 t -158.57 92.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -1.177 . . . . 0.46000000000000002 108.791 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER -97.42 161.64 13.69 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.252 1.025 . . . . 1.4199999999999999 112.094 -178.397 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 tt -97.27 121.15 38.84 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.104 -1.073 . . . . 0.54000000000000004 108.104 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.37 -18.21 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.248 -0.907 . . . . 1.4299999999999999 110.865 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.4 ' O ' HG23 ' B' ' 66' ' ' VAL . 1.9 m-20 -178.5 153.49 0.72 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.52 -1.362 . . . . 1.28 109.907 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 65' ' ' ASN . 87.5 t -158.19 136.56 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.93 -0.767 . . . . 0.90000000000000002 108.93 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLN . . . . . 0.648 ' HB3' HD12 ' B' ' 82' ' ' LEU . 24.0 tt0 -147.16 164.87 31.74 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.253 1.025 . . . . 1.4399999999999999 110.663 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.628 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -143.0 158.42 43.62 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.426 -0.953 . . . . 0.45000000000000001 108.426 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.67 151.84 11.78 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 106.934 -2.467 . . . . 0.28999999999999998 106.934 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.617 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 39.9 p -93.28 160.21 14.93 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.909 -1.348 . . . . 0.39000000000000001 108.535 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -159.09 174.62 14.62 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.925 -1.109 . . . . 1.49 110.061 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.432 ' O ' ' OE1' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -90.64 130.47 39.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 119.767 -0.773 . . . . 0.87 109.858 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.2 ttt85 -148.14 104.88 3.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.041 -0.726 . . . . 2.1800000000000002 109.041 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.2 t70 82.59 39.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.611 -0.515 . . . . 1.3500000000000001 109.611 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.62 31.86 20.26 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.063 0.935 . . . . 2.5699999999999998 108.793 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -154.86 152.75 30.17 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.056 -0.72 . . . . 3.1400000000000001 109.056 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -88.18 136.77 32.82 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.857 -1.137 . . . . 2.3900000000000001 110.734 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 tt -138.87 157.26 29.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.713 0.768 . . . . 0.57999999999999996 109.38 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.37 146.75 28.3 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.904 -1.146 . . . . 0.60999999999999999 107.904 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.618 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 2.3 t80 -136.98 139.78 41.72 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.961 -0.755 . . . . 4.0800000000000001 108.961 -175.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 12.9 tt -122.78 132.27 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 121.996 0.903 . . . . 0.90000000000000002 113.236 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' B' ' 67' ' ' GLN . 0.9 OUTLIER -108.81 108.08 18.75 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 105.999 -1.852 . . . . 0.37 105.999 177.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.73 121.26 43.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.227 -0.921 . . . . 0.97999999999999998 110.139 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.581 ' O ' HD12 ' B' ' 85' ' ' LEU . 33.9 ttt180 -97.28 168.26 10.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.873 -0.731 . . . . 0.70999999999999996 109.61 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.581 HD12 ' O ' ' B' ' 84' ' ' ARG . 1.0 OUTLIER -160.97 144.17 13.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.653 -0.819 . . . . 1.4399999999999999 109.99 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' B' ' 62' ' ' GLN . 1.8 tmtp? -125.64 147.27 49.38 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.542 -0.54 . . . . 1.3100000000000001 109.542 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -101.48 136.6 41.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.262 -0.898 . . . . 1.6399999999999999 109.845 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.94 -8.97 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.626 -0.879 . . . . 0.68000000000000005 108.626 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 21.0 t80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 118.017 -0.992 . . . . 1.77 109.564 179.659 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.34 -0.615 . . . . 6.3300000000000001 109.34 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.559 ' O ' HD11 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -42.67 135.14 2.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.571 -0.706 . . . . 2.5299999999999998 109.887 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' GLY . 4.6 mt-10 -76.33 -20.48 57.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.373 -0.829 . . . . 1.75 109.828 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 5' ' ' LEU . 5.3 ptpt -156.09 149.53 24.69 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.848 -1.158 . . . . 2.2400000000000002 109.585 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 1.9 tt 89.32 49.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.372 -0.973 . . . . 1.6699999999999999 108.372 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.723 ' ND2' HD13 ' A' ' 26' ' ' LEU . 48.0 t-20 -90.89 116.78 28.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.025 -0.731 . . . . 1.72 109.025 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 6.7 pt-20 -93.32 117.88 30.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.289 -0.882 . . . . 1.4399999999999999 109.671 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.645 HD11 ' ND2' ' A' ' 6' ' ' ASN . 53.5 mt -128.89 153.22 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 CA-C-O 122.189 0.995 . . . . 1.1100000000000001 112.384 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 37' ' ' LYS . 12.2 p -112.3 131.22 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.626 0.727 . . . . 1.3500000000000001 110.252 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.685 HG11 ' HB2' ' A' ' 46' ' ' ALA . 4.7 p -88.95 165.12 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.206 -1.035 . . . . 0.39000000000000001 108.206 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.53 ' N ' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.36 172.47 12.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.967 . . . . 2.27 110.002 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.554 ' NZ ' ' CZ ' ' A' ' 41' ' ' ARG . 6.1 pttp -98.06 -4.23 36.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.979 -0.748 . . . . 1.78 108.979 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.01 0.33 55.93 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.429 -1.323 . . . . 1.24 107.429 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -117.95 131.25 56.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.362 -1.348 . . . . 1.4099999999999999 107.362 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -67.88 173.17 4.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.751 -1.218 . . . . 1.25 110.435 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 17' ' ' GLU . 33.5 m -62.49 -35.65 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.361 -0.977 . . . . 0.48999999999999999 108.361 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' N ' HG23 ' A' ' 16' ' ' VAL . 9.2 pt-20 -69.76 -39.88 76.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.649 -0.871 . . . . 1.5600000000000001 108.649 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' N ' ' CG ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -48.5 -37.93 18.82 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.671 -1.268 . . . . 1.3799999999999999 111.93 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.689 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.4 m80 -93.87 -19.56 20.86 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.321 -1.487 . . . . 1.4299999999999999 108.667 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.68 -34.53 47.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 104.482 -2.414 . . . . 0.28999999999999998 104.482 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.791 ' O ' HG23 ' A' ' 25' ' ' VAL . 71.6 mt -69.07 -55.68 10.02 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.033 -0.985 . . . . 0.40999999999999998 108.556 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.68 -29.95 71.03 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.311 -0.868 . . . . 1.22 109.668 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 19' ' ' HIS . 24.9 t -70.42 -54.82 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.32000000000000001 108.953 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 24' ' ' ILE . 2.9 tt -61.73 -15.18 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.165 -0.959 . . . . 0.57999999999999996 108.839 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 21' ' ' LEU . 55.4 t -81.42 -47.32 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.40999999999999998 109.458 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.723 HD13 ' ND2' ' A' ' 6' ' ' ASN . 3.9 mt -65.84 -35.12 79.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.789 -1.194 . . . . 1.1899999999999999 110.017 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.597 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 3.1 t80 -62.39 -23.83 67.05 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.919 -1.511 . . . . 1.46 106.919 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.29 -29.54 70.84 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.338 -0.846 . . . . 1.1499999999999999 109.153 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -87.26 -14.08 41.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.945 -1.097 . . . . 1.1699999999999999 109.121 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 123.68 11.25 5.04 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.378 -1.089 . . . . 0.41999999999999998 110.378 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.559 HD11 ' O ' ' A' ' 2' ' ' THR . 32.3 mm -74.99 98.92 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.985 -1.303 . . . . 0.34999999999999998 109.172 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.11 -34.27 20.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.551 -0.907 . . . . 1.55 108.551 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 1.7 mt-10 -102.85 141.55 35.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.56 0.695 . . . . 1.5800000000000001 110.259 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -151.77 144.18 16.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.397 -0.921 . . . . 0.54000000000000004 109.859 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -121.63 128.54 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.38 0.609 . . . . 0.25 109.94 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.753 HD13 ' OH ' ' A' ' 50' ' ' TYR . 3.4 mp -111.78 123.56 50.5 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.236 0.541 . . . . 0.40000000000000002 110.241 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.626 ' O ' HG12 ' A' ' 10' ' ' VAL . 3.3 mtpt -102.9 128.82 49.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.246 -1.39 . . . . 2.7400000000000002 107.246 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.44 154.11 23.37 Favored Glycine 0 N--CA 1.501 3.029 0 C-N-CA 119.525 -1.321 . . . . 0.20999999999999999 111.031 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 41' ' ' ARG . 30.1 p -135.88 141.15 44.55 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.801 0.81 . . . . 0.56000000000000005 112.678 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.604 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 39.46 -84.26 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.728 -0.608 . . . . 0.33000000000000002 111.637 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -84.89 -51.14 6.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.157 -1.202 . . . . 3.0899999999999999 110.096 -178.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -25.07 64.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.624 -1.298 . . . . 1.0900000000000001 108.763 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 40' ' ' GLY . 5.7 tt -51.93 -36.66 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.628 -0.67 . . . . 0.87 111.335 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.402 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -84.7 -21.18 30.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.718 -1.239 . . . . 1.1399999999999999 109.133 -179.187 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 46' ' ' ALA . 8.0 mmtp -62.08 -71.67 0.15 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.819 -1.919 . . . . 1.8600000000000001 105.819 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.685 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -32.88 -45.37 0.13 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.267 0.556 . . . . 0.28999999999999998 111.167 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.708 HG13 ' HB ' ' B' ' 68' ' ' THR . 72.0 t -57.02 -70.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.986 -1.071 . . . . 0.22 110.267 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -44.49 -44.29 8.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.556 -0.715 . . . . 1.26 109.971 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.6 t -46.81 -57.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 119.967 -0.693 . . . . 1.0600000000000001 109.556 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.753 ' OH ' HD13 ' A' ' 36' ' ' LEU . 64.8 m-85 -65.13 -51.23 62.49 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.039 -1.038 . . . . 4.0199999999999996 112.668 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' ND2' ' N ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -51.05 -47.98 61.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.546 -1.346 . . . . 1.3400000000000001 107.55 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.514 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 11.1 p -65.45 -33.84 76.89 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.799 -0.761 . . . . 1.04 109.527 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.456 HD22 HG11 ' A' ' 23' ' ' VAL . 5.9 tp -84.13 -24.18 30.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.68 -1.263 . . . . 0.44 108.846 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.607 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.92 -48.81 12.83 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 104.756 -2.313 . . . . 1.0 104.756 177.606 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 32.0 t0 -50.1 -12.93 0.09 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.185 -1.37 . . . . 1.5800000000000001 107.786 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' N ' ' C ' ' A' ' 54' ' ' LYS . 5.0 tpt85 -64.7 -46.95 80.16 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.682 0.753 . . . . 1.6899999999999999 109.887 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 tp -155.35 -7.44 0.13 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.515 -0.874 . . . . 1.6599999999999999 110.388 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.27 -59.81 0.06 OUTLIER Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.594 -1.289 . . . . 0.39000000000000001 109.887 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -72.09 -35.83 69.33 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.808 -0.819 . . . . 1.3799999999999999 110.212 -178.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.75 20.54 9.16 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.364 -1.494 . . . . 0.26000000000000001 109.364 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.628 HG13 HD11 ' A' ' 85' ' ' LEU . 2.4 t -154.63 133.26 2.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.54 -1.282 . . . . 0.38 107.54 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.9 mm-40 -137.57 150.73 47.69 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.482 1.134 . . . . 1.3100000000000001 112.249 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 66' ' ' VAL . 7.4 tt -94.31 108.7 20.58 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.537 -1.282 . . . . 0.48999999999999999 107.537 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.89 -23.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.305 -0.872 . . . . 1.3500000000000001 110.369 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.578 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -162.38 153.82 18.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.172 -1.58 . . . . 1.2 109.348 177.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 63' ' ' LEU . 46.3 t -162.32 129.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.406 -0.809 . . . . 0.84999999999999998 109.485 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -140.78 157.15 45.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.107 0.955 . . . . 1.4099999999999999 110.606 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.432 ' HB ' HG13 ' B' ' 47' ' ' VAL . 0.7 OUTLIER -137.42 143.89 42.1 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.178 -0.675 . . . . 0.52000000000000002 109.178 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.674 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -167.35 159.94 33.43 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.384 -2.286 . . . . 0.40000000000000002 107.384 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.4 p -98.53 161.15 13.82 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 118.984 1.392 . . . . 0.41999999999999998 110.745 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -156.05 175.6 13.75 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.111 -0.993 . . . . 1.29 110.568 178.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.62 137.34 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.6 0.714 . . . . 1.02 110.553 -179.245 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 27.5 ttt-85 -148.41 102.58 3.35 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.567 -0.901 . . . . 2.23 108.567 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.9 t70 87.91 35.07 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.204 0.526 . . . . 1.3799999999999999 109.646 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 63.66 37.62 10.0 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.356 1.074 . . . . 2.6200000000000001 109.21 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -157.52 153.35 26.86 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.41 -0.806 . . . . 3.1499999999999999 108.837 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -86.31 135.19 33.63 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.775 1.274 . . . . 2.4399999999999999 110.662 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.409 HD11 ' HA3' ' A' ' 40' ' ' GLY . 4.8 tt -141.31 155.12 20.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.604 -1.258 . . . . 0.23000000000000001 107.604 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -87.44 159.99 18.47 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.227 -0.921 . . . . 0.73999999999999999 111.116 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.674 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.1 p90 -145.08 153.25 41.23 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.87 0.843 . . . . 4.1600000000000001 110.581 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -125.96 131.84 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.778 0.799 . . . . 0.92000000000000004 109.416 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.5 mt -109.5 122.56 47.69 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.695 -1.594 . . . . 0.35999999999999999 106.695 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.517 HD11 ' OG1' ' B' ' 68' ' ' THR . 0.5 OUTLIER -132.95 129.13 37.87 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.255 1.026 . . . . 0.97999999999999998 110.737 -177.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -99.25 172.25 7.47 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.128 -0.942 . . . . 0.57999999999999996 110.074 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.815 HD13 ' N ' ' A' ' 86' ' ' LYS . 1.0 OUTLIER -157.18 137.79 13.11 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.2 -1.0 . . . . 1.3899999999999999 108.85 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.815 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -125.78 140.69 52.47 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.399 0.618 . . . . 1.4199999999999999 109.468 179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.597 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 16.6 mmt85 -99.41 136.02 39.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.533 -0.73 . . . . 1.6399999999999999 109.979 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 88' ' ' VAL . 48.2 t -113.54 -0.97 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.496 -0.927 . . . . 0.63 108.496 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.7 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.988 -1.006 . . . . 1.76 109.415 178.901 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.653 -0.499 . . . . 6.3499999999999996 109.653 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 29.8 p 42.92 -149.76 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.747 . . . . 2.4199999999999999 109.886 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' B' ' 30' ' ' GLY . 3.3 mt-10 -164.14 -41.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.386 -0.968 . . . . 1.6799999999999999 108.386 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -148.74 65.93 1.05 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.618 -0.676 . . . . 2.3100000000000001 109.855 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -178.41 54.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.375 -0.972 . . . . 1.6200000000000001 108.375 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.504 ' OD1' HD13 ' B' ' 26' ' ' LEU . 0.2 OUTLIER -91.44 107.29 19.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.951 -1.093 . . . . 1.46 111.965 -177.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 7.0 pt-20 -93.41 116.45 28.99 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.524 -1.287 . . . . 1.49 107.524 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 75.6 mt -128.96 153.15 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.526 -0.734 . . . . 1.1699999999999999 110.815 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.553 HG23 ' HB2' ' B' ' 37' ' ' LYS . 7.9 p -105.79 126.81 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.451 0.643 . . . . 1.3700000000000001 110.169 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' B' ' 46' ' ' ALA . 3.7 p -86.86 166.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.834 -1.173 . . . . 0.37 107.834 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.596 ' N ' HG22 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -138.78 174.31 10.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 2.3700000000000001 110.902 -178.234 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.545 ' NZ ' ' CZ ' ' B' ' 41' ' ' ARG . 6.6 pttp -102.49 -12.88 17.49 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.171 -1.048 . . . . 1.75 108.171 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.72 -9.44 58.21 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.948 -1.13 . . . . 1.1899999999999999 107.948 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.471 ' O ' ' ND2' ' B' ' 15' ' ' ASN . 11.4 mmpt? -92.56 -129.74 0.11 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.451 -1.314 . . . . 1.47 107.451 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' B' ' 14' ' ' LYS . 0.4 OUTLIER -168.15 158.89 10.55 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.09 -1.006 . . . . 1.22 109.37 178.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.547 HG23 ' N ' ' B' ' 17' ' ' GLU . 12.9 m -57.69 -39.84 72.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.116 -1.068 . . . . 0.45000000000000001 108.116 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.547 ' N ' HG23 ' B' ' 16' ' ' VAL . 6.5 pt-20 -75.58 -34.04 60.63 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.916 -0.772 . . . . 1.7 108.916 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -63.49 -32.84 74.4 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.852 -1.155 . . . . 1.46 111.6 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.7 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.3 OUTLIER -91.96 -16.06 27.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.051 -1.656 . . . . 1.3999999999999999 108.032 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.14 -35.49 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 104.499 -2.408 . . . . 0.34000000000000002 104.499 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.788 ' O ' HG23 ' B' ' 25' ' ' VAL . 43.3 mt -67.87 -50.56 55.75 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.785 -1.098 . . . . 0.38 109.33 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.34 -33.57 75.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.978 -1.077 . . . . 1.21 109.307 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 19' ' ' HIS . 34.7 t -66.29 -52.76 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.29999999999999999 109.42 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.7 tt -65.3 -19.71 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.99 -1.069 . . . . 0.68999999999999995 109.025 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.788 HG23 ' O ' ' B' ' 21' ' ' LEU . 41.8 t -75.17 -45.51 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.203 -0.936 . . . . 0.41999999999999998 109.822 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.538 HD22 HG13 ' B' ' 31' ' ' ILE . 4.1 mt -68.02 -36.94 80.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.699 -1.251 . . . . 1.1499999999999999 109.829 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' PHE . . . . . 0.559 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 4.6 t80 -58.03 -29.84 65.65 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.229 -1.767 . . . . 1.46 106.229 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -26.74 66.57 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.818 -1.083 . . . . 1.1699999999999999 109.176 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.437 ' OE1' HD23 ' B' ' 26' ' ' LEU . 80.1 mt-30 -92.2 -1.09 57.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.008 . . . . 1.1699999999999999 109.337 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 108.02 13.9 18.48 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.765 -0.934 . . . . 0.38 110.765 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.538 HG13 HD22 ' B' ' 26' ' ' LEU . 12.9 mm -78.2 105.01 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.697 -1.473 . . . . 0.58999999999999997 107.987 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -91.3 -38.87 12.38 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.19 -0.944 . . . . 1.46 109.186 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.7 135.21 43.61 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.278 0.561 . . . . 1.2 110.159 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' B' ' 6' ' ' ASN . 0.3 OUTLIER -145.41 130.94 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.578 -0.849 . . . . 0.48999999999999999 110.397 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -106.34 124.37 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.686 -0.634 . . . . 0.31 110.069 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.901 HD13 ' OH ' ' B' ' 50' ' ' TYR . 2.6 mp -107.94 129.73 55.08 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.451 -0.78 . . . . 0.47999999999999998 110.887 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.592 ' O ' HG12 ' B' ' 10' ' ' VAL . 5.0 mtpt -106.11 126.18 51.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.177 -1.046 . . . . 2.7400000000000002 108.177 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.63 153.23 20.96 Favored Glycine 0 N--CA 1.505 3.241 0 C-N-CA 119.873 -1.156 . . . . 0.23999999999999999 110.799 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.635 ' O ' ' N ' ' B' ' 41' ' ' ARG . 24.9 p -133.87 142.65 47.88 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.785 -0.833 . . . . 0.48999999999999999 112.095 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.661 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 33.8 -79.23 0.0 OUTLIER Glycine 0 N--CA 1.505 3.277 0 N-CA-C 111.932 -0.467 . . . . 0.28000000000000003 111.932 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.635 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -84.04 -55.4 4.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.037 -1.272 . . . . 3.1600000000000001 109.377 -179.465 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -17.7 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.024 -1.048 . . . . 1.3799999999999999 109.852 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.661 HG22 ' O ' ' B' ' 40' ' ' GLY . 6.7 tt -61.64 -22.41 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.84999999999999998 109.913 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.41 -29.72 17.82 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.353 -0.98 . . . . 1.1200000000000001 108.353 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' B' ' 46' ' ' ALA . 7.5 mmtp -60.19 -67.18 0.42 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.332 -1.729 . . . . 1.8700000000000001 106.332 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.784 ' HB2' HG11 ' B' ' 10' ' ' VAL . . . -32.4 -47.01 0.14 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 116.082 -0.508 . . . . 0.26000000000000001 111.823 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.432 HG13 ' HB ' ' A' ' 68' ' ' THR . 84.9 t -66.4 -61.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.837 -1.164 . . . . 0.28000000000000003 111.3 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' B' ' 49' ' ' VAL . 9.2 t70 -45.54 -51.08 12.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.216 -0.928 . . . . 1.25 109.348 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' B' ' 48' ' ' ASP . 64.3 t -41.71 -54.22 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.751 -0.463 . . . . 1.0600000000000001 109.751 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.901 ' OH ' HD13 ' B' ' 36' ' ' LEU . 59.5 m-85 -68.12 -53.56 24.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -0.987 . . . . 4.1100000000000003 111.627 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' B' ' 52' ' ' SER . 0.0 OUTLIER -46.77 -55.76 7.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.858 -1.164 . . . . 1.4099999999999999 107.858 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.557 ' N ' ' ND2' ' B' ' 51' ' ' ASN . 0.7 OUTLIER -61.17 -39.68 91.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.628 -0.829 . . . . 0.65000000000000002 109.714 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.461 HD22 HG11 ' B' ' 23' ' ' VAL . 5.8 tp -71.2 -23.96 62.13 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.79 -1.194 . . . . 0.53000000000000003 108.614 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 50' ' ' TYR . 0.0 OUTLIER -76.5 -47.83 21.53 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.789 -1.56 . . . . 0.98999999999999999 106.789 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -44.67 -17.47 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.993 -1.003 . . . . 1.46 109.276 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' B' ' 54' ' ' LYS . 21.9 mmm180 -65.87 -39.8 91.03 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.38 -0.928 . . . . 1.71 109.997 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.3 tp -156.7 -12.46 0.09 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.429 -1.308 . . . . 1.77 111.528 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 67.3 -65.24 0.24 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.849 -1.7 . . . . 0.39000000000000001 108.849 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.5 -41.24 76.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.632 -0.922 . . . . 1.3999999999999999 109.704 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.16 17.07 2.51 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.543 -1.423 . . . . 0.34000000000000002 109.543 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.68 HG13 HD11 ' B' ' 85' ' ' LEU . 2.5 t -152.32 130.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.05 -1.463 . . . . 0.46000000000000002 107.05 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' B' ' 86' ' ' LYS . 5.4 mm-40 -137.94 152.01 48.54 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.303 1.049 . . . . 1.4199999999999999 112.455 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.578 HD11 HG21 ' B' ' 66' ' ' VAL . 8.4 tt -94.37 119.12 32.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.906 -1.146 . . . . 0.54000000000000004 107.906 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.49 ' O ' ' ND2' ' B' ' 65' ' ' ASN . 6.9 p -116.32 -13.39 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.337 -0.852 . . . . 1.4299999999999999 110.853 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' B' ' 64' ' ' VAL . 0.3 OUTLIER -171.23 143.66 1.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.399 -1.438 . . . . 1.28 109.482 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.578 HG21 HD11 ' B' ' 63' ' ' LEU . 96.7 t -156.83 133.92 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.054 -0.721 . . . . 0.90000000000000002 109.054 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLN . . . . . 0.611 ' HB3' HD12 ' B' ' 82' ' ' LEU . 48.5 tt0 -142.21 159.75 41.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.092 0.949 . . . . 1.4399999999999999 110.446 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.708 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -137.0 156.14 48.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.78 -0.822 . . . . 0.45000000000000001 108.78 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.681 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -179.74 157.98 21.33 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.745 -2.142 . . . . 0.28999999999999998 107.745 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 68.8 p -96.44 154.63 17.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.051 -1.264 . . . . 0.39000000000000001 109.44 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -153.17 170.7 19.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.827 -1.171 . . . . 1.49 110.446 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.418 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -89.02 137.09 21.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.852 0.834 . . . . 0.87 111.284 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 7.5 ttt-85 -149.78 97.87 2.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.08 -0.711 . . . . 2.1800000000000002 109.08 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 4.0 t0 88.34 36.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.427 -0.583 . . . . 1.3500000000000001 109.427 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 65.01 34.48 8.84 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.214 1.007 . . . . 2.5699999999999998 109.463 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -156.52 154.52 30.44 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.791 -0.818 . . . . 3.1400000000000001 108.791 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -88.11 145.77 25.77 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.585 1.183 . . . . 2.3900000000000001 111.842 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tt -144.36 159.49 15.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.871 -1.058 . . . . 0.57999999999999996 108.194 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.09 151.08 22.99 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 121.372 -0.83 . . . . 0.60999999999999999 109.036 -178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.681 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.2 p90 -143.83 151.91 40.51 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.615 -0.834 . . . . 4.0800000000000001 110.37 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.498 HG23 ' O ' ' B' ' 81' ' ' ILE . 20.4 tt -128.71 135.02 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.643 0.735 . . . . 0.90000000000000002 111.27 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' B' ' 67' ' ' GLN . 7.7 mt -110.69 124.31 51.7 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.69 -1.596 . . . . 0.37 106.69 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.67 127.15 39.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.143 -0.973 . . . . 0.97999999999999998 111.275 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -108.26 110.17 21.71 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.557 0.694 . . . . 0.70999999999999996 111.159 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.864 HD13 ' N ' ' B' ' 86' ' ' LYS . 1.3 tm? -96.42 140.46 31.04 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.986 -0.746 . . . . 1.4399999999999999 108.986 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.864 ' N ' HD13 ' B' ' 85' ' ' LEU . 0.0 OUTLIER -122.35 136.03 54.82 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.406 -0.591 . . . . 1.3100000000000001 109.406 179.297 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.559 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 16.4 mmt85 -96.12 140.26 31.09 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.33 -0.856 . . . . 1.6399999999999999 110.296 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.49 ' O ' HG12 ' B' ' 88' ' ' VAL . 36.2 t -118.08 -6.77 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.706 -0.85 . . . . 0.68000000000000005 108.706 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 74.8 t80 . . . . . 0 C--N 1.303 -1.432 0 CA-C-O 117.979 -1.01 . . . . 1.77 109.423 179.26 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.562 -0.533 . . . . 6.3300000000000001 109.562 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.503 ' O ' ' CD1' ' A' ' 31' ' ' ILE . 5.1 t -108.28 19.91 19.3 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.13 -0.692 . . . . 2.5299999999999998 109.13 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 30' ' ' GLY . 2.6 mt-10 -75.61 -30.48 59.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.684 -0.635 . . . . 1.75 110.232 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.91 57.51 1.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.8 0.81 . . . . 2.2400000000000002 109.476 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -161.84 152.38 17.46 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 104.469 -2.419 . . . . 1.6699999999999999 104.469 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.63 ' OD1' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -179.4 93.68 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 117.928 -1.509 . . . . 1.72 110.621 178.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 3.8 pt-20 -89.34 112.23 23.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.066 -1.646 . . . . 1.4399999999999999 108.262 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.63 HD11 ' OD1' ' A' ' 6' ' ' ASN . 5.6 mt -128.74 147.25 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 CA-C-O 122.189 0.995 . . . . 1.1100000000000001 112.195 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 37' ' ' LYS . 61.1 t -112.91 129.52 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.606 0.717 . . . . 1.3500000000000001 110.336 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.532 HG11 ' H ' ' A' ' 46' ' ' ALA . 1.7 p -87.65 167.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.055 -1.091 . . . . 0.39000000000000001 108.055 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.91 167.88 20.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 2.27 109.977 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -20.65 27.61 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.386 -0.968 . . . . 1.78 108.386 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -69.4 -65.41 0.72 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.761 -1.57 . . . . 1.24 106.761 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.524 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.4 mtmm -58.24 144.07 42.23 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.216 1.007 . . . . 1.4099999999999999 110.347 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.87 178.86 4.61 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.696 -0.684 . . . . 1.25 110.067 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.61 -28.79 25.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.254 -1.017 . . . . 0.48999999999999999 108.254 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.4 -33.85 61.01 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.484 -0.886 . . . . 1.5600000000000001 109.119 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.2 -31.59 69.16 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 120.396 -1.44 . . . . 1.3799999999999999 110.925 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.709 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -95.64 -18.3 20.64 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.692 -1.255 . . . . 1.4299999999999999 108.459 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -34.72 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 104.513 -2.403 . . . . 0.28999999999999998 104.513 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.773 ' O ' HG23 ' A' ' 25' ' ' VAL . 38.5 mt -68.33 -52.57 31.97 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.495 -1.23 . . . . 0.40999999999999998 108.771 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -66.34 -29.34 69.51 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.114 -0.991 . . . . 1.22 109.437 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 19' ' ' HIS . 19.7 t -69.79 -53.24 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.32000000000000001 109.453 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.23 -18.03 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.895 -1.128 . . . . 0.57999999999999996 108.617 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 21' ' ' LEU . 54.0 t -75.98 -43.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 119.335 -0.946 . . . . 0.40999999999999998 108.573 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD13 HD11 ' A' ' 8' ' ' ILE . 4.2 mt -64.79 -33.4 75.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.825 -1.172 . . . . 1.1899999999999999 110.029 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -65.87 -23.0 66.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.877 -1.527 . . . . 1.46 106.877 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -61.74 -30.77 70.99 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.123 -0.944 . . . . 1.1499999999999999 108.811 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -87.82 -6.34 58.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.27 -0.894 . . . . 1.1699999999999999 109.244 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 109.73 12.45 18.74 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.913 -1.275 . . . . 0.41999999999999998 109.913 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.503 ' CD1' ' O ' ' A' ' 2' ' ' THR . 47.6 mm -73.88 109.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.138 -1.213 . . . . 0.34999999999999998 109.25 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.22 -37.22 11.66 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.423 -0.798 . . . . 1.55 110.721 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 1.9 mt-10 -97.73 137.85 36.0 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.601 0.715 . . . . 1.5800000000000001 110.793 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -147.87 137.29 16.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.66 -0.816 . . . . 0.54000000000000004 109.826 -179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -117.08 126.04 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.753 -0.658 . . . . 0.25 109.591 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.4 mp -111.76 119.56 39.04 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 120.262 -0.575 . . . . 0.40000000000000002 109.519 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 9' ' ' VAL . 2.4 mttt -105.26 132.67 51.17 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.02 -1.104 . . . . 2.7400000000000002 108.02 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.19 151.79 21.6 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.748 -1.215 . . . . 0.20999999999999999 110.926 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 41' ' ' ARG . 64.3 p -126.01 134.03 51.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.986 -0.714 . . . . 0.56000000000000005 111.673 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 38.4 -83.56 0.0 OUTLIER Glycine 0 N--CA 1.495 2.632 0 O-C-N 121.615 -0.678 . . . . 0.33000000000000002 112.286 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.686 ' HE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.31 -54.2 6.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.127 -1.219 . . . . 3.0899999999999999 110.087 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.38 -20.99 63.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.64 -1.244 . . . . 1.0900000000000001 107.64 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 43' ' ' ILE . 1.5 tt -53.18 -36.46 25.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.233 -0.917 . . . . 0.87 110.858 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.61 -20.39 31.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.678 -1.264 . . . . 1.1399999999999999 108.747 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 46' ' ' ALA . 1.5 mptt -64.32 -71.02 0.19 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.518 -2.03 . . . . 1.8600000000000001 105.518 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.663 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -30.44 -48.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.403 0.621 . . . . 0.28999999999999998 110.37 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.691 HG13 ' HB ' ' B' ' 68' ' ' THR . 92.0 t -57.94 -71.68 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.378 -0.826 . . . . 0.22 109.995 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' OG ' ' A' ' 52' ' ' SER . 8.4 t70 -42.52 -46.72 4.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.755 -0.59 . . . . 1.26 110.05 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.2 t -48.75 -57.52 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.483 -0.887 . . . . 1.0600000000000001 108.82 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.571 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -61.03 -55.58 31.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 4.0199999999999996 110.978 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.681 HD21 ' HA2' ' B' ' 69' ' ' GLY . 14.0 t-20 -52.1 -51.14 59.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.873 -1.142 . . . . 1.3400000000000001 107.985 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 5.7 m -60.38 -34.15 73.49 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.528 -0.915 . . . . 1.04 108.528 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.434 HD22 HG11 ' A' ' 23' ' ' VAL . 7.1 tp -82.13 -21.64 36.56 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.078 -1.014 . . . . 0.44 108.389 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.29 -49.34 12.61 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.701 -1.963 . . . . 1.0 105.701 177.134 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 1.7 t0 -54.43 -8.64 0.23 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.754 -1.202 . . . . 1.5800000000000001 107.754 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 54' ' ' LYS . 4.6 tpt85 -68.7 -52.88 26.04 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.487 -0.758 . . . . 1.6899999999999999 109.196 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -153.14 -13.29 0.15 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.347 -0.941 . . . . 1.6599999999999999 110.948 179.307 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.441 ' N ' HD12 ' A' ' 57' ' ' LEU . . . 62.94 -47.44 0.07 OUTLIER Glycine 0 N--CA 1.494 2.509 0 C-N-CA 120.043 -1.075 . . . . 0.39000000000000001 110.842 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -72.72 -41.71 64.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.252 -1.146 . . . . 1.3799999999999999 109.986 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.482 ' H ' HD13 ' A' ' 57' ' ' LEU . . . -87.15 22.91 12.7 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.94 -1.264 . . . . 0.26000000000000001 109.94 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.577 HG13 HD21 ' A' ' 85' ' ' LEU . 2.4 t -149.37 132.5 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.979 -1.306 . . . . 0.38 107.705 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.605 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.7 mm-40 -135.51 155.74 50.02 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.034 0.921 . . . . 1.3100000000000001 111.575 -177.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.42 110.01 21.57 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.486 -0.931 . . . . 0.48999999999999999 108.486 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.8 -22.91 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.065 -1.022 . . . . 1.3500000000000001 109.775 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -172.85 152.56 2.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.699 -1.25 . . . . 1.2 109.759 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 65' ' ' ASN . 72.0 t -159.28 128.29 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.863 -0.792 . . . . 0.84999999999999998 108.863 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 68' ' ' THR . 31.9 tt0 -142.09 157.05 45.35 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.086 0.946 . . . . 1.4099999999999999 110.531 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.479 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -124.2 150.81 44.8 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.239 -0.892 . . . . 0.52000000000000002 108.737 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.683 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -175.89 148.88 9.57 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 107.607 -2.197 . . . . 0.40000000000000002 107.607 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 1.133 ' H ' ' ND2' ' B' ' 51' ' ' ASN . 37.1 p -95.75 158.01 15.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.703 -1.469 . . . . 0.41999999999999998 110.996 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' OE2' ' C ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -150.51 167.63 26.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.162 -0.961 . . . . 1.29 110.073 178.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.403 ' C ' ' OE2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -91.91 141.94 13.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.644 0.735 . . . . 1.02 111.044 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 7.5 ttt-85 -149.25 103.44 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.165 -0.68 . . . . 2.23 109.165 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.4 t70 86.38 36.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.049 0.452 . . . . 1.3799999999999999 110.339 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.29 32.71 12.08 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.174 0.988 . . . . 2.6200000000000001 109.045 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.19 146.12 26.67 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.284 -1.006 . . . . 3.1499999999999999 108.284 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.473 ' NH2' ' OD1' ' B' ' 51' ' ' ASN . 8.1 ttt180 -85.91 139.73 30.98 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.893 1.33 . . . . 2.4399999999999999 110.614 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.6 tt -142.71 154.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 114.276 -1.329 . . . . 0.23000000000000001 107.986 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.8 p -88.37 161.64 16.98 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 119.335 -0.946 . . . . 0.73999999999999999 110.444 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.683 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.4 p90 -148.35 156.4 42.46 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.313 -0.955 . . . . 4.1600000000000001 110.244 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 81' ' ' ILE . 10.3 tt -129.68 139.05 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.746 0.784 . . . . 0.92000000000000004 110.485 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.7 mt -111.32 124.0 51.35 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.952 -1.129 . . . . 0.35999999999999999 107.952 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 tt -131.64 126.52 34.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.122 -0.987 . . . . 0.97999999999999998 110.61 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -102.88 172.42 6.84 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.315 0.578 . . . . 0.57999999999999996 109.789 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.577 HD21 HG13 ' A' ' 61' ' ' VAL . 1.9 tp -160.82 144.93 13.7 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 118.679 -1.208 . . . . 1.3899999999999999 110.999 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.605 ' O ' ' N ' ' A' ' 62' ' ' GLN . 14.0 tptt -125.57 136.35 53.2 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.574 0.702 . . . . 1.4199999999999999 109.936 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.425 ' N ' ' HD2' ' A' ' 86' ' ' LYS . 22.6 mmt180 -94.41 136.4 34.75 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.059 -1.026 . . . . 1.6399999999999999 109.663 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.602 ' O ' HG12 ' A' ' 88' ' ' VAL . 69.4 t -121.62 1.21 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.824 -0.806 . . . . 0.63 108.824 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.424 ' CD2' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.383 0 CA-C-O 118.001 -0.999 . . . . 1.76 109.512 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.438 -0.578 . . . . 6.3499999999999996 109.438 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.51 ' O ' ' CD1' ' B' ' 31' ' ' ILE . 4.6 t -135.85 21.39 3.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.484 -0.76 . . . . 2.4199999999999999 109.692 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' B' ' 30' ' ' GLY . 4.9 mt-10 -84.12 -4.54 58.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.337 -0.852 . . . . 1.6799999999999999 109.147 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.437 ' O ' ' OE1' ' B' ' 33' ' ' GLU . 0.0 OUTLIER -155.95 58.31 0.6 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.034 -1.042 . . . . 2.3100000000000001 108.801 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -165.74 151.4 9.12 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 103.097 -2.927 . . . . 1.6200000000000001 103.097 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.523 ' OD1' HD11 ' B' ' 8' ' ' ILE . 0.5 OUTLIER -179.95 93.12 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 117.703 -1.599 . . . . 1.46 110.214 177.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.8 pt-20 -90.12 110.32 21.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.165 -1.585 . . . . 1.49 108.897 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.523 HD11 ' OD1' ' B' ' 6' ' ' ASN . 4.1 mt -126.41 142.52 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.848 0.832 . . . . 1.1699999999999999 110.677 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' B' ' 37' ' ' LYS . 63.2 t -104.22 130.47 54.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.49 0.662 . . . . 1.3700000000000001 109.581 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.538 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.4 OUTLIER -87.49 166.13 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.516 -0.92 . . . . 0.37 108.516 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.414 ' NE ' ' CE ' ' B' ' 14' ' ' LYS . 6.7 mtt180 -139.09 171.58 14.1 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.01 0.909 . . . . 2.3700000000000001 110.507 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.04 -11.52 20.5 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.187 -1.042 . . . . 1.75 108.187 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.86 -14.35 54.44 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.637 -0.825 . . . . 1.1899999999999999 109.758 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.574 ' O ' ' ND2' ' B' ' 15' ' ' ASN . 1.2 mttm -98.57 -120.65 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.281 -1.007 . . . . 1.47 108.281 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ASN . . . . . 0.574 ' ND2' ' O ' ' B' ' 14' ' ' LYS . 0.5 OUTLIER -170.94 172.44 5.53 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.097 -1.002 . . . . 1.22 109.15 179.306 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -72.38 -35.25 51.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.115 -1.069 . . . . 0.45000000000000001 108.115 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 10.0 pt-20 -72.46 -41.67 65.82 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.495 -0.928 . . . . 1.7 108.495 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.464 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 68.2 t0 -62.49 -30.81 71.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.141 -0.974 . . . . 1.46 112.082 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.759 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.1 OUTLIER -91.34 -16.46 27.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 119.892 -1.755 . . . . 1.3999999999999999 108.289 178.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 t -75.19 -40.11 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 105.152 -2.166 . . . . 0.34000000000000002 105.152 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.773 ' O ' HG23 ' B' ' 25' ' ' VAL . 59.1 mt -62.31 -49.46 75.54 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.909 -1.041 . . . . 0.38 108.481 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -67.3 -32.13 72.9 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.565 -0.854 . . . . 1.21 109.685 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.759 HG23 ' O ' ' B' ' 19' ' ' HIS . 41.0 t -69.57 -54.55 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.291 -0.881 . . . . 0.29999999999999999 110.068 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 20.4 tt -61.15 -24.05 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.893 -1.129 . . . . 0.68999999999999995 108.864 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.773 HG23 ' O ' ' B' ' 21' ' ' LEU . 39.3 t -68.19 -41.5 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -0.922 . . . . 0.41999999999999998 108.951 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.402 HD13 HD11 ' B' ' 8' ' ' ILE . 4.8 mt -66.52 -43.12 86.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.121 -0.987 . . . . 1.1499999999999999 109.7 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -55.19 -31.49 61.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.735 -1.58 . . . . 1.46 106.735 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -55.69 -30.69 61.53 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.273 -0.876 . . . . 1.1699999999999999 108.777 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -87.96 -3.02 58.95 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.809 -0.811 . . . . 1.1699999999999999 108.809 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 103.19 15.98 22.14 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.608 -1.397 . . . . 0.38 109.608 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' B' ' 2' ' ' THR . 36.8 mm -77.36 111.42 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.148 -1.207 . . . . 0.58999999999999997 108.421 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.39 -35.83 12.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.272 -0.893 . . . . 1.46 111.015 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' B' ' 4' ' ' LYS . 11.4 mt-10 -101.64 141.6 34.25 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.626 0.727 . . . . 1.2 110.954 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' B' ' 6' ' ' ASN . 0.8 OUTLIER -149.5 122.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.146 0.974 . . . . 0.48999999999999999 111.096 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.21 122.91 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.613 -0.679 . . . . 0.31 109.254 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' B' ' 46' ' ' ALA . 2.4 mp -105.57 121.76 44.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.431 -0.793 . . . . 0.47999999999999998 110.087 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.506 ' HB2' HG13 ' B' ' 9' ' ' VAL . 7.4 mttt -103.34 128.41 50.43 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.736 -0.839 . . . . 2.7400000000000002 108.736 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.51 150.83 20.64 Favored Glycine 0 N--CA 1.502 3.037 0 C-N-CA 119.572 -1.299 . . . . 0.23999999999999999 110.805 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.613 ' O ' ' N ' ' B' ' 41' ' ' ARG . 47.3 p -129.86 141.24 50.85 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.888 -0.772 . . . . 0.48999999999999999 111.841 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.666 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 32.84 -82.0 0.0 OUTLIER Glycine 0 N--CA 1.504 3.195 0 N-CA-C 111.785 -0.526 . . . . 0.28000000000000003 111.785 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.664 ' N ' ' HE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -80.14 -53.13 6.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.087 -1.243 . . . . 3.1600000000000001 110.057 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.3 OUTLIER -64.93 -13.7 57.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.945 -1.097 . . . . 1.3799999999999999 109.296 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.666 HG22 ' O ' ' B' ' 40' ' ' GLY . 8.1 tt -60.65 -26.03 36.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.26 -0.9 . . . . 0.84999999999999998 109.711 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.58 -25.95 23.34 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.29 -1.004 . . . . 1.1200000000000001 108.29 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' B' ' 46' ' ' ALA . 2.6 mptt -63.75 -70.54 0.21 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.5 -1.667 . . . . 1.8700000000000001 106.5 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.677 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -32.97 -41.17 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.217 0.532 . . . . 0.26000000000000001 110.99 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.63 -64.9 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.142 -0.974 . . . . 0.28000000000000003 109.567 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' B' ' 49' ' ' VAL . 5.8 t70 -48.47 -50.72 30.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.189 -0.944 . . . . 1.25 109.276 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.658 HG11 HD21 ' B' ' 36' ' ' LEU . 38.0 t -42.39 -56.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.96 -0.755 . . . . 1.0600000000000001 108.96 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.568 ' CD1' HD13 ' B' ' 85' ' ' LEU . 0.0 OUTLIER -67.66 -54.33 20.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.447 -0.783 . . . . 4.1100000000000003 110.564 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 1.133 ' ND2' ' H ' ' A' ' 70' ' ' SER . 24.7 t-20 -48.5 -57.98 5.35 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.119 -1.032 . . . . 1.4099999999999999 108.531 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -57.95 -30.81 66.27 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.172 -1.011 . . . . 0.65000000000000002 109.649 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.505 HD22 HG11 ' B' ' 23' ' ' VAL . 46.0 tp -75.05 -21.74 58.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.53000000000000003 110.287 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.46 -27.95 25.35 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.373 -1.714 . . . . 0.98999999999999999 106.373 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.412 ' OD2' ' NH2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -59.08 -14.52 10.17 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.686 -1.227 . . . . 1.46 107.686 177.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -75.74 -43.92 44.34 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.618 -0.833 . . . . 1.71 109.487 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' B' ' 59' ' ' ASP . 0.2 OUTLIER -152.1 -20.71 0.18 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.624 -1.23 . . . . 1.77 112.291 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.66 -56.02 0.14 Allowed Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.275 -1.441 . . . . 0.39000000000000001 110.035 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.58 -43.27 73.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.295 -1.121 . . . . 1.3999999999999999 109.989 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.418 ' HA3' HD22 ' B' ' 57' ' ' LEU . . . -82.52 24.97 4.66 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.9 -1.28 . . . . 0.34000000000000002 109.9 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.453 HG13 HD21 ' B' ' 85' ' ' LEU . 1.0 OUTLIER -149.24 130.25 4.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.478 -1.304 . . . . 0.46000000000000002 107.478 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' B' ' 86' ' ' LYS . 4.0 mm-40 -132.27 159.21 39.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.002 0.906 . . . . 1.4199999999999999 111.471 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.34 112.72 25.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.473 -0.936 . . . . 0.54000000000000004 108.473 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -23.51 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.161 -0.962 . . . . 1.4299999999999999 110.391 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.21 151.03 1.59 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.491 -1.38 . . . . 1.28 109.457 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 96.6 t -156.85 132.74 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.722 -0.844 . . . . 0.90000000000000002 108.722 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLN . . . . . 0.467 ' CG ' ' N ' ' B' ' 68' ' ' THR . 28.4 tt0 -145.94 165.21 29.62 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.282 1.039 . . . . 1.4399999999999999 110.823 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.691 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -135.72 154.8 51.14 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.221 -0.9 . . . . 0.45000000000000001 108.699 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.711 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -176.71 153.2 13.52 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 107.767 -2.133 . . . . 0.28999999999999998 107.767 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.549 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 6.0 p -96.57 155.98 16.54 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.882 1.341 . . . . 0.39000000000000001 109.382 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -148.98 166.75 27.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.946 -1.096 . . . . 1.49 110.05 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.42 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.2 OUTLIER -90.03 136.95 22.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.845 -0.742 . . . . 0.87 110.542 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.8 ttt-85 -147.17 101.52 3.41 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.337 -0.616 . . . . 2.1800000000000002 109.337 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 1.8 t70 83.02 39.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.427 -0.583 . . . . 1.3500000000000001 109.427 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.17 32.61 14.96 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.915 0.864 . . . . 2.5699999999999998 109.273 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.32 153.88 36.87 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.453 -0.779 . . . . 3.1400000000000001 109.207 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.534 ' NH2' ' OG ' ' B' ' 70' ' ' SER . 1.3 tpt180 -88.36 136.28 33.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.729 0.776 . . . . 2.3900000000000001 110.922 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 11.9 tt -136.31 153.54 31.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.743 -0.836 . . . . 0.57999999999999996 108.743 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 151.59 22.81 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.332 -0.855 . . . . 0.60999999999999999 109.039 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.711 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.0 p90 -144.35 150.86 38.48 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.467 -0.893 . . . . 4.0800000000000001 110.313 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.453 HD11 HG21 ' A' ' 68' ' ' THR . 6.0 tt -126.12 135.83 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.53 0.681 . . . . 0.90000000000000002 109.972 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' B' ' 80' ' ' TYR . 12.2 mt -109.23 121.19 44.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.168 -1.419 . . . . 0.37 107.168 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.517 HD11 ' CD2' ' B' ' 50' ' ' TYR . 6.1 tt -123.25 121.23 35.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.111 -0.993 . . . . 0.97999999999999998 110.338 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -110.12 107.02 16.7 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.264 0.554 . . . . 0.70999999999999996 110.259 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.568 HD13 ' CD1' ' B' ' 50' ' ' TYR . 8.7 tp -104.01 151.54 23.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.591 -0.693 . . . . 1.4399999999999999 110.609 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.1 OUTLIER -126.65 157.27 39.42 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.757 -0.46 . . . . 1.3100000000000001 109.757 -179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.497 HH22 HD11 ' B' ' 53' ' ' LEU . 22.2 mmt180 -109.98 141.94 42.06 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.225 -0.922 . . . . 1.6399999999999999 110.037 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.452 ' O ' HG12 ' B' ' 88' ' ' VAL . 18.8 t -121.94 -9.98 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.907 -0.775 . . . . 0.68000000000000005 108.907 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 118.066 -0.969 . . . . 1.77 109.537 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mtt . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.484 -0.562 . . . . 6.3300000000000001 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.8 133.36 6.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 2.5299999999999998 109.632 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -165.81 -39.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.023 -1.103 . . . . 1.75 108.023 178.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -156.09 54.37 0.57 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.267 -0.896 . . . . 2.2400000000000002 109.754 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 tp -174.74 50.89 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.531 -0.915 . . . . 1.6699999999999999 108.531 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.421 ' HB2' HD12 ' A' ' 31' ' ' ILE . 3.2 t-20 -91.62 105.18 17.55 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.298 -0.876 . . . . 1.72 111.193 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -93.82 123.47 37.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 1.4399999999999999 108.384 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -130.38 151.81 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 122.632 1.206 . . . . 1.1100000000000001 113.356 -177.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.4 p -104.7 127.11 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.317 -0.856 . . . . 1.3500000000000001 109.585 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.93 166.63 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.899 . . . . 0.39000000000000001 108.777 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.1 174.17 10.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.176 -0.952 . . . . 2.27 110.462 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' NZ ' ' HE ' ' A' ' 41' ' ' ARG . 12.4 pttt -94.99 -13.66 25.08 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.66 -0.867 . . . . 1.78 108.66 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 t -86.58 1.33 52.09 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.727 -1.212 . . . . 1.24 107.727 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.75 128.59 53.06 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.964 -1.495 . . . . 1.4099999999999999 106.964 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.28 -178.4 1.68 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.831 -0.748 . . . . 1.25 109.865 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 49' ' ' VAL . 1.8 m -79.93 -27.96 12.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 106.796 -1.557 . . . . 0.48999999999999999 106.796 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.72 -46.88 28.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.626 -0.716 . . . . 1.5600000000000001 109.369 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.79 -28.64 69.6 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.915 -1.115 . . . . 1.3799999999999999 110.957 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.708 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -92.08 -15.65 27.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.426 -1.421 . . . . 1.4299999999999999 109.688 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.91 -30.39 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 105.197 -2.149 . . . . 0.28999999999999998 105.197 176.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.555 ' O ' HG23 ' A' ' 25' ' ' VAL . 64.5 mt -70.12 -53.51 16.98 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.866 -1.061 . . . . 0.40999999999999998 108.834 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -65.2 -26.32 68.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 1.22 109.728 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 19' ' ' HIS . 38.6 t -73.64 -50.14 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.59 -0.893 . . . . 0.32000000000000001 108.59 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.75 -23.59 23.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.543 -0.91 . . . . 0.57999999999999996 108.543 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 21' ' ' LEU . 48.8 t -70.71 -42.81 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.247 -0.908 . . . . 0.40999999999999998 109.913 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -68.53 -33.64 74.47 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.447 -1.408 . . . . 1.1899999999999999 109.805 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.75 -27.13 68.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.166 -1.42 . . . . 1.46 107.166 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.97 -26.27 68.5 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.239 -0.891 . . . . 1.1499999999999999 109.887 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -88.97 -1.98 58.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.841 -1.162 . . . . 1.1699999999999999 109.267 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 106.5 14.52 19.7 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.766 -1.334 . . . . 0.41999999999999998 109.766 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 6' ' ' ASN . 20.7 mm -75.92 107.49 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -1.147 . . . . 0.34999999999999998 108.298 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 33' ' ' GLU . 1.6 p30 -93.65 -38.59 11.26 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.433 -0.792 . . . . 1.55 110.594 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 7.7 mt-10 -97.69 142.02 29.99 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.561 -0.712 . . . . 1.5800000000000001 110.189 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.439 HG13 ' OH ' ' A' ' 50' ' ' TYR . 14.6 p -152.32 139.98 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.041 -1.064 . . . . 0.54000000000000004 111.157 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.55 129.28 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 122.054 -0.404 . . . . 0.25 110.077 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 50' ' ' TYR . 1.8 mp -115.21 126.31 54.41 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.599 0.714 . . . . 0.40000000000000002 110.277 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.438 ' HG2' HG23 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -99.41 127.19 45.43 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.905 -1.146 . . . . 2.7400000000000002 107.905 177.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.54 143.31 14.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.725 -1.226 . . . . 0.20999999999999999 110.51 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 41' ' ' ARG . 31.8 p -131.07 138.45 49.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.922 -0.752 . . . . 0.56000000000000005 111.643 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' THR . . . 35.41 -83.11 0.0 OUTLIER Glycine 0 N--CA 1.501 3.008 0 O-C-N 121.735 -0.603 . . . . 0.33000000000000002 112.247 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -82.97 -56.32 3.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.249 . . . . 3.0899999999999999 109.886 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -15.17 8.71 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.99 -1.115 . . . . 1.0900000000000001 107.99 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.536 HG12 HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -55.5 -32.89 31.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.408 -0.807 . . . . 0.87 111.131 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.17 -22.9 23.79 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.963 -1.086 . . . . 1.1399999999999999 108.221 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 49' ' ' VAL . 2.7 mptt -62.35 -72.39 0.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.747 -1.946 . . . . 1.8600000000000001 105.747 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.638 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -33.24 -46.72 0.18 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.094 0.473 . . . . 0.28999999999999998 110.673 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.602 HG13 ' HB ' ' B' ' 68' ' ' THR . 98.5 t -66.51 -61.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.003 . . . . 0.22 109.297 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.458 ' OD1' HG21 ' A' ' 16' ' ' VAL . 10.5 t70 -51.33 -54.4 26.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 1.26 108.847 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 45' ' ' LYS . 46.7 t -42.66 -58.24 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.543 -0.91 . . . . 1.0600000000000001 108.543 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.655 ' CE1' HD22 ' A' ' 36' ' ' LEU . 3.0 m-30 -62.14 -50.6 71.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.85 -0.531 . . . . 4.0199999999999996 110.982 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.583 ' CG ' ' H ' ' B' ' 70' ' ' SER . 0.8 OUTLIER -56.07 -49.69 73.08 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.78 -1.193 . . . . 1.3400000000000001 107.78 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 4.3 p -59.96 -33.86 72.51 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.423 -0.954 . . . . 1.04 108.423 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.431 HD22 HG11 ' A' ' 23' ' ' VAL . 57.0 tp -79.06 -19.86 50.3 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.985 -1.117 . . . . 0.44 107.985 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.58 -44.47 17.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.539 -2.022 . . . . 1.0 105.539 177.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -59.34 -5.98 0.88 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.565 -1.272 . . . . 1.5800000000000001 107.565 177.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 54' ' ' LYS . 4.6 tpt85 -71.05 -49.13 48.11 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.58 -0.7 . . . . 1.6899999999999999 109.247 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.2 mt -151.64 -21.86 0.19 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.437 -0.905 . . . . 1.6599999999999999 110.302 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.15 -49.44 0.09 OUTLIER Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.847 -1.168 . . . . 0.39000000000000001 110.431 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -73.84 -45.41 51.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -1.202 . . . . 1.3799999999999999 109.929 -178.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.2 27.68 4.97 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.846 -1.702 . . . . 0.26000000000000001 108.846 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.475 ' CG2' ' NH1' ' A' ' 87' ' ' ARG . 5.7 t -151.84 129.39 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 107.525 -1.287 . . . . 0.38 107.525 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.0 mm100 -134.39 157.79 45.52 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.964 0.888 . . . . 1.3100000000000001 111.577 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tt -97.57 113.45 25.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.45 -0.944 . . . . 0.48999999999999999 108.45 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -23.31 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.122 -0.986 . . . . 1.3500000000000001 109.318 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.11 157.2 5.07 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.676 -1.21 . . . . 1.2 109.718 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.746 HG13 HG13 ' B' ' 66' ' ' VAL . 7.9 p -163.42 133.11 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.356 -0.84 . . . . 0.84999999999999998 109.614 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.464 ' CG ' ' N ' ' A' ' 68' ' ' THR . 32.7 tt0 -145.9 163.12 36.11 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.271 1.034 . . . . 1.4099999999999999 111.271 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.68 ' OG1' HD11 ' B' ' 83' ' ' LEU . 0.0 OUTLIER -138.74 149.0 44.58 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.654 -0.869 . . . . 0.52000000000000002 108.654 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.662 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -174.42 160.42 29.89 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 107.701 -2.16 . . . . 0.40000000000000002 107.701 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.533 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 40.0 p -102.02 158.85 15.85 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.777 1.288 . . . . 0.41999999999999998 110.583 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.8 OUTLIER -154.23 173.96 15.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 1.29 110.312 178.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.9 138.45 19.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.611 0.72 . . . . 1.02 111.262 -178.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 1.0 OUTLIER -148.16 101.77 3.3 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.045 -0.724 . . . . 2.23 109.045 177.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.0 t70 86.41 36.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.181 0.515 . . . . 1.3799999999999999 110.144 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.68 30.7 6.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.25 -0.906 . . . . 2.6200000000000001 109.338 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.18 151.62 32.15 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.244 -0.91 . . . . 3.1499999999999999 109.477 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -85.3 137.98 32.61 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.566 1.174 . . . . 2.4399999999999999 109.598 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 tt -143.35 155.91 16.8 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 114.925 -1.034 . . . . 0.23000000000000001 108.549 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.0 p -90.35 155.8 18.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.986 0.898 . . . . 0.73999999999999999 111.44 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.662 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 6.1 p90 -142.48 148.38 37.6 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.79 -0.641 . . . . 4.1600000000000001 109.977 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.662 HG21 HG21 ' B' ' 81' ' ' ILE . 2.0 pp -123.12 133.72 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.184 -1.043 . . . . 0.92000000000000004 108.184 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 80' ' ' TYR . 16.2 mt -106.89 126.06 51.82 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.437 -0.949 . . . . 0.35999999999999999 108.437 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.818 HD11 ' OG1' ' B' ' 68' ' ' THR . 0.5 OUTLIER -131.52 123.7 28.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.981 -1.075 . . . . 0.97999999999999998 111.025 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -102.46 165.58 11.02 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.197 -0.91 . . . . 0.57999999999999996 110.372 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 50' ' ' TYR . 2.5 tp -157.67 144.68 18.18 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 119.302 -0.959 . . . . 1.3899999999999999 111.423 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -126.4 143.69 51.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.17 0.509 . . . . 1.4199999999999999 110.326 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' NH1' ' CG2' ' A' ' 61' ' ' VAL . 20.3 mmt180 -96.9 139.05 33.51 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.379 -0.826 . . . . 1.6399999999999999 110.049 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 88' ' ' VAL . 51.4 t -117.14 -9.66 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.791 -0.818 . . . . 0.63 108.791 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 117.977 -1.011 . . . . 1.76 109.511 179.577 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.376 0.607 . . . . 6.3499999999999996 109.515 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.07 136.57 21.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 2.4199999999999999 109.153 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -157.77 -84.9 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.993 -1.114 . . . . 1.6799999999999999 107.993 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.0 58.1 0.6 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.518 -0.919 . . . . 2.3100000000000001 108.518 178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 8.1 tp -163.92 157.65 18.88 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.357 -1.349 . . . . 1.6200000000000001 107.357 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 179.12 91.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.574 -1.329 . . . . 1.46 110.664 176.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.0 pt-20 -94.01 107.37 19.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.661 -1.274 . . . . 1.49 107.724 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.44 146.33 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 122.205 1.002 . . . . 1.1699999999999999 110.884 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.491 HG13 ' O ' ' B' ' 9' ' ' VAL . 10.0 p -99.19 124.53 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.86 -0.609 . . . . 1.3700000000000001 109.375 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.43 166.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.376 -0.972 . . . . 0.37 108.376 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -136.9 168.34 19.75 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.815 0.817 . . . . 2.3700000000000001 110.927 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -87.62 -11.36 48.75 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.899 -0.778 . . . . 1.75 108.899 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' THR . . . . . 0.416 HG22 ' H ' ' B' ' 13' ' ' THR . 0.1 OUTLIER -76.23 -64.21 1.15 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.436 -1.306 . . . . 1.1899999999999999 107.806 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.408 ' H ' HG23 ' B' ' 13' ' ' THR . 0.0 OUTLIER -58.08 146.72 32.06 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.906 -1.121 . . . . 1.47 109.813 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.91 -179.8 6.26 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.049 -0.723 . . . . 1.22 109.049 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.474 ' HA ' HG22 ' B' ' 49' ' ' VAL . 2.4 m -76.75 -32.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.335 -0.987 . . . . 0.45000000000000001 108.335 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -81.04 -33.71 33.33 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.648 -0.871 . . . . 1.7 108.648 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -67.32 -28.32 67.89 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.742 -1.224 . . . . 1.46 109.843 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.789 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.1 OUTLIER -91.37 -18.18 24.67 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.385 -1.447 . . . . 1.3999999999999999 108.644 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.96 -29.39 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 104.98 -2.23 . . . . 0.34000000000000002 104.98 176.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.704 ' O ' HG23 ' B' ' 25' ' ' VAL . 34.9 mt -69.78 -50.75 40.1 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.498 -1.228 . . . . 0.38 108.52 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -65.82 -26.37 67.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.796 -1.19 . . . . 1.21 109.335 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.789 HG23 ' O ' ' B' ' 19' ' ' HIS . 77.2 t -74.71 -54.76 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.945 . . . . 0.29999999999999999 109.719 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.649 HD12 ' NH2' ' B' ' 87' ' ' ARG . 3.9 tp -57.72 -19.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.064 -1.022 . . . . 0.68999999999999995 108.574 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 21' ' ' LEU . 50.4 t -70.83 -41.59 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.185 -0.947 . . . . 0.41999999999999998 109.48 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.597 HD23 ' N ' ' B' ' 26' ' ' LEU . 0.3 OUTLIER -70.06 -37.99 75.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.539 -1.35 . . . . 1.1499999999999999 109.766 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.08 -29.36 67.28 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.608 -1.627 . . . . 1.46 106.608 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -25.59 65.98 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.035 -0.984 . . . . 1.1699999999999999 108.986 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -90.41 -7.17 53.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.959 . . . . 1.1699999999999999 109.194 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.01 15.07 10.27 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.287 -1.125 . . . . 0.38 110.287 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 40.4 mm -76.74 106.26 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.781 -1.423 . . . . 0.58999999999999997 108.471 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.7 -36.46 14.32 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.36 -0.838 . . . . 1.46 110.178 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -102.49 141.72 34.86 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.55 0.69 . . . . 1.2 110.582 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.415 HG13 ' OH ' ' B' ' 50' ' ' TYR . 11.6 p -151.66 141.94 15.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 119.504 -0.878 . . . . 0.48999999999999999 110.72 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.2 120.96 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 109.613 -0.514 . . . . 0.31 109.613 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.672 HD22 ' CE1' ' B' ' 50' ' ' TYR . 1.4 mp -106.65 131.96 53.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.565 -0.71 . . . . 0.47999999999999998 110.529 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.31 127.15 49.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.338 -0.986 . . . . 2.7400000000000002 108.338 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.28 141.64 12.82 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.993 -1.099 . . . . 0.23999999999999999 110.443 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.57 ' O ' ' N ' ' B' ' 41' ' ' ARG . 62.4 p -131.68 137.14 48.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.636 -0.92 . . . . 0.48999999999999999 111.42 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 35.81 -84.9 0.01 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 111.793 -0.523 . . . . 0.28000000000000003 111.793 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -82.3 -54.69 5.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.917 -1.343 . . . . 3.1600000000000001 109.767 -178.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -16.66 11.65 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.574 -1.269 . . . . 1.3799999999999999 107.574 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.6 HG12 HG23 ' B' ' 81' ' ' ILE . 0.3 OUTLIER -55.64 -33.46 33.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.214 -0.929 . . . . 0.84999999999999998 110.368 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.17 -22.44 36.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.121 -0.987 . . . . 1.1200000000000001 108.648 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.703 ' O ' HG23 ' B' ' 49' ' ' VAL . 1.2 mptt -68.07 -71.86 0.2 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.326 -1.361 . . . . 1.8700000000000001 107.326 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.589 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -37.12 -47.56 0.76 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.05 0.452 . . . . 0.26000000000000001 110.555 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.11 -61.35 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.096 -1.003 . . . . 0.28000000000000003 109.034 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ASP . . . . . 0.46 ' OD1' HG21 ' B' ' 16' ' ' VAL . 10.7 t70 -56.4 -49.73 73.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.291 -0.881 . . . . 1.25 109.149 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 45' ' ' LYS . 61.3 t -46.2 -56.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.411 -0.959 . . . . 1.0600000000000001 108.411 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.672 ' CE1' HD22 ' B' ' 36' ' ' LEU . 2.9 m-30 -64.54 -54.45 31.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.5 -0.75 . . . . 4.1100000000000003 110.75 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 0.533 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -50.77 -52.52 40.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.616 -1.303 . . . . 1.4099999999999999 108.398 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.42 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 1.1 m -59.88 -30.21 68.84 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.649 -0.82 . . . . 0.65000000000000002 109.522 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.453 HD11 ' NH2' ' B' ' 87' ' ' ARG . 27.7 tp -74.07 -23.62 59.39 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.966 -1.084 . . . . 0.53000000000000003 109.55 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' LYS . . . . . 0.407 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -82.26 -30.47 30.66 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.664 -1.606 . . . . 0.98999999999999999 106.664 178.303 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -14.67 6.31 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.752 -1.203 . . . . 1.46 107.752 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.407 ' N ' ' C ' ' B' ' 54' ' ' LYS . 20.5 mmm180 -73.29 -42.85 61.95 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.587 -0.845 . . . . 1.71 109.626 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.7 mt -153.32 -21.05 0.15 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.117 -1.433 . . . . 1.77 112.678 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.21 -62.0 0.06 OUTLIER Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.187 -1.482 . . . . 0.39000000000000001 110.212 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -67.74 -38.39 83.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.259 -1.142 . . . . 1.3999999999999999 109.555 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.83 28.2 6.7 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.07 -1.612 . . . . 0.34000000000000002 109.07 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.541 HG13 HD21 ' B' ' 85' ' ' LEU . 4.0 t -153.96 132.31 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.554 -1.276 . . . . 0.46000000000000002 107.554 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.7 mm100 -135.55 154.16 51.46 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.876 0.846 . . . . 1.4199999999999999 111.608 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 tt -94.43 118.57 31.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.482 -0.933 . . . . 0.54000000000000004 108.482 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.66 -17.82 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.815 . . . . 1.4299999999999999 110.551 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -178.4 157.29 1.01 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.651 -1.281 . . . . 1.28 109.458 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.746 HG13 HG13 ' A' ' 66' ' ' VAL . 2.6 p -165.26 136.83 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.408 -0.807 . . . . 0.90000000000000002 109.353 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLN . . . . . 0.436 ' CG ' ' N ' ' B' ' 68' ' ' THR . 33.1 tt0 -148.48 165.17 31.99 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.424 1.107 . . . . 1.4399999999999999 111.546 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.818 ' OG1' HD11 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -138.44 152.02 47.97 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.207 -0.906 . . . . 0.45000000000000001 108.56 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.66 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -176.96 157.36 22.35 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.261 -2.336 . . . . 0.28999999999999998 107.261 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.583 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 59.6 p -96.1 159.05 15.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.903 -1.351 . . . . 0.39000000000000001 109.41 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -154.03 172.39 17.57 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.002 -1.061 . . . . 1.49 109.95 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.448 HG23 ' H ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -89.52 134.02 29.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.768 -0.773 . . . . 0.87 110.64 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 0.0 OUTLIER -143.58 100.4 3.59 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.303 -0.628 . . . . 2.1800000000000002 109.303 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.7 t70 79.82 41.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.825 -0.547 . . . . 1.3500000000000001 109.888 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.14 26.31 10.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.34 -0.85 . . . . 2.5699999999999998 109.267 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.18 154.93 38.85 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.426 -0.796 . . . . 3.1400000000000001 109.341 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -88.72 136.53 32.96 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.209 -0.996 . . . . 2.3900000000000001 111.29 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.74 154.02 33.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.104 -1.073 . . . . 0.57999999999999996 108.104 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.32 152.57 22.64 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.552 -0.717 . . . . 0.60999999999999999 109.809 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.66 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 5.8 p90 -142.51 146.67 34.94 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.768 -0.773 . . . . 4.0800000000000001 109.992 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 81' ' ' ILE . 2.0 pp -120.64 133.59 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.016 -1.105 . . . . 0.90000000000000002 108.016 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' B' ' 80' ' ' TYR . 13.2 mt -109.24 122.74 47.98 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.336 -1.357 . . . . 0.37 107.336 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.68 HD11 ' OG1' ' A' ' 68' ' ' THR . 0.4 OUTLIER -128.67 127.22 41.72 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.088 -1.045 . . . . 0.97999999999999998 110.921 -178.567 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -102.02 169.32 8.83 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.494 -0.775 . . . . 0.70999999999999996 109.456 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.541 HD21 HG13 ' B' ' 61' ' ' VAL . 1.7 tp -160.45 140.22 11.12 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.288 -0.965 . . . . 1.4399999999999999 110.24 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.1 OUTLIER -123.11 146.39 47.76 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.528 -0.545 . . . . 1.3100000000000001 109.528 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.649 ' NH2' HD12 ' B' ' 24' ' ' ILE . 20.4 mmt180 -98.48 136.2 38.95 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.836 . . . . 1.6399999999999999 110.216 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.511 ' O ' HG12 ' B' ' 88' ' ' VAL . 23.2 t -113.4 -7.61 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.587 -0.894 . . . . 0.68000000000000005 108.587 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 117.941 -1.028 . . . . 1.77 109.48 179.559 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtt . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.321 -0.622 . . . . 6.3300000000000001 109.321 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 2' ' ' THR . 14.7 m -133.18 33.25 3.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.616 -0.677 . . . . 2.5299999999999998 109.708 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 30' ' ' GLY . 1.5 mt-10 -83.31 -4.21 58.23 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.243 -0.911 . . . . 1.75 109.29 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 1.8 ptmt -160.62 55.61 0.32 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.103 -0.998 . . . . 2.2400000000000002 109.103 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tp -174.01 46.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.312 -0.868 . . . . 1.6699999999999999 109.087 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.584 ' OD1' HD13 ' A' ' 26' ' ' LEU . 13.0 t-20 -90.55 112.2 23.8 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.188 -0.945 . . . . 1.72 111.123 -177.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 7' ' ' GLU . 9.9 pt-20 -91.91 119.47 31.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.893 -1.13 . . . . 1.4399999999999999 109.045 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 35' ' ' ILE . 3.5 mm -124.42 147.99 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 CA-C-O 122.32 1.057 . . . . 1.1100000000000001 112.091 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.3 t -111.6 130.31 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.783 0.801 . . . . 1.3500000000000001 109.959 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.585 HG11 ' H ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -88.33 161.47 2.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.257 -1.016 . . . . 0.39000000000000001 108.257 -178.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HD2' ' HZ3' ' A' ' 14' ' ' LYS . 1.5 mtt-85 -132.9 166.41 22.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.234 -0.916 . . . . 2.27 110.321 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -25.26 39.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.739 -0.837 . . . . 1.78 108.739 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.8 p -68.61 -63.04 1.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.224 -1.769 . . . . 1.24 106.224 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 11.9 mptt -55.42 131.93 47.07 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.068 0.937 . . . . 1.4099999999999999 110.123 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -72.12 180.0 3.07 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.592 0.71 . . . . 1.25 110.002 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 17' ' ' GLU . 4.0 m -73.45 -33.68 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.443 -1.317 . . . . 0.48999999999999999 107.443 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 3.7 tt0 -72.65 -37.48 67.97 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.358 -0.979 . . . . 1.5600000000000001 108.358 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -31.42 67.14 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.035 -1.041 . . . . 1.3799999999999999 111.439 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.735 ' O ' HG23 ' A' ' 23' ' ' VAL . 54.3 m-70 -93.69 -17.33 23.33 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.217 -1.552 . . . . 1.4299999999999999 108.66 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -34.14 59.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 104.296 -2.483 . . . . 0.28999999999999998 104.296 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 25' ' ' VAL . 66.6 mt -70.45 -51.14 31.45 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.72 -1.127 . . . . 0.40999999999999998 109.362 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.86 -30.94 71.24 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.888 -1.133 . . . . 1.22 109.298 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 19' ' ' HIS . 53.4 t -70.62 -55.22 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -0.86 . . . . 0.32000000000000001 109.822 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.3 tt -60.85 -19.77 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.939 -1.101 . . . . 0.57999999999999996 108.594 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 21' ' ' LEU . 5.2 t -73.39 -42.99 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.211 -0.931 . . . . 0.40999999999999998 108.961 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.584 HD13 ' OD1' ' A' ' 6' ' ' ASN . 4.3 mt -65.61 -34.88 79.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.773 -1.204 . . . . 1.1899999999999999 110.102 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -64.39 -26.22 68.37 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.319 -1.363 . . . . 1.46 107.319 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -26.92 68.71 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.309 -0.86 . . . . 1.1499999999999999 109.646 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -90.26 1.77 56.15 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.909 -1.119 . . . . 1.1699999999999999 109.402 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 101.65 13.81 31.38 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.201 -1.559 . . . . 0.41999999999999998 109.201 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.444 ' CD1' ' O ' ' A' ' 2' ' ' THR . 10.7 mm -75.57 109.27 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.252 -1.146 . . . . 0.34999999999999998 108.007 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -99.87 6.51 45.3 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.251 -0.906 . . . . 1.55 110.736 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' A' ' 4' ' ' LYS . 7.6 mt-10 -146.43 147.1 30.89 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.929 -1.107 . . . . 1.5800000000000001 108.936 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.53 142.02 11.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 118.786 -1.166 . . . . 0.54000000000000004 111.017 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -114.42 120.61 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.634 -0.712 . . . . 0.25 109.312 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 46' ' ' ALA . 4.2 mp -105.21 121.31 43.58 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.978 -0.689 . . . . 0.40000000000000002 109.812 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -108.03 133.18 52.7 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.89 -0.782 . . . . 2.7400000000000002 108.89 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -144.31 157.19 27.1 Favored Glycine 0 N--CA 1.503 3.114 0 C-N-CA 119.879 -1.153 . . . . 0.20999999999999999 111.539 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.56 ' CG2' ' CD2' ' A' ' 80' ' ' TYR . 10.2 p -137.88 145.23 41.9 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.582 -0.952 . . . . 0.56000000000000005 112.856 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.562 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 38.38 -87.26 0.01 OUTLIER Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.687 -0.965 . . . . 0.33000000000000002 110.687 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.675 ' HE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -80.22 -52.59 7.56 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.327 -1.102 . . . . 3.0899999999999999 109.829 -178.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.75 -19.61 64.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.892 -1.13 . . . . 1.0900000000000001 109.145 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 40' ' ' GLY . 7.1 tt -54.71 -35.49 33.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.142 -0.974 . . . . 0.87 111.202 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.432 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.32 -22.71 32.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.953 -1.092 . . . . 1.1399999999999999 108.875 -178.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' O ' HG12 ' A' ' 49' ' ' VAL . 1.3 mptt -63.47 -69.34 0.28 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.069 -2.196 . . . . 1.8600000000000001 105.069 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' H ' HG11 ' A' ' 10' ' ' VAL . . . -34.22 -38.1 0.06 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.479 0.657 . . . . 0.28999999999999998 109.843 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.764 HG13 ' HB ' ' B' ' 68' ' ' THR . 99.0 t -74.01 -73.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.243 -0.91 . . . . 0.22 109.546 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -40.41 -53.21 2.66 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.351 0.596 . . . . 1.26 111.103 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 50' ' ' TYR . 13.2 p -55.7 -47.64 78.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.318 -0.864 . . . . 1.0600000000000001 109.486 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.633 ' CD2' ' N ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -61.37 -54.86 38.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.665 -1.272 . . . . 4.0199999999999996 109.284 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.633 ' N ' ' CD2' ' A' ' 50' ' ' TYR . 27.9 t-20 -56.22 -48.55 76.24 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.546 -1.279 . . . . 1.3400000000000001 107.546 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.6 m -60.72 -32.7 71.95 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.915 -1.143 . . . . 1.04 107.915 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.548 HD22 HG11 ' A' ' 23' ' ' VAL . 10.5 tp -80.69 -20.85 42.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.64 -1.244 . . . . 0.44 107.64 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.14 -46.49 14.83 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.906 -1.887 . . . . 1.0 105.906 177.062 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -57.66 -6.53 0.52 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.772 -1.195 . . . . 1.5800000000000001 107.772 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -70.1 -50.42 41.01 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 121.427 -0.796 . . . . 1.6899999999999999 109.251 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.2 mt -152.19 -16.71 0.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.169 -1.013 . . . . 1.6599999999999999 110.748 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.53 -50.48 0.07 OUTLIER Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.75 -1.214 . . . . 0.39000000000000001 110.609 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -74.62 -47.1 34.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -1.176 . . . . 1.3799999999999999 110.35 -178.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.68 27.17 3.41 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.748 -1.741 . . . . 0.26000000000000001 108.748 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -154.23 136.25 6.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.26 -1.141 . . . . 0.38 108.267 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.718 ' O ' HD23 ' A' ' 85' ' ' LEU . 6.0 mm-40 -138.91 153.92 48.3 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 122.465 1.126 . . . . 1.3100000000000001 112.257 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.561 HD11 HG21 ' A' ' 66' ' ' VAL . 6.9 tt -95.85 109.15 21.54 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.155 -1.424 . . . . 0.48999999999999999 107.155 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.01 -23.79 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.163 -0.961 . . . . 1.3500000000000001 110.045 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -168.61 156.26 7.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.31 -1.494 . . . . 1.2 109.513 177.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 63' ' ' LEU . 74.1 t -161.15 131.49 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.91 -0.774 . . . . 0.84999999999999998 108.91 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 68' ' ' THR . 19.1 tt0 -143.2 158.38 43.67 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.998 0.904 . . . . 1.4099999999999999 110.612 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.469 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -109.25 165.54 11.54 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.578 0.704 . . . . 0.52000000000000002 109.356 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 80' ' ' TYR . . . -169.83 176.38 43.67 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.729 -1.348 . . . . 0.40000000000000002 109.729 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.434 ' OG ' ' OD1' ' B' ' 51' ' ' ASN . 10.9 p -153.0 152.9 31.91 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.906 -1.146 . . . . 0.41999999999999998 107.906 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -160.24 176.91 11.19 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.045 -1.034 . . . . 1.29 109.908 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -89.34 139.91 16.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 119.589 -0.844 . . . . 1.02 110.435 -178.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 52.1 ttt180 -146.23 98.89 3.16 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.805 -0.813 . . . . 2.23 108.805 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 8.3 t0 88.87 34.58 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.334 0.588 . . . . 1.3799999999999999 109.562 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.93 38.87 6.18 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.293 1.044 . . . . 2.6200000000000001 109.367 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -157.66 151.63 24.32 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.594 -0.891 . . . . 3.1499999999999999 108.594 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -84.77 138.55 32.54 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.848 1.308 . . . . 2.4399999999999999 110.757 -177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -139.07 152.63 24.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 114.271 -1.332 . . . . 0.23000000000000001 107.592 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 p -88.33 162.87 16.33 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.204 1.002 . . . . 0.73999999999999999 111.53 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.56 ' CD2' ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -139.72 138.52 36.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.38 -0.827 . . . . 4.1600000000000001 109.692 -177.206 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 81' ' ' ILE . 1.7 tt -119.04 129.48 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.858 -1.164 . . . . 0.92000000000000004 107.858 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 67' ' ' GLN . 14.9 mt -108.71 119.17 38.75 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.929 -1.508 . . . . 0.35999999999999999 106.929 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.1 tt -127.02 127.16 44.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.235 -0.916 . . . . 0.97999999999999998 110.647 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 14.4 ttt180 -99.92 172.21 7.37 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.98 -0.554 . . . . 0.57999999999999996 109.681 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 62' ' ' GLN . 3.0 mt -161.24 145.03 13.07 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.555 -0.858 . . . . 1.3899999999999999 110.094 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 62' ' ' GLN . 5.3 tmtm? -131.21 157.39 43.34 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.565 -0.531 . . . . 1.4199999999999999 109.565 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -113.56 139.41 49.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.438 -0.789 . . . . 1.6399999999999999 109.72 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 88' ' ' VAL . 48.8 t -116.2 -5.09 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.038 -0.727 . . . . 0.63 109.038 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 118.043 -0.979 . . . . 1.76 109.597 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.52 -0.548 . . . . 6.3499999999999996 109.52 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.426 ' O ' HG22 ' B' ' 2' ' ' THR . 10.3 m -95.69 34.78 1.45 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 2.4199999999999999 109.079 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.99 -73.63 0.17 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.385 -0.822 . . . . 1.6799999999999999 109.974 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.423 ' O ' ' OE1' ' B' ' 33' ' ' GLU . 0.0 OUTLIER -93.64 63.41 3.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.632 -1.293 . . . . 2.3100000000000001 109.543 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -161.62 153.77 19.63 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.68 -1.6 . . . . 1.6200000000000001 106.68 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.62 ' HB3' HG23 ' B' ' 34' ' ' VAL . 0.4 OUTLIER 179.76 93.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.623 -1.298 . . . . 1.46 110.772 177.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -89.7 103.55 16.19 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.339 -1.475 . . . . 1.49 107.875 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mm -114.34 139.86 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.738 0.78 . . . . 1.1699999999999999 109.78 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 66.9 t -104.19 129.0 57.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.594 0.711 . . . . 1.3700000000000001 109.614 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.554 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -88.38 162.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.148 -1.056 . . . . 0.37 108.148 -178.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -138.0 171.79 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 2.3700000000000001 110.183 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -9.64 39.74 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.463 -0.94 . . . . 1.75 108.463 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 33.5 p -89.41 -6.1 56.84 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.739 -0.785 . . . . 1.1899999999999999 109.038 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -97.6 -132.92 0.22 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.627 -1.249 . . . . 1.47 107.627 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -168.15 167.07 12.61 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.882 -0.784 . . . . 1.22 108.882 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.422 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.0 m -66.43 -36.6 77.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.754 -1.202 . . . . 0.45000000000000001 107.754 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 4.8 mm-40 -73.73 -39.94 63.92 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.328 -0.99 . . . . 1.7 108.328 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -60.87 -31.95 71.4 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.173 -0.954 . . . . 1.46 111.917 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.744 ' O ' HG23 ' B' ' 23' ' ' VAL . 49.1 m-70 -92.99 -17.54 23.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 119.835 -1.791 . . . . 1.3999999999999999 108.907 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -33.84 55.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 104.427 -2.435 . . . . 0.34000000000000002 104.427 176.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.553 ' O ' HG23 ' B' ' 25' ' ' VAL . 52.6 mt -68.72 -51.7 38.64 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.648 -1.16 . . . . 0.38 109.058 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.04 -31.48 72.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 1.21 109.729 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.744 HG23 ' O ' ' B' ' 19' ' ' HIS . 52.9 t -69.68 -55.91 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.29999999999999999 109.837 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 20.9 tt -61.32 -20.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.067 -1.021 . . . . 0.68999999999999995 108.873 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 21' ' ' LEU . 4.8 t -71.11 -42.95 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.41999999999999998 109.098 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.596 HD13 ' OD1' ' B' ' 6' ' ' ASN . 5.0 mt -65.73 -41.44 92.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.854 -1.154 . . . . 1.1499999999999999 109.739 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -58.05 -29.95 65.79 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.211 -1.403 . . . . 1.46 107.211 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -28.34 65.43 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.477 -0.783 . . . . 1.1699999999999999 108.899 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -89.55 -1.23 57.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 1.1699999999999999 109.368 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.92 15.01 23.39 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.57 -1.412 . . . . 0.38 109.57 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 45.6 mm -78.56 108.17 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -1.162 . . . . 0.58999999999999997 108.82 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -92.77 -36.5 12.85 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.26 -0.9 . . . . 1.46 110.226 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' B' ' 4' ' ' LYS . 6.5 mt-10 -101.54 143.37 31.61 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.577 0.703 . . . . 1.2 110.905 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' B' ' 6' ' ' ASN . 9.8 p -154.57 143.04 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 119.554 -0.858 . . . . 0.48999999999999999 111.026 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.54 123.2 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.223 0.535 . . . . 0.31 109.87 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.95 121.08 42.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.738 -0.602 . . . . 0.47999999999999998 109.991 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -106.75 129.84 54.56 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.37 -0.604 . . . . 2.7400000000000002 109.37 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -143.49 156.43 26.57 Favored Glycine 0 N--CA 1.507 3.385 0 C-N-CA 119.662 -1.256 . . . . 0.23999999999999999 111.76 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.602 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 1.8 p -137.95 145.97 42.65 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.481 -1.011 . . . . 0.48999999999999999 112.916 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.566 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 37.68 -86.1 0.01 OUTLIER Glycine 0 N--CA 1.499 2.869 0 N-CA-C 110.571 -1.012 . . . . 0.28000000000000003 110.571 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.67 ' N ' ' HE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -80.71 -52.99 6.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.359 -1.083 . . . . 3.1600000000000001 109.792 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -19.53 65.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.956 -1.09 . . . . 1.3799999999999999 109.535 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.566 HG22 ' O ' ' B' ' 40' ' ' GLY . 7.1 tt -56.01 -31.6 31.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.905 -1.122 . . . . 0.84999999999999998 109.818 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -24.6 33.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 1.1200000000000001 108.656 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.492 ' O ' HG12 ' B' ' 49' ' ' VAL . 2.2 mptt -65.04 -70.84 0.21 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.642 -1.985 . . . . 1.8700000000000001 105.642 177.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.554 ' H ' HG11 ' B' ' 10' ' ' VAL . . . -32.37 -40.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.25 0.548 . . . . 0.26000000000000001 110.527 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 43' ' ' ILE . 94.6 t -79.13 -64.5 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.111 -0.993 . . . . 0.28000000000000003 110.011 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -44.97 -52.95 8.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.347 -0.846 . . . . 1.25 109.952 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.583 HG13 ' N ' ' B' ' 50' ' ' TYR . 11.1 p -55.58 -46.62 79.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.576 -0.849 . . . . 1.0600000000000001 109.204 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.643 ' CD2' ' N ' ' B' ' 51' ' ' ASN . 0.0 OUTLIER -62.81 -54.89 32.0 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.91 -1.119 . . . . 4.1100000000000003 109.162 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 0.643 ' N ' ' CD2' ' B' ' 50' ' ' TYR . 23.3 t-20 -53.83 -47.64 70.71 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.271 -1.381 . . . . 1.4099999999999999 107.271 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -63.62 -31.57 72.77 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.194 -1.002 . . . . 0.65000000000000002 109.141 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.494 HD22 HG11 ' B' ' 23' ' ' VAL . 13.7 tp -73.49 -23.2 60.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.054 -1.029 . . . . 0.53000000000000003 109.774 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' LYS . . . . . 0.407 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -83.18 -30.57 27.69 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.47 -1.678 . . . . 0.98999999999999999 106.47 177.435 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.46 -14.6 3.17 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.745 -1.206 . . . . 1.46 107.745 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.407 ' N ' ' C ' ' B' ' 54' ' ' LYS . 1.0 OUTLIER -71.61 -47.41 54.85 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.532 -0.867 . . . . 1.71 109.559 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 57' ' ' LEU . . . . . 0.605 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.7 mt -155.11 -15.24 0.11 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.99 -1.484 . . . . 1.77 112.638 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.33 -57.52 0.07 OUTLIER Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.22 -1.466 . . . . 0.39000000000000001 110.219 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.605 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -71.05 -44.24 66.19 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.298 -1.119 . . . . 1.3999999999999999 110.089 -179.307 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.65 25.74 5.01 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.231 -1.548 . . . . 0.34000000000000002 109.231 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 22.6 t -154.6 135.42 4.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.0 -1.111 . . . . 0.46000000000000002 108.0 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.719 ' O ' HD23 ' B' ' 85' ' ' LEU . 5.4 mm-40 -140.86 154.39 46.16 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.534 1.159 . . . . 1.4199999999999999 112.422 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.446 HD11 HG21 ' B' ' 66' ' ' VAL . 6.5 tt -96.16 114.48 26.18 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.898 -1.047 . . . . 0.54000000000000004 108.285 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.88 -13.69 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 119.54 -0.864 . . . . 1.4299999999999999 110.763 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -177.69 151.43 0.72 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.06 -1.65 . . . . 1.28 110.63 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.446 HG21 HD11 ' B' ' 63' ' ' LEU . 63.1 t -158.22 135.43 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.554 -0.717 . . . . 0.90000000000000002 109.341 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' GLN . . . . . 0.508 ' HB3' HD12 ' B' ' 82' ' ' LEU . 36.0 tt0 -143.99 160.14 41.37 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.016 0.913 . . . . 1.4399999999999999 111.579 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.764 ' HB ' HG13 ' A' ' 47' ' ' VAL . 6.5 p -117.87 163.7 16.14 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.459 -0.791 . . . . 0.45000000000000001 109.025 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' B' ' 80' ' ' TYR . . . 177.76 134.61 2.08 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.717 -1.353 . . . . 0.28999999999999998 109.717 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.645 ' CB ' ' HE ' ' B' ' 77' ' ' ARG . 65.3 p -91.95 156.3 17.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.292 -1.711 . . . . 0.39000000000000001 109.513 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -150.65 164.48 35.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 1.49 110.088 -179.066 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.568 ' N ' ' OE1' ' B' ' 71' ' ' GLU . 0.1 OUTLIER -88.74 136.23 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.185 -0.947 . . . . 0.87 110.295 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 49.2 ttt180 -148.06 101.93 3.33 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.187 -0.946 . . . . 2.1800000000000002 109.661 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 6.7 t0 86.13 34.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.694 -0.854 . . . . 1.3500000000000001 108.694 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.7 34.47 9.62 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.094 0.949 . . . . 2.5699999999999998 108.601 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -152.98 150.28 29.06 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.601 -0.888 . . . . 3.1400000000000001 108.601 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.645 ' HE ' ' CB ' ' B' ' 70' ' ' SER . 4.2 ttt85 -87.04 140.67 29.32 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.525 1.155 . . . . 2.3900000000000001 111.218 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 10.3 tt -136.79 153.68 30.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.713 -1.218 . . . . 0.57999999999999996 107.713 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.32 155.49 21.31 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.221 -0.924 . . . . 0.60999999999999999 109.711 -176.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.602 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.1 OUTLIER -137.56 138.03 39.17 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.209 -0.663 . . . . 4.0800000000000001 109.209 -177.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.525 HG23 ' O ' ' B' ' 81' ' ' ILE . 1.3 tt -120.56 130.59 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.297 -1.001 . . . . 0.90000000000000002 108.297 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' B' ' 67' ' ' GLN . 3.7 mt -108.28 119.21 38.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.469 -1.678 . . . . 0.37 106.469 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tt -124.63 126.09 45.19 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.511 -0.876 . . . . 0.97999999999999998 110.721 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -97.14 171.54 8.39 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.757 -0.831 . . . . 0.70999999999999996 108.757 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.719 HD23 ' O ' ' B' ' 62' ' ' GLN . 2.4 mt -160.41 141.6 12.16 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.559 -0.857 . . . . 1.4399999999999999 109.352 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' B' ' 62' ' ' GLN . 9.2 tttm -127.26 148.11 50.22 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.019 0.437 . . . . 1.3100000000000001 110.188 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -106.0 137.76 43.36 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.505 -0.747 . . . . 1.6399999999999999 109.421 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.489 ' O ' HG12 ' B' ' 88' ' ' VAL . 75.7 t -116.2 -4.45 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.061 -0.718 . . . . 0.68000000000000005 109.061 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 118.077 -0.963 . . . . 1.77 109.473 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.822 ' ND2' HD11 ' A' ' 8' ' ' ILE . 48.2 t30 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.176 0.512 . . . . 1.72 111.137 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -91.47 124.98 36.05 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.456 -0.942 . . . . 1.44 108.456 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.822 HD11 ' ND2' ' A' ' 6' ' ' ASN . 10.4 mt -137.12 154.4 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 119.918 -0.713 . . . . 1.11 111.205 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.56 138.63 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.723 -0.843 . . . . 1.35 108.723 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 p -91.06 163.5 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.942 -1.099 . . . . 0.39 108.683 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -129.67 163.65 25.63 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.836 0.827 . . . . 2.27 109.986 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -95.11 -17.49 21.78 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.174 -1.047 . . . . 1.78 108.174 178.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -73.42 -44.56 58.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.374 -0.973 . . . . 1.24 108.374 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 146.51 39.08 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.236 -0.915 . . . . 1.41 109.294 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -69.0 -179.44 1.5 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.099 -1.001 . . . . 1.25 108.632 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.638 HG23 ' N ' ' A' ' 17' ' ' GLU . 27.2 m -78.62 -50.2 19.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.872 -1.142 . . . . 0.49 109.458 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.638 ' N ' HG23 ' A' ' 16' ' ' VAL . 4.1 pt-20 -57.88 -19.69 31.26 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.076 -1.015 . . . . 1.56 110.529 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.61 -30.37 69.09 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.379 -1.451 . . . . 1.38 108.239 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -89.27 -23.57 22.28 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.845 -0.742 . . . . 1.43 109.015 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.41 -27.8 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 106.532 -1.655 . . . . 0.29 106.532 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 25' ' ' VAL . 27.2 mt -75.37 -48.94 20.65 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.117 -1.068 . . . . 0.41 108.117 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -66.73 -22.01 66.06 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.537 -0.727 . . . . 1.22 109.597 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 19' ' ' HIS . 11.9 t -78.79 -54.41 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.154 -0.966 . . . . 0.32 109.783 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.1 tt -55.6 -28.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.147 -0.97 . . . . 0.58 108.924 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 21' ' ' LEU . 58.0 t -72.67 -43.97 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.231 -1.026 . . . . 0.41 108.231 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.646 HD13 HD22 ' A' ' 6' ' ' ASN . 44.8 mt -63.8 -39.73 94.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.53 -0.731 . . . . 1.19 109.692 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 3.2 t80 -69.77 -0.93 7.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 1.46 108.786 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.72 -26.69 19.41 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.981 -1.118 . . . . 1.15 107.981 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -86.82 3.96 43.14 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.519 -0.738 . . . . 1.17 109.648 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.64 6.84 34.95 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.171 -1.172 . . . . 0.42 110.171 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -75.7 95.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -1.234 . . . . 0.35 109.407 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -87.37 -33.95 18.97 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.232 -0.918 . . . . 1.55 108.82 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -99.5 147.71 25.02 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.366 0.603 . . . . 1.58 109.807 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.15 149.07 10.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 119.163 -1.015 . . . . 0.54 109.488 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.1 mt -129.7 117.24 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.494 0.664 . . . . 0.25 110.732 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 46' ' ' ALA . 4.6 mp -100.68 127.17 47.18 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.893 -0.781 . . . . 0.4 108.893 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -115.3 139.93 49.55 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.015 -1.106 . . . . 2.74 108.015 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.81 163.96 28.83 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 119.379 -1.391 . . . . 0.21 110.444 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 41' ' ' ARG . 36.4 p -137.46 148.1 45.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.503 -0.998 . . . . 0.56 110.914 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 36.94 -85.65 0.01 OUTLIER Glycine 0 N--CA 1.5 2.947 0 O-C-N 122.0 -0.438 . . . . 0.33 112.179 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -87.14 -42.87 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -1.174 . . . . 3.09 110.34 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.58 -22.34 66.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.66 -1.275 . . . . 1.09 109.511 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.539 HG13 HG22 ' A' ' 81' ' ' ILE . 8.3 tt -48.23 -54.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.87 109.978 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.497 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.61 -26.57 65.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.906 -1.121 . . . . 1.14 110.903 -178.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -41.27 95.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.638 -1.289 . . . . 1.86 109.066 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -59.83 -38.73 82.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.29 109.245 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.668 HG13 ' HB ' ' B' ' 68' ' ' THR . 48.5 t -59.75 -66.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.654 -0.654 . . . . 0.22 110.643 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -53.54 6.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.797 -0.564 . . . . 1.26 109.804 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG21 ' CB ' ' A' ' 19' ' ' HIS . 9.0 t -46.15 -55.19 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.555 -0.715 . . . . 1.06 109.494 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -64.66 -44.68 89.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.395 -0.816 . . . . 1.27 110.037 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.57 ' CG ' ' H ' ' B' ' 70' ' ' SER . 4.6 t30 -58.46 -48.33 81.08 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.094 -1.004 . . . . 1.34 108.467 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 p -67.46 -29.18 68.57 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.942 -0.762 . . . . 1.04 108.942 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.79 -25.39 44.29 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.385 -0.969 . . . . 0.44 108.385 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -76.28 -46.32 28.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.007 -1.849 . . . . 1.0 106.007 177.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 16.6 t0 -57.63 -6.96 0.56 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.827 -1.079 . . . . 1.58 108.351 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 54' ' ' LYS . 3.1 tpt85 -76.35 -46.53 27.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.727 -0.608 . . . . 1.69 110.148 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' ASP . 6.1 tp -152.42 -29.03 0.16 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.41 -0.916 . . . . 1.66 110.292 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.71 -49.32 0.64 Allowed Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.022 -1.561 . . . . 0.39 109.229 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.502 ' C ' ' H ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER -74.68 -49.79 20.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -1.223 . . . . 1.38 109.055 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.97 23.36 1.36 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.79 -1.724 . . . . 0.26 108.79 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 59' ' ' ASP . 24.1 t -149.86 139.51 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 121.505 -0.997 . . . . 0.38 108.511 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.5 mm-40 -143.27 142.36 31.33 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.229 1.014 . . . . 1.31 110.864 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 tt -93.84 94.26 8.41 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.471 -0.786 . . . . 0.49 109.114 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.427 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -79.33 -35.37 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.904 -1.122 . . . . 1.35 110.126 -179.138 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 64' ' ' VAL . 15.2 m-80 -165.99 157.63 13.94 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.139 -1.425 . . . . 1.2 112.155 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.1 t -158.16 145.37 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.397 -1.335 . . . . 0.85 107.397 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -148.11 165.23 31.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.754 -1.216 . . . . 1.41 108.896 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.4 ' HB ' HG13 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -147.36 129.64 15.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.52 111.007 -178.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -152.38 171.52 31.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.964 -1.655 . . . . 0.4 108.964 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.523 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 9.9 p -112.08 156.45 22.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.693 0.759 . . . . 0.42 110.366 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.29 175.84 13.03 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.511 -0.743 . . . . 1.29 109.552 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.4 t -87.99 132.78 32.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.388 -0.82 . . . . 1.02 110.651 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 34.4 ttt-85 -143.85 99.97 3.5 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.487 -0.931 . . . . 2.23 108.487 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.2 t70 85.69 40.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.205 0.526 . . . . 1.38 109.643 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 60.32 37.68 20.11 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.379 1.085 . . . . 2.62 108.897 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -155.51 149.0 25.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.111 -0.993 . . . . 3.15 108.765 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -83.02 140.88 32.46 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.223 -0.991 . . . . 2.44 109.626 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.3 tt -144.31 156.95 15.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.176 -0.676 . . . . 0.23 109.176 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -87.9 152.79 21.81 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.394 -0.816 . . . . 0.74 109.4 -178.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 9.8 p90 -146.82 151.87 37.82 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.063 -1.023 . . . . 4.16 110.348 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.539 HG22 HG13 ' A' ' 43' ' ' ILE . 10.6 tt -121.75 137.53 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-N 115.667 -0.697 . . . . 0.92 111.488 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.5 mt -110.23 104.71 13.57 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.076 -2.194 . . . . 0.36 105.076 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 tp -106.82 120.47 42.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.878 -0.514 . . . . 0.98 110.081 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -103.69 168.23 9.28 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.907 -0.775 . . . . 0.58 108.907 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.459 HD21 HG13 ' A' ' 61' ' ' VAL . 1.3 tp -160.57 160.11 31.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.951 -1.099 . . . . 1.39 109.999 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -142.15 145.26 34.01 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.52 -0.548 . . . . 1.42 109.52 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -105.08 136.62 44.24 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.55 -0.719 . . . . 1.64 109.373 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 t -107.63 -7.55 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.878 -1.156 . . . . 0.63 107.878 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 117.977 -1.011 . . . . 1.76 109.437 179.591 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.759 ' ND2' HD11 ' B' ' 8' ' ' ILE . 49.5 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.421 0.629 . . . . 1.46 111.387 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.1 pt-20 -93.1 121.88 34.9 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.38 -0.97 . . . . 1.49 108.38 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.759 HD11 ' ND2' ' B' ' 6' ' ' ASN . 40.1 mt -134.63 150.91 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.735 -0.603 . . . . 1.17 110.009 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.9 138.91 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.878 . . . . 1.37 108.909 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.445 HG23 ' CD2' ' B' ' 19' ' ' HIS . 1.4 p -90.26 160.1 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.967 -1.083 . . . . 0.37 108.499 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.403 ' HE ' ' HE3' ' B' ' 14' ' ' LYS . 12.1 mtt-85 -130.74 167.7 18.41 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.874 0.845 . . . . 2.37 110.505 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.25 -4.65 21.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.507 -0.923 . . . . 1.75 108.507 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' THR . . . . . 0.406 ' H ' HG22 ' B' ' 13' ' ' THR . 2.8 t -83.49 -29.05 28.27 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.647 -0.821 . . . . 1.19 110.447 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.411 ' O ' ' OD1' ' B' ' 15' ' ' ASN . 7.5 mttm -83.8 -113.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.78 -1.2 . . . . 1.47 109.415 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' B' ' 14' ' ' LYS . 2.6 m120 -166.18 173.63 10.02 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.393 -1.336 . . . . 1.22 107.393 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.63 HG23 ' N ' ' B' ' 17' ' ' GLU . 22.1 m -70.9 -51.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.606 -1.309 . . . . 0.45 109.112 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.63 ' N ' HG23 ' B' ' 16' ' ' VAL . 6.0 pt-20 -63.11 -24.94 68.13 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.147 -0.97 . . . . 1.7 110.106 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.42 -38.42 91.08 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.39 -1.444 . . . . 1.46 108.359 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.448 ' HB3' HG21 ' B' ' 49' ' ' VAL . 0.7 OUTLIER -83.76 -22.3 31.94 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.894 -0.722 . . . . 1.4 109.841 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.08 -31.05 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.074 -1.454 . . . . 0.34 107.074 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 37.4 mt -70.63 -48.64 53.98 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.264 -1.013 . . . . 0.38 108.264 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -65.62 -26.04 67.65 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.477 -0.764 . . . . 1.21 109.906 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.57 -54.14 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.11 -0.994 . . . . 0.3 110.026 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 5.5 tt -55.15 -28.54 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.69 109.246 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 t -73.38 -43.32 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.198 -0.939 . . . . 0.42 108.631 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mt -62.37 -45.97 90.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.45 -0.781 . . . . 1.15 109.524 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -53.92 -48.0 70.63 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.746 -1.205 . . . . 1.46 107.746 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -31.01 2.16 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.208 -0.597 . . . . 1.17 109.577 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -84.77 5.43 28.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.952 -1.093 . . . . 1.17 110.031 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.08 53.85 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.924 -1.27 . . . . 0.38 109.924 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 43.5 mm -76.17 88.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.067 -1.255 . . . . 0.59 108.588 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -83.49 -39.08 20.95 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.21 -0.931 . . . . 1.46 109.152 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -93.58 142.11 27.71 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.643 -0.661 . . . . 1.2 109.592 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 p -155.57 151.03 10.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.546 -0.862 . . . . 0.49 109.683 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.56 112.81 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.439 0.638 . . . . 0.31 110.055 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -95.53 133.05 39.98 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.542 -0.724 . . . . 0.48 109.187 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.99 140.03 52.96 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.463 -0.94 . . . . 2.74 108.463 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.99 164.19 28.59 Favored Glycine 0 N--CA 1.502 3.089 0 C-N-CA 119.498 -1.334 . . . . 0.24 110.232 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.548 ' O ' ' N ' ' B' ' 41' ' ' ARG . 76.9 p -135.87 146.37 47.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.701 -0.882 . . . . 0.49 110.763 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.503 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 36.27 -84.02 0.0 OUTLIER Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.847 -0.533 . . . . 0.28 112.615 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.0 OUTLIER -84.5 -45.31 12.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -1.187 . . . . 3.16 110.443 -178.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.2 OUTLIER -66.76 -23.92 66.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.727 -1.233 . . . . 1.38 109.045 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.558 HG13 HG22 ' B' ' 81' ' ' ILE . 7.9 tt -53.85 -20.71 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.85 109.036 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.11 -34.58 13.59 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.279 0.562 . . . . 1.12 110.196 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -25.38 66.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 1.87 110.212 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.435 ' HB2' HG11 ' B' ' 10' ' ' VAL . . . -73.26 -45.74 54.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.962 -1.086 . . . . 0.26 109.975 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.4 HG13 ' HB ' ' A' ' 68' ' ' THR . 88.5 t -61.88 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.28 109.68 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' B' ' 52' ' ' SER . 2.7 t70 -57.43 -56.37 22.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 1.25 109.474 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' B' ' 19' ' ' HIS . 10.3 t -43.89 -49.48 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.672 -0.643 . . . . 1.06 110.006 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.504 ' CE1' HD11 ' B' ' 85' ' ' LEU . 1.1 t80 -68.33 -53.18 25.92 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.426 -0.797 . . . . 1.28 110.295 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . 0.523 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 1.2 t30 -50.3 -45.88 54.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.032 -1.042 . . . . 1.41 108.527 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.6 OUTLIER -68.67 -37.15 79.39 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.559 -0.857 . . . . 0.65 109.171 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 tp -65.89 -26.84 67.8 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.378 -0.826 . . . . 0.53 108.817 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -75.25 -38.69 60.43 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.664 -1.236 . . . . 0.99 107.664 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.26 -7.78 0.41 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.036 -0.727 . . . . 1.46 109.036 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.472 ' H ' ' C ' ' B' ' 54' ' ' LYS . 21.1 mmm180 -82.66 -39.41 22.1 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.548 -0.72 . . . . 1.71 110.727 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' LEU . . . . . 0.425 HD23 ' H ' ' B' ' 60' ' ' GLY . 1.0 OUTLIER -157.14 -35.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 117.928 -1.509 . . . . 1.77 112.595 -179.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.78 -55.03 2.57 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 118.548 -1.786 . . . . 0.39 108.919 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' B' ' 61' ' ' VAL . 0.4 OUTLIER -72.16 -48.68 41.62 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.149 -1.206 . . . . 1.4 108.575 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.425 ' H ' HD23 ' B' ' 57' ' ' LEU . . . -76.79 25.11 1.81 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 108.969 -1.652 . . . . 0.34 108.969 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' B' ' 59' ' ' ASP . 13.0 t -153.07 140.2 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.392 -1.064 . . . . 0.46 108.72 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.5 mm-40 -143.87 141.9 30.54 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.297 1.046 . . . . 1.42 111.669 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.34 94.33 9.08 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.421 -0.809 . . . . 0.54 109.346 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.44 HG22 ' H ' ' B' ' 64' ' ' VAL . 0.0 OUTLIER -74.53 -39.55 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.945 -1.097 . . . . 1.43 110.53 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.491 ' O ' HG23 ' B' ' 66' ' ' VAL . 21.4 m-80 -164.46 164.69 21.88 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.336 -1.346 . . . . 1.28 111.831 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 65' ' ' ASN . 59.2 t -161.07 143.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.718 -1.216 . . . . 0.9 107.718 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -147.76 165.13 31.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.899 -1.125 . . . . 1.44 108.645 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.668 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -148.78 129.48 14.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.088 -1.007 . . . . 0.45 110.232 -178.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.551 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -149.29 169.58 29.61 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.061 -1.216 . . . . 0.29 110.061 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.57 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 23.9 p -104.32 151.21 23.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 122.038 -0.684 . . . . 0.39 109.986 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.65 172.01 16.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 1.49 110.224 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 67.9 t -87.58 133.95 29.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.474 -0.766 . . . . 0.87 110.692 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 17.7 ttt-85 -146.36 101.39 3.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.544 -0.722 . . . . 2.18 109.301 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 1.6 t70 82.2 41.84 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.319 0.58 . . . . 1.35 109.509 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 60.48 32.29 20.49 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.121 0.962 . . . . 2.57 109.212 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -151.9 154.96 37.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.563 -0.903 . . . . 3.14 108.563 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -87.37 142.17 28.08 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.389 -0.924 . . . . 2.39 110.644 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 tt -142.56 157.33 18.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.404 -0.962 . . . . 0.58 108.404 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.15 149.51 24.6 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.797 -0.816 . . . . 0.61 108.797 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.551 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 9.1 p90 -144.49 149.89 36.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.38 -0.825 . . . . 4.08 109.899 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.558 HG22 HG13 ' B' ' 43' ' ' ILE . 2.9 tt -122.08 138.95 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 115.899 -0.591 . . . . 0.9 111.766 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 21.0 mt -108.99 106.99 17.18 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.518 -2.03 . . . . 0.37 105.518 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.5 119.48 39.52 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 118.343 0.519 . . . . 0.98 110.566 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -102.81 164.84 11.39 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.912 -0.773 . . . . 0.71 108.912 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.504 HD11 ' CE1' ' B' ' 50' ' ' TYR . 1.9 tp -160.4 152.19 19.94 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.607 -0.837 . . . . 1.44 109.708 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -136.86 136.07 38.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.452 -0.573 . . . . 1.31 109.452 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -95.18 137.17 34.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.48 -0.762 . . . . 1.64 109.313 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 40.0 t -108.92 -6.85 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 0.68 108.21 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.964 -1.017 . . . . 1.77 109.513 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.608 HD21 HD22 ' A' ' 26' ' ' LEU . 5.7 m-20 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.978 0.418 . . . . 1.72 111.033 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 7.0 pt-20 -91.67 117.03 29.37 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.604 -1.258 . . . . 1.44 107.604 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 35' ' ' ILE . 12.6 mt -122.43 147.98 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-O 121.889 0.852 . . . . 1.11 112.062 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -111.78 128.17 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.65 0.738 . . . . 1.35 109.796 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -88.4 164.9 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.398 -0.964 . . . . 0.39 108.398 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -138.0 174.9 10.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.439 -0.788 . . . . 2.27 109.827 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -8.38 15.09 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.208 -1.034 . . . . 1.78 108.208 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.423 ' H ' HG22 ' A' ' 13' ' ' THR . 1.0 OUTLIER -90.44 -12.34 37.72 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.35 -1.352 . . . . 1.24 107.35 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -130.41 0.09 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.996 -1.483 . . . . 1.41 106.996 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.79 155.21 21.12 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.803 -1.186 . . . . 1.25 108.925 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 49' ' ' VAL . 11.5 m -62.7 -37.24 78.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 122.121 0.962 . . . . 0.49 108.859 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.86 -31.61 59.37 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.22 -0.925 . . . . 1.56 108.523 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.33 -32.04 73.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.614 -1.304 . . . . 1.38 111.452 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.71 ' O ' HG23 ' A' ' 23' ' ' VAL . 85.2 m-70 -90.37 -18.63 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 119.806 -1.809 . . . . 1.43 108.74 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.09 -32.15 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 105.147 -2.168 . . . . 0.29 105.147 176.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.816 ' O ' HG23 ' A' ' 25' ' ' VAL . 34.2 mt -69.53 -53.01 21.12 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.729 -1.123 . . . . 0.41 109.294 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -65.86 -28.81 69.24 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.98 -1.075 . . . . 1.22 109.546 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 19' ' ' HIS . 23.2 t -68.72 -54.42 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.421 -0.799 . . . . 0.32 109.01 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 tt -63.5 -17.05 19.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.181 -0.949 . . . . 0.58 108.978 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 21' ' ' LEU . 53.6 t -76.95 -46.7 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.064 -1.023 . . . . 0.41 109.408 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.608 HD22 HD21 ' A' ' 6' ' ' ASN . 11.9 mt -66.22 -33.13 75.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.614 -1.304 . . . . 1.19 110.273 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 4.2 t80 -64.33 -24.73 67.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.79 -1.559 . . . . 1.46 106.79 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -27.29 69.18 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.096 -0.956 . . . . 1.15 109.398 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.466 ' NE2' HD23 ' A' ' 26' ' ' LEU . 17.9 mt-30 -89.89 -4.69 57.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.901 -1.124 . . . . 1.17 109.254 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.74 12.22 15.1 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.368 -1.093 . . . . 0.42 110.368 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.4 mm -75.16 106.46 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.038 -1.272 . . . . 0.35 108.475 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.57 -36.91 15.06 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.339 -0.851 . . . . 1.55 110.306 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.95 143.32 31.24 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.827 0.822 . . . . 1.58 110.456 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.67 141.46 14.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 119.555 -0.858 . . . . 0.54 109.942 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -120.81 126.37 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 115.887 -0.597 . . . . 0.25 110.321 -178.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.465 ' CD2' HG21 ' A' ' 49' ' ' VAL . 6.9 mp -108.81 125.13 51.63 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 120.2 -0.6 . . . . 0.4 109.753 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -108.42 131.59 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.752 -1.203 . . . . 2.74 107.752 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.69 152.75 21.79 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 119.893 -1.146 . . . . 0.21 110.717 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.595 ' O ' ' N ' ' A' ' 41' ' ' ARG . 18.0 p -132.3 139.61 48.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.842 -0.799 . . . . 0.56 112.243 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.542 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 39.51 -85.08 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 N-CA-C 111.406 -0.677 . . . . 0.33 111.406 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -82.09 -54.2 5.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.256 -1.143 . . . . 3.09 109.913 -178.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -19.34 48.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.785 -1.197 . . . . 1.09 108.564 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 40' ' ' GLY . 4.9 tt -53.97 -30.91 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.388 -0.82 . . . . 0.87 110.673 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.41 ' HA ' HD13 ' B' ' 43' ' ' ILE . 0.8 OUTLIER -85.6 -22.53 27.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.563 -1.336 . . . . 1.14 108.54 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' VAL . 24.3 mmtp -63.33 -69.24 0.28 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.078 -1.823 . . . . 1.86 106.078 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -29.22 -38.18 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.784 0.802 . . . . 0.29 109.959 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.693 HG13 ' HB ' ' B' ' 68' ' ' THR . 65.8 t -73.64 -74.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.696 -0.627 . . . . 0.22 110.578 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -39.8 -56.55 1.73 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.412 0.625 . . . . 1.26 110.838 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.713 HG23 ' N ' ' A' ' 50' ' ' TYR . 31.2 m -47.19 -54.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.465 -0.772 . . . . 1.06 109.035 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.713 ' N ' HG23 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -58.34 -52.64 64.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 4.02 109.634 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.648 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 2.5 t30 -53.21 -52.74 57.9 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.605 -1.257 . . . . 1.34 107.605 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.5 p -59.44 -33.29 71.09 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.242 -1.022 . . . . 1.04 108.242 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.416 HD22 HG11 ' A' ' 23' ' ' VAL . 7.3 tp -78.98 -25.13 43.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.111 -0.993 . . . . 0.44 108.9 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.02 -45.19 20.69 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.216 -2.142 . . . . 1.0 105.216 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.418 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 9.9 t70 -56.53 -7.9 0.47 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.817 -1.179 . . . . 1.58 107.817 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 54' ' ' LYS . 6.9 tpt180 -72.03 -48.74 42.39 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.589 0.709 . . . . 1.69 109.834 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.0 tp -153.73 -24.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.203 -0.999 . . . . 1.66 110.994 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.37 -48.94 0.07 OUTLIER Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.77 -1.205 . . . . 0.39 110.181 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -72.3 -41.9 66.08 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.395 -1.062 . . . . 1.38 109.548 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.598 ' H ' HD23 ' A' ' 57' ' ' LEU . . . -92.65 28.96 8.34 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 108.844 -1.703 . . . . 0.26 108.844 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.2 t -154.58 130.21 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.541 -1.281 . . . . 0.38 107.541 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.733 ' O ' HD23 ' A' ' 85' ' ' LEU . 1.7 mm100 -136.98 158.44 44.46 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.349 1.071 . . . . 1.31 111.926 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.563 HD11 HG21 ' A' ' 66' ' ' VAL . 7.4 tt -94.73 114.6 26.54 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.495 -0.928 . . . . 0.49 108.495 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -22.11 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.166 -0.959 . . . . 1.35 109.712 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -173.57 157.02 3.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.549 -1.344 . . . . 1.2 109.835 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.563 HG21 HD11 ' A' ' 63' ' ' LEU . 58.0 t -159.78 130.94 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.703 -0.851 . . . . 0.85 108.703 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -142.0 157.63 44.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.131 0.967 . . . . 1.41 110.16 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.596 ' HB ' HG13 ' B' ' 47' ' ' VAL . 1.3 p -132.6 147.37 52.34 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.293 -1.002 . . . . 0.52 108.293 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.631 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -175.27 154.34 17.73 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.414 -2.675 . . . . 0.4 106.414 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.526 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 52.7 p -103.78 169.21 8.65 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 119.085 1.442 . . . . 0.42 110.128 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.24 164.88 34.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 1.29 109.525 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.75 91.65 3.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.638 -0.825 . . . . 1.02 109.874 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 47.0 ttt-85 -95.02 112.06 23.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.991 -1.068 . . . . 2.23 110.048 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.1 t70 77.73 39.75 0.17 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.454 -0.573 . . . . 1.38 109.454 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.426 HH11 ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER 60.86 29.43 19.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.462 -0.774 . . . . 2.62 108.954 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.66 144.99 30.74 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.026 -1.047 . . . . 3.15 108.671 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -84.35 126.54 33.31 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.94 1.353 . . . . 2.44 111.428 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 tt -136.4 147.53 27.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 106.943 -1.503 . . . . 0.23 106.943 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.71 159.59 17.73 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.077 -1.014 . . . . 0.74 110.938 -176.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.631 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 6.4 p90 -145.91 153.32 40.71 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.869 0.842 . . . . 4.16 110.608 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 81' ' ' ILE . 10.4 tt -125.14 132.63 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.623 0.725 . . . . 0.92 109.822 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.39 121.63 44.97 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.092 -1.448 . . . . 0.36 107.092 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.65 123.86 34.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.206 -0.934 . . . . 0.98 111.072 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -97.7 169.68 9.52 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.437 0.637 . . . . 0.58 110.11 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 62' ' ' GLN . 2.8 mt -159.68 140.04 11.99 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.362 -0.935 . . . . 1.39 110.349 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 62' ' ' GLN . 2.2 tmtp? -122.9 145.64 48.28 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.941 -0.475 . . . . 1.42 109.92 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.548 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 14.7 mmt85 -103.85 138.66 40.12 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.186 -0.946 . . . . 1.64 109.863 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.78 -6.84 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.718 -0.845 . . . . 0.63 108.718 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 CA-C-O 118.058 -0.972 . . . . 1.76 109.573 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.822 ' ND2' HD13 ' B' ' 26' ' ' LEU . 32.9 t-20 . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 121.264 0.554 . . . . 1.46 110.451 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.8 pt-20 -93.62 120.96 34.54 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.144 -0.973 . . . . 1.49 108.944 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.419 HD13 HG21 ' B' ' 8' ' ' ILE . 7.8 mt -123.58 146.0 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.971 0.891 . . . . 1.17 111.217 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.453 ' O ' HG13 ' B' ' 9' ' ' VAL . 9.8 p -105.45 129.38 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.147 -0.686 . . . . 1.37 109.147 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -89.45 166.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.526 -0.87 . . . . 0.37 108.749 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -141.18 175.78 9.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.431 -0.793 . . . . 2.37 109.996 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.433 ' C ' ' CD ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -112.96 -4.82 13.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.074 -1.084 . . . . 1.75 108.074 179.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' THR . . . . . 0.419 HG22 ' H ' ' B' ' 13' ' ' THR . 0.0 OUTLIER -85.68 -18.06 34.24 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.718 -0.845 . . . . 1.19 108.718 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -92.97 -115.91 0.09 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.443 -0.947 . . . . 1.47 108.443 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.21 166.06 12.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.389 -0.82 . . . . 1.22 108.967 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.436 ' H ' HG22 ' B' ' 16' ' ' VAL . 5.0 m -66.88 -35.12 73.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.043 0.925 . . . . 0.45 108.823 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 16.0 pt-20 -73.59 -37.97 65.28 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.03 -1.044 . . . . 1.7 108.8 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.41 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 0.3 OUTLIER -54.41 -36.66 64.22 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.653 -1.28 . . . . 1.46 111.772 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.711 ' O ' HG23 ' B' ' 23' ' ' VAL . 90.3 m-70 -91.39 -18.64 23.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.271 -1.518 . . . . 1.4 109.105 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -36.61 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 105.158 -2.164 . . . . 0.34 105.158 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.823 ' O ' HG23 ' B' ' 25' ' ' VAL . 69.2 mt -67.15 -52.16 44.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.377 -0.829 . . . . 0.38 108.983 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.89 -28.39 68.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -0.969 . . . . 1.21 109.844 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 19' ' ' HIS . 18.4 t -69.4 -53.55 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.3 108.951 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 tt -64.14 -18.92 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.197 -0.939 . . . . 0.69 109.116 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.823 HG23 ' O ' ' B' ' 21' ' ' LEU . 63.4 t -75.58 -46.68 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.42 109.244 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.822 HD13 ' ND2' ' B' ' 6' ' ' ASN . 12.7 mt -65.33 -33.45 76.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.796 -1.19 . . . . 1.15 110.073 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.517 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 4.9 t80 -64.92 -28.23 69.39 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.926 -1.509 . . . . 1.46 106.926 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -29.24 68.38 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.321 -0.854 . . . . 1.17 109.116 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.436 ' NE2' HD23 ' B' ' 26' ' ' LEU . 17.0 mt-30 -88.19 -0.59 57.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 1.17 109.466 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.07 12.14 26.34 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.588 -1.005 . . . . 0.38 110.588 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 33.6 mm -75.18 107.35 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.951 -1.323 . . . . 0.59 107.863 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -91.48 -41.33 10.9 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.317 -0.865 . . . . 1.46 110.518 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -97.17 143.72 27.7 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.569 0.7 . . . . 1.2 110.217 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -153.16 136.94 8.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 119.006 -1.078 . . . . 0.49 111.111 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.4 128.58 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 115.958 -0.565 . . . . 0.31 110.048 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.42 124.66 52.15 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.555 -0.716 . . . . 0.48 110.114 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -107.74 130.57 54.94 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.775 -0.578 . . . . 2.74 109.449 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.12 153.51 23.4 Favored Glycine 0 N--CA 1.502 3.06 0 C-N-CA 119.502 -1.333 . . . . 0.24 111.02 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.657 ' O ' ' N ' ' B' ' 41' ' ' ARG . 62.2 p -133.93 141.42 47.31 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.964 -0.727 . . . . 0.49 112.558 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.685 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 34.98 -78.98 0.0 OUTLIER Glycine 0 N--CA 1.504 3.191 0 N-CA-C 111.873 -0.491 . . . . 0.28 111.873 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.657 ' N ' ' O ' ' B' ' 39' ' ' THR . 1.4 mtp85 -83.3 -55.92 4.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.002 -1.293 . . . . 3.16 109.374 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.5 OUTLIER -63.13 -16.41 59.96 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.995 -1.066 . . . . 1.38 109.841 -178.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.685 HG22 ' O ' ' B' ' 40' ' ' GLY . 9.6 tt -59.69 -25.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.165 -0.959 . . . . 0.85 109.664 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.08 -25.86 27.3 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.89 -1.152 . . . . 1.12 107.89 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 47' ' ' VAL . 24.3 mmtp -63.32 -71.33 0.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.597 -1.631 . . . . 1.87 106.597 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -24.53 -43.29 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.375 0.607 . . . . 0.26 111.271 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.596 HG13 ' HB ' ' A' ' 68' ' ' THR . 94.5 t -77.54 -60.32 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.168 -0.958 . . . . 0.28 110.361 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ASP . . . . . 0.417 ' O ' ' OG ' ' B' ' 52' ' ' SER . 1.9 t0 -46.37 -62.63 1.27 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.046 -1.034 . . . . 1.25 109.456 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.674 HG23 ' N ' ' B' ' 50' ' ' TYR . 33.3 m -42.84 -51.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.824 -0.806 . . . . 1.06 108.824 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.674 ' N ' HG23 ' B' ' 49' ' ' VAL . 0.1 OUTLIER -62.31 -50.53 71.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 4.11 109.744 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . 0.619 ' N ' ' CD1' ' B' ' 50' ' ' TYR . 1.3 t30 -54.57 -54.53 40.03 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.729 -1.188 . . . . 1.41 107.896 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.1 OUTLIER -59.01 -37.81 77.78 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.57 -0.852 . . . . 0.65 108.832 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.408 HD22 HG11 ' B' ' 23' ' ' VAL . 10.1 tp -67.1 -23.48 65.84 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.128 -0.982 . . . . 0.53 108.379 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -39.38 50.12 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.769 -1.197 . . . . 0.99 107.769 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.94 -12.72 2.15 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.384 -0.826 . . . . 1.46 109.227 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -73.58 -43.48 59.66 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.035 -1.066 . . . . 1.71 109.39 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.9 tp -154.61 -23.59 0.12 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.368 -1.333 . . . . 1.77 112.209 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 65.15 -58.78 0.09 OUTLIER Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.224 -1.465 . . . . 0.39 109.551 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.95 -42.59 73.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -1.1 . . . . 1.4 109.773 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.475 ' H ' HD23 ' B' ' 57' ' ' LEU . . . -84.42 25.42 5.66 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.896 -1.682 . . . . 0.34 108.896 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' B' ' 58' ' ' GLY . 73.5 t -154.65 131.65 2.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.318 -1.364 . . . . 0.46 107.318 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.694 ' O ' HD23 ' B' ' 85' ' ' LEU . 1.1 mm100 -135.28 153.07 52.02 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.148 0.975 . . . . 1.42 112.273 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.585 HD11 HG21 ' B' ' 66' ' ' VAL . 7.4 tt -94.0 113.17 25.11 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.783 -1.191 . . . . 0.54 107.783 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -16.43 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.205 -0.935 . . . . 1.43 110.302 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.52 ' O ' HG23 ' B' ' 66' ' ' VAL . 0.9 OUTLIER -176.35 156.69 1.62 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.642 -1.286 . . . . 1.28 110.209 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.585 HG21 HD11 ' B' ' 63' ' ' LEU . 54.1 t -160.42 131.87 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.936 -0.764 . . . . 0.9 108.936 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . 0.501 ' HB3' HD12 ' B' ' 82' ' ' LEU . 20.1 tt0 -142.48 160.23 40.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.947 0.879 . . . . 1.44 110.14 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.693 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -136.26 152.24 50.52 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.249 -1.019 . . . . 0.45 108.249 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.638 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -175.03 154.16 17.52 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.391 -2.284 . . . . 0.29 107.391 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.593 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 25.2 p -98.61 161.97 13.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.161 -1.199 . . . . 0.39 109.343 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -146.05 159.19 43.61 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.035 -1.04 . . . . 1.49 109.95 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.38 90.6 3.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.325 -0.95 . . . . 0.87 109.55 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 53.8 ttt-85 -97.02 112.03 23.98 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.107 -0.996 . . . . 2.18 109.846 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.2 t70 78.21 39.13 0.16 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.152 -0.685 . . . . 1.35 109.152 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.27 26.79 16.05 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.288 -0.634 . . . . 2.57 109.288 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -146.04 148.39 32.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.048 -1.032 . . . . 3.14 108.509 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -87.02 134.62 33.47 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.913 1.339 . . . . 2.39 112.508 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -137.76 150.18 25.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.291 -1.322 . . . . 0.58 107.542 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.25 148.99 24.88 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.165 -0.96 . . . . 0.61 109.531 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.638 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.5 p90 -140.38 149.64 42.93 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.654 0.74 . . . . 4.08 110.598 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.52 HG23 ' O ' ' B' ' 81' ' ' ILE . 10.2 tt -124.62 130.82 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 122.094 0.949 . . . . 0.9 110.463 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' B' ' 67' ' ' GLN . 12.0 mt -104.2 119.06 38.13 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.288 -1.745 . . . . 0.37 106.288 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 tt -127.98 121.67 30.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.98 110.824 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -96.5 168.69 10.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.664 0.745 . . . . 0.71 110.222 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.694 HD23 ' O ' ' B' ' 62' ' ' GLN . 2.9 mt -159.78 136.78 9.41 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.891 -0.723 . . . . 1.44 110.06 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' B' ' 62' ' ' GLN . 2.0 tmtp? -121.86 146.75 46.79 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.233 -0.655 . . . . 1.31 109.233 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . 0.517 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 15.5 mmt85 -102.15 141.8 34.42 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.277 -0.89 . . . . 1.64 110.465 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.23 -12.33 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.881 -0.785 . . . . 0.68 108.881 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 118.028 -0.987 . . . . 1.77 109.558 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.595 ' ND2' HD13 ' A' ' 26' ' ' LEU . 22.3 t30 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.436 0.636 . . . . 1.72 110.441 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 6.8 pt-20 -93.03 117.6 30.24 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.271 -0.893 . . . . 1.44 108.769 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 35' ' ' ILE . 20.6 mt -119.04 142.29 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-O 121.709 0.766 . . . . 1.11 111.598 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.556 HG22 ' CG ' ' A' ' 37' ' ' LYS . 87.8 t -109.02 128.74 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.765 0.793 . . . . 1.35 110.282 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.513 HG11 ' H ' ' A' ' 46' ' ' ALA . 2.2 p -89.25 164.11 2.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.612 -0.885 . . . . 0.39 108.612 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.437 ' HE ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -138.76 173.57 11.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.559 -0.713 . . . . 2.27 109.758 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 pttt -92.85 -9.06 41.68 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.878 -0.786 . . . . 1.78 108.878 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -91.28 -0.27 57.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.204 -1.035 . . . . 1.24 108.204 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.527 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -118.28 134.14 55.29 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.462 -1.31 . . . . 1.41 107.462 178.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -69.87 175.69 4.18 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.845 -1.159 . . . . 1.25 109.773 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.57 -31.86 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.355 -0.98 . . . . 0.49 108.355 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -74.75 -31.12 61.7 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.585 -0.846 . . . . 1.56 108.95 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -33.88 70.01 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.644 -1.285 . . . . 1.38 111.319 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.696 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.1 m80 -95.74 -19.34 19.74 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.448 -1.407 . . . . 1.43 108.487 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -36.84 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 104.523 -2.399 . . . . 0.29 104.523 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 mt -68.18 -51.27 47.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.708 -1.133 . . . . 0.41 109.009 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -67.27 -31.77 72.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.17 -0.956 . . . . 1.22 109.442 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 19' ' ' HIS . 32.5 t -68.55 -52.59 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -0.811 . . . . 0.32 108.964 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 tt -61.31 -22.43 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.166 -0.959 . . . . 0.58 109.017 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.64 -41.67 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.165 -0.959 . . . . 0.41 109.265 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.595 HD13 ' ND2' ' A' ' 6' ' ' ASN . 4.2 mt -67.83 -37.3 81.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.874 -1.142 . . . . 1.19 110.025 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 18.6 t80 -61.1 -28.26 68.96 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.994 -1.484 . . . . 1.46 106.994 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.62 -25.68 66.46 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.42 -0.809 . . . . 1.15 109.02 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -89.88 -9.36 49.25 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.509 -0.923 . . . . 1.17 108.509 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.47 14.07 10.01 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.193 -1.163 . . . . 0.42 110.193 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -75.66 107.58 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.26 . . . . 0.35 108.688 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.05 -37.66 12.66 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.418 -0.801 . . . . 1.55 109.97 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -96.89 139.92 32.21 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.401 0.62 . . . . 1.58 109.614 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.39 136.66 12.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 119.279 -0.968 . . . . 0.54 110.086 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -116.1 124.75 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.229 0.537 . . . . 0.25 110.682 -178.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.731 HD21 HG11 ' A' ' 49' ' ' VAL . 5.6 mp -104.38 116.65 32.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.971 -0.456 . . . . 0.4 109.802 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.556 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -102.56 127.29 49.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.397 -0.964 . . . . 2.74 108.397 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.423 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -142.66 157.66 26.79 Favored Glycine 0 N--CA 1.508 3.44 0 O-C-N 121.093 -1.005 . . . . 0.21 111.636 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.67 ' CG2' ' CD2' ' A' ' 80' ' ' TYR . 7.2 p -141.58 147.7 38.09 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.434 -1.039 . . . . 0.56 112.84 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.566 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 38.67 -87.28 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.617 -0.993 . . . . 0.33 110.617 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' THR . 2.9 mtp180 -82.68 -51.78 7.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.348 -1.089 . . . . 3.09 109.506 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.56 -21.47 62.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.222 -0.924 . . . . 1.09 109.028 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 40' ' ' GLY . 6.5 tt -53.83 -33.81 24.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.579 -0.7 . . . . 0.87 110.756 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.492 ' HG ' ' HG ' ' B' ' 79' ' ' SER . 0.0 OUTLIER -83.09 -23.45 33.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 1.14 108.91 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.537 ' O ' HG23 ' A' ' 49' ' ' VAL . 21.1 mmtp -65.18 -69.22 0.31 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.682 -1.97 . . . . 1.86 105.682 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.69 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -34.31 -46.43 0.26 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.216 0.532 . . . . 0.29 110.484 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' B' ' 68' ' ' THR . 56.7 t -63.53 -66.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.076 -1.015 . . . . 0.22 109.694 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 52' ' ' SER . 13.1 t0 -44.76 -44.85 9.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.561 -0.712 . . . . 1.26 109.199 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.731 HG11 HD21 ' A' ' 36' ' ' LEU . 60.5 t -50.11 -55.19 6.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.704 -0.798 . . . . 1.06 108.936 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.635 ' CD2' ' N ' ' A' ' 51' ' ' ASN . 1.1 t80 -58.5 -60.49 3.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.064 -1.022 . . . . 4.02 110.607 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.635 ' N ' ' CD2' ' A' ' 50' ' ' TYR . 9.2 t-20 -49.11 -52.61 25.0 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.985 -1.117 . . . . 1.34 107.985 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 48' ' ' ASP . 2.8 m -62.18 -39.02 91.29 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.847 -0.798 . . . . 1.04 108.847 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.786 HD23 HD13 ' A' ' 85' ' ' LEU . 12.5 tp -72.94 -24.06 60.76 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.067 -1.021 . . . . 0.44 108.884 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' TYR . 4.1 tmtt? -81.34 -39.86 24.45 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.18 -1.575 . . . . 1.0 107.227 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -52.68 -14.56 0.54 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.857 -1.164 . . . . 1.58 107.857 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.483 ' N ' ' C ' ' A' ' 54' ' ' LYS . 11.5 mmm180 -56.15 -53.51 56.21 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.035 -0.666 . . . . 1.69 109.972 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.5 tp -161.83 -3.95 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 118.93 -1.108 . . . . 1.66 109.917 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.53 -50.94 0.1 OUTLIER Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.705 -1.236 . . . . 0.39 110.392 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -71.91 -41.52 67.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.255 -1.144 . . . . 1.38 110.521 -178.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 61' ' ' VAL . . . -87.97 25.31 8.92 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.773 -1.331 . . . . 0.26 109.773 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' GLY . 43.8 t -155.27 133.6 2.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.944 -1.327 . . . . 0.38 108.29 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.741 ' O ' HD23 ' A' ' 85' ' ' LEU . 9.9 mm-40 -140.06 156.83 46.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.406 1.098 . . . . 1.31 111.966 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.51 HD11 HG21 ' A' ' 66' ' ' VAL . 6.6 tt -97.08 118.45 33.53 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.044 -0.98 . . . . 0.49 108.537 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.528 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -108.35 -17.13 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.813 -0.755 . . . . 1.35 110.37 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 64' ' ' VAL . 0.2 OUTLIER -175.5 153.42 1.48 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.411 -1.431 . . . . 1.2 110.154 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.51 HG21 HD11 ' A' ' 63' ' ' LEU . 94.2 t -159.5 133.78 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.464 -0.939 . . . . 0.85 108.464 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' LEU . 19.7 tt0 -144.11 163.05 34.7 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.265 1.031 . . . . 1.41 110.6 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.629 ' HB ' HG13 ' B' ' 47' ' ' VAL . 1.3 p -136.51 157.18 47.39 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.751 -0.833 . . . . 0.52 108.751 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.401 ' HA2' HD22 ' B' ' 51' ' ' ASN . . . -175.01 145.15 7.73 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 107.682 -2.167 . . . . 0.4 107.682 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.696 ' H ' ' ND2' ' B' ' 51' ' ' ASN . 97.3 p -94.99 160.09 14.73 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.893 -1.357 . . . . 0.42 109.356 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.12 176.63 11.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.823 -1.151 . . . . 1.29 111.118 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.451 ' H ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -90.24 131.4 37.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.503 0.668 . . . . 1.02 109.865 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 3.6 ttt85 -148.74 103.05 3.35 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.692 -0.855 . . . . 2.23 108.692 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.7 t0 87.19 36.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.062 0.458 . . . . 1.38 110.117 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 65.6 33.55 8.43 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.083 0.944 . . . . 2.62 109.363 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -158.3 155.24 28.47 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.234 -0.916 . . . . 3.15 109.723 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -86.05 137.99 32.29 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.893 -1.123 . . . . 2.44 109.982 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.481 HG21 ' CB ' ' A' ' 73' ' ' ARG . 5.5 tt -142.3 156.96 19.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-N 115.236 -0.893 . . . . 0.23 109.489 -178.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.05 151.6 23.1 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.958 0.885 . . . . 0.74 110.015 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.67 ' CD2' ' CG2' ' A' ' 39' ' ' THR . 0.4 OUTLIER -135.62 137.19 41.66 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.123 -1.066 . . . . 4.16 108.123 -178.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 81' ' ' ILE . 5.1 tt -116.68 130.38 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.542 -0.91 . . . . 0.92 108.542 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 67' ' ' GLN . 52.9 mt -110.22 120.54 42.78 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.145 -1.428 . . . . 0.36 107.145 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -127.46 128.27 45.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.161 -0.962 . . . . 0.98 111.051 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -101.23 171.4 7.63 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.948 -0.569 . . . . 0.58 109.548 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.786 HD13 HD23 ' A' ' 53' ' ' LEU . 2.2 mt -162.54 141.96 9.26 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.548 -0.861 . . . . 1.39 109.859 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -126.63 149.19 49.63 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.103 0.477 . . . . 1.42 110.593 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.459 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 17.9 mmt85 -108.06 139.99 41.89 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.627 -0.671 . . . . 1.64 110.185 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.457 ' O ' ' CG1' ' A' ' 88' ' ' VAL . 4.3 t -115.01 -6.0 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.382 -0.969 . . . . 0.63 108.382 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.48 0 CA-C-O 117.967 -1.016 . . . . 1.76 109.497 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.498 HD22 HD13 ' B' ' 26' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.24 0.543 . . . . 1.46 112.251 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 5.8 pt-20 -93.03 111.93 23.72 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.204 -1.406 . . . . 1.49 107.204 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 18.7 mt -114.12 139.29 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.607 -0.683 . . . . 1.17 109.851 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 82.9 t -102.69 126.02 56.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.704 -0.623 . . . . 1.37 109.579 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.32 163.91 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.914 -1.143 . . . . 0.37 107.914 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.2 173.98 10.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.314 -0.866 . . . . 2.37 109.899 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.526 ' N ' ' OE1' ' B' ' 42' ' ' GLU . 7.6 pttt -96.65 -9.21 29.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.951 -0.759 . . . . 1.75 108.951 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -89.72 -4.78 57.54 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.649 -0.871 . . . . 1.19 108.649 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -99.34 -131.0 0.22 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.694 -1.224 . . . . 1.47 107.694 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -166.77 163.83 16.5 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.544 -0.91 . . . . 1.22 108.544 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -63.39 -37.41 79.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.179 -1.045 . . . . 0.45 108.179 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 6.8 pt-20 -76.24 -38.03 56.9 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.75 -0.78 . . . . 1.7 109.035 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.436 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 10.4 t70 -59.41 -31.59 69.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.721 -1.237 . . . . 1.46 111.598 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.667 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.3 OUTLIER -93.41 -16.44 24.58 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.173 -1.58 . . . . 1.4 108.222 178.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.06 -34.78 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 104.784 -2.302 . . . . 0.34 104.784 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.465 ' O ' HG23 ' B' ' 25' ' ' VAL . 57.5 mt -68.81 -52.31 31.45 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.972 -1.013 . . . . 0.38 109.191 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -66.49 -29.83 70.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.19 -0.944 . . . . 1.21 109.499 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.667 HG23 ' O ' ' B' ' 19' ' ' HIS . 24.3 t -70.06 -53.39 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.845 . . . . 0.3 109.202 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 tt -62.41 -20.47 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.076 -1.015 . . . . 0.69 108.944 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 21' ' ' LEU . 6.2 t -72.1 -42.55 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.233 -0.917 . . . . 0.42 109.035 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.498 HD13 HD22 ' B' ' 6' ' ' ASN . 3.8 mt -67.01 -36.31 81.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.97 -1.081 . . . . 1.15 109.569 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.511 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 23.3 t80 -61.16 -28.23 68.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.436 -1.32 . . . . 1.46 107.436 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -26.17 67.64 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.64 -0.709 . . . . 1.17 109.195 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -90.42 -1.98 57.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.173 -0.954 . . . . 1.17 109.455 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.88 12.28 24.53 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.912 -1.275 . . . . 0.38 109.912 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 mm -76.78 106.12 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.024 -1.28 . . . . 0.59 108.545 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.85 -38.6 12.23 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.22 -0.925 . . . . 1.46 110.821 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -98.59 142.58 29.99 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.57 0.7 . . . . 1.2 110.24 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.41 137.11 11.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 119.221 -0.992 . . . . 0.49 110.802 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.61 125.63 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-N 116.089 -0.505 . . . . 0.31 110.344 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' B' ' 46' ' ' ALA . 3.7 mp -105.36 120.21 41.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.67 -0.644 . . . . 0.48 110.696 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.43 124.36 46.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.612 -0.68 . . . . 2.74 109.168 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.437 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -138.64 153.83 22.78 Favored Glycine 0 N--CA 1.51 3.592 0 O-C-N 121.041 -1.037 . . . . 0.24 111.567 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.626 ' O ' ' N ' ' B' ' 41' ' ' ARG . 3.8 p -138.38 143.9 40.03 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.551 -0.97 . . . . 0.49 112.794 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.516 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 36.26 -83.17 0.0 OUTLIER Glycine 0 N--CA 1.499 2.863 0 N-CA-C 111.15 -0.78 . . . . 0.28 111.15 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.626 ' N ' ' O ' ' B' ' 39' ' ' THR . 5.2 mtp180 -82.03 -53.19 6.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.201 -1.176 . . . . 3.16 110.072 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' B' ' 12' ' ' LYS . 1.3 pm0 -64.27 -18.39 64.52 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.55 -1.344 . . . . 1.38 109.223 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.516 HG22 ' O ' ' B' ' 40' ' ' GLY . 5.6 tt -54.4 -30.86 21.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.073 -1.017 . . . . 0.85 109.84 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -24.92 32.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 1.12 108.948 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.48 ' O ' HG23 ' B' ' 49' ' ' VAL . 17.1 mmtp -65.86 -68.59 0.36 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.621 -1.992 . . . . 1.87 105.621 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.656 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -33.21 -50.64 0.31 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 116.163 -0.472 . . . . 0.26 111.281 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.629 HG13 ' HB ' ' A' ' 68' ' ' THR . 77.8 t -65.01 -59.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.768 -1.208 . . . . 0.28 109.68 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 21.3 t0 -48.51 -47.61 38.81 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.193 -0.942 . . . . 1.25 108.666 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.573 HG11 HD21 ' B' ' 36' ' ' LEU . 88.8 t -48.61 -53.6 6.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.776 -0.769 . . . . 1.06 109.038 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.614 ' CD2' ' N ' ' B' ' 51' ' ' ASN . 0.9 OUTLIER -59.67 -56.58 20.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.244 -0.91 . . . . 4.11 111.304 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . 0.696 ' ND2' ' H ' ' A' ' 70' ' ' SER . 21.1 t-20 -54.76 -48.51 72.55 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.759 -1.2 . . . . 1.41 107.759 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 1.5 m -63.37 -39.58 94.9 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.534 -0.866 . . . . 0.65 108.92 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.806 HD23 HD13 ' B' ' 85' ' ' LEU . 10.0 tp -74.86 -26.32 59.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.53 109.04 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' B' ' 56' ' ' ARG . 5.1 tmtt? -80.28 -46.1 16.77 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.069 -1.645 . . . . 0.99 106.859 177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -49.98 -11.84 0.07 Allowed 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.353 -1.294 . . . . 1.46 108.284 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' B' ' 54' ' ' LYS . 9.1 mmm180 -54.03 -54.5 38.33 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.827 0.822 . . . . 1.71 110.297 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.0 tp -159.83 -3.78 0.07 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.622 -0.881 . . . . 1.77 108.622 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.425 ' H ' ' H ' ' B' ' 57' ' ' LEU . . . 64.69 -47.96 0.11 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.944 -1.122 . . . . 0.39 110.561 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -73.77 -43.69 58.22 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.286 -1.126 . . . . 1.4 110.398 -178.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.424 ' O ' HG23 ' B' ' 61' ' ' VAL . . . -84.34 22.87 7.87 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 109.857 -1.297 . . . . 0.34 109.857 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' B' ' 54' ' ' LYS . 39.4 t -154.49 135.44 4.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 120.872 -1.37 . . . . 0.46 108.455 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.773 ' O ' HD23 ' B' ' 85' ' ' LEU . 2.6 tp60 -140.19 155.24 47.01 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.342 1.068 . . . . 1.42 112.145 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.09 119.1 32.46 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.344 -0.844 . . . . 0.54 108.88 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.4 ' O ' ' CG ' ' B' ' 65' ' ' ASN . 0.1 OUTLIER -102.09 -28.27 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.426 -0.796 . . . . 1.43 110.972 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.437 ' O ' HG23 ' B' ' 66' ' ' VAL . 1.3 m120 -173.37 161.28 4.12 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.498 -1.377 . . . . 1.28 109.41 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.437 HG23 ' O ' ' B' ' 65' ' ' ASN . 74.1 t -159.47 132.82 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.636 -0.875 . . . . 0.9 108.636 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . 0.665 ' HB3' HD12 ' B' ' 82' ' ' LEU . 28.4 tt0 -142.46 161.74 37.27 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.988 0.899 . . . . 1.44 109.969 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.706 ' HB ' HG13 ' A' ' 47' ' ' VAL . 1.8 p -136.59 159.25 42.37 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.959 -0.756 . . . . 0.45 108.959 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.4 144.19 7.09 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 107.926 -2.07 . . . . 0.29 107.926 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.582 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 14.4 p -93.58 160.07 14.94 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.968 -1.313 . . . . 0.39 108.39 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.83 175.92 12.04 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.744 -1.182 . . . . 1.49 110.941 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.47 132.28 34.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.85 -0.74 . . . . 0.87 109.283 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.3 ttt-85 -151.73 103.24 2.92 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.556 -0.715 . . . . 2.18 109.158 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 3.7 t0 86.91 35.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.102 0.477 . . . . 1.35 109.85 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.77 29.02 8.74 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.991 0.901 . . . . 2.57 109.451 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -156.74 157.51 35.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.344 -0.848 . . . . 3.14 109.601 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -87.51 139.85 30.12 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.987 -1.085 . . . . 2.39 110.943 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 tt -142.22 158.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.571 -0.74 . . . . 0.58 109.107 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . 0.492 ' HG ' ' HG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -86.37 149.26 25.15 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.015 0.912 . . . . 0.61 110.198 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.615 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.4 OUTLIER -133.95 137.27 44.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.464 -0.939 . . . . 4.08 108.464 -179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.554 HG23 ' O ' ' B' ' 81' ' ' ILE . 5.6 tt -118.02 129.6 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.866 -0.79 . . . . 0.9 108.866 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' B' ' 67' ' ' GLN . 6.3 mt -106.9 119.27 38.9 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.703 -1.591 . . . . 0.37 106.703 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 3.7 tt -126.76 126.73 43.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.061 -1.024 . . . . 0.98 111.08 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -99.48 169.59 9.21 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.342 -0.614 . . . . 0.71 109.342 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.806 HD13 HD23 ' B' ' 53' ' ' LEU . 2.1 mt -162.44 137.55 6.97 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.802 -0.759 . . . . 1.44 109.395 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -124.97 151.6 45.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.793 -0.567 . . . . 1.31 109.492 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . 0.511 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 19.0 mmt85 -107.5 141.23 39.25 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.469 0.652 . . . . 1.64 110.275 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.489 ' O ' HG12 ' B' ' 88' ' ' VAL . 13.7 t -115.18 -6.47 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.251 -1.018 . . . . 0.68 108.251 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.022 -0.989 . . . . 1.77 109.528 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.855 ' OD1' HG23 ' A' ' 34' ' ' VAL . 1.8 t-20 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.131 -0.322 . . . . 1.72 110.131 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 112.34 23.6 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.524 -1.36 . . . . 1.44 108.166 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.623 ' CG1' HD21 ' A' ' 6' ' ' ASN . 4.8 mm -125.13 148.88 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 122.288 1.042 . . . . 1.11 111.79 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.564 HG13 ' HG2' ' A' ' 37' ' ' LYS . 66.7 t -111.94 129.82 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.537 0.684 . . . . 1.35 110.485 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.52 HG23 ' ND1' ' A' ' 19' ' ' HIS . 1.3 p -88.2 162.9 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.866 -1.161 . . . . 0.39 107.866 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.442 ' HE ' ' HE3' ' A' ' 14' ' ' LYS . 1.9 mtt-85 -131.66 167.2 19.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.344 -0.847 . . . . 2.27 110.136 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.2 pttp -87.93 -16.31 34.2 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.806 -1.183 . . . . 1.78 107.806 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -74.37 -67.5 0.62 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.542 -1.651 . . . . 1.24 106.542 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.538 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.1 mtmm -58.0 143.44 43.21 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.241 -0.912 . . . . 1.41 110.113 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -72.27 178.09 4.12 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.48 0.657 . . . . 1.25 110.342 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.511 HG21 ' OD1' ' A' ' 48' ' ' ASP . 3.7 m -72.51 -31.86 39.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.908 0.861 . . . . 0.49 108.715 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -73.77 -30.77 62.97 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.454 -0.899 . . . . 1.56 109.219 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -30.51 69.63 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 120.445 -1.409 . . . . 1.38 110.881 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.681 ' O ' HG23 ' A' ' 23' ' ' VAL . 41.0 m80 -95.33 -19.75 19.71 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.585 -1.322 . . . . 1.43 108.236 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.71 -35.63 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 104.896 -2.261 . . . . 0.29 104.896 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 25' ' ' VAL . 46.8 mt -69.04 -52.5 27.93 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.823 -1.08 . . . . 0.41 108.703 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -66.76 -26.46 66.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 1.22 109.895 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 19' ' ' HIS . 13.9 t -73.62 -53.14 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.256 -0.902 . . . . 0.32 108.804 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tt -55.39 -24.57 15.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.503 -0.925 . . . . 0.58 108.503 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 21' ' ' LEU . 41.8 t -69.25 -40.81 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.234 -0.987 . . . . 0.41 109.443 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.452 HD13 ' ND2' ' A' ' 6' ' ' ASN . 7.1 mt -65.51 -38.03 88.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.524 -1.36 . . . . 1.19 109.613 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -28.61 69.68 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.071 -1.455 . . . . 1.46 107.071 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.36 -28.43 59.09 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.29 -0.868 . . . . 1.15 108.729 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -90.43 -18.43 25.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 1.17 109.222 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.43 17.22 7.21 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.793 -1.323 . . . . 0.42 109.793 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mm -74.19 113.99 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.395 -1.062 . . . . 0.35 108.793 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -93.38 -34.59 13.41 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 119.71 -0.796 . . . . 1.55 111.366 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 4.1 mt-10 -101.81 135.88 42.6 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.625 0.726 . . . . 1.58 111.351 -177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.855 HG23 ' OD1' ' A' ' 6' ' ' ASN . 3.8 p -149.55 141.92 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.96 -0.696 . . . . 0.54 110.297 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -122.35 124.9 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 116.06 -0.518 . . . . 0.25 110.767 -178.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.8 mp -106.36 123.08 47.52 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.279 -0.568 . . . . 0.4 110.042 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HG2' HG13 ' A' ' 9' ' ' VAL . 15.8 tttt -99.75 125.73 45.69 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.29 -1.004 . . . . 2.74 108.29 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.17 142.34 13.58 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.562 -1.304 . . . . 0.21 110.827 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 41' ' ' ARG . 54.1 p -126.31 135.72 51.86 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.878 0.846 . . . . 0.56 111.908 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' A' ' 78' ' ' ILE . . . 37.97 -87.41 0.01 OUTLIER Glycine 0 N--CA 1.496 2.678 0 O-C-N 121.623 -0.673 . . . . 0.33 111.815 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -80.11 -51.77 8.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.041 -1.27 . . . . 3.09 109.901 -178.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.66 -19.28 37.85 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.611 -1.305 . . . . 1.09 107.59 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' OG ' ' A' ' 79' ' ' SER . 2.2 tt -54.51 -33.66 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.719 -0.613 . . . . 0.87 110.934 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.77 -21.92 32.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.857 -1.152 . . . . 1.14 108.615 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.533 ' NZ ' ' O ' ' A' ' 14' ' ' LYS . 22.8 mmtp -66.17 -70.43 0.24 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.368 -1.715 . . . . 1.86 106.368 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.649 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -29.46 -51.34 0.11 Allowed 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.439 0.638 . . . . 0.29 110.598 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.697 HG13 ' HB ' ' B' ' 68' ' ' THR . 89.8 t -57.86 -68.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.37 -0.831 . . . . 0.22 109.937 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.511 ' OD1' HG21 ' A' ' 16' ' ' VAL . 12.8 t70 -45.54 -48.1 14.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.716 . . . . 1.26 109.584 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.572 HG11 HD21 ' A' ' 36' ' ' LEU . 91.7 t -47.36 -58.56 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.936 -0.764 . . . . 1.06 108.936 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -61.84 -54.52 40.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.16 -0.963 . . . . 4.02 111.432 -178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.524 ' ND2' ' OG ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -53.74 -48.27 69.82 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.691 -1.256 . . . . 1.34 107.804 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.495 ' N ' ' CG ' ' A' ' 51' ' ' ASN . 22.1 p -59.43 -35.88 74.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.839 -1.171 . . . . 1.04 107.839 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.721 HD21 HH12 ' A' ' 87' ' ' ARG . 6.8 tp -79.09 -22.12 45.71 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.095 -1.076 . . . . 0.44 108.095 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.98 -43.96 21.09 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.506 -2.035 . . . . 1.0 105.506 177.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -56.05 -9.21 0.57 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.562 -1.273 . . . . 1.58 107.562 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.498 ' H ' ' C ' ' A' ' 54' ' ' LYS . 8.8 tpt180 -70.83 -49.34 47.3 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.599 0.714 . . . . 1.69 109.559 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.639 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.1 tp -153.86 -15.45 0.14 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.381 -0.928 . . . . 1.66 110.794 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 61' ' ' VAL . . . 63.27 -55.62 0.05 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.004 -1.238 . . . . 0.39 110.004 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.639 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -73.08 -40.09 65.3 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.633 -0.922 . . . . 1.38 109.496 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.522 ' H ' HD23 ' A' ' 57' ' ' LEU . . . -83.34 23.57 6.19 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 108.883 -1.687 . . . . 0.26 108.883 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.609 HG13 HD21 ' A' ' 85' ' ' LEU . 2.8 t -155.15 131.71 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.57 -1.27 . . . . 0.38 107.57 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.597 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.7 mm-40 -138.09 157.4 46.4 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.427 1.108 . . . . 1.31 111.796 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.637 HD11 HG21 ' A' ' 66' ' ' VAL . 7.5 tt -94.55 116.4 28.73 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.363 -0.835 . . . . 0.49 109.504 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -105.34 -20.97 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.323 -0.861 . . . . 1.35 109.396 179.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.59 148.61 1.98 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.232 -1.387 . . . . 1.2 110.323 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.637 HG21 HD11 ' A' ' 63' ' ' LEU . 94.9 t -157.63 134.09 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.755 -0.831 . . . . 0.85 108.755 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.568 HE21 HD13 ' B' ' 63' ' ' LEU . 2.2 tp60 -144.92 159.9 42.17 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.077 0.942 . . . . 1.41 110.667 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.54 ' HB ' HG13 ' B' ' 47' ' ' VAL . 1.2 p -135.44 151.81 50.77 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.537 -0.912 . . . . 0.52 108.537 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.69 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -176.47 157.23 22.6 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 106.512 -2.635 . . . . 0.4 106.512 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.534 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 94.4 p -99.38 161.25 13.72 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 119.051 1.426 . . . . 0.42 110.396 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -155.77 175.73 13.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.102 -0.999 . . . . 1.29 110.737 178.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.434 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.02 134.59 29.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.72 0.771 . . . . 1.02 110.799 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 25.2 ttt-85 -145.7 101.39 3.55 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.321 -0.992 . . . . 2.23 108.321 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.9 t0 85.96 36.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.224 0.535 . . . . 1.38 109.766 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.1 32.36 12.78 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.967 0.889 . . . . 2.62 109.304 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -150.57 149.84 30.43 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.66 -0.867 . . . . 3.15 108.66 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -85.73 137.38 32.85 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.482 1.134 . . . . 2.44 110.077 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.558 HD11 ' HA3' ' A' ' 40' ' ' GLY . 4.7 tt -142.9 156.52 17.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.072 -0.967 . . . . 0.23 108.778 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.483 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -87.92 155.82 19.66 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.453 -0.779 . . . . 0.74 111.145 -176.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.69 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 7.7 p90 -146.47 153.75 40.79 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.774 0.797 . . . . 4.16 110.466 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.684 HD11 HG21 ' B' ' 68' ' ' THR . 13.2 tt -125.34 132.49 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.419 0.628 . . . . 0.92 109.993 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.53 HD12 ' HB3' ' A' ' 67' ' ' GLN . 12.3 mt -106.86 120.71 42.77 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.763 -1.569 . . . . 0.36 106.763 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 tt -128.99 124.84 36.02 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.313 -0.955 . . . . 0.98 110.582 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -101.4 172.0 7.25 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.663 -0.699 . . . . 0.58 109.465 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.609 HD21 HG13 ' A' ' 61' ' ' VAL . 1.6 tp -159.42 143.03 14.68 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 118.978 -1.089 . . . . 1.39 111.135 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -118.72 142.45 47.66 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.768 -0.827 . . . . 1.42 108.768 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.721 HH12 HD21 ' A' ' 53' ' ' LEU . 16.2 tpp180 -104.16 138.81 40.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.326 -0.858 . . . . 1.64 109.726 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.85 -7.18 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.052 -0.721 . . . . 0.63 109.052 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 117.978 -1.01 . . . . 1.76 109.587 179.422 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.457 ' OD1' ' CD1' ' B' ' 26' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 111.841 0.311 . . . . 1.46 111.841 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.75 107.52 19.23 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.018 -1.676 . . . . 1.49 107.147 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.437 ' CG1' ' OD1' ' B' ' 6' ' ' ASN . 43.1 mm -122.13 141.75 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 122.06 0.933 . . . . 1.17 110.215 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.634 HG13 ' HG2' ' B' ' 37' ' ' LYS . 59.0 t -101.26 129.05 52.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.778 -0.647 . . . . 1.37 109.476 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.9 164.27 2.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.613 -1.254 . . . . 0.37 107.613 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.479 ' HE ' ' CE ' ' B' ' 14' ' ' LYS . 11.6 mtt-85 -138.21 174.55 10.44 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.844 0.831 . . . . 2.37 110.149 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -103.56 -8.56 19.95 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.014 -1.106 . . . . 1.75 108.014 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' THR . . . . . 0.417 ' H ' HG23 ' B' ' 13' ' ' THR . 0.3 OUTLIER -86.43 -14.9 41.92 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.741 -0.784 . . . . 1.19 109.616 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.479 ' CE ' ' HE ' ' B' ' 11' ' ' ARG . 0.5 OUTLIER -97.81 -118.79 0.13 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.409 -0.96 . . . . 1.47 108.409 178.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.77 170.24 9.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.1 -1.0 . . . . 1.22 108.656 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.89 -32.85 45.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.187 -1.042 . . . . 0.45 108.187 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.455 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 7.3 pt-20 -77.1 -40.42 45.99 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.792 -0.763 . . . . 1.7 109.098 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.455 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 66.4 t0 -58.45 -31.87 68.18 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.605 -1.31 . . . . 1.46 110.975 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.691 ' O ' HG23 ' B' ' 23' ' ' VAL . 17.2 m80 -91.21 -16.89 26.92 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.137 -1.602 . . . . 1.4 108.546 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.22 -34.88 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.322 -2.103 . . . . 0.34 105.322 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.526 ' O ' HG23 ' B' ' 25' ' ' VAL . 72.4 mt -67.97 -52.97 29.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.144 -0.935 . . . . 0.38 108.949 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.04 -25.88 68.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.3 -0.875 . . . . 1.21 109.755 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.691 HG23 ' O ' ' B' ' 19' ' ' HIS . 20.1 t -74.57 -52.96 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.422 -0.798 . . . . 0.3 109.282 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 tt -57.04 -24.83 21.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.562 -0.903 . . . . 0.69 108.562 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 21' ' ' LEU . 40.8 t -67.32 -41.78 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.323 -0.861 . . . . 0.42 109.248 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.457 ' CD1' ' OD1' ' B' ' 6' ' ' ASN . 4.5 mt -65.15 -39.63 93.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.681 -1.262 . . . . 1.15 109.342 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -32.02 69.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.215 -1.402 . . . . 1.46 107.215 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -30.8 54.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.769 -0.826 . . . . 1.17 108.769 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -89.54 -6.36 56.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 1.17 109.926 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.39 16.47 24.76 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.556 -1.418 . . . . 0.38 109.556 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.9 113.88 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.814 -1.18 . . . . 0.59 107.814 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -98.35 -40.4 8.33 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.37 -0.832 . . . . 1.46 112.211 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -96.11 137.59 34.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 1.2 111.307 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' B' ' 6' ' ' ASN . 5.8 p -152.52 141.17 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.985 -1.086 . . . . 0.49 111.57 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.55 128.32 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 115.589 -0.732 . . . . 0.31 110.605 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.632 HD23 ' HA ' ' B' ' 46' ' ' ALA . 1.7 mp -108.91 122.56 47.47 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.471 -0.768 . . . . 0.48 110.034 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.634 ' HG2' HG13 ' B' ' 9' ' ' VAL . 6.7 tttt -102.96 130.07 49.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.331 -0.856 . . . . 2.74 108.851 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.16 147.65 19.26 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.654 -1.26 . . . . 0.24 110.649 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.613 ' O ' ' N ' ' B' ' 41' ' ' ARG . 42.6 p -129.71 140.06 51.19 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.074 -0.662 . . . . 0.49 112.117 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.631 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 33.51 -80.78 0.0 OUTLIER Glycine 0 N--CA 1.503 3.148 0 O-C-N 121.847 -0.533 . . . . 0.28 112.325 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.0 OUTLIER -83.53 -54.04 5.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.968 -1.313 . . . . 3.16 109.45 -178.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -15.84 36.83 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.845 -1.159 . . . . 1.38 109.048 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.631 HG22 ' O ' ' B' ' 40' ' ' GLY . 10.1 tt -58.25 -26.24 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.334 -0.854 . . . . 0.85 110.027 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -26.22 22.13 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.456 -0.942 . . . . 1.12 108.456 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' B' ' 46' ' ' ALA . 23.3 mmtp -63.18 -69.64 0.26 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.167 -1.79 . . . . 1.87 106.167 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.632 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -29.71 -50.41 0.11 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 116.159 -0.473 . . . . 0.26 111.582 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.54 HG13 ' HB ' ' A' ' 68' ' ' THR . 94.7 t -62.61 -59.33 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.802 -1.186 . . . . 0.28 109.957 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ASP . . . . . 0.418 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 12.3 t70 -52.19 -51.87 55.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.141 -0.975 . . . . 1.25 108.612 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.528 HG11 HD21 ' B' ' 36' ' ' LEU . 60.4 t -41.34 -61.33 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 109.028 -0.73 . . . . 1.06 109.028 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.506 ' CD1' HD11 ' B' ' 85' ' ' LEU . 0.1 OUTLIER -62.36 -50.75 70.33 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.515 -0.74 . . . . 4.11 109.906 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . 0.534 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -50.72 -55.22 17.63 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.975 -1.12 . . . . 1.41 107.975 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.477 ' N ' ' CG ' ' B' ' 51' ' ' ASN . 0.8 OUTLIER -59.9 -35.52 75.03 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.643 -0.823 . . . . 0.65 109.256 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.598 HD21 HH12 ' B' ' 87' ' ' ARG . 8.1 tp -72.1 -24.15 61.44 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.892 -1.13 . . . . 0.53 109.417 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.07 -29.72 31.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.266 -1.521 . . . . 0.99 107.277 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.0 -13.85 13.37 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.897 -1.149 . . . . 1.46 107.897 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -71.5 -42.66 67.76 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.492 -0.883 . . . . 1.71 109.342 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.3 tp -153.95 -18.21 0.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.532 -1.267 . . . . 1.77 111.602 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 65.86 -62.88 0.13 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.365 -1.494 . . . . 0.39 109.365 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -69.64 -41.61 75.36 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.387 -1.066 . . . . 1.4 109.089 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' B' ' 87' ' ' ARG . . . -76.81 20.03 3.08 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.592 -1.403 . . . . 0.34 109.592 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.559 HG13 HD21 ' B' ' 85' ' ' LEU . 2.5 t -153.16 131.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.412 -1.329 . . . . 0.46 107.412 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' B' ' 86' ' ' LYS . 3.0 mm-40 -134.0 153.35 51.84 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.048 0.928 . . . . 1.42 112.207 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.651 HD11 HG21 ' B' ' 66' ' ' VAL . 7.6 tt -93.54 116.49 29.01 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.177 -1.045 . . . . 0.54 108.177 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.83 -25.82 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.262 -0.899 . . . . 1.43 110.206 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -172.42 151.58 2.51 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.85 -1.156 . . . . 1.28 109.284 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.651 HG21 HD11 ' B' ' 63' ' ' LEU . 96.1 t -154.53 133.82 3.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.193 -1.04 . . . . 0.9 108.193 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . 0.636 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.7 tp60 -141.11 159.84 41.37 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.769 0.795 . . . . 1.44 109.47 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.697 ' HB ' HG13 ' A' ' 47' ' ' VAL . 1.3 p -138.98 151.85 47.2 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.109 -0.7 . . . . 0.45 109.109 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.665 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -174.81 160.38 29.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.683 -1.767 . . . . 0.29 108.683 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.524 ' OG ' ' ND2' ' A' ' 51' ' ' ASN . 89.9 p -98.35 155.11 17.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.275 -1.132 . . . . 0.39 109.403 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -151.9 172.86 15.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.67 -1.269 . . . . 1.49 110.996 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.423 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -89.64 136.63 23.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.847 0.832 . . . . 0.87 110.917 -178.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 5.2 ttt-85 -148.96 100.21 3.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.973 -0.751 . . . . 2.18 108.973 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 4.7 t0 85.07 36.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.246 -0.65 . . . . 1.35 109.246 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.44 28.5 11.6 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.849 0.833 . . . . 2.57 109.328 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.54 152.04 36.15 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.826 -0.805 . . . . 3.14 108.826 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 9.6 ttm-85 -87.29 141.65 28.48 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.018 -1.073 . . . . 2.39 111.099 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.91 158.58 23.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.635 -0.876 . . . . 0.58 108.635 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.84 148.14 24.8 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.514 -0.741 . . . . 0.61 109.553 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.665 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.8 p90 -140.75 148.11 40.19 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.573 0.702 . . . . 4.08 109.948 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.511 HG23 ' O ' ' B' ' 81' ' ' ILE . 6.4 tt -123.22 131.01 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.631 0.729 . . . . 0.9 110.037 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.636 HD12 ' HB3' ' B' ' 67' ' ' GLN . 11.7 mt -105.98 123.06 47.38 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.149 -1.426 . . . . 0.37 107.149 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -132.4 125.25 30.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.028 -1.045 . . . . 0.98 110.938 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -99.83 169.66 9.08 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.802 -0.635 . . . . 0.71 109.933 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.559 HD21 HG13 ' B' ' 61' ' ' VAL . 1.6 tp -159.86 136.1 8.84 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.55 -0.86 . . . . 1.44 110.661 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 62' ' ' GLN . 7.8 tmtt? -118.36 138.3 52.52 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.52 -0.919 . . . . 1.31 108.52 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . 0.598 HH12 HD21 ' B' ' 53' ' ' LEU . 16.6 tpp180 -95.48 143.7 26.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.465 -0.772 . . . . 1.64 110.753 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.22 -13.48 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.877 -0.786 . . . . 0.68 108.877 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.303 -1.428 0 CA-C-O 117.98 -1.009 . . . . 1.77 109.534 179.781 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.674 ' OD1' HD12 ' A' ' 31' ' ' ILE . 2.4 m120 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.023 0.44 . . . . 1.72 111.329 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 7.0 pt-20 -92.09 115.58 28.19 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.989 -1.485 . . . . 1.44 106.989 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.0 mt -115.64 140.0 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-O 122.132 0.968 . . . . 1.11 111.592 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.8 124.71 62.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.986 -0.552 . . . . 1.35 109.83 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.509 HG11 ' H ' ' A' ' 46' ' ' ALA . 2.1 p -89.53 165.07 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.631 -1.248 . . . . 0.39 107.631 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -140.19 175.43 9.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.913 . . . . 2.27 109.671 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.1 pttm -101.83 -9.71 20.52 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.006 -0.739 . . . . 1.78 109.006 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 t -90.71 -7.89 51.35 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.828 -1.175 . . . . 1.24 107.828 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.15 -132.76 0.18 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.423 -1.325 . . . . 1.41 107.423 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.81 159.65 21.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.557 -1.339 . . . . 1.25 109.4 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.569 HG23 ' N ' ' A' ' 17' ' ' GLU . 16.5 m -61.66 -40.97 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-O 121.869 0.842 . . . . 0.49 109.284 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 16' ' ' VAL . 3.5 pt-20 -77.86 -32.35 52.0 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.265 -0.897 . . . . 1.56 108.871 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 52.3 t0 -62.78 -31.07 71.96 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.63 -1.294 . . . . 1.38 111.164 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.672 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.6 m-70 -95.23 -17.15 21.96 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.176 -1.578 . . . . 1.43 108.389 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -31.89 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 104.436 -2.431 . . . . 0.29 104.436 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 25' ' ' VAL . 31.6 mt -70.43 -52.85 19.27 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.32 -1.309 . . . . 0.41 109.057 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -67.38 -29.46 68.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 1.22 109.671 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 19' ' ' HIS . 25.5 t -70.03 -54.29 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.32 108.964 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 tt -60.89 -20.36 21.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.203 -0.935 . . . . 0.58 108.894 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 21' ' ' LEU . 11.0 t -72.46 -40.83 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.095 -1.003 . . . . 0.41 109.025 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.03 -36.78 80.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.784 -1.197 . . . . 1.19 109.965 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -61.73 -24.72 66.99 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.237 -1.394 . . . . 1.46 107.237 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -27.03 68.67 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.343 -0.844 . . . . 1.15 109.109 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -89.32 -2.31 58.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 1.17 109.535 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.409 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . 107.74 12.4 22.73 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.898 -1.281 . . . . 0.42 109.898 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.674 HD12 ' OD1' ' A' ' 6' ' ' ASN . 50.0 mm -76.44 106.16 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.063 -1.257 . . . . 0.35 108.927 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -92.52 -35.76 13.42 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.312 -0.867 . . . . 1.55 110.232 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -98.63 140.12 33.33 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.387 0.613 . . . . 1.58 109.608 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.47 142.85 15.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 119.188 -1.005 . . . . 0.54 110.221 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.2 127.33 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.987 -0.551 . . . . 0.25 110.477 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.8 mp -111.71 118.37 35.43 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.501 0.667 . . . . 0.4 109.322 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.32 134.36 49.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.667 -0.864 . . . . 2.74 108.667 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.5 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -145.14 157.28 27.29 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 120.036 -1.078 . . . . 0.21 111.155 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 41' ' ' ARG . 14.9 p -139.0 146.92 41.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.466 -1.02 . . . . 0.56 112.664 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.526 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 39.76 -86.92 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.628 -0.989 . . . . 0.33 110.628 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -85.23 -51.86 6.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.32 -1.106 . . . . 3.09 109.682 -178.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -25.51 60.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.819 -1.176 . . . . 1.09 108.895 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 40' ' ' GLY . 7.0 tt -49.74 -36.37 11.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.552 -0.717 . . . . 0.87 110.83 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.45 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -83.54 -23.57 32.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.007 -1.058 . . . . 1.14 108.989 -178.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 46' ' ' ALA . 7.8 mmtt -62.29 -70.7 0.18 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 104.497 -2.409 . . . . 1.86 104.497 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.637 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -31.47 -49.63 0.16 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.17 0.51 . . . . 0.29 110.576 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.7 HG13 ' HB ' ' B' ' 68' ' ' THR . 97.4 t -59.37 -69.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.225 -0.922 . . . . 0.22 109.549 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 52' ' ' SER . 3.6 t0 -45.81 -49.04 15.54 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.52 -0.738 . . . . 1.26 109.563 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.485 HG11 HD21 ' A' ' 36' ' ' LEU . 70.4 t -48.14 -59.64 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.646 -0.822 . . . . 1.06 109.105 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -60.06 -53.45 57.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 4.02 110.228 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.602 ' CG ' ' H ' ' B' ' 70' ' ' SER . 0.5 OUTLIER -52.48 -49.82 63.95 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.662 -1.236 . . . . 1.34 107.662 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 49' ' ' VAL . 21.0 p -62.07 -35.04 77.45 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.73 -0.841 . . . . 1.04 108.73 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.474 HD23 ' CD2' ' A' ' 85' ' ' LEU . 7.5 tp -77.34 -22.38 51.94 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.065 -1.022 . . . . 0.44 108.737 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' C ' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -79.89 -42.5 24.04 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.172 -1.58 . . . . 1.0 106.858 177.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.49 -16.11 0.1 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.783 -1.099 . . . . 1.58 108.051 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.506 ' N ' ' C ' ' A' ' 54' ' ' LYS . 12.2 mmm180 -59.31 -55.7 31.49 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.356 0.598 . . . . 1.69 110.251 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 mt -159.16 0.58 0.09 Allowed 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 118.689 -1.204 . . . . 1.66 110.595 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 61' ' ' VAL . . . 64.92 -58.52 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.527 -1.321 . . . . 0.39 110.209 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -70.96 -41.98 70.36 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.495 -1.003 . . . . 1.38 110.49 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.49 17.64 3.24 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.414 -1.475 . . . . 0.26 109.414 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.681 HG13 HD21 ' A' ' 85' ' ' LEU . 2.4 t -155.94 127.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.785 -1.191 . . . . 0.38 107.785 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.6 mm-40 -132.94 157.51 44.96 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.176 0.988 . . . . 1.31 111.375 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.724 HD11 HG21 ' A' ' 66' ' ' VAL . 8.3 tt -96.05 112.6 24.29 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.072 -0.714 . . . . 0.49 109.072 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -20.86 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 1.35 110.001 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.477 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -167.86 153.23 7.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.18 -1.575 . . . . 1.2 109.784 177.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.724 HG21 HD11 ' A' ' 63' ' ' LEU . 70.3 t -159.65 129.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.463 -0.773 . . . . 0.85 109.457 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 82' ' ' LEU . 12.9 tt0 -146.06 164.79 31.03 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.285 1.04 . . . . 1.41 110.902 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.613 HG22 ' HA ' ' A' ' 81' ' ' ILE . 1.6 p -139.27 158.06 44.82 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.894 -0.78 . . . . 0.52 108.894 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 80' ' ' TYR . . . -174.55 147.38 9.12 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 107.195 -2.362 . . . . 0.4 107.195 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.587 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 87.4 p -93.45 163.05 13.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.662 -1.493 . . . . 0.42 110.175 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -147.85 159.88 43.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.237 -0.914 . . . . 1.29 110.648 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.17 87.71 2.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 118.991 -1.084 . . . . 1.02 109.226 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 46.1 ttt-85 -96.11 111.19 23.3 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.963 -1.086 . . . . 2.23 110.301 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.0 t70 80.64 37.25 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.888 -0.507 . . . . 1.38 110.178 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.46 28.86 15.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.397 -0.815 . . . . 2.62 109.129 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.26 146.14 28.51 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.083 -1.011 . . . . 3.15 108.776 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.695 ' NH2' HD21 ' B' ' 51' ' ' ASN . 5.5 tpt180 -84.46 133.23 34.49 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.779 1.276 . . . . 2.44 111.256 -177.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.462 HD11 ' HA3' ' A' ' 40' ' ' GLY . 13.5 tt -141.34 155.72 21.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.436 -1.256 . . . . 0.23 108.831 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.55 151.71 23.24 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.139 0.971 . . . . 0.74 111.305 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.5 ' CD1' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -131.45 135.5 47.18 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.455 -0.943 . . . . 4.16 108.455 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.613 ' HA ' HG22 ' A' ' 68' ' ' THR . 2.8 tt -117.11 126.79 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.168 -1.049 . . . . 0.92 108.168 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' GLN . 16.8 mt -107.5 121.06 43.86 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.311 -1.366 . . . . 0.36 107.311 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 tt -131.89 126.12 33.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.035 . . . . 0.98 111.123 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -100.56 171.61 7.62 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.784 -0.644 . . . . 0.58 109.985 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 61' ' ' VAL . 1.4 tp -159.49 142.38 14.07 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.112 -1.035 . . . . 1.39 110.72 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.59 ' O ' ' N ' ' A' ' 62' ' ' GLN . 13.7 tmtt? -121.85 141.21 51.48 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 116.073 -0.512 . . . . 1.42 110.442 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.1 mmt-85 -99.21 137.24 38.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.099 -1.001 . . . . 1.64 109.705 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.31 -0.79 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.537 -0.912 . . . . 0.63 108.537 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 t80 . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 118.028 -0.987 . . . . 1.76 109.53 179.524 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.442 0.639 . . . . 1.46 110.792 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.7 pt-20 -93.4 117.62 30.3 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.303 -0.999 . . . . 1.49 108.303 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 45.5 mt -113.23 133.9 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.741 0.782 . . . . 1.17 110.574 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -98.7 123.02 51.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.361 0.6 . . . . 1.37 109.703 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.421 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.4 OUTLIER -88.92 165.38 2.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.163 -1.051 . . . . 0.37 108.163 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.448 ' HE ' ' HE3' ' B' ' 14' ' ' LYS . 26.9 mtt-85 -141.79 175.33 9.79 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.431 -0.793 . . . . 2.37 109.747 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -102.53 -9.09 20.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.38 -0.97 . . . . 1.75 108.38 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -84.79 -14.49 47.99 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.478 -0.889 . . . . 1.19 109.614 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.448 ' HE3' ' HE ' ' B' ' 11' ' ' ARG . 12.7 mttm -94.95 -118.25 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.18 -0.95 . . . . 1.47 108.944 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.5 168.6 9.29 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.396 -0.815 . . . . 1.22 109.06 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.517 HG23 ' N ' ' B' ' 17' ' ' GLU . 15.1 m -68.25 -38.4 79.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.881 0.848 . . . . 0.45 109.097 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.517 ' N ' HG23 ' B' ' 16' ' ' VAL . 8.0 pt-20 -76.7 -31.46 57.22 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.024 -1.048 . . . . 1.7 109.51 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -32.28 72.6 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.453 -1.404 . . . . 1.46 111.268 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.66 ' O ' HG23 ' B' ' 23' ' ' VAL . 3.1 m-70 -94.96 -16.81 22.49 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.335 -1.478 . . . . 1.4 108.409 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.15 -35.21 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 104.538 -2.393 . . . . 0.34 104.538 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.57 ' O ' HG23 ' B' ' 25' ' ' VAL . 43.7 mt -68.93 -49.07 61.29 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.649 -1.16 . . . . 0.38 109.011 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -70.25 -32.06 69.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.153 -0.967 . . . . 1.21 109.536 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.66 HG23 ' O ' ' B' ' 19' ' ' HIS . 25.0 t -68.11 -52.53 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.3 109.165 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 tt -62.19 -23.31 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.217 -0.927 . . . . 0.69 108.883 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.57 HG23 ' O ' ' B' ' 21' ' ' LEU . 11.3 t -69.88 -39.91 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.111 -0.993 . . . . 0.42 109.27 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -68.71 -38.76 80.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.758 -1.214 . . . . 1.15 109.822 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.2 -27.64 65.91 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.81 -1.552 . . . . 1.46 106.81 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -25.25 68.28 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.235 -0.893 . . . . 1.17 109.143 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -91.64 0.62 57.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 1.17 109.351 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.25 25.8 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.034 -1.226 . . . . 0.38 110.034 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -78.08 108.49 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.931 -1.335 . . . . 0.59 108.393 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.7 OUTLIER -94.38 -37.97 11.2 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.409 -0.807 . . . . 1.46 110.642 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -100.38 139.03 36.63 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.714 -0.616 . . . . 1.2 110.046 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.75 142.93 16.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.089 -1.044 . . . . 0.49 111.234 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.85 124.79 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-N 115.889 -0.596 . . . . 0.31 110.405 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' B' ' 46' ' ' ALA . 2.8 mp -103.19 114.21 28.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.305 -0.872 . . . . 0.48 109.848 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -98.66 122.97 42.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 2.74 109.761 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.507 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -137.59 153.33 22.01 Favored Glycine 0 N--CA 1.505 3.266 0 C-N-CA 119.86 -1.162 . . . . 0.24 111.357 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.61 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 1.4 p -139.79 147.28 40.56 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 122.174 0.987 . . . . 0.49 112.949 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.531 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 36.93 -87.62 0.01 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.632 -0.987 . . . . 0.28 110.632 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -82.63 -52.77 6.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -1.084 . . . . 3.16 109.503 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -19.48 54.24 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.901 -1.124 . . . . 1.38 109.224 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.531 HG22 ' O ' ' B' ' 40' ' ' GLY . 6.6 tt -54.58 -28.61 19.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.267 -0.896 . . . . 0.85 109.618 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.98 -26.83 26.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.12 108.921 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.452 ' O ' ' C ' ' B' ' 46' ' ' ALA . 9.9 mmtt -64.0 -69.62 0.27 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.819 -1.919 . . . . 1.87 105.819 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.648 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -32.42 -49.69 0.22 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 116.123 -0.49 . . . . 0.26 111.166 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.583 HG13 ' HB ' ' A' ' 68' ' ' THR . 69.9 t -66.91 -62.74 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.73 -1.231 . . . . 0.28 109.884 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ASP . . . . . 0.438 ' O ' ' OG ' ' B' ' 52' ' ' SER . 7.5 t0 -48.22 -52.57 20.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 1.25 108.646 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 54.2 t -44.42 -55.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.722 -0.844 . . . . 1.06 108.722 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' B' ' 54' ' ' LYS . 0.1 OUTLIER -63.97 -51.89 62.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.542 -0.724 . . . . 4.11 110.503 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . 0.695 HD21 ' NH2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -53.25 -51.08 63.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.311 -1.366 . . . . 1.41 107.311 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 3.8 p -59.18 -36.73 75.84 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.564 -0.902 . . . . 0.65 108.564 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.473 ' O ' ' CG ' ' B' ' 56' ' ' ARG . 5.4 tp -77.13 -24.06 51.7 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.211 -0.931 . . . . 0.53 109.069 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . 0.531 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -81.78 -44.57 16.81 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 119.843 -1.786 . . . . 0.99 107.286 178.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' B' ' 55' ' ' ASP . 1.4 t0 -50.88 -11.22 0.08 Allowed 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.171 -1.377 . . . . 1.46 107.88 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.531 ' N ' ' C ' ' B' ' 54' ' ' LYS . 9.3 mmm180 -56.96 -57.25 13.36 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.119 0.961 . . . . 1.71 110.352 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.0 OUTLIER -156.53 -1.92 0.12 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.137 -1.061 . . . . 1.77 108.137 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.0 -52.93 0.1 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.011 -1.09 . . . . 0.39 110.427 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -72.51 -45.44 59.36 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.473 -1.016 . . . . 1.4 110.329 -178.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.417 ' O ' HG23 ' B' ' 61' ' ' VAL . . . -71.93 21.08 0.82 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 109.395 -1.482 . . . . 0.34 109.395 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.651 HG13 HD21 ' B' ' 85' ' ' LEU . 2.5 t -156.65 130.76 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.032 -1.275 . . . . 0.46 107.894 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.5 mm-40 -132.92 150.11 52.19 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.029 0.919 . . . . 1.42 111.695 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.667 ' C ' HD23 ' B' ' 63' ' ' LEU . 7.0 tt -94.23 114.83 27.0 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.84 -1.17 . . . . 0.54 107.84 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.36 -11.77 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.419 -0.801 . . . . 1.43 110.729 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' B' ' 84' ' ' ARG . 0.5 OUTLIER -175.57 146.42 0.77 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.343 -1.473 . . . . 1.28 109.655 178.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.661 HG21 HD11 ' B' ' 63' ' ' LEU . 87.2 t -156.79 134.29 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.507 -0.746 . . . . 0.9 109.038 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . 0.667 ' HB3' HD12 ' B' ' 82' ' ' LEU . 23.6 tt0 -146.28 162.87 37.16 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.133 0.968 . . . . 1.44 110.943 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.7 ' HB ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -126.74 164.86 20.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.303 -0.999 . . . . 0.45 108.303 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.55 136.85 3.05 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.024 -1.63 . . . . 0.29 109.024 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.602 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 51.8 p -94.36 156.81 16.32 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.185 -1.185 . . . . 0.39 108.231 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.83 173.09 17.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.805 -1.184 . . . . 1.49 110.605 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 t -89.54 137.75 20.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.805 -0.813 . . . . 0.87 108.805 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 27.3 ttt-85 -149.67 103.47 3.25 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.098 -1.075 . . . . 2.18 108.098 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.3 t70 82.22 34.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.434 -0.95 . . . . 1.35 108.434 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 66.45 25.84 10.15 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.727 0.775 . . . . 2.57 109.12 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -147.32 152.22 37.87 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.412 -0.805 . . . . 3.14 108.995 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.503 ' NH2' HD21 ' A' ' 51' ' ' ASN . 3.5 ttt180 -88.08 138.71 31.21 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.598 1.19 . . . . 2.39 112.253 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.01 156.41 22.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.016 -1.105 . . . . 0.58 108.016 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 2.8 m -86.68 151.52 23.34 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.203 -0.935 . . . . 0.61 110.372 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.61 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.2 OUTLIER -133.32 133.95 43.2 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.133 -1.062 . . . . 4.08 108.133 -178.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.532 HG23 ' O ' ' B' ' 81' ' ' ILE . 3.5 tt -116.06 128.79 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.872 -0.788 . . . . 0.9 108.872 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' B' ' 67' ' ' GLN . 4.4 mt -106.64 118.44 36.67 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.631 -1.618 . . . . 0.37 106.631 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tt -128.18 124.47 36.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.98 110.317 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' B' ' 65' ' ' ASN . 23.0 ttt180 -99.96 170.76 8.29 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.443 0.64 . . . . 0.71 109.965 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.651 HD21 HG13 ' B' ' 61' ' ' VAL . 1.5 tp -162.47 127.56 3.28 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.363 -0.935 . . . . 1.44 110.783 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 62' ' ' GLN . 12.6 tmtt? -109.1 148.65 30.5 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.199 -0.667 . . . . 1.31 109.199 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 29.3 mmt-85 -101.18 141.81 33.53 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.276 -0.89 . . . . 1.64 110.416 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.74 -7.79 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.032 -0.729 . . . . 0.68 109.032 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 13.5 t80 . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 117.973 -1.013 . . . . 1.77 109.54 179.438 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.851 ' ND2' HG23 ' A' ' 34' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.898 -0.408 . . . . 1.72 109.898 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 4.4 pt-20 -91.26 119.11 31.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.454 -1.404 . . . . 1.44 108.793 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.462 ' CG1' ' OD1' ' A' ' 6' ' ' ASN . 2.7 mt -129.76 145.99 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 CA-C-O 122.242 1.02 . . . . 1.11 111.732 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 37' ' ' LYS . 3.7 t -107.96 130.27 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.585 0.707 . . . . 1.35 109.632 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.408 HG11 ' H ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -88.47 162.98 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.244 -1.021 . . . . 0.39 108.244 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.23 175.01 9.99 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.276 1.036 . . . . 2.27 111.216 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' H ' ' HG3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -101.91 -12.47 18.2 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.086 -1.079 . . . . 1.78 108.086 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.587 ' C ' ' HZ3' ' A' ' 14' ' ' LYS . 30.0 p -86.42 -15.35 40.58 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.828 -0.749 . . . . 1.24 109.437 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HZ3' ' C ' ' A' ' 13' ' ' THR . 4.9 mmpm? -91.71 -123.55 0.08 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.118 -0.989 . . . . 1.41 108.841 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.49 167.09 13.95 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.887 -1.153 . . . . 1.25 107.887 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 16' ' ' VAL . 1.5 m -68.06 -30.12 46.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.897 -1.149 . . . . 0.49 107.897 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.5 pt-20 -79.46 -37.85 35.95 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.504 -0.878 . . . . 1.56 109.328 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -58.29 -33.23 69.21 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 120.146 -1.596 . . . . 1.38 110.899 -179.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.638 ' O ' HG23 ' A' ' 23' ' ' VAL . 70.4 m-70 -91.74 -16.87 26.25 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 120.379 -1.451 . . . . 1.43 108.922 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.56 -32.73 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 105.294 -2.113 . . . . 0.29 105.294 176.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 25' ' ' VAL . 65.9 mt -70.36 -56.15 7.38 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.228 -0.896 . . . . 0.41 109.517 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -64.79 -27.47 68.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 1.22 110.26 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 19' ' ' HIS . 38.8 t -73.25 -50.26 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.235 -0.915 . . . . 0.32 109.262 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 tt -64.52 -18.13 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.203 -0.935 . . . . 0.58 108.675 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 21' ' ' LEU . 9.0 t -74.95 -44.62 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.293 -0.879 . . . . 0.41 108.835 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -67.15 -31.95 72.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.008 -1.057 . . . . 1.19 110.147 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.596 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 15.6 t80 -65.36 -24.87 67.35 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.225 -1.398 . . . . 1.46 107.225 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -64.01 -27.32 69.04 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.36 -0.836 . . . . 1.15 109.318 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -89.41 -2.42 58.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.996 -1.065 . . . . 1.17 109.317 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.17 15.8 13.6 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.088 -1.205 . . . . 0.42 110.088 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -79.54 105.98 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.02 -1.282 . . . . 0.35 108.566 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -94.41 -37.77 11.28 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.337 -0.852 . . . . 1.55 110.482 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 3.4 mt-10 -95.08 135.27 36.84 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.297 -0.877 . . . . 1.58 109.697 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.851 HG23 ' ND2' ' A' ' 6' ' ' ASN . 2.8 p -149.14 138.55 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.329 -0.948 . . . . 0.54 110.466 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.99 127.64 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 115.911 -0.586 . . . . 0.25 110.865 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.2 mp -112.75 122.28 47.21 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.291 -0.633 . . . . 0.4 109.291 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -106.76 136.98 45.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.442 -0.947 . . . . 2.74 108.442 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.34 156.68 26.26 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 119.501 -1.333 . . . . 0.21 111.32 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.671 ' O ' ' N ' ' A' ' 41' ' ' ARG . 43.4 p -134.02 142.84 47.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.907 -0.76 . . . . 0.56 112.151 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.565 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 35.49 -77.19 0.0 OUTLIER Glycine 0 N--CA 1.503 3.122 0 CA-C-O 121.346 0.415 . . . . 0.33 112.182 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.671 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -87.11 -58.37 2.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.249 . . . . 3.09 109.429 -179.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -20.91 21.72 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.1 -1.0 . . . . 1.09 108.933 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 40' ' ' GLY . 8.4 tt -53.65 -33.84 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.152 -0.967 . . . . 0.87 111.046 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.14 -24.48 24.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.727 -1.233 . . . . 1.14 108.499 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -58.39 -67.7 0.33 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.206 -2.146 . . . . 1.86 105.206 177.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.561 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -34.32 -48.01 0.32 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 120.998 0.428 . . . . 0.29 110.556 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.661 HG13 ' HB ' ' B' ' 68' ' ' THR . 97.1 t -60.62 -64.93 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.034 -1.041 . . . . 0.22 109.343 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -46.53 -51.81 14.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.436 -0.95 . . . . 1.26 108.436 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.467 HG11 HD21 ' A' ' 36' ' ' LEU . 74.5 t -46.93 -57.34 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.875 -1.157 . . . . 1.06 107.875 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -58.35 -57.5 12.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.401 -0.812 . . . . 4.02 110.598 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.544 ' CG ' ' H ' ' B' ' 70' ' ' SER . 1.1 t30 -51.76 -53.44 39.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.899 -1.148 . . . . 1.34 107.899 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.9 p -59.4 -39.03 82.1 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.434 -0.906 . . . . 1.04 109.101 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.445 HD22 HG11 ' A' ' 23' ' ' VAL . 38.0 tp -75.53 -24.33 56.74 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.993 -1.067 . . . . 0.44 109.023 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' TYR . 5.9 tmtt? -80.88 -40.97 23.87 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.738 -1.949 . . . . 1.0 105.738 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -57.92 -7.18 0.69 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.331 -1.304 . . . . 1.58 107.817 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.4 tpt180 -71.59 -46.07 60.35 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.624 0.726 . . . . 1.69 110.067 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 mt -154.44 -19.47 0.13 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.777 -0.769 . . . . 1.66 109.657 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.79 -50.34 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.321 -1.112 . . . . 0.39 110.321 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -74.54 -41.73 60.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.347 -1.09 . . . . 1.38 109.94 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.25 25.05 7.34 Favored Glycine 0 N--CA 1.48 1.62 0 N-CA-C 109.273 -1.531 . . . . 0.26 109.273 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.562 HG13 HD21 ' A' ' 85' ' ' LEU . 4.0 t -151.97 119.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 106.943 -1.503 . . . . 0.38 106.943 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.1 mm100 -126.58 159.64 32.95 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.096 0.95 . . . . 1.31 111.604 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.709 HD11 HG21 ' A' ' 66' ' ' VAL . 8.4 tt -94.67 116.69 29.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.923 -0.769 . . . . 0.49 108.923 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -22.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.212 -0.93 . . . . 1.35 109.482 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.459 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -172.04 154.01 3.33 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.76 -1.176 . . . . 1.2 109.741 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.709 HG21 HD11 ' A' ' 63' ' ' LEU . 77.7 t -159.46 130.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.41 -0.959 . . . . 0.85 108.41 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -141.38 162.0 36.53 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.985 0.898 . . . . 1.41 109.945 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.57 148.77 51.64 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.84 -0.8 . . . . 0.52 108.84 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.637 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -172.04 155.35 23.53 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.602 -1.799 . . . . 0.4 108.602 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.578 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 83.2 p -100.48 156.85 17.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.188 -1.184 . . . . 0.42 109.907 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -144.18 160.27 41.22 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.085 -1.009 . . . . 1.29 110.278 179.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.43 91.07 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.808 -0.757 . . . . 1.02 111.141 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 9.0 ttt85 -96.07 107.84 20.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.064 -1.023 . . . . 2.23 110.18 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.8 t0 84.08 36.22 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.127 0.489 . . . . 1.38 110.263 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.478 HH11 ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER 62.6 29.82 16.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.378 -0.826 . . . . 2.62 108.794 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -145.09 144.09 30.76 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.022 -1.103 . . . . 3.15 108.022 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -84.25 136.28 34.0 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.822 1.296 . . . . 2.44 110.84 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.0 tt -143.91 155.79 15.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-N 114.316 -1.311 . . . . 0.23 108.156 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 p -90.49 154.35 19.7 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 121.356 -0.84 . . . . 0.74 111.43 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.637 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.8 p90 -143.56 150.91 39.54 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.81 0.814 . . . . 4.16 109.702 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 81' ' ' ILE . 6.0 tt -124.51 133.61 68.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.724 0.773 . . . . 0.92 109.582 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.2 mt -107.8 128.58 54.72 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.663 -1.236 . . . . 0.36 107.663 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 tt -137.13 127.43 26.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.976 -1.077 . . . . 0.98 111.519 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -104.9 166.36 10.44 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.681 -0.69 . . . . 0.58 110.295 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.562 HD21 HG13 ' A' ' 61' ' ' VAL . 4.7 tp -157.87 137.01 11.66 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.437 -0.905 . . . . 1.39 111.458 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -117.31 137.11 52.64 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.727 -0.471 . . . . 1.42 109.727 178.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 16.9 mmt85 -94.17 144.49 25.46 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.212 -0.93 . . . . 1.64 109.721 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 88' ' ' VAL . 27.1 t -123.63 -6.5 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.909 -0.774 . . . . 0.63 108.909 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 118.049 -0.976 . . . . 1.76 109.51 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.698 HD21 HD13 ' B' ' 26' ' ' LEU . 1.1 t30 . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.361 0.124 . . . . 1.46 110.887 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.1 pt-20 -92.06 105.12 17.43 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.183 -1.573 . . . . 1.49 108.032 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.642 HD11 HD22 ' B' ' 6' ' ' ASN . 4.0 mt -116.33 135.05 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.698 0.761 . . . . 1.17 109.954 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.646 HG13 ' HB2' ' B' ' 37' ' ' LYS . 11.9 t -97.79 127.72 49.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.508 0.671 . . . . 1.37 109.483 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.495 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -88.33 160.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.946 -1.131 . . . . 0.37 107.946 -179.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 172.25 12.97 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.934 0.873 . . . . 2.37 110.538 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.99 -13.02 39.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.705 -0.85 . . . . 1.75 108.705 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 47.8 p -76.86 -70.27 0.47 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.885 -1.524 . . . . 1.19 106.885 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 139.9 33.93 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.386 -0.821 . . . . 1.47 110.148 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -72.84 178.59 4.14 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.473 0.654 . . . . 1.22 109.843 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.11 -29.25 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.92 0.866 . . . . 0.45 108.795 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 13.0 pt-20 -74.62 -39.15 62.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.607 -0.886 . . . . 1.7 108.607 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 17.4 t0 -57.16 -29.54 63.72 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.088 -1.008 . . . . 1.46 111.375 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.687 ' O ' HG23 ' B' ' 23' ' ' VAL . 52.4 m-70 -94.83 -19.51 20.26 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 119.977 -1.702 . . . . 1.4 107.946 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -35.81 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 105.069 -2.197 . . . . 0.34 105.069 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.488 ' O ' HG23 ' B' ' 25' ' ' VAL . 68.9 mt -69.14 -51.92 33.38 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.204 -0.907 . . . . 0.38 108.732 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -66.78 -30.73 71.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 1.21 110.126 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.687 HG23 ' O ' ' B' ' 19' ' ' HIS . 42.2 t -71.71 -55.12 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.142 -0.974 . . . . 0.3 109.41 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 tt -58.67 -21.97 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.69 108.982 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 21' ' ' LEU . 5.6 t -71.12 -39.86 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.179 -0.951 . . . . 0.42 108.95 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.698 HD13 HD21 ' B' ' 6' ' ' ASN . 4.9 mt -68.44 -44.98 73.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 1.15 109.942 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.582 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 18.4 t80 -54.42 -27.5 37.36 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.29 -1.374 . . . . 1.46 107.29 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -62.76 -24.92 67.95 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.533 -0.758 . . . . 1.17 109.575 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -91.6 -4.38 55.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.917 -1.114 . . . . 1.17 109.083 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.16 14.13 14.01 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.429 -1.468 . . . . 0.38 109.429 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.448 HG21 ' CG ' ' B' ' 6' ' ' ASN . 32.6 mm -78.83 102.18 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.006 -1.291 . . . . 0.59 108.666 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.15 -35.03 14.79 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.278 -0.889 . . . . 1.46 111.517 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.68 135.42 44.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.382 -0.824 . . . . 1.2 110.471 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.59 142.5 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.305 -0.958 . . . . 0.49 111.707 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.86 123.42 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 121.204 0.526 . . . . 0.31 111.012 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.646 HD23 ' HA ' ' B' ' 46' ' ' ALA . 3.3 mp -102.5 121.89 43.26 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.439 -0.788 . . . . 0.48 110.141 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.646 ' HB2' HG13 ' B' ' 9' ' ' VAL . 4.0 mttt -103.01 128.56 49.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.223 -0.923 . . . . 2.74 109.214 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.91 150.95 21.12 Favored Glycine 0 N--CA 1.502 3.099 0 C-N-CA 119.366 -1.397 . . . . 0.24 111.667 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.591 ' O ' ' N ' ' B' ' 41' ' ' ARG . 81.8 p -131.88 139.5 48.81 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.826 -0.808 . . . . 0.49 112.174 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.451 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 35.79 -83.58 0.0 OUTLIER Glycine 0 N--CA 1.502 3.092 0 O-C-N 121.694 -0.629 . . . . 0.28 111.983 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.69 ' HE ' ' N ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -81.23 -54.61 5.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.084 -1.245 . . . . 3.16 109.388 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.26 -20.55 43.22 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.155 -0.965 . . . . 1.38 108.431 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.451 HG22 ' O ' ' B' ' 40' ' ' GLY . 3.7 tt -55.25 -33.55 30.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.049 -1.032 . . . . 0.85 110.301 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -22.65 32.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.035 -1.04 . . . . 1.12 108.858 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' B' ' 46' ' ' ALA . 0.0 OUTLIER -64.85 -68.73 0.34 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.533 -1.655 . . . . 1.87 106.533 177.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.646 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -37.23 -46.15 0.7 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.378 0.608 . . . . 0.26 110.272 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 43' ' ' ILE . 74.0 t -60.79 -66.3 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.185 -0.947 . . . . 0.28 109.132 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ASP . . . . . 0.438 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 26.8 t0 -48.23 -46.6 35.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.919 . . . . 1.25 108.848 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.608 HG11 HD21 ' B' ' 36' ' ' LEU . 75.0 t -47.87 -54.91 3.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.011 -1.107 . . . . 1.06 108.011 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.473 ' CE1' HD11 ' B' ' 85' ' ' LEU . 1.3 t80 -59.47 -60.67 3.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 4.11 110.611 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . 0.578 ' CG ' ' H ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -48.13 -54.79 12.09 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.276 -0.89 . . . . 1.41 108.599 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.438 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 0.7 OUTLIER -60.25 -38.3 83.03 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.377 -0.929 . . . . 0.65 109.378 -179.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.477 HD22 HG11 ' B' ' 23' ' ' VAL . 24.2 tp -73.32 -26.9 61.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.938 . . . . 0.53 109.276 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' B' ' 56' ' ' ARG . 1.6 tmtt? -75.03 -50.91 14.95 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.674 -1.602 . . . . 0.99 106.674 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.41 -17.96 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.053 -1.43 . . . . 1.46 109.479 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' B' ' 54' ' ' LYS . 12.7 mmm180 -69.17 -38.44 78.72 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.13 -1.028 . . . . 1.71 109.845 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.6 mt -155.39 -13.13 0.11 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.091 -1.444 . . . . 1.77 112.216 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.93 -67.81 0.05 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.228 -1.463 . . . . 0.39 110.187 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.17 -35.71 76.59 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.407 -1.055 . . . . 1.4 109.919 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.27 22.37 6.25 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.385 -1.486 . . . . 0.34 109.385 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.603 HG13 HD21 ' B' ' 85' ' ' LEU . 7.2 t -153.84 130.29 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.187 -1.184 . . . . 0.46 107.872 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.5 mm100 -133.11 155.54 49.08 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.306 1.051 . . . . 1.42 111.977 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.611 HD11 HG21 ' B' ' 66' ' ' VAL . 8.4 tt -94.85 118.97 32.65 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.517 -0.92 . . . . 0.54 108.517 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.97 -14.94 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.399 -0.813 . . . . 1.43 109.906 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.475 ' O ' HG23 ' B' ' 66' ' ' VAL . 1.2 m-80 -177.53 152.07 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.732 -1.23 . . . . 1.28 109.906 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.611 HG21 HD11 ' B' ' 63' ' ' LEU . 74.8 t -160.05 134.31 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.759 -0.83 . . . . 0.9 108.759 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . 0.422 ' HB3' HD12 ' B' ' 82' ' ' LEU . 32.1 tt0 -145.59 162.42 37.51 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.123 0.963 . . . . 1.44 110.973 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.661 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -136.66 154.69 50.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.416 -0.957 . . . . 0.45 108.416 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.656 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -177.98 155.9 18.26 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 107.443 -2.263 . . . . 0.29 107.443 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.544 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 90.7 p -94.03 156.74 16.44 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.055 -1.262 . . . . 0.39 108.959 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.419 ' OE1' ' C ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -147.0 164.71 32.12 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.939 -1.101 . . . . 1.49 110.141 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.419 ' C ' ' OE1' ' B' ' 71' ' ' GLU . 2.1 t -91.14 136.46 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 120.023 -0.671 . . . . 0.87 110.002 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 0.0 OUTLIER -148.51 106.66 3.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.416 -0.957 . . . . 2.18 108.416 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.8 t0 79.74 35.53 0.15 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.258 -1.015 . . . . 1.35 108.258 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.72 31.85 11.62 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.845 0.831 . . . . 2.57 109.169 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -150.01 150.76 32.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.21 -0.931 . . . . 3.14 109.298 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -88.4 138.5 31.38 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.393 1.092 . . . . 2.39 112.429 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.34 154.09 27.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.045 -1.094 . . . . 0.58 108.045 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 150.19 24.73 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.146 -0.972 . . . . 0.61 109.912 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.656 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.9 p90 -144.42 149.93 36.87 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.929 0.871 . . . . 4.08 110.826 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.483 HG23 ' O ' ' B' ' 81' ' ' ILE . 7.2 tt -125.35 134.04 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.59 0.709 . . . . 0.9 110.33 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.422 HD12 ' HB3' ' B' ' 67' ' ' GLN . 11.2 mt -108.31 119.93 40.93 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.591 -1.633 . . . . 0.37 106.591 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.12 125.02 43.08 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.396 -0.922 . . . . 0.98 111.065 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 -100.35 167.98 10.06 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.975 -0.75 . . . . 0.71 108.975 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.603 HD21 HG13 ' B' ' 61' ' ' VAL . 2.2 tp -159.42 136.28 9.43 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.45 -0.9 . . . . 1.44 110.448 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -118.0 143.01 46.76 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.285 -0.635 . . . . 1.31 109.285 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . 0.582 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 17.6 mmt85 -100.64 140.57 34.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.278 -0.889 . . . . 1.64 109.997 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 t -119.0 -7.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.658 -0.867 . . . . 0.68 108.658 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.455 0 CA-C-O 118.003 -0.999 . . . . 1.77 109.494 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.704 ' ND2' HD13 ' A' ' 26' ' ' LEU . 53.3 t30 . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.237 0.541 . . . . 1.72 110.824 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.99 120.58 32.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.861 -1.149 . . . . 1.44 108.36 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.543 HD11 HD21 ' A' ' 6' ' ' ASN . 3.5 mm -125.25 148.01 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-O 122.061 0.934 . . . . 1.11 111.551 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.9 t -111.18 131.67 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.605 0.716 . . . . 1.35 110.386 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.477 HG11 ' H ' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -90.46 162.36 2.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.47 -0.937 . . . . 0.39 108.47 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.435 ' HE ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -137.79 174.05 10.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 2.27 110.221 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 -10.99 18.62 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.872 -0.788 . . . . 1.78 108.872 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.419 ' H ' HG22 ' A' ' 13' ' ' THR . 0.5 OUTLIER -85.71 -8.82 57.95 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.45 -0.9 . . . . 1.24 109.082 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HD3' ' HE ' ' A' ' 11' ' ' ARG . 0.1 OUTLIER -100.3 -121.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.353 -1.351 . . . . 1.41 107.353 177.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.473 ' O ' ' ND1' ' A' ' 19' ' ' HIS . 5.4 m-80 -170.73 173.53 5.29 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.505 -1.372 . . . . 1.25 108.153 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.6 -31.57 51.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.073 -1.051 . . . . 0.49 108.214 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.6 pt-20 -79.21 -36.37 40.22 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.409 -0.917 . . . . 1.56 109.965 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.408 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -55.73 -33.26 64.09 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 119.908 -1.745 . . . . 1.38 110.814 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.709 ' O ' HG23 ' A' ' 23' ' ' VAL . 10.5 m80 -94.52 -19.4 20.57 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.695 -1.253 . . . . 1.43 109.021 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.74 -34.26 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 104.324 -2.473 . . . . 0.29 104.324 176.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.653 ' O ' HG23 ' A' ' 25' ' ' VAL . 51.9 mt -68.49 -54.68 15.33 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.59 -1.186 . . . . 0.41 108.935 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -67.41 -26.6 66.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 1.22 110.061 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 19' ' ' HIS . 35.3 t -72.41 -52.17 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.17 -0.957 . . . . 0.32 108.7 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 tt -61.86 -19.16 20.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.209 -0.932 . . . . 0.58 108.58 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 21' ' ' LEU . 40.2 t -75.52 -44.71 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.244 -0.91 . . . . 0.41 109.221 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' ND2' ' A' ' 6' ' ' ASN . 4.5 mt -64.94 -34.67 78.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.814 -1.179 . . . . 1.19 110.673 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -65.91 -24.47 66.85 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.534 -1.284 . . . . 1.46 107.534 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.36 -24.97 67.83 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.452 -0.795 . . . . 1.15 109.796 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -92.07 1.18 57.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.794 -1.191 . . . . 1.17 109.189 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.65 12.37 30.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.585 -1.406 . . . . 0.42 109.585 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.3 mm -74.35 108.96 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -1.184 . . . . 0.35 108.248 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -93.31 -41.18 10.0 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.443 -0.786 . . . . 1.55 110.57 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -94.96 142.15 27.82 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.357 -0.839 . . . . 1.58 109.902 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.76 137.78 11.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.049 -1.06 . . . . 0.54 110.57 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -116.83 122.1 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.977 -0.556 . . . . 0.25 110.284 -178.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 46' ' ' ALA . 2.3 mp -104.33 120.71 41.81 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 120.115 -0.634 . . . . 0.4 109.379 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.88 134.97 50.84 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.681 -0.859 . . . . 2.74 108.681 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -152.48 164.7 30.71 Favored Glycine 0 N--CA 1.508 3.435 0 C-N-CA 119.763 -1.208 . . . . 0.21 111.603 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -145.69 152.33 39.44 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.391 -1.064 . . . . 0.56 113.649 -177.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.593 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 38.13 -86.29 0.01 OUTLIER Glycine 0 N--CA 1.499 2.838 0 N-CA-C 111.254 -0.739 . . . . 0.33 111.254 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.657 ' NE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -82.46 -54.32 5.29 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.224 -1.162 . . . . 3.09 109.485 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -20.63 58.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.201 -0.937 . . . . 1.09 109.148 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.705 HD12 HD12 ' B' ' 43' ' ' ILE . 0.2 OUTLIER -52.78 -38.04 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.004 . . . . 0.87 110.759 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -82.38 -25.37 33.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.745 -1.222 . . . . 1.14 108.871 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' O ' ' C ' ' A' ' 46' ' ' ALA . 3.2 mptt -62.06 -69.4 0.25 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.675 -1.972 . . . . 1.86 105.675 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.637 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -34.22 -47.56 0.29 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.139 0.495 . . . . 0.29 110.276 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.628 HG13 ' HB ' ' B' ' 68' ' ' THR . 68.9 t -62.19 -68.14 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.111 -0.993 . . . . 0.22 109.537 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 49' ' ' VAL . 0.7 OUTLIER -45.49 -49.61 13.47 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.793 -0.818 . . . . 1.26 108.793 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 36' ' ' LEU . 47.7 t -45.59 -57.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.582 -0.896 . . . . 1.06 108.582 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -62.99 -58.21 8.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.299 -0.875 . . . . 4.02 110.153 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.617 ' CG ' ' H ' ' B' ' 70' ' ' SER . 1.3 t30 -46.97 -54.72 9.51 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.97 -1.122 . . . . 1.34 107.97 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -59.49 -34.72 72.93 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.596 -0.89 . . . . 1.04 108.596 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 23' ' ' VAL . 10.1 tp -76.85 -21.76 54.53 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.227 -1.027 . . . . 0.44 108.227 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -78.26 -46.28 20.69 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.091 -1.818 . . . . 1.0 106.091 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -58.49 -5.86 0.6 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.025 -1.102 . . . . 1.58 108.025 178.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 54' ' ' LYS . 3.4 tpt85 -75.87 -47.35 25.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.722 0.772 . . . . 1.69 109.639 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.629 HD23 ' H ' ' A' ' 60' ' ' GLY . 2.4 tp -152.14 -27.08 0.17 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.663 -0.815 . . . . 1.66 109.88 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.62 -47.93 0.08 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.149 -1.181 . . . . 0.39 110.149 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.617 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.6 OUTLIER -74.8 -44.28 50.26 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.484 -1.009 . . . . 1.38 109.772 -179.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.629 ' H ' HD23 ' A' ' 57' ' ' LEU . . . -85.93 27.04 5.63 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.007 -1.637 . . . . 0.26 109.007 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.7 t -154.75 129.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.339 -1.356 . . . . 0.38 107.339 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 86' ' ' LYS . 0.8 OUTLIER -136.39 157.01 47.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.122 0.963 . . . . 1.31 111.594 -177.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.554 HD11 HG21 ' A' ' 66' ' ' VAL . 7.1 tt -93.13 112.16 24.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.845 -0.798 . . . . 0.49 108.845 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.35 -27.7 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.175 -0.953 . . . . 1.35 109.902 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.494 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -169.88 156.29 6.15 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.612 -1.305 . . . . 1.2 109.694 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 63' ' ' LEU . 68.2 t -159.52 131.34 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.596 0.712 . . . . 0.85 109.343 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.506 ' CG ' ' N ' ' A' ' 68' ' ' THR . 30.6 tt0 -144.21 163.15 34.48 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.166 0.984 . . . . 1.41 109.985 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.506 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -139.65 149.8 44.17 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.569 -0.901 . . . . 0.52 108.569 -178.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.95 148.43 13.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.621 -2.192 . . . . 0.4 107.621 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.59 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 28.1 p -95.55 162.53 13.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.98 -1.306 . . . . 0.42 109.008 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -164.36 178.96 7.09 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.293 -0.963 . . . . 1.29 110.131 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.446 HG23 ' H ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -89.05 135.44 25.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 119.609 -0.836 . . . . 1.02 109.77 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 17.8 ttt85 -151.57 102.46 2.88 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.546 -0.909 . . . . 2.23 108.546 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.3 t70 88.5 33.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.114 0.483 . . . . 1.38 109.721 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.93 34.18 5.45 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.201 1.001 . . . . 2.62 109.364 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.25 153.64 27.85 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.14 -0.975 . . . . 3.15 109.534 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -84.85 137.97 32.83 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.381 1.086 . . . . 2.44 109.14 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.415 ' CG1' ' N ' ' A' ' 79' ' ' SER . 4.2 tt -146.18 159.87 11.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.324 -0.853 . . . . 0.23 108.851 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.415 ' N ' ' CG1' ' A' ' 78' ' ' ILE . 5.1 p -86.58 149.84 24.65 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.076 0.941 . . . . 0.74 109.864 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' CD2' HG22 ' A' ' 39' ' ' THR . 0.6 OUTLIER -133.15 141.21 48.01 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.507 -0.769 . . . . 4.16 109.033 -178.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 81' ' ' ILE . 8.8 tt -117.66 127.34 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.879 0.847 . . . . 0.92 111.225 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 34.6 mt -107.35 115.95 31.08 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.287 -1.746 . . . . 0.36 106.287 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.52 127.2 40.29 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.011 -1.055 . . . . 0.98 111.117 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.604 ' O ' HD12 ' A' ' 85' ' ' LEU . 10.1 ttt180 -103.12 169.41 8.58 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.482 0.658 . . . . 0.58 110.936 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 84' ' ' ARG . 0.9 OUTLIER -161.86 145.26 12.19 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.25 -0.58 . . . . 1.39 110.174 178.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 62' ' ' GLN . 1.5 tmtp? -127.35 145.51 50.78 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.53 -0.545 . . . . 1.42 109.53 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -96.87 138.98 33.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.455 -0.778 . . . . 1.64 110.291 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.16 -6.52 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.6 -0.889 . . . . 0.63 108.6 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.0 t80 . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 118.089 -0.957 . . . . 1.76 109.511 179.772 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.718 ' ND2' HD13 ' B' ' 26' ' ' LEU . 1.2 t30 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.574 0.226 . . . . 1.46 110.605 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -90.4 100.2 13.08 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.41 -1.431 . . . . 1.49 107.56 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.431 ' CG1' HD22 ' B' ' 6' ' ' ASN . 4.2 mm -111.3 140.72 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 109.336 -0.616 . . . . 1.17 109.336 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' B' ' 37' ' ' LYS . 63.5 t -104.29 131.45 53.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.69 0.757 . . . . 1.37 110.481 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.573 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -89.13 159.54 2.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.981 -1.118 . . . . 0.37 107.981 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -134.68 169.19 17.7 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.024 0.916 . . . . 2.37 111.025 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.439 ' C ' ' CD ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -97.55 -11.09 24.1 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.834 -0.802 . . . . 1.75 108.834 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.38 -10.17 44.91 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.737 -0.785 . . . . 1.19 109.179 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -96.18 -127.78 0.14 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.999 -1.112 . . . . 1.47 107.999 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . 0.405 ' O ' ' ND1' ' B' ' 19' ' ' HIS . 5.2 m-80 -167.02 162.69 15.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -0.942 . . . . 1.22 109.331 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -63.25 -38.65 82.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 122.001 0.905 . . . . 0.45 108.959 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.455 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 7.3 pt-20 -71.94 -32.75 67.63 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.625 -0.88 . . . . 1.7 108.625 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -63.43 -31.01 72.05 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.349 -0.844 . . . . 1.46 112.402 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.759 ' O ' HG23 ' B' ' 23' ' ' VAL . 23.0 m80 -94.54 -20.87 19.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 119.822 -1.799 . . . . 1.4 108.383 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.99 -38.98 82.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 104.275 -2.491 . . . . 0.34 104.275 176.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.722 ' O ' HG23 ' B' ' 25' ' ' VAL . 48.9 mt -65.73 -49.22 69.23 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.435 -1.257 . . . . 0.38 108.689 178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.5 -31.64 68.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.227 -0.921 . . . . 1.21 109.779 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.759 HG23 ' O ' ' B' ' 19' ' ' HIS . 55.5 t -68.79 -57.32 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.947 -1.096 . . . . 0.3 108.92 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 tt -56.6 -24.67 19.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.336 -0.853 . . . . 0.69 108.937 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.722 HG23 ' O ' ' B' ' 21' ' ' LEU . 25.2 t -70.08 -40.65 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.132 -0.98 . . . . 0.42 109.661 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.718 HD13 ' ND2' ' B' ' 6' ' ' ASN . 4.7 mt -67.45 -44.37 78.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.723 -1.236 . . . . 1.15 110.185 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -57.24 -30.77 64.9 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.139 -1.43 . . . . 1.46 107.139 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -24.1 61.6 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.49 -0.777 . . . . 1.17 109.2 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -92.95 -3.39 54.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 1.17 109.151 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.64 14.51 19.46 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.304 -1.518 . . . . 0.38 109.304 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.42 107.82 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.111 -1.229 . . . . 0.59 108.503 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -91.18 -36.82 13.72 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.477 -0.765 . . . . 1.46 111.415 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' B' ' 85' ' ' LEU . 7.3 mt-10 -107.1 136.47 46.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.542 -0.723 . . . . 1.2 111.135 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' B' ' 6' ' ' ASN . 13.4 p -145.94 145.39 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 119.706 -0.798 . . . . 0.49 111.171 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.69 119.49 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.261 0.553 . . . . 0.31 110.439 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' B' ' 46' ' ' ALA . 2.7 mp -95.47 121.88 37.61 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.268 -0.895 . . . . 0.48 110.918 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.477 ' HB2' HG13 ' B' ' 9' ' ' VAL . 2.8 mtpp -102.88 125.73 49.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.488 -0.758 . . . . 2.74 109.33 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.4 156.85 26.98 Favored Glycine 0 N--CA 1.507 3.407 0 C-N-CA 119.362 -1.399 . . . . 0.24 111.942 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 17.1 p -142.48 149.79 39.67 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.008 0.909 . . . . 0.49 113.309 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.543 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 34.28 -85.51 0.01 OUTLIER Glycine 0 N--CA 1.498 2.773 0 N-CA-C 111.144 -0.782 . . . . 0.28 111.144 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.652 ' N ' ' NE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -81.22 -53.08 6.67 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.417 -1.049 . . . . 3.16 109.267 -179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.452 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.4 OUTLIER -61.02 -17.73 53.86 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.068 -1.02 . . . . 1.38 108.254 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -53.28 -35.54 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.351 -0.843 . . . . 0.85 110.358 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -24.86 33.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.717 -1.239 . . . . 1.12 109.036 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.499 ' CD ' ' N ' ' B' ' 45' ' ' LYS . 5.4 mptt -66.44 -68.58 0.36 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.692 -1.595 . . . . 1.87 106.692 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.654 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -36.44 -49.13 0.71 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.056 0.455 . . . . 0.26 110.671 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 68' ' ' THR . 79.7 t -66.89 -64.89 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.083 -1.011 . . . . 0.28 109.8 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' B' ' 47' ' ' VAL . 4.5 t70 -46.59 -48.81 19.58 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.442 -0.947 . . . . 1.25 108.442 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.604 HG11 HD21 ' B' ' 36' ' ' LEU . 25.5 t -45.98 -52.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.389 -0.967 . . . . 1.06 108.389 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.547 ' C ' ' CD1' ' B' ' 50' ' ' TYR . 0.2 OUTLIER -66.78 -60.25 2.84 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.377 -0.827 . . . . 4.11 110.26 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . 0.59 ' CG ' ' H ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -45.13 -50.53 11.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.155 -1.018 . . . . 1.41 108.539 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -64.97 -34.63 78.88 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.349 -0.94 . . . . 0.65 109.882 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.449 HD22 HG11 ' B' ' 23' ' ' VAL . 11.2 tp -69.98 -23.99 63.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.976 -1.078 . . . . 0.53 109.921 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -28.41 33.47 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.095 -1.628 . . . . 0.99 106.683 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -16.3 12.16 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.978 -1.119 . . . . 1.46 107.978 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -78.39 -40.04 37.29 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 120.222 -0.591 . . . . 1.71 110.073 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.2 tp -153.53 -24.7 0.14 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 118.329 -1.348 . . . . 1.77 112.118 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.29 -60.88 0.06 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.367 -1.397 . . . . 0.39 109.914 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -67.71 -37.66 82.56 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.351 -1.088 . . . . 1.4 109.764 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.508 ' O ' HG23 ' B' ' 61' ' ' VAL . . . -90.93 28.34 7.99 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.534 -1.426 . . . . 0.34 109.534 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 60' ' ' GLY . 48.6 t -158.57 92.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -1.177 . . . . 0.46 108.791 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER -97.42 161.64 13.69 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.252 1.025 . . . . 1.42 112.094 -178.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 tt -97.27 121.15 38.84 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.104 -1.073 . . . . 0.54 108.104 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.37 -18.21 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.248 -0.907 . . . . 1.43 110.865 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.4 ' O ' HG23 ' B' ' 66' ' ' VAL . 1.9 m-20 -178.5 153.49 0.72 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.52 -1.362 . . . . 1.28 109.907 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 65' ' ' ASN . 87.5 t -158.19 136.56 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.93 -0.767 . . . . 0.9 108.93 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . 0.648 ' HB3' HD12 ' B' ' 82' ' ' LEU . 24.0 tt0 -147.16 164.87 31.74 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.253 1.025 . . . . 1.44 110.663 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.628 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -143.0 158.42 43.62 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.426 -0.953 . . . . 0.45 108.426 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.67 151.84 11.78 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 106.934 -2.467 . . . . 0.29 106.934 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.617 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 39.9 p -93.28 160.21 14.93 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.909 -1.348 . . . . 0.39 108.535 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -159.09 174.62 14.62 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.925 -1.109 . . . . 1.49 110.061 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.432 ' O ' ' OE1' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -90.64 130.47 39.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 119.767 -0.773 . . . . 0.87 109.858 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.2 ttt85 -148.14 104.88 3.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.041 -0.726 . . . . 2.18 109.041 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.2 t70 82.59 39.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.611 -0.515 . . . . 1.35 109.611 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.62 31.86 20.26 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.063 0.935 . . . . 2.57 108.793 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -154.86 152.75 30.17 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.056 -0.72 . . . . 3.14 109.056 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -88.18 136.77 32.82 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.857 -1.137 . . . . 2.39 110.734 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 tt -138.87 157.26 29.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.713 0.768 . . . . 0.58 109.38 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.37 146.75 28.3 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.904 -1.146 . . . . 0.61 107.904 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.618 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 2.3 t80 -136.98 139.78 41.72 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.961 -0.755 . . . . 4.08 108.961 -175.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 12.9 tt -122.78 132.27 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 121.996 0.903 . . . . 0.9 113.236 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' B' ' 67' ' ' GLN . 0.9 OUTLIER -108.81 108.08 18.75 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 105.999 -1.852 . . . . 0.37 105.999 177.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.73 121.26 43.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.227 -0.921 . . . . 0.98 110.139 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . 0.581 ' O ' HD12 ' B' ' 85' ' ' LEU . 33.9 ttt180 -97.28 168.26 10.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.873 -0.731 . . . . 0.71 109.61 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.581 HD12 ' O ' ' B' ' 84' ' ' ARG . 1.0 OUTLIER -160.97 144.17 13.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.653 -0.819 . . . . 1.44 109.99 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' B' ' 62' ' ' GLN . 1.8 tmtp? -125.64 147.27 49.38 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.542 -0.54 . . . . 1.31 109.542 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -101.48 136.6 41.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.262 -0.898 . . . . 1.64 109.845 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.94 -8.97 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.626 -0.879 . . . . 0.68 108.626 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 21.0 t80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 118.017 -0.992 . . . . 1.77 109.564 179.659 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.723 ' ND2' HD13 ' A' ' 26' ' ' LEU . 48.0 t-20 . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.025 -0.731 . . . . 1.72 109.025 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 6.7 pt-20 -93.32 117.88 30.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.289 -0.882 . . . . 1.44 109.671 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.645 HD11 ' ND2' ' A' ' 6' ' ' ASN . 53.5 mt -128.89 153.22 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 CA-C-O 122.189 0.995 . . . . 1.11 112.384 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 37' ' ' LYS . 12.2 p -112.3 131.22 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.626 0.727 . . . . 1.35 110.252 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.685 HG11 ' HB2' ' A' ' 46' ' ' ALA . 4.7 p -88.95 165.12 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.206 -1.035 . . . . 0.39 108.206 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.53 ' N ' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.36 172.47 12.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.967 . . . . 2.27 110.002 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.554 ' NZ ' ' CZ ' ' A' ' 41' ' ' ARG . 6.1 pttp -98.06 -4.23 36.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.979 -0.748 . . . . 1.78 108.979 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.01 0.33 55.93 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.429 -1.323 . . . . 1.24 107.429 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -117.95 131.25 56.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.362 -1.348 . . . . 1.41 107.362 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -67.88 173.17 4.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.751 -1.218 . . . . 1.25 110.435 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 17' ' ' GLU . 33.5 m -62.49 -35.65 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.361 -0.977 . . . . 0.49 108.361 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' N ' HG23 ' A' ' 16' ' ' VAL . 9.2 pt-20 -69.76 -39.88 76.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.649 -0.871 . . . . 1.56 108.649 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' N ' ' CG ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -48.5 -37.93 18.82 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.671 -1.268 . . . . 1.38 111.93 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.689 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.4 m80 -93.87 -19.56 20.86 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.321 -1.487 . . . . 1.43 108.667 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.68 -34.53 47.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 104.482 -2.414 . . . . 0.29 104.482 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.791 ' O ' HG23 ' A' ' 25' ' ' VAL . 71.6 mt -69.07 -55.68 10.02 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.033 -0.985 . . . . 0.41 108.556 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.68 -29.95 71.03 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.311 -0.868 . . . . 1.22 109.668 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 19' ' ' HIS . 24.9 t -70.42 -54.82 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.32 108.953 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 24' ' ' ILE . 2.9 tt -61.73 -15.18 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.165 -0.959 . . . . 0.58 108.839 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 21' ' ' LEU . 55.4 t -81.42 -47.32 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.41 109.458 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.723 HD13 ' ND2' ' A' ' 6' ' ' ASN . 3.9 mt -65.84 -35.12 79.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.789 -1.194 . . . . 1.19 110.017 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.597 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 3.1 t80 -62.39 -23.83 67.05 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.919 -1.511 . . . . 1.46 106.919 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.29 -29.54 70.84 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.338 -0.846 . . . . 1.15 109.153 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.43 ' NE2' HD23 ' A' ' 26' ' ' LEU . 17.7 mt-30 -87.26 -14.08 41.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.945 -1.097 . . . . 1.17 109.121 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.68 11.25 5.04 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.378 -1.089 . . . . 0.42 110.378 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 6' ' ' ASN . 32.3 mm -74.99 98.92 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.985 -1.303 . . . . 0.35 109.172 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.11 -34.27 20.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.551 -0.907 . . . . 1.55 108.551 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 1.7 mt-10 -102.85 141.55 35.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.56 0.695 . . . . 1.58 110.259 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -151.77 144.18 16.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.397 -0.921 . . . . 0.54 109.859 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -121.63 128.54 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.38 0.609 . . . . 0.25 109.94 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.753 HD13 ' OH ' ' A' ' 50' ' ' TYR . 3.4 mp -111.78 123.56 50.5 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.236 0.541 . . . . 0.4 110.241 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.626 ' O ' HG12 ' A' ' 10' ' ' VAL . 3.3 mtpt -102.9 128.82 49.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.246 -1.39 . . . . 2.74 107.246 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.44 154.11 23.37 Favored Glycine 0 N--CA 1.501 3.029 0 C-N-CA 119.525 -1.321 . . . . 0.21 111.031 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 41' ' ' ARG . 30.1 p -135.88 141.15 44.55 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.801 0.81 . . . . 0.56 112.678 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.604 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 39.46 -84.26 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.728 -0.608 . . . . 0.33 111.637 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -84.89 -51.14 6.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.157 -1.202 . . . . 3.09 110.096 -178.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -25.07 64.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.624 -1.298 . . . . 1.09 108.763 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 40' ' ' GLY . 5.7 tt -51.93 -36.66 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.628 -0.67 . . . . 0.87 111.335 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.402 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -84.7 -21.18 30.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.718 -1.239 . . . . 1.14 109.133 -179.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 46' ' ' ALA . 8.0 mmtp -62.08 -71.67 0.15 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.819 -1.919 . . . . 1.86 105.819 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.685 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -32.88 -45.37 0.13 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.267 0.556 . . . . 0.29 111.167 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.708 HG13 ' HB ' ' B' ' 68' ' ' THR . 72.0 t -57.02 -70.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.986 -1.071 . . . . 0.22 110.267 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -44.49 -44.29 8.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.556 -0.715 . . . . 1.26 109.971 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.6 t -46.81 -57.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 119.967 -0.693 . . . . 1.06 109.556 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.753 ' OH ' HD13 ' A' ' 36' ' ' LEU . 64.8 m-85 -65.13 -51.23 62.49 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.039 -1.038 . . . . 4.02 112.668 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' ND2' ' N ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -51.05 -47.98 61.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.546 -1.346 . . . . 1.34 107.55 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.514 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 11.1 p -65.45 -33.84 76.89 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.799 -0.761 . . . . 1.04 109.527 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.456 HD22 HG11 ' A' ' 23' ' ' VAL . 5.9 tp -84.13 -24.18 30.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.68 -1.263 . . . . 0.44 108.846 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.607 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.92 -48.81 12.83 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 104.756 -2.313 . . . . 1.0 104.756 177.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 32.0 t0 -50.1 -12.93 0.09 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.185 -1.37 . . . . 1.58 107.786 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' N ' ' C ' ' A' ' 54' ' ' LYS . 5.0 tpt85 -64.7 -46.95 80.16 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.682 0.753 . . . . 1.69 109.887 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 tp -155.35 -7.44 0.13 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.515 -0.874 . . . . 1.66 110.388 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.27 -59.81 0.06 OUTLIER Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.594 -1.289 . . . . 0.39 109.887 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -72.09 -35.83 69.33 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.808 -0.819 . . . . 1.38 110.212 -178.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.75 20.54 9.16 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.364 -1.494 . . . . 0.26 109.364 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.628 HG13 HD11 ' A' ' 85' ' ' LEU . 2.4 t -154.63 133.26 2.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.54 -1.282 . . . . 0.38 107.54 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.9 mm-40 -137.57 150.73 47.69 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.482 1.134 . . . . 1.31 112.249 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 66' ' ' VAL . 7.4 tt -94.31 108.7 20.58 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.537 -1.282 . . . . 0.49 107.537 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.89 -23.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.305 -0.872 . . . . 1.35 110.369 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.578 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -162.38 153.82 18.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.172 -1.58 . . . . 1.2 109.348 177.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 63' ' ' LEU . 46.3 t -162.32 129.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.406 -0.809 . . . . 0.85 109.485 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -140.78 157.15 45.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.107 0.955 . . . . 1.41 110.606 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.432 ' HB ' HG13 ' B' ' 47' ' ' VAL . 0.7 OUTLIER -137.42 143.89 42.1 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.178 -0.675 . . . . 0.52 109.178 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.674 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -167.35 159.94 33.43 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.384 -2.286 . . . . 0.4 107.384 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.4 p -98.53 161.15 13.82 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 118.984 1.392 . . . . 0.42 110.745 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -156.05 175.6 13.75 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.111 -0.993 . . . . 1.29 110.568 178.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.62 137.34 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.6 0.714 . . . . 1.02 110.553 -179.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 27.5 ttt-85 -148.41 102.58 3.35 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.567 -0.901 . . . . 2.23 108.567 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.9 t70 87.91 35.07 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.204 0.526 . . . . 1.38 109.646 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 63.66 37.62 10.0 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.356 1.074 . . . . 2.62 109.21 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -157.52 153.35 26.86 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.41 -0.806 . . . . 3.15 108.837 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -86.31 135.19 33.63 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.775 1.274 . . . . 2.44 110.662 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.409 HD11 ' HA3' ' A' ' 40' ' ' GLY . 4.8 tt -141.31 155.12 20.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.604 -1.258 . . . . 0.23 107.604 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -87.44 159.99 18.47 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.227 -0.921 . . . . 0.74 111.116 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.674 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.1 p90 -145.08 153.25 41.23 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.87 0.843 . . . . 4.16 110.581 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.546 ' O ' HG23 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -125.96 131.84 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.778 0.799 . . . . 0.92 109.416 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.5 mt -109.5 122.56 47.69 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.695 -1.594 . . . . 0.36 106.695 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.517 HD11 ' OG1' ' B' ' 68' ' ' THR . 0.5 OUTLIER -132.95 129.13 37.87 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.255 1.026 . . . . 0.98 110.737 -177.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -99.25 172.25 7.47 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.128 -0.942 . . . . 0.58 110.074 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.815 HD13 ' N ' ' A' ' 86' ' ' LYS . 1.0 OUTLIER -157.18 137.79 13.11 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.2 -1.0 . . . . 1.39 108.85 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.815 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -125.78 140.69 52.47 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.399 0.618 . . . . 1.42 109.468 179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.597 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 16.6 mmt85 -99.41 136.02 39.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.533 -0.73 . . . . 1.64 109.979 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 88' ' ' VAL . 48.2 t -113.54 -0.97 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.496 -0.927 . . . . 0.63 108.496 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.7 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.988 -1.006 . . . . 1.76 109.415 178.901 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.723 HD22 HD13 ' B' ' 26' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.243 0.544 . . . . 1.46 111.965 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 7.0 pt-20 -93.41 116.45 28.99 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.524 -1.287 . . . . 1.49 107.524 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.488 HD11 HD22 ' B' ' 6' ' ' ASN . 75.6 mt -128.96 153.15 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.526 -0.734 . . . . 1.17 110.815 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.553 HG23 ' HB2' ' B' ' 37' ' ' LYS . 7.9 p -105.79 126.81 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.451 0.643 . . . . 1.37 110.169 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' B' ' 46' ' ' ALA . 3.7 p -86.86 166.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.834 -1.173 . . . . 0.37 107.834 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.596 ' N ' HG22 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -138.78 174.31 10.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 2.37 110.902 -178.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.545 ' NZ ' ' CZ ' ' B' ' 41' ' ' ARG . 6.6 pttp -102.49 -12.88 17.49 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.171 -1.048 . . . . 1.75 108.171 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.72 -9.44 58.21 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.948 -1.13 . . . . 1.19 107.948 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -92.56 -129.74 0.11 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.451 -1.314 . . . . 1.47 107.451 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.15 158.89 10.55 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.09 -1.006 . . . . 1.22 109.37 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.547 HG23 ' N ' ' B' ' 17' ' ' GLU . 12.9 m -57.69 -39.84 72.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.116 -1.068 . . . . 0.45 108.116 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.547 ' N ' HG23 ' B' ' 16' ' ' VAL . 6.5 pt-20 -75.58 -34.04 60.63 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.916 -0.772 . . . . 1.7 108.916 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -63.49 -32.84 74.4 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.852 -1.155 . . . . 1.46 111.6 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.7 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.3 OUTLIER -91.96 -16.06 27.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.051 -1.656 . . . . 1.4 108.032 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.14 -35.49 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 104.499 -2.408 . . . . 0.34 104.499 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.788 ' O ' HG23 ' B' ' 25' ' ' VAL . 43.3 mt -67.87 -50.56 55.75 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.785 -1.098 . . . . 0.38 109.33 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.34 -33.57 75.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.978 -1.077 . . . . 1.21 109.307 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 19' ' ' HIS . 34.7 t -66.29 -52.76 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.3 109.42 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.7 tt -65.3 -19.71 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.99 -1.069 . . . . 0.69 109.025 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.788 HG23 ' O ' ' B' ' 21' ' ' LEU . 41.8 t -75.17 -45.51 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.203 -0.936 . . . . 0.42 109.822 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.723 HD13 HD22 ' B' ' 6' ' ' ASN . 4.1 mt -68.02 -36.94 80.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.699 -1.251 . . . . 1.15 109.829 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . 0.559 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 4.6 t80 -58.03 -29.84 65.65 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.229 -1.767 . . . . 1.46 106.229 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -26.74 66.57 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.818 -1.083 . . . . 1.17 109.176 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.588 ' NE2' HD23 ' B' ' 26' ' ' LEU . 17.5 mt-30 -92.2 -1.09 57.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.008 . . . . 1.17 109.337 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.02 13.9 18.48 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.765 -0.934 . . . . 0.38 110.765 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.538 HG13 HD22 ' B' ' 26' ' ' LEU . 12.9 mm -78.2 105.01 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.697 -1.473 . . . . 0.59 107.987 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -91.3 -38.87 12.38 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.19 -0.944 . . . . 1.46 109.186 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.7 135.21 43.61 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.278 0.561 . . . . 1.2 110.159 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' B' ' 6' ' ' ASN . 0.3 OUTLIER -145.41 130.94 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.578 -0.849 . . . . 0.49 110.397 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -106.34 124.37 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.686 -0.634 . . . . 0.31 110.069 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.901 HD13 ' OH ' ' B' ' 50' ' ' TYR . 2.6 mp -107.94 129.73 55.08 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.451 -0.78 . . . . 0.48 110.887 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.592 ' O ' HG12 ' B' ' 10' ' ' VAL . 5.0 mtpt -106.11 126.18 51.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.177 -1.046 . . . . 2.74 108.177 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.63 153.23 20.96 Favored Glycine 0 N--CA 1.505 3.241 0 C-N-CA 119.873 -1.156 . . . . 0.24 110.799 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.635 ' O ' ' N ' ' B' ' 41' ' ' ARG . 24.9 p -133.87 142.65 47.88 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.785 -0.833 . . . . 0.49 112.095 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.661 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 33.8 -79.23 0.0 OUTLIER Glycine 0 N--CA 1.505 3.277 0 N-CA-C 111.932 -0.467 . . . . 0.28 111.932 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.635 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -84.04 -55.4 4.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.037 -1.272 . . . . 3.16 109.377 -179.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -17.7 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.024 -1.048 . . . . 1.38 109.852 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.661 HG22 ' O ' ' B' ' 40' ' ' GLY . 6.7 tt -61.64 -22.41 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.85 109.913 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.41 -29.72 17.82 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.353 -0.98 . . . . 1.12 108.353 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' B' ' 46' ' ' ALA . 7.5 mmtp -60.19 -67.18 0.42 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.332 -1.729 . . . . 1.87 106.332 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.784 ' HB2' HG11 ' B' ' 10' ' ' VAL . . . -32.4 -47.01 0.14 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 116.082 -0.508 . . . . 0.26 111.823 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.432 HG13 ' HB ' ' A' ' 68' ' ' THR . 84.9 t -66.4 -61.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.837 -1.164 . . . . 0.28 111.3 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' B' ' 49' ' ' VAL . 9.2 t70 -45.54 -51.08 12.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.216 -0.928 . . . . 1.25 109.348 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' B' ' 48' ' ' ASP . 64.3 t -41.71 -54.22 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.751 -0.463 . . . . 1.06 109.751 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.901 ' OH ' HD13 ' B' ' 36' ' ' LEU . 59.5 m-85 -68.12 -53.56 24.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -0.987 . . . . 4.11 111.627 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' B' ' 52' ' ' SER . 0.0 OUTLIER -46.77 -55.76 7.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.858 -1.164 . . . . 1.41 107.858 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.557 ' N ' ' ND2' ' B' ' 51' ' ' ASN . 0.7 OUTLIER -61.17 -39.68 91.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.628 -0.829 . . . . 0.65 109.714 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.461 HD22 HG11 ' B' ' 23' ' ' VAL . 5.8 tp -71.2 -23.96 62.13 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.79 -1.194 . . . . 0.53 108.614 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 50' ' ' TYR . 0.0 OUTLIER -76.5 -47.83 21.53 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.789 -1.56 . . . . 0.99 106.789 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -44.67 -17.47 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.993 -1.003 . . . . 1.46 109.276 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' B' ' 54' ' ' LYS . 21.9 mmm180 -65.87 -39.8 91.03 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.38 -0.928 . . . . 1.71 109.997 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.3 tp -156.7 -12.46 0.09 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.429 -1.308 . . . . 1.77 111.528 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 67.3 -65.24 0.24 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.849 -1.7 . . . . 0.39 108.849 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.5 -41.24 76.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.632 -0.922 . . . . 1.4 109.704 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.16 17.07 2.51 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.543 -1.423 . . . . 0.34 109.543 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.68 HG13 HD11 ' B' ' 85' ' ' LEU . 2.5 t -152.32 130.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.05 -1.463 . . . . 0.46 107.05 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' B' ' 86' ' ' LYS . 5.4 mm-40 -137.94 152.01 48.54 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.303 1.049 . . . . 1.42 112.455 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.578 HD11 HG21 ' B' ' 66' ' ' VAL . 8.4 tt -94.37 119.12 32.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.906 -1.146 . . . . 0.54 107.906 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.49 ' O ' ' ND2' ' B' ' 65' ' ' ASN . 6.9 p -116.32 -13.39 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.337 -0.852 . . . . 1.43 110.853 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' B' ' 64' ' ' VAL . 0.3 OUTLIER -171.23 143.66 1.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.399 -1.438 . . . . 1.28 109.482 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.578 HG21 HD11 ' B' ' 63' ' ' LEU . 96.7 t -156.83 133.92 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.054 -0.721 . . . . 0.9 109.054 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . 0.611 ' HB3' HD12 ' B' ' 82' ' ' LEU . 48.5 tt0 -142.21 159.75 41.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.092 0.949 . . . . 1.44 110.446 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.708 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -137.0 156.14 48.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.78 -0.822 . . . . 0.45 108.78 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.681 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -179.74 157.98 21.33 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.745 -2.142 . . . . 0.29 107.745 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 68.8 p -96.44 154.63 17.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.051 -1.264 . . . . 0.39 109.44 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -153.17 170.7 19.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.827 -1.171 . . . . 1.49 110.446 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.418 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -89.02 137.09 21.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.852 0.834 . . . . 0.87 111.284 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 7.5 ttt-85 -149.78 97.87 2.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.08 -0.711 . . . . 2.18 109.08 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 4.0 t0 88.34 36.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.427 -0.583 . . . . 1.35 109.427 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 65.01 34.48 8.84 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.214 1.007 . . . . 2.57 109.463 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -156.52 154.52 30.44 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.791 -0.818 . . . . 3.14 108.791 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -88.11 145.77 25.77 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.585 1.183 . . . . 2.39 111.842 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tt -144.36 159.49 15.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.871 -1.058 . . . . 0.58 108.194 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.09 151.08 22.99 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 121.372 -0.83 . . . . 0.61 109.036 -178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.681 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.2 p90 -143.83 151.91 40.51 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.615 -0.834 . . . . 4.08 110.37 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.498 HG23 ' O ' ' B' ' 81' ' ' ILE . 20.4 tt -128.71 135.02 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.643 0.735 . . . . 0.9 111.27 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' B' ' 67' ' ' GLN . 7.7 mt -110.69 124.31 51.7 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.69 -1.596 . . . . 0.37 106.69 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.67 127.15 39.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.143 -0.973 . . . . 0.98 111.275 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -108.26 110.17 21.71 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.557 0.694 . . . . 0.71 111.159 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.864 HD13 ' N ' ' B' ' 86' ' ' LYS . 1.3 tm? -96.42 140.46 31.04 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.986 -0.746 . . . . 1.44 108.986 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.864 ' N ' HD13 ' B' ' 85' ' ' LEU . 0.0 OUTLIER -122.35 136.03 54.82 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.406 -0.591 . . . . 1.31 109.406 179.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . 0.559 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 16.4 mmt85 -96.12 140.26 31.09 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.33 -0.856 . . . . 1.64 110.296 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.49 ' O ' HG12 ' B' ' 88' ' ' VAL . 36.2 t -118.08 -6.77 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.706 -0.85 . . . . 0.68 108.706 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 74.8 t80 . . . . . 0 C--N 1.303 -1.432 0 CA-C-O 117.979 -1.01 . . . . 1.77 109.423 179.26 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.63 ' OD1' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.576 0.227 . . . . 1.72 110.621 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 3.8 pt-20 -89.34 112.23 23.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.066 -1.646 . . . . 1.44 108.262 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.63 HD11 ' OD1' ' A' ' 6' ' ' ASN . 5.6 mt -128.74 147.25 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 CA-C-O 122.189 0.995 . . . . 1.11 112.195 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 37' ' ' LYS . 61.1 t -112.91 129.52 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.606 0.717 . . . . 1.35 110.336 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.532 HG11 ' H ' ' A' ' 46' ' ' ALA . 1.7 p -87.65 167.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.055 -1.091 . . . . 0.39 108.055 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.91 167.88 20.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 2.27 109.977 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -20.65 27.61 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.386 -0.968 . . . . 1.78 108.386 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -69.4 -65.41 0.72 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.761 -1.57 . . . . 1.24 106.761 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.524 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.4 mtmm -58.24 144.07 42.23 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.216 1.007 . . . . 1.41 110.347 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.87 178.86 4.61 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.696 -0.684 . . . . 1.25 110.067 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.61 -28.79 25.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.254 -1.017 . . . . 0.49 108.254 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.4 -33.85 61.01 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.484 -0.886 . . . . 1.56 109.119 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.2 -31.59 69.16 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 120.396 -1.44 . . . . 1.38 110.925 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.709 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -95.64 -18.3 20.64 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.692 -1.255 . . . . 1.43 108.459 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -34.72 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 104.513 -2.403 . . . . 0.29 104.513 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.773 ' O ' HG23 ' A' ' 25' ' ' VAL . 38.5 mt -68.33 -52.57 31.97 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.495 -1.23 . . . . 0.41 108.771 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -66.34 -29.34 69.51 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.114 -0.991 . . . . 1.22 109.437 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 19' ' ' HIS . 19.7 t -69.79 -53.24 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.32 109.453 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.23 -18.03 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.895 -1.128 . . . . 0.58 108.617 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 21' ' ' LEU . 54.0 t -75.98 -43.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 119.335 -0.946 . . . . 0.41 108.573 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.415 HD13 HD11 ' A' ' 8' ' ' ILE . 4.2 mt -64.79 -33.4 75.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.825 -1.172 . . . . 1.19 110.029 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -65.87 -23.0 66.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.877 -1.527 . . . . 1.46 106.877 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -61.74 -30.77 70.99 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.123 -0.944 . . . . 1.15 108.811 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -87.82 -6.34 58.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.27 -0.894 . . . . 1.17 109.244 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.73 12.45 18.74 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.913 -1.275 . . . . 0.42 109.913 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.6 mm -73.88 109.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.138 -1.213 . . . . 0.35 109.25 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.22 -37.22 11.66 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.423 -0.798 . . . . 1.55 110.721 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 1.9 mt-10 -97.73 137.85 36.0 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.601 0.715 . . . . 1.58 110.793 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -147.87 137.29 16.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.66 -0.816 . . . . 0.54 109.826 -179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -117.08 126.04 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.753 -0.658 . . . . 0.25 109.591 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.4 mp -111.76 119.56 39.04 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 120.262 -0.575 . . . . 0.4 109.519 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 9' ' ' VAL . 2.4 mttt -105.26 132.67 51.17 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.02 -1.104 . . . . 2.74 108.02 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.19 151.79 21.6 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.748 -1.215 . . . . 0.21 110.926 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 41' ' ' ARG . 64.3 p -126.01 134.03 51.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.986 -0.714 . . . . 0.56 111.673 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 38.4 -83.56 0.0 OUTLIER Glycine 0 N--CA 1.495 2.632 0 O-C-N 121.615 -0.678 . . . . 0.33 112.286 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.686 ' HE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.31 -54.2 6.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.127 -1.219 . . . . 3.09 110.087 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.38 -20.99 63.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.64 -1.244 . . . . 1.09 107.64 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 43' ' ' ILE . 1.5 tt -53.18 -36.46 25.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.233 -0.917 . . . . 0.87 110.858 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.61 -20.39 31.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.678 -1.264 . . . . 1.14 108.747 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 46' ' ' ALA . 1.5 mptt -64.32 -71.02 0.19 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.518 -2.03 . . . . 1.86 105.518 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.663 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -30.44 -48.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.403 0.621 . . . . 0.29 110.37 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.691 HG13 ' HB ' ' B' ' 68' ' ' THR . 92.0 t -57.94 -71.68 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.378 -0.826 . . . . 0.22 109.995 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' OG ' ' A' ' 52' ' ' SER . 8.4 t70 -42.52 -46.72 4.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.755 -0.59 . . . . 1.26 110.05 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.2 t -48.75 -57.52 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.483 -0.887 . . . . 1.06 108.82 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.571 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -61.03 -55.58 31.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 4.02 110.978 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.549 ' CG ' ' H ' ' B' ' 70' ' ' SER . 4.7 t30 -52.1 -51.14 59.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.873 -1.142 . . . . 1.34 107.985 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 5.7 m -60.38 -34.15 73.49 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.528 -0.915 . . . . 1.04 108.528 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.434 HD22 HG11 ' A' ' 23' ' ' VAL . 7.1 tp -82.13 -21.64 36.56 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.078 -1.014 . . . . 0.44 108.389 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.29 -49.34 12.61 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.701 -1.963 . . . . 1.0 105.701 177.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 1.7 t0 -54.43 -8.64 0.23 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.754 -1.202 . . . . 1.58 107.754 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 54' ' ' LYS . 4.6 tpt85 -68.7 -52.88 26.04 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.487 -0.758 . . . . 1.69 109.196 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -153.14 -13.29 0.15 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.347 -0.941 . . . . 1.66 110.948 179.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.441 ' N ' HD12 ' A' ' 57' ' ' LEU . . . 62.94 -47.44 0.07 OUTLIER Glycine 0 N--CA 1.494 2.509 0 C-N-CA 120.043 -1.075 . . . . 0.39 110.842 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -72.72 -41.71 64.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.252 -1.146 . . . . 1.38 109.986 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.482 ' H ' HD13 ' A' ' 57' ' ' LEU . . . -87.15 22.91 12.7 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.94 -1.264 . . . . 0.26 109.94 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.577 HG13 HD21 ' A' ' 85' ' ' LEU . 2.4 t -149.37 132.5 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.979 -1.306 . . . . 0.38 107.705 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.605 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.7 mm-40 -135.51 155.74 50.02 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.034 0.921 . . . . 1.31 111.575 -177.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.42 110.01 21.57 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.486 -0.931 . . . . 0.49 108.486 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.8 -22.91 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.065 -1.022 . . . . 1.35 109.775 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -172.85 152.56 2.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.699 -1.25 . . . . 1.2 109.759 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 65' ' ' ASN . 72.0 t -159.28 128.29 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.863 -0.792 . . . . 0.85 108.863 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 68' ' ' THR . 31.9 tt0 -142.09 157.05 45.35 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.086 0.946 . . . . 1.41 110.531 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.479 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -124.2 150.81 44.8 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.239 -0.892 . . . . 0.52 108.737 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.683 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -175.89 148.88 9.57 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 107.607 -2.197 . . . . 0.4 107.607 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.565 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 37.1 p -95.75 158.01 15.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.703 -1.469 . . . . 0.42 110.996 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' OE2' ' C ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -150.51 167.63 26.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.162 -0.961 . . . . 1.29 110.073 178.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.403 ' C ' ' OE2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -91.91 141.94 13.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.644 0.735 . . . . 1.02 111.044 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 7.5 ttt-85 -149.25 103.44 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.165 -0.68 . . . . 2.23 109.165 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.4 t70 86.38 36.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.049 0.452 . . . . 1.38 110.339 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.29 32.71 12.08 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.174 0.988 . . . . 2.62 109.045 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.19 146.12 26.67 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.284 -1.006 . . . . 3.15 108.284 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.622 ' NH2' ' ND2' ' B' ' 51' ' ' ASN . 8.1 ttt180 -85.91 139.73 30.98 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.893 1.33 . . . . 2.44 110.614 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.6 tt -142.71 154.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 114.276 -1.329 . . . . 0.23 107.986 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.8 p -88.37 161.64 16.98 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 119.335 -0.946 . . . . 0.74 110.444 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.683 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.4 p90 -148.35 156.4 42.46 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.313 -0.955 . . . . 4.16 110.244 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 81' ' ' ILE . 10.3 tt -129.68 139.05 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.746 0.784 . . . . 0.92 110.485 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.7 mt -111.32 124.0 51.35 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.952 -1.129 . . . . 0.36 107.952 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 tt -131.64 126.52 34.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.122 -0.987 . . . . 0.98 110.61 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -102.88 172.42 6.84 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.315 0.578 . . . . 0.58 109.789 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.577 HD21 HG13 ' A' ' 61' ' ' VAL . 1.9 tp -160.82 144.93 13.7 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 118.679 -1.208 . . . . 1.39 110.999 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.605 ' O ' ' N ' ' A' ' 62' ' ' GLN . 14.0 tptt -125.57 136.35 53.2 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.574 0.702 . . . . 1.42 109.936 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.425 ' N ' ' HD2' ' A' ' 86' ' ' LYS . 22.6 mmt180 -94.41 136.4 34.75 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.059 -1.026 . . . . 1.64 109.663 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 88' ' ' VAL . 69.4 t -121.62 1.21 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.824 -0.806 . . . . 0.63 108.824 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.424 ' CD2' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.383 0 CA-C-O 118.001 -0.999 . . . . 1.76 109.512 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.523 ' OD1' HD11 ' B' ' 8' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 110.214 -0.291 . . . . 1.46 110.214 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.8 pt-20 -90.12 110.32 21.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.165 -1.585 . . . . 1.49 108.897 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.523 HD11 ' OD1' ' B' ' 6' ' ' ASN . 4.1 mt -126.41 142.52 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.848 0.832 . . . . 1.17 110.677 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' B' ' 37' ' ' LYS . 63.2 t -104.22 130.47 54.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.49 0.662 . . . . 1.37 109.581 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.538 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.4 OUTLIER -87.49 166.13 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.516 -0.92 . . . . 0.37 108.516 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.414 ' NE ' ' CE ' ' B' ' 14' ' ' LYS . 6.7 mtt180 -139.09 171.58 14.1 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.01 0.909 . . . . 2.37 110.507 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.04 -11.52 20.5 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.187 -1.042 . . . . 1.75 108.187 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.86 -14.35 54.44 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.637 -0.825 . . . . 1.19 109.758 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' B' ' 15' ' ' ASN . 1.2 mttm -98.57 -120.65 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.281 -1.007 . . . . 1.47 108.281 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' B' ' 14' ' ' LYS . 0.7 OUTLIER -170.94 172.44 5.53 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.097 -1.002 . . . . 1.22 109.15 179.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -72.38 -35.25 51.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.115 -1.069 . . . . 0.45 108.115 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 10.0 pt-20 -72.46 -41.67 65.82 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.495 -0.928 . . . . 1.7 108.495 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.464 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 68.2 t0 -62.49 -30.81 71.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.141 -0.974 . . . . 1.46 112.082 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.759 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.1 OUTLIER -91.34 -16.46 27.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 119.892 -1.755 . . . . 1.4 108.289 178.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 t -75.19 -40.11 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 105.152 -2.166 . . . . 0.34 105.152 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.773 ' O ' HG23 ' B' ' 25' ' ' VAL . 59.1 mt -62.31 -49.46 75.54 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.909 -1.041 . . . . 0.38 108.481 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -67.3 -32.13 72.9 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.565 -0.854 . . . . 1.21 109.685 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.759 HG23 ' O ' ' B' ' 19' ' ' HIS . 41.0 t -69.57 -54.55 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.291 -0.881 . . . . 0.3 110.068 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 20.4 tt -61.15 -24.05 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.893 -1.129 . . . . 0.69 108.864 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.773 HG23 ' O ' ' B' ' 21' ' ' LEU . 39.3 t -68.19 -41.5 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -0.922 . . . . 0.42 108.951 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.402 HD13 HD11 ' B' ' 8' ' ' ILE . 4.8 mt -66.52 -43.12 86.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.121 -0.987 . . . . 1.15 109.7 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -55.19 -31.49 61.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.735 -1.58 . . . . 1.46 106.735 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -55.69 -30.69 61.53 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.273 -0.876 . . . . 1.17 108.777 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -87.96 -3.02 58.95 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.809 -0.811 . . . . 1.17 108.809 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.19 15.98 22.14 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.608 -1.397 . . . . 0.38 109.608 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 36.8 mm -77.36 111.42 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.148 -1.207 . . . . 0.59 108.421 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.39 -35.83 12.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.272 -0.893 . . . . 1.46 111.015 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -101.64 141.6 34.25 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.626 0.727 . . . . 1.2 110.954 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' B' ' 6' ' ' ASN . 0.8 OUTLIER -149.5 122.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.146 0.974 . . . . 0.49 111.096 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.21 122.91 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.613 -0.679 . . . . 0.31 109.254 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' B' ' 46' ' ' ALA . 2.4 mp -105.57 121.76 44.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.431 -0.793 . . . . 0.48 110.087 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.506 ' HB2' HG13 ' B' ' 9' ' ' VAL . 7.4 mttt -103.34 128.41 50.43 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.736 -0.839 . . . . 2.74 108.736 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.51 150.83 20.64 Favored Glycine 0 N--CA 1.502 3.037 0 C-N-CA 119.572 -1.299 . . . . 0.24 110.805 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.613 ' O ' ' N ' ' B' ' 41' ' ' ARG . 47.3 p -129.86 141.24 50.85 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.888 -0.772 . . . . 0.49 111.841 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.666 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 32.84 -82.0 0.0 OUTLIER Glycine 0 N--CA 1.504 3.195 0 N-CA-C 111.785 -0.526 . . . . 0.28 111.785 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.664 ' HE ' ' N ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -80.14 -53.13 6.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.087 -1.243 . . . . 3.16 110.057 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.3 OUTLIER -64.93 -13.7 57.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.945 -1.097 . . . . 1.38 109.296 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.666 HG22 ' O ' ' B' ' 40' ' ' GLY . 8.1 tt -60.65 -26.03 36.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.26 -0.9 . . . . 0.85 109.711 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.58 -25.95 23.34 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.29 -1.004 . . . . 1.12 108.29 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' B' ' 46' ' ' ALA . 2.6 mptt -63.75 -70.54 0.21 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.5 -1.667 . . . . 1.87 106.5 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.677 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -32.97 -41.17 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.217 0.532 . . . . 0.26 110.99 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.63 -64.9 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.142 -0.974 . . . . 0.28 109.567 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' B' ' 49' ' ' VAL . 5.8 t70 -48.47 -50.72 30.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.189 -0.944 . . . . 1.25 109.276 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.658 HG11 HD21 ' B' ' 36' ' ' LEU . 38.0 t -42.39 -56.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.96 -0.755 . . . . 1.06 108.96 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.568 ' CD1' HD13 ' B' ' 85' ' ' LEU . 0.0 OUTLIER -67.66 -54.33 20.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.447 -0.783 . . . . 4.11 110.564 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . 0.622 ' ND2' ' NH2' ' A' ' 77' ' ' ARG . 2.8 t30 -48.5 -57.98 5.35 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.119 -1.032 . . . . 1.41 108.531 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -57.95 -30.81 66.27 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.172 -1.011 . . . . 0.65 109.649 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.505 HD22 HG11 ' B' ' 23' ' ' VAL . 46.0 tp -75.05 -21.74 58.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.53 110.287 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.46 -27.95 25.35 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.373 -1.714 . . . . 0.99 106.373 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.412 ' OD2' ' NH2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -59.08 -14.52 10.17 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.686 -1.227 . . . . 1.46 107.686 177.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -75.74 -43.92 44.34 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.618 -0.833 . . . . 1.71 109.487 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' B' ' 59' ' ' ASP . 0.2 OUTLIER -152.1 -20.71 0.18 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.624 -1.23 . . . . 1.77 112.291 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.66 -56.02 0.14 Allowed Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.275 -1.441 . . . . 0.39 110.035 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.58 -43.27 73.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.295 -1.121 . . . . 1.4 109.989 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.418 ' HA3' HD22 ' B' ' 57' ' ' LEU . . . -82.52 24.97 4.66 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.9 -1.28 . . . . 0.34 109.9 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.453 HG13 HD21 ' B' ' 85' ' ' LEU . 1.0 OUTLIER -149.24 130.25 4.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.478 -1.304 . . . . 0.46 107.478 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' B' ' 86' ' ' LYS . 4.0 mm-40 -132.27 159.21 39.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.002 0.906 . . . . 1.42 111.471 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.34 112.72 25.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.473 -0.936 . . . . 0.54 108.473 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -23.51 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.161 -0.962 . . . . 1.43 110.391 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.21 151.03 1.59 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.491 -1.38 . . . . 1.28 109.457 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 96.6 t -156.85 132.74 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.722 -0.844 . . . . 0.9 108.722 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . 0.467 ' CG ' ' N ' ' B' ' 68' ' ' THR . 28.4 tt0 -145.94 165.21 29.62 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.282 1.039 . . . . 1.44 110.823 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.691 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -135.72 154.8 51.14 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.221 -0.9 . . . . 0.45 108.699 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.711 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -176.71 153.2 13.52 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 107.767 -2.133 . . . . 0.29 107.767 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.549 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 6.0 p -96.57 155.98 16.54 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.882 1.341 . . . . 0.39 109.382 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -148.98 166.75 27.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.946 -1.096 . . . . 1.49 110.05 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.42 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.2 OUTLIER -90.03 136.95 22.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.845 -0.742 . . . . 0.87 110.542 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.8 ttt-85 -147.17 101.52 3.41 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.337 -0.616 . . . . 2.18 109.337 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 1.8 t70 83.02 39.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.427 -0.583 . . . . 1.35 109.427 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.17 32.61 14.96 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.915 0.864 . . . . 2.57 109.273 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.32 153.88 36.87 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.453 -0.779 . . . . 3.14 109.207 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.534 ' NH2' ' OG ' ' B' ' 70' ' ' SER . 1.3 tpt180 -88.36 136.28 33.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.729 0.776 . . . . 2.39 110.922 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 11.9 tt -136.31 153.54 31.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.743 -0.836 . . . . 0.58 108.743 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 151.59 22.81 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.332 -0.855 . . . . 0.61 109.039 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.711 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.0 p90 -144.35 150.86 38.48 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.467 -0.893 . . . . 4.08 110.313 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.453 HD11 HG21 ' A' ' 68' ' ' THR . 6.0 tt -126.12 135.83 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.53 0.681 . . . . 0.9 109.972 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' B' ' 80' ' ' TYR . 12.2 mt -109.23 121.19 44.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.168 -1.419 . . . . 0.37 107.168 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.517 HD11 ' CD2' ' B' ' 50' ' ' TYR . 6.1 tt -123.25 121.23 35.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.111 -0.993 . . . . 0.98 110.338 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -110.12 107.02 16.7 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.264 0.554 . . . . 0.71 110.259 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.568 HD13 ' CD1' ' B' ' 50' ' ' TYR . 8.7 tp -104.01 151.54 23.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.591 -0.693 . . . . 1.44 110.609 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.1 OUTLIER -126.65 157.27 39.42 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.757 -0.46 . . . . 1.31 109.757 -179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . 0.497 HH22 HD11 ' B' ' 53' ' ' LEU . 22.2 mmt180 -109.98 141.94 42.06 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.225 -0.922 . . . . 1.64 110.037 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.452 ' O ' HG12 ' B' ' 88' ' ' VAL . 18.8 t -121.94 -9.98 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.907 -0.775 . . . . 0.68 108.907 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 118.066 -0.969 . . . . 1.77 109.537 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.561 ' ND2' HD11 ' A' ' 8' ' ' ILE . 47.3 t30 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 121.33 0.586 . . . . 1.72 111.193 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -93.82 123.47 37.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 1.44 108.384 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.561 HD11 ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -130.38 151.81 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 122.632 1.206 . . . . 1.11 113.356 -177.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.4 p -104.7 127.11 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.317 -0.856 . . . . 1.35 109.585 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.93 166.63 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.899 . . . . 0.39 108.777 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.1 174.17 10.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.176 -0.952 . . . . 2.27 110.462 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' NZ ' ' HE ' ' A' ' 41' ' ' ARG . 12.4 pttt -94.99 -13.66 25.08 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.66 -0.867 . . . . 1.78 108.66 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 t -86.58 1.33 52.09 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.727 -1.212 . . . . 1.24 107.727 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.75 128.59 53.06 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.964 -1.495 . . . . 1.41 106.964 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.28 -178.4 1.68 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.831 -0.748 . . . . 1.25 109.865 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 49' ' ' VAL . 1.8 m -79.93 -27.96 12.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 106.796 -1.557 . . . . 0.49 106.796 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.72 -46.88 28.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.626 -0.716 . . . . 1.56 109.369 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.79 -28.64 69.6 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.915 -1.115 . . . . 1.38 110.957 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.708 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -92.08 -15.65 27.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.426 -1.421 . . . . 1.43 109.688 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.91 -30.39 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 105.197 -2.149 . . . . 0.29 105.197 176.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.555 ' O ' HG23 ' A' ' 25' ' ' VAL . 64.5 mt -70.12 -53.51 16.98 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.866 -1.061 . . . . 0.41 108.834 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -65.2 -26.32 68.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 1.22 109.728 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 19' ' ' HIS . 38.6 t -73.64 -50.14 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.59 -0.893 . . . . 0.32 108.59 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.75 -23.59 23.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.543 -0.91 . . . . 0.58 108.543 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 21' ' ' LEU . 48.8 t -70.71 -42.81 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.247 -0.908 . . . . 0.41 109.913 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.614 ' N ' HD23 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -68.53 -33.64 74.47 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.447 -1.408 . . . . 1.19 109.805 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.75 -27.13 68.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.166 -1.42 . . . . 1.46 107.166 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.97 -26.27 68.5 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.239 -0.891 . . . . 1.15 109.887 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -88.97 -1.98 58.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.841 -1.162 . . . . 1.17 109.267 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.5 14.52 19.7 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.766 -1.334 . . . . 0.42 109.766 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 6' ' ' ASN . 20.7 mm -75.92 107.49 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -1.147 . . . . 0.35 108.298 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 33' ' ' GLU . 1.6 p30 -93.65 -38.59 11.26 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.433 -0.792 . . . . 1.55 110.594 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 7.7 mt-10 -97.69 142.02 29.99 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.561 -0.712 . . . . 1.58 110.189 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.439 HG13 ' OH ' ' A' ' 50' ' ' TYR . 14.6 p -152.32 139.98 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.041 -1.064 . . . . 0.54 111.157 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.55 129.28 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 122.054 -0.404 . . . . 0.25 110.077 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 50' ' ' TYR . 1.8 mp -115.21 126.31 54.41 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.599 0.714 . . . . 0.4 110.277 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.438 ' HG2' HG23 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -99.41 127.19 45.43 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.905 -1.146 . . . . 2.74 107.905 177.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.54 143.31 14.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.725 -1.226 . . . . 0.21 110.51 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 41' ' ' ARG . 31.8 p -131.07 138.45 49.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.922 -0.752 . . . . 0.56 111.643 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' THR . . . 35.41 -83.11 0.0 OUTLIER Glycine 0 N--CA 1.501 3.008 0 O-C-N 121.735 -0.603 . . . . 0.33 112.247 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -82.97 -56.32 3.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.249 . . . . 3.09 109.886 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -15.17 8.71 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.99 -1.115 . . . . 1.09 107.99 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.536 HG12 HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -55.5 -32.89 31.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.408 -0.807 . . . . 0.87 111.131 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.17 -22.9 23.79 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.963 -1.086 . . . . 1.14 108.221 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 49' ' ' VAL . 2.7 mptt -62.35 -72.39 0.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.747 -1.946 . . . . 1.86 105.747 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.638 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -33.24 -46.72 0.18 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.094 0.473 . . . . 0.29 110.673 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.602 HG13 ' HB ' ' B' ' 68' ' ' THR . 98.5 t -66.51 -61.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.003 . . . . 0.22 109.297 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.458 ' OD1' HG21 ' A' ' 16' ' ' VAL . 10.5 t70 -51.33 -54.4 26.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 1.26 108.847 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 45' ' ' LYS . 46.7 t -42.66 -58.24 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.543 -0.91 . . . . 1.06 108.543 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.655 ' CE1' HD22 ' A' ' 36' ' ' LEU . 3.0 m-30 -62.14 -50.6 71.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.85 -0.531 . . . . 4.02 110.982 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.583 ' CG ' ' H ' ' B' ' 70' ' ' SER . 0.8 OUTLIER -56.07 -49.69 73.08 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.78 -1.193 . . . . 1.34 107.78 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 4.3 p -59.96 -33.86 72.51 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.423 -0.954 . . . . 1.04 108.423 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.431 HD22 HG11 ' A' ' 23' ' ' VAL . 57.0 tp -79.06 -19.86 50.3 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.985 -1.117 . . . . 0.44 107.985 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.58 -44.47 17.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.539 -2.022 . . . . 1.0 105.539 177.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -59.34 -5.98 0.88 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.565 -1.272 . . . . 1.58 107.565 177.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 54' ' ' LYS . 4.6 tpt85 -71.05 -49.13 48.11 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.58 -0.7 . . . . 1.69 109.247 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.2 mt -151.64 -21.86 0.19 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.437 -0.905 . . . . 1.66 110.302 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.15 -49.44 0.09 OUTLIER Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.847 -1.168 . . . . 0.39 110.431 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -73.84 -45.41 51.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -1.202 . . . . 1.38 109.929 -178.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.2 27.68 4.97 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.846 -1.702 . . . . 0.26 108.846 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.475 ' CG2' ' NH1' ' A' ' 87' ' ' ARG . 5.7 t -151.84 129.39 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 107.525 -1.287 . . . . 0.38 107.525 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.0 mm100 -134.39 157.79 45.52 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.964 0.888 . . . . 1.31 111.577 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tt -97.57 113.45 25.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.45 -0.944 . . . . 0.49 108.45 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -23.31 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.122 -0.986 . . . . 1.35 109.318 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.11 157.2 5.07 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.676 -1.21 . . . . 1.2 109.718 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.746 HG13 HG13 ' B' ' 66' ' ' VAL . 7.9 p -163.42 133.11 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.356 -0.84 . . . . 0.85 109.614 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.464 ' CG ' ' N ' ' A' ' 68' ' ' THR . 32.7 tt0 -145.9 163.12 36.11 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.271 1.034 . . . . 1.41 111.271 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.68 ' OG1' HD11 ' B' ' 83' ' ' LEU . 0.0 OUTLIER -138.74 149.0 44.58 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.654 -0.869 . . . . 0.52 108.654 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.662 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -174.42 160.42 29.89 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 107.701 -2.16 . . . . 0.4 107.701 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.533 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 40.0 p -102.02 158.85 15.85 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.777 1.288 . . . . 0.42 110.583 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.8 OUTLIER -154.23 173.96 15.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 1.29 110.312 178.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.9 138.45 19.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.611 0.72 . . . . 1.02 111.262 -178.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 1.0 OUTLIER -148.16 101.77 3.3 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.045 -0.724 . . . . 2.23 109.045 177.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.0 t70 86.41 36.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.181 0.515 . . . . 1.38 110.144 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.68 30.7 6.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.25 -0.906 . . . . 2.62 109.338 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.18 151.62 32.15 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.244 -0.91 . . . . 3.15 109.477 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -85.3 137.98 32.61 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.566 1.174 . . . . 2.44 109.598 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 tt -143.35 155.91 16.8 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 114.925 -1.034 . . . . 0.23 108.549 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.0 p -90.35 155.8 18.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.986 0.898 . . . . 0.74 111.44 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.662 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 6.1 p90 -142.48 148.38 37.6 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.79 -0.641 . . . . 4.16 109.977 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.662 HG21 HG21 ' B' ' 81' ' ' ILE . 2.0 pp -123.12 133.72 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.184 -1.043 . . . . 0.92 108.184 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 80' ' ' TYR . 16.2 mt -106.89 126.06 51.82 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.437 -0.949 . . . . 0.36 108.437 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.818 HD11 ' OG1' ' B' ' 68' ' ' THR . 0.5 OUTLIER -131.52 123.7 28.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.981 -1.075 . . . . 0.98 111.025 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -102.46 165.58 11.02 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.197 -0.91 . . . . 0.58 110.372 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 50' ' ' TYR . 2.5 tp -157.67 144.68 18.18 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 119.302 -0.959 . . . . 1.39 111.423 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -126.4 143.69 51.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.17 0.509 . . . . 1.42 110.326 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.475 ' NH1' ' CG2' ' A' ' 61' ' ' VAL . 20.3 mmt180 -96.9 139.05 33.51 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.379 -0.826 . . . . 1.64 110.049 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 88' ' ' VAL . 51.4 t -117.14 -9.66 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.791 -0.818 . . . . 0.63 108.791 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 117.977 -1.011 . . . . 1.76 109.511 179.577 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.518 HD22 HD11 ' B' ' 8' ' ' ILE . 1.4 t30 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 120.878 0.37 . . . . 1.46 110.664 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.0 pt-20 -94.01 107.37 19.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.661 -1.274 . . . . 1.49 107.724 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.518 HD11 HD22 ' B' ' 6' ' ' ASN . 0.2 OUTLIER -120.44 146.33 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 122.205 1.002 . . . . 1.17 110.884 -178.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.491 ' O ' HG13 ' B' ' 9' ' ' VAL . 10.0 p -99.19 124.53 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.86 -0.609 . . . . 1.37 109.375 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.43 166.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.376 -0.972 . . . . 0.37 108.376 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -136.9 168.34 19.75 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.815 0.817 . . . . 2.37 110.927 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -87.62 -11.36 48.75 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.899 -0.778 . . . . 1.75 108.899 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' THR . . . . . 0.416 HG22 ' H ' ' B' ' 13' ' ' THR . 0.1 OUTLIER -76.23 -64.21 1.15 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.436 -1.306 . . . . 1.19 107.806 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.408 ' H ' HG23 ' B' ' 13' ' ' THR . 0.0 OUTLIER -58.08 146.72 32.06 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.906 -1.121 . . . . 1.47 109.813 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.91 -179.8 6.26 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.049 -0.723 . . . . 1.22 109.049 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.474 ' HA ' HG22 ' B' ' 49' ' ' VAL . 2.4 m -76.75 -32.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.335 -0.987 . . . . 0.45 108.335 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -81.04 -33.71 33.33 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.648 -0.871 . . . . 1.7 108.648 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -67.32 -28.32 67.89 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.742 -1.224 . . . . 1.46 109.843 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.789 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.1 OUTLIER -91.37 -18.18 24.67 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.385 -1.447 . . . . 1.4 108.644 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.96 -29.39 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 104.98 -2.23 . . . . 0.34 104.98 176.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.704 ' O ' HG23 ' B' ' 25' ' ' VAL . 34.9 mt -69.78 -50.75 40.1 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.498 -1.228 . . . . 0.38 108.52 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -65.82 -26.37 67.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.796 -1.19 . . . . 1.21 109.335 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.789 HG23 ' O ' ' B' ' 19' ' ' HIS . 77.2 t -74.71 -54.76 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.945 . . . . 0.3 109.719 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.649 HD12 ' NH2' ' B' ' 87' ' ' ARG . 3.9 tp -57.72 -19.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.064 -1.022 . . . . 0.69 108.574 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 21' ' ' LEU . 50.4 t -70.83 -41.59 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.185 -0.947 . . . . 0.42 109.48 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.597 HD23 ' N ' ' B' ' 26' ' ' LEU . 0.3 OUTLIER -70.06 -37.99 75.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.539 -1.35 . . . . 1.15 109.766 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.08 -29.36 67.28 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.608 -1.627 . . . . 1.46 106.608 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -25.59 65.98 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.035 -0.984 . . . . 1.17 108.986 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -90.41 -7.17 53.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.959 . . . . 1.17 109.194 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.01 15.07 10.27 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.287 -1.125 . . . . 0.38 110.287 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 40.4 mm -76.74 106.26 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.781 -1.423 . . . . 0.59 108.471 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.7 -36.46 14.32 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.36 -0.838 . . . . 1.46 110.178 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -102.49 141.72 34.86 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.55 0.69 . . . . 1.2 110.582 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.415 HG13 ' OH ' ' B' ' 50' ' ' TYR . 11.6 p -151.66 141.94 15.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 119.504 -0.878 . . . . 0.49 110.72 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.2 120.96 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 109.613 -0.514 . . . . 0.31 109.613 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.672 HD22 ' CE1' ' B' ' 50' ' ' TYR . 1.4 mp -106.65 131.96 53.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.565 -0.71 . . . . 0.48 110.529 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.31 127.15 49.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.338 -0.986 . . . . 2.74 108.338 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.28 141.64 12.82 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.993 -1.099 . . . . 0.24 110.443 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.57 ' O ' ' N ' ' B' ' 41' ' ' ARG . 62.4 p -131.68 137.14 48.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.636 -0.92 . . . . 0.49 111.42 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 35.81 -84.9 0.01 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 111.793 -0.523 . . . . 0.28 111.793 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -82.3 -54.69 5.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.917 -1.343 . . . . 3.16 109.767 -178.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -16.66 11.65 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.574 -1.269 . . . . 1.38 107.574 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.6 HG12 HG23 ' B' ' 81' ' ' ILE . 0.3 OUTLIER -55.64 -33.46 33.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.214 -0.929 . . . . 0.85 110.368 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.17 -22.44 36.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.121 -0.987 . . . . 1.12 108.648 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.703 ' O ' HG23 ' B' ' 49' ' ' VAL . 1.2 mptt -68.07 -71.86 0.2 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.326 -1.361 . . . . 1.87 107.326 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.589 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -37.12 -47.56 0.76 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.05 0.452 . . . . 0.26 110.555 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.11 -61.35 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.096 -1.003 . . . . 0.28 109.034 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ASP . . . . . 0.46 ' OD1' HG21 ' B' ' 16' ' ' VAL . 10.7 t70 -56.4 -49.73 73.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.291 -0.881 . . . . 1.25 109.149 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 45' ' ' LYS . 61.3 t -46.2 -56.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.411 -0.959 . . . . 1.06 108.411 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.672 ' CE1' HD22 ' B' ' 36' ' ' LEU . 2.9 m-30 -64.54 -54.45 31.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.5 -0.75 . . . . 4.11 110.75 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . 0.533 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -50.77 -52.52 40.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.616 -1.303 . . . . 1.41 108.398 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.42 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 1.1 m -59.88 -30.21 68.84 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.649 -0.82 . . . . 0.65 109.522 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.453 HD11 ' NH2' ' B' ' 87' ' ' ARG . 27.7 tp -74.07 -23.62 59.39 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.966 -1.084 . . . . 0.53 109.55 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . 0.407 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -82.26 -30.47 30.66 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.664 -1.606 . . . . 0.99 106.664 178.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -14.67 6.31 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.752 -1.203 . . . . 1.46 107.752 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.407 ' N ' ' C ' ' B' ' 54' ' ' LYS . 20.5 mmm180 -73.29 -42.85 61.95 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.587 -0.845 . . . . 1.71 109.626 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.7 mt -153.32 -21.05 0.15 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.117 -1.433 . . . . 1.77 112.678 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.21 -62.0 0.06 OUTLIER Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.187 -1.482 . . . . 0.39 110.212 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -67.74 -38.39 83.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.259 -1.142 . . . . 1.4 109.555 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.83 28.2 6.7 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.07 -1.612 . . . . 0.34 109.07 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.541 HG13 HD21 ' B' ' 85' ' ' LEU . 4.0 t -153.96 132.31 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.554 -1.276 . . . . 0.46 107.554 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.7 mm100 -135.55 154.16 51.46 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.876 0.846 . . . . 1.42 111.608 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 tt -94.43 118.57 31.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.482 -0.933 . . . . 0.54 108.482 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.66 -17.82 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.815 . . . . 1.43 110.551 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -178.4 157.29 1.01 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.651 -1.281 . . . . 1.28 109.458 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.746 HG13 HG13 ' A' ' 66' ' ' VAL . 2.6 p -165.26 136.83 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.408 -0.807 . . . . 0.9 109.353 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . 0.436 ' CG ' ' N ' ' B' ' 68' ' ' THR . 33.1 tt0 -148.48 165.17 31.99 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.424 1.107 . . . . 1.44 111.546 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.818 ' OG1' HD11 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -138.44 152.02 47.97 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.207 -0.906 . . . . 0.45 108.56 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.66 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -176.96 157.36 22.35 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.261 -2.336 . . . . 0.29 107.261 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.583 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 59.6 p -96.1 159.05 15.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.903 -1.351 . . . . 0.39 109.41 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -154.03 172.39 17.57 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.002 -1.061 . . . . 1.49 109.95 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.448 HG23 ' H ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -89.52 134.02 29.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.768 -0.773 . . . . 0.87 110.64 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 0.0 OUTLIER -143.58 100.4 3.59 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.303 -0.628 . . . . 2.18 109.303 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.7 t70 79.82 41.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.825 -0.547 . . . . 1.35 109.888 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.14 26.31 10.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.34 -0.85 . . . . 2.57 109.267 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.18 154.93 38.85 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.426 -0.796 . . . . 3.14 109.341 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -88.72 136.53 32.96 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.209 -0.996 . . . . 2.39 111.29 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.74 154.02 33.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.104 -1.073 . . . . 0.58 108.104 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.32 152.57 22.64 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.552 -0.717 . . . . 0.61 109.809 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.66 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 5.8 p90 -142.51 146.67 34.94 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.768 -0.773 . . . . 4.08 109.992 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 81' ' ' ILE . 2.0 pp -120.64 133.59 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.016 -1.105 . . . . 0.9 108.016 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' B' ' 80' ' ' TYR . 13.2 mt -109.24 122.74 47.98 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.336 -1.357 . . . . 0.37 107.336 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.68 HD11 ' OG1' ' A' ' 68' ' ' THR . 0.4 OUTLIER -128.67 127.22 41.72 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.088 -1.045 . . . . 0.98 110.921 -178.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -102.02 169.32 8.83 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.494 -0.775 . . . . 0.71 109.456 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.541 HD21 HG13 ' B' ' 61' ' ' VAL . 1.7 tp -160.45 140.22 11.12 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.288 -0.965 . . . . 1.44 110.24 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.1 OUTLIER -123.11 146.39 47.76 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.528 -0.545 . . . . 1.31 109.528 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . 0.649 ' NH2' HD12 ' B' ' 24' ' ' ILE . 20.4 mmt180 -98.48 136.2 38.95 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.836 . . . . 1.64 110.216 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.511 ' O ' HG12 ' B' ' 88' ' ' VAL . 23.2 t -113.4 -7.61 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.587 -0.894 . . . . 0.68 108.587 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 117.941 -1.028 . . . . 1.77 109.48 179.559 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.734 ' ND2' HD13 ' A' ' 26' ' ' LEU . 50.0 t30 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 121.252 0.548 . . . . 1.72 111.123 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 7' ' ' GLU . 9.9 pt-20 -91.91 119.47 31.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.893 -1.13 . . . . 1.44 109.045 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.533 HD11 HD21 ' A' ' 6' ' ' ASN . 3.5 mm -124.42 147.99 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 CA-C-O 122.32 1.057 . . . . 1.11 112.091 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.3 t -111.6 130.31 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.783 0.801 . . . . 1.35 109.959 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.585 HG11 ' H ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -88.33 161.47 2.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.257 -1.016 . . . . 0.39 108.257 -178.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HD2' ' HZ3' ' A' ' 14' ' ' LYS . 1.5 mtt-85 -132.9 166.41 22.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.234 -0.916 . . . . 2.27 110.321 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -25.26 39.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.739 -0.837 . . . . 1.78 108.739 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.8 p -68.61 -63.04 1.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.224 -1.769 . . . . 1.24 106.224 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.519 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 11.9 mptt -55.42 131.93 47.07 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.068 0.937 . . . . 1.41 110.123 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -72.12 180.0 3.07 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.592 0.71 . . . . 1.25 110.002 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 17' ' ' GLU . 4.0 m -73.45 -33.68 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.443 -1.317 . . . . 0.49 107.443 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 3.7 tt0 -72.65 -37.48 67.97 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.358 -0.979 . . . . 1.56 108.358 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -31.42 67.14 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.035 -1.041 . . . . 1.38 111.439 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.735 ' O ' HG23 ' A' ' 23' ' ' VAL . 54.3 m-70 -93.69 -17.33 23.33 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.217 -1.552 . . . . 1.43 108.66 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -34.14 59.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 104.296 -2.483 . . . . 0.29 104.296 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 25' ' ' VAL . 66.6 mt -70.45 -51.14 31.45 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.72 -1.127 . . . . 0.41 109.362 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.86 -30.94 71.24 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.888 -1.133 . . . . 1.22 109.298 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 19' ' ' HIS . 53.4 t -70.62 -55.22 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -0.86 . . . . 0.32 109.822 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.3 tt -60.85 -19.77 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.939 -1.101 . . . . 0.58 108.594 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 21' ' ' LEU . 5.2 t -73.39 -42.99 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.211 -0.931 . . . . 0.41 108.961 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.734 HD13 ' ND2' ' A' ' 6' ' ' ASN . 4.3 mt -65.61 -34.88 79.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.773 -1.204 . . . . 1.19 110.102 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -64.39 -26.22 68.37 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.319 -1.363 . . . . 1.46 107.319 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -26.92 68.71 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.309 -0.86 . . . . 1.15 109.646 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -90.26 1.77 56.15 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.909 -1.119 . . . . 1.17 109.402 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.65 13.81 31.38 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.201 -1.559 . . . . 0.42 109.201 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mm -75.57 109.27 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.252 -1.146 . . . . 0.35 108.007 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -99.87 6.51 45.3 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.251 -0.906 . . . . 1.55 110.736 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -146.43 147.1 30.89 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.929 -1.107 . . . . 1.58 108.936 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.53 142.02 11.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 118.786 -1.166 . . . . 0.54 111.017 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -114.42 120.61 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.634 -0.712 . . . . 0.25 109.312 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 46' ' ' ALA . 4.2 mp -105.21 121.31 43.58 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.978 -0.689 . . . . 0.4 109.812 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -108.03 133.18 52.7 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.89 -0.782 . . . . 2.74 108.89 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.488 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -144.31 157.19 27.1 Favored Glycine 0 N--CA 1.503 3.114 0 C-N-CA 119.879 -1.153 . . . . 0.21 111.539 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.56 ' CG2' ' CD2' ' A' ' 80' ' ' TYR . 10.2 p -137.88 145.23 41.9 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.582 -0.952 . . . . 0.56 112.856 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.562 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 38.38 -87.26 0.01 OUTLIER Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.687 -0.965 . . . . 0.33 110.687 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.675 ' HE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -80.22 -52.59 7.56 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.327 -1.102 . . . . 3.09 109.829 -178.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.75 -19.61 64.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.892 -1.13 . . . . 1.09 109.145 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 40' ' ' GLY . 7.1 tt -54.71 -35.49 33.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.142 -0.974 . . . . 0.87 111.202 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.432 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.32 -22.71 32.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.953 -1.092 . . . . 1.14 108.875 -178.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' O ' HG12 ' A' ' 49' ' ' VAL . 1.3 mptt -63.47 -69.34 0.28 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.069 -2.196 . . . . 1.86 105.069 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' H ' HG11 ' A' ' 10' ' ' VAL . . . -34.22 -38.1 0.06 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.479 0.657 . . . . 0.29 109.843 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.764 HG13 ' HB ' ' B' ' 68' ' ' THR . 99.0 t -74.01 -73.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.243 -0.91 . . . . 0.22 109.546 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -40.41 -53.21 2.66 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.351 0.596 . . . . 1.26 111.103 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 50' ' ' TYR . 13.2 p -55.7 -47.64 78.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.318 -0.864 . . . . 1.06 109.486 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.633 ' CD2' ' N ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -61.37 -54.86 38.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.665 -1.272 . . . . 4.02 109.284 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.633 ' N ' ' CD2' ' A' ' 50' ' ' TYR . 27.9 t-20 -56.22 -48.55 76.24 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.546 -1.279 . . . . 1.34 107.546 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.6 m -60.72 -32.7 71.95 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.915 -1.143 . . . . 1.04 107.915 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.548 HD22 HG11 ' A' ' 23' ' ' VAL . 10.5 tp -80.69 -20.85 42.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.64 -1.244 . . . . 0.44 107.64 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.14 -46.49 14.83 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.906 -1.887 . . . . 1.0 105.906 177.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -57.66 -6.53 0.52 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.772 -1.195 . . . . 1.58 107.772 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -70.1 -50.42 41.01 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 121.427 -0.796 . . . . 1.69 109.251 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.2 mt -152.19 -16.71 0.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.169 -1.013 . . . . 1.66 110.748 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.53 -50.48 0.07 OUTLIER Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.75 -1.214 . . . . 0.39 110.609 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -74.62 -47.1 34.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -1.176 . . . . 1.38 110.35 -178.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.68 27.17 3.41 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.748 -1.741 . . . . 0.26 108.748 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -154.23 136.25 6.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.26 -1.141 . . . . 0.38 108.267 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.718 ' O ' HD23 ' A' ' 85' ' ' LEU . 6.0 mm-40 -138.91 153.92 48.3 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 122.465 1.126 . . . . 1.31 112.257 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.561 HD11 HG21 ' A' ' 66' ' ' VAL . 6.9 tt -95.85 109.15 21.54 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.155 -1.424 . . . . 0.49 107.155 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.01 -23.79 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.163 -0.961 . . . . 1.35 110.045 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -168.61 156.26 7.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.31 -1.494 . . . . 1.2 109.513 177.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 63' ' ' LEU . 74.1 t -161.15 131.49 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.91 -0.774 . . . . 0.85 108.91 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 68' ' ' THR . 19.1 tt0 -143.2 158.38 43.67 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.998 0.904 . . . . 1.41 110.612 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.469 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -109.25 165.54 11.54 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.578 0.704 . . . . 0.52 109.356 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 80' ' ' TYR . . . -169.83 176.38 43.67 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.729 -1.348 . . . . 0.4 109.729 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.434 ' OG ' ' OD1' ' B' ' 51' ' ' ASN . 10.9 p -153.0 152.9 31.91 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.906 -1.146 . . . . 0.42 107.906 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -160.24 176.91 11.19 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.045 -1.034 . . . . 1.29 109.908 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -89.34 139.91 16.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 119.589 -0.844 . . . . 1.02 110.435 -178.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 52.1 ttt180 -146.23 98.89 3.16 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.805 -0.813 . . . . 2.23 108.805 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 8.3 t0 88.87 34.58 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.334 0.588 . . . . 1.38 109.562 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.93 38.87 6.18 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.293 1.044 . . . . 2.62 109.367 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -157.66 151.63 24.32 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.594 -0.891 . . . . 3.15 108.594 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -84.77 138.55 32.54 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.848 1.308 . . . . 2.44 110.757 -177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -139.07 152.63 24.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 114.271 -1.332 . . . . 0.23 107.592 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 p -88.33 162.87 16.33 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.204 1.002 . . . . 0.74 111.53 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.56 ' CD2' ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -139.72 138.52 36.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.38 -0.827 . . . . 4.16 109.692 -177.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.7 tt -119.04 129.48 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.858 -1.164 . . . . 0.92 107.858 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 67' ' ' GLN . 14.9 mt -108.71 119.17 38.75 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.929 -1.508 . . . . 0.36 106.929 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.1 tt -127.02 127.16 44.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.235 -0.916 . . . . 0.98 110.647 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 14.4 ttt180 -99.92 172.21 7.37 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.98 -0.554 . . . . 0.58 109.681 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 62' ' ' GLN . 3.0 mt -161.24 145.03 13.07 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.555 -0.858 . . . . 1.39 110.094 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 62' ' ' GLN . 5.3 tmtm? -131.21 157.39 43.34 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.565 -0.531 . . . . 1.42 109.565 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -113.56 139.41 49.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.438 -0.789 . . . . 1.64 109.72 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 88' ' ' VAL . 48.8 t -116.2 -5.09 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.038 -0.727 . . . . 0.63 109.038 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 118.043 -0.979 . . . . 1.76 109.597 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.742 ' ND2' HD13 ' B' ' 26' ' ' LEU . 1.2 t30 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.51 0.195 . . . . 1.46 110.772 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -89.7 103.55 16.19 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.339 -1.475 . . . . 1.49 107.875 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mm -114.34 139.86 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.738 0.78 . . . . 1.17 109.78 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 66.9 t -104.19 129.0 57.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.594 0.711 . . . . 1.37 109.614 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.554 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -88.38 162.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.148 -1.056 . . . . 0.37 108.148 -178.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -138.0 171.79 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 2.37 110.183 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -9.64 39.74 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.463 -0.94 . . . . 1.75 108.463 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 33.5 p -89.41 -6.1 56.84 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.739 -0.785 . . . . 1.19 109.038 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -97.6 -132.92 0.22 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.627 -1.249 . . . . 1.47 107.627 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -168.15 167.07 12.61 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.882 -0.784 . . . . 1.22 108.882 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.422 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.0 m -66.43 -36.6 77.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.754 -1.202 . . . . 0.45 107.754 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 4.8 mm-40 -73.73 -39.94 63.92 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.328 -0.99 . . . . 1.7 108.328 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -60.87 -31.95 71.4 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.173 -0.954 . . . . 1.46 111.917 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.744 ' O ' HG23 ' B' ' 23' ' ' VAL . 49.1 m-70 -92.99 -17.54 23.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 119.835 -1.791 . . . . 1.4 108.907 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -33.84 55.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 104.427 -2.435 . . . . 0.34 104.427 176.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.553 ' O ' HG23 ' B' ' 25' ' ' VAL . 52.6 mt -68.72 -51.7 38.64 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.648 -1.16 . . . . 0.38 109.058 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.04 -31.48 72.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 1.21 109.729 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.744 HG23 ' O ' ' B' ' 19' ' ' HIS . 52.9 t -69.68 -55.91 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.3 109.837 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 20.9 tt -61.32 -20.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.067 -1.021 . . . . 0.69 108.873 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 21' ' ' LEU . 4.8 t -71.11 -42.95 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.42 109.098 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.742 HD13 ' ND2' ' B' ' 6' ' ' ASN . 5.0 mt -65.73 -41.44 92.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.854 -1.154 . . . . 1.15 109.739 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -58.05 -29.95 65.79 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.211 -1.403 . . . . 1.46 107.211 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -28.34 65.43 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.477 -0.783 . . . . 1.17 108.899 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -89.55 -1.23 57.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 1.17 109.368 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.92 15.01 23.39 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.57 -1.412 . . . . 0.38 109.57 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 45.6 mm -78.56 108.17 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -1.162 . . . . 0.59 108.82 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -92.77 -36.5 12.85 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.26 -0.9 . . . . 1.46 110.226 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -101.54 143.37 31.61 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.577 0.703 . . . . 1.2 110.905 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' B' ' 6' ' ' ASN . 9.8 p -154.57 143.04 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 119.554 -0.858 . . . . 0.49 111.026 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.54 123.2 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.223 0.535 . . . . 0.31 109.87 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.95 121.08 42.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.738 -0.602 . . . . 0.48 109.991 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -106.75 129.84 54.56 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.37 -0.604 . . . . 2.74 109.37 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -143.49 156.43 26.57 Favored Glycine 0 N--CA 1.507 3.385 0 C-N-CA 119.662 -1.256 . . . . 0.24 111.76 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.602 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 1.8 p -137.95 145.97 42.65 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.481 -1.011 . . . . 0.49 112.916 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.566 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 37.68 -86.1 0.01 OUTLIER Glycine 0 N--CA 1.499 2.869 0 N-CA-C 110.571 -1.012 . . . . 0.28 110.571 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.67 ' HE ' ' N ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -80.71 -52.99 6.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.359 -1.083 . . . . 3.16 109.792 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -19.53 65.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.956 -1.09 . . . . 1.38 109.535 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.566 HG22 ' O ' ' B' ' 40' ' ' GLY . 7.1 tt -56.01 -31.6 31.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.905 -1.122 . . . . 0.85 109.818 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -24.6 33.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 1.12 108.656 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.492 ' O ' HG12 ' B' ' 49' ' ' VAL . 2.2 mptt -65.04 -70.84 0.21 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.642 -1.985 . . . . 1.87 105.642 177.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.554 ' H ' HG11 ' B' ' 10' ' ' VAL . . . -32.37 -40.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.25 0.548 . . . . 0.26 110.527 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 43' ' ' ILE . 94.6 t -79.13 -64.5 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.111 -0.993 . . . . 0.28 110.011 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -44.97 -52.95 8.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.347 -0.846 . . . . 1.25 109.952 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.583 HG13 ' N ' ' B' ' 50' ' ' TYR . 11.1 p -55.58 -46.62 79.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.576 -0.849 . . . . 1.06 109.204 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.643 ' CD2' ' N ' ' B' ' 51' ' ' ASN . 0.0 OUTLIER -62.81 -54.89 32.0 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.91 -1.119 . . . . 4.11 109.162 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . 0.643 ' N ' ' CD2' ' B' ' 50' ' ' TYR . 23.3 t-20 -53.83 -47.64 70.71 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.271 -1.381 . . . . 1.41 107.271 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -63.62 -31.57 72.77 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.194 -1.002 . . . . 0.65 109.141 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.494 HD22 HG11 ' B' ' 23' ' ' VAL . 13.7 tp -73.49 -23.2 60.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.054 -1.029 . . . . 0.53 109.774 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' LYS . . . . . 0.407 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -83.18 -30.57 27.69 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.47 -1.678 . . . . 0.99 106.47 177.435 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.46 -14.6 3.17 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.745 -1.206 . . . . 1.46 107.745 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.407 ' N ' ' C ' ' B' ' 54' ' ' LYS . 1.0 OUTLIER -71.61 -47.41 54.85 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.532 -0.867 . . . . 1.71 109.559 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' LEU . . . . . 0.605 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.7 mt -155.11 -15.24 0.11 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.99 -1.484 . . . . 1.77 112.638 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.33 -57.52 0.07 OUTLIER Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.22 -1.466 . . . . 0.39 110.219 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.605 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -71.05 -44.24 66.19 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.298 -1.119 . . . . 1.4 110.089 -179.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.65 25.74 5.01 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.231 -1.548 . . . . 0.34 109.231 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 22.6 t -154.6 135.42 4.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.0 -1.111 . . . . 0.46 108.0 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.719 ' O ' HD23 ' B' ' 85' ' ' LEU . 5.4 mm-40 -140.86 154.39 46.16 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.534 1.159 . . . . 1.42 112.422 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.446 HD11 HG21 ' B' ' 66' ' ' VAL . 6.5 tt -96.16 114.48 26.18 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.898 -1.047 . . . . 0.54 108.285 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.88 -13.69 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 119.54 -0.864 . . . . 1.43 110.763 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -177.69 151.43 0.72 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.06 -1.65 . . . . 1.28 110.63 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.446 HG21 HD11 ' B' ' 63' ' ' LEU . 63.1 t -158.22 135.43 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.554 -0.717 . . . . 0.9 109.341 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' GLN . . . . . 0.508 ' HB3' HD12 ' B' ' 82' ' ' LEU . 36.0 tt0 -143.99 160.14 41.37 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.016 0.913 . . . . 1.44 111.579 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.764 ' HB ' HG13 ' A' ' 47' ' ' VAL . 6.5 p -117.87 163.7 16.14 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.459 -0.791 . . . . 0.45 109.025 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' B' ' 80' ' ' TYR . . . 177.76 134.61 2.08 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.717 -1.353 . . . . 0.29 109.717 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.645 ' CB ' ' HE ' ' B' ' 77' ' ' ARG . 65.3 p -91.95 156.3 17.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.292 -1.711 . . . . 0.39 109.513 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -150.65 164.48 35.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 1.49 110.088 -179.066 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.568 ' N ' ' OE1' ' B' ' 71' ' ' GLU . 0.1 OUTLIER -88.74 136.23 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.185 -0.947 . . . . 0.87 110.295 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 49.2 ttt180 -148.06 101.93 3.33 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.187 -0.946 . . . . 2.18 109.661 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 6.7 t0 86.13 34.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.694 -0.854 . . . . 1.35 108.694 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.7 34.47 9.62 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.094 0.949 . . . . 2.57 108.601 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -152.98 150.28 29.06 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.601 -0.888 . . . . 3.14 108.601 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.645 ' HE ' ' CB ' ' B' ' 70' ' ' SER . 4.2 ttt85 -87.04 140.67 29.32 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.525 1.155 . . . . 2.39 111.218 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 10.3 tt -136.79 153.68 30.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.713 -1.218 . . . . 0.58 107.713 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.32 155.49 21.31 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.221 -0.924 . . . . 0.61 109.711 -176.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.602 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.1 OUTLIER -137.56 138.03 39.17 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.209 -0.663 . . . . 4.08 109.209 -177.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.525 HG23 ' O ' ' B' ' 81' ' ' ILE . 1.3 tt -120.56 130.59 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.297 -1.001 . . . . 0.9 108.297 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' B' ' 67' ' ' GLN . 3.7 mt -108.28 119.21 38.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.469 -1.678 . . . . 0.37 106.469 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tt -124.63 126.09 45.19 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.511 -0.876 . . . . 0.98 110.721 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -97.14 171.54 8.39 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.757 -0.831 . . . . 0.71 108.757 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.719 HD23 ' O ' ' B' ' 62' ' ' GLN . 2.4 mt -160.41 141.6 12.16 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.559 -0.857 . . . . 1.44 109.352 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' B' ' 62' ' ' GLN . 9.2 tttm -127.26 148.11 50.22 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.019 0.437 . . . . 1.31 110.188 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -106.0 137.76 43.36 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.505 -0.747 . . . . 1.64 109.421 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.489 ' O ' HG12 ' B' ' 88' ' ' VAL . 75.7 t -116.2 -4.45 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.061 -0.718 . . . . 0.68 109.061 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 118.077 -0.963 . . . . 1.77 109.473 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.51 -0.552 . . . . 6.33 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.49 66.69 1.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.717 0.77 . . . . 2.53 109.069 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' O ' ' O ' ' A' ' 30' ' ' GLY . 6.9 mt-10 -76.95 -29.62 55.66 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.606 -0.684 . . . . 1.75 110.08 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.59 59.14 1.2 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.479 -0.763 . . . . 2.24 110.105 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.2 tp -172.51 52.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.684 -0.858 . . . . 1.67 108.684 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.822 ' ND2' HD11 ' A' ' 8' ' ' ILE . 48.2 t30 -88.64 103.14 15.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.903 . . . . 1.72 111.137 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -91.47 124.98 36.05 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.456 -0.942 . . . . 1.44 108.456 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.822 HD11 ' ND2' ' A' ' 6' ' ' ASN . 10.4 mt -137.12 154.4 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 119.918 -0.713 . . . . 1.11 111.205 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.56 138.63 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.723 -0.843 . . . . 1.35 108.723 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 p -91.06 163.5 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.942 -1.099 . . . . 0.39 108.683 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -129.67 163.65 25.63 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.836 0.827 . . . . 2.27 109.986 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -95.11 -17.49 21.78 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.174 -1.047 . . . . 1.78 108.174 178.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -73.42 -44.56 58.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.374 -0.973 . . . . 1.24 108.374 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 146.51 39.08 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.236 -0.915 . . . . 1.41 109.294 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -69.0 -179.44 1.5 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.099 -1.001 . . . . 1.25 108.632 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.638 HG23 ' N ' ' A' ' 17' ' ' GLU . 27.2 m -78.62 -50.2 19.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.872 -1.142 . . . . 0.49 109.458 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.638 ' N ' HG23 ' A' ' 16' ' ' VAL . 4.1 pt-20 -57.88 -19.69 31.26 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.076 -1.015 . . . . 1.56 110.529 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.61 -30.37 69.09 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.379 -1.451 . . . . 1.38 108.239 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.8 OUTLIER -89.27 -23.57 22.28 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.845 -0.742 . . . . 1.43 109.015 179.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.41 -27.8 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 106.532 -1.655 . . . . 0.29 106.532 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 25' ' ' VAL . 27.2 mt -75.37 -48.94 20.65 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.117 -1.068 . . . . 0.41 108.117 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -66.73 -22.01 66.06 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.537 -0.727 . . . . 1.22 109.597 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 19' ' ' HIS . 11.9 t -78.79 -54.41 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.154 -0.966 . . . . 0.32 109.783 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.1 tt -55.6 -28.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.147 -0.97 . . . . 0.58 108.924 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 21' ' ' LEU . 58.0 t -72.67 -43.97 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.231 -1.026 . . . . 0.41 108.231 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.646 HD13 HD22 ' A' ' 6' ' ' ASN . 44.8 mt -63.8 -39.73 94.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.53 -0.731 . . . . 1.19 109.692 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 3.2 t80 -69.77 -0.93 7.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 1.46 108.786 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.72 -26.69 19.41 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.981 -1.118 . . . . 1.15 107.981 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -86.82 3.96 43.14 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.519 -0.738 . . . . 1.17 109.648 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 106.64 6.84 34.95 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.171 -1.172 . . . . 0.42 110.171 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -75.7 95.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -1.234 . . . . 0.35 109.407 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -87.37 -33.95 18.97 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.232 -0.918 . . . . 1.55 108.82 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -99.5 147.71 25.02 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.366 0.603 . . . . 1.58 109.807 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.15 149.07 10.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 119.163 -1.015 . . . . 0.54 109.488 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.1 mt -129.7 117.24 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.494 0.664 . . . . 0.25 110.732 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 46' ' ' ALA . 4.6 mp -100.68 127.17 47.18 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.893 -0.781 . . . . 0.4 108.893 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -115.3 139.93 49.55 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.015 -1.106 . . . . 2.74 108.015 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.81 163.96 28.83 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 119.379 -1.391 . . . . 0.21 110.444 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 41' ' ' ARG . 36.4 p -137.46 148.1 45.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.503 -0.998 . . . . 0.56 110.914 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 36.94 -85.65 0.01 OUTLIER Glycine 0 N--CA 1.5 2.947 0 O-C-N 122.0 -0.438 . . . . 0.33 112.179 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -87.14 -42.87 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -1.174 . . . . 3.09 110.34 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.58 -22.34 66.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.66 -1.275 . . . . 1.09 109.511 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.539 HG13 HG22 ' A' ' 81' ' ' ILE . 8.3 tt -48.23 -54.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.87 109.978 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.497 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.61 -26.57 65.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.906 -1.121 . . . . 1.14 110.903 -178.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -41.27 95.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.638 -1.289 . . . . 1.86 109.066 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -59.83 -38.73 82.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.29 109.245 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.668 HG13 ' HB ' ' B' ' 68' ' ' THR . 48.5 t -59.75 -66.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.654 -0.654 . . . . 0.22 110.643 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -53.54 6.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.797 -0.564 . . . . 1.26 109.804 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG21 ' CB ' ' A' ' 19' ' ' HIS . 9.0 t -46.15 -55.19 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.555 -0.715 . . . . 1.06 109.494 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -64.66 -44.68 89.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.395 -0.816 . . . . 1.27 110.037 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.57 ' CG ' ' H ' ' B' ' 70' ' ' SER . 4.6 t30 -58.46 -48.33 81.08 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.094 -1.004 . . . . 1.34 108.467 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 p -67.46 -29.18 68.57 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.942 -0.762 . . . . 1.04 108.942 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.79 -25.39 44.29 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.385 -0.969 . . . . 0.44 108.385 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -76.28 -46.32 28.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.007 -1.849 . . . . 1.0 106.007 177.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 16.6 t0 -57.63 -6.96 0.56 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.827 -1.079 . . . . 1.58 108.351 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 54' ' ' LYS . 3.1 tpt85 -76.35 -46.53 27.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.727 -0.608 . . . . 1.69 110.148 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' ASP . 6.1 tp -152.42 -29.03 0.16 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.41 -0.916 . . . . 1.66 110.292 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.71 -49.32 0.64 Allowed Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.022 -1.561 . . . . 0.39 109.229 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.502 ' C ' ' H ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER -74.68 -49.79 20.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -1.223 . . . . 1.38 109.055 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.97 23.36 1.36 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.79 -1.724 . . . . 0.26 108.79 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 59' ' ' ASP . 24.1 t -149.86 139.51 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 121.505 -0.997 . . . . 0.38 108.511 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.5 mm-40 -143.27 142.36 31.33 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.229 1.014 . . . . 1.31 110.864 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 tt -93.84 94.26 8.41 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.471 -0.786 . . . . 0.49 109.114 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.427 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -79.33 -35.37 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.904 -1.122 . . . . 1.35 110.126 -179.138 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 64' ' ' VAL . 15.2 m-80 -165.99 157.63 13.94 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.139 -1.425 . . . . 1.2 112.155 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.1 t -158.16 145.37 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.397 -1.335 . . . . 0.85 107.397 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -148.11 165.23 31.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.754 -1.216 . . . . 1.41 108.896 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.4 ' HB ' HG13 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -147.36 129.64 15.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.52 111.007 -178.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -152.38 171.52 31.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.964 -1.655 . . . . 0.4 108.964 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.523 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 9.9 p -112.08 156.45 22.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.693 0.759 . . . . 0.42 110.366 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.29 175.84 13.03 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.511 -0.743 . . . . 1.29 109.552 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.4 t -87.99 132.78 32.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.388 -0.82 . . . . 1.02 110.651 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 34.4 ttt-85 -143.85 99.97 3.5 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.487 -0.931 . . . . 2.23 108.487 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.2 t70 85.69 40.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.205 0.526 . . . . 1.38 109.643 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 60.32 37.68 20.11 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.379 1.085 . . . . 2.62 108.897 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -155.51 149.0 25.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.111 -0.993 . . . . 3.15 108.765 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -83.02 140.88 32.46 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.223 -0.991 . . . . 2.44 109.626 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.3 tt -144.31 156.95 15.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.176 -0.676 . . . . 0.23 109.176 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -87.9 152.79 21.81 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.394 -0.816 . . . . 0.74 109.4 -178.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 9.8 p90 -146.82 151.87 37.82 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.063 -1.023 . . . . 4.16 110.348 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.539 HG22 HG13 ' A' ' 43' ' ' ILE . 10.6 tt -121.75 137.53 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-N 115.667 -0.697 . . . . 0.92 111.488 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.5 mt -110.23 104.71 13.57 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.076 -2.194 . . . . 0.36 105.076 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 tp -106.82 120.47 42.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.878 -0.514 . . . . 0.98 110.081 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -103.69 168.23 9.28 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.907 -0.775 . . . . 0.58 108.907 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.459 HD21 HG13 ' A' ' 61' ' ' VAL . 1.3 tp -160.57 160.11 31.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.951 -1.099 . . . . 1.39 109.999 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -142.15 145.26 34.01 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.52 -0.548 . . . . 1.42 109.52 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -105.08 136.62 44.24 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.55 -0.719 . . . . 1.64 109.373 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 t -107.63 -7.55 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.878 -1.156 . . . . 0.63 107.878 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 117.977 -1.011 . . . . 1.76 109.437 179.591 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mmt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.326 -0.62 . . . . 6.35 109.326 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.2 68.08 1.15 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 2.42 109.562 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 30' ' ' GLY . 83.5 mt-10 -79.59 -20.79 46.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.211 -0.93 . . . . 1.68 109.588 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 59.25 0.93 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.136 -0.978 . . . . 2.31 110.338 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 18.0 tp -172.56 49.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.553 -0.906 . . . . 1.62 108.553 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.759 ' ND2' HD11 ' B' ' 8' ' ' ILE . 49.5 t30 -89.23 101.84 14.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 1.46 111.387 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.1 pt-20 -93.1 121.88 34.9 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.38 -0.97 . . . . 1.49 108.38 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.759 HD11 ' ND2' ' B' ' 6' ' ' ASN . 40.1 mt -134.63 150.91 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.735 -0.603 . . . . 1.17 110.009 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -99.9 138.91 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.878 . . . . 1.37 108.909 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.445 HG23 ' CD2' ' B' ' 19' ' ' HIS . 1.4 p -90.26 160.1 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.967 -1.083 . . . . 0.37 108.499 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.403 ' HE ' ' HE3' ' B' ' 14' ' ' LYS . 12.1 mtt-85 -130.74 167.7 18.41 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.874 0.845 . . . . 2.37 110.505 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.25 -4.65 21.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.507 -0.923 . . . . 1.75 108.507 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . 0.406 ' H ' HG22 ' B' ' 13' ' ' THR . 2.8 t -83.49 -29.05 28.27 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.647 -0.821 . . . . 1.19 110.447 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.411 ' O ' ' OD1' ' B' ' 15' ' ' ASN . 7.5 mttm -83.8 -113.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.78 -1.2 . . . . 1.47 109.415 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' B' ' 14' ' ' LYS . 2.6 m120 -166.18 173.63 10.02 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.393 -1.336 . . . . 1.22 107.393 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.63 HG23 ' N ' ' B' ' 17' ' ' GLU . 22.1 m -70.9 -51.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.606 -1.309 . . . . 0.45 109.112 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.63 ' N ' HG23 ' B' ' 16' ' ' VAL . 6.0 pt-20 -63.11 -24.94 68.13 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.147 -0.97 . . . . 1.7 110.106 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.42 -38.42 91.08 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.39 -1.444 . . . . 1.46 108.359 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.448 ' HB3' HG21 ' B' ' 49' ' ' VAL . 0.7 OUTLIER -83.76 -22.3 31.94 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.894 -0.722 . . . . 1.4 109.841 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.08 -31.05 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.074 -1.454 . . . . 0.34 107.074 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 37.4 mt -70.63 -48.64 53.98 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.264 -1.013 . . . . 0.38 108.264 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -65.62 -26.04 67.65 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.477 -0.764 . . . . 1.21 109.906 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.57 -54.14 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.11 -0.994 . . . . 0.3 110.026 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 5.5 tt -55.15 -28.54 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.69 109.246 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 t -73.38 -43.32 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.198 -0.939 . . . . 0.42 108.631 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 mt -62.37 -45.97 90.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.45 -0.781 . . . . 1.15 109.524 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -53.92 -48.0 70.63 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.746 -1.205 . . . . 1.46 107.746 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -31.01 2.16 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.208 -0.597 . . . . 1.17 109.577 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -84.77 5.43 28.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.952 -1.093 . . . . 1.17 110.031 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 100.25 6.08 53.85 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.924 -1.27 . . . . 0.38 109.924 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 43.5 mm -76.17 88.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.067 -1.255 . . . . 0.59 108.588 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -83.49 -39.08 20.95 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.21 -0.931 . . . . 1.46 109.152 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -93.58 142.11 27.71 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.643 -0.661 . . . . 1.2 109.592 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 p -155.57 151.03 10.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.546 -0.862 . . . . 0.49 109.683 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.56 112.81 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.439 0.638 . . . . 0.31 110.055 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -95.53 133.05 39.98 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.542 -0.724 . . . . 0.48 109.187 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.99 140.03 52.96 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.463 -0.94 . . . . 2.74 108.463 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.99 164.19 28.59 Favored Glycine 0 N--CA 1.502 3.089 0 C-N-CA 119.498 -1.334 . . . . 0.24 110.232 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.548 ' O ' ' N ' ' B' ' 41' ' ' ARG . 76.9 p -135.87 146.37 47.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.701 -0.882 . . . . 0.49 110.763 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.503 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 36.27 -84.02 0.0 OUTLIER Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.847 -0.533 . . . . 0.28 112.615 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.0 OUTLIER -84.5 -45.31 12.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -1.187 . . . . 3.16 110.443 -178.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.2 OUTLIER -66.76 -23.92 66.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.727 -1.233 . . . . 1.38 109.045 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.558 HG13 HG22 ' B' ' 81' ' ' ILE . 7.9 tt -53.85 -20.71 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.85 109.036 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.11 -34.58 13.59 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.279 0.562 . . . . 1.12 110.196 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -25.38 66.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 1.87 110.212 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.435 ' HB2' HG11 ' B' ' 10' ' ' VAL . . . -73.26 -45.74 54.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.962 -1.086 . . . . 0.26 109.975 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.4 HG13 ' HB ' ' A' ' 68' ' ' THR . 88.5 t -61.88 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.28 109.68 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' B' ' 52' ' ' SER . 2.7 t70 -57.43 -56.37 22.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 1.25 109.474 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' B' ' 19' ' ' HIS . 10.3 t -43.89 -49.48 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.672 -0.643 . . . . 1.06 110.006 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.504 ' CE1' HD11 ' B' ' 85' ' ' LEU . 1.1 t80 -68.33 -53.18 25.92 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.426 -0.797 . . . . 1.28 110.295 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.523 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 1.2 t30 -50.3 -45.88 54.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.032 -1.042 . . . . 1.41 108.527 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.6 OUTLIER -68.67 -37.15 79.39 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.559 -0.857 . . . . 0.65 109.171 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 tp -65.89 -26.84 67.8 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.378 -0.826 . . . . 0.53 108.817 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -75.25 -38.69 60.43 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.664 -1.236 . . . . 0.99 107.664 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.26 -7.78 0.41 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.036 -0.727 . . . . 1.46 109.036 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.472 ' H ' ' C ' ' B' ' 54' ' ' LYS . 21.1 mmm180 -82.66 -39.41 22.1 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.548 -0.72 . . . . 1.71 110.727 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' LEU . . . . . 0.425 HD23 ' H ' ' B' ' 60' ' ' GLY . 1.0 OUTLIER -157.14 -35.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 117.928 -1.509 . . . . 1.77 112.595 -179.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.78 -55.03 2.57 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 118.548 -1.786 . . . . 0.39 108.919 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' B' ' 61' ' ' VAL . 0.4 OUTLIER -72.16 -48.68 41.62 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.149 -1.206 . . . . 1.4 108.575 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.425 ' H ' HD23 ' B' ' 57' ' ' LEU . . . -76.79 25.11 1.81 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 108.969 -1.652 . . . . 0.34 108.969 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' B' ' 59' ' ' ASP . 13.0 t -153.07 140.2 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.392 -1.064 . . . . 0.46 108.72 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.5 mm-40 -143.87 141.9 30.54 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.297 1.046 . . . . 1.42 111.669 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.34 94.33 9.08 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.421 -0.809 . . . . 0.54 109.346 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.44 HG22 ' H ' ' B' ' 64' ' ' VAL . 0.0 OUTLIER -74.53 -39.55 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.945 -1.097 . . . . 1.43 110.53 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.491 ' O ' HG23 ' B' ' 66' ' ' VAL . 21.4 m-80 -164.46 164.69 21.88 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.336 -1.346 . . . . 1.28 111.831 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 65' ' ' ASN . 59.2 t -161.07 143.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.718 -1.216 . . . . 0.9 107.718 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -147.76 165.13 31.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.899 -1.125 . . . . 1.44 108.645 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.668 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -148.78 129.48 14.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.088 -1.007 . . . . 0.45 110.232 -178.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.551 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -149.29 169.58 29.61 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.061 -1.216 . . . . 0.29 110.061 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.57 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 23.9 p -104.32 151.21 23.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 122.038 -0.684 . . . . 0.39 109.986 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.65 172.01 16.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 1.49 110.224 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 67.9 t -87.58 133.95 29.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.474 -0.766 . . . . 0.87 110.692 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 17.7 ttt-85 -146.36 101.39 3.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.544 -0.722 . . . . 2.18 109.301 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 1.6 t70 82.2 41.84 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.319 0.58 . . . . 1.35 109.509 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 60.48 32.29 20.49 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.121 0.962 . . . . 2.57 109.212 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -151.9 154.96 37.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.563 -0.903 . . . . 3.14 108.563 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -87.37 142.17 28.08 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.389 -0.924 . . . . 2.39 110.644 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 tt -142.56 157.33 18.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.404 -0.962 . . . . 0.58 108.404 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.15 149.51 24.6 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.797 -0.816 . . . . 0.61 108.797 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.551 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 9.1 p90 -144.49 149.89 36.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.38 -0.825 . . . . 4.08 109.899 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.558 HG22 HG13 ' B' ' 43' ' ' ILE . 2.9 tt -122.08 138.95 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 115.899 -0.591 . . . . 0.9 111.766 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 21.0 mt -108.99 106.99 17.18 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.518 -2.03 . . . . 0.37 105.518 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.5 119.48 39.52 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 118.343 0.519 . . . . 0.98 110.566 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -102.81 164.84 11.39 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.912 -0.773 . . . . 0.71 108.912 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.504 HD11 ' CE1' ' B' ' 50' ' ' TYR . 1.9 tp -160.4 152.19 19.94 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.607 -0.837 . . . . 1.44 109.708 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -136.86 136.07 38.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.452 -0.573 . . . . 1.31 109.452 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -95.18 137.17 34.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.48 -0.762 . . . . 1.64 109.313 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 40.0 t -108.92 -6.85 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 0.68 108.21 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.964 -1.017 . . . . 1.77 109.513 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.498 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.233 0.54 . . . . 6.33 109.548 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.56 103.67 8.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 2.53 109.604 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 30' ' ' GLY . 1.6 mt-10 -165.69 -49.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.799 -0.815 . . . . 1.75 108.799 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.53 53.86 0.54 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.956 0.884 . . . . 2.24 109.687 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -172.1 49.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.563 -1.336 . . . . 1.67 110.15 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.608 HD21 HD22 ' A' ' 26' ' ' LEU . 5.7 m-20 -91.78 111.77 23.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.048 -1.032 . . . . 1.72 111.033 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 7.0 pt-20 -91.67 117.03 29.37 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.604 -1.258 . . . . 1.44 107.604 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 35' ' ' ILE . 12.6 mt -122.43 147.98 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-O 121.889 0.852 . . . . 1.11 112.062 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -111.78 128.17 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.65 0.738 . . . . 1.35 109.796 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -88.4 164.9 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.398 -0.964 . . . . 0.39 108.398 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -138.0 174.9 10.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.439 -0.788 . . . . 2.27 109.827 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -8.38 15.09 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.208 -1.034 . . . . 1.78 108.208 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.423 ' H ' HG22 ' A' ' 13' ' ' THR . 1.0 OUTLIER -90.44 -12.34 37.72 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.35 -1.352 . . . . 1.24 107.35 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -130.41 0.09 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.996 -1.483 . . . . 1.41 106.996 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.79 155.21 21.12 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.803 -1.186 . . . . 1.25 108.925 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 49' ' ' VAL . 11.5 m -62.7 -37.24 78.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 122.121 0.962 . . . . 0.49 108.859 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.86 -31.61 59.37 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.22 -0.925 . . . . 1.56 108.523 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.33 -32.04 73.19 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.614 -1.304 . . . . 1.38 111.452 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.71 ' O ' HG23 ' A' ' 23' ' ' VAL . 85.2 m-70 -90.37 -18.63 25.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 119.806 -1.809 . . . . 1.43 108.74 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.09 -32.15 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 105.147 -2.168 . . . . 0.29 105.147 176.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.816 ' O ' HG23 ' A' ' 25' ' ' VAL . 34.2 mt -69.53 -53.01 21.12 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.729 -1.123 . . . . 0.41 109.294 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -65.86 -28.81 69.24 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.98 -1.075 . . . . 1.22 109.546 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 19' ' ' HIS . 23.2 t -68.72 -54.42 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.421 -0.799 . . . . 0.32 109.01 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 tt -63.5 -17.05 19.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.181 -0.949 . . . . 0.58 108.978 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 21' ' ' LEU . 53.6 t -76.95 -46.7 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.064 -1.023 . . . . 0.41 109.408 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.608 HD22 HD21 ' A' ' 6' ' ' ASN . 11.9 mt -66.22 -33.13 75.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.614 -1.304 . . . . 1.19 110.273 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 4.2 t80 -64.33 -24.73 67.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.79 -1.559 . . . . 1.46 106.79 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -27.29 69.18 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.096 -0.956 . . . . 1.15 109.398 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.466 ' NE2' HD23 ' A' ' 26' ' ' LEU . 17.9 mt-30 -89.89 -4.69 57.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.901 -1.124 . . . . 1.17 109.254 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 111.74 12.22 15.1 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.368 -1.093 . . . . 0.42 110.368 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.4 mm -75.16 106.46 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.038 -1.272 . . . . 0.35 108.475 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.57 -36.91 15.06 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.339 -0.851 . . . . 1.55 110.306 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.95 143.32 31.24 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.827 0.822 . . . . 1.58 110.456 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.67 141.46 14.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 119.555 -0.858 . . . . 0.54 109.942 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -120.81 126.37 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 115.887 -0.597 . . . . 0.25 110.321 -178.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.465 ' CD2' HG21 ' A' ' 49' ' ' VAL . 6.9 mp -108.81 125.13 51.63 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 120.2 -0.6 . . . . 0.4 109.753 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -108.42 131.59 54.62 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.752 -1.203 . . . . 2.74 107.752 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.69 152.75 21.79 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 119.893 -1.146 . . . . 0.21 110.717 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.595 ' O ' ' N ' ' A' ' 41' ' ' ARG . 18.0 p -132.3 139.61 48.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.842 -0.799 . . . . 0.56 112.243 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.542 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 39.51 -85.08 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 N-CA-C 111.406 -0.677 . . . . 0.33 111.406 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -82.09 -54.2 5.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.256 -1.143 . . . . 3.09 109.913 -178.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -19.34 48.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.785 -1.197 . . . . 1.09 108.564 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 40' ' ' GLY . 4.9 tt -53.97 -30.91 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.388 -0.82 . . . . 0.87 110.673 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.41 ' HA ' HD13 ' B' ' 43' ' ' ILE . 0.8 OUTLIER -85.6 -22.53 27.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.563 -1.336 . . . . 1.14 108.54 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' VAL . 24.3 mmtp -63.33 -69.24 0.28 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.078 -1.823 . . . . 1.86 106.078 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 45' ' ' LYS . . . -29.22 -38.18 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.784 0.802 . . . . 0.29 109.959 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.693 HG13 ' HB ' ' B' ' 68' ' ' THR . 65.8 t -73.64 -74.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.696 -0.627 . . . . 0.22 110.578 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -39.8 -56.55 1.73 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.412 0.625 . . . . 1.26 110.838 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.713 HG23 ' N ' ' A' ' 50' ' ' TYR . 31.2 m -47.19 -54.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.465 -0.772 . . . . 1.06 109.035 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.713 ' N ' HG23 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -58.34 -52.64 64.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 4.02 109.634 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.648 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 2.5 t30 -53.21 -52.74 57.9 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.605 -1.257 . . . . 1.34 107.605 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.5 p -59.44 -33.29 71.09 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.242 -1.022 . . . . 1.04 108.242 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.416 HD22 HG11 ' A' ' 23' ' ' VAL . 7.3 tp -78.98 -25.13 43.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.111 -0.993 . . . . 0.44 108.9 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.02 -45.19 20.69 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.216 -2.142 . . . . 1.0 105.216 177.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.418 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 9.9 t70 -56.53 -7.9 0.47 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.817 -1.179 . . . . 1.58 107.817 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 54' ' ' LYS . 6.9 tpt180 -72.03 -48.74 42.39 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.589 0.709 . . . . 1.69 109.834 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.0 tp -153.73 -24.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.203 -0.999 . . . . 1.66 110.994 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.37 -48.94 0.07 OUTLIER Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.77 -1.205 . . . . 0.39 110.181 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -72.3 -41.9 66.08 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.395 -1.062 . . . . 1.38 109.548 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.598 ' H ' HD23 ' A' ' 57' ' ' LEU . . . -92.65 28.96 8.34 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 108.844 -1.703 . . . . 0.26 108.844 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.2 t -154.58 130.21 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.541 -1.281 . . . . 0.38 107.541 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.733 ' O ' HD23 ' A' ' 85' ' ' LEU . 1.7 mm100 -136.98 158.44 44.46 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.349 1.071 . . . . 1.31 111.926 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.563 HD11 HG21 ' A' ' 66' ' ' VAL . 7.4 tt -94.73 114.6 26.54 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.495 -0.928 . . . . 0.49 108.495 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -22.11 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.166 -0.959 . . . . 1.35 109.712 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -173.57 157.02 3.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.549 -1.344 . . . . 1.2 109.835 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.563 HG21 HD11 ' A' ' 63' ' ' LEU . 58.0 t -159.78 130.94 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.703 -0.851 . . . . 0.85 108.703 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -142.0 157.63 44.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.131 0.967 . . . . 1.41 110.16 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.596 ' HB ' HG13 ' B' ' 47' ' ' VAL . 1.3 p -132.6 147.37 52.34 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.293 -1.002 . . . . 0.52 108.293 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.631 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -175.27 154.34 17.73 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.414 -2.675 . . . . 0.4 106.414 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.526 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 52.7 p -103.78 169.21 8.65 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 119.085 1.442 . . . . 0.42 110.128 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.24 164.88 34.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 1.29 109.525 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.5 t -93.75 91.65 3.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.638 -0.825 . . . . 1.02 109.874 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 47.0 ttt-85 -95.02 112.06 23.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.991 -1.068 . . . . 2.23 110.048 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.1 t70 77.73 39.75 0.17 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.454 -0.573 . . . . 1.38 109.454 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.426 HH11 ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER 60.86 29.43 19.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.462 -0.774 . . . . 2.62 108.954 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.66 144.99 30.74 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.026 -1.047 . . . . 3.15 108.671 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -84.35 126.54 33.31 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.94 1.353 . . . . 2.44 111.428 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 tt -136.4 147.53 27.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 106.943 -1.503 . . . . 0.23 106.943 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.71 159.59 17.73 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.077 -1.014 . . . . 0.74 110.938 -176.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.631 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 6.4 p90 -145.91 153.32 40.71 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.869 0.842 . . . . 4.16 110.608 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 81' ' ' ILE . 10.4 tt -125.14 132.63 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.623 0.725 . . . . 0.92 109.822 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.39 121.63 44.97 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.092 -1.448 . . . . 0.36 107.092 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.65 123.86 34.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.206 -0.934 . . . . 0.98 111.072 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -97.7 169.68 9.52 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.437 0.637 . . . . 0.58 110.11 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 62' ' ' GLN . 2.8 mt -159.68 140.04 11.99 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.362 -0.935 . . . . 1.39 110.349 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 62' ' ' GLN . 2.2 tmtp? -122.9 145.64 48.28 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.941 -0.475 . . . . 1.42 109.92 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.548 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 14.7 mmt85 -103.85 138.66 40.12 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.186 -0.946 . . . . 1.64 109.863 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.78 -6.84 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.718 -0.845 . . . . 0.63 108.718 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 CA-C-O 118.058 -0.972 . . . . 1.76 109.573 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.502 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.486 -0.561 . . . . 6.35 109.486 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.95 104.51 5.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 2.42 109.419 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' B' ' 30' ' ' GLY . 41.9 tt0 -165.82 -50.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.138 0.971 . . . . 1.68 108.604 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.21 58.43 0.35 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.313 -0.867 . . . . 2.31 109.323 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -175.91 46.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.187 -1.042 . . . . 1.62 108.187 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.822 ' ND2' HD13 ' B' ' 26' ' ' LEU . 32.9 t-20 -93.35 111.44 23.1 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.56 -0.712 . . . . 1.46 110.451 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.8 pt-20 -93.62 120.96 34.54 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.144 -0.973 . . . . 1.49 108.944 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.419 HD13 HG21 ' B' ' 8' ' ' ILE . 7.8 mt -123.58 146.0 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.971 0.891 . . . . 1.17 111.217 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.453 ' O ' HG13 ' B' ' 9' ' ' VAL . 9.8 p -105.45 129.38 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.147 -0.686 . . . . 1.37 109.147 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -89.45 166.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 119.526 -0.87 . . . . 0.37 108.749 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -141.18 175.78 9.37 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.431 -0.793 . . . . 2.37 109.996 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.433 ' C ' ' CD ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -112.96 -4.82 13.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.074 -1.084 . . . . 1.75 108.074 179.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . 0.419 HG22 ' H ' ' B' ' 13' ' ' THR . 0.0 OUTLIER -85.68 -18.06 34.24 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.718 -0.845 . . . . 1.19 108.718 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -92.97 -115.91 0.09 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.443 -0.947 . . . . 1.47 108.443 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.21 166.06 12.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.389 -0.82 . . . . 1.22 108.967 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.436 ' H ' HG22 ' B' ' 16' ' ' VAL . 5.0 m -66.88 -35.12 73.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.043 0.925 . . . . 0.45 108.823 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 16.0 pt-20 -73.59 -37.97 65.28 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.03 -1.044 . . . . 1.7 108.8 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.41 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 0.3 OUTLIER -54.41 -36.66 64.22 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.653 -1.28 . . . . 1.46 111.772 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.711 ' O ' HG23 ' B' ' 23' ' ' VAL . 90.3 m-70 -91.39 -18.64 23.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.271 -1.518 . . . . 1.4 109.105 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -36.61 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 105.158 -2.164 . . . . 0.34 105.158 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.823 ' O ' HG23 ' B' ' 25' ' ' VAL . 69.2 mt -67.15 -52.16 44.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.377 -0.829 . . . . 0.38 108.983 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.89 -28.39 68.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -0.969 . . . . 1.21 109.844 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 19' ' ' HIS . 18.4 t -69.4 -53.55 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.3 108.951 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 tt -64.14 -18.92 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.197 -0.939 . . . . 0.69 109.116 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.823 HG23 ' O ' ' B' ' 21' ' ' LEU . 63.4 t -75.58 -46.68 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.42 109.244 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.822 HD13 ' ND2' ' B' ' 6' ' ' ASN . 12.7 mt -65.33 -33.45 76.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.796 -1.19 . . . . 1.15 110.073 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.517 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 4.9 t80 -64.92 -28.23 69.39 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.926 -1.509 . . . . 1.46 106.926 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -29.24 68.38 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.321 -0.854 . . . . 1.17 109.116 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.436 ' NE2' HD23 ' B' ' 26' ' ' LEU . 17.0 mt-30 -88.19 -0.59 57.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 1.17 109.466 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 106.07 12.14 26.34 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.588 -1.005 . . . . 0.38 110.588 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 33.6 mm -75.18 107.35 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.951 -1.323 . . . . 0.59 107.863 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -91.48 -41.33 10.9 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.317 -0.865 . . . . 1.46 110.518 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -97.17 143.72 27.7 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.569 0.7 . . . . 1.2 110.217 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -153.16 136.94 8.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 119.006 -1.078 . . . . 0.49 111.111 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.4 128.58 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 115.958 -0.565 . . . . 0.31 110.048 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.42 124.66 52.15 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.555 -0.716 . . . . 0.48 110.114 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -107.74 130.57 54.94 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.775 -0.578 . . . . 2.74 109.449 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.12 153.51 23.4 Favored Glycine 0 N--CA 1.502 3.06 0 C-N-CA 119.502 -1.333 . . . . 0.24 111.02 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.657 ' O ' ' N ' ' B' ' 41' ' ' ARG . 62.2 p -133.93 141.42 47.31 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.964 -0.727 . . . . 0.49 112.558 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.685 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 34.98 -78.98 0.0 OUTLIER Glycine 0 N--CA 1.504 3.191 0 N-CA-C 111.873 -0.491 . . . . 0.28 111.873 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.657 ' N ' ' O ' ' B' ' 39' ' ' THR . 1.4 mtp85 -83.3 -55.92 4.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.002 -1.293 . . . . 3.16 109.374 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.5 OUTLIER -63.13 -16.41 59.96 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.995 -1.066 . . . . 1.38 109.841 -178.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.685 HG22 ' O ' ' B' ' 40' ' ' GLY . 9.6 tt -59.69 -25.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.165 -0.959 . . . . 0.85 109.664 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.08 -25.86 27.3 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.89 -1.152 . . . . 1.12 107.89 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 47' ' ' VAL . 24.3 mmtp -63.32 -71.33 0.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.597 -1.631 . . . . 1.87 106.597 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' B' ' 45' ' ' LYS . . . -24.53 -43.29 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.375 0.607 . . . . 0.26 111.271 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.596 HG13 ' HB ' ' A' ' 68' ' ' THR . 94.5 t -77.54 -60.32 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.168 -0.958 . . . . 0.28 110.361 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . 0.417 ' O ' ' OG ' ' B' ' 52' ' ' SER . 1.9 t0 -46.37 -62.63 1.27 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.046 -1.034 . . . . 1.25 109.456 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.674 HG23 ' N ' ' B' ' 50' ' ' TYR . 33.3 m -42.84 -51.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.824 -0.806 . . . . 1.06 108.824 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.674 ' N ' HG23 ' B' ' 49' ' ' VAL . 0.1 OUTLIER -62.31 -50.53 71.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 4.11 109.744 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.619 ' N ' ' CD1' ' B' ' 50' ' ' TYR . 1.3 t30 -54.57 -54.53 40.03 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.729 -1.188 . . . . 1.41 107.896 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 0.1 OUTLIER -59.01 -37.81 77.78 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.57 -0.852 . . . . 0.65 108.832 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.408 HD22 HG11 ' B' ' 23' ' ' VAL . 10.1 tp -67.1 -23.48 65.84 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.128 -0.982 . . . . 0.53 108.379 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -39.38 50.12 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.769 -1.197 . . . . 0.99 107.769 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.94 -12.72 2.15 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.384 -0.826 . . . . 1.46 109.227 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -73.58 -43.48 59.66 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.035 -1.066 . . . . 1.71 109.39 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.9 tp -154.61 -23.59 0.12 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.368 -1.333 . . . . 1.77 112.209 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 65.15 -58.78 0.09 OUTLIER Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.224 -1.465 . . . . 0.39 109.551 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.95 -42.59 73.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -1.1 . . . . 1.4 109.773 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.475 ' H ' HD23 ' B' ' 57' ' ' LEU . . . -84.42 25.42 5.66 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.896 -1.682 . . . . 0.34 108.896 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' B' ' 58' ' ' GLY . 73.5 t -154.65 131.65 2.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.318 -1.364 . . . . 0.46 107.318 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.694 ' O ' HD23 ' B' ' 85' ' ' LEU . 1.1 mm100 -135.28 153.07 52.02 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.148 0.975 . . . . 1.42 112.273 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.585 HD11 HG21 ' B' ' 66' ' ' VAL . 7.4 tt -94.0 113.17 25.11 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.783 -1.191 . . . . 0.54 107.783 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -16.43 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.205 -0.935 . . . . 1.43 110.302 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.52 ' O ' HG23 ' B' ' 66' ' ' VAL . 0.9 OUTLIER -176.35 156.69 1.62 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.642 -1.286 . . . . 1.28 110.209 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.585 HG21 HD11 ' B' ' 63' ' ' LEU . 54.1 t -160.42 131.87 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.936 -0.764 . . . . 0.9 108.936 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . 0.501 ' HB3' HD12 ' B' ' 82' ' ' LEU . 20.1 tt0 -142.48 160.23 40.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.947 0.879 . . . . 1.44 110.14 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.693 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -136.26 152.24 50.52 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.249 -1.019 . . . . 0.45 108.249 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.638 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -175.03 154.16 17.52 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.391 -2.284 . . . . 0.29 107.391 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.593 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 25.2 p -98.61 161.97 13.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.161 -1.199 . . . . 0.39 109.343 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -146.05 159.19 43.61 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.035 -1.04 . . . . 1.49 109.95 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.38 90.6 3.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.325 -0.95 . . . . 0.87 109.55 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 53.8 ttt-85 -97.02 112.03 23.98 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.107 -0.996 . . . . 2.18 109.846 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.2 t70 78.21 39.13 0.16 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.152 -0.685 . . . . 1.35 109.152 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.27 26.79 16.05 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.288 -0.634 . . . . 2.57 109.288 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -146.04 148.39 32.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.048 -1.032 . . . . 3.14 108.509 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -87.02 134.62 33.47 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.913 1.339 . . . . 2.39 112.508 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -137.76 150.18 25.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.291 -1.322 . . . . 0.58 107.542 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.25 148.99 24.88 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.165 -0.96 . . . . 0.61 109.531 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.638 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.5 p90 -140.38 149.64 42.93 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.654 0.74 . . . . 4.08 110.598 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.52 HG23 ' O ' ' B' ' 81' ' ' ILE . 10.2 tt -124.62 130.82 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 122.094 0.949 . . . . 0.9 110.463 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' B' ' 67' ' ' GLN . 12.0 mt -104.2 119.06 38.13 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.288 -1.745 . . . . 0.37 106.288 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 tt -127.98 121.67 30.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.98 110.824 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -96.5 168.69 10.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.664 0.745 . . . . 0.71 110.222 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.694 HD23 ' O ' ' B' ' 62' ' ' GLN . 2.9 mt -159.78 136.78 9.41 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.891 -0.723 . . . . 1.44 110.06 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' B' ' 62' ' ' GLN . 2.0 tmtp? -121.86 146.75 46.79 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.233 -0.655 . . . . 1.31 109.233 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.517 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 15.5 mmt85 -102.15 141.8 34.42 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.277 -0.89 . . . . 1.64 110.465 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.23 -12.33 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.881 -0.785 . . . . 0.68 108.881 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 CA-C-O 118.028 -0.987 . . . . 1.77 109.558 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.522 -0.548 . . . . 6.33 109.522 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.04 110.74 21.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 2.53 109.392 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 30' ' ' GLY . 38.2 tt0 -164.53 -53.83 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.294 -0.879 . . . . 1.75 108.809 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.63 57.67 0.44 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.91 0.862 . . . . 2.24 109.26 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.21 46.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.115 -0.991 . . . . 1.67 108.628 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.595 ' ND2' HD13 ' A' ' 26' ' ' LEU . 22.3 t30 -91.3 115.1 27.76 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.301 -0.874 . . . . 1.72 110.441 -178.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 6.8 pt-20 -93.03 117.6 30.24 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.271 -0.893 . . . . 1.44 108.769 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 35' ' ' ILE . 20.6 mt -119.04 142.29 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-O 121.709 0.766 . . . . 1.11 111.598 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.556 HG22 ' CG ' ' A' ' 37' ' ' LYS . 87.8 t -109.02 128.74 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.765 0.793 . . . . 1.35 110.282 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.513 HG11 ' H ' ' A' ' 46' ' ' ALA . 2.2 p -89.25 164.11 2.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.612 -0.885 . . . . 0.39 108.612 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.437 ' HE ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -138.76 173.57 11.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.559 -0.713 . . . . 2.27 109.758 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 pttt -92.85 -9.06 41.68 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.878 -0.786 . . . . 1.78 108.878 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -91.28 -0.27 57.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.204 -1.035 . . . . 1.24 108.204 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -118.28 134.14 55.29 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.462 -1.31 . . . . 1.41 107.462 178.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -69.87 175.69 4.18 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.845 -1.159 . . . . 1.25 109.773 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.57 -31.86 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.355 -0.98 . . . . 0.49 108.355 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -74.75 -31.12 61.7 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.585 -0.846 . . . . 1.56 108.95 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -33.88 70.01 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.644 -1.285 . . . . 1.38 111.319 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.696 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.1 m80 -95.74 -19.34 19.74 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.448 -1.407 . . . . 1.43 108.487 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -36.84 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 104.523 -2.399 . . . . 0.29 104.523 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 mt -68.18 -51.27 47.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.708 -1.133 . . . . 0.41 109.009 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -67.27 -31.77 72.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.17 -0.956 . . . . 1.22 109.442 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 19' ' ' HIS . 32.5 t -68.55 -52.59 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -0.811 . . . . 0.32 108.964 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 tt -61.31 -22.43 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.166 -0.959 . . . . 0.58 109.017 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.64 -41.67 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.165 -0.959 . . . . 0.41 109.265 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.595 HD13 ' ND2' ' A' ' 6' ' ' ASN . 4.2 mt -67.83 -37.3 81.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.874 -1.142 . . . . 1.19 110.025 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 18.6 t80 -61.1 -28.26 68.96 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.994 -1.484 . . . . 1.46 106.994 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.62 -25.68 66.46 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.42 -0.809 . . . . 1.15 109.02 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -89.88 -9.36 49.25 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.509 -0.923 . . . . 1.17 108.509 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 113.47 14.07 10.01 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.193 -1.163 . . . . 0.42 110.193 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -75.66 107.58 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.26 . . . . 0.35 108.688 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -92.05 -37.66 12.66 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.418 -0.801 . . . . 1.55 109.97 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -96.89 139.92 32.21 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.401 0.62 . . . . 1.58 109.614 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.39 136.66 12.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 119.279 -0.968 . . . . 0.54 110.086 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -116.1 124.75 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.229 0.537 . . . . 0.25 110.682 -178.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.731 HD21 HG11 ' A' ' 49' ' ' VAL . 5.6 mp -104.38 116.65 32.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.971 -0.456 . . . . 0.4 109.802 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.556 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -102.56 127.29 49.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.397 -0.964 . . . . 2.74 108.397 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.423 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -142.66 157.66 26.79 Favored Glycine 0 N--CA 1.508 3.44 0 O-C-N 121.093 -1.005 . . . . 0.21 111.636 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.67 ' CG2' ' CD2' ' A' ' 80' ' ' TYR . 7.2 p -141.58 147.7 38.09 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.434 -1.039 . . . . 0.56 112.84 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.566 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 38.67 -87.28 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.617 -0.993 . . . . 0.33 110.617 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' THR . 2.9 mtp180 -82.68 -51.78 7.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.348 -1.089 . . . . 3.09 109.506 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.56 -21.47 62.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.222 -0.924 . . . . 1.09 109.028 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 40' ' ' GLY . 6.5 tt -53.83 -33.81 24.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.579 -0.7 . . . . 0.87 110.756 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.492 ' HG ' ' HG ' ' B' ' 79' ' ' SER . 0.0 OUTLIER -83.09 -23.45 33.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 1.14 108.91 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.537 ' O ' HG23 ' A' ' 49' ' ' VAL . 21.1 mmtp -65.18 -69.22 0.31 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.682 -1.97 . . . . 1.86 105.682 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.69 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -34.31 -46.43 0.26 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.216 0.532 . . . . 0.29 110.484 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' B' ' 68' ' ' THR . 56.7 t -63.53 -66.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.076 -1.015 . . . . 0.22 109.694 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 52' ' ' SER . 13.1 t0 -44.76 -44.85 9.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.561 -0.712 . . . . 1.26 109.199 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.731 HG11 HD21 ' A' ' 36' ' ' LEU . 60.5 t -50.11 -55.19 6.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.704 -0.798 . . . . 1.06 108.936 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.635 ' CD2' ' N ' ' A' ' 51' ' ' ASN . 1.1 t80 -58.5 -60.49 3.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.064 -1.022 . . . . 4.02 110.607 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.635 ' N ' ' CD2' ' A' ' 50' ' ' TYR . 9.2 t-20 -49.11 -52.61 25.0 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.985 -1.117 . . . . 1.34 107.985 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 48' ' ' ASP . 2.8 m -62.18 -39.02 91.29 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.847 -0.798 . . . . 1.04 108.847 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.786 HD23 HD13 ' A' ' 85' ' ' LEU . 12.5 tp -72.94 -24.06 60.76 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.067 -1.021 . . . . 0.44 108.884 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' TYR . 4.1 tmtt? -81.34 -39.86 24.45 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.18 -1.575 . . . . 1.0 107.227 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -52.68 -14.56 0.54 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.857 -1.164 . . . . 1.58 107.857 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' N ' ' C ' ' A' ' 54' ' ' LYS . 11.5 mmm180 -56.15 -53.51 56.21 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.035 -0.666 . . . . 1.69 109.972 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.5 tp -161.83 -3.95 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 118.93 -1.108 . . . . 1.66 109.917 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.53 -50.94 0.1 OUTLIER Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.705 -1.236 . . . . 0.39 110.392 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -71.91 -41.52 67.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.255 -1.144 . . . . 1.38 110.521 -178.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 61' ' ' VAL . . . -87.97 25.31 8.92 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.773 -1.331 . . . . 0.26 109.773 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' GLY . 43.8 t -155.27 133.6 2.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.944 -1.327 . . . . 0.38 108.29 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.741 ' O ' HD23 ' A' ' 85' ' ' LEU . 9.9 mm-40 -140.06 156.83 46.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.406 1.098 . . . . 1.31 111.966 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.51 HD11 HG21 ' A' ' 66' ' ' VAL . 6.6 tt -97.08 118.45 33.53 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.044 -0.98 . . . . 0.49 108.537 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.528 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -108.35 -17.13 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.813 -0.755 . . . . 1.35 110.37 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 64' ' ' VAL . 0.2 OUTLIER -175.5 153.42 1.48 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.411 -1.431 . . . . 1.2 110.154 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.51 HG21 HD11 ' A' ' 63' ' ' LEU . 94.2 t -159.5 133.78 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.464 -0.939 . . . . 0.85 108.464 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' LEU . 19.7 tt0 -144.11 163.05 34.7 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.265 1.031 . . . . 1.41 110.6 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.629 ' HB ' HG13 ' B' ' 47' ' ' VAL . 1.3 p -136.51 157.18 47.39 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.751 -0.833 . . . . 0.52 108.751 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.401 ' HA2' HD22 ' B' ' 51' ' ' ASN . . . -175.01 145.15 7.73 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 107.682 -2.167 . . . . 0.4 107.682 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.696 ' H ' ' ND2' ' B' ' 51' ' ' ASN . 97.3 p -94.99 160.09 14.73 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.893 -1.357 . . . . 0.42 109.356 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.12 176.63 11.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.823 -1.151 . . . . 1.29 111.118 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.451 ' H ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -90.24 131.4 37.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.503 0.668 . . . . 1.02 109.865 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 3.6 ttt85 -148.74 103.05 3.35 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.692 -0.855 . . . . 2.23 108.692 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.7 t0 87.19 36.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.062 0.458 . . . . 1.38 110.117 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 65.6 33.55 8.43 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.083 0.944 . . . . 2.62 109.363 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -158.3 155.24 28.47 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.234 -0.916 . . . . 3.15 109.723 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -86.05 137.99 32.29 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.893 -1.123 . . . . 2.44 109.982 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.481 HG21 ' CB ' ' A' ' 73' ' ' ARG . 5.5 tt -142.3 156.96 19.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-N 115.236 -0.893 . . . . 0.23 109.489 -178.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.05 151.6 23.1 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.958 0.885 . . . . 0.74 110.015 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.67 ' CD2' ' CG2' ' A' ' 39' ' ' THR . 0.4 OUTLIER -135.62 137.19 41.66 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.123 -1.066 . . . . 4.16 108.123 -178.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 81' ' ' ILE . 5.1 tt -116.68 130.38 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.542 -0.91 . . . . 0.92 108.542 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 67' ' ' GLN . 52.9 mt -110.22 120.54 42.78 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.145 -1.428 . . . . 0.36 107.145 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -127.46 128.27 45.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.161 -0.962 . . . . 0.98 111.051 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -101.23 171.4 7.63 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.948 -0.569 . . . . 0.58 109.548 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.786 HD13 HD23 ' A' ' 53' ' ' LEU . 2.2 mt -162.54 141.96 9.26 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.548 -0.861 . . . . 1.39 109.859 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -126.63 149.19 49.63 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.103 0.477 . . . . 1.42 110.593 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.459 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 17.9 mmt85 -108.06 139.99 41.89 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.627 -0.671 . . . . 1.64 110.185 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.457 ' O ' ' CG1' ' A' ' 88' ' ' VAL . 4.3 t -115.01 -6.0 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.382 -0.969 . . . . 0.63 108.382 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.48 0 CA-C-O 117.967 -1.016 . . . . 1.76 109.497 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.462 -0.569 . . . . 6.35 109.462 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.83 111.71 23.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 2.42 109.588 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' B' ' 30' ' ' GLY . 1.7 mt-10 -166.17 -51.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.35 -0.844 . . . . 1.68 108.952 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.64 58.45 0.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.834 0.826 . . . . 2.31 109.57 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.93 47.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.623 -1.298 . . . . 1.62 109.479 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.498 HD22 HD13 ' B' ' 26' ' ' LEU . 1.0 OUTLIER -91.36 113.58 25.88 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.226 -0.921 . . . . 1.46 112.251 -177.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 5.8 pt-20 -93.03 111.93 23.72 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.204 -1.406 . . . . 1.49 107.204 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 18.7 mt -114.12 139.29 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.607 -0.683 . . . . 1.17 109.851 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 82.9 t -102.69 126.02 56.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.704 -0.623 . . . . 1.37 109.579 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.32 163.91 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.914 -1.143 . . . . 0.37 107.914 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.2 173.98 10.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.314 -0.866 . . . . 2.37 109.899 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.526 ' N ' ' OE1' ' B' ' 42' ' ' GLU . 7.6 pttt -96.65 -9.21 29.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.951 -0.759 . . . . 1.75 108.951 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -89.72 -4.78 57.54 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.649 -0.871 . . . . 1.19 108.649 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -99.34 -131.0 0.22 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.694 -1.224 . . . . 1.47 107.694 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -166.77 163.83 16.5 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.544 -0.91 . . . . 1.22 108.544 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -63.39 -37.41 79.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.179 -1.045 . . . . 0.45 108.179 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 6.8 pt-20 -76.24 -38.03 56.9 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.75 -0.78 . . . . 1.7 109.035 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.436 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 10.4 t70 -59.41 -31.59 69.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.721 -1.237 . . . . 1.46 111.598 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.667 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.3 OUTLIER -93.41 -16.44 24.58 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.173 -1.58 . . . . 1.4 108.222 178.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.06 -34.78 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 104.784 -2.302 . . . . 0.34 104.784 176.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.465 ' O ' HG23 ' B' ' 25' ' ' VAL . 57.5 mt -68.81 -52.31 31.45 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.972 -1.013 . . . . 0.38 109.191 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -66.49 -29.83 70.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.19 -0.944 . . . . 1.21 109.499 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.667 HG23 ' O ' ' B' ' 19' ' ' HIS . 24.3 t -70.06 -53.39 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.845 . . . . 0.3 109.202 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 tt -62.41 -20.47 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.076 -1.015 . . . . 0.69 108.944 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 21' ' ' LEU . 6.2 t -72.1 -42.55 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.233 -0.917 . . . . 0.42 109.035 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.498 HD13 HD22 ' B' ' 6' ' ' ASN . 3.8 mt -67.01 -36.31 81.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.97 -1.081 . . . . 1.15 109.569 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.511 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 23.3 t80 -61.16 -28.23 68.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.436 -1.32 . . . . 1.46 107.436 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -26.17 67.64 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.64 -0.709 . . . . 1.17 109.195 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -90.42 -1.98 57.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.173 -0.954 . . . . 1.17 109.455 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 106.88 12.28 24.53 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.912 -1.275 . . . . 0.38 109.912 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 mm -76.78 106.12 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.024 -1.28 . . . . 0.59 108.545 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.85 -38.6 12.23 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.22 -0.925 . . . . 1.46 110.821 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -98.59 142.58 29.99 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.57 0.7 . . . . 1.2 110.24 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.41 137.11 11.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 119.221 -0.992 . . . . 0.49 110.802 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.61 125.63 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-N 116.089 -0.505 . . . . 0.31 110.344 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' B' ' 46' ' ' ALA . 3.7 mp -105.36 120.21 41.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.67 -0.644 . . . . 0.48 110.696 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.43 124.36 46.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.612 -0.68 . . . . 2.74 109.168 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.437 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -138.64 153.83 22.78 Favored Glycine 0 N--CA 1.51 3.592 0 O-C-N 121.041 -1.037 . . . . 0.24 111.567 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.626 ' O ' ' N ' ' B' ' 41' ' ' ARG . 3.8 p -138.38 143.9 40.03 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.551 -0.97 . . . . 0.49 112.794 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.516 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 36.26 -83.17 0.0 OUTLIER Glycine 0 N--CA 1.499 2.863 0 N-CA-C 111.15 -0.78 . . . . 0.28 111.15 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.626 ' N ' ' O ' ' B' ' 39' ' ' THR . 5.2 mtp180 -82.03 -53.19 6.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.201 -1.176 . . . . 3.16 110.072 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' B' ' 12' ' ' LYS . 1.3 pm0 -64.27 -18.39 64.52 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.55 -1.344 . . . . 1.38 109.223 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.516 HG22 ' O ' ' B' ' 40' ' ' GLY . 5.6 tt -54.4 -30.86 21.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.073 -1.017 . . . . 0.85 109.84 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -24.92 32.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 1.12 108.948 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.48 ' O ' HG23 ' B' ' 49' ' ' VAL . 17.1 mmtp -65.86 -68.59 0.36 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.621 -1.992 . . . . 1.87 105.621 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.656 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -33.21 -50.64 0.31 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 116.163 -0.472 . . . . 0.26 111.281 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.629 HG13 ' HB ' ' A' ' 68' ' ' THR . 77.8 t -65.01 -59.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.768 -1.208 . . . . 0.28 109.68 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 21.3 t0 -48.51 -47.61 38.81 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.193 -0.942 . . . . 1.25 108.666 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.573 HG11 HD21 ' B' ' 36' ' ' LEU . 88.8 t -48.61 -53.6 6.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.776 -0.769 . . . . 1.06 109.038 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.614 ' CD2' ' N ' ' B' ' 51' ' ' ASN . 0.9 OUTLIER -59.67 -56.58 20.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.244 -0.91 . . . . 4.11 111.304 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.696 ' ND2' ' H ' ' A' ' 70' ' ' SER . 21.1 t-20 -54.76 -48.51 72.55 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.759 -1.2 . . . . 1.41 107.759 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 1.5 m -63.37 -39.58 94.9 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.534 -0.866 . . . . 0.65 108.92 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.806 HD23 HD13 ' B' ' 85' ' ' LEU . 10.0 tp -74.86 -26.32 59.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.53 109.04 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' B' ' 56' ' ' ARG . 5.1 tmtt? -80.28 -46.1 16.77 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.069 -1.645 . . . . 0.99 106.859 177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -49.98 -11.84 0.07 Allowed 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.353 -1.294 . . . . 1.46 108.284 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' B' ' 54' ' ' LYS . 9.1 mmm180 -54.03 -54.5 38.33 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.827 0.822 . . . . 1.71 110.297 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.0 tp -159.83 -3.78 0.07 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.622 -0.881 . . . . 1.77 108.622 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.425 ' H ' ' H ' ' B' ' 57' ' ' LEU . . . 64.69 -47.96 0.11 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.944 -1.122 . . . . 0.39 110.561 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -73.77 -43.69 58.22 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.286 -1.126 . . . . 1.4 110.398 -178.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.424 ' O ' HG23 ' B' ' 61' ' ' VAL . . . -84.34 22.87 7.87 Favored Glycine 0 N--CA 1.482 1.733 0 N-CA-C 109.857 -1.297 . . . . 0.34 109.857 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' B' ' 54' ' ' LYS . 39.4 t -154.49 135.44 4.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 120.872 -1.37 . . . . 0.46 108.455 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.773 ' O ' HD23 ' B' ' 85' ' ' LEU . 2.6 tp60 -140.19 155.24 47.01 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.342 1.068 . . . . 1.42 112.145 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.09 119.1 32.46 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.344 -0.844 . . . . 0.54 108.88 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.4 ' O ' ' CG ' ' B' ' 65' ' ' ASN . 0.1 OUTLIER -102.09 -28.27 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.426 -0.796 . . . . 1.43 110.972 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.437 ' O ' HG23 ' B' ' 66' ' ' VAL . 1.3 m120 -173.37 161.28 4.12 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.498 -1.377 . . . . 1.28 109.41 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.437 HG23 ' O ' ' B' ' 65' ' ' ASN . 74.1 t -159.47 132.82 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.636 -0.875 . . . . 0.9 108.636 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . 0.665 ' HB3' HD12 ' B' ' 82' ' ' LEU . 28.4 tt0 -142.46 161.74 37.27 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.988 0.899 . . . . 1.44 109.969 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.706 ' HB ' HG13 ' A' ' 47' ' ' VAL . 1.8 p -136.59 159.25 42.37 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.959 -0.756 . . . . 0.45 108.959 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.4 144.19 7.09 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 107.926 -2.07 . . . . 0.29 107.926 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.582 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 14.4 p -93.58 160.07 14.94 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.968 -1.313 . . . . 0.39 108.39 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.83 175.92 12.04 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.744 -1.182 . . . . 1.49 110.941 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.47 132.28 34.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.85 -0.74 . . . . 0.87 109.283 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.3 ttt-85 -151.73 103.24 2.92 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.556 -0.715 . . . . 2.18 109.158 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 3.7 t0 86.91 35.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.102 0.477 . . . . 1.35 109.85 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.77 29.02 8.74 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.991 0.901 . . . . 2.57 109.451 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -156.74 157.51 35.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.344 -0.848 . . . . 3.14 109.601 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -87.51 139.85 30.12 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.987 -1.085 . . . . 2.39 110.943 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 tt -142.22 158.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.571 -0.74 . . . . 0.58 109.107 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . 0.492 ' HG ' ' HG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -86.37 149.26 25.15 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.015 0.912 . . . . 0.61 110.198 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.615 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.4 OUTLIER -133.95 137.27 44.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.464 -0.939 . . . . 4.08 108.464 -179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.554 HG23 ' O ' ' B' ' 81' ' ' ILE . 5.6 tt -118.02 129.6 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.866 -0.79 . . . . 0.9 108.866 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' B' ' 67' ' ' GLN . 6.3 mt -106.9 119.27 38.9 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.703 -1.591 . . . . 0.37 106.703 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 3.7 tt -126.76 126.73 43.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.061 -1.024 . . . . 0.98 111.08 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -99.48 169.59 9.21 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.342 -0.614 . . . . 0.71 109.342 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.806 HD13 HD23 ' B' ' 53' ' ' LEU . 2.1 mt -162.44 137.55 6.97 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.802 -0.759 . . . . 1.44 109.395 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -124.97 151.6 45.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.793 -0.567 . . . . 1.31 109.492 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.511 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 19.0 mmt85 -107.5 141.23 39.25 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.469 0.652 . . . . 1.64 110.275 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.489 ' O ' HG12 ' B' ' 88' ' ' VAL . 13.7 t -115.18 -6.47 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.251 -1.018 . . . . 0.68 108.251 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.022 -0.989 . . . . 1.77 109.528 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.546 -0.539 . . . . 6.33 109.546 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.479 ' C ' ' H ' ' A' ' 4' ' ' LYS . 10.1 p -96.37 -72.11 0.65 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 2.53 109.384 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 2' ' ' THR . 5.2 tt0 74.02 -32.93 0.24 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.988 -1.07 . . . . 1.75 109.809 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 2' ' ' THR . 7.4 mtmm -155.88 53.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.076 0.941 . . . . 2.24 108.582 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 6' ' ' ASN . 0.7 OUTLIER -161.31 151.61 17.57 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 104.146 -2.538 . . . . 1.67 104.146 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.855 ' OD1' HG23 ' A' ' 34' ' ' VAL . 1.8 t-20 177.45 94.51 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 118.061 -1.456 . . . . 1.72 110.131 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 112.34 23.6 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.524 -1.36 . . . . 1.44 108.166 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.623 ' CG1' HD21 ' A' ' 6' ' ' ASN . 4.8 mm -125.13 148.88 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 CA-C-O 122.288 1.042 . . . . 1.11 111.79 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.564 HG13 ' HG2' ' A' ' 37' ' ' LYS . 66.7 t -111.94 129.82 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.537 0.684 . . . . 1.35 110.485 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.52 HG23 ' ND1' ' A' ' 19' ' ' HIS . 1.3 p -88.2 162.9 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.866 -1.161 . . . . 0.39 107.866 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.442 ' HE ' ' HE3' ' A' ' 14' ' ' LYS . 1.9 mtt-85 -131.66 167.2 19.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.344 -0.847 . . . . 2.27 110.136 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.2 pttp -87.93 -16.31 34.2 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.806 -1.183 . . . . 1.78 107.806 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -74.37 -67.5 0.62 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.542 -1.651 . . . . 1.24 106.542 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.538 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.1 mtmm -58.0 143.44 43.21 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.241 -0.912 . . . . 1.41 110.113 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -72.27 178.09 4.12 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.48 0.657 . . . . 1.25 110.342 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.511 HG21 ' OD1' ' A' ' 48' ' ' ASP . 3.7 m -72.51 -31.86 39.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.908 0.861 . . . . 0.49 108.715 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -73.77 -30.77 62.97 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.454 -0.899 . . . . 1.56 109.219 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -30.51 69.63 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 120.445 -1.409 . . . . 1.38 110.881 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.681 ' O ' HG23 ' A' ' 23' ' ' VAL . 41.0 m80 -95.33 -19.75 19.71 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.585 -1.322 . . . . 1.43 108.236 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.71 -35.63 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 104.896 -2.261 . . . . 0.29 104.896 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 25' ' ' VAL . 46.8 mt -69.04 -52.5 27.93 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.823 -1.08 . . . . 0.41 108.703 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -66.76 -26.46 66.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 1.22 109.895 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 19' ' ' HIS . 13.9 t -73.62 -53.14 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.256 -0.902 . . . . 0.32 108.804 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tt -55.39 -24.57 15.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.503 -0.925 . . . . 0.58 108.503 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 21' ' ' LEU . 41.8 t -69.25 -40.81 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.234 -0.987 . . . . 0.41 109.443 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.452 HD13 ' ND2' ' A' ' 6' ' ' ASN . 7.1 mt -65.51 -38.03 88.49 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.524 -1.36 . . . . 1.19 109.613 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -28.61 69.68 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.071 -1.455 . . . . 1.46 107.071 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.36 -28.43 59.09 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.29 -0.868 . . . . 1.15 108.729 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -90.43 -18.43 25.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 1.17 109.222 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 114.43 17.22 7.21 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.793 -1.323 . . . . 0.42 109.793 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mm -74.19 113.99 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.395 -1.062 . . . . 0.35 108.793 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -93.38 -34.59 13.41 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 119.71 -0.796 . . . . 1.55 111.366 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 4.1 mt-10 -101.81 135.88 42.6 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.625 0.726 . . . . 1.58 111.351 -177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.855 HG23 ' OD1' ' A' ' 6' ' ' ASN . 3.8 p -149.55 141.92 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.96 -0.696 . . . . 0.54 110.297 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -122.35 124.9 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 116.06 -0.518 . . . . 0.25 110.767 -178.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.8 mp -106.36 123.08 47.52 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.279 -0.568 . . . . 0.4 110.042 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HG2' HG13 ' A' ' 9' ' ' VAL . 15.8 tttt -99.75 125.73 45.69 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.29 -1.004 . . . . 2.74 108.29 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.17 142.34 13.58 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.562 -1.304 . . . . 0.21 110.827 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 41' ' ' ARG . 54.1 p -126.31 135.72 51.86 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.878 0.846 . . . . 0.56 111.908 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' A' ' 78' ' ' ILE . . . 37.97 -87.41 0.01 OUTLIER Glycine 0 N--CA 1.496 2.678 0 O-C-N 121.623 -0.673 . . . . 0.33 111.815 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -80.11 -51.77 8.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.041 -1.27 . . . . 3.09 109.901 -178.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.66 -19.28 37.85 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.611 -1.305 . . . . 1.09 107.59 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' OG ' ' A' ' 79' ' ' SER . 2.2 tt -54.51 -33.66 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.719 -0.613 . . . . 0.87 110.934 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.77 -21.92 32.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.857 -1.152 . . . . 1.14 108.615 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.533 ' NZ ' ' O ' ' A' ' 14' ' ' LYS . 22.8 mmtp -66.17 -70.43 0.24 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.368 -1.715 . . . . 1.86 106.368 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.649 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -29.46 -51.34 0.11 Allowed 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.439 0.638 . . . . 0.29 110.598 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.697 HG13 ' HB ' ' B' ' 68' ' ' THR . 89.8 t -57.86 -68.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.37 -0.831 . . . . 0.22 109.937 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.511 ' OD1' HG21 ' A' ' 16' ' ' VAL . 12.8 t70 -45.54 -48.1 14.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.716 . . . . 1.26 109.584 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.572 HG11 HD21 ' A' ' 36' ' ' LEU . 91.7 t -47.36 -58.56 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.936 -0.764 . . . . 1.06 108.936 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -61.84 -54.52 40.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.16 -0.963 . . . . 4.02 111.432 -178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.524 ' ND2' ' OG ' ' B' ' 70' ' ' SER . 0.0 OUTLIER -53.74 -48.27 69.82 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.691 -1.256 . . . . 1.34 107.804 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.495 ' N ' ' CG ' ' A' ' 51' ' ' ASN . 22.1 p -59.43 -35.88 74.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.839 -1.171 . . . . 1.04 107.839 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.721 HD21 HH12 ' A' ' 87' ' ' ARG . 6.8 tp -79.09 -22.12 45.71 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.095 -1.076 . . . . 0.44 108.095 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.98 -43.96 21.09 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.506 -2.035 . . . . 1.0 105.506 177.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -56.05 -9.21 0.57 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.562 -1.273 . . . . 1.58 107.562 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.498 ' H ' ' C ' ' A' ' 54' ' ' LYS . 8.8 tpt180 -70.83 -49.34 47.3 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.599 0.714 . . . . 1.69 109.559 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.639 ' O ' ' N ' ' A' ' 59' ' ' ASP . 2.1 tp -153.86 -15.45 0.14 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.381 -0.928 . . . . 1.66 110.794 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 61' ' ' VAL . . . 63.27 -55.62 0.05 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.004 -1.238 . . . . 0.39 110.004 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.639 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -73.08 -40.09 65.3 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.633 -0.922 . . . . 1.38 109.496 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.522 ' H ' HD23 ' A' ' 57' ' ' LEU . . . -83.34 23.57 6.19 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 108.883 -1.687 . . . . 0.26 108.883 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.609 HG13 HD21 ' A' ' 85' ' ' LEU . 2.8 t -155.15 131.71 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.57 -1.27 . . . . 0.38 107.57 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.597 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.7 mm-40 -138.09 157.4 46.4 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.427 1.108 . . . . 1.31 111.796 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.637 HD11 HG21 ' A' ' 66' ' ' VAL . 7.5 tt -94.55 116.4 28.73 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.363 -0.835 . . . . 0.49 109.504 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -105.34 -20.97 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.323 -0.861 . . . . 1.35 109.396 179.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.59 148.61 1.98 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.232 -1.387 . . . . 1.2 110.323 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.637 HG21 HD11 ' A' ' 63' ' ' LEU . 94.9 t -157.63 134.09 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.755 -0.831 . . . . 0.85 108.755 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.568 HE21 HD13 ' B' ' 63' ' ' LEU . 2.2 tp60 -144.92 159.9 42.17 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.077 0.942 . . . . 1.41 110.667 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.54 ' HB ' HG13 ' B' ' 47' ' ' VAL . 1.2 p -135.44 151.81 50.77 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.537 -0.912 . . . . 0.52 108.537 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.69 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -176.47 157.23 22.6 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 106.512 -2.635 . . . . 0.4 106.512 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.534 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 94.4 p -99.38 161.25 13.72 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 119.051 1.426 . . . . 0.42 110.396 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -155.77 175.73 13.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.102 -0.999 . . . . 1.29 110.737 178.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.434 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.02 134.59 29.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.72 0.771 . . . . 1.02 110.799 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 25.2 ttt-85 -145.7 101.39 3.55 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.321 -0.992 . . . . 2.23 108.321 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.9 t0 85.96 36.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.224 0.535 . . . . 1.38 109.766 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.1 32.36 12.78 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.967 0.889 . . . . 2.62 109.304 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -150.57 149.84 30.43 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.66 -0.867 . . . . 3.15 108.66 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -85.73 137.38 32.85 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.482 1.134 . . . . 2.44 110.077 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.558 HD11 ' HA3' ' A' ' 40' ' ' GLY . 4.7 tt -142.9 156.52 17.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.072 -0.967 . . . . 0.23 108.778 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.483 ' OG ' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -87.92 155.82 19.66 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.453 -0.779 . . . . 0.74 111.145 -176.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.69 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 7.7 p90 -146.47 153.75 40.79 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.774 0.797 . . . . 4.16 110.466 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.684 HD11 HG21 ' B' ' 68' ' ' THR . 13.2 tt -125.34 132.49 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.419 0.628 . . . . 0.92 109.993 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.53 HD12 ' HB3' ' A' ' 67' ' ' GLN . 12.3 mt -106.86 120.71 42.77 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.763 -1.569 . . . . 0.36 106.763 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 tt -128.99 124.84 36.02 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.313 -0.955 . . . . 0.98 110.582 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -101.4 172.0 7.25 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.663 -0.699 . . . . 0.58 109.465 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.609 HD21 HG13 ' A' ' 61' ' ' VAL . 1.6 tp -159.42 143.03 14.68 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 118.978 -1.089 . . . . 1.39 111.135 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -118.72 142.45 47.66 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.768 -0.827 . . . . 1.42 108.768 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.721 HH12 HD21 ' A' ' 53' ' ' LEU . 16.2 tpp180 -104.16 138.81 40.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.326 -0.858 . . . . 1.64 109.726 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.85 -7.18 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.052 -0.721 . . . . 0.63 109.052 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 117.978 -1.01 . . . . 1.76 109.587 179.422 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mtt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.533 -0.544 . . . . 6.35 109.533 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 73.0 p -138.64 81.19 1.83 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.523 -0.735 . . . . 2.42 109.775 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' B' ' 30' ' ' GLY . 12.1 mt-10 -78.64 -10.87 59.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.868 -1.145 . . . . 1.68 108.747 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.42 ' HA ' ' H ' ' B' ' 32' ' ' ASP . 12.5 mtmm -152.18 60.59 0.84 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.533 -0.867 . . . . 2.31 110.131 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.609 HD23 ' H ' ' B' ' 6' ' ' ASN . 0.6 OUTLIER -162.09 153.18 17.93 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.535 -2.024 . . . . 1.62 105.535 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.609 ' H ' HD23 ' B' ' 5' ' ' LEU . 1.0 OUTLIER -178.35 91.54 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.367 -1.333 . . . . 1.46 111.841 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.75 107.52 19.23 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.018 -1.676 . . . . 1.49 107.147 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.437 ' CG1' ' OD1' ' B' ' 6' ' ' ASN . 43.1 mm -122.13 141.75 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 122.06 0.933 . . . . 1.17 110.215 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.634 HG13 ' HG2' ' B' ' 37' ' ' LYS . 59.0 t -101.26 129.05 52.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.778 -0.647 . . . . 1.37 109.476 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.9 164.27 2.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.613 -1.254 . . . . 0.37 107.613 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.479 ' HE ' ' CE ' ' B' ' 14' ' ' LYS . 11.6 mtt-85 -138.21 174.55 10.44 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.844 0.831 . . . . 2.37 110.149 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -103.56 -8.56 19.95 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.014 -1.106 . . . . 1.75 108.014 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . 0.417 ' H ' HG23 ' B' ' 13' ' ' THR . 0.3 OUTLIER -86.43 -14.9 41.92 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.741 -0.784 . . . . 1.19 109.616 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.479 ' CE ' ' HE ' ' B' ' 11' ' ' ARG . 0.5 OUTLIER -97.81 -118.79 0.13 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.409 -0.96 . . . . 1.47 108.409 178.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -168.77 170.24 9.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.1 -1.0 . . . . 1.22 108.656 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.89 -32.85 45.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.187 -1.042 . . . . 0.45 108.187 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.455 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 7.3 pt-20 -77.1 -40.42 45.99 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.792 -0.763 . . . . 1.7 109.098 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.455 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 66.4 t0 -58.45 -31.87 68.18 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.605 -1.31 . . . . 1.46 110.975 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.691 ' O ' HG23 ' B' ' 23' ' ' VAL . 17.2 m80 -91.21 -16.89 26.92 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.137 -1.602 . . . . 1.4 108.546 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.22 -34.88 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.322 -2.103 . . . . 0.34 105.322 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.526 ' O ' HG23 ' B' ' 25' ' ' VAL . 72.4 mt -67.97 -52.97 29.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.144 -0.935 . . . . 0.38 108.949 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.04 -25.88 68.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.3 -0.875 . . . . 1.21 109.755 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.691 HG23 ' O ' ' B' ' 19' ' ' HIS . 20.1 t -74.57 -52.96 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.422 -0.798 . . . . 0.3 109.282 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 tt -57.04 -24.83 21.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.562 -0.903 . . . . 0.69 108.562 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 21' ' ' LEU . 40.8 t -67.32 -41.78 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.323 -0.861 . . . . 0.42 109.248 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.457 ' CD1' ' OD1' ' B' ' 6' ' ' ASN . 4.5 mt -65.15 -39.63 93.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.681 -1.262 . . . . 1.15 109.342 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -32.02 69.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.215 -1.402 . . . . 1.46 107.215 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -30.8 54.27 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.769 -0.826 . . . . 1.17 108.769 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -89.54 -6.36 56.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 1.17 109.926 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 101.39 16.47 24.76 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.556 -1.418 . . . . 0.38 109.556 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.9 113.88 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.814 -1.18 . . . . 0.59 107.814 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.42 ' H ' ' HA ' ' B' ' 4' ' ' LYS . 5.6 m-20 -98.35 -40.4 8.33 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.37 -0.832 . . . . 1.46 112.211 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -96.11 137.59 34.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 1.2 111.307 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' B' ' 6' ' ' ASN . 5.8 p -152.52 141.17 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.985 -1.086 . . . . 0.49 111.57 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.55 128.32 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 115.589 -0.732 . . . . 0.31 110.605 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.632 HD23 ' HA ' ' B' ' 46' ' ' ALA . 1.7 mp -108.91 122.56 47.47 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.471 -0.768 . . . . 0.48 110.034 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.634 ' HG2' HG13 ' B' ' 9' ' ' VAL . 6.7 tttt -102.96 130.07 49.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.331 -0.856 . . . . 2.74 108.851 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.16 147.65 19.26 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.654 -1.26 . . . . 0.24 110.649 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.613 ' O ' ' N ' ' B' ' 41' ' ' ARG . 42.6 p -129.71 140.06 51.19 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.074 -0.662 . . . . 0.49 112.117 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.631 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 33.51 -80.78 0.0 OUTLIER Glycine 0 N--CA 1.503 3.148 0 O-C-N 121.847 -0.533 . . . . 0.28 112.325 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.0 OUTLIER -83.53 -54.04 5.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.968 -1.313 . . . . 3.16 109.45 -178.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -15.84 36.83 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.845 -1.159 . . . . 1.38 109.048 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.631 HG22 ' O ' ' B' ' 40' ' ' GLY . 10.1 tt -58.25 -26.24 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.334 -0.854 . . . . 0.85 110.027 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -26.22 22.13 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.456 -0.942 . . . . 1.12 108.456 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' B' ' 46' ' ' ALA . 23.3 mmtp -63.18 -69.64 0.26 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.167 -1.79 . . . . 1.87 106.167 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.632 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -29.71 -50.41 0.11 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 116.159 -0.473 . . . . 0.26 111.582 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.54 HG13 ' HB ' ' A' ' 68' ' ' THR . 94.7 t -62.61 -59.33 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.802 -1.186 . . . . 0.28 109.957 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . 0.418 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 12.3 t70 -52.19 -51.87 55.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.141 -0.975 . . . . 1.25 108.612 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.528 HG11 HD21 ' B' ' 36' ' ' LEU . 60.4 t -41.34 -61.33 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 109.028 -0.73 . . . . 1.06 109.028 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.506 ' CD1' HD11 ' B' ' 85' ' ' LEU . 0.1 OUTLIER -62.36 -50.75 70.33 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.515 -0.74 . . . . 4.11 109.906 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.534 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -50.72 -55.22 17.63 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.975 -1.12 . . . . 1.41 107.975 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.477 ' N ' ' CG ' ' B' ' 51' ' ' ASN . 0.8 OUTLIER -59.9 -35.52 75.03 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.643 -0.823 . . . . 0.65 109.256 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.598 HD21 HH12 ' B' ' 87' ' ' ARG . 8.1 tp -72.1 -24.15 61.44 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.892 -1.13 . . . . 0.53 109.417 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.07 -29.72 31.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.266 -1.521 . . . . 0.99 107.277 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.0 -13.85 13.37 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.897 -1.149 . . . . 1.46 107.897 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -71.5 -42.66 67.76 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.492 -0.883 . . . . 1.71 109.342 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.3 tp -153.95 -18.21 0.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.532 -1.267 . . . . 1.77 111.602 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 65.86 -62.88 0.13 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.365 -1.494 . . . . 0.39 109.365 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -69.64 -41.61 75.36 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.387 -1.066 . . . . 1.4 109.089 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' B' ' 87' ' ' ARG . . . -76.81 20.03 3.08 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.592 -1.403 . . . . 0.34 109.592 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.559 HG13 HD21 ' B' ' 85' ' ' LEU . 2.5 t -153.16 131.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.412 -1.329 . . . . 0.46 107.412 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' B' ' 86' ' ' LYS . 3.0 mm-40 -134.0 153.35 51.84 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.048 0.928 . . . . 1.42 112.207 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.651 HD11 HG21 ' B' ' 66' ' ' VAL . 7.6 tt -93.54 116.49 29.01 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.177 -1.045 . . . . 0.54 108.177 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.83 -25.82 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.262 -0.899 . . . . 1.43 110.206 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -172.42 151.58 2.51 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.85 -1.156 . . . . 1.28 109.284 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.651 HG21 HD11 ' B' ' 63' ' ' LEU . 96.1 t -154.53 133.82 3.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.193 -1.04 . . . . 0.9 108.193 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . 0.636 ' HB3' HD12 ' B' ' 82' ' ' LEU . 2.7 tp60 -141.11 159.84 41.37 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.769 0.795 . . . . 1.44 109.47 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.697 ' HB ' HG13 ' A' ' 47' ' ' VAL . 1.3 p -138.98 151.85 47.2 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.109 -0.7 . . . . 0.45 109.109 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.665 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -174.81 160.38 29.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.683 -1.767 . . . . 0.29 108.683 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.524 ' OG ' ' ND2' ' A' ' 51' ' ' ASN . 89.9 p -98.35 155.11 17.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.275 -1.132 . . . . 0.39 109.403 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -151.9 172.86 15.56 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.67 -1.269 . . . . 1.49 110.996 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.423 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -89.64 136.63 23.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.847 0.832 . . . . 0.87 110.917 -178.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 5.2 ttt-85 -148.96 100.21 3.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.973 -0.751 . . . . 2.18 108.973 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 4.7 t0 85.07 36.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.246 -0.65 . . . . 1.35 109.246 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.44 28.5 11.6 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.849 0.833 . . . . 2.57 109.328 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.54 152.04 36.15 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.826 -0.805 . . . . 3.14 108.826 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 9.6 ttm-85 -87.29 141.65 28.48 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.018 -1.073 . . . . 2.39 111.099 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.91 158.58 23.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.635 -0.876 . . . . 0.58 108.635 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.84 148.14 24.8 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.514 -0.741 . . . . 0.61 109.553 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.665 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.8 p90 -140.75 148.11 40.19 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.573 0.702 . . . . 4.08 109.948 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.511 HG23 ' O ' ' B' ' 81' ' ' ILE . 6.4 tt -123.22 131.01 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.631 0.729 . . . . 0.9 110.037 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.636 HD12 ' HB3' ' B' ' 67' ' ' GLN . 11.7 mt -105.98 123.06 47.38 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.149 -1.426 . . . . 0.37 107.149 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -132.4 125.25 30.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.028 -1.045 . . . . 0.98 110.938 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -99.83 169.66 9.08 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.802 -0.635 . . . . 0.71 109.933 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.559 HD21 HG13 ' B' ' 61' ' ' VAL . 1.6 tp -159.86 136.1 8.84 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.55 -0.86 . . . . 1.44 110.661 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 62' ' ' GLN . 7.8 tmtt? -118.36 138.3 52.52 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.52 -0.919 . . . . 1.31 108.52 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.598 HH12 HD21 ' B' ' 53' ' ' LEU . 16.6 tpp180 -95.48 143.7 26.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.465 -0.772 . . . . 1.64 110.753 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.22 -13.48 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.877 -0.786 . . . . 0.68 108.877 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.303 -1.428 0 CA-C-O 117.98 -1.009 . . . . 1.77 109.534 179.781 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.662 ' N ' HD21 ' A' ' 6' ' ' ASN . 9.1 ttt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 6.33 109.472 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 4' ' ' LYS . 6.7 p -144.64 17.8 1.65 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 2.53 109.549 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 30' ' ' GLY . 2.2 tt0 67.74 -48.34 0.51 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.5 -0.75 . . . . 1.75 109.845 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -157.85 55.37 0.48 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.488 -0.885 . . . . 2.24 110.355 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.496 ' N ' ' OG1' ' A' ' 2' ' ' THR . 1.1 tt -173.17 49.7 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.274 -0.971 . . . . 1.67 109.728 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.674 ' OD1' HD12 ' A' ' 31' ' ' ILE . 2.4 m120 -91.0 116.0 28.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.8 -1.187 . . . . 1.72 111.329 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 7.0 pt-20 -92.09 115.58 28.19 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.989 -1.485 . . . . 1.44 106.989 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.0 mt -115.64 140.0 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-O 122.132 0.968 . . . . 1.11 111.592 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.8 124.71 62.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.986 -0.552 . . . . 1.35 109.83 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.509 HG11 ' H ' ' A' ' 46' ' ' ALA . 2.1 p -89.53 165.07 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.631 -1.248 . . . . 0.39 107.631 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -140.19 175.43 9.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.913 . . . . 2.27 109.671 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.1 pttm -101.83 -9.71 20.52 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.006 -0.739 . . . . 1.78 109.006 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 t -90.71 -7.89 51.35 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.828 -1.175 . . . . 1.24 107.828 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.15 -132.76 0.18 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.423 -1.325 . . . . 1.41 107.423 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.81 159.65 21.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.557 -1.339 . . . . 1.25 109.4 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.569 HG23 ' N ' ' A' ' 17' ' ' GLU . 16.5 m -61.66 -40.97 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-O 121.869 0.842 . . . . 0.49 109.284 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 16' ' ' VAL . 3.5 pt-20 -77.86 -32.35 52.0 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.265 -0.897 . . . . 1.56 108.871 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 52.3 t0 -62.78 -31.07 71.96 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.63 -1.294 . . . . 1.38 111.164 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.672 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.6 m-70 -95.23 -17.15 21.96 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.176 -1.578 . . . . 1.43 108.389 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -31.89 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 104.436 -2.431 . . . . 0.29 104.436 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 25' ' ' VAL . 31.6 mt -70.43 -52.85 19.27 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.32 -1.309 . . . . 0.41 109.057 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -67.38 -29.46 68.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 1.22 109.671 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 19' ' ' HIS . 25.5 t -70.03 -54.29 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.32 108.964 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 tt -60.89 -20.36 21.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.203 -0.935 . . . . 0.58 108.894 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 21' ' ' LEU . 11.0 t -72.46 -40.83 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.095 -1.003 . . . . 0.41 109.025 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.03 -36.78 80.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.784 -1.197 . . . . 1.19 109.965 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -61.73 -24.72 66.99 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.237 -1.394 . . . . 1.46 107.237 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -27.03 68.67 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.343 -0.844 . . . . 1.15 109.109 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -89.32 -2.31 58.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 1.17 109.535 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 107.74 12.4 22.73 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.898 -1.281 . . . . 0.42 109.898 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.674 HD12 ' OD1' ' A' ' 6' ' ' ASN . 50.0 mm -76.44 106.16 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.063 -1.257 . . . . 0.35 108.927 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -92.52 -35.76 13.42 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.312 -0.867 . . . . 1.55 110.232 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -98.63 140.12 33.33 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.387 0.613 . . . . 1.58 109.608 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.47 142.85 15.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 119.188 -1.005 . . . . 0.54 110.221 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.2 127.33 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.987 -0.551 . . . . 0.25 110.477 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.8 mp -111.71 118.37 35.43 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.501 0.667 . . . . 0.4 109.322 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.32 134.36 49.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.667 -0.864 . . . . 2.74 108.667 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.5 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -145.14 157.28 27.29 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 120.036 -1.078 . . . . 0.21 111.155 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 41' ' ' ARG . 14.9 p -139.0 146.92 41.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.466 -1.02 . . . . 0.56 112.664 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.526 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 39.76 -86.92 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.628 -0.989 . . . . 0.33 110.628 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -85.23 -51.86 6.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.32 -1.106 . . . . 3.09 109.682 -178.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -25.51 60.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.819 -1.176 . . . . 1.09 108.895 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 40' ' ' GLY . 7.0 tt -49.74 -36.37 11.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.552 -0.717 . . . . 0.87 110.83 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.45 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -83.54 -23.57 32.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.007 -1.058 . . . . 1.14 108.989 -178.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 46' ' ' ALA . 7.8 mmtt -62.29 -70.7 0.18 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 104.497 -2.409 . . . . 1.86 104.497 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.637 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -31.47 -49.63 0.16 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.17 0.51 . . . . 0.29 110.576 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.7 HG13 ' HB ' ' B' ' 68' ' ' THR . 97.4 t -59.37 -69.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.225 -0.922 . . . . 0.22 109.549 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 52' ' ' SER . 3.6 t0 -45.81 -49.04 15.54 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.52 -0.738 . . . . 1.26 109.563 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.485 HG11 HD21 ' A' ' 36' ' ' LEU . 70.4 t -48.14 -59.64 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.646 -0.822 . . . . 1.06 109.105 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -60.06 -53.45 57.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 4.02 110.228 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.602 ' CG ' ' H ' ' B' ' 70' ' ' SER . 0.5 OUTLIER -52.48 -49.82 63.95 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.662 -1.236 . . . . 1.34 107.662 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 49' ' ' VAL . 21.0 p -62.07 -35.04 77.45 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.73 -0.841 . . . . 1.04 108.73 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.474 HD23 ' CD2' ' A' ' 85' ' ' LEU . 7.5 tp -77.34 -22.38 51.94 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.065 -1.022 . . . . 0.44 108.737 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' C ' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -79.89 -42.5 24.04 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.172 -1.58 . . . . 1.0 106.858 177.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.49 -16.11 0.1 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.783 -1.099 . . . . 1.58 108.051 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.506 ' N ' ' C ' ' A' ' 54' ' ' LYS . 12.2 mmm180 -59.31 -55.7 31.49 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.356 0.598 . . . . 1.69 110.251 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 mt -159.16 0.58 0.09 Allowed 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 118.689 -1.204 . . . . 1.66 110.595 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 61' ' ' VAL . . . 64.92 -58.52 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.527 -1.321 . . . . 0.39 110.209 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -70.96 -41.98 70.36 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.495 -1.003 . . . . 1.38 110.49 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.49 17.64 3.24 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.414 -1.475 . . . . 0.26 109.414 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.681 HG13 HD21 ' A' ' 85' ' ' LEU . 2.4 t -155.94 127.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.785 -1.191 . . . . 0.38 107.785 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.6 mm-40 -132.94 157.51 44.96 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.176 0.988 . . . . 1.31 111.375 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.724 HD11 HG21 ' A' ' 66' ' ' VAL . 8.3 tt -96.05 112.6 24.29 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.072 -0.714 . . . . 0.49 109.072 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -20.86 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 1.35 110.001 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.477 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -167.86 153.23 7.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.18 -1.575 . . . . 1.2 109.784 177.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.724 HG21 HD11 ' A' ' 63' ' ' LEU . 70.3 t -159.65 129.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.463 -0.773 . . . . 0.85 109.457 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 82' ' ' LEU . 12.9 tt0 -146.06 164.79 31.03 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.285 1.04 . . . . 1.41 110.902 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.613 HG22 ' HA ' ' A' ' 81' ' ' ILE . 1.6 p -139.27 158.06 44.82 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.894 -0.78 . . . . 0.52 108.894 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 80' ' ' TYR . . . -174.55 147.38 9.12 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 107.195 -2.362 . . . . 0.4 107.195 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.587 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 87.4 p -93.45 163.05 13.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.662 -1.493 . . . . 0.42 110.175 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -147.85 159.88 43.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.237 -0.914 . . . . 1.29 110.648 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.17 87.71 2.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 118.991 -1.084 . . . . 1.02 109.226 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 46.1 ttt-85 -96.11 111.19 23.3 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.963 -1.086 . . . . 2.23 110.301 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.0 t70 80.64 37.25 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.888 -0.507 . . . . 1.38 110.178 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.46 28.86 15.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.397 -0.815 . . . . 2.62 109.129 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.26 146.14 28.51 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.083 -1.011 . . . . 3.15 108.776 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.695 ' NH2' HD21 ' B' ' 51' ' ' ASN . 5.5 tpt180 -84.46 133.23 34.49 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.779 1.276 . . . . 2.44 111.256 -177.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.462 HD11 ' HA3' ' A' ' 40' ' ' GLY . 13.5 tt -141.34 155.72 21.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.436 -1.256 . . . . 0.23 108.831 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.55 151.71 23.24 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.139 0.971 . . . . 0.74 111.305 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.5 ' CD1' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -131.45 135.5 47.18 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.455 -0.943 . . . . 4.16 108.455 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.613 ' HA ' HG22 ' A' ' 68' ' ' THR . 2.8 tt -117.11 126.79 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.168 -1.049 . . . . 0.92 108.168 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' GLN . 16.8 mt -107.5 121.06 43.86 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.311 -1.366 . . . . 0.36 107.311 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 tt -131.89 126.12 33.4 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.035 . . . . 0.98 111.123 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -100.56 171.61 7.62 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.784 -0.644 . . . . 0.58 109.985 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 61' ' ' VAL . 1.4 tp -159.49 142.38 14.07 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.112 -1.035 . . . . 1.39 110.72 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.59 ' O ' ' N ' ' A' ' 62' ' ' GLN . 13.7 tmtt? -121.85 141.21 51.48 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 116.073 -0.512 . . . . 1.42 110.442 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.1 mmt-85 -99.21 137.24 38.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.099 -1.001 . . . . 1.64 109.705 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.31 -0.79 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.537 -0.912 . . . . 0.63 108.537 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 t80 . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 118.028 -0.987 . . . . 1.76 109.53 179.524 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ttt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.494 -0.558 . . . . 6.35 109.494 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.479 ' O ' ' CB ' ' B' ' 3' ' ' GLU . 15.7 p -144.05 13.52 1.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 2.42 109.93 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' B' ' 2' ' ' THR . 7.8 tt0 72.28 -50.73 0.7 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 1.68 109.817 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 57.4 0.5 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.303 -0.873 . . . . 2.31 109.857 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.433 ' N ' ' OG1' ' B' ' 2' ' ' THR . 1.1 tt -175.38 46.6 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.422 -0.955 . . . . 1.62 108.422 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -92.32 114.92 27.59 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.251 -0.906 . . . . 1.46 110.792 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 6.7 pt-20 -93.4 117.62 30.3 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.303 -0.999 . . . . 1.49 108.303 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 45.5 mt -113.23 133.9 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.741 0.782 . . . . 1.17 110.574 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -98.7 123.02 51.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.361 0.6 . . . . 1.37 109.703 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.421 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.4 OUTLIER -88.92 165.38 2.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.163 -1.051 . . . . 0.37 108.163 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.448 ' HE ' ' HE3' ' B' ' 14' ' ' LYS . 26.9 mtt-85 -141.79 175.33 9.79 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.431 -0.793 . . . . 2.37 109.747 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -102.53 -9.09 20.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.38 -0.97 . . . . 1.75 108.38 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -84.79 -14.49 47.99 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.478 -0.889 . . . . 1.19 109.614 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.448 ' HE3' ' HE ' ' B' ' 11' ' ' ARG . 12.7 mttm -94.95 -118.25 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.18 -0.95 . . . . 1.47 108.944 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.5 168.6 9.29 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.396 -0.815 . . . . 1.22 109.06 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.517 HG23 ' N ' ' B' ' 17' ' ' GLU . 15.1 m -68.25 -38.4 79.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.881 0.848 . . . . 0.45 109.097 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.517 ' N ' HG23 ' B' ' 16' ' ' VAL . 8.0 pt-20 -76.7 -31.46 57.22 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.024 -1.048 . . . . 1.7 109.51 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -32.28 72.6 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.453 -1.404 . . . . 1.46 111.268 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.66 ' O ' HG23 ' B' ' 23' ' ' VAL . 3.1 m-70 -94.96 -16.81 22.49 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.335 -1.478 . . . . 1.4 108.409 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.15 -35.21 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 104.538 -2.393 . . . . 0.34 104.538 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.57 ' O ' HG23 ' B' ' 25' ' ' VAL . 43.7 mt -68.93 -49.07 61.29 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.649 -1.16 . . . . 0.38 109.011 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -70.25 -32.06 69.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.153 -0.967 . . . . 1.21 109.536 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.66 HG23 ' O ' ' B' ' 19' ' ' HIS . 25.0 t -68.11 -52.53 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.3 109.165 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 2.8 tt -62.19 -23.31 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.217 -0.927 . . . . 0.69 108.883 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.57 HG23 ' O ' ' B' ' 21' ' ' LEU . 11.3 t -69.88 -39.91 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.111 -0.993 . . . . 0.42 109.27 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -68.71 -38.76 80.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.758 -1.214 . . . . 1.15 109.822 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.2 -27.64 65.91 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.81 -1.552 . . . . 1.46 106.81 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -25.25 68.28 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.235 -0.893 . . . . 1.17 109.143 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -91.64 0.62 57.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 1.17 109.351 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 103.68 14.25 25.8 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.034 -1.226 . . . . 0.38 110.034 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -78.08 108.49 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.931 -1.335 . . . . 0.59 108.393 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.7 OUTLIER -94.38 -37.97 11.2 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.409 -0.807 . . . . 1.46 110.642 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -100.38 139.03 36.63 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.714 -0.616 . . . . 1.2 110.046 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.75 142.93 16.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.089 -1.044 . . . . 0.49 111.234 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.85 124.79 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-N 115.889 -0.596 . . . . 0.31 110.405 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' B' ' 46' ' ' ALA . 2.8 mp -103.19 114.21 28.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.305 -0.872 . . . . 0.48 109.848 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -98.66 122.97 42.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 2.74 109.761 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.507 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -137.59 153.33 22.01 Favored Glycine 0 N--CA 1.505 3.266 0 C-N-CA 119.86 -1.162 . . . . 0.24 111.357 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.61 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 1.4 p -139.79 147.28 40.56 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 122.174 0.987 . . . . 0.49 112.949 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.531 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 36.93 -87.62 0.01 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.632 -0.987 . . . . 0.28 110.632 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -82.63 -52.77 6.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -1.084 . . . . 3.16 109.503 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -19.48 54.24 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.901 -1.124 . . . . 1.38 109.224 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.531 HG22 ' O ' ' B' ' 40' ' ' GLY . 6.6 tt -54.58 -28.61 19.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.267 -0.896 . . . . 0.85 109.618 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.98 -26.83 26.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 1.12 108.921 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.452 ' O ' ' C ' ' B' ' 46' ' ' ALA . 9.9 mmtt -64.0 -69.62 0.27 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.819 -1.919 . . . . 1.87 105.819 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.648 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -32.42 -49.69 0.22 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 116.123 -0.49 . . . . 0.26 111.166 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.583 HG13 ' HB ' ' A' ' 68' ' ' THR . 69.9 t -66.91 -62.74 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.73 -1.231 . . . . 0.28 109.884 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . 0.438 ' O ' ' OG ' ' B' ' 52' ' ' SER . 7.5 t0 -48.22 -52.57 20.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 1.25 108.646 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 54.2 t -44.42 -55.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.722 -0.844 . . . . 1.06 108.722 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' B' ' 54' ' ' LYS . 0.1 OUTLIER -63.97 -51.89 62.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.542 -0.724 . . . . 4.11 110.503 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.695 HD21 ' NH2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -53.25 -51.08 63.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.311 -1.366 . . . . 1.41 107.311 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' B' ' 48' ' ' ASP . 3.8 p -59.18 -36.73 75.84 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.564 -0.902 . . . . 0.65 108.564 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.473 ' O ' ' CG ' ' B' ' 56' ' ' ARG . 5.4 tp -77.13 -24.06 51.7 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.211 -0.931 . . . . 0.53 109.069 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . 0.531 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -81.78 -44.57 16.81 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 119.843 -1.786 . . . . 0.99 107.286 178.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' B' ' 55' ' ' ASP . 1.4 t0 -50.88 -11.22 0.08 Allowed 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.171 -1.377 . . . . 1.46 107.88 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.531 ' N ' ' C ' ' B' ' 54' ' ' LYS . 9.3 mmm180 -56.96 -57.25 13.36 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.119 0.961 . . . . 1.71 110.352 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.0 OUTLIER -156.53 -1.92 0.12 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.137 -1.061 . . . . 1.77 108.137 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.0 -52.93 0.1 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.011 -1.09 . . . . 0.39 110.427 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -72.51 -45.44 59.36 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.473 -1.016 . . . . 1.4 110.329 -178.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.417 ' O ' HG23 ' B' ' 61' ' ' VAL . . . -71.93 21.08 0.82 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 109.395 -1.482 . . . . 0.34 109.395 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.651 HG13 HD21 ' B' ' 85' ' ' LEU . 2.5 t -156.65 130.76 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.032 -1.275 . . . . 0.46 107.894 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.5 mm-40 -132.92 150.11 52.19 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.029 0.919 . . . . 1.42 111.695 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.667 ' C ' HD23 ' B' ' 63' ' ' LEU . 7.0 tt -94.23 114.83 27.0 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.84 -1.17 . . . . 0.54 107.84 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.36 -11.77 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.419 -0.801 . . . . 1.43 110.729 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' B' ' 84' ' ' ARG . 0.5 OUTLIER -175.57 146.42 0.77 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.343 -1.473 . . . . 1.28 109.655 178.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.661 HG21 HD11 ' B' ' 63' ' ' LEU . 87.2 t -156.79 134.29 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.507 -0.746 . . . . 0.9 109.038 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . 0.667 ' HB3' HD12 ' B' ' 82' ' ' LEU . 23.6 tt0 -146.28 162.87 37.16 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.133 0.968 . . . . 1.44 110.943 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.7 ' HB ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -126.74 164.86 20.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.303 -0.999 . . . . 0.45 108.303 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.55 136.85 3.05 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.024 -1.63 . . . . 0.29 109.024 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.602 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 51.8 p -94.36 156.81 16.32 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.185 -1.185 . . . . 0.39 108.231 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.83 173.09 17.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.805 -1.184 . . . . 1.49 110.605 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 t -89.54 137.75 20.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.805 -0.813 . . . . 0.87 108.805 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 27.3 ttt-85 -149.67 103.47 3.25 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.098 -1.075 . . . . 2.18 108.098 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.3 t70 82.22 34.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.434 -0.95 . . . . 1.35 108.434 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 66.45 25.84 10.15 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.727 0.775 . . . . 2.57 109.12 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -147.32 152.22 37.87 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.412 -0.805 . . . . 3.14 108.995 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.503 ' NH2' HD21 ' A' ' 51' ' ' ASN . 3.5 ttt180 -88.08 138.71 31.21 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.598 1.19 . . . . 2.39 112.253 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.01 156.41 22.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.016 -1.105 . . . . 0.58 108.016 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 2.8 m -86.68 151.52 23.34 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.203 -0.935 . . . . 0.61 110.372 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.61 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.2 OUTLIER -133.32 133.95 43.2 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.133 -1.062 . . . . 4.08 108.133 -178.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.532 HG23 ' O ' ' B' ' 81' ' ' ILE . 3.5 tt -116.06 128.79 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.872 -0.788 . . . . 0.9 108.872 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' B' ' 67' ' ' GLN . 4.4 mt -106.64 118.44 36.67 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.631 -1.618 . . . . 0.37 106.631 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tt -128.18 124.47 36.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.98 110.317 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' B' ' 65' ' ' ASN . 23.0 ttt180 -99.96 170.76 8.29 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.443 0.64 . . . . 0.71 109.965 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.651 HD21 HG13 ' B' ' 61' ' ' VAL . 1.5 tp -162.47 127.56 3.28 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.363 -0.935 . . . . 1.44 110.783 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 62' ' ' GLN . 12.6 tmtt? -109.1 148.65 30.5 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.199 -0.667 . . . . 1.31 109.199 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 29.3 mmt-85 -101.18 141.81 33.53 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.276 -0.89 . . . . 1.64 110.416 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.74 -7.79 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.032 -0.729 . . . . 0.68 109.032 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 13.5 t80 . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 117.973 -1.013 . . . . 1.77 109.54 179.438 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.438 -0.579 . . . . 6.33 109.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.414 ' O ' ' CD1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -168.09 -162.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 2.53 109.643 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.509 ' O ' HD13 ' A' ' 31' ' ' ILE . 1.4 mm-40 -71.41 -57.31 4.56 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.509 -0.744 . . . . 1.75 109.827 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.72 63.81 0.61 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.626 -0.671 . . . . 2.24 109.319 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.1 tp -165.0 156.27 14.74 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.17 -1.789 . . . . 1.67 106.17 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.851 ' ND2' HG23 ' A' ' 34' ' ' VAL . 1.0 OUTLIER 175.84 96.13 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.683 -1.207 . . . . 1.72 109.898 176.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 4.4 pt-20 -91.26 119.11 31.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.454 -1.404 . . . . 1.44 108.793 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.462 ' CG1' ' OD1' ' A' ' 6' ' ' ASN . 2.7 mt -129.76 145.99 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 CA-C-O 122.242 1.02 . . . . 1.11 111.732 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 37' ' ' LYS . 3.7 t -107.96 130.27 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.585 0.707 . . . . 1.35 109.632 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.408 HG11 ' H ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -88.47 162.98 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.244 -1.021 . . . . 0.39 108.244 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.23 175.01 9.99 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.276 1.036 . . . . 2.27 111.216 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.46 ' H ' ' HG3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -101.91 -12.47 18.2 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.086 -1.079 . . . . 1.78 108.086 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.587 ' C ' ' HZ3' ' A' ' 14' ' ' LYS . 30.0 p -86.42 -15.35 40.58 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.828 -0.749 . . . . 1.24 109.437 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HZ3' ' C ' ' A' ' 13' ' ' THR . 4.9 mmpm? -91.71 -123.55 0.08 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.118 -0.989 . . . . 1.41 108.841 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.49 167.09 13.95 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.887 -1.153 . . . . 1.25 107.887 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 16' ' ' VAL . 1.5 m -68.06 -30.12 46.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.897 -1.149 . . . . 0.49 107.897 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.5 pt-20 -79.46 -37.85 35.95 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.504 -0.878 . . . . 1.56 109.328 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.418 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -58.29 -33.23 69.21 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 120.146 -1.596 . . . . 1.38 110.899 -179.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.638 ' O ' HG23 ' A' ' 23' ' ' VAL . 70.4 m-70 -91.74 -16.87 26.25 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 120.379 -1.451 . . . . 1.43 108.922 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.56 -32.73 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 105.294 -2.113 . . . . 0.29 105.294 176.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 25' ' ' VAL . 65.9 mt -70.36 -56.15 7.38 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.228 -0.896 . . . . 0.41 109.517 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -64.79 -27.47 68.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 1.22 110.26 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 19' ' ' HIS . 38.8 t -73.25 -50.26 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.235 -0.915 . . . . 0.32 109.262 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 tt -64.52 -18.13 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.203 -0.935 . . . . 0.58 108.675 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 21' ' ' LEU . 9.0 t -74.95 -44.62 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.293 -0.879 . . . . 0.41 108.835 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -67.15 -31.95 72.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.008 -1.057 . . . . 1.19 110.147 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.596 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 15.6 t80 -65.36 -24.87 67.35 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.225 -1.398 . . . . 1.46 107.225 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -64.01 -27.32 69.04 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.36 -0.836 . . . . 1.15 109.318 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -89.41 -2.42 58.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.996 -1.065 . . . . 1.17 109.317 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.17 15.8 13.6 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.088 -1.205 . . . . 0.42 110.088 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.509 HD13 ' O ' ' A' ' 3' ' ' GLU . 48.8 mm -79.54 105.98 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.02 -1.282 . . . . 0.35 108.566 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -94.41 -37.77 11.28 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.337 -0.852 . . . . 1.55 110.482 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 3.4 mt-10 -95.08 135.27 36.84 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.297 -0.877 . . . . 1.58 109.697 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.851 HG23 ' ND2' ' A' ' 6' ' ' ASN . 2.8 p -149.14 138.55 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.329 -0.948 . . . . 0.54 110.466 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.99 127.64 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 115.911 -0.586 . . . . 0.25 110.865 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.2 mp -112.75 122.28 47.21 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.291 -0.633 . . . . 0.4 109.291 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -106.76 136.98 45.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.442 -0.947 . . . . 2.74 108.442 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.34 156.68 26.26 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 119.501 -1.333 . . . . 0.21 111.32 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.671 ' O ' ' N ' ' A' ' 41' ' ' ARG . 43.4 p -134.02 142.84 47.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.907 -0.76 . . . . 0.56 112.151 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.565 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 35.49 -77.19 0.0 OUTLIER Glycine 0 N--CA 1.503 3.122 0 CA-C-O 121.346 0.415 . . . . 0.33 112.182 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.671 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -87.11 -58.37 2.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.249 . . . . 3.09 109.429 -179.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -20.91 21.72 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.1 -1.0 . . . . 1.09 108.933 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 40' ' ' GLY . 8.4 tt -53.65 -33.84 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.152 -0.967 . . . . 0.87 111.046 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.14 -24.48 24.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.727 -1.233 . . . . 1.14 108.499 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -58.39 -67.7 0.33 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.206 -2.146 . . . . 1.86 105.206 177.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.561 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -34.32 -48.01 0.32 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 120.998 0.428 . . . . 0.29 110.556 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.661 HG13 ' HB ' ' B' ' 68' ' ' THR . 97.1 t -60.62 -64.93 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.034 -1.041 . . . . 0.22 109.343 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -46.53 -51.81 14.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.436 -0.95 . . . . 1.26 108.436 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.467 HG11 HD21 ' A' ' 36' ' ' LEU . 74.5 t -46.93 -57.34 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.875 -1.157 . . . . 1.06 107.875 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -58.35 -57.5 12.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.401 -0.812 . . . . 4.02 110.598 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.544 ' CG ' ' H ' ' B' ' 70' ' ' SER . 1.1 t30 -51.76 -53.44 39.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.899 -1.148 . . . . 1.34 107.899 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.9 p -59.4 -39.03 82.1 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.434 -0.906 . . . . 1.04 109.101 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.445 HD22 HG11 ' A' ' 23' ' ' VAL . 38.0 tp -75.53 -24.33 56.74 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.993 -1.067 . . . . 0.44 109.023 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' TYR . 5.9 tmtt? -80.88 -40.97 23.87 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.738 -1.949 . . . . 1.0 105.738 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -57.92 -7.18 0.69 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.331 -1.304 . . . . 1.58 107.817 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.4 tpt180 -71.59 -46.07 60.35 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.624 0.726 . . . . 1.69 110.067 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 mt -154.44 -19.47 0.13 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.777 -0.769 . . . . 1.66 109.657 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.79 -50.34 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.321 -1.112 . . . . 0.39 110.321 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -74.54 -41.73 60.08 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.347 -1.09 . . . . 1.38 109.94 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.25 25.05 7.34 Favored Glycine 0 N--CA 1.48 1.62 0 N-CA-C 109.273 -1.531 . . . . 0.26 109.273 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.562 HG13 HD21 ' A' ' 85' ' ' LEU . 4.0 t -151.97 119.27 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 106.943 -1.503 . . . . 0.38 106.943 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.1 mm100 -126.58 159.64 32.95 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.096 0.95 . . . . 1.31 111.604 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.709 HD11 HG21 ' A' ' 66' ' ' VAL . 8.4 tt -94.67 116.69 29.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.923 -0.769 . . . . 0.49 108.923 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -22.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.212 -0.93 . . . . 1.35 109.482 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.459 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -172.04 154.01 3.33 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.76 -1.176 . . . . 1.2 109.741 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.709 HG21 HD11 ' A' ' 63' ' ' LEU . 77.7 t -159.46 130.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.41 -0.959 . . . . 0.85 108.41 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -141.38 162.0 36.53 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.985 0.898 . . . . 1.41 109.945 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.57 148.77 51.64 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.84 -0.8 . . . . 0.52 108.84 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.637 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -172.04 155.35 23.53 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.602 -1.799 . . . . 0.4 108.602 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.578 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 83.2 p -100.48 156.85 17.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.188 -1.184 . . . . 0.42 109.907 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -144.18 160.27 41.22 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.085 -1.009 . . . . 1.29 110.278 179.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.43 91.07 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.808 -0.757 . . . . 1.02 111.141 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 9.0 ttt85 -96.07 107.84 20.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.064 -1.023 . . . . 2.23 110.18 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.8 t0 84.08 36.22 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.127 0.489 . . . . 1.38 110.263 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.478 HH11 ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER 62.6 29.82 16.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.378 -0.826 . . . . 2.62 108.794 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -145.09 144.09 30.76 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.022 -1.103 . . . . 3.15 108.022 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -84.25 136.28 34.0 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.822 1.296 . . . . 2.44 110.84 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.0 tt -143.91 155.79 15.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-N 114.316 -1.311 . . . . 0.23 108.156 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 p -90.49 154.35 19.7 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 121.356 -0.84 . . . . 0.74 111.43 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.637 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.8 p90 -143.56 150.91 39.54 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.81 0.814 . . . . 4.16 109.702 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 81' ' ' ILE . 6.0 tt -124.51 133.61 68.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.724 0.773 . . . . 0.92 109.582 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.2 mt -107.8 128.58 54.72 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.663 -1.236 . . . . 0.36 107.663 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 tt -137.13 127.43 26.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.976 -1.077 . . . . 0.98 111.519 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -104.9 166.36 10.44 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.681 -0.69 . . . . 0.58 110.295 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.562 HD21 HG13 ' A' ' 61' ' ' VAL . 4.7 tp -157.87 137.01 11.66 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.437 -0.905 . . . . 1.39 111.458 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -117.31 137.11 52.64 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.727 -0.471 . . . . 1.42 109.727 178.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 16.9 mmt85 -94.17 144.49 25.46 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.212 -0.93 . . . . 1.64 109.721 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 88' ' ' VAL . 27.1 t -123.63 -6.5 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.909 -0.774 . . . . 0.63 108.909 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 118.049 -0.976 . . . . 1.76 109.51 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mtt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.244 0.545 . . . . 6.35 109.626 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -160.21 -167.92 2.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 2.42 109.11 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 30' ' ' GLY . 1.5 mt-10 -83.84 7.33 18.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.113 -0.992 . . . . 1.68 109.633 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.02 50.29 0.3 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.868 0.842 . . . . 2.31 109.348 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 5.6 tp -162.85 155.98 19.61 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 105.545 -2.02 . . . . 1.62 105.545 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.698 HD21 HD13 ' B' ' 26' ' ' LEU . 1.1 t30 -178.94 92.96 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 117.852 -1.539 . . . . 1.46 110.887 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.1 pt-20 -92.06 105.12 17.43 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.183 -1.573 . . . . 1.49 108.032 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.642 HD11 HD22 ' B' ' 6' ' ' ASN . 4.0 mt -116.33 135.05 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.698 0.761 . . . . 1.17 109.954 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.646 HG13 ' HB2' ' B' ' 37' ' ' LYS . 11.9 t -97.79 127.72 49.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.508 0.671 . . . . 1.37 109.483 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.495 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -88.33 160.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.946 -1.131 . . . . 0.37 107.946 -179.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 172.25 12.97 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.934 0.873 . . . . 2.37 110.538 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.99 -13.02 39.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.705 -0.85 . . . . 1.75 108.705 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 47.8 p -76.86 -70.27 0.47 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.885 -1.524 . . . . 1.19 106.885 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 139.9 33.93 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.386 -0.821 . . . . 1.47 110.148 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -72.84 178.59 4.14 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.473 0.654 . . . . 1.22 109.843 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.11 -29.25 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.92 0.866 . . . . 0.45 108.795 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 13.0 pt-20 -74.62 -39.15 62.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.607 -0.886 . . . . 1.7 108.607 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 17.4 t0 -57.16 -29.54 63.72 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.088 -1.008 . . . . 1.46 111.375 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.687 ' O ' HG23 ' B' ' 23' ' ' VAL . 52.4 m-70 -94.83 -19.51 20.26 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 119.977 -1.702 . . . . 1.4 107.946 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -35.81 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 105.069 -2.197 . . . . 0.34 105.069 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.488 ' O ' HG23 ' B' ' 25' ' ' VAL . 68.9 mt -69.14 -51.92 33.38 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.204 -0.907 . . . . 0.38 108.732 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -66.78 -30.73 71.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 1.21 110.126 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.687 HG23 ' O ' ' B' ' 19' ' ' HIS . 42.2 t -71.71 -55.12 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.142 -0.974 . . . . 0.3 109.41 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 tt -58.67 -21.97 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.69 108.982 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 21' ' ' LEU . 5.6 t -71.12 -39.86 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.179 -0.951 . . . . 0.42 108.95 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.698 HD13 HD21 ' B' ' 6' ' ' ASN . 4.9 mt -68.44 -44.98 73.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 1.15 109.942 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.582 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 18.4 t80 -54.42 -27.5 37.36 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.29 -1.374 . . . . 1.46 107.29 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -62.76 -24.92 67.95 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.533 -0.758 . . . . 1.17 109.575 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -91.6 -4.38 55.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.917 -1.114 . . . . 1.17 109.083 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 110.16 14.13 14.01 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.429 -1.468 . . . . 0.38 109.429 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' B' ' 2' ' ' THR . 32.6 mm -78.83 102.18 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.006 -1.291 . . . . 0.59 108.666 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.15 -35.03 14.79 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.278 -0.889 . . . . 1.46 111.517 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.68 135.42 44.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.382 -0.824 . . . . 1.2 110.471 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.59 142.5 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.305 -0.958 . . . . 0.49 111.707 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.86 123.42 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 121.204 0.526 . . . . 0.31 111.012 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.646 HD23 ' HA ' ' B' ' 46' ' ' ALA . 3.3 mp -102.5 121.89 43.26 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.439 -0.788 . . . . 0.48 110.141 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.646 ' HB2' HG13 ' B' ' 9' ' ' VAL . 4.0 mttt -103.01 128.56 49.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.223 -0.923 . . . . 2.74 109.214 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.91 150.95 21.12 Favored Glycine 0 N--CA 1.502 3.099 0 C-N-CA 119.366 -1.397 . . . . 0.24 111.667 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.591 ' O ' ' N ' ' B' ' 41' ' ' ARG . 81.8 p -131.88 139.5 48.81 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.826 -0.808 . . . . 0.49 112.174 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.451 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 35.79 -83.58 0.0 OUTLIER Glycine 0 N--CA 1.502 3.092 0 O-C-N 121.694 -0.629 . . . . 0.28 111.983 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.69 ' HE ' ' N ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -81.23 -54.61 5.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.084 -1.245 . . . . 3.16 109.388 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.26 -20.55 43.22 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.155 -0.965 . . . . 1.38 108.431 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.451 HG22 ' O ' ' B' ' 40' ' ' GLY . 3.7 tt -55.25 -33.55 30.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.049 -1.032 . . . . 0.85 110.301 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -22.65 32.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.035 -1.04 . . . . 1.12 108.858 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' B' ' 46' ' ' ALA . 0.0 OUTLIER -64.85 -68.73 0.34 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.533 -1.655 . . . . 1.87 106.533 177.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.646 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -37.23 -46.15 0.7 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.378 0.608 . . . . 0.26 110.272 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 43' ' ' ILE . 74.0 t -60.79 -66.3 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.185 -0.947 . . . . 0.28 109.132 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . 0.438 ' OD1' ' OG ' ' B' ' 52' ' ' SER . 26.8 t0 -48.23 -46.6 35.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.919 . . . . 1.25 108.848 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.608 HG11 HD21 ' B' ' 36' ' ' LEU . 75.0 t -47.87 -54.91 3.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.011 -1.107 . . . . 1.06 108.011 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.473 ' CE1' HD11 ' B' ' 85' ' ' LEU . 1.3 t80 -59.47 -60.67 3.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 4.11 110.611 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.578 ' CG ' ' H ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -48.13 -54.79 12.09 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.276 -0.89 . . . . 1.41 108.599 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.438 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 0.7 OUTLIER -60.25 -38.3 83.03 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.377 -0.929 . . . . 0.65 109.378 -179.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.477 HD22 HG11 ' B' ' 23' ' ' VAL . 24.2 tp -73.32 -26.9 61.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.938 . . . . 0.53 109.276 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' B' ' 56' ' ' ARG . 1.6 tmtt? -75.03 -50.91 14.95 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.674 -1.602 . . . . 0.99 106.674 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.41 -17.96 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.053 -1.43 . . . . 1.46 109.479 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' B' ' 54' ' ' LYS . 12.7 mmm180 -69.17 -38.44 78.72 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.13 -1.028 . . . . 1.71 109.845 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.6 mt -155.39 -13.13 0.11 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.091 -1.444 . . . . 1.77 112.216 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.93 -67.81 0.05 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.228 -1.463 . . . . 0.39 110.187 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.17 -35.71 76.59 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.407 -1.055 . . . . 1.4 109.919 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.27 22.37 6.25 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 109.385 -1.486 . . . . 0.34 109.385 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.603 HG13 HD21 ' B' ' 85' ' ' LEU . 7.2 t -153.84 130.29 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.187 -1.184 . . . . 0.46 107.872 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' B' ' 86' ' ' LYS . 2.5 mm100 -133.11 155.54 49.08 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.306 1.051 . . . . 1.42 111.977 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.611 HD11 HG21 ' B' ' 66' ' ' VAL . 8.4 tt -94.85 118.97 32.65 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.517 -0.92 . . . . 0.54 108.517 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.97 -14.94 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.399 -0.813 . . . . 1.43 109.906 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.475 ' O ' HG23 ' B' ' 66' ' ' VAL . 1.2 m-80 -177.53 152.07 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.732 -1.23 . . . . 1.28 109.906 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.611 HG21 HD11 ' B' ' 63' ' ' LEU . 74.8 t -160.05 134.31 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.759 -0.83 . . . . 0.9 108.759 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . 0.422 ' HB3' HD12 ' B' ' 82' ' ' LEU . 32.1 tt0 -145.59 162.42 37.51 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.123 0.963 . . . . 1.44 110.973 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.661 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -136.66 154.69 50.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.416 -0.957 . . . . 0.45 108.416 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.656 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -177.98 155.9 18.26 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 107.443 -2.263 . . . . 0.29 107.443 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.544 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 90.7 p -94.03 156.74 16.44 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.055 -1.262 . . . . 0.39 108.959 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.419 ' OE1' ' C ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -147.0 164.71 32.12 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.939 -1.101 . . . . 1.49 110.141 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.419 ' C ' ' OE1' ' B' ' 71' ' ' GLU . 2.1 t -91.14 136.46 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 120.023 -0.671 . . . . 0.87 110.002 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 0.0 OUTLIER -148.51 106.66 3.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.416 -0.957 . . . . 2.18 108.416 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.8 t0 79.74 35.53 0.15 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.258 -1.015 . . . . 1.35 108.258 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.72 31.85 11.62 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.845 0.831 . . . . 2.57 109.169 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -150.01 150.76 32.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.21 -0.931 . . . . 3.14 109.298 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -88.4 138.5 31.38 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.393 1.092 . . . . 2.39 112.429 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.34 154.09 27.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.045 -1.094 . . . . 0.58 108.045 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 150.19 24.73 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.146 -0.972 . . . . 0.61 109.912 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.656 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.9 p90 -144.42 149.93 36.87 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.929 0.871 . . . . 4.08 110.826 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.483 HG23 ' O ' ' B' ' 81' ' ' ILE . 7.2 tt -125.35 134.04 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.59 0.709 . . . . 0.9 110.33 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.422 HD12 ' HB3' ' B' ' 67' ' ' GLN . 11.2 mt -108.31 119.93 40.93 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.591 -1.633 . . . . 0.37 106.591 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.12 125.02 43.08 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.396 -0.922 . . . . 0.98 111.065 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 -100.35 167.98 10.06 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.975 -0.75 . . . . 0.71 108.975 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.603 HD21 HG13 ' B' ' 61' ' ' VAL . 2.2 tp -159.42 136.28 9.43 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.45 -0.9 . . . . 1.44 110.448 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.0 OUTLIER -118.0 143.01 46.76 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.285 -0.635 . . . . 1.31 109.285 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.582 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 17.6 mmt85 -100.64 140.57 34.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.278 -0.889 . . . . 1.64 109.997 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 t -119.0 -7.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.658 -0.867 . . . . 0.68 108.658 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.455 0 CA-C-O 118.003 -0.999 . . . . 1.77 109.494 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 mmt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.518 -0.549 . . . . 6.33 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.481 ' O ' ' CD1' ' A' ' 31' ' ' ILE . 5.5 t -138.05 23.28 2.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.456 -0.778 . . . . 2.53 109.803 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 30' ' ' GLY . 2.3 mt-10 -84.26 -2.72 57.46 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.746 -0.835 . . . . 1.75 108.746 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 53.84 0.38 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 2.24 109.706 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -173.24 46.92 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.186 -1.042 . . . . 1.67 108.186 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.704 ' ND2' HD13 ' A' ' 26' ' ' LEU . 53.3 t30 -91.38 110.52 21.83 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.313 -0.867 . . . . 1.72 110.824 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.99 120.58 32.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.861 -1.149 . . . . 1.44 108.36 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.543 HD11 HD21 ' A' ' 6' ' ' ASN . 3.5 mm -125.25 148.01 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-O 122.061 0.934 . . . . 1.11 111.551 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.9 t -111.18 131.67 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.605 0.716 . . . . 1.35 110.386 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.477 HG11 ' H ' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -90.46 162.36 2.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.47 -0.937 . . . . 0.39 108.47 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.435 ' HE ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -137.79 174.05 10.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 2.27 110.221 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 -10.99 18.62 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.872 -0.788 . . . . 1.78 108.872 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.419 ' H ' HG22 ' A' ' 13' ' ' THR . 0.5 OUTLIER -85.71 -8.82 57.95 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.45 -0.9 . . . . 1.24 109.082 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HD3' ' HE ' ' A' ' 11' ' ' ARG . 0.1 OUTLIER -100.3 -121.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.353 -1.351 . . . . 1.41 107.353 177.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.473 ' O ' ' ND1' ' A' ' 19' ' ' HIS . 5.4 m-80 -170.73 173.53 5.29 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.505 -1.372 . . . . 1.25 108.153 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.6 -31.57 51.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.073 -1.051 . . . . 0.49 108.214 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.6 pt-20 -79.21 -36.37 40.22 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.409 -0.917 . . . . 1.56 109.965 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -55.73 -33.26 64.09 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 119.908 -1.745 . . . . 1.38 110.814 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.709 ' O ' HG23 ' A' ' 23' ' ' VAL . 10.5 m80 -94.52 -19.4 20.57 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.695 -1.253 . . . . 1.43 109.021 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.74 -34.26 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 104.324 -2.473 . . . . 0.29 104.324 176.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.653 ' O ' HG23 ' A' ' 25' ' ' VAL . 51.9 mt -68.49 -54.68 15.33 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.59 -1.186 . . . . 0.41 108.935 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -67.41 -26.6 66.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 1.22 110.061 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 19' ' ' HIS . 35.3 t -72.41 -52.17 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.17 -0.957 . . . . 0.32 108.7 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 tt -61.86 -19.16 20.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.209 -0.932 . . . . 0.58 108.58 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 21' ' ' LEU . 40.2 t -75.52 -44.71 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.244 -0.91 . . . . 0.41 109.221 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' ND2' ' A' ' 6' ' ' ASN . 4.5 mt -64.94 -34.67 78.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.814 -1.179 . . . . 1.19 110.673 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -65.91 -24.47 66.85 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.534 -1.284 . . . . 1.46 107.534 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -64.36 -24.97 67.83 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.452 -0.795 . . . . 1.15 109.796 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -92.07 1.18 57.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.794 -1.191 . . . . 1.17 109.189 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 103.65 12.37 30.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.585 -1.406 . . . . 0.42 109.585 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 2' ' ' THR . 19.3 mm -74.35 108.96 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -1.184 . . . . 0.35 108.248 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -93.31 -41.18 10.0 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.443 -0.786 . . . . 1.55 110.57 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -94.96 142.15 27.82 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.357 -0.839 . . . . 1.58 109.902 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.76 137.78 11.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.049 -1.06 . . . . 0.54 110.57 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -116.83 122.1 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.977 -0.556 . . . . 0.25 110.284 -178.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 46' ' ' ALA . 2.3 mp -104.33 120.71 41.81 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 120.115 -0.634 . . . . 0.4 109.379 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.88 134.97 50.84 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.681 -0.859 . . . . 2.74 108.681 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -152.48 164.7 30.71 Favored Glycine 0 N--CA 1.508 3.435 0 C-N-CA 119.763 -1.208 . . . . 0.21 111.603 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -145.69 152.33 39.44 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.391 -1.064 . . . . 0.56 113.649 -177.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.593 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 38.13 -86.29 0.01 OUTLIER Glycine 0 N--CA 1.499 2.838 0 N-CA-C 111.254 -0.739 . . . . 0.33 111.254 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.657 ' NE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -82.46 -54.32 5.29 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.224 -1.162 . . . . 3.09 109.485 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -20.63 58.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.201 -0.937 . . . . 1.09 109.148 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.705 HD12 HD12 ' B' ' 43' ' ' ILE . 0.2 OUTLIER -52.78 -38.04 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.004 . . . . 0.87 110.759 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -82.38 -25.37 33.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.745 -1.222 . . . . 1.14 108.871 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' O ' ' C ' ' A' ' 46' ' ' ALA . 3.2 mptt -62.06 -69.4 0.25 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.675 -1.972 . . . . 1.86 105.675 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.637 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -34.22 -47.56 0.29 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.139 0.495 . . . . 0.29 110.276 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.628 HG13 ' HB ' ' B' ' 68' ' ' THR . 68.9 t -62.19 -68.14 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.111 -0.993 . . . . 0.22 109.537 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 49' ' ' VAL . 0.7 OUTLIER -45.49 -49.61 13.47 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.793 -0.818 . . . . 1.26 108.793 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 36' ' ' LEU . 47.7 t -45.59 -57.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.582 -0.896 . . . . 1.06 108.582 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -62.99 -58.21 8.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.299 -0.875 . . . . 4.02 110.153 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.617 ' CG ' ' H ' ' B' ' 70' ' ' SER . 1.3 t30 -46.97 -54.72 9.51 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.97 -1.122 . . . . 1.34 107.97 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -59.49 -34.72 72.93 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.596 -0.89 . . . . 1.04 108.596 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 23' ' ' VAL . 10.1 tp -76.85 -21.76 54.53 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.227 -1.027 . . . . 0.44 108.227 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -78.26 -46.28 20.69 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.091 -1.818 . . . . 1.0 106.091 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -58.49 -5.86 0.6 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.025 -1.102 . . . . 1.58 108.025 178.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 54' ' ' LYS . 3.4 tpt85 -75.87 -47.35 25.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.722 0.772 . . . . 1.69 109.639 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.629 HD23 ' H ' ' A' ' 60' ' ' GLY . 2.4 tp -152.14 -27.08 0.17 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.663 -0.815 . . . . 1.66 109.88 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.62 -47.93 0.08 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.149 -1.181 . . . . 0.39 110.149 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.617 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.6 OUTLIER -74.8 -44.28 50.26 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.484 -1.009 . . . . 1.38 109.772 -179.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.629 ' H ' HD23 ' A' ' 57' ' ' LEU . . . -85.93 27.04 5.63 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.007 -1.637 . . . . 0.26 109.007 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.7 t -154.75 129.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.339 -1.356 . . . . 0.38 107.339 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 86' ' ' LYS . 0.8 OUTLIER -136.39 157.01 47.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.122 0.963 . . . . 1.31 111.594 -177.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.554 HD11 HG21 ' A' ' 66' ' ' VAL . 7.1 tt -93.13 112.16 24.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.845 -0.798 . . . . 0.49 108.845 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.35 -27.7 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.175 -0.953 . . . . 1.35 109.902 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.494 ' O ' HG23 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -169.88 156.29 6.15 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.612 -1.305 . . . . 1.2 109.694 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 63' ' ' LEU . 68.2 t -159.52 131.34 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.596 0.712 . . . . 0.85 109.343 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.506 ' CG ' ' N ' ' A' ' 68' ' ' THR . 30.6 tt0 -144.21 163.15 34.48 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.166 0.984 . . . . 1.41 109.985 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.506 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -139.65 149.8 44.17 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.569 -0.901 . . . . 0.52 108.569 -178.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.95 148.43 13.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.621 -2.192 . . . . 0.4 107.621 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.59 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 28.1 p -95.55 162.53 13.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.98 -1.306 . . . . 0.42 109.008 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -164.36 178.96 7.09 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.293 -0.963 . . . . 1.29 110.131 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.446 HG23 ' H ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -89.05 135.44 25.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 119.609 -0.836 . . . . 1.02 109.77 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 17.8 ttt85 -151.57 102.46 2.88 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.546 -0.909 . . . . 2.23 108.546 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.3 t70 88.5 33.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.114 0.483 . . . . 1.38 109.721 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.93 34.18 5.45 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.201 1.001 . . . . 2.62 109.364 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.25 153.64 27.85 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.14 -0.975 . . . . 3.15 109.534 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -84.85 137.97 32.83 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.381 1.086 . . . . 2.44 109.14 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.415 ' CG1' ' N ' ' A' ' 79' ' ' SER . 4.2 tt -146.18 159.87 11.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.324 -0.853 . . . . 0.23 108.851 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.415 ' N ' ' CG1' ' A' ' 78' ' ' ILE . 5.1 p -86.58 149.84 24.65 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.076 0.941 . . . . 0.74 109.864 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.44 ' CD2' HG22 ' A' ' 39' ' ' THR . 0.6 OUTLIER -133.15 141.21 48.01 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.507 -0.769 . . . . 4.16 109.033 -178.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 81' ' ' ILE . 8.8 tt -117.66 127.34 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.879 0.847 . . . . 0.92 111.225 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 34.6 mt -107.35 115.95 31.08 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.287 -1.746 . . . . 0.36 106.287 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.52 127.2 40.29 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.011 -1.055 . . . . 0.98 111.117 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.604 ' O ' HD12 ' A' ' 85' ' ' LEU . 10.1 ttt180 -103.12 169.41 8.58 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.482 0.658 . . . . 0.58 110.936 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 84' ' ' ARG . 0.9 OUTLIER -161.86 145.26 12.19 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.25 -0.58 . . . . 1.39 110.174 178.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 62' ' ' GLN . 1.5 tmtp? -127.35 145.51 50.78 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.53 -0.545 . . . . 1.42 109.53 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -96.87 138.98 33.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.455 -0.778 . . . . 1.64 110.291 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -111.16 -6.52 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.6 -0.889 . . . . 0.63 108.6 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.0 t80 . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 118.089 -0.957 . . . . 1.76 109.511 179.772 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.355 -0.609 . . . . 6.35 109.355 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.485 ' O ' HG23 ' B' ' 2' ' ' THR . 5.6 t -96.36 24.03 6.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 2.42 109.007 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.58 -72.51 0.2 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.599 -0.688 . . . . 1.68 110.159 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.73 62.12 4.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.446 -1.409 . . . . 2.31 110.124 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.11 154.08 19.01 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.959 -1.497 . . . . 1.62 106.959 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.718 ' ND2' HD13 ' B' ' 26' ' ' LEU . 1.2 t30 179.06 93.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.718 -1.239 . . . . 1.46 110.605 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -90.4 100.2 13.08 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.41 -1.431 . . . . 1.49 107.56 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.431 ' CG1' HD22 ' B' ' 6' ' ' ASN . 4.2 mm -111.3 140.72 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 109.336 -0.616 . . . . 1.17 109.336 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' B' ' 37' ' ' LYS . 63.5 t -104.29 131.45 53.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.69 0.757 . . . . 1.37 110.481 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.573 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -89.13 159.54 2.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 107.981 -1.118 . . . . 0.37 107.981 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -134.68 169.19 17.7 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.024 0.916 . . . . 2.37 111.025 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.439 ' C ' ' CD ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -97.55 -11.09 24.1 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.834 -0.802 . . . . 1.75 108.834 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.38 -10.17 44.91 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.737 -0.785 . . . . 1.19 109.179 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -96.18 -127.78 0.14 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.999 -1.112 . . . . 1.47 107.999 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . 0.405 ' O ' ' ND1' ' B' ' 19' ' ' HIS . 5.2 m-80 -167.02 162.69 15.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -0.942 . . . . 1.22 109.331 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -63.25 -38.65 82.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 122.001 0.905 . . . . 0.45 108.959 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.455 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 7.3 pt-20 -71.94 -32.75 67.63 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.625 -0.88 . . . . 1.7 108.625 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -63.43 -31.01 72.05 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.349 -0.844 . . . . 1.46 112.402 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.759 ' O ' HG23 ' B' ' 23' ' ' VAL . 23.0 m80 -94.54 -20.87 19.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 119.822 -1.799 . . . . 1.4 108.383 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.99 -38.98 82.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 104.275 -2.491 . . . . 0.34 104.275 176.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.722 ' O ' HG23 ' B' ' 25' ' ' VAL . 48.9 mt -65.73 -49.22 69.23 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.435 -1.257 . . . . 0.38 108.689 178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.5 -31.64 68.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.227 -0.921 . . . . 1.21 109.779 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.759 HG23 ' O ' ' B' ' 19' ' ' HIS . 55.5 t -68.79 -57.32 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.947 -1.096 . . . . 0.3 108.92 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 tt -56.6 -24.67 19.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.336 -0.853 . . . . 0.69 108.937 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.722 HG23 ' O ' ' B' ' 21' ' ' LEU . 25.2 t -70.08 -40.65 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.132 -0.98 . . . . 0.42 109.661 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.718 HD13 ' ND2' ' B' ' 6' ' ' ASN . 4.7 mt -67.45 -44.37 78.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.723 -1.236 . . . . 1.15 110.185 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -57.24 -30.77 64.9 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.139 -1.43 . . . . 1.46 107.139 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -24.1 61.6 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.49 -0.777 . . . . 1.17 109.2 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -92.95 -3.39 54.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 1.17 109.151 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.64 14.51 19.46 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.304 -1.518 . . . . 0.38 109.304 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.42 107.82 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.111 -1.229 . . . . 0.59 108.503 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -91.18 -36.82 13.72 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.477 -0.765 . . . . 1.46 111.415 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' B' ' 85' ' ' LEU . 7.3 mt-10 -107.1 136.47 46.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.542 -0.723 . . . . 1.2 111.135 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' B' ' 6' ' ' ASN . 13.4 p -145.94 145.39 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 119.706 -0.798 . . . . 0.49 111.171 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.69 119.49 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.261 0.553 . . . . 0.31 110.439 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' B' ' 46' ' ' ALA . 2.7 mp -95.47 121.88 37.61 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.268 -0.895 . . . . 0.48 110.918 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.477 ' HB2' HG13 ' B' ' 9' ' ' VAL . 2.8 mtpp -102.88 125.73 49.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.488 -0.758 . . . . 2.74 109.33 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.4 156.85 26.98 Favored Glycine 0 N--CA 1.507 3.407 0 C-N-CA 119.362 -1.399 . . . . 0.24 111.942 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 17.1 p -142.48 149.79 39.67 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.008 0.909 . . . . 0.49 113.309 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.543 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 34.28 -85.51 0.01 OUTLIER Glycine 0 N--CA 1.498 2.773 0 N-CA-C 111.144 -0.782 . . . . 0.28 111.144 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.652 ' N ' ' NE ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -81.22 -53.08 6.67 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.417 -1.049 . . . . 3.16 109.267 -179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.452 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.4 OUTLIER -61.02 -17.73 53.86 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.068 -1.02 . . . . 1.38 108.254 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -53.28 -35.54 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.351 -0.843 . . . . 0.85 110.358 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -24.86 33.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.717 -1.239 . . . . 1.12 109.036 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.499 ' CD ' ' N ' ' B' ' 45' ' ' LYS . 5.4 mptt -66.44 -68.58 0.36 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.692 -1.595 . . . . 1.87 106.692 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.654 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -36.44 -49.13 0.71 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.056 0.455 . . . . 0.26 110.671 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 68' ' ' THR . 79.7 t -66.89 -64.89 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.083 -1.011 . . . . 0.28 109.8 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' B' ' 47' ' ' VAL . 4.5 t70 -46.59 -48.81 19.58 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.442 -0.947 . . . . 1.25 108.442 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.604 HG11 HD21 ' B' ' 36' ' ' LEU . 25.5 t -45.98 -52.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.389 -0.967 . . . . 1.06 108.389 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.547 ' C ' ' CD1' ' B' ' 50' ' ' TYR . 0.2 OUTLIER -66.78 -60.25 2.84 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.377 -0.827 . . . . 4.11 110.26 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.59 ' CG ' ' H ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -45.13 -50.53 11.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.155 -1.018 . . . . 1.41 108.539 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -64.97 -34.63 78.88 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.349 -0.94 . . . . 0.65 109.882 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.449 HD22 HG11 ' B' ' 23' ' ' VAL . 11.2 tp -69.98 -23.99 63.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.976 -1.078 . . . . 0.53 109.921 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -28.41 33.47 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.095 -1.628 . . . . 0.99 106.683 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -16.3 12.16 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.978 -1.119 . . . . 1.46 107.978 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -78.39 -40.04 37.29 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 120.222 -0.591 . . . . 1.71 110.073 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.2 tp -153.53 -24.7 0.14 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 118.329 -1.348 . . . . 1.77 112.118 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.29 -60.88 0.06 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.367 -1.397 . . . . 0.39 109.914 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -67.71 -37.66 82.56 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.351 -1.088 . . . . 1.4 109.764 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.508 ' O ' HG23 ' B' ' 61' ' ' VAL . . . -90.93 28.34 7.99 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.534 -1.426 . . . . 0.34 109.534 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 60' ' ' GLY . 48.6 t -158.57 92.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -1.177 . . . . 0.46 108.791 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER -97.42 161.64 13.69 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.252 1.025 . . . . 1.42 112.094 -178.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 tt -97.27 121.15 38.84 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.104 -1.073 . . . . 0.54 108.104 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.37 -18.21 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.248 -0.907 . . . . 1.43 110.865 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.4 ' O ' HG23 ' B' ' 66' ' ' VAL . 1.9 m-20 -178.5 153.49 0.72 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.52 -1.362 . . . . 1.28 109.907 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 65' ' ' ASN . 87.5 t -158.19 136.56 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.93 -0.767 . . . . 0.9 108.93 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . 0.648 ' HB3' HD12 ' B' ' 82' ' ' LEU . 24.0 tt0 -147.16 164.87 31.74 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.253 1.025 . . . . 1.44 110.663 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.628 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -143.0 158.42 43.62 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.426 -0.953 . . . . 0.45 108.426 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.67 151.84 11.78 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 106.934 -2.467 . . . . 0.29 106.934 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.617 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 39.9 p -93.28 160.21 14.93 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.909 -1.348 . . . . 0.39 108.535 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -159.09 174.62 14.62 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.925 -1.109 . . . . 1.49 110.061 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.432 ' O ' ' OE1' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -90.64 130.47 39.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 119.767 -0.773 . . . . 0.87 109.858 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.2 ttt85 -148.14 104.88 3.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.041 -0.726 . . . . 2.18 109.041 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.2 t70 82.59 39.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.611 -0.515 . . . . 1.35 109.611 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.62 31.86 20.26 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.063 0.935 . . . . 2.57 108.793 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -154.86 152.75 30.17 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.056 -0.72 . . . . 3.14 109.056 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -88.18 136.77 32.82 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.857 -1.137 . . . . 2.39 110.734 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 tt -138.87 157.26 29.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.713 0.768 . . . . 0.58 109.38 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.37 146.75 28.3 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.904 -1.146 . . . . 0.61 107.904 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.618 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 2.3 t80 -136.98 139.78 41.72 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.961 -0.755 . . . . 4.08 108.961 -175.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 12.9 tt -122.78 132.27 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 121.996 0.903 . . . . 0.9 113.236 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' B' ' 67' ' ' GLN . 0.9 OUTLIER -108.81 108.08 18.75 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 105.999 -1.852 . . . . 0.37 105.999 177.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.73 121.26 43.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.227 -0.921 . . . . 0.98 110.139 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.581 ' O ' HD12 ' B' ' 85' ' ' LEU . 33.9 ttt180 -97.28 168.26 10.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.873 -0.731 . . . . 0.71 109.61 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.581 HD12 ' O ' ' B' ' 84' ' ' ARG . 1.0 OUTLIER -160.97 144.17 13.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.653 -0.819 . . . . 1.44 109.99 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' B' ' 62' ' ' GLN . 1.8 tmtp? -125.64 147.27 49.38 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.542 -0.54 . . . . 1.31 109.542 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -101.48 136.6 41.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.262 -0.898 . . . . 1.64 109.845 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.94 -8.97 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.626 -0.879 . . . . 0.68 108.626 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 21.0 t80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 118.017 -0.992 . . . . 1.77 109.564 179.659 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.34 -0.615 . . . . 6.33 109.34 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.559 ' O ' HD11 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -42.67 135.14 2.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.571 -0.706 . . . . 2.53 109.887 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' GLY . 4.6 mt-10 -76.33 -20.48 57.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.373 -0.829 . . . . 1.75 109.828 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 5' ' ' LEU . 5.3 ptpt -156.09 149.53 24.69 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.848 -1.158 . . . . 2.24 109.585 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 1.9 tt 89.32 49.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.372 -0.973 . . . . 1.67 108.372 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.723 ' ND2' HD13 ' A' ' 26' ' ' LEU . 48.0 t-20 -90.89 116.78 28.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.025 -0.731 . . . . 1.72 109.025 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 6.7 pt-20 -93.32 117.88 30.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.289 -0.882 . . . . 1.44 109.671 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.645 HD11 ' ND2' ' A' ' 6' ' ' ASN . 53.5 mt -128.89 153.22 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 CA-C-O 122.189 0.995 . . . . 1.11 112.384 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 37' ' ' LYS . 12.2 p -112.3 131.22 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.626 0.727 . . . . 1.35 110.252 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.685 HG11 ' HB2' ' A' ' 46' ' ' ALA . 4.7 p -88.95 165.12 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.206 -1.035 . . . . 0.39 108.206 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.53 ' N ' HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.36 172.47 12.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.967 . . . . 2.27 110.002 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.554 ' NZ ' ' CZ ' ' A' ' 41' ' ' ARG . 6.1 pttp -98.06 -4.23 36.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.979 -0.748 . . . . 1.78 108.979 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.01 0.33 55.93 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.429 -1.323 . . . . 1.24 107.429 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -117.95 131.25 56.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.362 -1.348 . . . . 1.41 107.362 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -67.88 173.17 4.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.751 -1.218 . . . . 1.25 110.435 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 17' ' ' GLU . 33.5 m -62.49 -35.65 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.361 -0.977 . . . . 0.49 108.361 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' N ' HG23 ' A' ' 16' ' ' VAL . 9.2 pt-20 -69.76 -39.88 76.43 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.649 -0.871 . . . . 1.56 108.649 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' N ' ' CG ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -48.5 -37.93 18.82 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.671 -1.268 . . . . 1.38 111.93 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.689 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.4 m80 -93.87 -19.56 20.86 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.321 -1.487 . . . . 1.43 108.667 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.68 -34.53 47.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 104.482 -2.414 . . . . 0.29 104.482 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.791 ' O ' HG23 ' A' ' 25' ' ' VAL . 71.6 mt -69.07 -55.68 10.02 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.033 -0.985 . . . . 0.41 108.556 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.68 -29.95 71.03 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.311 -0.868 . . . . 1.22 109.668 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 19' ' ' HIS . 24.9 t -70.42 -54.82 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.32 108.953 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 24' ' ' ILE . 2.9 tt -61.73 -15.18 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.165 -0.959 . . . . 0.58 108.839 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 21' ' ' LEU . 55.4 t -81.42 -47.32 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.41 109.458 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.723 HD13 ' ND2' ' A' ' 6' ' ' ASN . 3.9 mt -65.84 -35.12 79.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.789 -1.194 . . . . 1.19 110.017 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.597 ' CG ' ' NH1' ' A' ' 87' ' ' ARG . 3.1 t80 -62.39 -23.83 67.05 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.919 -1.511 . . . . 1.46 106.919 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.29 -29.54 70.84 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.338 -0.846 . . . . 1.15 109.153 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.43 ' NE2' HD23 ' A' ' 26' ' ' LEU . 17.7 mt-30 -87.26 -14.08 41.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.945 -1.097 . . . . 1.17 109.121 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 123.68 11.25 5.04 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.378 -1.089 . . . . 0.42 110.378 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.559 HD11 ' O ' ' A' ' 2' ' ' THR . 32.3 mm -74.99 98.92 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.985 -1.303 . . . . 0.35 109.172 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.11 -34.27 20.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.551 -0.907 . . . . 1.55 108.551 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 1.7 mt-10 -102.85 141.55 35.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.56 0.695 . . . . 1.58 110.259 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -151.77 144.18 16.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.397 -0.921 . . . . 0.54 109.859 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -121.63 128.54 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.38 0.609 . . . . 0.25 109.94 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.753 HD13 ' OH ' ' A' ' 50' ' ' TYR . 3.4 mp -111.78 123.56 50.5 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.236 0.541 . . . . 0.4 110.241 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.626 ' O ' HG12 ' A' ' 10' ' ' VAL . 3.3 mtpt -102.9 128.82 49.54 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.246 -1.39 . . . . 2.74 107.246 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.44 154.11 23.37 Favored Glycine 0 N--CA 1.501 3.029 0 C-N-CA 119.525 -1.321 . . . . 0.21 111.031 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 41' ' ' ARG . 30.1 p -135.88 141.15 44.55 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.801 0.81 . . . . 0.56 112.678 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.604 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 39.46 -84.26 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.728 -0.608 . . . . 0.33 111.637 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -84.89 -51.14 6.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.157 -1.202 . . . . 3.09 110.096 -178.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -25.07 64.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.624 -1.298 . . . . 1.09 108.763 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 40' ' ' GLY . 5.7 tt -51.93 -36.66 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.628 -0.67 . . . . 0.87 111.335 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.402 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -84.7 -21.18 30.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.718 -1.239 . . . . 1.14 109.133 -179.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 46' ' ' ALA . 8.0 mmtp -62.08 -71.67 0.15 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.819 -1.919 . . . . 1.86 105.819 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.685 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -32.88 -45.37 0.13 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.267 0.556 . . . . 0.29 111.167 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.708 HG13 ' HB ' ' B' ' 68' ' ' THR . 72.0 t -57.02 -70.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.986 -1.071 . . . . 0.22 110.267 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -44.49 -44.29 8.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.556 -0.715 . . . . 1.26 109.971 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.6 t -46.81 -57.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 119.967 -0.693 . . . . 1.06 109.556 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.753 ' OH ' HD13 ' A' ' 36' ' ' LEU . 64.8 m-85 -65.13 -51.23 62.49 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.039 -1.038 . . . . 4.02 112.668 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' ND2' ' N ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -51.05 -47.98 61.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.546 -1.346 . . . . 1.34 107.55 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.514 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 11.1 p -65.45 -33.84 76.89 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.799 -0.761 . . . . 1.04 109.527 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.456 HD22 HG11 ' A' ' 23' ' ' VAL . 5.9 tp -84.13 -24.18 30.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.68 -1.263 . . . . 0.44 108.846 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.607 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.92 -48.81 12.83 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 104.756 -2.313 . . . . 1.0 104.756 177.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 32.0 t0 -50.1 -12.93 0.09 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.185 -1.37 . . . . 1.58 107.786 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' N ' ' C ' ' A' ' 54' ' ' LYS . 5.0 tpt85 -64.7 -46.95 80.16 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.682 0.753 . . . . 1.69 109.887 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.4 tp -155.35 -7.44 0.13 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.515 -0.874 . . . . 1.66 110.388 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.27 -59.81 0.06 OUTLIER Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.594 -1.289 . . . . 0.39 109.887 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -72.09 -35.83 69.33 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.808 -0.819 . . . . 1.38 110.212 -178.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.75 20.54 9.16 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.364 -1.494 . . . . 0.26 109.364 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.628 HG13 HD11 ' A' ' 85' ' ' LEU . 2.4 t -154.63 133.26 2.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.54 -1.282 . . . . 0.38 107.54 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.9 mm-40 -137.57 150.73 47.69 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.482 1.134 . . . . 1.31 112.249 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 66' ' ' VAL . 7.4 tt -94.31 108.7 20.58 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.537 -1.282 . . . . 0.49 107.537 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.89 -23.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.305 -0.872 . . . . 1.35 110.369 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.578 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -162.38 153.82 18.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.172 -1.58 . . . . 1.2 109.348 177.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 63' ' ' LEU . 46.3 t -162.32 129.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.406 -0.809 . . . . 0.85 109.485 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -140.78 157.15 45.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.107 0.955 . . . . 1.41 110.606 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.432 ' HB ' HG13 ' B' ' 47' ' ' VAL . 0.7 OUTLIER -137.42 143.89 42.1 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.178 -0.675 . . . . 0.52 109.178 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.674 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -167.35 159.94 33.43 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.384 -2.286 . . . . 0.4 107.384 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.4 p -98.53 161.15 13.82 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 118.984 1.392 . . . . 0.42 110.745 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -156.05 175.6 13.75 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.111 -0.993 . . . . 1.29 110.568 178.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.62 137.34 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.6 0.714 . . . . 1.02 110.553 -179.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 27.5 ttt-85 -148.41 102.58 3.35 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.567 -0.901 . . . . 2.23 108.567 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 3.9 t70 87.91 35.07 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.204 0.526 . . . . 1.38 109.646 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 63.66 37.62 10.0 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.356 1.074 . . . . 2.62 109.21 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -157.52 153.35 26.86 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.41 -0.806 . . . . 3.15 108.837 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -86.31 135.19 33.63 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.775 1.274 . . . . 2.44 110.662 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.409 HD11 ' HA3' ' A' ' 40' ' ' GLY . 4.8 tt -141.31 155.12 20.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.604 -1.258 . . . . 0.23 107.604 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -87.44 159.99 18.47 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.227 -0.921 . . . . 0.74 111.116 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.674 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.1 p90 -145.08 153.25 41.23 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.87 0.843 . . . . 4.16 110.581 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.546 ' O ' HG23 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -125.96 131.84 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.778 0.799 . . . . 0.92 109.416 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.5 mt -109.5 122.56 47.69 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.695 -1.594 . . . . 0.36 106.695 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.517 HD11 ' OG1' ' B' ' 68' ' ' THR . 0.5 OUTLIER -132.95 129.13 37.87 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.255 1.026 . . . . 0.98 110.737 -177.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -99.25 172.25 7.47 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.128 -0.942 . . . . 0.58 110.074 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.815 HD13 ' N ' ' A' ' 86' ' ' LYS . 1.0 OUTLIER -157.18 137.79 13.11 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.2 -1.0 . . . . 1.39 108.85 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.815 ' N ' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -125.78 140.69 52.47 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.399 0.618 . . . . 1.42 109.468 179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.597 ' NH1' ' CG ' ' A' ' 27' ' ' PHE . 16.6 mmt85 -99.41 136.02 39.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.533 -0.73 . . . . 1.64 109.979 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 88' ' ' VAL . 48.2 t -113.54 -0.97 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.496 -0.927 . . . . 0.63 108.496 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.7 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.988 -1.006 . . . . 1.76 109.415 178.901 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.653 -0.499 . . . . 6.35 109.653 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 29.8 p 42.92 -149.76 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.747 . . . . 2.42 109.886 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' B' ' 30' ' ' GLY . 3.3 mt-10 -164.14 -41.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.386 -0.968 . . . . 1.68 108.386 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -148.74 65.93 1.05 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.618 -0.676 . . . . 2.31 109.855 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -178.41 54.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.375 -0.972 . . . . 1.62 108.375 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.723 HD22 HD13 ' B' ' 26' ' ' LEU . 0.9 OUTLIER -91.44 107.29 19.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.951 -1.093 . . . . 1.46 111.965 -177.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 7.0 pt-20 -93.41 116.45 28.99 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.524 -1.287 . . . . 1.49 107.524 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.488 HD11 HD22 ' B' ' 6' ' ' ASN . 75.6 mt -128.96 153.15 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.526 -0.734 . . . . 1.17 110.815 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.553 HG23 ' HB2' ' B' ' 37' ' ' LYS . 7.9 p -105.79 126.81 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.451 0.643 . . . . 1.37 110.169 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' B' ' 46' ' ' ALA . 3.7 p -86.86 166.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.834 -1.173 . . . . 0.37 107.834 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.596 ' N ' HG22 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -138.78 174.31 10.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 2.37 110.902 -178.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.545 ' NZ ' ' CZ ' ' B' ' 41' ' ' ARG . 6.6 pttp -102.49 -12.88 17.49 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.171 -1.048 . . . . 1.75 108.171 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.72 -9.44 58.21 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.948 -1.13 . . . . 1.19 107.948 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -92.56 -129.74 0.11 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.451 -1.314 . . . . 1.47 107.451 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.15 158.89 10.55 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.09 -1.006 . . . . 1.22 109.37 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.547 HG23 ' N ' ' B' ' 17' ' ' GLU . 12.9 m -57.69 -39.84 72.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.116 -1.068 . . . . 0.45 108.116 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.547 ' N ' HG23 ' B' ' 16' ' ' VAL . 6.5 pt-20 -75.58 -34.04 60.63 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.916 -0.772 . . . . 1.7 108.916 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -63.49 -32.84 74.4 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.852 -1.155 . . . . 1.46 111.6 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.7 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.3 OUTLIER -91.96 -16.06 27.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.051 -1.656 . . . . 1.4 108.032 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.14 -35.49 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 104.499 -2.408 . . . . 0.34 104.499 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.788 ' O ' HG23 ' B' ' 25' ' ' VAL . 43.3 mt -67.87 -50.56 55.75 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.785 -1.098 . . . . 0.38 109.33 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.34 -33.57 75.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.978 -1.077 . . . . 1.21 109.307 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.7 HG23 ' O ' ' B' ' 19' ' ' HIS . 34.7 t -66.29 -52.76 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.3 109.42 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.7 tt -65.3 -19.71 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.99 -1.069 . . . . 0.69 109.025 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.788 HG23 ' O ' ' B' ' 21' ' ' LEU . 41.8 t -75.17 -45.51 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.203 -0.936 . . . . 0.42 109.822 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.723 HD13 HD22 ' B' ' 6' ' ' ASN . 4.1 mt -68.02 -36.94 80.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.699 -1.251 . . . . 1.15 109.829 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . 0.559 ' CG ' ' NH1' ' B' ' 87' ' ' ARG . 4.6 t80 -58.03 -29.84 65.65 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.229 -1.767 . . . . 1.46 106.229 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -26.74 66.57 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.818 -1.083 . . . . 1.17 109.176 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.588 ' NE2' HD23 ' B' ' 26' ' ' LEU . 17.5 mt-30 -92.2 -1.09 57.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.008 . . . . 1.17 109.337 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 108.02 13.9 18.48 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.765 -0.934 . . . . 0.38 110.765 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.538 HG13 HD22 ' B' ' 26' ' ' LEU . 12.9 mm -78.2 105.01 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.697 -1.473 . . . . 0.59 107.987 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -91.3 -38.87 12.38 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.19 -0.944 . . . . 1.46 109.186 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.7 135.21 43.61 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.278 0.561 . . . . 1.2 110.159 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' B' ' 6' ' ' ASN . 0.3 OUTLIER -145.41 130.94 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.578 -0.849 . . . . 0.49 110.397 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -106.34 124.37 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.686 -0.634 . . . . 0.31 110.069 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.901 HD13 ' OH ' ' B' ' 50' ' ' TYR . 2.6 mp -107.94 129.73 55.08 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.451 -0.78 . . . . 0.48 110.887 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.592 ' O ' HG12 ' B' ' 10' ' ' VAL . 5.0 mtpt -106.11 126.18 51.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.177 -1.046 . . . . 2.74 108.177 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.63 153.23 20.96 Favored Glycine 0 N--CA 1.505 3.241 0 C-N-CA 119.873 -1.156 . . . . 0.24 110.799 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.635 ' O ' ' N ' ' B' ' 41' ' ' ARG . 24.9 p -133.87 142.65 47.88 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.785 -0.833 . . . . 0.49 112.095 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.661 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 33.8 -79.23 0.0 OUTLIER Glycine 0 N--CA 1.505 3.277 0 N-CA-C 111.932 -0.467 . . . . 0.28 111.932 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.635 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -84.04 -55.4 4.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.037 -1.272 . . . . 3.16 109.377 -179.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -17.7 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.024 -1.048 . . . . 1.38 109.852 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.661 HG22 ' O ' ' B' ' 40' ' ' GLY . 6.7 tt -61.64 -22.41 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.85 109.913 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.41 -29.72 17.82 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.353 -0.98 . . . . 1.12 108.353 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' B' ' 46' ' ' ALA . 7.5 mmtp -60.19 -67.18 0.42 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.332 -1.729 . . . . 1.87 106.332 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.784 ' HB2' HG11 ' B' ' 10' ' ' VAL . . . -32.4 -47.01 0.14 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 116.082 -0.508 . . . . 0.26 111.823 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.432 HG13 ' HB ' ' A' ' 68' ' ' THR . 84.9 t -66.4 -61.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.837 -1.164 . . . . 0.28 111.3 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' B' ' 49' ' ' VAL . 9.2 t70 -45.54 -51.08 12.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.216 -0.928 . . . . 1.25 109.348 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' B' ' 48' ' ' ASP . 64.3 t -41.71 -54.22 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.751 -0.463 . . . . 1.06 109.751 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.901 ' OH ' HD13 ' B' ' 36' ' ' LEU . 59.5 m-85 -68.12 -53.56 24.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -0.987 . . . . 4.11 111.627 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' B' ' 52' ' ' SER . 0.0 OUTLIER -46.77 -55.76 7.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.858 -1.164 . . . . 1.41 107.858 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.557 ' N ' ' ND2' ' B' ' 51' ' ' ASN . 0.7 OUTLIER -61.17 -39.68 91.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.628 -0.829 . . . . 0.65 109.714 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.461 HD22 HG11 ' B' ' 23' ' ' VAL . 5.8 tp -71.2 -23.96 62.13 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.79 -1.194 . . . . 0.53 108.614 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 50' ' ' TYR . 0.0 OUTLIER -76.5 -47.83 21.53 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.789 -1.56 . . . . 0.99 106.789 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -44.67 -17.47 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.993 -1.003 . . . . 1.46 109.276 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' B' ' 54' ' ' LYS . 21.9 mmm180 -65.87 -39.8 91.03 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.38 -0.928 . . . . 1.71 109.997 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' B' ' 59' ' ' ASP . 2.3 tp -156.7 -12.46 0.09 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.429 -1.308 . . . . 1.77 111.528 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' B' ' 61' ' ' VAL . . . 67.3 -65.24 0.24 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.849 -1.7 . . . . 0.39 108.849 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.5 -41.24 76.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.632 -0.922 . . . . 1.4 109.704 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.16 17.07 2.51 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.543 -1.423 . . . . 0.34 109.543 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.68 HG13 HD11 ' B' ' 85' ' ' LEU . 2.5 t -152.32 130.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.05 -1.463 . . . . 0.46 107.05 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' B' ' 86' ' ' LYS . 5.4 mm-40 -137.94 152.01 48.54 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.303 1.049 . . . . 1.42 112.455 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.578 HD11 HG21 ' B' ' 66' ' ' VAL . 8.4 tt -94.37 119.12 32.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.906 -1.146 . . . . 0.54 107.906 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.49 ' O ' ' ND2' ' B' ' 65' ' ' ASN . 6.9 p -116.32 -13.39 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.337 -0.852 . . . . 1.43 110.853 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' B' ' 64' ' ' VAL . 0.3 OUTLIER -171.23 143.66 1.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.399 -1.438 . . . . 1.28 109.482 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.578 HG21 HD11 ' B' ' 63' ' ' LEU . 96.7 t -156.83 133.92 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.054 -0.721 . . . . 0.9 109.054 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . 0.611 ' HB3' HD12 ' B' ' 82' ' ' LEU . 48.5 tt0 -142.21 159.75 41.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.092 0.949 . . . . 1.44 110.446 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.708 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -137.0 156.14 48.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.78 -0.822 . . . . 0.45 108.78 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.681 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -179.74 157.98 21.33 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.745 -2.142 . . . . 0.29 107.745 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 68.8 p -96.44 154.63 17.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.051 -1.264 . . . . 0.39 109.44 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -153.17 170.7 19.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.827 -1.171 . . . . 1.49 110.446 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.418 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.0 OUTLIER -89.02 137.09 21.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.852 0.834 . . . . 0.87 111.284 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 7.5 ttt-85 -149.78 97.87 2.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.08 -0.711 . . . . 2.18 109.08 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 4.0 t0 88.34 36.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.427 -0.583 . . . . 1.35 109.427 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 65.01 34.48 8.84 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.214 1.007 . . . . 2.57 109.463 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -156.52 154.52 30.44 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.791 -0.818 . . . . 3.14 108.791 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -88.11 145.77 25.77 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.585 1.183 . . . . 2.39 111.842 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tt -144.36 159.49 15.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.871 -1.058 . . . . 0.58 108.194 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.09 151.08 22.99 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 121.372 -0.83 . . . . 0.61 109.036 -178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.681 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.2 p90 -143.83 151.91 40.51 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.615 -0.834 . . . . 4.08 110.37 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.498 HG23 ' O ' ' B' ' 81' ' ' ILE . 20.4 tt -128.71 135.02 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.643 0.735 . . . . 0.9 111.27 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' B' ' 67' ' ' GLN . 7.7 mt -110.69 124.31 51.7 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.69 -1.596 . . . . 0.37 106.69 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.67 127.15 39.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.143 -0.973 . . . . 0.98 111.275 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -108.26 110.17 21.71 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.557 0.694 . . . . 0.71 111.159 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.864 HD13 ' N ' ' B' ' 86' ' ' LYS . 1.3 tm? -96.42 140.46 31.04 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.986 -0.746 . . . . 1.44 108.986 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.864 ' N ' HD13 ' B' ' 85' ' ' LEU . 0.0 OUTLIER -122.35 136.03 54.82 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.406 -0.591 . . . . 1.31 109.406 179.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.559 ' NH1' ' CG ' ' B' ' 27' ' ' PHE . 16.4 mmt85 -96.12 140.26 31.09 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.33 -0.856 . . . . 1.64 110.296 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.49 ' O ' HG12 ' B' ' 88' ' ' VAL . 36.2 t -118.08 -6.77 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.706 -0.85 . . . . 0.68 108.706 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 74.8 t80 . . . . . 0 C--N 1.303 -1.432 0 CA-C-O 117.979 -1.01 . . . . 1.77 109.423 179.26 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.562 -0.533 . . . . 6.33 109.562 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.503 ' O ' ' CD1' ' A' ' 31' ' ' ILE . 5.1 t -108.28 19.91 19.3 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.13 -0.692 . . . . 2.53 109.13 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 30' ' ' GLY . 2.6 mt-10 -75.61 -30.48 59.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.684 -0.635 . . . . 1.75 110.232 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.91 57.51 1.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.8 0.81 . . . . 2.24 109.476 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -161.84 152.38 17.46 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 104.469 -2.419 . . . . 1.67 104.469 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.63 ' OD1' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -179.4 93.68 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 117.928 -1.509 . . . . 1.72 110.621 178.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 3.8 pt-20 -89.34 112.23 23.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.066 -1.646 . . . . 1.44 108.262 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.63 HD11 ' OD1' ' A' ' 6' ' ' ASN . 5.6 mt -128.74 147.25 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 CA-C-O 122.189 0.995 . . . . 1.11 112.195 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 37' ' ' LYS . 61.1 t -112.91 129.52 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.606 0.717 . . . . 1.35 110.336 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.532 HG11 ' H ' ' A' ' 46' ' ' ALA . 1.7 p -87.65 167.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.055 -1.091 . . . . 0.39 108.055 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.91 167.88 20.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 2.27 109.977 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -20.65 27.61 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.386 -0.968 . . . . 1.78 108.386 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -69.4 -65.41 0.72 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.761 -1.57 . . . . 1.24 106.761 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.524 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.4 mtmm -58.24 144.07 42.23 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.216 1.007 . . . . 1.41 110.347 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.87 178.86 4.61 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.696 -0.684 . . . . 1.25 110.067 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.61 -28.79 25.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.254 -1.017 . . . . 0.49 108.254 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.4 -33.85 61.01 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.484 -0.886 . . . . 1.56 109.119 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.2 -31.59 69.16 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 120.396 -1.44 . . . . 1.38 110.925 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.709 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -95.64 -18.3 20.64 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.692 -1.255 . . . . 1.43 108.459 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.35 -34.72 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 104.513 -2.403 . . . . 0.29 104.513 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.773 ' O ' HG23 ' A' ' 25' ' ' VAL . 38.5 mt -68.33 -52.57 31.97 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.495 -1.23 . . . . 0.41 108.771 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -66.34 -29.34 69.51 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.114 -0.991 . . . . 1.22 109.437 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 19' ' ' HIS . 19.7 t -69.79 -53.24 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.32 109.453 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.5 tt -63.23 -18.03 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.895 -1.128 . . . . 0.58 108.617 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 21' ' ' LEU . 54.0 t -75.98 -43.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 119.335 -0.946 . . . . 0.41 108.573 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD13 HD11 ' A' ' 8' ' ' ILE . 4.2 mt -64.79 -33.4 75.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.825 -1.172 . . . . 1.19 110.029 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -65.87 -23.0 66.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.877 -1.527 . . . . 1.46 106.877 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -61.74 -30.77 70.99 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.123 -0.944 . . . . 1.15 108.811 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -87.82 -6.34 58.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.27 -0.894 . . . . 1.17 109.244 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 109.73 12.45 18.74 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.913 -1.275 . . . . 0.42 109.913 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.503 ' CD1' ' O ' ' A' ' 2' ' ' THR . 47.6 mm -73.88 109.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.138 -1.213 . . . . 0.35 109.25 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.22 -37.22 11.66 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.423 -0.798 . . . . 1.55 110.721 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 1.9 mt-10 -97.73 137.85 36.0 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.601 0.715 . . . . 1.58 110.793 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -147.87 137.29 16.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.66 -0.816 . . . . 0.54 109.826 -179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -117.08 126.04 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.753 -0.658 . . . . 0.25 109.591 -178.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 46' ' ' ALA . 3.4 mp -111.76 119.56 39.04 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 120.262 -0.575 . . . . 0.4 109.519 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 9' ' ' VAL . 2.4 mttt -105.26 132.67 51.17 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.02 -1.104 . . . . 2.74 108.02 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.19 151.79 21.6 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.748 -1.215 . . . . 0.21 110.926 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 41' ' ' ARG . 64.3 p -126.01 134.03 51.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.986 -0.714 . . . . 0.56 111.673 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 38.4 -83.56 0.0 OUTLIER Glycine 0 N--CA 1.495 2.632 0 O-C-N 121.615 -0.678 . . . . 0.33 112.286 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.686 ' HE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.31 -54.2 6.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.127 -1.219 . . . . 3.09 110.087 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.38 -20.99 63.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.64 -1.244 . . . . 1.09 107.64 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 43' ' ' ILE . 1.5 tt -53.18 -36.46 25.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.233 -0.917 . . . . 0.87 110.858 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.61 -20.39 31.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.678 -1.264 . . . . 1.14 108.747 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 46' ' ' ALA . 1.5 mptt -64.32 -71.02 0.19 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.518 -2.03 . . . . 1.86 105.518 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.663 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -30.44 -48.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.403 0.621 . . . . 0.29 110.37 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.691 HG13 ' HB ' ' B' ' 68' ' ' THR . 92.0 t -57.94 -71.68 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.378 -0.826 . . . . 0.22 109.995 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' OG ' ' A' ' 52' ' ' SER . 8.4 t70 -42.52 -46.72 4.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.755 -0.59 . . . . 1.26 110.05 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.2 t -48.75 -57.52 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.483 -0.887 . . . . 1.06 108.82 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.571 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -61.03 -55.58 31.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 4.02 110.978 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.549 ' CG ' ' H ' ' B' ' 70' ' ' SER . 4.7 t30 -52.1 -51.14 59.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.873 -1.142 . . . . 1.34 107.985 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 5.7 m -60.38 -34.15 73.49 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.528 -0.915 . . . . 1.04 108.528 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.434 HD22 HG11 ' A' ' 23' ' ' VAL . 7.1 tp -82.13 -21.64 36.56 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.078 -1.014 . . . . 0.44 108.389 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -79.29 -49.34 12.61 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.701 -1.963 . . . . 1.0 105.701 177.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 1.7 t0 -54.43 -8.64 0.23 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.754 -1.202 . . . . 1.58 107.754 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 54' ' ' LYS . 4.6 tpt85 -68.7 -52.88 26.04 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.487 -0.758 . . . . 1.69 109.196 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -153.14 -13.29 0.15 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.347 -0.941 . . . . 1.66 110.948 179.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.441 ' N ' HD12 ' A' ' 57' ' ' LEU . . . 62.94 -47.44 0.07 OUTLIER Glycine 0 N--CA 1.494 2.509 0 C-N-CA 120.043 -1.075 . . . . 0.39 110.842 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -72.72 -41.71 64.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.252 -1.146 . . . . 1.38 109.986 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.482 ' H ' HD13 ' A' ' 57' ' ' LEU . . . -87.15 22.91 12.7 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.94 -1.264 . . . . 0.26 109.94 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.577 HG13 HD21 ' A' ' 85' ' ' LEU . 2.4 t -149.37 132.5 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.979 -1.306 . . . . 0.38 107.705 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.605 ' N ' ' O ' ' A' ' 86' ' ' LYS . 3.7 mm-40 -135.51 155.74 50.02 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.034 0.921 . . . . 1.31 111.575 -177.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.42 110.01 21.57 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.486 -0.931 . . . . 0.49 108.486 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.8 -22.91 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.065 -1.022 . . . . 1.35 109.775 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -172.85 152.56 2.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.699 -1.25 . . . . 1.2 109.759 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 65' ' ' ASN . 72.0 t -159.28 128.29 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.863 -0.792 . . . . 0.85 108.863 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 68' ' ' THR . 31.9 tt0 -142.09 157.05 45.35 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.086 0.946 . . . . 1.41 110.531 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.479 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -124.2 150.81 44.8 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.239 -0.892 . . . . 0.52 108.737 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.683 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -175.89 148.88 9.57 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 107.607 -2.197 . . . . 0.4 107.607 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.565 ' H ' ' CG ' ' B' ' 51' ' ' ASN . 37.1 p -95.75 158.01 15.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.703 -1.469 . . . . 0.42 110.996 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' OE2' ' C ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -150.51 167.63 26.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.162 -0.961 . . . . 1.29 110.073 178.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.403 ' C ' ' OE2' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -91.91 141.94 13.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.644 0.735 . . . . 1.02 111.044 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 7.5 ttt-85 -149.25 103.44 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.165 -0.68 . . . . 2.23 109.165 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 2.4 t70 86.38 36.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.049 0.452 . . . . 1.38 110.339 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.29 32.71 12.08 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.174 0.988 . . . . 2.62 109.045 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.19 146.12 26.67 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.284 -1.006 . . . . 3.15 108.284 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.622 ' NH2' ' ND2' ' B' ' 51' ' ' ASN . 8.1 ttt180 -85.91 139.73 30.98 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.893 1.33 . . . . 2.44 110.614 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.6 tt -142.71 154.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 114.276 -1.329 . . . . 0.23 107.986 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.8 p -88.37 161.64 16.98 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 119.335 -0.946 . . . . 0.74 110.444 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.683 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 4.4 p90 -148.35 156.4 42.46 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.313 -0.955 . . . . 4.16 110.244 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 81' ' ' ILE . 10.3 tt -129.68 139.05 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.746 0.784 . . . . 0.92 110.485 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.7 mt -111.32 124.0 51.35 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.952 -1.129 . . . . 0.36 107.952 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 tt -131.64 126.52 34.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.122 -0.987 . . . . 0.98 110.61 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -102.88 172.42 6.84 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.315 0.578 . . . . 0.58 109.789 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.577 HD21 HG13 ' A' ' 61' ' ' VAL . 1.9 tp -160.82 144.93 13.7 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 118.679 -1.208 . . . . 1.39 110.999 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.605 ' O ' ' N ' ' A' ' 62' ' ' GLN . 14.0 tptt -125.57 136.35 53.2 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.574 0.702 . . . . 1.42 109.936 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.425 ' N ' ' HD2' ' A' ' 86' ' ' LYS . 22.6 mmt180 -94.41 136.4 34.75 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.059 -1.026 . . . . 1.64 109.663 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 88' ' ' VAL . 69.4 t -121.62 1.21 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.824 -0.806 . . . . 0.63 108.824 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.424 ' CD2' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.383 0 CA-C-O 118.001 -0.999 . . . . 1.76 109.512 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.438 -0.578 . . . . 6.35 109.438 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.51 ' O ' ' CD1' ' B' ' 31' ' ' ILE . 4.6 t -135.85 21.39 3.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.484 -0.76 . . . . 2.42 109.692 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' B' ' 30' ' ' GLY . 4.9 mt-10 -84.12 -4.54 58.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.337 -0.852 . . . . 1.68 109.147 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.437 ' O ' ' OE1' ' B' ' 33' ' ' GLU . 0.0 OUTLIER -155.95 58.31 0.6 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.034 -1.042 . . . . 2.31 108.801 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -165.74 151.4 9.12 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 103.097 -2.927 . . . . 1.62 103.097 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.523 ' OD1' HD11 ' B' ' 8' ' ' ILE . 0.5 OUTLIER -179.95 93.12 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 117.703 -1.599 . . . . 1.46 110.214 177.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.8 pt-20 -90.12 110.32 21.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.165 -1.585 . . . . 1.49 108.897 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.523 HD11 ' OD1' ' B' ' 6' ' ' ASN . 4.1 mt -126.41 142.52 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.848 0.832 . . . . 1.17 110.677 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' B' ' 37' ' ' LYS . 63.2 t -104.22 130.47 54.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.49 0.662 . . . . 1.37 109.581 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.538 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.4 OUTLIER -87.49 166.13 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.516 -0.92 . . . . 0.37 108.516 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.414 ' NE ' ' CE ' ' B' ' 14' ' ' LYS . 6.7 mtt180 -139.09 171.58 14.1 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.01 0.909 . . . . 2.37 110.507 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.04 -11.52 20.5 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.187 -1.042 . . . . 1.75 108.187 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.86 -14.35 54.44 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.637 -0.825 . . . . 1.19 109.758 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' B' ' 15' ' ' ASN . 1.2 mttm -98.57 -120.65 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.281 -1.007 . . . . 1.47 108.281 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' B' ' 14' ' ' LYS . 0.7 OUTLIER -170.94 172.44 5.53 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.097 -1.002 . . . . 1.22 109.15 179.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.5 m -72.38 -35.25 51.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.115 -1.069 . . . . 0.45 108.115 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' B' ' 18' ' ' ASP . 10.0 pt-20 -72.46 -41.67 65.82 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.495 -0.928 . . . . 1.7 108.495 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.464 ' N ' ' CG ' ' B' ' 17' ' ' GLU . 68.2 t0 -62.49 -30.81 71.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.141 -0.974 . . . . 1.46 112.082 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.759 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.1 OUTLIER -91.34 -16.46 27.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 119.892 -1.755 . . . . 1.4 108.289 178.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 t -75.19 -40.11 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 105.152 -2.166 . . . . 0.34 105.152 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.773 ' O ' HG23 ' B' ' 25' ' ' VAL . 59.1 mt -62.31 -49.46 75.54 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.909 -1.041 . . . . 0.38 108.481 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -67.3 -32.13 72.9 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.565 -0.854 . . . . 1.21 109.685 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.759 HG23 ' O ' ' B' ' 19' ' ' HIS . 41.0 t -69.57 -54.55 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.291 -0.881 . . . . 0.3 110.068 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 20.4 tt -61.15 -24.05 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.893 -1.129 . . . . 0.69 108.864 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.773 HG23 ' O ' ' B' ' 21' ' ' LEU . 39.3 t -68.19 -41.5 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -0.922 . . . . 0.42 108.951 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.402 HD13 HD11 ' B' ' 8' ' ' ILE . 4.8 mt -66.52 -43.12 86.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.121 -0.987 . . . . 1.15 109.7 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -55.19 -31.49 61.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.735 -1.58 . . . . 1.46 106.735 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -55.69 -30.69 61.53 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.273 -0.876 . . . . 1.17 108.777 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -87.96 -3.02 58.95 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.809 -0.811 . . . . 1.17 108.809 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' B' ' 3' ' ' GLU . . . 103.19 15.98 22.14 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.608 -1.397 . . . . 0.38 109.608 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' B' ' 2' ' ' THR . 36.8 mm -77.36 111.42 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.148 -1.207 . . . . 0.59 108.421 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.39 -35.83 12.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.272 -0.893 . . . . 1.46 111.015 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' B' ' 4' ' ' LYS . 11.4 mt-10 -101.64 141.6 34.25 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.626 0.727 . . . . 1.2 110.954 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' B' ' 6' ' ' ASN . 0.8 OUTLIER -149.5 122.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.146 0.974 . . . . 0.49 111.096 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.21 122.91 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.613 -0.679 . . . . 0.31 109.254 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' B' ' 46' ' ' ALA . 2.4 mp -105.57 121.76 44.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.431 -0.793 . . . . 0.48 110.087 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.506 ' HB2' HG13 ' B' ' 9' ' ' VAL . 7.4 mttt -103.34 128.41 50.43 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.736 -0.839 . . . . 2.74 108.736 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.51 150.83 20.64 Favored Glycine 0 N--CA 1.502 3.037 0 C-N-CA 119.572 -1.299 . . . . 0.24 110.805 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.613 ' O ' ' N ' ' B' ' 41' ' ' ARG . 47.3 p -129.86 141.24 50.85 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.888 -0.772 . . . . 0.49 111.841 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.666 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 32.84 -82.0 0.0 OUTLIER Glycine 0 N--CA 1.504 3.195 0 N-CA-C 111.785 -0.526 . . . . 0.28 111.785 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.664 ' HE ' ' N ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -80.14 -53.13 6.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.087 -1.243 . . . . 3.16 110.057 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' B' ' 39' ' ' THR . 0.3 OUTLIER -64.93 -13.7 57.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.945 -1.097 . . . . 1.38 109.296 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.666 HG22 ' O ' ' B' ' 40' ' ' GLY . 8.1 tt -60.65 -26.03 36.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.26 -0.9 . . . . 0.85 109.711 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.58 -25.95 23.34 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.29 -1.004 . . . . 1.12 108.29 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' B' ' 46' ' ' ALA . 2.6 mptt -63.75 -70.54 0.21 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.5 -1.667 . . . . 1.87 106.5 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.677 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -32.97 -41.17 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.217 0.532 . . . . 0.26 110.99 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.63 -64.9 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.142 -0.974 . . . . 0.28 109.567 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' B' ' 49' ' ' VAL . 5.8 t70 -48.47 -50.72 30.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.189 -0.944 . . . . 1.25 109.276 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.658 HG11 HD21 ' B' ' 36' ' ' LEU . 38.0 t -42.39 -56.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.96 -0.755 . . . . 1.06 108.96 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.568 ' CD1' HD13 ' B' ' 85' ' ' LEU . 0.0 OUTLIER -67.66 -54.33 20.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.447 -0.783 . . . . 4.11 110.564 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.622 ' ND2' ' NH2' ' A' ' 77' ' ' ARG . 2.8 t30 -48.5 -57.98 5.35 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.119 -1.032 . . . . 1.41 108.531 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -57.95 -30.81 66.27 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.172 -1.011 . . . . 0.65 109.649 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.505 HD22 HG11 ' B' ' 23' ' ' VAL . 46.0 tp -75.05 -21.74 58.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.53 110.287 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.46 -27.95 25.35 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.373 -1.714 . . . . 0.99 106.373 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.412 ' OD2' ' NH2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -59.08 -14.52 10.17 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.686 -1.227 . . . . 1.46 107.686 177.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -75.74 -43.92 44.34 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.618 -0.833 . . . . 1.71 109.487 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' B' ' 59' ' ' ASP . 0.2 OUTLIER -152.1 -20.71 0.18 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.624 -1.23 . . . . 1.77 112.291 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.66 -56.02 0.14 Allowed Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.275 -1.441 . . . . 0.39 110.035 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.3 OUTLIER -69.58 -43.27 73.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.295 -1.121 . . . . 1.4 109.989 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.418 ' HA3' HD22 ' B' ' 57' ' ' LEU . . . -82.52 24.97 4.66 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.9 -1.28 . . . . 0.34 109.9 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.453 HG13 HD21 ' B' ' 85' ' ' LEU . 1.0 OUTLIER -149.24 130.25 4.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.478 -1.304 . . . . 0.46 107.478 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' B' ' 86' ' ' LYS . 4.0 mm-40 -132.27 159.21 39.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.002 0.906 . . . . 1.42 111.471 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.34 112.72 25.08 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.473 -0.936 . . . . 0.54 108.473 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -23.51 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.161 -0.962 . . . . 1.43 110.391 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.21 151.03 1.59 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.491 -1.38 . . . . 1.28 109.457 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 96.6 t -156.85 132.74 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.722 -0.844 . . . . 0.9 108.722 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . 0.467 ' CG ' ' N ' ' B' ' 68' ' ' THR . 28.4 tt0 -145.94 165.21 29.62 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.282 1.039 . . . . 1.44 110.823 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.691 ' HB ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -135.72 154.8 51.14 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.221 -0.9 . . . . 0.45 108.699 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.711 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -176.71 153.2 13.52 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 107.767 -2.133 . . . . 0.29 107.767 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.549 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 6.0 p -96.57 155.98 16.54 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.882 1.341 . . . . 0.39 109.382 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -148.98 166.75 27.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.946 -1.096 . . . . 1.49 110.05 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.42 ' O ' ' OE2' ' B' ' 71' ' ' GLU . 0.2 OUTLIER -90.03 136.95 22.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.845 -0.742 . . . . 0.87 110.542 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 3.8 ttt-85 -147.17 101.52 3.41 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.337 -0.616 . . . . 2.18 109.337 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 1.8 t70 83.02 39.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.427 -0.583 . . . . 1.35 109.427 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.17 32.61 14.96 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.915 0.864 . . . . 2.57 109.273 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.32 153.88 36.87 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.453 -0.779 . . . . 3.14 109.207 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.534 ' NH2' ' OG ' ' B' ' 70' ' ' SER . 1.3 tpt180 -88.36 136.28 33.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.729 0.776 . . . . 2.39 110.922 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 11.9 tt -136.31 153.54 31.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.743 -0.836 . . . . 0.58 108.743 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 151.59 22.81 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.332 -0.855 . . . . 0.61 109.039 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.711 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 4.0 p90 -144.35 150.86 38.48 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.467 -0.893 . . . . 4.08 110.313 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.453 HD11 HG21 ' A' ' 68' ' ' THR . 6.0 tt -126.12 135.83 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.53 0.681 . . . . 0.9 109.972 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' B' ' 80' ' ' TYR . 12.2 mt -109.23 121.19 44.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.168 -1.419 . . . . 0.37 107.168 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.517 HD11 ' CD2' ' B' ' 50' ' ' TYR . 6.1 tt -123.25 121.23 35.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.111 -0.993 . . . . 0.98 110.338 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -110.12 107.02 16.7 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.264 0.554 . . . . 0.71 110.259 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.568 HD13 ' CD1' ' B' ' 50' ' ' TYR . 8.7 tp -104.01 151.54 23.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.591 -0.693 . . . . 1.44 110.609 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.1 OUTLIER -126.65 157.27 39.42 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.757 -0.46 . . . . 1.31 109.757 -179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.497 HH22 HD11 ' B' ' 53' ' ' LEU . 22.2 mmt180 -109.98 141.94 42.06 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.225 -0.922 . . . . 1.64 110.037 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.452 ' O ' HG12 ' B' ' 88' ' ' VAL . 18.8 t -121.94 -9.98 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.907 -0.775 . . . . 0.68 108.907 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 118.066 -0.969 . . . . 1.77 109.537 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mtt . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.484 -0.562 . . . . 6.33 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.8 133.36 6.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 2.53 109.632 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -165.81 -39.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.023 -1.103 . . . . 1.75 108.023 178.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -156.09 54.37 0.57 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.267 -0.896 . . . . 2.24 109.754 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 tp -174.74 50.89 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.531 -0.915 . . . . 1.67 108.531 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.561 ' ND2' HD11 ' A' ' 8' ' ' ILE . 47.3 t30 -91.62 105.18 17.55 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.298 -0.876 . . . . 1.72 111.193 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -93.82 123.47 37.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 1.44 108.384 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.561 HD11 ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -130.38 151.81 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-O 122.632 1.206 . . . . 1.11 113.356 -177.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.4 p -104.7 127.11 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.317 -0.856 . . . . 1.35 109.585 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.93 166.63 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.899 . . . . 0.39 108.777 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.1 174.17 10.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.176 -0.952 . . . . 2.27 110.462 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' NZ ' ' HE ' ' A' ' 41' ' ' ARG . 12.4 pttt -94.99 -13.66 25.08 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.66 -0.867 . . . . 1.78 108.66 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 t -86.58 1.33 52.09 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.727 -1.212 . . . . 1.24 107.727 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.75 128.59 53.06 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.964 -1.495 . . . . 1.41 106.964 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.28 -178.4 1.68 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.831 -0.748 . . . . 1.25 109.865 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 49' ' ' VAL . 1.8 m -79.93 -27.96 12.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 106.796 -1.557 . . . . 0.49 106.796 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.72 -46.88 28.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.626 -0.716 . . . . 1.56 109.369 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.79 -28.64 69.6 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.915 -1.115 . . . . 1.38 110.957 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.708 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -92.08 -15.65 27.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.426 -1.421 . . . . 1.43 109.688 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.91 -30.39 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 105.197 -2.149 . . . . 0.29 105.197 176.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.555 ' O ' HG23 ' A' ' 25' ' ' VAL . 64.5 mt -70.12 -53.51 16.98 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.866 -1.061 . . . . 0.41 108.834 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -65.2 -26.32 68.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 1.22 109.728 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 19' ' ' HIS . 38.6 t -73.64 -50.14 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.59 -0.893 . . . . 0.32 108.59 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.75 -23.59 23.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.543 -0.91 . . . . 0.58 108.543 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 21' ' ' LEU . 48.8 t -70.71 -42.81 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.247 -0.908 . . . . 0.41 109.913 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.614 ' N ' HD23 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -68.53 -33.64 74.47 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.447 -1.408 . . . . 1.19 109.805 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -61.75 -27.13 68.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.166 -1.42 . . . . 1.46 107.166 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.97 -26.27 68.5 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.239 -0.891 . . . . 1.15 109.887 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -88.97 -1.98 58.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.841 -1.162 . . . . 1.17 109.267 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 106.5 14.52 19.7 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.766 -1.334 . . . . 0.42 109.766 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 6' ' ' ASN . 20.7 mm -75.92 107.49 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -1.147 . . . . 0.35 108.298 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 33' ' ' GLU . 1.6 p30 -93.65 -38.59 11.26 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.433 -0.792 . . . . 1.55 110.594 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 7.7 mt-10 -97.69 142.02 29.99 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.561 -0.712 . . . . 1.58 110.189 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.439 HG13 ' OH ' ' A' ' 50' ' ' TYR . 14.6 p -152.32 139.98 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.041 -1.064 . . . . 0.54 111.157 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.55 129.28 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 122.054 -0.404 . . . . 0.25 110.077 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 50' ' ' TYR . 1.8 mp -115.21 126.31 54.41 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.599 0.714 . . . . 0.4 110.277 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.438 ' HG2' HG23 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -99.41 127.19 45.43 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.905 -1.146 . . . . 2.74 107.905 177.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.54 143.31 14.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.725 -1.226 . . . . 0.21 110.51 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 41' ' ' ARG . 31.8 p -131.07 138.45 49.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.922 -0.752 . . . . 0.56 111.643 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 39' ' ' THR . . . 35.41 -83.11 0.0 OUTLIER Glycine 0 N--CA 1.501 3.008 0 O-C-N 121.735 -0.603 . . . . 0.33 112.247 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -82.97 -56.32 3.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.249 . . . . 3.09 109.886 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -15.17 8.71 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.99 -1.115 . . . . 1.09 107.99 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.536 HG12 HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -55.5 -32.89 31.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.408 -0.807 . . . . 0.87 111.131 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.17 -22.9 23.79 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.963 -1.086 . . . . 1.14 108.221 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 49' ' ' VAL . 2.7 mptt -62.35 -72.39 0.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.747 -1.946 . . . . 1.86 105.747 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.638 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -33.24 -46.72 0.18 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.094 0.473 . . . . 0.29 110.673 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.602 HG13 ' HB ' ' B' ' 68' ' ' THR . 98.5 t -66.51 -61.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.003 . . . . 0.22 109.297 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.458 ' OD1' HG21 ' A' ' 16' ' ' VAL . 10.5 t70 -51.33 -54.4 26.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 1.26 108.847 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 45' ' ' LYS . 46.7 t -42.66 -58.24 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.543 -0.91 . . . . 1.06 108.543 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.655 ' CE1' HD22 ' A' ' 36' ' ' LEU . 3.0 m-30 -62.14 -50.6 71.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.85 -0.531 . . . . 4.02 110.982 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.583 ' CG ' ' H ' ' B' ' 70' ' ' SER . 0.8 OUTLIER -56.07 -49.69 73.08 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.78 -1.193 . . . . 1.34 107.78 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 48' ' ' ASP . 4.3 p -59.96 -33.86 72.51 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.423 -0.954 . . . . 1.04 108.423 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.431 HD22 HG11 ' A' ' 23' ' ' VAL . 57.0 tp -79.06 -19.86 50.3 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.985 -1.117 . . . . 0.44 107.985 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.58 -44.47 17.23 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.539 -2.022 . . . . 1.0 105.539 177.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -59.34 -5.98 0.88 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.565 -1.272 . . . . 1.58 107.565 177.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 54' ' ' LYS . 4.6 tpt85 -71.05 -49.13 48.11 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.58 -0.7 . . . . 1.69 109.247 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.2 mt -151.64 -21.86 0.19 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.437 -0.905 . . . . 1.66 110.302 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.15 -49.44 0.09 OUTLIER Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.847 -1.168 . . . . 0.39 110.431 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -73.84 -45.41 51.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -1.202 . . . . 1.38 109.929 -178.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.2 27.68 4.97 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.846 -1.702 . . . . 0.26 108.846 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.475 ' CG2' ' NH1' ' A' ' 87' ' ' ARG . 5.7 t -151.84 129.39 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 107.525 -1.287 . . . . 0.38 107.525 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' LYS . 2.0 mm100 -134.39 157.79 45.52 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.964 0.888 . . . . 1.31 111.577 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tt -97.57 113.45 25.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.45 -0.944 . . . . 0.49 108.45 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -23.31 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.122 -0.986 . . . . 1.35 109.318 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.11 157.2 5.07 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.676 -1.21 . . . . 1.2 109.718 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.746 HG13 HG13 ' B' ' 66' ' ' VAL . 7.9 p -163.42 133.11 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.356 -0.84 . . . . 0.85 109.614 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.464 ' CG ' ' N ' ' A' ' 68' ' ' THR . 32.7 tt0 -145.9 163.12 36.11 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.271 1.034 . . . . 1.41 111.271 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.68 ' OG1' HD11 ' B' ' 83' ' ' LEU . 0.0 OUTLIER -138.74 149.0 44.58 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.654 -0.869 . . . . 0.52 108.654 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.662 ' O ' ' CD2' ' A' ' 80' ' ' TYR . . . -174.42 160.42 29.89 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 107.701 -2.16 . . . . 0.4 107.701 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.533 ' OG ' ' ND2' ' B' ' 51' ' ' ASN . 40.0 p -102.02 158.85 15.85 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 118.777 1.288 . . . . 0.42 110.583 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 72' ' ' VAL . 0.8 OUTLIER -154.23 173.96 15.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 1.29 110.312 178.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.9 138.45 19.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.611 0.72 . . . . 1.02 111.262 -178.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 1.0 OUTLIER -148.16 101.77 3.3 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.045 -0.724 . . . . 2.23 109.045 177.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 4.0 t70 86.41 36.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.181 0.515 . . . . 1.38 110.144 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.68 30.7 6.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.25 -0.906 . . . . 2.62 109.338 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.18 151.62 32.15 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.244 -0.91 . . . . 3.15 109.477 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -85.3 137.98 32.61 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.566 1.174 . . . . 2.44 109.598 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 tt -143.35 155.91 16.8 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 114.925 -1.034 . . . . 0.23 108.549 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.0 p -90.35 155.8 18.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.986 0.898 . . . . 0.74 111.44 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.662 ' CD2' ' O ' ' A' ' 69' ' ' GLY . 6.1 p90 -142.48 148.38 37.6 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.79 -0.641 . . . . 4.16 109.977 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.662 HG21 HG21 ' B' ' 81' ' ' ILE . 2.0 pp -123.12 133.72 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.184 -1.043 . . . . 0.92 108.184 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 80' ' ' TYR . 16.2 mt -106.89 126.06 51.82 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.437 -0.949 . . . . 0.36 108.437 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.818 HD11 ' OG1' ' B' ' 68' ' ' THR . 0.5 OUTLIER -131.52 123.7 28.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.981 -1.075 . . . . 0.98 111.025 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -102.46 165.58 11.02 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.197 -0.91 . . . . 0.58 110.372 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 50' ' ' TYR . 2.5 tp -157.67 144.68 18.18 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 119.302 -0.959 . . . . 1.39 111.423 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -126.4 143.69 51.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.17 0.509 . . . . 1.42 110.326 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' NH1' ' CG2' ' A' ' 61' ' ' VAL . 20.3 mmt180 -96.9 139.05 33.51 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.379 -0.826 . . . . 1.64 110.049 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 88' ' ' VAL . 51.4 t -117.14 -9.66 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.791 -0.818 . . . . 0.63 108.791 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 117.977 -1.011 . . . . 1.76 109.511 179.577 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.376 0.607 . . . . 6.35 109.515 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.07 136.57 21.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 2.42 109.153 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -157.77 -84.9 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.993 -1.114 . . . . 1.68 107.993 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.0 58.1 0.6 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.518 -0.919 . . . . 2.31 108.518 178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 8.1 tp -163.92 157.65 18.88 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.357 -1.349 . . . . 1.62 107.357 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.518 HD22 HD11 ' B' ' 8' ' ' ILE . 1.4 t30 179.12 91.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.574 -1.329 . . . . 1.46 110.664 176.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' B' ' 7' ' ' GLU . 3.0 pt-20 -94.01 107.37 19.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.661 -1.274 . . . . 1.49 107.724 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.518 HD11 HD22 ' B' ' 6' ' ' ASN . 0.2 OUTLIER -120.44 146.33 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 122.205 1.002 . . . . 1.17 110.884 -178.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.491 ' O ' HG13 ' B' ' 9' ' ' VAL . 10.0 p -99.19 124.53 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.86 -0.609 . . . . 1.37 109.375 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.43 166.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.376 -0.972 . . . . 0.37 108.376 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -136.9 168.34 19.75 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.815 0.817 . . . . 2.37 110.927 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -87.62 -11.36 48.75 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.899 -0.778 . . . . 1.75 108.899 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . 0.416 HG22 ' H ' ' B' ' 13' ' ' THR . 0.1 OUTLIER -76.23 -64.21 1.15 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.436 -1.306 . . . . 1.19 107.806 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.408 ' H ' HG23 ' B' ' 13' ' ' THR . 0.0 OUTLIER -58.08 146.72 32.06 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.906 -1.121 . . . . 1.47 109.813 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.91 -179.8 6.26 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.049 -0.723 . . . . 1.22 109.049 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.474 ' HA ' HG22 ' B' ' 49' ' ' VAL . 2.4 m -76.75 -32.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.335 -0.987 . . . . 0.45 108.335 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -81.04 -33.71 33.33 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.648 -0.871 . . . . 1.7 108.648 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -67.32 -28.32 67.89 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.742 -1.224 . . . . 1.46 109.843 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.789 ' O ' HG23 ' B' ' 23' ' ' VAL . 0.1 OUTLIER -91.37 -18.18 24.67 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.385 -1.447 . . . . 1.4 108.644 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.96 -29.39 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 104.98 -2.23 . . . . 0.34 104.98 176.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.704 ' O ' HG23 ' B' ' 25' ' ' VAL . 34.9 mt -69.78 -50.75 40.1 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.498 -1.228 . . . . 0.38 108.52 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -65.82 -26.37 67.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.796 -1.19 . . . . 1.21 109.335 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.789 HG23 ' O ' ' B' ' 19' ' ' HIS . 77.2 t -74.71 -54.76 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.945 . . . . 0.3 109.719 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.649 HD12 ' NH2' ' B' ' 87' ' ' ARG . 3.9 tp -57.72 -19.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.064 -1.022 . . . . 0.69 108.574 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.704 HG23 ' O ' ' B' ' 21' ' ' LEU . 50.4 t -70.83 -41.59 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.185 -0.947 . . . . 0.42 109.48 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.597 HD23 ' N ' ' B' ' 26' ' ' LEU . 0.3 OUTLIER -70.06 -37.99 75.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.539 -1.35 . . . . 1.15 109.766 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.08 -29.36 67.28 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.608 -1.627 . . . . 1.46 106.608 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -25.59 65.98 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.035 -0.984 . . . . 1.17 108.986 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -90.41 -7.17 53.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.959 . . . . 1.17 109.194 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.01 15.07 10.27 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.287 -1.125 . . . . 0.38 110.287 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 40.4 mm -76.74 106.26 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.781 -1.423 . . . . 0.59 108.471 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.7 -36.46 14.32 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.36 -0.838 . . . . 1.46 110.178 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -102.49 141.72 34.86 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.55 0.69 . . . . 1.2 110.582 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.415 HG13 ' OH ' ' B' ' 50' ' ' TYR . 11.6 p -151.66 141.94 15.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 119.504 -0.878 . . . . 0.49 110.72 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.2 120.96 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 109.613 -0.514 . . . . 0.31 109.613 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.672 HD22 ' CE1' ' B' ' 50' ' ' TYR . 1.4 mp -106.65 131.96 53.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.565 -0.71 . . . . 0.48 110.529 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.31 127.15 49.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.338 -0.986 . . . . 2.74 108.338 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.28 141.64 12.82 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.993 -1.099 . . . . 0.24 110.443 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.57 ' O ' ' N ' ' B' ' 41' ' ' ARG . 62.4 p -131.68 137.14 48.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.636 -0.92 . . . . 0.49 111.42 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' B' ' 39' ' ' THR . . . 35.81 -84.9 0.01 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 111.793 -0.523 . . . . 0.28 111.793 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -82.3 -54.69 5.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.917 -1.343 . . . . 3.16 109.767 -178.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -16.66 11.65 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.574 -1.269 . . . . 1.38 107.574 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.6 HG12 HG23 ' B' ' 81' ' ' ILE . 0.3 OUTLIER -55.64 -33.46 33.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.214 -0.929 . . . . 0.85 110.368 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.17 -22.44 36.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.121 -0.987 . . . . 1.12 108.648 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.703 ' O ' HG23 ' B' ' 49' ' ' VAL . 1.2 mptt -68.07 -71.86 0.2 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.326 -1.361 . . . . 1.87 107.326 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.589 ' HA ' HD23 ' B' ' 36' ' ' LEU . . . -37.12 -47.56 0.76 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.05 0.452 . . . . 0.26 110.555 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.11 -61.35 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.096 -1.003 . . . . 0.28 109.034 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . 0.46 ' OD1' HG21 ' B' ' 16' ' ' VAL . 10.7 t70 -56.4 -49.73 73.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.291 -0.881 . . . . 1.25 109.149 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.703 HG23 ' O ' ' B' ' 45' ' ' LYS . 61.3 t -46.2 -56.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.411 -0.959 . . . . 1.06 108.411 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.672 ' CE1' HD22 ' B' ' 36' ' ' LEU . 2.9 m-30 -64.54 -54.45 31.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.5 -0.75 . . . . 4.11 110.75 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.533 ' ND2' ' OG ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -50.77 -52.52 40.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.616 -1.303 . . . . 1.41 108.398 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.42 ' OG ' ' OD1' ' B' ' 48' ' ' ASP . 1.1 m -59.88 -30.21 68.84 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.649 -0.82 . . . . 0.65 109.522 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.453 HD11 ' NH2' ' B' ' 87' ' ' ARG . 27.7 tp -74.07 -23.62 59.39 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.966 -1.084 . . . . 0.53 109.55 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . 0.407 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -82.26 -30.47 30.66 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 106.664 -1.606 . . . . 0.99 106.664 178.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -14.67 6.31 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.752 -1.203 . . . . 1.46 107.752 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.407 ' N ' ' C ' ' B' ' 54' ' ' LYS . 20.5 mmm180 -73.29 -42.85 61.95 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.587 -0.845 . . . . 1.71 109.626 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.7 mt -153.32 -21.05 0.15 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.117 -1.433 . . . . 1.77 112.678 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.21 -62.0 0.06 OUTLIER Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.187 -1.482 . . . . 0.39 110.212 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -67.74 -38.39 83.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.259 -1.142 . . . . 1.4 109.555 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.83 28.2 6.7 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.07 -1.612 . . . . 0.34 109.07 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.541 HG13 HD21 ' B' ' 85' ' ' LEU . 4.0 t -153.96 132.31 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.554 -1.276 . . . . 0.46 107.554 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 86' ' ' LYS . 1.7 mm100 -135.55 154.16 51.46 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.876 0.846 . . . . 1.42 111.608 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 tt -94.43 118.57 31.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.482 -0.933 . . . . 0.54 108.482 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.66 -17.82 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.815 . . . . 1.43 110.551 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -178.4 157.29 1.01 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.651 -1.281 . . . . 1.28 109.458 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.746 HG13 HG13 ' A' ' 66' ' ' VAL . 2.6 p -165.26 136.83 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.408 -0.807 . . . . 0.9 109.353 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . 0.436 ' CG ' ' N ' ' B' ' 68' ' ' THR . 33.1 tt0 -148.48 165.17 31.99 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.424 1.107 . . . . 1.44 111.546 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.818 ' OG1' HD11 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -138.44 152.02 47.97 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.207 -0.906 . . . . 0.45 108.56 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.66 ' O ' ' CD2' ' B' ' 80' ' ' TYR . . . -176.96 157.36 22.35 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.261 -2.336 . . . . 0.29 107.261 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.583 ' H ' ' CG ' ' A' ' 51' ' ' ASN . 59.6 p -96.1 159.05 15.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.903 -1.351 . . . . 0.39 109.41 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -154.03 172.39 17.57 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.002 -1.061 . . . . 1.49 109.95 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.448 HG23 ' H ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -89.52 134.02 29.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.768 -0.773 . . . . 0.87 110.64 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 0.0 OUTLIER -143.58 100.4 3.59 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.303 -0.628 . . . . 2.18 109.303 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 2.7 t70 79.82 41.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.825 -0.547 . . . . 1.35 109.888 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.14 26.31 10.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.34 -0.85 . . . . 2.57 109.267 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.18 154.93 38.85 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.426 -0.796 . . . . 3.14 109.341 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -88.72 136.53 32.96 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.209 -0.996 . . . . 2.39 111.29 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.74 154.02 33.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.104 -1.073 . . . . 0.58 108.104 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.32 152.57 22.64 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.552 -0.717 . . . . 0.61 109.809 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.66 ' CD2' ' O ' ' B' ' 69' ' ' GLY . 5.8 p90 -142.51 146.67 34.94 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.768 -0.773 . . . . 4.08 109.992 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 81' ' ' ILE . 2.0 pp -120.64 133.59 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.016 -1.105 . . . . 0.9 108.016 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' B' ' 80' ' ' TYR . 13.2 mt -109.24 122.74 47.98 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.336 -1.357 . . . . 0.37 107.336 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.68 HD11 ' OG1' ' A' ' 68' ' ' THR . 0.4 OUTLIER -128.67 127.22 41.72 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.088 -1.045 . . . . 0.98 110.921 -178.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -102.02 169.32 8.83 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.494 -0.775 . . . . 0.71 109.456 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.541 HD21 HG13 ' B' ' 61' ' ' VAL . 1.7 tp -160.45 140.22 11.12 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.288 -0.965 . . . . 1.44 110.24 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' B' ' 62' ' ' GLN . 0.1 OUTLIER -123.11 146.39 47.76 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.528 -0.545 . . . . 1.31 109.528 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.649 ' NH2' HD12 ' B' ' 24' ' ' ILE . 20.4 mmt180 -98.48 136.2 38.95 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.836 . . . . 1.64 110.216 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.511 ' O ' HG12 ' B' ' 88' ' ' VAL . 23.2 t -113.4 -7.61 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.587 -0.894 . . . . 0.68 108.587 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 117.941 -1.028 . . . . 1.77 109.48 179.559 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtt . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.321 -0.622 . . . . 6.33 109.321 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 2' ' ' THR . 14.7 m -133.18 33.25 3.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.616 -0.677 . . . . 2.53 109.708 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 30' ' ' GLY . 1.5 mt-10 -83.31 -4.21 58.23 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.243 -0.911 . . . . 1.75 109.29 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 1.8 ptmt -160.62 55.61 0.32 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.103 -0.998 . . . . 2.24 109.103 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tp -174.01 46.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.312 -0.868 . . . . 1.67 109.087 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.734 ' ND2' HD13 ' A' ' 26' ' ' LEU . 50.0 t30 -90.55 112.2 23.8 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.188 -0.945 . . . . 1.72 111.123 -177.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 7' ' ' GLU . 9.9 pt-20 -91.91 119.47 31.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.893 -1.13 . . . . 1.44 109.045 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.533 HD11 HD21 ' A' ' 6' ' ' ASN . 3.5 mm -124.42 147.99 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 CA-C-O 122.32 1.057 . . . . 1.11 112.091 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.3 t -111.6 130.31 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.783 0.801 . . . . 1.35 109.959 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.585 HG11 ' H ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -88.33 161.47 2.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.257 -1.016 . . . . 0.39 108.257 -178.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HD2' ' HZ3' ' A' ' 14' ' ' LYS . 1.5 mtt-85 -132.9 166.41 22.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.234 -0.916 . . . . 2.27 110.321 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -25.26 39.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.739 -0.837 . . . . 1.78 108.739 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.8 p -68.61 -63.04 1.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.224 -1.769 . . . . 1.24 106.224 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 11.9 mptt -55.42 131.93 47.07 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.068 0.937 . . . . 1.41 110.123 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -72.12 180.0 3.07 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.592 0.71 . . . . 1.25 110.002 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 17' ' ' GLU . 4.0 m -73.45 -33.68 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.443 -1.317 . . . . 0.49 107.443 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 3.7 tt0 -72.65 -37.48 67.97 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.358 -0.979 . . . . 1.56 108.358 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -31.42 67.14 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.035 -1.041 . . . . 1.38 111.439 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.735 ' O ' HG23 ' A' ' 23' ' ' VAL . 54.3 m-70 -93.69 -17.33 23.33 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.217 -1.552 . . . . 1.43 108.66 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -34.14 59.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 104.296 -2.483 . . . . 0.29 104.296 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 25' ' ' VAL . 66.6 mt -70.45 -51.14 31.45 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.72 -1.127 . . . . 0.41 109.362 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.86 -30.94 71.24 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.888 -1.133 . . . . 1.22 109.298 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 19' ' ' HIS . 53.4 t -70.62 -55.22 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -0.86 . . . . 0.32 109.822 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.3 tt -60.85 -19.77 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.939 -1.101 . . . . 0.58 108.594 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 21' ' ' LEU . 5.2 t -73.39 -42.99 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.211 -0.931 . . . . 0.41 108.961 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.734 HD13 ' ND2' ' A' ' 6' ' ' ASN . 4.3 mt -65.61 -34.88 79.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.773 -1.204 . . . . 1.19 110.102 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -64.39 -26.22 68.37 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.319 -1.363 . . . . 1.46 107.319 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -26.92 68.71 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.309 -0.86 . . . . 1.15 109.646 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -90.26 1.77 56.15 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.909 -1.119 . . . . 1.17 109.402 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 101.65 13.81 31.38 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.201 -1.559 . . . . 0.42 109.201 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.444 ' CD1' ' O ' ' A' ' 2' ' ' THR . 10.7 mm -75.57 109.27 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.252 -1.146 . . . . 0.35 108.007 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -99.87 6.51 45.3 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.251 -0.906 . . . . 1.55 110.736 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' A' ' 4' ' ' LYS . 7.6 mt-10 -146.43 147.1 30.89 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.929 -1.107 . . . . 1.58 108.936 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.53 142.02 11.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 118.786 -1.166 . . . . 0.54 111.017 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -114.42 120.61 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.634 -0.712 . . . . 0.25 109.312 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 46' ' ' ALA . 4.2 mp -105.21 121.31 43.58 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.978 -0.689 . . . . 0.4 109.812 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -108.03 133.18 52.7 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.89 -0.782 . . . . 2.74 108.89 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' O ' ' CD1' ' A' ' 80' ' ' TYR . . . -144.31 157.19 27.1 Favored Glycine 0 N--CA 1.503 3.114 0 C-N-CA 119.879 -1.153 . . . . 0.21 111.539 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.56 ' CG2' ' CD2' ' A' ' 80' ' ' TYR . 10.2 p -137.88 145.23 41.9 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.582 -0.952 . . . . 0.56 112.856 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.562 ' O ' HG22 ' A' ' 43' ' ' ILE . . . 38.38 -87.26 0.01 OUTLIER Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.687 -0.965 . . . . 0.33 110.687 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.675 ' HE ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -80.22 -52.59 7.56 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.327 -1.102 . . . . 3.09 109.829 -178.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.75 -19.61 64.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.892 -1.13 . . . . 1.09 109.145 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 40' ' ' GLY . 7.1 tt -54.71 -35.49 33.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.142 -0.974 . . . . 0.87 111.202 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.432 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.32 -22.71 32.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.953 -1.092 . . . . 1.14 108.875 -178.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' O ' HG12 ' A' ' 49' ' ' VAL . 1.3 mptt -63.47 -69.34 0.28 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.069 -2.196 . . . . 1.86 105.069 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' H ' HG11 ' A' ' 10' ' ' VAL . . . -34.22 -38.1 0.06 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.479 0.657 . . . . 0.29 109.843 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.764 HG13 ' HB ' ' B' ' 68' ' ' THR . 99.0 t -74.01 -73.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.243 -0.91 . . . . 0.22 109.546 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -40.41 -53.21 2.66 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.351 0.596 . . . . 1.26 111.103 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 50' ' ' TYR . 13.2 p -55.7 -47.64 78.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.318 -0.864 . . . . 1.06 109.486 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.633 ' CD2' ' N ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -61.37 -54.86 38.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.665 -1.272 . . . . 4.02 109.284 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.633 ' N ' ' CD2' ' A' ' 50' ' ' TYR . 27.9 t-20 -56.22 -48.55 76.24 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.546 -1.279 . . . . 1.34 107.546 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.6 m -60.72 -32.7 71.95 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.915 -1.143 . . . . 1.04 107.915 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.548 HD22 HG11 ' A' ' 23' ' ' VAL . 10.5 tp -80.69 -20.85 42.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.64 -1.244 . . . . 0.44 107.64 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.14 -46.49 14.83 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.906 -1.887 . . . . 1.0 105.906 177.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -57.66 -6.53 0.52 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.772 -1.195 . . . . 1.58 107.772 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -70.1 -50.42 41.01 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 121.427 -0.796 . . . . 1.69 109.251 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 59' ' ' ASP . 1.2 mt -152.19 -16.71 0.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.169 -1.013 . . . . 1.66 110.748 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.53 -50.48 0.07 OUTLIER Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.75 -1.214 . . . . 0.39 110.609 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -74.62 -47.1 34.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -1.176 . . . . 1.38 110.35 -178.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.68 27.17 3.41 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.748 -1.741 . . . . 0.26 108.748 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -154.23 136.25 6.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.26 -1.141 . . . . 0.38 108.267 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.718 ' O ' HD23 ' A' ' 85' ' ' LEU . 6.0 mm-40 -138.91 153.92 48.3 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 122.465 1.126 . . . . 1.31 112.257 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.561 HD11 HG21 ' A' ' 66' ' ' VAL . 6.9 tt -95.85 109.15 21.54 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.155 -1.424 . . . . 0.49 107.155 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.01 -23.79 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.163 -0.961 . . . . 1.35 110.045 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -168.61 156.26 7.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.31 -1.494 . . . . 1.2 109.513 177.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 63' ' ' LEU . 74.1 t -161.15 131.49 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.91 -0.774 . . . . 0.85 108.91 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 68' ' ' THR . 19.1 tt0 -143.2 158.38 43.67 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.998 0.904 . . . . 1.41 110.612 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.469 ' N ' ' CG ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -109.25 165.54 11.54 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.578 0.704 . . . . 0.52 109.356 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 80' ' ' TYR . . . -169.83 176.38 43.67 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.729 -1.348 . . . . 0.4 109.729 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.434 ' OG ' ' OD1' ' B' ' 51' ' ' ASN . 10.9 p -153.0 152.9 31.91 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.906 -1.146 . . . . 0.42 107.906 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -160.24 176.91 11.19 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.045 -1.034 . . . . 1.29 109.908 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -89.34 139.91 16.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 119.589 -0.844 . . . . 1.02 110.435 -178.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 52.1 ttt180 -146.23 98.89 3.16 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.805 -0.813 . . . . 2.23 108.805 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' ARG . 8.3 t0 88.87 34.58 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.334 0.588 . . . . 1.38 109.562 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.93 38.87 6.18 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.293 1.044 . . . . 2.62 109.367 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -157.66 151.63 24.32 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.594 -0.891 . . . . 3.15 108.594 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -84.77 138.55 32.54 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.848 1.308 . . . . 2.44 110.757 -177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 tt -139.07 152.63 24.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 114.271 -1.332 . . . . 0.23 107.592 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 p -88.33 162.87 16.33 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.204 1.002 . . . . 0.74 111.53 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.56 ' CD2' ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -139.72 138.52 36.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.38 -0.827 . . . . 4.16 109.692 -177.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.7 tt -119.04 129.48 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.858 -1.164 . . . . 0.92 107.858 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 67' ' ' GLN . 14.9 mt -108.71 119.17 38.75 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.929 -1.508 . . . . 0.36 106.929 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.1 tt -127.02 127.16 44.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.235 -0.916 . . . . 0.98 110.647 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 14.4 ttt180 -99.92 172.21 7.37 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.98 -0.554 . . . . 0.58 109.681 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 62' ' ' GLN . 3.0 mt -161.24 145.03 13.07 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.555 -0.858 . . . . 1.39 110.094 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 62' ' ' GLN . 5.3 tmtm? -131.21 157.39 43.34 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.565 -0.531 . . . . 1.42 109.565 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -113.56 139.41 49.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.438 -0.789 . . . . 1.64 109.72 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 88' ' ' VAL . 48.8 t -116.2 -5.09 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.038 -0.727 . . . . 0.63 109.038 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 118.043 -0.979 . . . . 1.76 109.597 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.52 -0.548 . . . . 6.35 109.52 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.426 HG22 ' O ' ' B' ' 2' ' ' THR . 10.3 m -95.69 34.78 1.45 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 2.42 109.079 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.99 -73.63 0.17 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.385 -0.822 . . . . 1.68 109.974 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.423 ' O ' ' OE1' ' B' ' 33' ' ' GLU . 0.0 OUTLIER -93.64 63.41 3.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.632 -1.293 . . . . 2.31 109.543 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -161.62 153.77 19.63 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.68 -1.6 . . . . 1.62 106.68 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.742 ' ND2' HD13 ' B' ' 26' ' ' LEU . 1.2 t30 179.76 93.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.623 -1.298 . . . . 1.46 110.772 177.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -89.7 103.55 16.19 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.339 -1.475 . . . . 1.49 107.875 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mm -114.34 139.86 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.738 0.78 . . . . 1.17 109.78 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 66.9 t -104.19 129.0 57.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.594 0.711 . . . . 1.37 109.614 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.554 HG11 ' H ' ' B' ' 46' ' ' ALA . 0.3 OUTLIER -88.38 162.78 2.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.148 -1.056 . . . . 0.37 108.148 -178.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -138.0 171.79 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 2.37 110.183 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.8 -9.64 39.74 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.463 -0.94 . . . . 1.75 108.463 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . . . . . . . . . 33.5 p -89.41 -6.1 56.84 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.739 -0.785 . . . . 1.19 109.038 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -97.6 -132.92 0.22 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.627 -1.249 . . . . 1.47 107.627 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -168.15 167.07 12.61 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.882 -0.784 . . . . 1.22 108.882 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.422 ' CG2' ' N ' ' B' ' 17' ' ' GLU . 3.0 m -66.43 -36.6 77.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.754 -1.202 . . . . 0.45 107.754 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 4.8 mm-40 -73.73 -39.94 63.92 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.328 -0.99 . . . . 1.7 108.328 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -60.87 -31.95 71.4 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.173 -0.954 . . . . 1.46 111.917 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.744 ' O ' HG23 ' B' ' 23' ' ' VAL . 49.1 m-70 -92.99 -17.54 23.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 119.835 -1.791 . . . . 1.4 108.907 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -33.84 55.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 104.427 -2.435 . . . . 0.34 104.427 176.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.553 ' O ' HG23 ' B' ' 25' ' ' VAL . 52.6 mt -68.72 -51.7 38.64 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.648 -1.16 . . . . 0.38 109.058 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.04 -31.48 72.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 1.21 109.729 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.744 HG23 ' O ' ' B' ' 19' ' ' HIS . 52.9 t -69.68 -55.91 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.3 109.837 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 20.9 tt -61.32 -20.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.067 -1.021 . . . . 0.69 108.873 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 21' ' ' LEU . 4.8 t -71.11 -42.95 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.42 109.098 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.742 HD13 ' ND2' ' B' ' 6' ' ' ASN . 5.0 mt -65.73 -41.44 92.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.854 -1.154 . . . . 1.15 109.739 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -58.05 -29.95 65.79 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.211 -1.403 . . . . 1.46 107.211 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -28.34 65.43 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.477 -0.783 . . . . 1.17 108.899 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -89.55 -1.23 57.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 1.17 109.368 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.92 15.01 23.39 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.57 -1.412 . . . . 0.38 109.57 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 45.6 mm -78.56 108.17 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -1.162 . . . . 0.59 108.82 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -92.77 -36.5 12.85 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.26 -0.9 . . . . 1.46 110.226 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' B' ' 4' ' ' LYS . 6.5 mt-10 -101.54 143.37 31.61 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.577 0.703 . . . . 1.2 110.905 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' B' ' 6' ' ' ASN . 9.8 p -154.57 143.04 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 119.554 -0.858 . . . . 0.49 111.026 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.54 123.2 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.223 0.535 . . . . 0.31 109.87 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.95 121.08 42.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.738 -0.602 . . . . 0.48 109.991 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -106.75 129.84 54.56 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.37 -0.604 . . . . 2.74 109.37 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' B' ' 80' ' ' TYR . . . -143.49 156.43 26.57 Favored Glycine 0 N--CA 1.507 3.385 0 C-N-CA 119.662 -1.256 . . . . 0.24 111.76 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.602 ' CG2' ' CD2' ' B' ' 80' ' ' TYR . 1.8 p -137.95 145.97 42.65 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.481 -1.011 . . . . 0.49 112.916 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.566 ' O ' HG22 ' B' ' 43' ' ' ILE . . . 37.68 -86.1 0.01 OUTLIER Glycine 0 N--CA 1.499 2.869 0 N-CA-C 110.571 -1.012 . . . . 0.28 110.571 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.67 ' HE ' ' N ' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -80.71 -52.99 6.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.359 -1.083 . . . . 3.16 109.792 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -19.53 65.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.956 -1.09 . . . . 1.38 109.535 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.566 HG22 ' O ' ' B' ' 40' ' ' GLY . 7.1 tt -56.01 -31.6 31.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.905 -1.122 . . . . 0.85 109.818 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -24.6 33.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 1.12 108.656 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.492 ' O ' HG12 ' B' ' 49' ' ' VAL . 2.2 mptt -65.04 -70.84 0.21 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.642 -1.985 . . . . 1.87 105.642 177.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.554 ' H ' HG11 ' B' ' 10' ' ' VAL . . . -32.37 -40.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.25 0.548 . . . . 0.26 110.527 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 43' ' ' ILE . 94.6 t -79.13 -64.5 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.111 -0.993 . . . . 0.28 110.011 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -44.97 -52.95 8.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.347 -0.846 . . . . 1.25 109.952 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.583 HG13 ' N ' ' B' ' 50' ' ' TYR . 11.1 p -55.58 -46.62 79.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.576 -0.849 . . . . 1.06 109.204 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.643 ' CD2' ' N ' ' B' ' 51' ' ' ASN . 0.0 OUTLIER -62.81 -54.89 32.0 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.91 -1.119 . . . . 4.11 109.162 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.643 ' N ' ' CD2' ' B' ' 50' ' ' TYR . 23.3 t-20 -53.83 -47.64 70.71 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.271 -1.381 . . . . 1.41 107.271 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -63.62 -31.57 72.77 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.194 -1.002 . . . . 0.65 109.141 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.494 HD22 HG11 ' B' ' 23' ' ' VAL . 13.7 tp -73.49 -23.2 60.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.054 -1.029 . . . . 0.53 109.774 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . 0.407 ' C ' ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -83.18 -30.57 27.69 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.47 -1.678 . . . . 0.99 106.47 177.435 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.46 -14.6 3.17 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.745 -1.206 . . . . 1.46 107.745 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.407 ' N ' ' C ' ' B' ' 54' ' ' LYS . 1.0 OUTLIER -71.61 -47.41 54.85 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.532 -0.867 . . . . 1.71 109.559 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' LEU . . . . . 0.605 ' O ' ' N ' ' B' ' 59' ' ' ASP . 1.7 mt -155.11 -15.24 0.11 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.99 -1.484 . . . . 1.77 112.638 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.33 -57.52 0.07 OUTLIER Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.22 -1.466 . . . . 0.39 110.219 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.605 ' N ' ' O ' ' B' ' 57' ' ' LEU . 0.2 OUTLIER -71.05 -44.24 66.19 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.298 -1.119 . . . . 1.4 110.089 -179.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.65 25.74 5.01 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.231 -1.548 . . . . 0.34 109.231 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 22.6 t -154.6 135.42 4.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.0 -1.111 . . . . 0.46 108.0 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.719 ' O ' HD23 ' B' ' 85' ' ' LEU . 5.4 mm-40 -140.86 154.39 46.16 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.534 1.159 . . . . 1.42 112.422 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.446 HD11 HG21 ' B' ' 66' ' ' VAL . 6.5 tt -96.16 114.48 26.18 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.898 -1.047 . . . . 0.54 108.285 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.88 -13.69 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 119.54 -0.864 . . . . 1.43 110.763 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -177.69 151.43 0.72 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.06 -1.65 . . . . 1.28 110.63 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.446 HG21 HD11 ' B' ' 63' ' ' LEU . 63.1 t -158.22 135.43 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.554 -0.717 . . . . 0.9 109.341 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' GLN . . . . . 0.508 ' HB3' HD12 ' B' ' 82' ' ' LEU . 36.0 tt0 -143.99 160.14 41.37 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.016 0.913 . . . . 1.44 111.579 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.764 ' HB ' HG13 ' A' ' 47' ' ' VAL . 6.5 p -117.87 163.7 16.14 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.459 -0.791 . . . . 0.45 109.025 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' B' ' 80' ' ' TYR . . . 177.76 134.61 2.08 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.717 -1.353 . . . . 0.29 109.717 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.645 ' CB ' ' HE ' ' B' ' 77' ' ' ARG . 65.3 p -91.95 156.3 17.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.292 -1.711 . . . . 0.39 109.513 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -150.65 164.48 35.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 1.49 110.088 -179.066 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.568 ' N ' ' OE1' ' B' ' 71' ' ' GLU . 0.1 OUTLIER -88.74 136.23 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.185 -0.947 . . . . 0.87 110.295 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 74' ' ' ASP . 49.2 ttt180 -148.06 101.93 3.33 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.187 -0.946 . . . . 2.18 109.661 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' B' ' 73' ' ' ARG . 6.7 t0 86.13 34.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.694 -0.854 . . . . 1.35 108.694 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.7 34.47 9.62 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.094 0.949 . . . . 2.57 108.601 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -152.98 150.28 29.06 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.601 -0.888 . . . . 3.14 108.601 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.645 ' HE ' ' CB ' ' B' ' 70' ' ' SER . 4.2 ttt85 -87.04 140.67 29.32 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.525 1.155 . . . . 2.39 111.218 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 10.3 tt -136.79 153.68 30.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.713 -1.218 . . . . 0.58 107.713 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.32 155.49 21.31 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.221 -0.924 . . . . 0.61 109.711 -176.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.602 ' CD2' ' CG2' ' B' ' 39' ' ' THR . 0.1 OUTLIER -137.56 138.03 39.17 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.209 -0.663 . . . . 4.08 109.209 -177.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.525 HG23 ' O ' ' B' ' 81' ' ' ILE . 1.3 tt -120.56 130.59 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.297 -1.001 . . . . 0.9 108.297 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' B' ' 67' ' ' GLN . 3.7 mt -108.28 119.21 38.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.469 -1.678 . . . . 0.37 106.469 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tt -124.63 126.09 45.19 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.511 -0.876 . . . . 0.98 110.721 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -97.14 171.54 8.39 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.757 -0.831 . . . . 0.71 108.757 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.719 HD23 ' O ' ' B' ' 62' ' ' GLN . 2.4 mt -160.41 141.6 12.16 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.559 -0.857 . . . . 1.44 109.352 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' B' ' 62' ' ' GLN . 9.2 tttm -127.26 148.11 50.22 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.019 0.437 . . . . 1.31 110.188 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -106.0 137.76 43.36 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.505 -0.747 . . . . 1.64 109.421 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.489 ' O ' HG12 ' B' ' 88' ' ' VAL . 75.7 t -116.2 -4.45 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.061 -0.718 . . . . 0.68 109.061 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 118.077 -0.963 . . . . 1.77 109.473 179.363 . . . . . . . . 1 1 . 1 stop_ save_